data_1pfh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1pfh _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -81.2 126.78 31.93 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.339 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -123.76 123.52 40.68 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 113.702 -1.59 . . . . 0.0 111.461 -175.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -129.91 110.46 11.71 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 125.134 1.521 . . . . 0.0 112.997 168.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -83.53 106.25 15.11 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.354 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.4 m -115.51 144.5 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 114.141 -1.391 . . . . 0.0 113.655 -173.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.6 p -103.63 118.4 36.64 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 113.868 -1.515 . . . . 0.0 111.308 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.0 mt -74.22 113.53 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.653 172.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 p -96.07 -23.15 16.92 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.22 133.56 94.33 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 124.383 1.073 . . . . 0.0 112.082 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -53.17 -55.93 3.22 Favored 'Trans proline' 0 N--CA 1.481 0.752 0 C-N-CA 124.365 3.377 . . . . 0.0 113.755 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -67.58 -37.31 82.42 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.12 0.968 . . . . 0.0 112.874 176.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.37 -128.01 9.14 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.8 mt . . . . . 0 N--CA 1.478 0.931 0 CA-C-N 113.827 -1.186 . . . . 0.0 113.039 171.094 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.2 p . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.346 15.7 mmt180 -87.17 -45.47 0.52 Allowed Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 118.017 2.599 . . . . 0.0 118.017 -175.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -59.01 -33.14 98.65 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 CA-C-N 122.655 1.984 . . . . 0.0 111.751 165.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.67 -48.29 77.93 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.149 0.98 . . . . 0.0 113.46 165.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.01 -38.81 90.03 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.23 -43.0 99.81 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 169.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -58.89 -42.22 89.02 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 124.375 1.047 . . . . 0.0 111.348 172.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 66.8 t -57.28 -52.0 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 123.971 0.909 . . . . 0.0 111.032 171.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -53.45 -46.51 69.92 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 124.029 0.831 . . . . 0.0 112.08 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -66.9 -44.96 79.43 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.199 0.999 . . . . 0.0 113.221 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.17 -37.23 76.85 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 124.312 1.045 . . . . 0.0 113.681 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -59.42 -22.15 61.01 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 171.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.21 -20.16 74.74 Favored Glycine 0 N--CA 1.487 2.054 0 O-C-N 124.973 1.421 . . . . 0.0 114.663 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -98.18 148.85 23.16 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.18 0.592 . . . . 0.0 112.387 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.1 p -68.5 -43.37 76.99 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.962 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.0 p -61.1 161.57 8.43 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.816 1.246 . . . . 0.0 113.086 170.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -116.48 102.4 9.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 122.304 1.049 . . . . 0.0 111.979 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.1 mm -65.25 106.75 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 112.392 -2.185 . . . . 0.0 111.894 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.0 p -94.25 122.19 36.53 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.573 1.178 . . . . 0.0 109.984 167.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.6 t -104.41 107.09 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 111.95 -2.386 . . . . 0.0 107.848 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.3 m -96.25 113.39 24.99 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.098 -1.864 . . . . 0.0 111.627 -174.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 t -129.01 121.68 28.45 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.594 172.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 p30 37.94 64.44 0.68 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 125.18 1.55 . . . . 0.0 114.419 -170.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.45 -33.92 1.57 Allowed Glycine 0 N--CA 1.486 1.991 0 CA-C-N 113.636 -1.62 . . . . 0.0 114.509 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -68.51 88.69 0.34 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.315 1.046 . . . . 0.0 112.107 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.9 m -77.28 99.9 5.67 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 113.223 -1.808 . . . . 0.0 111.882 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.95 123.53 46.02 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.46 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.5 t -58.98 103.85 0.2 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.785 168.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.57 -32.33 70.26 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.331 175.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -65.96 -24.69 66.85 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.827 0.851 . . . . 0.0 112.254 174.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.8 t -94.26 111.1 22.82 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 123.104 1.43 . . . . 0.0 112.608 170.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.6 tp -32.54 -73.35 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.934 2.494 . . . . 0.0 116.13 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -64.87 -30.21 71.2 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -62.8 -48.29 79.77 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.603 0.761 . . . . 0.0 111.638 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.3 tp -69.48 -46.58 66.3 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 124.251 0.97 . . . . 0.0 113.066 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -52.61 -32.0 39.38 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 t -114.35 24.01 12.31 Favored 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.8 tp -70.35 -48.06 58.13 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.374 -0.829 . . . . 0.0 112.259 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.08 87.35 1.36 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.51 87.24 2.72 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.708 -0.746 . . . . 0.0 111.925 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -135.09 176.14 8.94 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.238 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -58.33 116.34 3.54 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.457 1.103 . . . . 0.0 110.245 172.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.07 -33.78 6.16 Favored Glycine 0 N--CA 1.485 1.932 0 CA-C-N 114.397 -1.274 . . . . 0.0 114.251 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.1 p -59.88 112.84 2.0 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 117.612 0.706 . . . . 0.0 112.421 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.51 129.92 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.335 -1.757 . . . . 0.0 108.026 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 m -129.73 118.4 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.443 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 m -85.21 104.81 15.41 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.826 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.9 mt -82.9 109.92 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.9 m -118.01 141.46 48.44 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 113.157 -1.838 . . . . 0.0 111.38 -173.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.91 139.43 27.6 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -133.33 132.27 41.1 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.658 -1.61 . . . . 0.0 108.826 169.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.31 -161.9 28.18 Favored Glycine 0 N--CA 1.481 1.683 0 C-N-CA 125.023 1.297 . . . . 0.0 111.542 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -59.93 -64.54 0.91 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.917 0.865 . . . . 0.0 113.167 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -83.56 31.59 0.47 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -53.0 -58.21 7.74 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -172.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -43.11 99.61 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -65.62 -45.03 84.66 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.036 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.39 -52.19 65.55 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.125 0.97 . . . . 0.0 113.173 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.8 t -59.5 -53.06 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.949 0.899 . . . . 0.0 110.078 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -51.0 -54.04 27.96 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.215 1.406 . . . . 0.0 112.73 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -62.88 -45.7 91.33 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.7 mt -64.88 -36.22 83.64 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.35 -50.79 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.435 0.694 . . . . 0.0 110.527 169.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -56.21 -47.11 79.03 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.7 tp -49.03 -59.23 3.79 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.607 1.163 . . . . 0.0 111.927 173.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.0 tmm? -58.06 -42.6 85.81 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.32 1.048 . . . . 0.0 112.949 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.03 -29.89 67.05 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -87.66 -31.69 19.63 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 69.1 mt . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 179.023 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttp . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -120.79 112.31 18.67 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.827 1.329 . . . . 0.0 110.087 172.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -107.57 126.81 53.01 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.019 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -122.93 120.17 32.62 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -99.89 92.72 5.42 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 125.294 1.621 . . . . 0.0 108.794 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.31 143.39 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 111.469 -2.605 . . . . 0.0 112.641 -173.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 p -78.54 131.45 36.8 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -176.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.9 mt -92.59 116.97 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-N 113.485 -1.689 . . . . 0.0 107.159 159.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 p -116.36 -17.81 10.63 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 111.85 -2.432 . . . . 0.0 114.38 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.06 129.96 58.54 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 124.929 1.292 . . . . 0.0 111.694 172.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -56.97 -54.11 4.11 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 124.394 3.396 . . . . 0.0 114.862 -165.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -88.23 -36.97 16.45 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 123.782 0.676 . . . . 0.0 111.762 171.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.89 -128.34 9.53 Favored Glycine 0 N--CA 1.475 1.291 0 O-C-N 123.799 0.687 . . . . 0.0 112.46 167.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 179.397 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.6 p . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.326 24.1 mtt180 -83.79 -37.36 0.67 Allowed Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 118.396 2.739 . . . . 0.0 118.396 -168.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -62.52 -39.81 42.62 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 121.763 1.642 . . . . 0.0 112.617 163.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.21 -38.18 73.33 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 168.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.18 -38.56 86.94 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 172.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -64.27 -43.91 93.34 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.414 0.686 . . . . 0.0 112.147 172.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -59.02 -44.17 91.69 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.175 1.39 . . . . 0.0 112.221 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.6 t -53.97 -60.06 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.042 1.337 . . . . 0.0 112.034 169.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -49.55 -39.06 33.38 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.936 -1.029 . . . . 0.0 113.156 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.451 ' CD ' ' HE2' ' A' ' 76' ' ' HIS . 8.5 tp10 -61.86 -66.0 0.6 Allowed 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.522 1.139 . . . . 0.0 110.891 169.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.93 -35.16 6.17 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -42.36 -38.21 1.78 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.24 -30.19 70.33 Favored Glycine 0 CA--C 1.546 1.972 0 C-N-CA 124.97 1.272 . . . . 0.0 115.805 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -75.28 144.8 42.3 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -175.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.411 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 66.3 p -66.46 -50.27 63.9 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.303 0.641 . . . . 0.0 111.891 -175.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.3 p -66.09 173.61 2.99 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 124.877 1.361 . . . . 0.0 113.35 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -114.65 94.32 4.72 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.704 0.764 . . . . 0.0 109.331 174.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.75 113.57 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 113.118 -1.855 . . . . 0.0 109.382 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 p -105.78 137.61 43.36 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.677 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.0 t -118.87 126.57 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 113.206 -1.815 . . . . 0.0 109.944 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.3 m -110.98 123.37 50.04 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.214 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.8 t -126.5 120.37 29.5 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.717 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 p30 40.3 64.03 0.99 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.742 1.617 . . . . 0.0 114.634 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.35 -34.96 1.54 Allowed Glycine 0 CA--C 1.542 1.773 0 CA-C-N 113.187 -1.824 . . . . 0.0 115.658 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -81.94 133.04 35.28 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.598 0.759 . . . . 0.0 110.254 -169.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 t -108.4 129.29 55.26 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.123 0.89 . . . . 0.0 113.269 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.71 160.85 27.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 112.541 -2.118 . . . . 0.0 109.626 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.3 t -106.08 128.26 53.74 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.131 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.04 -29.47 69.83 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.878 1.361 . . . . 0.0 111.338 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -90.81 21.69 3.98 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.245 -0.888 . . . . 0.0 112.609 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 m -148.01 116.46 6.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.028 1.331 . . . . 0.0 112.274 173.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.1 tp -51.21 -59.63 3.99 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 112.429 -2.169 . . . . 0.0 113.324 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -63.85 -32.34 73.82 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.221 -1.354 . . . . 0.0 113.317 -174.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -69.24 -58.48 3.98 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 118.318 -0.848 . . . . 0.0 113.033 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.9 tp -60.36 -40.3 90.25 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.201 0.938 . . . . 0.0 112.441 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -62.34 -40.1 95.28 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 t -89.86 8.14 33.59 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.3 tp -72.67 -60.95 1.98 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.91 92.88 1.6 Allowed Glycine 0 CA--C 1.535 1.334 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.0 mt -128.47 82.75 2.1 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.269 1.427 . . . . 0.0 109.956 -174.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 t -146.49 164.67 31.78 Favored 'General case' 0 C--O 1.25 1.1 0 C-N-CA 125.826 1.65 . . . . 0.0 110.835 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -41.61 126.63 2.99 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.444 1.898 . . . . 0.0 115.137 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.69 -31.56 5.51 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-N 113.891 -1.504 . . . . 0.0 115.379 173.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.35 121.32 21.19 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.828 2.159 . . . . 0.0 116.828 -173.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.9 t -87.01 94.03 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 m -89.82 125.72 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -169.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.07 93.45 5.78 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.967 1.707 . . . . 0.0 110.429 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.6 mt -98.73 113.33 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 125.496 1.518 . . . . 0.0 107.134 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 m -129.68 124.29 33.24 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.216 -167.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.66 140.84 51.56 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -140.74 110.1 6.27 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.258 1.423 . . . . 0.0 110.301 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.82 -157.05 19.57 Favored Glycine 0 N--CA 1.478 1.497 0 N-CA-C 107.621 -2.191 . . . . 0.0 107.621 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -65.51 -43.5 89.9 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 117.243 0.521 . . . . 0.0 110.156 170.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.411 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 6.2 p30 -86.25 26.94 0.97 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 -178.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -54.06 -52.64 60.25 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.45 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -78.42 -44.13 25.58 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.649 1.58 . . . . 0.0 113.007 -179.386 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -67.65 -35.83 79.6 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.77 -47.4 53.84 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.707 0.803 . . . . 0.0 112.862 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.9 t -61.6 -48.1 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 118.0 -1.0 . . . . 0.0 111.156 176.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -46.12 -49.01 17.17 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.7 1.2 . . . . 0.0 111.845 171.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.451 ' HE2' ' CD ' ' A' ' 25' ' ' GLU . 80.2 t60 -68.19 -62.48 1.38 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.0 mt -59.77 -38.63 82.35 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.4 t -61.42 -48.24 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.315 174.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -59.07 -48.88 80.0 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.297 0.998 . . . . 0.0 112.953 173.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.3 tp -52.55 -47.99 66.43 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.642 0.777 . . . . 0.0 112.03 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 48.5 ttp -62.2 -52.26 64.5 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.923 0.889 . . . . 0.0 112.367 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.64 -35.9 63.95 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -88.46 -13.67 39.77 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.775 0 C-N-CA 124.093 0.957 . . . . 0.0 112.411 167.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ttt . . . . . 0 N--CA 1.463 0.204 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -113.79 127.97 56.22 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 124.657 1.223 . . . . 0.0 109.708 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -131.11 94.66 3.63 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.309 -167.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -112.44 108.49 17.64 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 122.518 1.151 . . . . 0.0 113.343 -171.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -80.96 103.99 11.16 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 112.45 -2.159 . . . . 0.0 111.159 175.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.3 148.46 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 114.933 -1.03 . . . . 0.0 113.138 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 p -102.72 128.33 49.48 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.905 -175.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.3 mt -79.54 108.9 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.359 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 p -96.83 -13.51 22.5 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 175.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.9 135.83 90.22 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 124.31 1.044 . . . . 0.0 111.766 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -48.88 -52.45 8.64 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.182 3.255 . . . . 0.0 114.718 -174.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -106.88 -28.43 10.1 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 124.591 1.182 . . . . 0.0 113.741 175.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.25 -153.91 21.6 Favored Glycine 0 N--CA 1.479 1.563 0 CA-C-O 122.045 0.803 . . . . 0.0 113.897 165.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.0 mt . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 177.036 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.5 p . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.303 40.6 mtt85 -89.77 -41.44 0.42 Allowed Pre-proline 0 N--CA 1.486 1.336 0 N-CA-C 118.616 2.821 . . . . 0.0 118.616 -166.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -61.72 -30.8 85.55 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 CA-C-N 120.867 1.345 . . . . 0.0 112.412 163.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.19 -44.2 95.3 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 165.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.51 90.61 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 172.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -59.84 -45.5 92.22 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.386 1.074 . . . . 0.0 112.452 172.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -57.86 -46.07 85.37 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.074 1.35 . . . . 0.0 111.782 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.2 t -56.0 -42.47 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.025 0.53 . . . . 0.0 112.278 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -60.96 -46.43 90.74 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 124.07 0.856 . . . . 0.0 111.916 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -69.58 -44.44 70.79 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.077 0.861 . . . . 0.0 112.616 176.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.37 -33.59 65.85 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -53.81 -34.77 60.21 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 170.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.27 13.74 56.52 Favored Glycine 0 N--CA 1.483 1.81 0 O-C-N 124.557 1.161 . . . . 0.0 115.159 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -119.49 151.19 38.99 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.046 0.497 . . . . 0.0 111.297 172.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.4 p -82.69 -44.2 15.97 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.862 -175.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.3 p -66.08 133.26 50.37 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 124.999 1.437 . . . . 0.0 110.615 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -85.7 103.62 14.67 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.609 1.195 . . . . 0.0 111.831 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.4 mm -63.69 113.53 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 111.757 -2.474 . . . . 0.0 111.125 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.1 p -111.66 131.04 55.56 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.601 173.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.3 t -111.0 108.27 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 113.483 -1.689 . . . . 0.0 107.723 -177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.0 m -103.91 124.05 48.26 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.777 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.2 t -128.16 131.99 48.91 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.286 176.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.6 p30 49.83 34.62 7.92 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.39 5.33 87.7 Favored Glycine 0 CA--C 1.545 1.926 0 N-CA-C 115.806 1.082 . . . . 0.0 115.806 -175.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -112.56 140.66 47.13 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.977 0.911 . . . . 0.0 109.915 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.0 t -119.22 135.04 54.88 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -167.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -130.61 121.27 25.32 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.036 -1.893 . . . . 0.0 111.398 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.9 t -72.98 129.09 37.32 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.633 173.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.75 -14.7 62.08 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 113.175 -1.829 . . . . 0.0 113.297 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.0 mttt -77.29 -2.47 34.98 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 171.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.3 m -123.14 118.62 28.09 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.394 0.677 . . . . 0.0 112.217 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 tp -45.93 -65.87 0.48 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.588 -1.642 . . . . 0.0 113.732 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -54.09 -50.93 65.7 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.5 mmtt -42.04 -58.59 2.04 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.4 tp -66.96 -43.0 84.25 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.638 1.211 . . . . 0.0 113.202 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -59.36 -41.38 89.14 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.989 175.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.263 15.2 t -100.54 54.01 0.88 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 123.497 1.617 . . . . 0.0 113.897 175.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 tt -111.24 -56.5 2.36 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 112.874 -1.966 . . . . 0.0 109.246 161.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.27 66.9 0.61 Allowed Glycine 0 N--CA 1.477 1.416 0 O-C-N 124.348 1.03 . . . . 0.0 111.851 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.2 mt -88.74 98.11 11.51 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.682 0.793 . . . . 0.0 111.537 -174.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.9 t -137.47 175.99 9.11 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.876 -176.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -47.95 128.68 13.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.899 2.08 . . . . 0.0 112.813 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.68 -54.72 0.55 Allowed Glycine 0 N--CA 1.48 1.61 0 CA-C-N 113.408 -1.724 . . . . 0.0 114.175 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.1 p -64.56 131.98 48.55 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -165.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.4 t -79.89 108.48 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 111.124 -2.762 . . . . 0.0 107.193 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.6 m -105.0 109.49 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 113.523 -1.671 . . . . 0.0 113.214 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.5 95.99 2.85 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.626 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.2 mt -86.61 101.19 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.117 175.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.3 m -106.15 134.56 49.09 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 112.642 -2.072 . . . . 0.0 112.905 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.07 138.22 36.92 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 124.638 1.211 . . . . 0.0 113.223 172.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -132.62 118.7 19.5 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 124.8 1.312 . . . . 0.0 109.484 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.44 -155.5 26.18 Favored Glycine 0 CA--C 1.544 1.879 0 C-N-CA 124.685 1.136 . . . . 0.0 111.232 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -68.09 -61.14 2.0 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -80.56 28.15 0.34 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -53.26 -48.32 68.36 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.78 -50.61 33.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.835 0.854 . . . . 0.0 111.809 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -58.89 -50.92 72.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.587 1.555 . . . . 0.0 112.829 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.25 -44.58 95.14 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.471 1.107 . . . . 0.0 113.587 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.63 -55.52 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.078 175.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -52.05 -50.57 61.22 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.051 0.941 . . . . 0.0 112.975 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -60.01 -50.5 73.49 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.468 1.107 . . . . 0.0 112.64 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.8 mt -64.72 -28.32 69.51 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.5 t -69.65 -47.57 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 122.896 0.479 . . . . 0.0 110.896 171.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -51.76 -50.92 59.73 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.937 0.895 . . . . 0.0 111.527 174.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.67 -54.62 21.52 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.213 1.805 . . . . 0.0 112.236 176.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 40.3 ttp -57.12 -47.87 80.03 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.467 1.107 . . . . 0.0 112.363 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.9 -27.84 68.49 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.275 1.43 . . . . 0.0 114.84 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -78.71 -35.74 44.45 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.4 mt . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 175.284 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 ttt . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -103.22 136.96 42.02 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 125.095 1.497 . . . . 0.0 108.329 170.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -146.16 134.41 21.74 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.565 -1.652 . . . . 0.0 111.016 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -123.48 118.94 28.56 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.847 170.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -83.98 106.87 15.98 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.079 165.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.6 m -120.73 140.21 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 114.726 -1.124 . . . . 0.0 113.649 -178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.8 p -83.31 136.21 34.45 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.302 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 52.7 mt -81.81 90.31 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 168.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.7 p -74.07 -22.41 59.53 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.513 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.32 131.74 94.89 Favored Pre-proline 0 N--CA 1.484 1.229 0 C-N-CA 125.296 1.438 . . . . 0.0 111.935 -175.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.04 -44.17 9.54 Favored 'Trans proline' 0 N--CA 1.489 1.207 1 C-N-CA 125.355 4.036 . . . . 0.0 117.56 -166.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -110.45 -45.03 3.6 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.85 -147.63 17.6 Favored Glycine 0 N--CA 1.478 1.492 0 CA-C-O 121.725 0.625 . . . . 0.0 112.817 167.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 178.308 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.3 p . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.286 48.4 mtt85 -86.08 -39.27 0.57 Allowed Pre-proline 0 N--CA 1.487 1.411 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -174.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -62.13 -35.71 73.88 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 121.712 1.608 . . . . 0.0 111.686 164.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.06 -44.38 78.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.601 0.76 . . . . 0.0 112.897 167.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.49 98.81 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 171.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -56.64 -45.25 81.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.716 0.806 . . . . 0.0 113.146 171.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -57.93 -44.18 86.75 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.864 1.266 . . . . 0.0 111.689 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 95.7 t -57.12 -42.81 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.322 1.049 . . . . 0.0 113.154 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -53.03 -45.27 67.93 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 123.462 0.476 . . . . 0.0 112.17 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -74.61 -50.94 15.95 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.831 1.332 . . . . 0.0 112.215 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.35 -35.95 65.78 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -60.14 -19.38 53.41 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 173.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.45 27.03 14.89 Favored Glycine 0 CA--C 1.544 1.869 0 O-C-N 124.432 1.082 . . . . 0.0 113.646 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -127.93 142.97 51.11 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.143 0.977 . . . . 0.0 111.575 172.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.6 p -71.85 -40.0 69.34 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.438 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 63.0 p -65.23 145.86 55.69 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 124.483 1.115 . . . . 0.0 111.624 168.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.445 ' CD ' ' HG ' ' A' ' 43' ' ' SER . 34.9 tt0 -95.73 109.51 21.79 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.321 -0.862 . . . . 0.0 110.968 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.3 mm -70.54 102.06 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 112.64 -2.073 . . . . 0.0 108.852 171.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.3 p -101.89 126.44 48.79 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.497 173.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.7 t -103.54 113.85 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 125.445 1.716 . . . . 0.0 107.767 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.9 m -114.2 127.54 55.95 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.652 -174.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.4 t -122.66 115.04 21.43 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.316 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.5 p30 39.94 51.31 2.52 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -174.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.47 -35.8 4.05 Favored Glycine 0 N--CA 1.484 1.898 0 CA-C-N 113.17 -1.832 . . . . 0.0 114.501 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -72.55 121.63 19.99 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 116.897 0.348 . . . . 0.0 111.11 -174.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.0 t -102.25 136.29 42.35 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.78 1.3 . . . . 0.0 113.789 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -129.72 106.77 8.93 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 112.748 -2.024 . . . . 0.0 112.005 175.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.445 ' HG ' ' CD ' ' A' ' 32' ' ' GLU . 13.7 t -59.5 121.73 12.26 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.526 171.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.61 -30.55 68.31 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.598 170.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -61.8 -32.64 72.95 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.2 m -96.37 104.24 16.19 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 122.028 0.918 . . . . 0.0 111.89 169.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 tp -44.94 -60.62 1.97 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.54 1.536 . . . . 0.0 113.05 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -57.21 -37.6 72.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -61.5 -49.82 75.2 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.8 tp -62.48 -41.33 98.72 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 174.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -61.07 -24.88 66.55 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.261 9.6 t -118.12 75.31 1.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 123.449 1.595 . . . . 0.0 114.228 172.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.7 tp -124.0 -45.39 2.01 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 112.128 -2.305 . . . . 0.0 113.141 168.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.45 69.1 0.84 Allowed Glycine 0 CA--C 1.534 1.266 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -167.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.7 mt -95.28 80.64 3.56 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.06 0.933 . . . . 0.0 110.936 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -123.83 151.49 43.34 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 112.748 -2.024 . . . . 0.0 112.889 -165.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -49.13 132.9 19.28 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.46 1.124 . . . . 0.0 112.427 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.58 -69.06 0.22 Allowed Glycine 0 CA--C 1.534 1.267 0 CA-C-N 113.467 -1.697 . . . . 0.0 110.257 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.5 p -30.79 113.19 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.2 t -72.96 108.1 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 112.601 -2.09 . . . . 0.0 106.688 168.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.7 m -105.09 111.48 34.75 Favored 'Isoleucine or valine' 0 C--O 1.253 1.261 0 CA-C-N 113.991 -1.458 . . . . 0.0 112.743 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.8 m -65.99 99.11 0.47 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 126.558 1.943 . . . . 0.0 108.87 176.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 80.8 mt -96.64 106.73 18.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.7 m -118.53 133.79 55.59 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 112.703 -2.044 . . . . 0.0 112.588 -169.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.78 138.12 24.25 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 125.334 1.646 . . . . 0.0 112.681 170.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -120.05 129.72 54.37 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.97 170.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.1 -157.11 27.26 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.766 1.203 . . . . 0.0 114.909 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -71.77 -44.09 64.63 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -100.63 24.84 8.49 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.69 -51.22 68.03 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -36.79 83.98 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.254 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -71.73 -52.8 15.91 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.563 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.17 -51.7 68.46 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.513 1.525 . . . . 0.0 114.266 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.7 t -60.77 -50.64 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.003 0.521 . . . . 0.0 110.863 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -54.58 -55.33 30.5 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.557 1.143 . . . . 0.0 111.514 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -53.76 -54.1 42.96 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.733 1.613 . . . . 0.0 112.923 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.3 mt -69.41 -28.64 66.33 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.54 -43.46 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 119.038 -0.506 . . . . 0.0 110.816 171.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -55.77 -43.81 77.08 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.248 0.619 . . . . 0.0 111.716 172.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.26 -51.08 70.79 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.522 1.129 . . . . 0.0 112.757 174.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 44.4 ttm -55.08 -45.6 75.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 123.531 0.519 . . . . 0.0 112.286 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.09 -19.95 66.24 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -114.85 36.19 3.96 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 mt . . . . . 0 N--CA 1.48 1.068 0 C-N-CA 125.303 1.441 . . . . 0.0 112.73 173.549 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 ttp . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -100.45 131.93 46.1 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 125.597 1.81 . . . . 0.0 107.962 169.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -124.78 115.44 20.7 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.584 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -127.05 110.21 12.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.223 1.011 . . . . 0.0 112.386 173.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -91.59 112.45 24.38 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.624 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 m -128.37 165.35 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 113.134 -1.848 . . . . 0.0 112.301 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 78.5 p -120.73 147.27 45.53 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.196 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.8 mt -87.93 97.13 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.887 175.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.8 p -85.3 -17.79 35.83 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.47 142.2 41.2 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.985 1.314 . . . . 0.0 112.608 174.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -47.6 -46.96 19.34 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 124.586 3.524 . . . . 0.0 116.246 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -114.86 -39.17 3.76 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.83 -142.51 17.1 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 122.198 0.888 . . . . 0.0 112.824 167.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 -174.078 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 76.8 p . . . . . 0 N--CA 1.476 0.833 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 65.2 mtt85 -60.57 -53.95 59.49 Favored Pre-proline 0 N--CA 1.488 1.445 0 CA-C-O 116.238 -1.839 . . . . 0.0 115.181 -171.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -67.2 -31.12 36.69 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 CA-C-N 122.072 1.776 . . . . 0.0 114.198 174.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.96 85.1 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 171.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.41 -39.29 86.88 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 171.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -62.09 -44.68 96.13 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.006 0.923 . . . . 0.0 113.15 172.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -59.76 -43.5 94.27 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.105 0.878 . . . . 0.0 111.662 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 66.8 t -55.66 -51.67 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.569 0.748 . . . . 0.0 111.654 172.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -46.84 -51.74 15.9 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.617 0.767 . . . . 0.0 111.755 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -65.14 -51.81 59.01 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.466 1.104 . . . . 0.0 111.559 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.28 -34.02 66.06 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -60.51 -32.84 71.83 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 172.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.22 26.24 3.98 Favored Glycine 0 N--CA 1.479 1.526 0 O-C-N 124.382 1.051 . . . . 0.0 114.375 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -129.17 146.24 51.14 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.725 1.21 . . . . 0.0 110.261 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.445 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 67.6 p -69.39 -42.15 75.5 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.442 0.697 . . . . 0.0 112.872 -176.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 p -66.55 157.07 33.24 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.867 1.267 . . . . 0.0 112.836 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -103.4 113.74 27.48 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 122.32 1.057 . . . . 0.0 110.239 172.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.7 mm -81.81 105.74 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 111.818 -2.446 . . . . 0.0 108.495 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.3 p -101.79 121.27 41.77 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.141 0.496 . . . . 0.0 110.805 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.6 t -101.51 97.85 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 125.905 2.003 . . . . 0.0 107.612 -172.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.1 m -88.39 101.14 13.6 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.778 -1.555 . . . . 0.0 111.047 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 t -100.35 99.88 10.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.198 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 p30 45.54 62.61 2.11 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 113.186 -1.824 . . . . 0.0 114.009 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.47 -30.36 3.78 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 114.015 -1.448 . . . . 0.0 114.636 -176.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -86.31 92.76 8.9 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.644 0.735 . . . . 0.0 109.67 -174.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.3 t -82.73 123.33 29.2 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.771 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.2 132.86 51.69 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.597 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.6 t -71.22 129.7 39.57 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.715 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.2 -19.0 61.81 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 112.972 -1.922 . . . . 0.0 112.508 170.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -77.11 -6.11 51.56 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 m -112.49 115.93 29.46 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.4 tp -52.84 -64.79 0.7 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 111.325 -2.67 . . . . 0.0 114.302 -170.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -77.39 -28.77 52.9 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -60.65 -44.85 95.93 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 tp -69.62 -35.52 75.33 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.591 1.182 . . . . 0.0 113.283 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -65.48 -35.9 82.28 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 172.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.251 14.0 t -100.06 50.66 0.91 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 123.716 1.722 . . . . 0.0 112.547 173.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.5 tp -115.6 -37.86 3.88 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 112.883 -1.962 . . . . 0.0 112.742 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.09 55.92 1.66 Allowed Glycine 0 CA--C 1.53 1.031 0 C-N-CA 123.962 0.791 . . . . 0.0 111.824 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 78.3 mt -77.51 85.5 3.88 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -133.41 175.97 8.94 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 113.873 -1.512 . . . . 0.0 112.928 -172.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -46.47 112.78 0.54 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.471 1.909 . . . . 0.0 111.613 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.15 -38.71 3.09 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-N 113.259 -1.791 . . . . 0.0 114.157 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.5 p -48.84 110.22 0.33 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -172.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.38 123.59 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-N 111.083 -2.78 . . . . 0.0 108.067 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 m -127.98 101.19 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 113.708 -1.587 . . . . 0.0 112.638 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.6 m -77.81 90.04 4.05 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.118 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 73.0 mt -78.84 96.88 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 113.006 -1.907 . . . . 0.0 107.725 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.0 m -119.88 136.83 54.35 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 113.136 -1.847 . . . . 0.0 111.991 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.78 142.59 25.66 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.636 1.21 . . . . 0.0 113.305 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -123.37 126.84 47.57 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.656 1.222 . . . . 0.0 110.431 170.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.44 -165.68 36.83 Favored Glycine 0 N--CA 1.484 1.869 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.094 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -63.94 -55.44 22.55 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.445 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 10.8 p30 -92.42 17.91 9.24 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -45.0 -58.96 2.83 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -173.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.402 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -60.98 -48.9 79.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.923 1.289 . . . . 0.0 114.285 179.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -64.4 -46.28 83.99 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.786 0.834 . . . . 0.0 112.256 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.65 -52.38 65.67 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.247 1.019 . . . . 0.0 112.688 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.8 t -63.58 -47.1 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 117.586 -1.197 . . . . 0.0 111.306 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -50.33 -59.32 4.09 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.226 1.01 . . . . 0.0 111.656 175.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -53.94 -49.55 68.45 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.323 1.049 . . . . 0.0 113.438 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.5 mt -62.9 -39.66 95.2 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.7 t -58.17 -44.06 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.75 0.82 . . . . 0.0 111.084 174.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -60.26 -53.73 54.25 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.852 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.7 tp -51.6 -49.72 61.6 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.162 0.985 . . . . 0.0 113.277 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.8 ttt -62.66 -36.6 83.41 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.984 0.914 . . . . 0.0 113.188 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.17 -35.32 56.03 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -86.27 1.99 48.85 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.8 mt . . . . . 0 N--CA 1.488 1.433 0 C-N-CA 124.653 1.181 . . . . 0.0 114.055 170.539 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ttp . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -121.41 132.06 54.53 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 125.259 1.6 . . . . 0.0 112.026 173.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.93 146.93 52.23 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.6 174.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -119.22 150.9 39.31 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 124.384 1.053 . . . . 0.0 110.871 169.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -117.28 98.69 6.56 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 123.309 1.528 . . . . 0.0 110.823 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.24 149.55 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 113.902 -1.499 . . . . 0.0 112.219 -169.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 p -100.87 143.44 31.02 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.269 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.5 mp -81.16 115.97 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 165.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.2 p -99.85 -36.09 9.54 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 112.594 -2.094 . . . . 0.0 112.497 -174.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.99 142.15 46.73 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.978 0.911 . . . . 0.0 112.462 170.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.48 -44.27 38.89 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.996 3.131 . . . . 0.0 115.332 -172.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . 0.257 11.1 p30 -105.21 -29.92 10.02 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 176.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.71 -127.24 7.86 Favored Glycine 0 CA--C 1.538 1.5 0 O-C-N 124.287 0.992 . . . . 0.0 114.263 169.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -174.956 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.341 97.0 mtt180 -83.36 -43.46 0.84 Allowed Pre-proline 0 N--CA 1.479 1.014 0 N-CA-C 118.049 2.611 . . . . 0.0 118.049 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -62.0 -37.21 66.52 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 CA-C-N 123.233 2.19 . . . . 0.0 110.884 170.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.65 -30.52 21.93 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 164.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.38 -40.62 97.07 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 119.474 1.034 . . . . 0.0 112.327 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.83 -35.54 80.28 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 118.436 -0.792 . . . . 0.0 112.973 171.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -62.17 -48.03 81.87 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.94 0.336 . . . . 0.0 111.032 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.1 t -50.61 -50.72 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.933 0.873 . . . . 0.0 111.411 173.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.42 -44.21 95.98 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.54 -1.209 . . . . 0.0 113.121 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -63.36 -40.29 96.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.355 1.462 . . . . 0.0 113.67 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.42 99.13 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.101 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -56.99 -30.15 63.9 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.6 -25.73 36.39 Favored Glycine 0 CA--C 1.543 1.818 0 O-C-N 125.343 1.652 . . . . 0.0 114.849 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -97.63 146.68 25.07 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.093 0.957 . . . . 0.0 112.928 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.459 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 68.2 p -58.61 -50.35 74.16 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.758 1.623 . . . . 0.0 112.387 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.1 p -53.15 147.61 9.54 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 125.043 1.465 . . . . 0.0 113.975 170.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -103.06 87.67 2.97 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 122.706 1.241 . . . . 0.0 109.422 170.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.3 mm -48.57 112.34 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 112.131 -2.304 . . . . 0.0 111.556 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.5 p -101.18 143.5 31.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.458 171.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.5 t -127.75 111.77 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.2 m -109.98 126.97 54.49 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.538 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -123.89 136.77 54.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.643 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.6 p30 51.08 22.83 1.35 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 128.739 2.816 . . . . 0.0 117.067 -178.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.54 -28.4 14.39 Favored Glycine 0 CA--C 1.544 1.894 0 CA-C-N 115.238 -0.892 . . . . 0.0 114.367 -171.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -81.09 135.47 35.81 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.447 0.624 . . . . 0.0 111.345 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.0 t -113.55 120.26 40.35 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.847 -170.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.19 129.2 48.53 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.702 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.5 t -76.15 131.77 39.59 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.898 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.15 -40.95 82.24 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 125.149 1.531 . . . . 0.0 112.559 174.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -57.76 -18.42 21.42 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 171.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 t -107.39 114.43 28.44 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.618 1.199 . . . . 0.0 110.045 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.3 tp -62.03 -59.21 5.42 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.94 -1.936 . . . . 0.0 115.555 -165.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -69.68 -31.1 68.95 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -57.03 -61.4 2.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.016 0.926 . . . . 0.0 109.919 171.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.0 tp -57.39 -44.66 84.67 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -61.9 -42.84 99.56 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 t -67.45 -12.67 60.83 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.4 tp -69.87 -52.51 24.21 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -173.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.03 72.88 0.88 Allowed Glycine 0 N--CA 1.471 0.985 0 O-C-N 124.256 0.973 . . . . 0.0 112.383 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.1 mt -86.55 73.66 10.04 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 123.62 1.676 . . . . 0.0 111.007 175.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.4 t -127.8 172.25 11.01 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 111.802 -2.454 . . . . 0.0 111.517 -172.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -40.26 143.4 0.3 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.521 1.929 . . . . 0.0 112.236 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.37 -33.76 2.02 Favored Glycine 0 N--CA 1.481 1.644 0 CA-C-O 118.362 -1.243 . . . . 0.0 114.875 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.0 p -61.97 115.68 4.27 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.064 1.432 . . . . 0.0 114.492 -174.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.7 t -88.81 100.94 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 110.721 -2.945 . . . . 0.0 106.184 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.0 m -102.78 123.8 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 112.902 -1.954 . . . . 0.0 111.611 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 p -84.5 109.76 18.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 112.306 -2.224 . . . . 0.0 111.391 171.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.8 mt -104.55 110.38 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.079 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 m -117.57 126.44 52.55 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 113.741 -1.572 . . . . 0.0 115.098 -168.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -126.18 137.84 53.6 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.293 -1.321 . . . . 0.0 112.921 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -139.1 113.98 9.31 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.446 -1.706 . . . . 0.0 108.996 166.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.75 -155.59 16.74 Favored Glycine 0 N--CA 1.479 1.545 0 C-N-CA 126.07 1.795 . . . . 0.0 109.439 -175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -77.78 -35.33 51.68 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 122.218 1.009 . . . . 0.0 111.569 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.459 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 4.8 p30 -105.02 26.94 8.66 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.848 1.659 . . . . 0.0 115.154 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -44.61 -43.15 7.97 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -46.43 49.2 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 174.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -72.76 -32.04 65.34 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.119 1.368 . . . . 0.0 113.271 -173.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.96 -53.37 58.75 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.027 1.331 . . . . 0.0 111.269 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 t -65.66 -52.44 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.135 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -47.03 -57.2 5.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.021 1.328 . . . . 0.0 112.478 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -60.29 -60.32 4.0 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mt -58.23 -36.0 72.53 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.83 -42.77 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.568 0.747 . . . . 0.0 111.572 171.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -63.82 -34.52 78.1 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 tp -58.37 -52.54 65.16 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.447 1.099 . . . . 0.0 112.157 164.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 48.2 ttm -48.86 -51.43 29.74 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.867 0.867 . . . . 0.0 112.581 173.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.5 -50.5 73.67 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -84.77 15.08 4.11 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -174.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.552 1.05 0 C-N-CA 124.299 1.039 . . . . 0.0 111.594 169.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -127.98 141.15 51.61 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.398 1.479 . . . . 0.0 109.879 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.48 128.36 11.75 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.053 0.541 . . . . 0.0 111.863 -172.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -125.13 119.46 28.64 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -83.08 115.68 21.98 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 113.18 -1.827 . . . . 0.0 111.086 164.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.1 164.31 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 113.249 -1.796 . . . . 0.0 113.076 176.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.9 p -121.31 126.04 48.53 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -172.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.5 mt -80.26 111.9 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.411 170.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 p -107.07 -8.77 16.4 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 113.218 -1.81 . . . . 0.0 115.555 173.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.27 137.03 68.45 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.965 0.906 . . . . 0.0 112.535 177.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -45.78 -46.17 15.76 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 124.843 3.695 . . . . 0.0 115.943 -170.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.22 -34.32 5.96 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 175.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.32 -135.56 12.54 Favored Glycine 0 N--CA 1.482 1.74 0 O-C-N 123.761 0.663 . . . . 0.0 111.627 169.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -176.652 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.5 p . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 63.4 mtt-85 -75.27 -45.18 4.59 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-O 115.706 -2.093 . . . . 0.0 115.599 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -63.34 -28.46 71.97 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 CA-C-N 122.565 1.952 . . . . 0.0 112.569 168.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.2 -22.24 64.57 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 169.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.4 -36.36 63.48 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -55.9 -47.27 77.75 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 170.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -55.62 -43.61 76.27 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.899 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.5 t -59.23 -52.55 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.752 0.821 . . . . 0.0 111.214 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.22 -56.44 11.09 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.584 1.154 . . . . 0.0 113.028 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -58.8 -45.2 90.43 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 124.779 1.3 . . . . 0.0 112.395 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.59 80.18 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -50.25 -38.42 40.69 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 175.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.94 3.78 55.87 Favored Glycine 0 CA--C 1.54 1.605 0 O-C-N 124.769 1.293 . . . . 0.0 116.298 -173.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -100.75 158.3 16.06 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.305 1.042 . . . . 0.0 112.869 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.444 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 40.3 p -68.57 -52.32 33.1 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 118.639 -0.696 . . . . 0.0 109.482 168.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.0 p -59.05 136.52 57.97 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.875 1.27 . . . . 0.0 112.947 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -95.27 92.15 6.61 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.362 173.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.7 mm -57.55 115.68 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 112.132 -2.304 . . . . 0.0 110.211 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.5 p -105.54 117.29 33.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.702 173.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.6 t -103.89 117.71 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.717 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.0 m -107.8 129.7 55.03 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 112.553 -2.112 . . . . 0.0 112.042 -175.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.1 t -136.25 137.68 41.03 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 111.979 -2.373 . . . . 0.0 107.727 171.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.8 p30 40.02 44.54 1.47 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.36 -40.65 3.08 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 124.185 0.898 . . . . 0.0 114.388 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -57.84 123.93 17.46 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.872 1.269 . . . . 0.0 112.645 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -109.74 101.44 10.33 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.489 -176.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.71 134.65 47.52 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.622 1.201 . . . . 0.0 112.846 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.0 t -73.21 112.19 9.03 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 112.485 -2.143 . . . . 0.0 112.143 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.55 -14.58 63.11 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 112.717 -2.038 . . . . 0.0 114.232 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -72.27 -22.28 61.24 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.2 t -109.91 122.43 47.53 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.843 0.83 . . . . 0.0 111.744 -176.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.3 tp -55.54 -59.4 4.89 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.588 -2.096 . . . . 0.0 114.615 -169.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -64.79 -33.38 75.86 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -61.97 -51.72 66.91 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 123.805 0.69 . . . . 0.0 112.382 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.5 tp -61.96 -38.74 89.67 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -64.9 -39.28 93.29 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -72.96 -28.68 62.55 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 172.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.3 tp -45.19 -60.95 1.85 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.61 93.46 2.02 Favored Glycine 0 CA--C 1.539 1.57 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 71.5 mt -120.06 87.04 2.67 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 113.337 -1.432 . . . . 0.0 107.906 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 t -135.38 -174.87 3.75 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.337 -1.302 . . . . 0.0 111.351 -173.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -61.05 118.48 6.82 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.288 0.566 . . . . 0.0 109.993 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.78 -7.81 65.44 Favored Glycine 0 N--CA 1.478 1.435 0 CA-C-N 114.368 -1.287 . . . . 0.0 115.665 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.3 p -71.44 99.59 2.03 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.351 1.075 . . . . 0.0 111.652 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.2 t -60.44 104.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 111.497 -2.592 . . . . 0.0 107.986 173.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.4 m -106.78 113.4 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.418 -168.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.7 m -100.25 104.97 16.49 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 112.271 -2.24 . . . . 0.0 108.973 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 24.3 mt -98.64 102.25 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.118 -1.855 . . . . 0.0 107.9 -174.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -102.56 140.86 36.28 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 113.642 -1.617 . . . . 0.0 112.31 -176.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.71 142.05 27.43 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.419 1.074 . . . . 0.0 112.904 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -140.12 114.25 9.05 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.12 169.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.99 -152.56 15.13 Favored Glycine 0 N--CA 1.483 1.791 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.581 -175.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -86.32 -57.7 2.91 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 120.742 0.306 . . . . 0.0 110.503 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.444 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 4.2 p30 -73.55 5.49 3.81 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.783 2.142 . . . . 0.0 116.783 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -41.93 -53.71 3.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -49.24 78.56 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.949 1.3 . . . . 0.0 113.477 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -76.62 -34.94 58.32 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.278 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.42 68.5 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.015 0.926 . . . . 0.0 111.959 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.54 -45.51 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-O 118.459 -0.782 . . . . 0.0 111.731 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -52.94 -51.06 62.67 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 123.876 0.735 . . . . 0.0 111.994 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -59.23 -51.82 68.33 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.438 1.495 . . . . 0.0 111.697 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.2 mt -65.93 -29.91 70.41 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.94 -46.19 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 121.329 0.585 . . . . 0.0 109.725 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -71.42 -30.31 65.93 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.432 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.54 -52.84 63.85 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 124.142 0.901 . . . . 0.0 112.459 166.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.7 tmm? -53.12 -47.47 68.63 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 124.49 1.119 . . . . 0.0 111.892 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.04 -40.35 97.46 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -90.0 -9.98 46.64 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.479 1.004 0 C-N-CA 122.888 0.475 . . . . 0.0 110.696 161.485 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -118.4 118.91 33.05 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 125.425 1.703 . . . . 0.0 110.567 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.75 122.34 37.18 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.438 -172.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -134.02 140.28 46.58 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.751 0.821 . . . . 0.0 113.073 171.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -112.32 122.87 48.96 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.958 -172.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 m -128.63 130.33 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.21 128.01 36.86 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 113.684 -1.598 . . . . 0.0 111.518 -177.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.1 mt -87.5 118.14 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.709 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 p -95.51 -26.72 15.7 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 113.516 -1.675 . . . . 0.0 113.748 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.28 127.95 92.66 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 123.486 0.714 . . . . 0.0 111.943 173.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -54.62 -51.98 9.19 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.171 3.247 . . . . 0.0 113.725 -170.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -95.81 -46.39 6.59 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.866 1.354 . . . . 0.0 111.031 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.09 -107.86 2.26 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.655 1.121 . . . . 0.0 112.764 166.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.0 mt . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 176.839 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.4 p . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -74.43 -44.56 5.77 Favored Pre-proline 0 N--CA 1.483 1.188 0 CA-C-O 116.248 -1.834 . . . . 0.0 115.908 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -64.3 -40.61 24.55 Favored 'Trans proline' 0 N--CA 1.486 1.063 0 CA-C-N 121.826 1.688 . . . . 0.0 112.866 170.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.16 -37.56 47.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.587 1.155 . . . . 0.0 113.959 172.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.73 75.71 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 175.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -80.73 -28.18 36.66 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 174.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -62.04 -38.91 90.53 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.296 0.639 . . . . 0.0 110.551 168.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.65 -48.12 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 124.472 1.109 . . . . 0.0 110.978 169.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -51.47 -46.97 63.29 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 118.895 -0.574 . . . . 0.0 111.622 175.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -61.58 -56.28 21.64 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 125.13 1.519 . . . . 0.0 111.567 174.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.82 -40.71 63.55 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -57.93 -27.85 63.75 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 176.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.68 -46.38 94.56 Favored Glycine 0 CA--C 1.542 1.772 0 C-N-CA 124.948 1.261 . . . . 0.0 112.892 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -69.12 144.15 53.96 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.991 0.916 . . . . 0.0 112.459 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.411 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 65.3 p -67.72 -45.77 74.11 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.285 -176.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.7 p -63.12 167.0 5.34 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.683 1.593 . . . . 0.0 113.206 171.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -114.03 111.57 21.86 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 122.365 1.078 . . . . 0.0 110.903 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 39.5 mm -69.47 103.77 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 112.567 -2.106 . . . . 0.0 110.773 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.9 p -88.3 118.2 27.75 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.315 167.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -105.39 92.45 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 113.545 -1.661 . . . . 0.0 106.876 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.0 m -81.59 124.94 29.95 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 112.12 -2.309 . . . . 0.0 110.961 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -128.65 106.64 9.09 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.662 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 p30 35.43 83.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 112.557 -2.111 . . . . 0.0 116.533 -176.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.52 -52.68 4.59 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-N 113.037 -1.892 . . . . 0.0 112.903 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -69.21 117.68 11.15 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.305 1.042 . . . . 0.0 111.509 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t -111.29 108.94 18.73 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.81 -177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.49 118.6 37.05 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.478 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.4 t -57.11 111.88 1.19 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.185 -1.371 . . . . 0.0 111.153 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.22 -24.34 67.18 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.876 172.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -70.46 -26.87 63.84 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.236 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -95.29 102.6 14.42 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 123.063 1.411 . . . . 0.0 112.006 172.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.9 tp -39.43 -59.86 1.02 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.093 2.157 . . . . 0.0 115.704 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -66.32 -33.15 75.08 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -67.07 -44.52 79.88 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.43 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 tp -66.93 -45.47 77.78 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 124.444 1.09 . . . . 0.0 112.02 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -57.49 -30.55 65.19 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 t -94.07 -0.0 55.65 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.5 -41.8 96.22 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.23 86.65 1.86 Allowed Glycine 0 CA--C 1.537 1.417 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -172.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.6 mt -115.29 77.22 1.06 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.192 0.996 . . . . 0.0 109.73 -172.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.9 t -132.05 168.29 18.2 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.468 -163.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -57.54 106.71 0.36 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.031 0.932 . . . . 0.0 111.468 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.62 -38.21 2.61 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 113.311 -1.768 . . . . 0.0 114.526 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.8 p -64.55 122.85 17.78 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 118.165 0.982 . . . . 0.0 112.88 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.1 t -97.86 111.22 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 113.073 -1.876 . . . . 0.0 106.792 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.7 m -105.52 117.07 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 112.701 -2.045 . . . . 0.0 113.778 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.3 93.66 9.14 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 112.466 -2.152 . . . . 0.0 111.88 -175.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.2 mt -80.15 102.81 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 113.845 -1.525 . . . . 0.0 107.724 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.2 m -121.31 134.08 55.14 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 112.62 -2.082 . . . . 0.0 112.978 -175.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.84 152.31 39.29 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 124.822 1.326 . . . . 0.0 112.767 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -137.28 133.27 34.82 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.971 172.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.44 -159.73 24.9 Favored Glycine 0 N--CA 1.484 1.894 0 O-C-N 124.169 0.918 . . . . 0.0 113.519 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -50.26 -47.47 55.17 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.411 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 3.7 p30 -108.79 31.23 5.81 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -51.26 -52.29 46.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.407 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -71.8 -42.21 67.33 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 112.765 -2.016 . . . . 0.0 113.151 178.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -66.62 -47.36 72.88 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.593 1.157 . . . . 0.0 111.987 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.33 -47.36 86.37 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.366 1.066 . . . . 0.0 113.429 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.4 t -68.94 -45.81 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 117.537 -1.221 . . . . 0.0 111.261 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -52.08 -49.76 62.91 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.981 0.913 . . . . 0.0 111.019 175.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -62.69 -58.1 8.65 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.107 1.363 . . . . 0.0 113.442 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.3 mt -64.74 -29.78 70.77 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.5 t -63.24 -54.79 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 124.036 0.835 . . . . 0.0 110.686 168.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt -56.34 -47.05 79.6 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.736 0.814 . . . . 0.0 112.969 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.7 tp -52.51 -56.08 17.65 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.435 1.094 . . . . 0.0 111.607 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.5 tmm? -53.99 -43.72 70.23 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.085 0.954 . . . . 0.0 112.021 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.6 -35.56 80.5 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -177.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.99 -21.04 34.05 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.7 mt . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -177.928 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -132.87 139.55 47.48 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 125.337 1.648 . . . . 0.0 108.907 165.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -137.58 128.46 27.23 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.227 -177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -125.05 108.04 11.42 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.976 168.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -87.3 97.25 10.68 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 112.587 -2.097 . . . . 0.0 109.123 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 m -120.34 117.49 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 112.243 -2.253 . . . . 0.0 112.91 -173.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 p -71.77 126.77 30.57 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.728 -1.123 . . . . 0.0 111.665 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.9 mt -71.2 126.54 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 114.876 -1.057 . . . . 0.0 108.756 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -98.94 -37.53 9.36 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 113.957 -1.474 . . . . 0.0 114.336 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.68 123.86 24.94 Favored Pre-proline 0 N--CA 1.482 1.147 0 O-C-N 123.863 0.727 . . . . 0.0 111.485 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -51.3 -42.43 54.39 Favored 'Trans proline' 0 N--CA 1.482 0.851 0 C-N-CA 123.973 3.116 . . . . 0.0 112.03 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -71.91 -56.07 6.36 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.922 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.7 -127.28 9.09 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.932 1.253 . . . . 0.0 110.522 171.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 N--CA 1.482 1.157 0 CA-C-N 113.931 -1.135 . . . . 0.0 113.241 176.885 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.3 p . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.4 mmt-85 -64.22 -48.39 76.65 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-O 116.03 -1.938 . . . . 0.0 114.593 -174.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -65.41 -41.7 14.96 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.415 2.077 . . . . 0.0 112.912 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.73 -38.22 60.47 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.41 -41.68 94.4 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.919 0.887 . . . . 0.0 113.013 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -67.5 -44.44 78.48 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.344 1.058 . . . . 0.0 111.631 175.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -58.36 -45.76 87.61 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.256 1.423 . . . . 0.0 111.447 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 51.9 t -53.88 -46.7 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 124.296 1.038 . . . . 0.0 111.672 173.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -57.05 -44.99 83.55 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 118.98 -0.534 . . . . 0.0 111.876 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -62.36 -47.79 82.65 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.501 1.126 . . . . 0.0 112.627 174.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.24 -39.52 83.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.68 1.192 . . . . 0.0 114.174 175.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -60.03 -26.24 65.95 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 172.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.86 -20.93 64.9 Favored Glycine 0 CA--C 1.546 1.977 0 O-C-N 124.535 1.147 . . . . 0.0 114.187 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -99.95 145.84 27.37 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.592 1.187 . . . . 0.0 113.307 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.1 p -73.14 -37.04 66.75 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.334 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.6 p -63.38 160.55 15.86 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 124.599 1.187 . . . . 0.0 112.121 168.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -107.05 110.57 22.73 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.2 mm -72.43 92.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.024 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.2 107.44 14.0 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 110.845 -2.889 . . . . 0.0 107.886 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.96 101.85 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.269 -176.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.5 m -96.74 118.69 33.75 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 113.523 -1.671 . . . . 0.0 112.043 -177.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.9 t -130.53 114.37 15.4 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.325 171.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 p30 43.26 70.13 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 125.372 1.469 . . . . 0.0 114.17 -172.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.91 -35.5 1.24 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-N 113.389 -1.732 . . . . 0.0 115.241 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -74.34 108.58 7.21 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.163 0.985 . . . . 0.0 111.415 -174.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.5 m -98.96 100.62 11.82 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.871 176.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -105.91 115.31 30.01 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.837 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.3 t -64.56 119.06 9.75 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.889 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -23.13 65.96 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.433 -1.712 . . . . 0.0 113.525 171.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -70.78 -24.07 62.52 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.137 177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.9 t -103.07 123.43 46.63 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.217 0.532 . . . . 0.0 111.393 167.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.4 tp -42.91 -61.32 1.31 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 111.041 -2.8 . . . . 0.0 114.919 -171.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -82.75 -6.96 59.66 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -74.01 -58.31 3.39 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.8 tp -54.11 -39.51 66.48 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -67.24 -2.88 6.52 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.2 t -133.1 59.37 1.74 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 124.578 2.132 . . . . 0.0 112.538 166.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.2 tp -110.3 -50.71 2.94 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 113.08 -1.873 . . . . 0.0 113.095 176.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.72 90.12 1.93 Allowed Glycine 0 CA--C 1.531 1.087 0 N-CA-C 107.804 -2.119 . . . . 0.0 107.804 -169.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.4 mt -122.88 90.25 3.26 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.054 -1.073 . . . . 0.0 109.44 -171.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.4 t -162.94 157.81 21.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 126.385 2.303 . . . . 0.0 109.346 -164.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -40.05 132.04 1.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.19 -20.58 32.65 Favored Glycine 0 N--CA 1.479 1.553 0 CA-C-N 113.003 -1.908 . . . . 0.0 114.518 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.3 p -60.98 108.06 0.81 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 122.925 1.345 . . . . 0.0 112.992 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.3 94.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 110.779 -2.919 . . . . 0.0 106.919 -175.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.5 m -92.25 98.0 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 113.648 -1.614 . . . . 0.0 112.691 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.8 m -73.66 88.03 1.69 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 111.834 -2.439 . . . . 0.0 108.778 175.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.9 mt -82.22 108.28 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.158 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.3 m -120.0 136.74 54.44 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 113.404 -1.725 . . . . 0.0 113.427 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.83 130.81 19.3 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.042 172.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -123.19 118.65 28.12 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.682 -1.145 . . . . 0.0 107.984 163.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 170.14 -173.44 44.17 Favored Glycine 0 N--CA 1.478 1.486 0 CA-C-N 113.93 -1.486 . . . . 0.0 112.697 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -47.41 -45.95 25.91 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 125.015 1.326 . . . . 0.0 113.667 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -114.22 34.78 4.49 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -46.05 -72.85 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.22 -43.33 64.21 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 177.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -62.77 -45.82 90.9 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.319 -1.31 . . . . 0.0 112.864 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.1 -52.44 65.27 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.481 1.113 . . . . 0.0 112.802 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.6 t -64.75 -46.36 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.952 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -55.07 -52.25 63.8 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -60.78 -48.42 81.9 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.888 0.875 . . . . 0.0 113.076 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.4 mt -63.03 -37.79 88.6 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.82 -45.27 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.316 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -55.15 -54.35 44.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 123.617 0.573 . . . . 0.0 111.052 173.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -49.36 -54.86 15.12 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 125.636 1.575 . . . . 0.0 111.846 175.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -58.12 -40.62 81.71 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.466 1.106 . . . . 0.0 113.07 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.79 -44.06 64.6 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 175.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -70.56 -3.27 17.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.518 1.527 . . . . 0.0 114.293 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.9 mt . . . . . 0 N--CA 1.48 1.056 0 C-N-CA 124.856 1.262 . . . . 0.0 110.761 169.628 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ttt . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.77 141.84 39.02 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.282 -1.326 . . . . 0.0 113.091 173.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -148.55 127.82 12.98 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.427 -1.715 . . . . 0.0 110.031 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -126.77 117.7 23.2 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.012 0.82 . . . . 0.0 112.597 164.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -84.06 97.81 9.52 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 125.643 1.84 . . . . 0.0 108.623 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.93 141.48 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 113.592 -1.64 . . . . 0.0 112.491 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.4 p -107.77 137.87 45.02 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.3 mt -76.75 122.85 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.487 175.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.2 p -91.49 -43.47 9.67 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.107 -1.406 . . . . 0.0 114.114 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -28.77 133.44 0.19 Allowed Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 126.978 2.111 . . . . 0.0 115.121 175.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.53 -54.19 4.98 Favored 'Trans proline' 0 N--CA 1.482 0.841 0 C-N-CA 124.296 3.331 . . . . 0.0 112.49 -173.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -78.15 -43.59 28.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.166 0.986 . . . . 0.0 112.559 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.12 -152.91 19.02 Favored Glycine 0 N--CA 1.475 1.239 0 C-N-CA 125.464 1.507 . . . . 0.0 110.508 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 172.687 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.279 83.0 mmt-85 -85.32 -44.06 0.65 Allowed Pre-proline 0 N--CA 1.483 1.205 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -62.74 -37.35 56.89 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 121.528 1.486 . . . . 0.0 111.703 164.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.27 -40.95 71.6 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.96 -36.97 75.72 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 173.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -66.66 -49.77 65.08 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.822 0.701 . . . . 0.0 111.418 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -54.99 -43.48 73.6 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 124.045 0.841 . . . . 0.0 111.45 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.1 t -53.18 -61.83 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.657 1.183 . . . . 0.0 111.324 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -49.23 -46.37 45.8 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 124.176 0.922 . . . . 0.0 111.822 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.32 -55.62 17.22 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.678 1.236 . . . . 0.0 112.906 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.56 -30.17 70.49 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -55.51 -30.82 61.36 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 170.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.99 -5.9 66.47 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.12 1.343 . . . . 0.0 114.896 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -95.89 142.48 28.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.153 0.581 . . . . 0.0 111.737 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.434 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 44.7 p -63.87 -39.01 93.2 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.174 0.99 . . . . 0.0 111.51 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 p -62.04 141.43 58.09 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.372 -1.285 . . . . 0.0 112.71 168.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -94.26 108.56 20.43 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 123.311 1.529 . . . . 0.0 110.117 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.4 mm -73.79 106.91 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 111.228 -2.715 . . . . 0.0 109.87 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.4 p -108.8 110.41 21.78 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 122.806 1.288 . . . . 0.0 112.063 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.0 t -81.87 106.27 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 112.379 -2.192 . . . . 0.0 109.057 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.5 m -85.72 105.67 16.42 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 122.354 1.073 . . . . 0.0 110.016 172.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.8 t -118.75 109.42 16.06 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 113.338 -1.756 . . . . 0.0 110.458 171.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 p30 43.94 71.25 0.26 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.72 9.25 37.85 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-N 112.99 -1.914 . . . . 0.0 116.349 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -118.82 99.25 6.64 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 122.328 -0.513 . . . . 0.0 110.841 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.4 m -79.97 98.76 7.31 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.651 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.88 124.53 49.11 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 113.366 -1.743 . . . . 0.0 112.709 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.6 t -70.37 132.17 45.22 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 113.164 -1.835 . . . . 0.0 113.297 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.77 -25.37 59.03 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 113.924 -1.489 . . . . 0.0 114.054 167.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -73.69 -27.27 61.13 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.8 t -96.16 92.65 6.51 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.347 1.07 . . . . 0.0 109.177 171.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.2 tp -37.78 -55.01 1.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 126.98 2.112 . . . . 0.0 114.529 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -65.69 -33.48 75.99 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -59.98 -49.48 77.52 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tp -63.84 -39.63 94.68 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -65.69 -37.49 86.62 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 t -99.84 78.69 2.14 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 125.046 2.355 . . . . 0.0 111.91 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.2 tp -149.58 -51.0 0.15 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 111.361 -2.654 . . . . 0.0 112.473 -173.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.5 65.26 0.93 Allowed Glycine 0 N--CA 1.472 1.06 0 O-C-N 125.467 1.73 . . . . 0.0 110.387 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 78.7 mt -85.14 91.63 8.17 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.441 0.638 . . . . 0.0 110.258 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.4 t -135.91 -163.43 1.4 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.373 -171.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -63.8 118.83 8.9 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.825 0.85 . . . . 0.0 111.145 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.11 -10.05 76.04 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-N 113.6 -1.636 . . . . 0.0 115.371 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.2 p -75.81 142.5 42.25 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 117.656 0.728 . . . . 0.0 112.383 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.28 137.21 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 113.022 -1.899 . . . . 0.0 109.307 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 m -110.54 78.85 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-N 112.473 -2.149 . . . . 0.0 107.398 165.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -74.95 86.29 2.28 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 173.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.1 mt -74.72 87.65 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.246 -173.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 75.0 m -88.67 125.55 34.89 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 112.806 -1.997 . . . . 0.0 110.272 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.55 136.15 20.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.281 -1.327 . . . . 0.0 113.489 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -130.91 128.66 40.97 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.334 1.022 . . . . 0.0 110.067 172.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.39 -176.93 30.44 Favored Glycine 0 N--CA 1.492 2.428 0 O-C-N 124.193 0.933 . . . . 0.0 115.142 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -53.85 -33.79 57.38 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.434 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 5.3 p30 -111.61 19.18 18.35 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -46.8 -51.93 15.31 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.439 ' NE2' ' H ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -62.54 -42.58 99.62 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 177.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -69.09 -46.13 68.55 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.477 -177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.67 -53.98 44.36 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.313 1.445 . . . . 0.0 113.133 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.8 t -59.09 -52.75 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.36 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.34 -47.54 81.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.737 0.815 . . . . 0.0 113.14 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -57.48 -55.46 34.58 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.84 1.256 . . . . 0.0 111.423 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.9 mt -66.44 -30.17 70.47 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.7 t -65.58 -48.56 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 123.373 0.42 . . . . 0.0 110.059 170.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -63.62 -44.8 92.88 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 117.94 -1.029 . . . . 0.0 113.294 175.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.7 tp -51.51 -51.52 54.52 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.359 1.063 . . . . 0.0 111.313 172.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -57.75 -42.57 84.24 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.051 0.94 . . . . 0.0 112.994 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.28 -43.87 66.33 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -82.98 35.68 0.48 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.845 1.658 . . . . 0.0 112.932 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 mt . . . . . 0 N--CA 1.481 1.121 0 C-N-CA 125.572 1.549 . . . . 0.0 112.704 179.298 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttt . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -110.48 136.89 48.92 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 125.958 2.036 . . . . 0.0 109.883 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -120.02 143.72 47.92 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 113.336 -1.756 . . . . 0.0 109.171 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -141.95 102.07 4.07 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.525 1.141 . . . . 0.0 109.674 171.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -81.87 102.13 10.66 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 111.938 -2.392 . . . . 0.0 108.682 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 m -125.02 158.2 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 112.507 -2.133 . . . . 0.0 111.76 -177.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.5 p -109.68 137.46 47.46 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.805 0.812 . . . . 0.0 111.696 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.2 mt -91.53 93.18 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 166.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 p -86.43 -17.05 35.3 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 111.424 -2.625 . . . . 0.0 115.43 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.49 133.97 85.53 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.611 1.165 . . . . 0.0 112.155 175.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -44.55 -51.49 7.04 Favored 'Trans proline' 0 CA--C 1.541 0.836 1 C-N-CA 125.318 4.012 . . . . 0.0 116.563 -170.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -106.13 -27.64 10.97 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 172.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.21 -108.67 2.6 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 124.467 1.032 . . . . 0.0 112.691 170.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.1 mt . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -175.389 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.8 p . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.256 88.5 mmt-85 -74.74 -56.45 2.21 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-O 115.721 -2.085 . . . . 0.0 115.011 -175.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -59.47 -34.57 97.18 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.778 2.319 . . . . 0.0 113.952 174.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.7 -25.99 2.08 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 172.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.26 98.57 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -65.99 -38.83 89.51 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.977 0.911 . . . . 0.0 112.674 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.41 -42.01 86.23 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.06 0.85 . . . . 0.0 112.134 172.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.3 t -64.92 -51.5 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.274 0.63 . . . . 0.0 112.06 170.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -49.87 -43.13 48.98 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.606 1.162 . . . . 0.0 112.608 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -67.58 -51.67 47.64 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.019 0.824 . . . . 0.0 111.915 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.49 -32.18 73.56 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -44.65 -39.39 5.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.896 1.278 . . . . 0.0 114.431 167.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.35 -32.22 75.39 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 125.15 1.531 . . . . 0.0 114.898 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -74.82 133.46 41.91 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.461 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 76.0 p -65.89 -46.87 76.78 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.972 -173.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.2 p -66.53 137.75 57.01 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.817 1.647 . . . . 0.0 111.473 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -83.95 101.57 11.8 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 122.876 1.322 . . . . 0.0 111.758 -178.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.9 mm -70.05 100.41 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.281 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.2 p -94.2 103.93 15.96 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.325 174.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.6 96.29 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 112.776 -2.011 . . . . 0.0 107.514 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.6 m -88.84 104.52 17.0 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 113.473 -1.694 . . . . 0.0 111.322 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.4 t -108.31 99.24 8.67 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.72 172.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 p30 47.57 75.0 0.14 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.853 1.661 . . . . 0.0 114.011 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.05 -39.77 1.18 Allowed Glycine 0 CA--C 1.542 1.771 0 CA-C-N 113.176 -1.829 . . . . 0.0 114.044 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -77.03 106.9 9.01 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 123.606 1.67 . . . . 0.0 110.807 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -108.86 106.38 16.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 112.355 -2.202 . . . . 0.0 110.621 -170.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -110.47 122.63 48.18 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.93 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.2 t -64.91 119.05 9.96 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 113.468 -1.696 . . . . 0.0 111.676 174.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.66 -11.34 53.48 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.296 -1.774 . . . . 0.0 114.568 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -72.84 -21.12 61.0 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 166.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.5 t -112.55 99.97 8.37 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.38 1.072 . . . . 0.0 112.596 -174.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp -36.77 -54.88 0.9 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 112.99 -1.914 . . . . 0.0 115.131 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -63.48 -46.4 86.33 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.495 -1.684 . . . . 0.0 113.659 -172.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.8 tttm -63.03 -44.42 95.96 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.275 0.63 . . . . 0.0 112.282 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.8 tp -66.61 -44.03 83.2 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -60.56 -26.12 66.69 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.3 t -108.41 60.61 0.61 Allowed 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 124.449 2.071 . . . . 0.0 112.415 172.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 tp -124.99 -48.38 1.75 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 111.804 -2.453 . . . . 0.0 110.799 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.09 67.41 0.81 Allowed Glycine 0 CA--C 1.535 1.329 0 O-C-N 124.833 1.333 . . . . 0.0 110.57 176.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.5 mt -88.01 86.68 7.16 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.084 0.945 . . . . 0.0 110.151 -174.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -133.81 -175.24 3.77 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 112.211 -2.268 . . . . 0.0 113.772 -169.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -59.02 112.96 1.87 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.766 2.426 . . . . 0.0 111.915 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.08 -6.9 56.71 Favored Glycine 0 CA--C 1.547 2.076 0 CA-C-N 112.992 -1.913 . . . . 0.0 114.489 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.0 p -75.66 103.34 5.72 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.7 t -65.38 115.21 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 112.858 -1.974 . . . . 0.0 109.05 170.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.5 m -118.94 106.12 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 112.971 -1.922 . . . . 0.0 111.658 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 42.5 m -83.44 95.18 8.18 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 112.233 -2.258 . . . . 0.0 109.358 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -89.48 91.82 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 112.103 -2.317 . . . . 0.0 108.443 -175.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.0 m -104.58 122.48 45.7 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 111.334 -2.666 . . . . 0.0 112.266 -170.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -137.3 147.96 46.02 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 124.86 1.35 . . . . 0.0 112.627 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -134.37 128.29 33.34 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.692 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.08 -159.78 24.76 Favored Glycine 0 N--CA 1.489 2.181 0 O-C-N 124.491 1.119 . . . . 0.0 114.82 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -49.66 -34.98 19.95 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.461 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 11.6 p30 -119.94 12.76 12.1 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 118.947 2.943 . . . . 0.0 118.947 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -33.02 -54.28 0.38 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -60.22 2.61 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 176.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -53.62 -34.46 58.61 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.683 1.593 . . . . 0.0 114.055 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.19 -59.55 3.35 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.825 1.25 . . . . 0.0 112.775 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.87 -51.77 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.928 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -49.27 -51.82 31.31 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.428 1.091 . . . . 0.0 112.71 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -58.83 -55.55 33.69 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.05 0.94 . . . . 0.0 112.416 176.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.4 tp -61.91 -36.88 82.64 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.238 1.415 . . . . 0.0 113.252 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.5 t -73.58 -36.28 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.793 0.837 . . . . 0.0 111.583 175.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -60.12 -37.19 79.27 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 118.2 -0.905 . . . . 0.0 113.17 168.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.3 tp -57.34 -40.68 78.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 123.886 0.741 . . . . 0.0 112.211 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -69.28 -27.08 65.1 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.76 1.224 . . . . 0.0 113.377 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.57 -26.63 26.02 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.538 1.135 . . . . 0.0 113.372 176.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -89.71 28.79 1.25 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.15 1.38 . . . . 0.0 113.227 170.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.3 mt . . . . . 0 CA--C 1.548 0.886 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.664 178.425 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 ttt . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -95.1 130.19 41.9 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 124.595 1.184 . . . . 0.0 109.157 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -125.4 122.08 35.71 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.303 -1.771 . . . . 0.0 110.004 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -122.58 119.1 29.84 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.488 1.137 . . . . 0.0 112.343 170.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -96.99 89.2 4.74 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.927 -1.942 . . . . 0.0 108.915 -174.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 m -111.68 141.4 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 114.089 -1.414 . . . . 0.0 114.419 -169.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.1 p -89.72 116.35 27.77 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 114.665 -1.152 . . . . 0.0 113.931 -173.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.16 101.98 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 166.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.0 p -94.09 -11.88 29.66 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 112.391 -2.186 . . . . 0.0 114.23 174.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.74 131.53 94.92 Favored Pre-proline 0 N--CA 1.481 1.112 0 C-N-CA 125.344 1.458 . . . . 0.0 111.092 175.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -50.44 -50.25 14.12 Favored 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 124.205 3.27 . . . . 0.0 114.132 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -98.68 -48.38 4.98 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.08 0.863 . . . . 0.0 112.769 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.09 -126.94 7.68 Favored Glycine 0 N--CA 1.48 1.616 0 O-C-N 124.269 0.981 . . . . 0.0 113.086 170.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.5 mt . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -176.463 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.265 5.5 mmt180 -80.75 -46.45 1.24 Allowed Pre-proline 0 N--CA 1.482 1.162 0 CA-C-O 116.774 -1.584 . . . . 0.0 115.173 -172.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -61.19 -37.09 76.99 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 121.983 1.789 . . . . 0.0 112.585 166.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.21 -42.86 66.73 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 170.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.63 -38.17 90.08 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 174.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -64.85 -41.55 95.61 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.317 1.047 . . . . 0.0 112.62 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -59.73 -44.3 93.81 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.972 1.309 . . . . 0.0 111.425 172.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.1 t -59.59 -44.65 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 124.073 0.949 . . . . 0.0 111.982 173.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -48.75 -51.23 30.07 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.9 0.88 . . . . 0.0 111.254 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -65.85 -55.78 15.27 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 124.961 1.413 . . . . 0.0 111.766 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.53 -34.7 62.21 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -56.84 -28.32 61.47 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 172.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.81 3.1 65.66 Favored Glycine 0 N--CA 1.49 2.287 0 O-C-N 125.199 1.562 . . . . 0.0 114.874 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -102.6 153.83 19.72 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.546 0.738 . . . . 0.0 111.469 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.487 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 52.4 p -63.08 -44.35 96.01 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.396 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 p -64.04 151.71 42.22 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -97.88 110.63 23.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 113.942 -1.481 . . . . 0.0 107.94 166.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.5 mm -81.19 119.11 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 CA-C-N 111.878 -2.419 . . . . 0.0 109.189 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.08 113.5 27.07 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.091 0.948 . . . . 0.0 112.417 173.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.6 t -94.73 97.69 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 112.634 -2.075 . . . . 0.0 106.345 175.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.8 m -95.91 122.29 38.56 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 113.414 -1.721 . . . . 0.0 110.997 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -128.55 96.6 4.45 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.74 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.8 p30 33.77 90.25 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 126.481 1.912 . . . . 0.0 115.707 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.92 -66.7 3.29 Favored Glycine 0 N--CA 1.479 1.529 0 CA-C-N 112.729 -2.032 . . . . 0.0 112.109 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.54 135.55 47.1 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 115.134 -0.533 . . . . 0.0 111.33 -172.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.4 t -123.25 118.1 26.81 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 124.717 1.261 . . . . 0.0 111.878 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.67 111.36 22.29 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 114.05 -1.432 . . . . 0.0 114.172 -174.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.8 t -61.88 124.37 20.59 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 113.445 -1.707 . . . . 0.0 112.66 169.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.31 7.06 17.64 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.032 -1.44 . . . . 0.0 113.843 171.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -94.92 -10.84 29.92 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 160.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 t -109.72 114.97 29.0 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.177 0.991 . . . . 0.0 110.234 171.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 tp -49.88 -53.57 25.03 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.287 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -64.45 -38.32 90.63 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -60.68 -49.63 76.73 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.11 -39.16 91.58 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 173.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -67.67 -32.91 73.91 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 t -116.31 67.85 0.72 Allowed 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 124.039 1.876 . . . . 0.0 113.089 170.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.6 tp -116.17 -50.91 2.65 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 111.717 -2.492 . . . . 0.0 113.79 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.96 78.6 1.19 Allowed Glycine 0 N--CA 1.477 1.369 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -170.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.3 mt -107.33 80.87 1.46 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.286 -0.957 . . . . 0.0 110.737 -173.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.6 t -142.58 175.5 9.75 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.844 -1.526 . . . . 0.0 114.208 -165.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -50.6 127.2 17.34 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.615 1.966 . . . . 0.0 111.442 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.07 -29.45 10.67 Favored Glycine 0 N--CA 1.482 1.737 0 CA-C-N 112.853 -1.976 . . . . 0.0 113.058 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.8 p -66.98 113.15 4.76 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.4 t -86.04 105.42 14.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 112.739 -2.028 . . . . 0.0 105.797 171.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.4 m -99.55 105.76 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 113.761 -1.563 . . . . 0.0 112.342 -174.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.92 95.71 1.6 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.233 -1.803 . . . . 0.0 109.952 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 79.6 mt -82.18 97.14 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.649 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.7 m -110.03 121.54 45.5 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 112.679 -2.055 . . . . 0.0 109.926 -175.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.96 138.41 45.45 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -133.76 141.73 47.63 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.166 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.78 -150.49 19.04 Favored Glycine 0 CA--C 1.538 1.527 0 O-C-N 124.9 1.375 . . . . 0.0 110.62 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.09 -60.62 3.49 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.487 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 5.9 p30 -91.64 39.26 1.0 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -175.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -52.31 -55.76 19.31 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -45.45 77.53 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.43 1.092 . . . . 0.0 113.06 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -59.59 -50.26 74.56 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.819 1.248 . . . . 0.0 112.049 -176.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.19 -54.06 51.08 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.294 1.038 . . . . 0.0 112.728 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.6 t -62.41 -48.49 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-O 118.06 -0.971 . . . . 0.0 111.045 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -54.23 -53.5 52.72 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.299 1.04 . . . . 0.0 111.718 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -56.33 -52.29 65.09 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.341 1.057 . . . . 0.0 112.449 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.9 mt -66.44 -34.5 78.09 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.95 -51.42 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-O 118.849 -0.596 . . . . 0.0 109.971 170.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -58.34 -42.91 87.89 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.2 tt -55.04 -56.87 14.98 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.245 1.018 . . . . 0.0 111.639 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -57.75 -39.28 76.99 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.842 0.857 . . . . 0.0 112.774 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.83 -29.55 69.51 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -86.51 -25.05 25.3 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.3 tp . . . . . 0 CA--C 1.549 0.905 0 C-N-CA 124.087 0.955 . . . . 0.0 110.691 173.746 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 ttt . . . . . 0 C--O 1.233 0.203 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -121.74 111.58 17.34 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.941 0.776 . . . . 0.0 111.056 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -108.8 116.36 31.83 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 112.603 -2.09 . . . . 0.0 110.45 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -119.62 118.13 30.17 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.251 172.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -89.7 111.66 22.7 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 112.745 -2.025 . . . . 0.0 107.427 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.2 m -127.75 162.09 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.713 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.1 p -113.4 137.65 51.22 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.083 171.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 mt -95.92 111.47 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -103.74 -18.73 14.57 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.98 141.93 74.95 Favored Pre-proline 0 C--O 1.256 1.438 0 CA-C-O 116.989 -1.482 . . . . 0.0 114.173 177.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.93 -56.83 2.7 Favored 'Trans proline' 0 N--CA 1.493 1.475 1 C-N-CA 125.973 4.449 . . . . 0.0 116.256 -169.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -102.67 -20.27 14.47 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.4 -118.26 11.55 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.236 1.874 . . . . 0.0 113.19 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.7 mt . . . . . 0 N--CA 1.474 0.743 0 CA-C-N 112.096 -2.052 . . . . 0.0 114.415 -176.129 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.0 p . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -75.26 -43.35 4.4 Favored Pre-proline 0 N--CA 1.486 1.348 0 CA-C-O 115.932 -1.985 . . . . 0.0 114.68 -172.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -61.81 -26.48 79.49 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 121.974 1.782 . . . . 0.0 112.091 166.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.05 -35.38 61.9 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.148 0.579 . . . . 0.0 112.476 175.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.96 -38.03 75.27 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.746 1.219 . . . . 0.0 112.482 168.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -65.14 -43.46 91.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.621 0.768 . . . . 0.0 111.971 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -64.05 -39.25 93.67 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.465 1.106 . . . . 0.0 111.558 175.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.4 t -58.53 -49.26 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 125.005 1.322 . . . . 0.0 111.877 173.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -56.21 -42.95 78.04 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.04 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -68.71 -42.26 77.94 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.188 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.12 -27.49 68.08 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -68.93 -11.48 60.69 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 172.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.51 -33.18 7.27 Favored Glycine 0 N--CA 1.481 1.674 0 C-N-CA 124.774 1.178 . . . . 0.0 112.957 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -72.6 128.45 35.6 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.081 1.352 . . . . 0.0 111.765 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.504 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 64.5 p -54.3 -36.92 64.23 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.457 -1.247 . . . . 0.0 113.659 172.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.3 p -61.69 146.24 49.79 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.371 1.044 . . . . 0.0 111.598 167.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -102.15 98.09 8.3 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 113.663 -1.608 . . . . 0.0 108.991 169.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.3 mm -62.22 113.11 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 112.501 -2.136 . . . . 0.0 110.232 177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.1 p -97.62 134.94 40.14 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.048 165.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.2 t -111.37 94.84 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 111.49 -2.595 . . . . 0.0 108.61 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.9 m -88.52 101.67 14.17 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 111.413 -2.63 . . . . 0.0 112.029 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 t -117.85 112.77 20.82 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.841 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.25 20.4 p30 44.73 61.36 2.49 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 126.046 1.738 . . . . 0.0 115.662 -173.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.68 19.87 63.29 Favored Glycine 0 CA--C 1.546 1.974 0 N-CA-C 116.896 1.519 . . . . 0.0 116.896 -176.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.9 mttt -118.75 107.85 14.15 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.743 0.771 . . . . 0.0 109.773 171.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.2 m -90.23 105.71 17.99 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 122.809 1.29 . . . . 0.0 111.606 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.88 105.3 14.43 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.675 -2.057 . . . . 0.0 111.525 -176.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.5 t -50.54 111.35 0.52 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 114.221 -1.354 . . . . 0.0 114.213 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.33 -18.42 65.3 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.283 -1.78 . . . . 0.0 113.666 169.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -77.94 -10.64 59.68 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.2 t -111.81 118.11 34.66 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.48 1.133 . . . . 0.0 112.057 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -46.2 -53.52 10.39 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 111.016 -2.811 . . . . 0.0 113.672 -172.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -69.29 -39.95 78.01 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -64.13 -52.06 60.95 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -167.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.68 -46.43 82.47 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.435 1.094 . . . . 0.0 113.105 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -63.92 -33.87 76.67 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.261 11.1 t -74.23 -48.41 29.01 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.3 tp -37.38 -53.19 1.12 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -167.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.13 67.19 0.52 Allowed Glycine 0 N--CA 1.484 1.839 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.9 mt -81.26 94.77 6.78 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 122.297 1.046 . . . . 0.0 111.4 174.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -150.41 -172.13 4.1 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.301 -2.227 . . . . 0.0 111.213 -168.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -52.21 125.91 17.24 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.812 2.045 . . . . 0.0 114.617 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.28 22.34 63.07 Favored Glycine 0 N--CA 1.484 1.888 0 CA-C-N 111.704 -2.498 . . . . 0.0 114.595 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.3 p -103.39 104.48 14.59 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 122.536 1.16 . . . . 0.0 112.5 -172.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 t -69.69 113.57 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 111.156 -2.747 . . . . 0.0 108.725 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.71 117.24 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 112.892 -1.958 . . . . 0.0 110.812 -175.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.3 m -87.06 100.31 12.55 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.613 174.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.2 mt -89.1 101.4 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 113.655 -1.611 . . . . 0.0 108.674 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.4 m -116.46 127.17 54.35 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 109.76 -3.382 . . . . 0.0 111.086 -167.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.23 123.99 40.74 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.475 -176.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -119.13 108.05 14.22 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.931 1.394 . . . . 0.0 108.379 174.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.44 178.21 30.35 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.58 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -51.77 -41.84 61.93 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -176.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.504 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 13.4 p30 -102.47 39.8 1.46 Allowed 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -176.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -55.04 -40.06 69.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.01 -46.06 10.17 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.723 -176.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -52.39 -46.41 66.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.043 1.737 . . . . 0.0 114.82 171.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.19 -53.46 44.4 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -176.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 68.8 t -60.78 -44.47 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.31 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -56.33 -51.44 68.25 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.421 1.089 . . . . 0.0 111.893 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -54.0 -51.58 63.49 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.778 0.831 . . . . 0.0 112.515 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 98.0 mt -65.62 -47.94 73.92 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.0 t -58.56 -38.28 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 118.945 0.793 . . . . 0.0 110.756 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -60.67 -62.98 1.47 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.68 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.8 tp -47.09 -44.17 20.95 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.942 2.097 . . . . 0.0 114.287 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.6 tmm? -53.59 -61.76 2.1 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.684 1.593 . . . . 0.0 112.427 172.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.43 -26.31 66.35 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -68.05 -29.74 68.78 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 172.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 CA--C 1.545 0.788 0 C-N-CA 122.917 0.487 . . . . 0.0 111.891 171.193 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ttt . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -81.85 133.59 35.34 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.479 167.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -137.17 133.87 35.7 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 112.581 -2.1 . . . . 0.0 110.003 -173.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -126.19 111.29 14.43 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.147 172.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -79.3 80.81 5.63 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.913 1.34 . . . . 0.0 109.72 167.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 m -107.61 135.49 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 114.158 -1.383 . . . . 0.0 113.899 -175.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 p -76.34 140.56 41.49 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 112.444 -2.162 . . . . 0.0 113.471 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.9 mt -105.54 118.12 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.684 167.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.9 p -112.84 -12.39 13.32 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.32 132.66 95.19 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-O 118.024 -0.988 . . . . 0.0 111.712 173.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -42.88 -54.67 3.19 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 124.725 3.617 . . . . 0.0 116.602 -170.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -97.78 -41.9 7.85 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 174.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.06 -120.66 7.32 Favored Glycine 0 CA--C 1.541 1.681 0 C-N-CA 124.059 0.838 . . . . 0.0 112.36 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 31.4 mt . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -171.671 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.283 21.0 mmt180 -76.37 -49.42 3.01 Favored Pre-proline 0 N--CA 1.487 1.41 0 CA-C-O 116.442 -1.742 . . . . 0.0 115.242 -174.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -64.5 -31.45 60.9 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 121.698 1.642 . . . . 0.0 113.627 167.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.22 -38.93 77.75 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 169.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.82 -39.97 86.86 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -61.92 -44.7 96.25 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.628 0.771 . . . . 0.0 112.262 173.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -55.27 -43.69 74.93 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.929 1.292 . . . . 0.0 111.588 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.97 -51.03 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 123.661 0.784 . . . . 0.0 111.895 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -48.56 -47.62 39.29 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.673 0.789 . . . . 0.0 110.995 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.62 -50.89 47.93 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.743 1.277 . . . . 0.0 113.276 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.1 -36.63 63.41 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -60.63 -27.38 67.73 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 173.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.79 -23.17 76.99 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.292 1.425 . . . . 0.0 114.159 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -89.98 149.26 22.64 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.952 0.901 . . . . 0.0 110.69 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.42 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 72.1 p -71.5 -39.42 70.83 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.39 0.676 . . . . 0.0 112.073 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.5 p -65.71 137.97 57.65 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.681 1.192 . . . . 0.0 114.163 175.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -85.28 104.21 14.92 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.605 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.7 mm -72.93 94.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 111.94 -2.391 . . . . 0.0 110.289 173.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.4 p -89.48 113.86 25.29 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.275 -1.329 . . . . 0.0 108.993 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -100.57 96.52 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 113.183 -1.826 . . . . 0.0 107.563 -177.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.8 m -87.92 116.65 26.23 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 112.962 -1.927 . . . . 0.0 111.473 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -111.12 105.85 14.7 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.733 173.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 p30 40.21 69.29 0.32 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.591 1.556 . . . . 0.0 114.204 -173.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.33 -39.71 3.0 Favored Glycine 0 N--CA 1.485 1.918 0 CA-C-N 113.197 -1.819 . . . . 0.0 114.15 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -72.74 99.05 2.51 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.353 1.061 . . . . 0.0 112.438 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.3 m -83.94 108.42 16.91 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.541 -1.663 . . . . 0.0 113.398 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.57 115.13 28.66 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.182 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.9 t -67.08 125.77 27.06 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 113.916 -1.493 . . . . 0.0 113.219 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.84 -5.24 47.51 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 112.402 -2.181 . . . . 0.0 113.422 171.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -83.65 8.2 15.11 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 167.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 t -144.41 131.04 20.02 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.933 0.493 . . . . 0.0 112.129 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.07 -68.31 0.22 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 113.733 -1.576 . . . . 0.0 113.552 -171.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -54.64 -39.38 67.93 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -57.1 -55.0 40.38 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 124.165 0.916 . . . . 0.0 112.935 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 tp -68.0 -48.57 65.37 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.895 1.372 . . . . 0.0 113.616 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -61.41 -34.44 75.37 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 -172.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.2 t -72.17 -20.03 61.66 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.1 tp -70.11 -37.53 75.38 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.51 73.83 1.28 Allowed Glycine 0 N--CA 1.484 1.847 0 O-C-N 124.439 1.087 . . . . 0.0 113.074 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.1 mt -84.81 92.93 8.37 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.387 0.613 . . . . 0.0 110.273 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.9 t -141.5 -175.0 4.2 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -169.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -56.5 112.93 1.4 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.106 0.963 . . . . 0.0 111.146 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.54 -30.8 6.25 Favored Glycine 0 CA--C 1.542 1.72 0 CA-C-N 113.611 -1.631 . . . . 0.0 114.496 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.6 p -70.11 103.58 2.35 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.4 t -68.11 117.78 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 163.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.8 m -118.17 109.59 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 113.654 -1.612 . . . . 0.0 113.004 -175.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.71 86.87 2.75 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.052 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.2 mt -78.8 95.28 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.7 m -105.42 128.14 53.37 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 112.948 -1.933 . . . . 0.0 110.693 -174.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.49 116.13 28.34 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -105.97 97.42 7.24 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.74 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.09 -175.05 28.5 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-N 114.536 -1.211 . . . . 0.0 113.361 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -55.88 -54.46 44.34 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 -169.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.42 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 6.2 p30 -83.52 28.88 0.53 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -38.78 -60.64 0.81 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -50.58 72.07 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -67.09 -40.09 86.89 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -175.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.34 -52.43 65.65 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 123.767 0.667 . . . . 0.0 112.678 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.0 t -63.5 -49.58 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.647 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -49.93 -57.44 7.49 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.573 1.549 . . . . 0.0 112.011 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -59.46 -50.79 72.56 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.898 0.879 . . . . 0.0 113.102 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.4 mt -63.22 -36.05 82.36 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -62.02 -48.64 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 123.808 0.693 . . . . 0.0 110.566 171.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -54.25 -55.5 27.51 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 118.234 -0.888 . . . . 0.0 113.062 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.8 tp -52.66 -48.97 66.13 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.047 0.939 . . . . 0.0 112.832 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -57.36 -45.53 84.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.402 1.081 . . . . 0.0 112.642 175.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.54 -25.22 60.3 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -74.55 -41.09 61.17 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.15 1.166 . . . . 0.0 114.15 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.7 mt . . . . . 0 N--CA 1.483 1.192 0 C-N-CA 124.343 1.057 . . . . 0.0 113.342 177.247 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.435 ' H3 ' ' CD ' ' A' ' 70' ' ' GLU . 24.3 ttt . . . . . 0 N--CA 1.465 0.28 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -119.83 139.94 51.58 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 125.066 1.479 . . . . 0.0 110.01 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -134.03 129.75 36.55 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 124.59 1.181 . . . . 0.0 111.729 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -128.47 136.64 51.1 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.374 1.046 . . . . 0.0 112.454 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -98.89 110.24 22.87 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.187 -1.37 . . . . 0.0 110.449 173.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 m -119.79 152.8 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 114.468 -1.242 . . . . 0.0 114.242 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.6 p -111.98 121.94 46.39 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 113.531 -1.668 . . . . 0.0 111.447 -173.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.1 mt -79.69 96.47 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.17 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -74.67 -34.7 62.74 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.15 134.42 68.52 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 125.486 1.514 . . . . 0.0 113.67 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -45.71 -43.91 18.28 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.539 3.493 . . . . 0.0 117.493 -173.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -114.5 -40.8 3.54 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 172.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.17 -114.47 3.91 Favored Glycine 0 N--CA 1.475 1.279 0 C-N-CA 123.986 0.803 . . . . 0.0 111.769 168.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.1 mt . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 114.185 1.179 . . . . 0.0 114.185 -167.983 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.8 p . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.266 20.2 mmt180 -71.8 -54.08 6.56 Favored Pre-proline 0 N--CA 1.487 1.418 0 CA-C-O 116.579 -1.677 . . . . 0.0 115.168 -174.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -62.93 -34.26 71.98 Favored 'Trans proline' 0 N--CA 1.479 0.632 0 CA-C-N 121.899 1.714 . . . . 0.0 113.653 171.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.73 -36.91 62.8 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 172.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.71 -40.38 83.51 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 174.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.32 -45.42 91.4 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -55.48 -45.73 76.94 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.795 1.238 . . . . 0.0 110.934 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.47 -50.22 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 123.403 0.681 . . . . 0.0 111.228 175.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -50.03 -47.08 53.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.289 1.036 . . . . 0.0 112.275 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.09 -49.15 65.96 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 124.269 0.98 . . . . 0.0 113.387 174.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.5 -39.61 76.85 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -47.7 -44.26 27.39 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.71 1.604 . . . . 0.0 113.898 167.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.17 -34.22 69.72 Favored Glycine 0 N--CA 1.475 1.261 0 O-C-N 125.435 1.709 . . . . 0.0 114.355 -176.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -65.69 145.87 55.5 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.306 0.643 . . . . 0.0 111.702 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.488 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 57.9 p -64.12 -35.19 79.94 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.216 176.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.0 p -68.71 144.97 54.24 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.294 -1.321 . . . . 0.0 114.497 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.404 ' CD ' ' HG ' ' A' ' 43' ' ' SER . 16.9 tt0 -92.56 118.21 30.77 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.938 169.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.1 mm -86.17 103.25 12.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 111.706 -2.497 . . . . 0.0 110.195 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.4 p -103.47 118.91 37.84 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.378 175.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.6 t -99.24 95.95 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 112.961 -1.927 . . . . 0.0 107.504 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.5 m -91.34 110.29 21.58 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 113.657 -1.61 . . . . 0.0 110.79 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.8 t -108.16 95.27 5.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 113.544 -1.662 . . . . 0.0 109.634 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.3 p30 43.63 72.43 0.19 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.365 1.466 . . . . 0.0 114.349 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.62 -38.93 2.92 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-N 113.028 -1.896 . . . . 0.0 114.496 -175.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -75.45 88.91 2.65 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -175.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.5 m -74.13 113.62 11.54 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.381 -1.282 . . . . 0.0 112.982 170.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.12 122.77 47.99 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.088 170.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.404 ' HG ' ' CD ' ' A' ' 32' ' ' GLU . 36.9 t -86.84 128.26 35.04 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.331 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.46 16.28 6.7 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 113.117 -1.856 . . . . 0.0 114.092 176.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -92.58 2.84 56.48 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.663 0.744 . . . . 0.0 112.663 158.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.1 t -127.84 125.93 40.67 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.847 1.659 . . . . 0.0 110.799 172.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.65 -54.04 50.66 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.813 171.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -57.69 -48.93 78.16 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.152 -1.385 . . . . 0.0 113.862 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -60.98 -46.57 90.2 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 tp -68.17 -47.88 66.81 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 123.821 0.7 . . . . 0.0 112.002 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -57.1 -42.26 80.47 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -71.78 -14.51 62.01 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.4 tp -75.37 -42.35 54.2 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.56 82.51 0.7 Allowed Glycine 0 N--CA 1.478 1.481 0 O-C-N 124.394 1.059 . . . . 0.0 112.527 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.8 mt -82.85 78.32 9.46 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 122.877 1.322 . . . . 0.0 112.298 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.0 t -85.36 -174.27 5.12 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 111.914 -2.403 . . . . 0.0 112.569 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -60.23 144.23 50.72 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.979 1.712 . . . . 0.0 111.114 175.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.57 -38.07 3.27 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 114.251 -1.34 . . . . 0.0 114.642 171.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.4 p -54.96 104.62 0.12 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.184 1.549 . . . . 0.0 115.184 -174.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.7 t -66.74 112.46 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 112.152 -2.295 . . . . 0.0 107.177 169.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.5 m -119.32 118.08 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 113.35 -1.75 . . . . 0.0 114.641 -172.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.3 m -80.23 100.45 8.33 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 125.447 1.717 . . . . 0.0 109.084 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 80.2 mt -91.76 102.44 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.586 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 m -100.12 131.66 45.94 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.141 -178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.12 105.86 13.97 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 124.035 0.835 . . . . 0.0 112.353 172.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -104.06 92.46 4.39 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.233 -1.348 . . . . 0.0 111.266 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.3 -167.55 39.94 Favored Glycine 0 N--CA 1.48 1.623 0 CA-C-N 112.252 -2.249 . . . . 0.0 111.148 174.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.01 -51.5 66.57 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.488 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 6.7 p30 -82.38 36.49 0.48 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.435 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 5.9 pt-20 -45.83 -72.53 0.05 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 -173.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.05 -47.99 53.1 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -63.05 -47.25 83.75 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.577 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.32 -46.08 80.03 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.23 0.957 . . . . 0.0 113.538 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.0 t -67.35 -56.06 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.225 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -51.02 -47.16 61.7 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.477 1.111 . . . . 0.0 112.687 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -53.15 -61.41 2.31 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.032 1.333 . . . . 0.0 112.067 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.9 mt -64.27 -33.23 75.35 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.7 t -62.05 -56.31 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.103 0.961 . . . . 0.0 110.527 171.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -57.55 -48.26 79.82 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.449 1.099 . . . . 0.0 111.25 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.2 tp -54.57 -52.01 63.47 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.448 1.499 . . . . 0.0 111.954 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -57.86 -44.91 86.88 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.226 1.011 . . . . 0.0 112.033 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.54 -33.62 75.43 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -75.85 -30.39 58.9 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.484 1.245 0 C-N-CA 123.927 0.891 . . . . 0.0 112.629 175.676 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -108.39 129.18 55.26 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 125.72 1.888 . . . . 0.0 108.001 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -126.98 131.23 51.09 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.621 -170.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -129.32 122.87 30.44 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.432 1.082 . . . . 0.0 113.025 168.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -87.03 100.6 12.74 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 112.442 -2.163 . . . . 0.0 107.945 176.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.5 m -116.97 143.52 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 114.22 -1.355 . . . . 0.0 114.173 -173.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 p -94.03 122.14 36.23 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.408 1.099 . . . . 0.0 111.495 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.2 mt -78.9 97.92 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.6 167.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.7 p -82.81 -26.66 31.52 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 109.962 -3.29 . . . . 0.0 113.526 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.12 120.63 14.44 Favored Pre-proline 0 N--CA 1.476 0.847 0 O-C-N 124.715 1.259 . . . . 0.0 112.277 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -57.38 -48.71 16.33 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 123.785 2.99 . . . . 0.0 113.77 -175.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -68.94 -43.46 75.02 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.545 0.338 . . . . 0.0 111.688 170.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.88 -148.01 17.62 Favored Glycine 0 N--CA 1.475 1.279 0 O-C-N 124.75 1.281 . . . . 0.0 110.984 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 CA--C 1.545 0.777 0 CA-C-N 113.639 -1.28 . . . . 0.0 112.407 173.295 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.7 -44.23 53.03 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-O 116.874 -1.536 . . . . 0.0 114.903 -175.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -69.17 -33.74 18.12 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.734 1.623 . . . . 0.0 113.391 172.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.49 97.45 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.47 0.708 . . . . 0.0 112.487 171.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.89 -46.2 90.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.235 0.614 . . . . 0.0 112.577 169.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -58.81 -43.7 90.64 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 171.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.16 -43.12 87.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.136 0.974 . . . . 0.0 112.895 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.5 t -61.51 -48.91 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 122.478 0.311 . . . . 0.0 110.95 172.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -52.98 -45.44 67.81 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.498 0.719 . . . . 0.0 112.839 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -64.49 -49.4 71.5 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.568 1.147 . . . . 0.0 112.881 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.88 -29.2 67.45 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -51.91 -26.44 10.26 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 168.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.95 -22.83 77.21 Favored Glycine 0 CA--C 1.543 1.826 0 O-C-N 125.109 1.505 . . . . 0.0 115.704 175.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -96.98 143.4 27.88 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.88 0.847 . . . . 0.0 112.406 -178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.515 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 74.8 p -66.35 -37.15 84.67 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.075 -178.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.9 p -63.84 138.6 58.55 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.748 170.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -95.22 96.67 9.34 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 123.412 1.577 . . . . 0.0 108.95 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mt -77.07 128.81 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 111.612 -2.54 . . . . 0.0 110.542 -172.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.4 p -102.32 134.92 44.83 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.349 173.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.8 t -102.29 90.25 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 170.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.1 m -89.41 112.85 24.08 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.14 -1.391 . . . . 0.0 113.723 -170.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.4 t -116.27 97.36 6.0 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 124.377 1.048 . . . . 0.0 111.156 173.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 p30 39.59 83.02 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.816 1.646 . . . . 0.0 115.183 -175.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.03 -41.3 1.97 Allowed Glycine 0 CA--C 1.55 2.258 0 CA-C-N 114.266 -1.333 . . . . 0.0 113.71 -173.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -71.85 79.75 0.88 Allowed 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.4 m -72.02 111.78 7.55 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.029 -1.441 . . . . 0.0 112.937 168.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.09 99.02 9.98 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 113.835 -1.529 . . . . 0.0 112.638 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 t -55.45 119.2 5.26 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.57 1.176 . . . . 0.0 113.186 174.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.17 9.57 1.96 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 112.847 -1.979 . . . . 0.0 114.006 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -104.65 19.99 19.43 Favored 'General case' 0 C--O 1.25 1.082 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 164.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.8 t -140.78 125.42 17.93 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.161 1.384 . . . . 0.0 112.749 174.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -55.73 -44.27 77.38 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 113.58 -1.645 . . . . 0.0 114.209 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -64.39 -39.16 93.32 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.16 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -55.4 -56.41 20.44 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.9 mp -67.91 -31.22 70.85 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -176.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -78.64 -34.28 46.62 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.023 -0.99 . . . . 0.0 113.371 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.7 t -79.09 -32.51 44.68 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.3 tp -51.97 -49.79 62.54 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.366 1.246 . . . . 0.0 114.366 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.76 89.04 1.78 Allowed Glycine 0 N--CA 1.476 1.352 0 O-C-N 125.352 1.657 . . . . 0.0 110.817 -175.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.0 mt -109.05 99.41 8.73 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.813 -0.694 . . . . 0.0 112.315 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.3 t -150.98 170.57 19.02 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.627 1.571 . . . . 0.0 110.589 -174.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -50.13 118.39 2.92 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.598 1.159 . . . . 0.0 112.987 -172.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.81 -29.4 7.5 Favored Glycine 0 CA--C 1.543 1.781 0 CA-C-N 112.585 -2.098 . . . . 0.0 113.696 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.4 p -62.33 100.91 0.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.2 t -78.76 115.9 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 113.356 -1.747 . . . . 0.0 106.811 171.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 m -127.95 129.5 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 113.58 -1.646 . . . . 0.0 112.982 -174.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.4 m -89.05 96.95 10.94 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.421 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.2 mt -67.25 96.83 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 113.476 -1.693 . . . . 0.0 107.404 167.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.6 m -111.27 103.42 11.82 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 112.968 -1.924 . . . . 0.0 111.669 -175.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.28 100.19 12.1 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.624 0.726 . . . . 0.0 112.034 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -99.5 96.36 7.63 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 112.916 -1.947 . . . . 0.0 111.588 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.88 -162.07 28.83 Favored Glycine 0 N--CA 1.48 1.63 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.606 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -60.63 -28.47 68.57 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 120.452 3.501 . . . . 0.0 120.452 -168.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.515 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 20.2 p30 -116.72 50.56 1.06 Allowed 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 175.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -49.16 -55.43 12.41 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -53.29 59.96 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.918 1.287 . . . . 0.0 114.312 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -55.45 -47.45 76.02 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.021 1.328 . . . . 0.0 113.958 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.96 -53.43 57.35 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.571 -1.195 . . . . 0.0 113.372 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 51.1 t -60.83 -50.63 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 118.936 -0.554 . . . . 0.0 112.128 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -52.78 -57.24 10.81 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.458 1.103 . . . . 0.0 112.841 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -54.55 -50.11 68.72 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.46 1.104 . . . . 0.0 113.075 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 72.1 mt -67.57 -38.03 83.51 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.33 -45.35 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.059 0.543 . . . . 0.0 110.559 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -58.14 -49.05 78.32 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 118.313 -0.851 . . . . 0.0 113.153 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.8 tp -54.19 -51.76 63.38 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.891 0.876 . . . . 0.0 112.586 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -59.64 -44.92 93.32 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.98 0.912 . . . . 0.0 112.884 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.06 91.07 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -79.47 -19.76 49.01 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 172.089 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ttt . . . . . 0 C--O 1.236 0.385 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -117.57 115.33 24.89 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 125.1 1.5 . . . . 0.0 109.123 175.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -102.65 129.92 49.4 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.361 -178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -123.37 103.58 8.58 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 171.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -73.78 95.34 2.38 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.294 -1.776 . . . . 0.0 110.675 172.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 m -117.16 146.22 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 113.388 -1.733 . . . . 0.0 113.862 -174.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.0 p -108.56 128.52 54.89 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.714 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 mp -75.81 130.32 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.765 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 p -88.18 -37.32 16.24 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.323 171.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.61 133.38 88.88 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 125.399 1.48 . . . . 0.0 113.704 -175.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.52 -68.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 124.166 3.244 . . . . 0.0 112.431 -172.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -62.06 -34.59 76.55 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.906 0.882 . . . . 0.0 112.222 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.37 -126.27 7.78 Favored Glycine 0 N--CA 1.481 1.647 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 168.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 N--CA 1.475 0.82 0 CA-C-N 113.527 -1.337 . . . . 0.0 113.682 176.464 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.315 12.9 mmt180 -88.04 -39.69 0.48 Allowed Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 -173.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -61.74 -38.76 58.03 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 121.983 1.789 . . . . 0.0 111.384 163.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.23 73.58 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 168.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.26 86.88 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -60.2 -46.32 90.13 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 124.181 0.926 . . . . 0.0 112.513 174.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -55.57 -53.64 53.87 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.499 1.12 . . . . 0.0 110.766 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.2 t -57.91 -49.75 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.645 0.778 . . . . 0.0 111.313 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -49.74 -52.51 31.07 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.335 1.054 . . . . 0.0 112.992 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -68.97 -43.24 75.36 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.689 1.243 . . . . 0.0 112.772 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.68 -37.8 76.82 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 173.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -53.46 -39.64 64.63 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.0 0.92 . . . . 0.0 112.816 169.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.3 15.0 4.64 Favored Glycine 0 CA--C 1.543 1.792 0 O-C-N 124.747 1.28 . . . . 0.0 115.413 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -113.36 152.03 30.49 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.977 0.894 . . . . 0.0 111.992 172.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.48 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 63.4 p -69.94 -40.3 75.56 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.15 175.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -73.66 145.32 45.39 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.796 0.839 . . . . 0.0 112.882 173.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -96.4 109.78 22.25 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.645 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 mp -83.22 106.89 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 112.182 -2.281 . . . . 0.0 109.45 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.0 p -102.39 128.5 48.95 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 112.959 -1.928 . . . . 0.0 110.214 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.06 105.0 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 113.288 -1.778 . . . . 0.0 107.569 -176.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.0 m -106.83 126.2 52.0 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.3 t -116.25 97.32 5.98 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 112.99 -1.914 . . . . 0.0 110.02 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.257 4.0 p30 40.63 73.47 0.12 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 113.518 -1.674 . . . . 0.0 114.706 -175.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.09 -53.22 4.19 Favored Glycine 0 N--CA 1.488 2.111 0 CA-C-N 113.705 -1.589 . . . . 0.0 113.513 -178.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -60.72 104.56 0.36 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.38 1.472 . . . . 0.0 113.525 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 t -90.93 136.03 33.34 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.644 1.349 . . . . 0.0 114.644 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.28 97.43 5.06 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 113.879 -1.51 . . . . 0.0 113.081 173.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -54.6 130.21 39.28 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.985 168.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.81 13.81 21.29 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.109 -1.405 . . . . 0.0 114.337 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.63 -8.88 27.92 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.074 153.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -113.09 111.61 22.43 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 123.464 1.602 . . . . 0.0 112.54 169.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -54.43 -59.51 4.59 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 111.556 -2.565 . . . . 0.0 114.278 -169.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -65.47 -28.56 69.3 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -54.7 -48.12 72.86 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.4 tp -61.32 -43.26 99.17 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 176.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -58.17 -46.89 84.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 124.051 0.844 . . . . 0.0 112.64 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.2 t -66.72 -37.15 84.1 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.5 tp -66.6 -41.77 87.92 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.41 83.97 0.34 Allowed Glycine 0 N--CA 1.476 1.358 0 C-N-CA 124.348 0.975 . . . . 0.0 115.053 170.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 mp -75.03 109.47 8.53 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.336 -0.932 . . . . 0.0 109.598 174.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -135.59 -174.7 3.72 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.928 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -52.2 109.15 0.35 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.549 1.94 . . . . 0.0 112.729 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.82 35.2 51.29 Favored Glycine 0 CA--C 1.543 1.837 0 CA-C-N 114.627 -1.17 . . . . 0.0 115.545 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.2 p -83.35 118.28 23.58 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 117.313 0.556 . . . . 0.0 110.18 168.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.0 t -90.96 80.5 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 125.758 1.911 . . . . 0.0 106.413 -177.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.1 m -100.15 133.15 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 112.154 -2.294 . . . . 0.0 112.501 -172.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.8 p -92.99 95.95 9.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.314 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 88.4 mt -74.32 94.18 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.428 173.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.6 m -113.94 110.48 20.14 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 112.828 -1.987 . . . . 0.0 111.889 -172.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.14 125.19 50.71 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.827 175.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -115.87 131.2 57.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 112.9 -1.955 . . . . 0.0 109.623 172.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.22 -160.29 24.97 Favored Glycine 0 N--CA 1.482 1.766 0 CA-C-N 113.359 -1.746 . . . . 0.0 110.783 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -58.88 -61.34 2.7 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.48 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 3.8 p30 -88.71 39.03 0.9 Allowed 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -46.27 -55.0 7.84 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 117.976 2.584 . . . . 0.0 117.976 -175.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.423 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -71.88 -45.42 61.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.641 1.176 . . . . 0.0 113.914 -177.338 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -66.07 -45.77 80.12 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.745 1.218 . . . . 0.0 112.466 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.86 -44.18 94.28 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.146 0.903 . . . . 0.0 113.406 176.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.0 t -63.87 -50.81 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 118.612 -0.708 . . . . 0.0 112.343 173.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -50.16 -48.36 53.89 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -57.23 -58.12 9.62 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.037 0.935 . . . . 0.0 111.298 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.53 -29.21 69.25 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.2 t -66.86 -51.67 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 123.497 0.498 . . . . 0.0 111.474 170.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -59.73 -41.22 90.39 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.049 0.54 . . . . 0.0 111.877 175.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.33 -45.69 92.56 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.199 1.399 . . . . 0.0 112.404 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.9 tmm? -57.92 -41.75 83.36 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.19 0.596 . . . . 0.0 111.521 174.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.22 96.7 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -78.06 -22.54 48.93 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.0 mt . . . . . 0 N--CA 1.479 0.996 0 O-C-N 121.666 -0.646 . . . . 0.0 111.246 165.15 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.403 ' H3 ' ' CD ' ' A' ' 70' ' ' GLU . 21.7 ttt . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -127.64 137.94 52.68 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 125.79 1.931 . . . . 0.0 108.701 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.08 139.9 53.02 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.262 -176.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -148.0 121.82 9.32 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 124.24 0.963 . . . . 0.0 111.314 169.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -92.12 115.27 27.93 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.778 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.1 m -117.32 146.3 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 114.765 -1.107 . . . . 0.0 113.816 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 p -95.93 119.2 33.99 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.56 -1.654 . . . . 0.0 113.628 -174.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.8 mt -82.12 105.71 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.849 170.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.0 p -99.82 -1.74 36.8 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.216 -1.811 . . . . 0.0 114.31 171.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.69 127.43 93.38 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 124.562 1.145 . . . . 0.0 111.95 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -48.91 -44.23 32.81 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 124.381 3.387 . . . . 0.0 117.59 -170.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -105.75 -23.53 12.7 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 173.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.86 -138.16 13.75 Favored Glycine 0 N--CA 1.474 1.225 0 C-N-CA 124.536 1.065 . . . . 0.0 111.147 170.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -179.64 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.8 p . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -75.95 -47.6 3.73 Favored Pre-proline 0 N--CA 1.487 1.376 0 CA-C-O 115.752 -2.071 . . . . 0.0 115.732 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -59.03 -39.73 77.62 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.171 1.914 . . . . 0.0 112.004 168.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.22 -51.7 65.75 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 171.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.67 -36.27 78.31 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 175.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -68.11 -44.87 75.2 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 173.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -53.96 -40.86 67.2 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.768 1.227 . . . . 0.0 111.404 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.2 t -55.16 -60.31 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 124.087 0.867 . . . . 0.0 111.687 172.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -62.24 -31.92 72.53 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -174.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -66.23 -55.26 17.05 Favored 'General case' 0 CA--C 1.55 0.942 0 O-C-N 124.26 0.975 . . . . 0.0 111.151 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.89 -37.87 64.2 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 171.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -58.59 -29.56 66.52 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 176.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.46 -12.38 58.57 Favored Glycine 0 CA--C 1.54 1.621 0 O-C-N 125.108 1.505 . . . . 0.0 115.377 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -92.0 158.45 16.24 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.169 0.988 . . . . 0.0 111.863 174.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.437 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 62.2 p -68.78 -46.01 69.83 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.266 177.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.6 p -59.28 137.76 57.86 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.625 1.17 . . . . 0.0 113.919 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -92.23 111.58 23.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.607 -1.179 . . . . 0.0 107.83 170.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mt -95.6 133.01 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-N 111.428 -2.624 . . . . 0.0 110.683 -172.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.5 p -109.05 135.35 50.36 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.228 -1.805 . . . . 0.0 112.133 174.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.97 87.51 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 111.855 -2.429 . . . . 0.0 106.396 177.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.2 m -90.69 109.4 20.58 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.552 -1.658 . . . . 0.0 111.39 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.4 t -116.48 87.65 2.73 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 p30 9.74 108.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 128.208 2.603 . . . . 0.0 118.001 -173.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.12 -49.3 2.45 Favored Glycine 0 N--CA 1.481 1.671 0 CA-C-N 112.985 -1.916 . . . . 0.0 111.881 -171.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -93.95 99.03 11.44 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.793 0.806 . . . . 0.0 111.384 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.1 t -107.25 95.8 5.97 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.93 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.68 142.8 30.49 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 113.604 -1.635 . . . . 0.0 112.297 -176.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.7 t -83.34 123.54 29.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.589 173.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.29 12.83 3.26 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 124.353 1.033 . . . . 0.0 112.793 172.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -112.59 -6.81 13.91 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 168.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.9 t -119.42 131.6 55.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.638 1.175 . . . . 0.0 111.269 172.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -62.09 -62.58 1.68 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 113.286 -1.779 . . . . 0.0 112.307 -172.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -60.15 -29.73 68.85 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 113.912 -1.494 . . . . 0.0 114.593 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -56.67 -57.37 12.71 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.914 0.886 . . . . 0.0 112.022 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.87 -44.9 84.02 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 173.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -54.21 -37.14 64.25 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 t -81.2 -26.04 36.25 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 116.924 2.194 . . . . 0.0 116.924 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.4 tp -41.91 -54.22 3.52 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -167.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.07 88.16 2.04 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -172.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mp -116.21 98.36 6.56 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 125.168 1.158 . . . . 0.0 108.327 -177.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.2 t -138.23 176.9 8.29 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 125.503 1.752 . . . . 0.0 111.781 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -59.83 109.56 0.96 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.839 1.256 . . . . 0.0 110.354 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.39 -30.51 6.43 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 113.948 -1.478 . . . . 0.0 115.069 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.4 p -73.02 96.83 2.21 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 117.942 0.871 . . . . 0.0 112.697 -172.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.0 t -69.4 130.96 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.808 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.2 m -124.35 120.33 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 114.691 -1.141 . . . . 0.0 113.924 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.6 113.34 20.76 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.738 173.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.2 mt -95.54 103.48 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 m -116.48 119.88 37.01 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 112.546 -2.116 . . . . 0.0 110.892 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.48 124.53 51.95 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.355 0.598 . . . . 0.0 112.544 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -117.21 105.96 12.79 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.195 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.79 -160.32 28.56 Favored Glycine 0 N--CA 1.482 1.702 0 CA-C-N 113.037 -1.892 . . . . 0.0 112.972 178.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.54 -49.34 78.16 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.063 1.745 . . . . 0.0 115.243 -174.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.437 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 7.8 p30 -96.21 41.53 1.1 Allowed 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.403 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 7.4 pt-20 -43.27 -67.72 0.25 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -38.47 91.24 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -66.36 -47.97 71.71 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.169 1.388 . . . . 0.0 112.246 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.01 -48.47 81.48 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.903 0.881 . . . . 0.0 112.444 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.8 t -61.25 -52.73 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.571 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -49.41 -51.56 34.46 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.073 0.949 . . . . 0.0 113.073 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -58.5 -51.64 69.0 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.89 0.876 . . . . 0.0 112.44 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.7 mt -70.71 -27.97 64.39 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.0 t -61.64 -55.69 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 123.348 0.659 . . . . 0.0 109.77 168.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -52.68 -51.31 60.81 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 124.417 1.073 . . . . 0.0 112.691 175.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.4 tt -53.45 -50.73 64.66 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.344 1.058 . . . . 0.0 112.737 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -59.55 -44.89 93.11 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.88 0.872 . . . . 0.0 112.428 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.74 -37.28 79.31 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -79.65 10.54 3.89 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 N--CA 1.474 0.745 0 C-N-CA 123.235 0.614 . . . . 0.0 111.552 177.348 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -96.05 105.06 17.05 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.575 1.172 . . . . 0.0 110.187 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -103.06 94.72 5.69 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 111.424 -2.626 . . . . 0.0 108.939 -176.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -112.61 114.43 27.05 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.541 1.163 . . . . 0.0 111.701 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -86.64 107.34 18.14 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 111.836 -2.438 . . . . 0.0 109.842 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 m -116.05 142.56 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 113.919 -1.492 . . . . 0.0 112.699 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 p -96.47 114.97 26.68 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.284 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.8 mt -66.89 118.3 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.359 172.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -96.04 -30.42 13.58 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.47 -1.241 . . . . 0.0 114.297 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -43.75 121.88 3.64 Favored Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 173.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.67 -55.08 4.1 Favored 'Trans proline' 0 N--CA 1.485 0.999 1 C-N-CA 125.53 4.153 . . . . 0.0 115.147 -166.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -90.76 -37.39 13.7 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.341 0.657 . . . . 0.0 112.193 172.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.18 -142.41 16.06 Favored Glycine 0 N--CA 1.481 1.683 0 O-C-N 124.692 1.245 . . . . 0.0 112.824 168.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 N--CA 1.479 1.003 0 CA-C-N 112.648 -1.776 . . . . 0.0 114.967 -177.661 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.5 p . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.282 86.4 mtt-85 -71.88 -40.31 7.91 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 116.866 2.173 . . . . 0.0 116.866 -170.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -65.8 -36.06 33.51 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.268 1.312 . . . . 0.0 112.696 167.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.87 -38.4 64.68 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 172.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.54 -45.46 77.2 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -56.51 -45.13 81.22 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 172.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -61.15 -47.21 87.27 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.432 0.693 . . . . 0.0 112.415 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.5 t -56.2 -53.79 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 123.837 0.711 . . . . 0.0 111.536 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -62.48 -37.57 86.47 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -61.84 -52.76 62.85 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.003 1.321 . . . . 0.0 111.112 175.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.99 -44.68 82.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.64 1.176 . . . . 0.0 113.7 174.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -64.45 -25.15 67.88 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 176.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.83 -5.93 48.73 Favored Glycine 0 CA--C 1.543 1.795 0 C-N-CA 125.197 1.38 . . . . 0.0 114.017 172.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -99.88 147.98 24.95 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.19 0.996 . . . . 0.0 110.337 169.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.78 -41.03 98.03 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.91 176.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.476 ' HG ' ' CG ' ' A' ' 69' ' ' ASP . 54.7 m -53.34 132.36 39.13 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 124.57 1.169 . . . . 0.0 113.78 173.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -82.75 103.56 12.33 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.697 1.237 . . . . 0.0 110.078 173.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.1 mt -89.78 115.16 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 111.346 -2.661 . . . . 0.0 111.055 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.3 p -111.86 139.02 47.69 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.275 171.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.8 t -114.65 116.32 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.952 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.9 m -110.69 127.63 55.38 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.892 -1.504 . . . . 0.0 111.533 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.0 m -136.23 107.72 6.92 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.661 171.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 p30 25.66 64.08 0.06 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.65 -53.16 0.6 Allowed Glycine 0 CA--C 1.539 1.582 0 CA-C-N 113.634 -1.621 . . . . 0.0 112.85 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -76.93 89.41 3.51 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.895 0.855 . . . . 0.0 112.421 -176.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 t -96.21 102.28 14.04 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.953 172.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -118.63 123.39 44.85 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.057 -1.429 . . . . 0.0 113.365 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.2 t -54.79 123.98 15.06 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.179 -1.828 . . . . 0.0 113.688 173.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.37 11.17 8.92 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.067 171.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -96.9 -17.52 20.08 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.915 162.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.5 t -102.34 117.34 34.53 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 122.037 0.922 . . . . 0.0 111.245 172.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -50.25 -62.73 1.41 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.043 -1.89 . . . . 0.0 113.294 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -64.56 -39.87 94.54 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 113.825 -1.534 . . . . 0.0 114.264 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -57.76 -50.32 73.64 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 175.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 tp -68.05 -42.79 80.01 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -59.26 -21.19 59.22 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.6 t -109.29 22.54 15.69 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.2 tt -74.54 -52.15 12.68 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.816 -1.177 . . . . 0.0 110.142 171.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.97 88.9 2.08 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 mt -108.29 81.15 1.44 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.216 -0.992 . . . . 0.0 110.569 -171.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -132.14 172.54 12.26 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.021 -174.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -46.29 116.5 1.28 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.949 1.7 . . . . 0.0 112.133 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.72 -27.87 17.82 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 113.751 -1.568 . . . . 0.0 115.09 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.3 p -61.85 115.4 3.99 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.721 0.772 . . . . 0.0 112.582 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.1 t -84.2 102.93 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 111.9 -2.409 . . . . 0.0 106.884 -176.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.3 m -109.76 117.3 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 113.975 -1.466 . . . . 0.0 113.78 -170.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.56 99.78 12.44 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.437 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.9 mp -78.51 98.19 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 172.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.1 m -103.35 101.85 11.77 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 112.356 -2.202 . . . . 0.0 110.412 -177.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.35 104.42 15.41 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.657 -1.61 . . . . 0.0 113.639 -173.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.31 96.22 10.43 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.297 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.09 -173.19 44.69 Favored Glycine 0 N--CA 1.475 1.295 0 CA-C-N 114.122 -1.399 . . . . 0.0 112.676 173.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -67.87 -46.09 72.69 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.63 1.172 . . . . 0.0 112.749 175.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.476 ' CG ' ' HG ' ' A' ' 31' ' ' SER . 6.3 p-10 -79.09 33.64 0.23 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.715 1.606 . . . . 0.0 113.715 176.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -54.14 -69.29 0.13 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.536 1.935 . . . . 0.0 114.616 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -35.28 65.23 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -66.04 -47.68 73.6 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.152 0.981 . . . . 0.0 112.1 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.81 -49.65 67.88 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.394 1.059 . . . . 0.0 112.155 173.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.86 -50.18 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.191 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.19 -58.31 3.76 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.992 1.317 . . . . 0.0 112.662 178.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -58.31 -51.15 71.01 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.346 1.029 . . . . 0.0 112.283 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.85 -38.69 89.17 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.4 -53.08 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.21 0.604 . . . . 0.0 109.81 174.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -53.89 -52.24 61.14 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.638 1.211 . . . . 0.0 112.614 178.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.9 tp -49.31 -58.12 5.64 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.103 1.761 . . . . 0.0 113.073 174.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.9 tmm? -61.39 -35.44 77.51 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.222 1.409 . . . . 0.0 113.633 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.87 -37.83 18.73 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -77.16 38.74 0.22 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.7 mt . . . . . 0 CA--C 1.545 0.777 0 C-N-CA 126.095 1.758 . . . . 0.0 110.185 179.182 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.409 ' H3 ' ' CD ' ' A' ' 70' ' ' GLU . 27.2 ttt . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -126.44 130.42 50.65 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 126.019 2.075 . . . . 0.0 109.238 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -123.97 135.43 53.64 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.714 -1.584 . . . . 0.0 112.149 177.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -123.91 116.85 23.58 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.417 164.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -89.74 97.97 11.5 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.24 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.8 m -113.18 157.9 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 112.244 -2.253 . . . . 0.0 112.517 -174.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.6 p -105.15 139.37 39.91 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.896 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.5 mt -107.95 105.75 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 169.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.3 p -126.03 46.98 2.32 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 114.416 -1.265 . . . . 0.0 114.294 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -116.97 139.49 25.84 Favored Pre-proline 0 N--CA 1.475 0.787 0 CA-C-O 116.962 -1.494 . . . . 0.0 108.854 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -32.04 -56.89 0.27 Allowed 'Trans proline' 0 N--CA 1.483 0.909 1 C-N-CA 125.747 4.298 . . . . 0.0 116.86 -168.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -113.43 -38.87 4.24 Favored 'General case' 0 CA--C 1.551 0.992 0 O-C-N 124.131 0.894 . . . . 0.0 112.407 168.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.05 -89.35 1.44 Allowed Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.908 0.766 . . . . 0.0 113.561 163.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -171.047 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.2 p . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.342 60.4 mtt-85 -92.05 -39.15 0.37 Allowed Pre-proline 0 N--CA 1.479 1.024 0 N-CA-C 119.044 2.979 . . . . 0.0 119.044 -170.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -61.98 -39.2 52.27 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 CA-C-N 121.283 1.494 . . . . 0.0 111.353 161.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.88 -34.79 42.72 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 171.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.1 -42.83 63.57 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -52.15 -52.96 48.59 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.689 1.195 . . . . 0.0 113.203 173.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -55.31 -52.57 63.03 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.579 1.552 . . . . 0.0 111.183 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.9 t -70.29 -38.96 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -174.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.65 -32.14 73.54 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 176.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -71.36 -49.45 42.08 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.047 0.939 . . . . 0.0 110.137 173.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.44 -46.01 76.76 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 176.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -60.77 -23.93 65.37 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 173.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.52 -25.45 67.84 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.317 0.96 . . . . 0.0 113.664 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -73.56 139.36 45.55 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.217 1.008 . . . . 0.0 112.56 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.49 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER -58.91 -37.6 77.02 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 113.19 -1.823 . . . . 0.0 113.025 174.353 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.498 ' HG ' ' CG ' ' A' ' 69' ' ' ASP . 50.3 m -63.08 141.93 58.58 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 171.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.89 113.8 22.99 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.842 0.83 . . . . 0.0 108.94 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 mt -106.99 101.57 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.615 -1.63 . . . . 0.0 109.989 -172.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.0 p -86.32 135.2 33.62 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.878 171.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 97.3 t -118.97 100.73 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.9 m -100.43 124.1 45.5 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.729 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.1 t -144.41 137.54 27.11 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.58 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.277 0.2 OUTLIER 43.57 51.77 6.25 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.859 1.664 . . . . 0.0 113.968 -173.027 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.15 -29.39 1.14 Allowed Glycine 0 CA--C 1.547 2.088 0 CA-C-N 114.103 -1.408 . . . . 0.0 114.885 -175.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -70.49 106.49 3.46 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.031 0.932 . . . . 0.0 112.448 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.7 t -89.65 128.82 36.13 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.696 -1.593 . . . . 0.0 111.942 169.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.81 119.81 14.45 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 113.389 -1.732 . . . . 0.0 110.24 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -64.91 124.93 23.3 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 113.117 -1.856 . . . . 0.0 112.376 171.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.54 -3.28 11.09 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 112.949 -1.932 . . . . 0.0 114.627 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -65.33 -11.64 43.86 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 122.086 0.946 . . . . 0.0 113.502 160.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.4 t -124.84 105.45 9.27 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.161 -0.962 . . . . 0.0 112.972 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -40.53 -51.43 2.92 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.175 -1.83 . . . . 0.0 112.524 164.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -55.57 -50.74 69.24 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 113.254 -1.794 . . . . 0.0 113.452 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -66.05 -47.87 72.92 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tp -72.97 -30.18 63.64 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -176.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -65.66 -18.69 65.51 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 t -112.21 61.12 0.63 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 124.029 1.871 . . . . 0.0 112.748 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.4 tp -122.12 -65.95 1.07 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 112.895 -1.957 . . . . 0.0 112.296 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.62 90.96 0.83 Allowed Glycine 0 N--CA 1.478 1.438 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -172.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 mt -121.68 87.06 2.68 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.513 -0.843 . . . . 0.0 109.4 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -153.19 -175.62 5.42 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.714 -168.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -60.2 108.89 0.86 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.119 0.968 . . . . 0.0 112.128 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.08 -12.56 24.28 Favored Glycine 0 N--CA 1.477 1.388 0 CA-C-N 112.477 -2.147 . . . . 0.0 114.591 177.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.0 p -77.83 116.5 18.39 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 117.772 0.786 . . . . 0.0 112.814 -175.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.1 t -92.26 119.97 40.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 113.1 -1.864 . . . . 0.0 107.192 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.42 115.05 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 113.878 -1.51 . . . . 0.0 113.385 -172.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.4 90.57 6.19 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.823 174.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.8 mt -72.97 101.2 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -120.05 101.33 7.77 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.816 -164.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.21 121.01 42.38 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -104.71 112.22 25.23 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 112.947 -1.933 . . . . 0.0 109.412 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.79 -161.22 32.61 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.084 175.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -78.85 -44.76 22.22 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.98 0.895 . . . . 0.0 112.532 176.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.498 ' CG ' ' HG ' ' A' ' 31' ' ' SER . 11.9 p-10 -76.89 22.41 0.19 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.865 1.666 . . . . 0.0 114.369 175.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.409 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 6.9 pt-20 -44.98 -54.67 6.29 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.581 1.952 . . . . 0.0 114.976 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -47.74 67.6 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -62.52 -49.01 77.02 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.704 -1.134 . . . . 0.0 113.191 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.06 -49.17 74.54 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.207 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.02 -51.4 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 117.946 -1.026 . . . . 0.0 111.973 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -52.67 -48.66 66.34 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 124.219 0.949 . . . . 0.0 112.047 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -60.72 -48.53 81.37 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.363 1.065 . . . . 0.0 112.957 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.08 -37.03 84.78 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.7 t -59.04 -50.09 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 123.938 0.774 . . . . 0.0 109.851 172.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -53.66 -55.72 23.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 124.036 0.835 . . . . 0.0 113.096 175.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.2 tt -51.31 -52.12 48.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.524 1.13 . . . . 0.0 112.462 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.9 tmm? -59.86 -49.09 79.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.102 0.961 . . . . 0.0 112.859 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.05 -26.49 67.53 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -83.35 -2.04 54.79 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 87.1 mt . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 177.374 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -81.2 126.78 31.93 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.339 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -123.76 123.52 40.68 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 113.702 -1.59 . . . . 0.0 111.461 -175.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -129.91 110.46 11.71 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 125.134 1.521 . . . . 0.0 112.997 168.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -83.53 106.25 15.11 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.354 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.4 m -115.51 144.5 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 114.141 -1.391 . . . . 0.0 113.655 -173.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.6 p -103.63 118.4 36.64 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 113.868 -1.515 . . . . 0.0 111.308 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.0 mt -74.22 113.53 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.653 172.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 p -96.07 -23.15 16.92 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.22 133.56 94.33 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 124.383 1.073 . . . . 0.0 112.082 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -53.17 -55.93 3.22 Favored 'Trans proline' 0 N--CA 1.481 0.752 0 C-N-CA 124.365 3.377 . . . . 0.0 113.755 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -67.58 -37.31 82.42 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.12 0.968 . . . . 0.0 112.874 176.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.37 -128.01 9.14 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.8 mt -114.13 -17.56 11.88 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 113.827 -1.186 . . . . 0.0 113.039 171.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.2 p -107.6 -44.21 4.33 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 118.038 -2.914 . . . . 0.0 113.737 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.346 15.7 mmt180 -87.17 -45.47 0.52 Allowed Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 118.017 2.599 . . . . 0.0 118.017 -175.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -59.01 -33.14 98.65 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 CA-C-N 122.655 1.984 . . . . 0.0 111.751 165.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.67 -48.29 77.93 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.149 0.98 . . . . 0.0 113.46 165.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.01 -38.81 90.03 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.23 -43.0 99.81 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 169.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -58.89 -42.22 89.02 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 124.375 1.047 . . . . 0.0 111.348 172.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 66.8 t -57.28 -52.0 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 123.971 0.909 . . . . 0.0 111.032 171.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -53.45 -46.51 69.92 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 124.029 0.831 . . . . 0.0 112.08 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -66.9 -44.96 79.43 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.199 0.999 . . . . 0.0 113.221 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.17 -37.23 76.85 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 124.312 1.045 . . . . 0.0 113.681 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -59.42 -22.15 61.01 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 171.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.21 -20.16 74.74 Favored Glycine 0 N--CA 1.487 2.054 0 O-C-N 124.973 1.421 . . . . 0.0 114.663 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -98.18 148.85 23.16 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.18 0.592 . . . . 0.0 112.387 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.1 p -68.5 -43.37 76.99 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.962 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.0 p -61.1 161.57 8.43 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.816 1.246 . . . . 0.0 113.086 170.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -116.48 102.4 9.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 122.304 1.049 . . . . 0.0 111.979 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.1 mm -65.25 106.75 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 112.392 -2.185 . . . . 0.0 111.894 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.0 p -94.25 122.19 36.53 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.573 1.178 . . . . 0.0 109.984 167.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.6 t -104.41 107.09 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 111.95 -2.386 . . . . 0.0 107.848 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.3 m -96.25 113.39 24.99 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.098 -1.864 . . . . 0.0 111.627 -174.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 t -129.01 121.68 28.45 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.594 172.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 p30 37.94 64.44 0.68 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 125.18 1.55 . . . . 0.0 114.419 -170.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.45 -33.92 1.57 Allowed Glycine 0 N--CA 1.486 1.991 0 CA-C-N 113.636 -1.62 . . . . 0.0 114.509 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -68.51 88.69 0.34 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.315 1.046 . . . . 0.0 112.107 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.9 m -77.28 99.9 5.67 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 113.223 -1.808 . . . . 0.0 111.882 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.95 123.53 46.02 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.46 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.5 t -58.98 103.85 0.2 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.785 168.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.57 -32.33 70.26 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.331 175.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -65.96 -24.69 66.85 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.827 0.851 . . . . 0.0 112.254 174.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.8 t -94.26 111.1 22.82 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 123.104 1.43 . . . . 0.0 112.608 170.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.6 tp -32.54 -73.35 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.934 2.494 . . . . 0.0 116.13 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -64.87 -30.21 71.2 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -62.8 -48.29 79.77 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.603 0.761 . . . . 0.0 111.638 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.3 tp -69.48 -46.58 66.3 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 124.251 0.97 . . . . 0.0 113.066 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -52.61 -32.0 39.38 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 t -114.35 24.01 12.31 Favored 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.8 tp -70.35 -48.06 58.13 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.374 -0.829 . . . . 0.0 112.259 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.08 87.35 1.36 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.51 87.24 2.72 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.708 -0.746 . . . . 0.0 111.925 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -135.09 176.14 8.94 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.238 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -58.33 116.34 3.54 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.457 1.103 . . . . 0.0 110.245 172.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.07 -33.78 6.16 Favored Glycine 0 N--CA 1.485 1.932 0 CA-C-N 114.397 -1.274 . . . . 0.0 114.251 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.1 p -59.88 112.84 2.0 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 117.612 0.706 . . . . 0.0 112.421 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.51 129.92 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.335 -1.757 . . . . 0.0 108.026 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 m -129.73 118.4 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.443 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 m -85.21 104.81 15.41 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.826 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.9 mt -82.9 109.92 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.9 m -118.01 141.46 48.44 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 113.157 -1.838 . . . . 0.0 111.38 -173.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.91 139.43 27.6 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -133.33 132.27 41.1 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.658 -1.61 . . . . 0.0 108.826 169.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.31 -161.9 28.18 Favored Glycine 0 N--CA 1.481 1.683 0 C-N-CA 125.023 1.297 . . . . 0.0 111.542 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -59.93 -64.54 0.91 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.917 0.865 . . . . 0.0 113.167 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -83.56 31.59 0.47 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -53.0 -58.21 7.74 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -172.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -43.11 99.61 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -65.62 -45.03 84.66 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.036 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.39 -52.19 65.55 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.125 0.97 . . . . 0.0 113.173 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.8 t -59.5 -53.06 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.949 0.899 . . . . 0.0 110.078 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -51.0 -54.04 27.96 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.215 1.406 . . . . 0.0 112.73 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -62.88 -45.7 91.33 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.7 mt -64.88 -36.22 83.64 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.35 -50.79 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.435 0.694 . . . . 0.0 110.527 169.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -56.21 -47.11 79.03 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.7 tp -49.03 -59.23 3.79 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.607 1.163 . . . . 0.0 111.927 173.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.0 tmm? -58.06 -42.6 85.81 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.32 1.048 . . . . 0.0 112.949 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.03 -29.89 67.05 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -87.66 -31.69 19.63 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 69.1 mt -48.79 144.73 4.27 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 . . . . . 0 N--CA 1.483 1.2 0 O-C-N 125.618 1.824 . . . . 0.0 114.429 -178.2 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttp . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -120.79 112.31 18.67 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.827 1.329 . . . . 0.0 110.087 172.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -107.57 126.81 53.01 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.019 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -122.93 120.17 32.62 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -99.89 92.72 5.42 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 125.294 1.621 . . . . 0.0 108.794 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.31 143.39 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 111.469 -2.605 . . . . 0.0 112.641 -173.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 p -78.54 131.45 36.8 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -176.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.9 mt -92.59 116.97 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-N 113.485 -1.689 . . . . 0.0 107.159 159.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 p -116.36 -17.81 10.63 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 111.85 -2.432 . . . . 0.0 114.38 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.06 129.96 58.54 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 124.929 1.292 . . . . 0.0 111.694 172.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -56.97 -54.11 4.11 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 124.394 3.396 . . . . 0.0 114.862 -165.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -88.23 -36.97 16.45 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 123.782 0.676 . . . . 0.0 111.762 171.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.89 -128.34 9.53 Favored Glycine 0 N--CA 1.475 1.291 0 O-C-N 123.799 0.687 . . . . 0.0 112.46 167.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.5 mt -104.45 -32.82 8.82 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.6 p -100.2 -62.67 1.21 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 118.112 -2.867 . . . . 0.0 113.489 174.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.326 24.1 mtt180 -83.79 -37.36 0.67 Allowed Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 118.396 2.739 . . . . 0.0 118.396 -168.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -62.52 -39.81 42.62 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 121.763 1.642 . . . . 0.0 112.617 163.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.21 -38.18 73.33 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 168.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.18 -38.56 86.94 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 172.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -64.27 -43.91 93.34 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.414 0.686 . . . . 0.0 112.147 172.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -59.02 -44.17 91.69 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.175 1.39 . . . . 0.0 112.221 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.6 t -53.97 -60.06 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.042 1.337 . . . . 0.0 112.034 169.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -49.55 -39.06 33.38 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.936 -1.029 . . . . 0.0 113.156 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.451 ' CD ' ' HE2' ' A' ' 76' ' ' HIS . 8.5 tp10 -61.86 -66.0 0.6 Allowed 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.522 1.139 . . . . 0.0 110.891 169.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.93 -35.16 6.17 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -42.36 -38.21 1.78 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.24 -30.19 70.33 Favored Glycine 0 CA--C 1.546 1.972 0 C-N-CA 124.97 1.272 . . . . 0.0 115.805 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -75.28 144.8 42.3 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -175.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.411 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 66.3 p -66.46 -50.27 63.9 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.303 0.641 . . . . 0.0 111.891 -175.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.3 p -66.09 173.61 2.99 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 124.877 1.361 . . . . 0.0 113.35 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -114.65 94.32 4.72 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.704 0.764 . . . . 0.0 109.331 174.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.75 113.57 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 113.118 -1.855 . . . . 0.0 109.382 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 p -105.78 137.61 43.36 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.677 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.0 t -118.87 126.57 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 113.206 -1.815 . . . . 0.0 109.944 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.3 m -110.98 123.37 50.04 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.214 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.8 t -126.5 120.37 29.5 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.717 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 p30 40.3 64.03 0.99 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.742 1.617 . . . . 0.0 114.634 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.35 -34.96 1.54 Allowed Glycine 0 CA--C 1.542 1.773 0 CA-C-N 113.187 -1.824 . . . . 0.0 115.658 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -81.94 133.04 35.28 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.598 0.759 . . . . 0.0 110.254 -169.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 t -108.4 129.29 55.26 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.123 0.89 . . . . 0.0 113.269 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.71 160.85 27.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 112.541 -2.118 . . . . 0.0 109.626 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.3 t -106.08 128.26 53.74 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.131 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.04 -29.47 69.83 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.878 1.361 . . . . 0.0 111.338 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -90.81 21.69 3.98 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.245 -0.888 . . . . 0.0 112.609 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.0 m -148.01 116.46 6.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.028 1.331 . . . . 0.0 112.274 173.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.1 tp -51.21 -59.63 3.99 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 112.429 -2.169 . . . . 0.0 113.324 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -63.85 -32.34 73.82 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.221 -1.354 . . . . 0.0 113.317 -174.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -69.24 -58.48 3.98 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 118.318 -0.848 . . . . 0.0 113.033 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.9 tp -60.36 -40.3 90.25 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.201 0.938 . . . . 0.0 112.441 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -62.34 -40.1 95.28 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 t -89.86 8.14 33.59 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.3 tp -72.67 -60.95 1.98 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.91 92.88 1.6 Allowed Glycine 0 CA--C 1.535 1.334 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.0 mt -128.47 82.75 2.1 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.269 1.427 . . . . 0.0 109.956 -174.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 t -146.49 164.67 31.78 Favored 'General case' 0 C--O 1.25 1.1 0 C-N-CA 125.826 1.65 . . . . 0.0 110.835 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -41.61 126.63 2.99 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.444 1.898 . . . . 0.0 115.137 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.69 -31.56 5.51 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-N 113.891 -1.504 . . . . 0.0 115.379 173.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.35 121.32 21.19 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.828 2.159 . . . . 0.0 116.828 -173.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.9 t -87.01 94.03 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 m -89.82 125.72 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -169.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.07 93.45 5.78 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.967 1.707 . . . . 0.0 110.429 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.6 mt -98.73 113.33 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 125.496 1.518 . . . . 0.0 107.134 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 m -129.68 124.29 33.24 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.216 -167.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.66 140.84 51.56 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -140.74 110.1 6.27 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.258 1.423 . . . . 0.0 110.301 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.82 -157.05 19.57 Favored Glycine 0 N--CA 1.478 1.497 0 N-CA-C 107.621 -2.191 . . . . 0.0 107.621 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -65.51 -43.5 89.9 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 117.243 0.521 . . . . 0.0 110.156 170.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.411 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 6.2 p30 -86.25 26.94 0.97 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 -178.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -54.06 -52.64 60.25 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.45 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -78.42 -44.13 25.58 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.649 1.58 . . . . 0.0 113.007 -179.386 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -67.65 -35.83 79.6 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.77 -47.4 53.84 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.707 0.803 . . . . 0.0 112.862 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.9 t -61.6 -48.1 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 118.0 -1.0 . . . . 0.0 111.156 176.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -46.12 -49.01 17.17 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.7 1.2 . . . . 0.0 111.845 171.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.451 ' HE2' ' CD ' ' A' ' 25' ' ' GLU . 80.2 t60 -68.19 -62.48 1.38 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.0 mt -59.77 -38.63 82.35 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.4 t -61.42 -48.24 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.315 174.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -59.07 -48.88 80.0 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.297 0.998 . . . . 0.0 112.953 173.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.3 tp -52.55 -47.99 66.43 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.642 0.777 . . . . 0.0 112.03 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 48.5 ttp -62.2 -52.26 64.5 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.923 0.889 . . . . 0.0 112.367 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.64 -35.9 63.95 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -88.46 -13.67 39.77 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.37 153.07 36.26 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 124.093 0.957 . . . . 0.0 112.411 167.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 . . . . . 0 N--CA 1.486 1.366 0 C-N-CA 125.318 1.447 . . . . 0.0 110.632 -175.782 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ttt . . . . . 0 N--CA 1.463 0.204 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -113.79 127.97 56.22 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 124.657 1.223 . . . . 0.0 109.708 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -131.11 94.66 3.63 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.309 -167.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -112.44 108.49 17.64 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 122.518 1.151 . . . . 0.0 113.343 -171.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -80.96 103.99 11.16 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 112.45 -2.159 . . . . 0.0 111.159 175.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.3 148.46 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 114.933 -1.03 . . . . 0.0 113.138 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 p -102.72 128.33 49.48 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.905 -175.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.3 mt -79.54 108.9 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.359 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 p -96.83 -13.51 22.5 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 175.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.9 135.83 90.22 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 124.31 1.044 . . . . 0.0 111.766 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -48.88 -52.45 8.64 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.182 3.255 . . . . 0.0 114.718 -174.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -106.88 -28.43 10.1 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 124.591 1.182 . . . . 0.0 113.741 175.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.25 -153.91 21.6 Favored Glycine 0 N--CA 1.479 1.563 0 CA-C-O 122.045 0.803 . . . . 0.0 113.897 165.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.0 mt -72.08 -34.05 68.39 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.5 p -88.0 -51.54 5.76 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 117.133 -3.48 . . . . 0.0 115.563 170.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.303 40.6 mtt85 -89.77 -41.44 0.42 Allowed Pre-proline 0 N--CA 1.486 1.336 0 N-CA-C 118.616 2.821 . . . . 0.0 118.616 -166.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -61.72 -30.8 85.55 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 CA-C-N 120.867 1.345 . . . . 0.0 112.412 163.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.19 -44.2 95.3 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 165.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.51 90.61 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 172.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -59.84 -45.5 92.22 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.386 1.074 . . . . 0.0 112.452 172.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -57.86 -46.07 85.37 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.074 1.35 . . . . 0.0 111.782 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.2 t -56.0 -42.47 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.025 0.53 . . . . 0.0 112.278 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -60.96 -46.43 90.74 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 124.07 0.856 . . . . 0.0 111.916 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -69.58 -44.44 70.79 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.077 0.861 . . . . 0.0 112.616 176.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.37 -33.59 65.85 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -53.81 -34.77 60.21 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 170.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.27 13.74 56.52 Favored Glycine 0 N--CA 1.483 1.81 0 O-C-N 124.557 1.161 . . . . 0.0 115.159 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -119.49 151.19 38.99 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.046 0.497 . . . . 0.0 111.297 172.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.4 p -82.69 -44.2 15.97 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.862 -175.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.3 p -66.08 133.26 50.37 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 124.999 1.437 . . . . 0.0 110.615 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -85.7 103.62 14.67 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.609 1.195 . . . . 0.0 111.831 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.4 mm -63.69 113.53 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 111.757 -2.474 . . . . 0.0 111.125 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.1 p -111.66 131.04 55.56 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.601 173.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.3 t -111.0 108.27 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 113.483 -1.689 . . . . 0.0 107.723 -177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.0 m -103.91 124.05 48.26 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.777 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.2 t -128.16 131.99 48.91 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.286 176.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.6 p30 49.83 34.62 7.92 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.39 5.33 87.7 Favored Glycine 0 CA--C 1.545 1.926 0 N-CA-C 115.806 1.082 . . . . 0.0 115.806 -175.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -112.56 140.66 47.13 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.977 0.911 . . . . 0.0 109.915 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.0 t -119.22 135.04 54.88 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -167.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -130.61 121.27 25.32 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.036 -1.893 . . . . 0.0 111.398 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.9 t -72.98 129.09 37.32 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.633 173.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.75 -14.7 62.08 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 113.175 -1.829 . . . . 0.0 113.297 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.0 mttt -77.29 -2.47 34.98 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 171.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.3 m -123.14 118.62 28.09 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.394 0.677 . . . . 0.0 112.217 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 tp -45.93 -65.87 0.48 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.588 -1.642 . . . . 0.0 113.732 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -54.09 -50.93 65.7 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.5 mmtt -42.04 -58.59 2.04 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.4 tp -66.96 -43.0 84.25 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.638 1.211 . . . . 0.0 113.202 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -59.36 -41.38 89.14 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.989 175.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.263 15.2 t -100.54 54.01 0.88 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 123.497 1.617 . . . . 0.0 113.897 175.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 tt -111.24 -56.5 2.36 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 112.874 -1.966 . . . . 0.0 109.246 161.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.27 66.9 0.61 Allowed Glycine 0 N--CA 1.477 1.416 0 O-C-N 124.348 1.03 . . . . 0.0 111.851 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.2 mt -88.74 98.11 11.51 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.682 0.793 . . . . 0.0 111.537 -174.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.9 t -137.47 175.99 9.11 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.876 -176.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -47.95 128.68 13.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.899 2.08 . . . . 0.0 112.813 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.68 -54.72 0.55 Allowed Glycine 0 N--CA 1.48 1.61 0 CA-C-N 113.408 -1.724 . . . . 0.0 114.175 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.1 p -64.56 131.98 48.55 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -165.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.4 t -79.89 108.48 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 111.124 -2.762 . . . . 0.0 107.193 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.6 m -105.0 109.49 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 113.523 -1.671 . . . . 0.0 113.214 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.5 95.99 2.85 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.626 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 77.2 mt -86.61 101.19 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.117 175.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.3 m -106.15 134.56 49.09 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 112.642 -2.072 . . . . 0.0 112.905 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.07 138.22 36.92 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 124.638 1.211 . . . . 0.0 113.223 172.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -132.62 118.7 19.5 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 124.8 1.312 . . . . 0.0 109.484 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.44 -155.5 26.18 Favored Glycine 0 CA--C 1.544 1.879 0 C-N-CA 124.685 1.136 . . . . 0.0 111.232 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -68.09 -61.14 2.0 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -80.56 28.15 0.34 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -53.26 -48.32 68.36 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.78 -50.61 33.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.835 0.854 . . . . 0.0 111.809 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -58.89 -50.92 72.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.587 1.555 . . . . 0.0 112.829 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.25 -44.58 95.14 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.471 1.107 . . . . 0.0 113.587 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.63 -55.52 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.078 175.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -52.05 -50.57 61.22 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.051 0.941 . . . . 0.0 112.975 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -60.01 -50.5 73.49 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.468 1.107 . . . . 0.0 112.64 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.8 mt -64.72 -28.32 69.51 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.5 t -69.65 -47.57 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 122.896 0.479 . . . . 0.0 110.896 171.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -51.76 -50.92 59.73 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.937 0.895 . . . . 0.0 111.527 174.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.67 -54.62 21.52 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.213 1.805 . . . . 0.0 112.236 176.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 40.3 ttp -57.12 -47.87 80.03 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.467 1.107 . . . . 0.0 112.363 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.9 -27.84 68.49 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.275 1.43 . . . . 0.0 114.84 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -78.71 -35.74 44.45 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.4 mt -57.64 156.93 7.7 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 C--O 1.259 1.562 0 C-N-CA 126.558 1.943 . . . . 0.0 114.771 -173.858 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 ttt . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -103.22 136.96 42.02 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 125.095 1.497 . . . . 0.0 108.329 170.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -146.16 134.41 21.74 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.565 -1.652 . . . . 0.0 111.016 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -123.48 118.94 28.56 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.847 170.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -83.98 106.87 15.98 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.079 165.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.6 m -120.73 140.21 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 114.726 -1.124 . . . . 0.0 113.649 -178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.8 p -83.31 136.21 34.45 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.302 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 52.7 mt -81.81 90.31 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 168.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.7 p -74.07 -22.41 59.53 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.513 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.32 131.74 94.89 Favored Pre-proline 0 N--CA 1.484 1.229 0 C-N-CA 125.296 1.438 . . . . 0.0 111.935 -175.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.04 -44.17 9.54 Favored 'Trans proline' 0 N--CA 1.489 1.207 1 C-N-CA 125.355 4.036 . . . . 0.0 117.56 -166.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -110.45 -45.03 3.6 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.85 -147.63 17.6 Favored Glycine 0 N--CA 1.478 1.492 0 CA-C-O 121.725 0.625 . . . . 0.0 112.817 167.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.6 mt -88.31 -30.34 19.68 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.3 p -111.37 -46.13 3.32 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 118.201 -2.812 . . . . 0.0 115.213 170.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.286 48.4 mtt85 -86.08 -39.27 0.57 Allowed Pre-proline 0 N--CA 1.487 1.411 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -174.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -62.13 -35.71 73.88 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 121.712 1.608 . . . . 0.0 111.686 164.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.06 -44.38 78.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.601 0.76 . . . . 0.0 112.897 167.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.49 98.81 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 171.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -56.64 -45.25 81.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.716 0.806 . . . . 0.0 113.146 171.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -57.93 -44.18 86.75 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.864 1.266 . . . . 0.0 111.689 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 95.7 t -57.12 -42.81 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.322 1.049 . . . . 0.0 113.154 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -53.03 -45.27 67.93 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 123.462 0.476 . . . . 0.0 112.17 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -74.61 -50.94 15.95 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.831 1.332 . . . . 0.0 112.215 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.35 -35.95 65.78 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -60.14 -19.38 53.41 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 173.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.45 27.03 14.89 Favored Glycine 0 CA--C 1.544 1.869 0 O-C-N 124.432 1.082 . . . . 0.0 113.646 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -127.93 142.97 51.11 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.143 0.977 . . . . 0.0 111.575 172.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.6 p -71.85 -40.0 69.34 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.438 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 63.0 p -65.23 145.86 55.69 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 124.483 1.115 . . . . 0.0 111.624 168.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.445 ' CD ' ' HG ' ' A' ' 43' ' ' SER . 34.9 tt0 -95.73 109.51 21.79 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.321 -0.862 . . . . 0.0 110.968 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.3 mm -70.54 102.06 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 112.64 -2.073 . . . . 0.0 108.852 171.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.3 p -101.89 126.44 48.79 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.497 173.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.7 t -103.54 113.85 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 125.445 1.716 . . . . 0.0 107.767 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.9 m -114.2 127.54 55.95 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.652 -174.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.4 t -122.66 115.04 21.43 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.316 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.5 p30 39.94 51.31 2.52 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -174.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.47 -35.8 4.05 Favored Glycine 0 N--CA 1.484 1.898 0 CA-C-N 113.17 -1.832 . . . . 0.0 114.501 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -72.55 121.63 19.99 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 116.897 0.348 . . . . 0.0 111.11 -174.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.0 t -102.25 136.29 42.35 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.78 1.3 . . . . 0.0 113.789 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -129.72 106.77 8.93 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 112.748 -2.024 . . . . 0.0 112.005 175.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.445 ' HG ' ' CD ' ' A' ' 32' ' ' GLU . 13.7 t -59.5 121.73 12.26 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.526 171.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.61 -30.55 68.31 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.598 170.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -61.8 -32.64 72.95 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.2 m -96.37 104.24 16.19 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 122.028 0.918 . . . . 0.0 111.89 169.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 tp -44.94 -60.62 1.97 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.54 1.536 . . . . 0.0 113.05 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -57.21 -37.6 72.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -61.5 -49.82 75.2 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.8 tp -62.48 -41.33 98.72 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 174.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -61.07 -24.88 66.55 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.261 9.6 t -118.12 75.31 1.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 123.449 1.595 . . . . 0.0 114.228 172.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.7 tp -124.0 -45.39 2.01 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 112.128 -2.305 . . . . 0.0 113.141 168.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.45 69.1 0.84 Allowed Glycine 0 CA--C 1.534 1.266 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -167.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.7 mt -95.28 80.64 3.56 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.06 0.933 . . . . 0.0 110.936 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -123.83 151.49 43.34 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 112.748 -2.024 . . . . 0.0 112.889 -165.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -49.13 132.9 19.28 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.46 1.124 . . . . 0.0 112.427 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.58 -69.06 0.22 Allowed Glycine 0 CA--C 1.534 1.267 0 CA-C-N 113.467 -1.697 . . . . 0.0 110.257 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.5 p -30.79 113.19 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.2 t -72.96 108.1 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 112.601 -2.09 . . . . 0.0 106.688 168.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.7 m -105.09 111.48 34.75 Favored 'Isoleucine or valine' 0 C--O 1.253 1.261 0 CA-C-N 113.991 -1.458 . . . . 0.0 112.743 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.8 m -65.99 99.11 0.47 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 126.558 1.943 . . . . 0.0 108.87 176.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 80.8 mt -96.64 106.73 18.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.7 m -118.53 133.79 55.59 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 112.703 -2.044 . . . . 0.0 112.588 -169.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.78 138.12 24.25 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 125.334 1.646 . . . . 0.0 112.681 170.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -120.05 129.72 54.37 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.97 170.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.1 -157.11 27.26 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.766 1.203 . . . . 0.0 114.909 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -71.77 -44.09 64.63 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -100.63 24.84 8.49 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.69 -51.22 68.03 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -36.79 83.98 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.254 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -71.73 -52.8 15.91 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.563 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.17 -51.7 68.46 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.513 1.525 . . . . 0.0 114.266 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.7 t -60.77 -50.64 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.003 0.521 . . . . 0.0 110.863 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -54.58 -55.33 30.5 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.557 1.143 . . . . 0.0 111.514 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -53.76 -54.1 42.96 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.733 1.613 . . . . 0.0 112.923 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.3 mt -69.41 -28.64 66.33 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.54 -43.46 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 119.038 -0.506 . . . . 0.0 110.816 171.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -55.77 -43.81 77.08 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.248 0.619 . . . . 0.0 111.716 172.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.26 -51.08 70.79 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.522 1.129 . . . . 0.0 112.757 174.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 44.4 ttm -55.08 -45.6 75.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 123.531 0.519 . . . . 0.0 112.286 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.09 -19.95 66.24 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -114.85 36.19 3.96 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 mt -107.06 175.24 5.57 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.303 1.441 . . . . 0.0 112.73 173.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 . . . . . 0 N--CA 1.488 1.442 0 C-N-CA 125.59 1.556 . . . . 0.0 112.273 178.273 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 ttp . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -100.45 131.93 46.1 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 125.597 1.81 . . . . 0.0 107.962 169.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -124.78 115.44 20.7 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.584 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -127.05 110.21 12.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.223 1.011 . . . . 0.0 112.386 173.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -91.59 112.45 24.38 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.624 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 m -128.37 165.35 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 113.134 -1.848 . . . . 0.0 112.301 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 78.5 p -120.73 147.27 45.53 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.196 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.8 mt -87.93 97.13 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.887 175.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.8 p -85.3 -17.79 35.83 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.47 142.2 41.2 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.985 1.314 . . . . 0.0 112.608 174.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -47.6 -46.96 19.34 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 124.586 3.524 . . . . 0.0 116.246 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -114.86 -39.17 3.76 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.83 -142.51 17.1 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 122.198 0.888 . . . . 0.0 112.824 167.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 mp -104.21 -27.87 11.78 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 -174.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 76.8 p -101.22 -68.05 0.83 Allowed 'General case' 0 N--CA 1.476 0.833 0 O-C-N 117.449 -3.282 . . . . 0.0 114.358 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 65.2 mtt85 -60.57 -53.95 59.49 Favored Pre-proline 0 N--CA 1.488 1.445 0 CA-C-O 116.238 -1.839 . . . . 0.0 115.181 -171.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -67.2 -31.12 36.69 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 CA-C-N 122.072 1.776 . . . . 0.0 114.198 174.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.96 85.1 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 171.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.41 -39.29 86.88 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 171.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -62.09 -44.68 96.13 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.006 0.923 . . . . 0.0 113.15 172.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -59.76 -43.5 94.27 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.105 0.878 . . . . 0.0 111.662 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 66.8 t -55.66 -51.67 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.569 0.748 . . . . 0.0 111.654 172.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -46.84 -51.74 15.9 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.617 0.767 . . . . 0.0 111.755 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -65.14 -51.81 59.01 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.466 1.104 . . . . 0.0 111.559 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.28 -34.02 66.06 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -60.51 -32.84 71.83 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 172.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.22 26.24 3.98 Favored Glycine 0 N--CA 1.479 1.526 0 O-C-N 124.382 1.051 . . . . 0.0 114.375 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -129.17 146.24 51.14 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.725 1.21 . . . . 0.0 110.261 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.445 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 67.6 p -69.39 -42.15 75.5 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.442 0.697 . . . . 0.0 112.872 -176.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 p -66.55 157.07 33.24 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.867 1.267 . . . . 0.0 112.836 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -103.4 113.74 27.48 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 122.32 1.057 . . . . 0.0 110.239 172.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.7 mm -81.81 105.74 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 111.818 -2.446 . . . . 0.0 108.495 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.3 p -101.79 121.27 41.77 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.141 0.496 . . . . 0.0 110.805 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.6 t -101.51 97.85 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 125.905 2.003 . . . . 0.0 107.612 -172.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.1 m -88.39 101.14 13.6 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.778 -1.555 . . . . 0.0 111.047 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 t -100.35 99.88 10.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.198 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 p30 45.54 62.61 2.11 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 113.186 -1.824 . . . . 0.0 114.009 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.47 -30.36 3.78 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 114.015 -1.448 . . . . 0.0 114.636 -176.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -86.31 92.76 8.9 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.644 0.735 . . . . 0.0 109.67 -174.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.3 t -82.73 123.33 29.2 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.771 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.2 132.86 51.69 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.597 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.6 t -71.22 129.7 39.57 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.715 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.2 -19.0 61.81 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 112.972 -1.922 . . . . 0.0 112.508 170.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -77.11 -6.11 51.56 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 m -112.49 115.93 29.46 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.4 tp -52.84 -64.79 0.7 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 111.325 -2.67 . . . . 0.0 114.302 -170.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -77.39 -28.77 52.9 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -60.65 -44.85 95.93 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 tp -69.62 -35.52 75.33 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.591 1.182 . . . . 0.0 113.283 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -65.48 -35.9 82.28 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 172.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.251 14.0 t -100.06 50.66 0.91 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 123.716 1.722 . . . . 0.0 112.547 173.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.5 tp -115.6 -37.86 3.88 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 112.883 -1.962 . . . . 0.0 112.742 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.09 55.92 1.66 Allowed Glycine 0 CA--C 1.53 1.031 0 C-N-CA 123.962 0.791 . . . . 0.0 111.824 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 78.3 mt -77.51 85.5 3.88 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -133.41 175.97 8.94 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 113.873 -1.512 . . . . 0.0 112.928 -172.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -46.47 112.78 0.54 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.471 1.909 . . . . 0.0 111.613 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.15 -38.71 3.09 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-N 113.259 -1.791 . . . . 0.0 114.157 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.5 p -48.84 110.22 0.33 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -172.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.38 123.59 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-N 111.083 -2.78 . . . . 0.0 108.067 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 m -127.98 101.19 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 113.708 -1.587 . . . . 0.0 112.638 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.6 m -77.81 90.04 4.05 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.118 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 73.0 mt -78.84 96.88 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 113.006 -1.907 . . . . 0.0 107.725 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.0 m -119.88 136.83 54.35 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 113.136 -1.847 . . . . 0.0 111.991 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.78 142.59 25.66 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.636 1.21 . . . . 0.0 113.305 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -123.37 126.84 47.57 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.656 1.222 . . . . 0.0 110.431 170.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.44 -165.68 36.83 Favored Glycine 0 N--CA 1.484 1.869 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.094 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -63.94 -55.44 22.55 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.445 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 10.8 p30 -92.42 17.91 9.24 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -45.0 -58.96 2.83 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -173.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.402 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -60.98 -48.9 79.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.923 1.289 . . . . 0.0 114.285 179.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -64.4 -46.28 83.99 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.786 0.834 . . . . 0.0 112.256 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.65 -52.38 65.67 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.247 1.019 . . . . 0.0 112.688 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.8 t -63.58 -47.1 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 117.586 -1.197 . . . . 0.0 111.306 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -50.33 -59.32 4.09 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.226 1.01 . . . . 0.0 111.656 175.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -53.94 -49.55 68.45 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.323 1.049 . . . . 0.0 113.438 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.5 mt -62.9 -39.66 95.2 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.7 t -58.17 -44.06 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.75 0.82 . . . . 0.0 111.084 174.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -60.26 -53.73 54.25 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.852 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.7 tp -51.6 -49.72 61.6 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.162 0.985 . . . . 0.0 113.277 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.8 ttt -62.66 -36.6 83.41 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.984 0.914 . . . . 0.0 113.188 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.17 -35.32 56.03 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -86.27 1.99 48.85 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.8 mt -77.45 151.05 34.89 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.653 1.181 . . . . 0.0 114.055 170.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.557 1.239 0 C-N-CA 127.995 2.518 . . . . 0.0 113.157 -173.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ttp . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -121.41 132.06 54.53 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 125.259 1.6 . . . . 0.0 112.026 173.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.93 146.93 52.23 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.6 174.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -119.22 150.9 39.31 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 124.384 1.053 . . . . 0.0 110.871 169.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -117.28 98.69 6.56 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 123.309 1.528 . . . . 0.0 110.823 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.24 149.55 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 113.902 -1.499 . . . . 0.0 112.219 -169.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 p -100.87 143.44 31.02 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.269 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.5 mp -81.16 115.97 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 165.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.2 p -99.85 -36.09 9.54 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 112.594 -2.094 . . . . 0.0 112.497 -174.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.99 142.15 46.73 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.978 0.911 . . . . 0.0 112.462 170.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.48 -44.27 38.89 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.996 3.131 . . . . 0.0 115.332 -172.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . 0.257 11.1 p30 -105.21 -29.92 10.02 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 176.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.71 -127.24 7.86 Favored Glycine 0 CA--C 1.538 1.5 0 O-C-N 124.287 0.992 . . . . 0.0 114.263 169.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.87 -30.45 12.03 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.57 -48.3 2.94 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 118.592 -2.568 . . . . 0.0 113.626 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.341 97.0 mtt180 -83.36 -43.46 0.84 Allowed Pre-proline 0 N--CA 1.479 1.014 0 N-CA-C 118.049 2.611 . . . . 0.0 118.049 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -62.0 -37.21 66.52 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 CA-C-N 123.233 2.19 . . . . 0.0 110.884 170.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.65 -30.52 21.93 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 164.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.38 -40.62 97.07 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 119.474 1.034 . . . . 0.0 112.327 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.83 -35.54 80.28 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 118.436 -0.792 . . . . 0.0 112.973 171.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -62.17 -48.03 81.87 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.94 0.336 . . . . 0.0 111.032 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.1 t -50.61 -50.72 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.933 0.873 . . . . 0.0 111.411 173.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.42 -44.21 95.98 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.54 -1.209 . . . . 0.0 113.121 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -63.36 -40.29 96.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.355 1.462 . . . . 0.0 113.67 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.42 99.13 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.101 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -56.99 -30.15 63.9 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.6 -25.73 36.39 Favored Glycine 0 CA--C 1.543 1.818 0 O-C-N 125.343 1.652 . . . . 0.0 114.849 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -97.63 146.68 25.07 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.093 0.957 . . . . 0.0 112.928 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.459 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 68.2 p -58.61 -50.35 74.16 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.758 1.623 . . . . 0.0 112.387 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.1 p -53.15 147.61 9.54 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 125.043 1.465 . . . . 0.0 113.975 170.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -103.06 87.67 2.97 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 122.706 1.241 . . . . 0.0 109.422 170.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.3 mm -48.57 112.34 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 112.131 -2.304 . . . . 0.0 111.556 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.5 p -101.18 143.5 31.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.458 171.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.5 t -127.75 111.77 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.2 m -109.98 126.97 54.49 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.538 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -123.89 136.77 54.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.643 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.6 p30 51.08 22.83 1.35 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 128.739 2.816 . . . . 0.0 117.067 -178.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.54 -28.4 14.39 Favored Glycine 0 CA--C 1.544 1.894 0 CA-C-N 115.238 -0.892 . . . . 0.0 114.367 -171.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -81.09 135.47 35.81 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.447 0.624 . . . . 0.0 111.345 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.0 t -113.55 120.26 40.35 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.847 -170.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.19 129.2 48.53 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.702 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.5 t -76.15 131.77 39.59 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.898 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.15 -40.95 82.24 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 125.149 1.531 . . . . 0.0 112.559 174.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -57.76 -18.42 21.42 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 171.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 t -107.39 114.43 28.44 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.618 1.199 . . . . 0.0 110.045 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.3 tp -62.03 -59.21 5.42 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.94 -1.936 . . . . 0.0 115.555 -165.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -69.68 -31.1 68.95 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -57.03 -61.4 2.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.016 0.926 . . . . 0.0 109.919 171.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.0 tp -57.39 -44.66 84.67 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -61.9 -42.84 99.56 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 t -67.45 -12.67 60.83 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.4 tp -69.87 -52.51 24.21 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -173.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.03 72.88 0.88 Allowed Glycine 0 N--CA 1.471 0.985 0 O-C-N 124.256 0.973 . . . . 0.0 112.383 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.1 mt -86.55 73.66 10.04 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 123.62 1.676 . . . . 0.0 111.007 175.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.4 t -127.8 172.25 11.01 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 111.802 -2.454 . . . . 0.0 111.517 -172.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -40.26 143.4 0.3 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.521 1.929 . . . . 0.0 112.236 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.37 -33.76 2.02 Favored Glycine 0 N--CA 1.481 1.644 0 CA-C-O 118.362 -1.243 . . . . 0.0 114.875 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.0 p -61.97 115.68 4.27 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.064 1.432 . . . . 0.0 114.492 -174.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.7 t -88.81 100.94 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 110.721 -2.945 . . . . 0.0 106.184 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.0 m -102.78 123.8 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 112.902 -1.954 . . . . 0.0 111.611 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 p -84.5 109.76 18.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 112.306 -2.224 . . . . 0.0 111.391 171.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.8 mt -104.55 110.38 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.079 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 m -117.57 126.44 52.55 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 113.741 -1.572 . . . . 0.0 115.098 -168.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -126.18 137.84 53.6 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.293 -1.321 . . . . 0.0 112.921 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -139.1 113.98 9.31 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.446 -1.706 . . . . 0.0 108.996 166.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.75 -155.59 16.74 Favored Glycine 0 N--CA 1.479 1.545 0 C-N-CA 126.07 1.795 . . . . 0.0 109.439 -175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -77.78 -35.33 51.68 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 122.218 1.009 . . . . 0.0 111.569 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.459 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 4.8 p30 -105.02 26.94 8.66 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.848 1.659 . . . . 0.0 115.154 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -44.61 -43.15 7.97 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -46.43 49.2 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 174.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -72.76 -32.04 65.34 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.119 1.368 . . . . 0.0 113.271 -173.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.96 -53.37 58.75 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.027 1.331 . . . . 0.0 111.269 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 t -65.66 -52.44 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.135 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -47.03 -57.2 5.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.021 1.328 . . . . 0.0 112.478 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -60.29 -60.32 4.0 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mt -58.23 -36.0 72.53 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.83 -42.77 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.568 0.747 . . . . 0.0 111.572 171.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -63.82 -34.52 78.1 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 tp -58.37 -52.54 65.16 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.447 1.099 . . . . 0.0 112.157 164.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 48.2 ttm -48.86 -51.43 29.74 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.867 0.867 . . . . 0.0 112.581 173.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.5 -50.5 73.67 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -84.77 15.08 4.11 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -174.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.85 -150.03 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.299 1.039 . . . . 0.0 111.594 169.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.589 -0.719 . . . . 0.0 110.9 -170.543 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -127.98 141.15 51.61 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.398 1.479 . . . . 0.0 109.879 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.48 128.36 11.75 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.053 0.541 . . . . 0.0 111.863 -172.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -125.13 119.46 28.64 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -83.08 115.68 21.98 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 113.18 -1.827 . . . . 0.0 111.086 164.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.1 164.31 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 113.249 -1.796 . . . . 0.0 113.076 176.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.9 p -121.31 126.04 48.53 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -172.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.5 mt -80.26 111.9 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.411 170.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 p -107.07 -8.77 16.4 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 113.218 -1.81 . . . . 0.0 115.555 173.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.27 137.03 68.45 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.965 0.906 . . . . 0.0 112.535 177.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -45.78 -46.17 15.76 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 124.843 3.695 . . . . 0.0 115.943 -170.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.22 -34.32 5.96 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 175.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.32 -135.56 12.54 Favored Glycine 0 N--CA 1.482 1.74 0 O-C-N 123.761 0.663 . . . . 0.0 111.627 169.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.7 mp -103.64 -26.59 12.73 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.5 p -110.34 -51.9 2.83 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 117.762 -3.086 . . . . 0.0 114.156 173.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 63.4 mtt-85 -75.27 -45.18 4.59 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-O 115.706 -2.093 . . . . 0.0 115.599 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -63.34 -28.46 71.97 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 CA-C-N 122.565 1.952 . . . . 0.0 112.569 168.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.2 -22.24 64.57 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 169.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.4 -36.36 63.48 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -55.9 -47.27 77.75 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 170.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -55.62 -43.61 76.27 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.899 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.5 t -59.23 -52.55 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.752 0.821 . . . . 0.0 111.214 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.22 -56.44 11.09 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.584 1.154 . . . . 0.0 113.028 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -58.8 -45.2 90.43 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 124.779 1.3 . . . . 0.0 112.395 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.59 80.18 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -50.25 -38.42 40.69 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 175.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.94 3.78 55.87 Favored Glycine 0 CA--C 1.54 1.605 0 O-C-N 124.769 1.293 . . . . 0.0 116.298 -173.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -100.75 158.3 16.06 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.305 1.042 . . . . 0.0 112.869 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.444 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 40.3 p -68.57 -52.32 33.1 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 118.639 -0.696 . . . . 0.0 109.482 168.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.0 p -59.05 136.52 57.97 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.875 1.27 . . . . 0.0 112.947 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -95.27 92.15 6.61 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.362 173.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.7 mm -57.55 115.68 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 112.132 -2.304 . . . . 0.0 110.211 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.5 p -105.54 117.29 33.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.702 173.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.6 t -103.89 117.71 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.717 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.0 m -107.8 129.7 55.03 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 112.553 -2.112 . . . . 0.0 112.042 -175.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.1 t -136.25 137.68 41.03 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 111.979 -2.373 . . . . 0.0 107.727 171.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.8 p30 40.02 44.54 1.47 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.36 -40.65 3.08 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 124.185 0.898 . . . . 0.0 114.388 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -57.84 123.93 17.46 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.872 1.269 . . . . 0.0 112.645 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -109.74 101.44 10.33 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.489 -176.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.71 134.65 47.52 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.622 1.201 . . . . 0.0 112.846 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.0 t -73.21 112.19 9.03 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 112.485 -2.143 . . . . 0.0 112.143 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.55 -14.58 63.11 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 112.717 -2.038 . . . . 0.0 114.232 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -72.27 -22.28 61.24 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.2 t -109.91 122.43 47.53 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.843 0.83 . . . . 0.0 111.744 -176.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.3 tp -55.54 -59.4 4.89 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.588 -2.096 . . . . 0.0 114.615 -169.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -64.79 -33.38 75.86 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -61.97 -51.72 66.91 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 123.805 0.69 . . . . 0.0 112.382 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.5 tp -61.96 -38.74 89.67 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -64.9 -39.28 93.29 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -72.96 -28.68 62.55 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 172.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.3 tp -45.19 -60.95 1.85 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.61 93.46 2.02 Favored Glycine 0 CA--C 1.539 1.57 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 71.5 mt -120.06 87.04 2.67 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 113.337 -1.432 . . . . 0.0 107.906 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 t -135.38 -174.87 3.75 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.337 -1.302 . . . . 0.0 111.351 -173.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -61.05 118.48 6.82 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.288 0.566 . . . . 0.0 109.993 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.78 -7.81 65.44 Favored Glycine 0 N--CA 1.478 1.435 0 CA-C-N 114.368 -1.287 . . . . 0.0 115.665 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.3 p -71.44 99.59 2.03 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.351 1.075 . . . . 0.0 111.652 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.2 t -60.44 104.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 111.497 -2.592 . . . . 0.0 107.986 173.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.4 m -106.78 113.4 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.418 -168.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.7 m -100.25 104.97 16.49 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 112.271 -2.24 . . . . 0.0 108.973 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 24.3 mt -98.64 102.25 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.118 -1.855 . . . . 0.0 107.9 -174.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -102.56 140.86 36.28 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 113.642 -1.617 . . . . 0.0 112.31 -176.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.71 142.05 27.43 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.419 1.074 . . . . 0.0 112.904 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -140.12 114.25 9.05 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.12 169.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.99 -152.56 15.13 Favored Glycine 0 N--CA 1.483 1.791 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.581 -175.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -86.32 -57.7 2.91 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 120.742 0.306 . . . . 0.0 110.503 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.444 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 4.2 p30 -73.55 5.49 3.81 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.783 2.142 . . . . 0.0 116.783 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -41.93 -53.71 3.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -49.24 78.56 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.949 1.3 . . . . 0.0 113.477 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -76.62 -34.94 58.32 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.278 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.42 68.5 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.015 0.926 . . . . 0.0 111.959 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.54 -45.51 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-O 118.459 -0.782 . . . . 0.0 111.731 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -52.94 -51.06 62.67 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 123.876 0.735 . . . . 0.0 111.994 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -59.23 -51.82 68.33 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.438 1.495 . . . . 0.0 111.697 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.2 mt -65.93 -29.91 70.41 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.94 -46.19 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 121.329 0.585 . . . . 0.0 109.725 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -71.42 -30.31 65.93 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.432 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.54 -52.84 63.85 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 124.142 0.901 . . . . 0.0 112.459 166.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.7 tmm? -53.12 -47.47 68.63 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 124.49 1.119 . . . . 0.0 111.892 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.04 -40.35 97.46 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -90.0 -9.98 46.64 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.4 mt -63.9 145.55 55.63 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.888 0.475 . . . . 0.0 110.696 161.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 C--O 1.255 1.358 0 O-C-N 125.671 1.857 . . . . 0.0 111.147 -166.525 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -118.4 118.91 33.05 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 125.425 1.703 . . . . 0.0 110.567 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.75 122.34 37.18 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.438 -172.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -134.02 140.28 46.58 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.751 0.821 . . . . 0.0 113.073 171.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -112.32 122.87 48.96 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.958 -172.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 m -128.63 130.33 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.21 128.01 36.86 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 113.684 -1.598 . . . . 0.0 111.518 -177.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.1 mt -87.5 118.14 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.709 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 p -95.51 -26.72 15.7 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 113.516 -1.675 . . . . 0.0 113.748 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.28 127.95 92.66 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 123.486 0.714 . . . . 0.0 111.943 173.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -54.62 -51.98 9.19 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.171 3.247 . . . . 0.0 113.725 -170.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -95.81 -46.39 6.59 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.866 1.354 . . . . 0.0 111.031 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.09 -107.86 2.26 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.655 1.121 . . . . 0.0 112.764 166.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 24.0 mt -84.44 -29.78 25.83 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.4 p -118.5 -47.75 2.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 118.181 -2.824 . . . . 0.0 112.963 169.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -74.43 -44.56 5.77 Favored Pre-proline 0 N--CA 1.483 1.188 0 CA-C-O 116.248 -1.834 . . . . 0.0 115.908 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -64.3 -40.61 24.55 Favored 'Trans proline' 0 N--CA 1.486 1.063 0 CA-C-N 121.826 1.688 . . . . 0.0 112.866 170.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.16 -37.56 47.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.587 1.155 . . . . 0.0 113.959 172.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.73 75.71 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 175.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -80.73 -28.18 36.66 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 174.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -62.04 -38.91 90.53 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.296 0.639 . . . . 0.0 110.551 168.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.65 -48.12 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 124.472 1.109 . . . . 0.0 110.978 169.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -51.47 -46.97 63.29 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 118.895 -0.574 . . . . 0.0 111.622 175.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -61.58 -56.28 21.64 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 125.13 1.519 . . . . 0.0 111.567 174.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.82 -40.71 63.55 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -57.93 -27.85 63.75 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 176.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.68 -46.38 94.56 Favored Glycine 0 CA--C 1.542 1.772 0 C-N-CA 124.948 1.261 . . . . 0.0 112.892 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -69.12 144.15 53.96 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.991 0.916 . . . . 0.0 112.459 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.411 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 65.3 p -67.72 -45.77 74.11 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.285 -176.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.7 p -63.12 167.0 5.34 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.683 1.593 . . . . 0.0 113.206 171.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -114.03 111.57 21.86 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 122.365 1.078 . . . . 0.0 110.903 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 39.5 mm -69.47 103.77 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 112.567 -2.106 . . . . 0.0 110.773 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.9 p -88.3 118.2 27.75 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.315 167.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -105.39 92.45 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 113.545 -1.661 . . . . 0.0 106.876 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.0 m -81.59 124.94 29.95 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 112.12 -2.309 . . . . 0.0 110.961 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -128.65 106.64 9.09 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.662 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 p30 35.43 83.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 112.557 -2.111 . . . . 0.0 116.533 -176.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.52 -52.68 4.59 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-N 113.037 -1.892 . . . . 0.0 112.903 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -69.21 117.68 11.15 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.305 1.042 . . . . 0.0 111.509 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t -111.29 108.94 18.73 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.81 -177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.49 118.6 37.05 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.478 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.4 t -57.11 111.88 1.19 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.185 -1.371 . . . . 0.0 111.153 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.22 -24.34 67.18 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.876 172.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -70.46 -26.87 63.84 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.236 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -95.29 102.6 14.42 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 123.063 1.411 . . . . 0.0 112.006 172.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.9 tp -39.43 -59.86 1.02 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.093 2.157 . . . . 0.0 115.704 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -66.32 -33.15 75.08 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -67.07 -44.52 79.88 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.43 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 tp -66.93 -45.47 77.78 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 124.444 1.09 . . . . 0.0 112.02 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -57.49 -30.55 65.19 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 t -94.07 -0.0 55.65 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.5 -41.8 96.22 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.23 86.65 1.86 Allowed Glycine 0 CA--C 1.537 1.417 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -172.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.6 mt -115.29 77.22 1.06 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.192 0.996 . . . . 0.0 109.73 -172.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.9 t -132.05 168.29 18.2 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.468 -163.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -57.54 106.71 0.36 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.031 0.932 . . . . 0.0 111.468 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.62 -38.21 2.61 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 113.311 -1.768 . . . . 0.0 114.526 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.8 p -64.55 122.85 17.78 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 118.165 0.982 . . . . 0.0 112.88 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.1 t -97.86 111.22 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 113.073 -1.876 . . . . 0.0 106.792 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.7 m -105.52 117.07 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 112.701 -2.045 . . . . 0.0 113.778 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.3 93.66 9.14 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 112.466 -2.152 . . . . 0.0 111.88 -175.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.2 mt -80.15 102.81 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 113.845 -1.525 . . . . 0.0 107.724 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.2 m -121.31 134.08 55.14 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 112.62 -2.082 . . . . 0.0 112.978 -175.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.84 152.31 39.29 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 124.822 1.326 . . . . 0.0 112.767 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -137.28 133.27 34.82 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.971 172.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.44 -159.73 24.9 Favored Glycine 0 N--CA 1.484 1.894 0 O-C-N 124.169 0.918 . . . . 0.0 113.519 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -50.26 -47.47 55.17 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.411 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 3.7 p30 -108.79 31.23 5.81 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 177.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -51.26 -52.29 46.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.407 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -71.8 -42.21 67.33 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 112.765 -2.016 . . . . 0.0 113.151 178.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -66.62 -47.36 72.88 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.593 1.157 . . . . 0.0 111.987 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.33 -47.36 86.37 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.366 1.066 . . . . 0.0 113.429 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.4 t -68.94 -45.81 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 117.537 -1.221 . . . . 0.0 111.261 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -52.08 -49.76 62.91 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.981 0.913 . . . . 0.0 111.019 175.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -62.69 -58.1 8.65 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.107 1.363 . . . . 0.0 113.442 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.3 mt -64.74 -29.78 70.77 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.5 t -63.24 -54.79 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 124.036 0.835 . . . . 0.0 110.686 168.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt -56.34 -47.05 79.6 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.736 0.814 . . . . 0.0 112.969 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.7 tp -52.51 -56.08 17.65 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.435 1.094 . . . . 0.0 111.607 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.5 tmm? -53.99 -43.72 70.23 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.085 0.954 . . . . 0.0 112.021 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.6 -35.56 80.5 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -177.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.99 -21.04 34.05 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.7 mt -62.59 158.81 17.25 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 . . . . . 0 N--CA 1.487 1.391 0 C-N-CA 125.768 1.627 . . . . 0.0 112.696 167.325 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -132.87 139.55 47.48 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 125.337 1.648 . . . . 0.0 108.907 165.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -137.58 128.46 27.23 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.227 -177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -125.05 108.04 11.42 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.976 168.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -87.3 97.25 10.68 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 112.587 -2.097 . . . . 0.0 109.123 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 m -120.34 117.49 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 112.243 -2.253 . . . . 0.0 112.91 -173.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 p -71.77 126.77 30.57 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.728 -1.123 . . . . 0.0 111.665 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.9 mt -71.2 126.54 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 114.876 -1.057 . . . . 0.0 108.756 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -98.94 -37.53 9.36 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 113.957 -1.474 . . . . 0.0 114.336 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.68 123.86 24.94 Favored Pre-proline 0 N--CA 1.482 1.147 0 O-C-N 123.863 0.727 . . . . 0.0 111.485 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -51.3 -42.43 54.39 Favored 'Trans proline' 0 N--CA 1.482 0.851 0 C-N-CA 123.973 3.116 . . . . 0.0 112.03 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -71.91 -56.07 6.36 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.922 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.7 -127.28 9.09 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.932 1.253 . . . . 0.0 110.522 171.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 21.2 mt -112.17 -13.13 13.56 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 113.931 -1.135 . . . . 0.0 113.241 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.3 p -103.69 -55.73 2.33 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 117.519 -3.238 . . . . 0.0 114.05 171.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.4 mmt-85 -64.22 -48.39 76.65 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-O 116.03 -1.938 . . . . 0.0 114.593 -174.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -65.41 -41.7 14.96 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.415 2.077 . . . . 0.0 112.912 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.73 -38.22 60.47 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.41 -41.68 94.4 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.919 0.887 . . . . 0.0 113.013 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -67.5 -44.44 78.48 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.344 1.058 . . . . 0.0 111.631 175.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -58.36 -45.76 87.61 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.256 1.423 . . . . 0.0 111.447 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 51.9 t -53.88 -46.7 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 124.296 1.038 . . . . 0.0 111.672 173.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -57.05 -44.99 83.55 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 118.98 -0.534 . . . . 0.0 111.876 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -62.36 -47.79 82.65 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.501 1.126 . . . . 0.0 112.627 174.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.24 -39.52 83.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.68 1.192 . . . . 0.0 114.174 175.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -60.03 -26.24 65.95 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 172.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.86 -20.93 64.9 Favored Glycine 0 CA--C 1.546 1.977 0 O-C-N 124.535 1.147 . . . . 0.0 114.187 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -99.95 145.84 27.37 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.592 1.187 . . . . 0.0 113.307 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.1 p -73.14 -37.04 66.75 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.334 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.6 p -63.38 160.55 15.86 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 124.599 1.187 . . . . 0.0 112.121 168.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -107.05 110.57 22.73 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.2 mm -72.43 92.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.024 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.2 107.44 14.0 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 110.845 -2.889 . . . . 0.0 107.886 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.96 101.85 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.269 -176.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.5 m -96.74 118.69 33.75 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 113.523 -1.671 . . . . 0.0 112.043 -177.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.9 t -130.53 114.37 15.4 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.325 171.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 p30 43.26 70.13 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 125.372 1.469 . . . . 0.0 114.17 -172.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.91 -35.5 1.24 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-N 113.389 -1.732 . . . . 0.0 115.241 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -74.34 108.58 7.21 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.163 0.985 . . . . 0.0 111.415 -174.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.5 m -98.96 100.62 11.82 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.871 176.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -105.91 115.31 30.01 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.837 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.3 t -64.56 119.06 9.75 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.889 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -23.13 65.96 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.433 -1.712 . . . . 0.0 113.525 171.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -70.78 -24.07 62.52 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.137 177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.9 t -103.07 123.43 46.63 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.217 0.532 . . . . 0.0 111.393 167.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.4 tp -42.91 -61.32 1.31 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 111.041 -2.8 . . . . 0.0 114.919 -171.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -82.75 -6.96 59.66 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -74.01 -58.31 3.39 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.8 tp -54.11 -39.51 66.48 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -67.24 -2.88 6.52 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.2 t -133.1 59.37 1.74 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 124.578 2.132 . . . . 0.0 112.538 166.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.2 tp -110.3 -50.71 2.94 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 113.08 -1.873 . . . . 0.0 113.095 176.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.72 90.12 1.93 Allowed Glycine 0 CA--C 1.531 1.087 0 N-CA-C 107.804 -2.119 . . . . 0.0 107.804 -169.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.4 mt -122.88 90.25 3.26 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.054 -1.073 . . . . 0.0 109.44 -171.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.4 t -162.94 157.81 21.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 126.385 2.303 . . . . 0.0 109.346 -164.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -40.05 132.04 1.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.19 -20.58 32.65 Favored Glycine 0 N--CA 1.479 1.553 0 CA-C-N 113.003 -1.908 . . . . 0.0 114.518 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.3 p -60.98 108.06 0.81 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 122.925 1.345 . . . . 0.0 112.992 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.3 94.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 110.779 -2.919 . . . . 0.0 106.919 -175.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.5 m -92.25 98.0 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 113.648 -1.614 . . . . 0.0 112.691 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.8 m -73.66 88.03 1.69 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 111.834 -2.439 . . . . 0.0 108.778 175.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.9 mt -82.22 108.28 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.158 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.3 m -120.0 136.74 54.44 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 113.404 -1.725 . . . . 0.0 113.427 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.83 130.81 19.3 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.042 172.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -123.19 118.65 28.12 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.682 -1.145 . . . . 0.0 107.984 163.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 170.14 -173.44 44.17 Favored Glycine 0 N--CA 1.478 1.486 0 CA-C-N 113.93 -1.486 . . . . 0.0 112.697 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -47.41 -45.95 25.91 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 125.015 1.326 . . . . 0.0 113.667 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -114.22 34.78 4.49 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -46.05 -72.85 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.22 -43.33 64.21 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 177.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -62.77 -45.82 90.9 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.319 -1.31 . . . . 0.0 112.864 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.1 -52.44 65.27 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.481 1.113 . . . . 0.0 112.802 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.6 t -64.75 -46.36 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.952 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -55.07 -52.25 63.8 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -60.78 -48.42 81.9 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.888 0.875 . . . . 0.0 113.076 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.4 mt -63.03 -37.79 88.6 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.82 -45.27 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.316 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -55.15 -54.35 44.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 123.617 0.573 . . . . 0.0 111.052 173.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -49.36 -54.86 15.12 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 125.636 1.575 . . . . 0.0 111.846 175.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -58.12 -40.62 81.71 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.466 1.106 . . . . 0.0 113.07 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.79 -44.06 64.6 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 175.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -70.56 -3.27 17.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.518 1.527 . . . . 0.0 114.293 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.9 mt -90.15 101.8 14.51 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.856 1.262 . . . . 0.0 110.761 169.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 C--O 1.254 1.291 0 O-C-N 124.985 1.428 . . . . 0.0 112.388 -178.087 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ttt . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.77 141.84 39.02 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.282 -1.326 . . . . 0.0 113.091 173.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -148.55 127.82 12.98 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.427 -1.715 . . . . 0.0 110.031 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -126.77 117.7 23.2 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.012 0.82 . . . . 0.0 112.597 164.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -84.06 97.81 9.52 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 125.643 1.84 . . . . 0.0 108.623 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.93 141.48 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 113.592 -1.64 . . . . 0.0 112.491 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.4 p -107.77 137.87 45.02 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.3 mt -76.75 122.85 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.487 175.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.2 p -91.49 -43.47 9.67 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.107 -1.406 . . . . 0.0 114.114 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -28.77 133.44 0.19 Allowed Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 126.978 2.111 . . . . 0.0 115.121 175.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.53 -54.19 4.98 Favored 'Trans proline' 0 N--CA 1.482 0.841 0 C-N-CA 124.296 3.331 . . . . 0.0 112.49 -173.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -78.15 -43.59 28.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.166 0.986 . . . . 0.0 112.559 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.12 -152.91 19.02 Favored Glycine 0 N--CA 1.475 1.239 0 C-N-CA 125.464 1.507 . . . . 0.0 110.508 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.8 mt -87.57 -26.98 22.85 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 172.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.2 p -109.69 -43.05 4.13 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 117.679 -3.138 . . . . 0.0 115.631 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.279 83.0 mmt-85 -85.32 -44.06 0.65 Allowed Pre-proline 0 N--CA 1.483 1.205 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -62.74 -37.35 56.89 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 121.528 1.486 . . . . 0.0 111.703 164.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.27 -40.95 71.6 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.96 -36.97 75.72 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 173.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -66.66 -49.77 65.08 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.822 0.701 . . . . 0.0 111.418 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -54.99 -43.48 73.6 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 124.045 0.841 . . . . 0.0 111.45 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.1 t -53.18 -61.83 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.657 1.183 . . . . 0.0 111.324 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -49.23 -46.37 45.8 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 124.176 0.922 . . . . 0.0 111.822 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.32 -55.62 17.22 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.678 1.236 . . . . 0.0 112.906 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.56 -30.17 70.49 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -55.51 -30.82 61.36 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 170.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.99 -5.9 66.47 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.12 1.343 . . . . 0.0 114.896 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -95.89 142.48 28.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.153 0.581 . . . . 0.0 111.737 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.434 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 44.7 p -63.87 -39.01 93.2 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.174 0.99 . . . . 0.0 111.51 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 p -62.04 141.43 58.09 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.372 -1.285 . . . . 0.0 112.71 168.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -94.26 108.56 20.43 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 123.311 1.529 . . . . 0.0 110.117 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.4 mm -73.79 106.91 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 111.228 -2.715 . . . . 0.0 109.87 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.4 p -108.8 110.41 21.78 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 122.806 1.288 . . . . 0.0 112.063 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.0 t -81.87 106.27 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 112.379 -2.192 . . . . 0.0 109.057 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.5 m -85.72 105.67 16.42 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 122.354 1.073 . . . . 0.0 110.016 172.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.8 t -118.75 109.42 16.06 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 113.338 -1.756 . . . . 0.0 110.458 171.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 p30 43.94 71.25 0.26 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.72 9.25 37.85 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-N 112.99 -1.914 . . . . 0.0 116.349 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -118.82 99.25 6.64 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 122.328 -0.513 . . . . 0.0 110.841 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.4 m -79.97 98.76 7.31 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.651 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.88 124.53 49.11 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 113.366 -1.743 . . . . 0.0 112.709 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.6 t -70.37 132.17 45.22 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 113.164 -1.835 . . . . 0.0 113.297 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.77 -25.37 59.03 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 113.924 -1.489 . . . . 0.0 114.054 167.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -73.69 -27.27 61.13 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.8 t -96.16 92.65 6.51 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.347 1.07 . . . . 0.0 109.177 171.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.2 tp -37.78 -55.01 1.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 126.98 2.112 . . . . 0.0 114.529 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -65.69 -33.48 75.99 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -59.98 -49.48 77.52 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tp -63.84 -39.63 94.68 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -65.69 -37.49 86.62 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 t -99.84 78.69 2.14 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 125.046 2.355 . . . . 0.0 111.91 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.2 tp -149.58 -51.0 0.15 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 111.361 -2.654 . . . . 0.0 112.473 -173.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.5 65.26 0.93 Allowed Glycine 0 N--CA 1.472 1.06 0 O-C-N 125.467 1.73 . . . . 0.0 110.387 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 78.7 mt -85.14 91.63 8.17 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.441 0.638 . . . . 0.0 110.258 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.4 t -135.91 -163.43 1.4 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.373 -171.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -63.8 118.83 8.9 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.825 0.85 . . . . 0.0 111.145 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.11 -10.05 76.04 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-N 113.6 -1.636 . . . . 0.0 115.371 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.2 p -75.81 142.5 42.25 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 117.656 0.728 . . . . 0.0 112.383 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.28 137.21 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 113.022 -1.899 . . . . 0.0 109.307 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 m -110.54 78.85 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-N 112.473 -2.149 . . . . 0.0 107.398 165.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -74.95 86.29 2.28 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 173.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.1 mt -74.72 87.65 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.246 -173.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 75.0 m -88.67 125.55 34.89 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 112.806 -1.997 . . . . 0.0 110.272 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.55 136.15 20.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.281 -1.327 . . . . 0.0 113.489 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -130.91 128.66 40.97 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.334 1.022 . . . . 0.0 110.067 172.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.39 -176.93 30.44 Favored Glycine 0 N--CA 1.492 2.428 0 O-C-N 124.193 0.933 . . . . 0.0 115.142 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -53.85 -33.79 57.38 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.434 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 5.3 p30 -111.61 19.18 18.35 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -46.8 -51.93 15.31 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.439 ' NE2' ' H ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -62.54 -42.58 99.62 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 177.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -69.09 -46.13 68.55 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.477 -177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.67 -53.98 44.36 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.313 1.445 . . . . 0.0 113.133 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.8 t -59.09 -52.75 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.36 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.34 -47.54 81.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.737 0.815 . . . . 0.0 113.14 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -57.48 -55.46 34.58 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.84 1.256 . . . . 0.0 111.423 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.9 mt -66.44 -30.17 70.47 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.7 t -65.58 -48.56 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 123.373 0.42 . . . . 0.0 110.059 170.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -63.62 -44.8 92.88 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 117.94 -1.029 . . . . 0.0 113.294 175.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.7 tp -51.51 -51.52 54.52 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.359 1.063 . . . . 0.0 111.313 172.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -57.75 -42.57 84.24 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.051 0.94 . . . . 0.0 112.994 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.28 -43.87 66.33 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -82.98 35.68 0.48 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.845 1.658 . . . . 0.0 112.932 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 mt -127.03 117.06 21.72 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.572 1.549 . . . . 0.0 112.704 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 . . . . . 0 C--O 1.259 1.572 0 C-N-CA 126.073 1.749 . . . . 0.0 108.473 -177.354 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttt . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -110.48 136.89 48.92 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 125.958 2.036 . . . . 0.0 109.883 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -120.02 143.72 47.92 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 113.336 -1.756 . . . . 0.0 109.171 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -141.95 102.07 4.07 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.525 1.141 . . . . 0.0 109.674 171.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -81.87 102.13 10.66 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 111.938 -2.392 . . . . 0.0 108.682 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 m -125.02 158.2 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 112.507 -2.133 . . . . 0.0 111.76 -177.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.5 p -109.68 137.46 47.46 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.805 0.812 . . . . 0.0 111.696 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.2 mt -91.53 93.18 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 166.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 p -86.43 -17.05 35.3 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 111.424 -2.625 . . . . 0.0 115.43 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.49 133.97 85.53 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.611 1.165 . . . . 0.0 112.155 175.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -44.55 -51.49 7.04 Favored 'Trans proline' 0 CA--C 1.541 0.836 1 C-N-CA 125.318 4.012 . . . . 0.0 116.563 -170.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -106.13 -27.64 10.97 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 172.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.21 -108.67 2.6 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 124.467 1.032 . . . . 0.0 112.691 170.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.1 mt -112.92 -24.6 9.44 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -175.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.8 p -112.12 -43.19 3.59 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 117.813 -3.054 . . . . 0.0 111.817 167.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.256 88.5 mmt-85 -74.74 -56.45 2.21 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-O 115.721 -2.085 . . . . 0.0 115.011 -175.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -59.47 -34.57 97.18 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.778 2.319 . . . . 0.0 113.952 174.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.7 -25.99 2.08 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 172.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.26 98.57 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -65.99 -38.83 89.51 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.977 0.911 . . . . 0.0 112.674 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.41 -42.01 86.23 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.06 0.85 . . . . 0.0 112.134 172.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.3 t -64.92 -51.5 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.274 0.63 . . . . 0.0 112.06 170.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -49.87 -43.13 48.98 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.606 1.162 . . . . 0.0 112.608 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -67.58 -51.67 47.64 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.019 0.824 . . . . 0.0 111.915 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.49 -32.18 73.56 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -44.65 -39.39 5.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.896 1.278 . . . . 0.0 114.431 167.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.35 -32.22 75.39 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 125.15 1.531 . . . . 0.0 114.898 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -74.82 133.46 41.91 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.461 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 76.0 p -65.89 -46.87 76.78 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.972 -173.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.2 p -66.53 137.75 57.01 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.817 1.647 . . . . 0.0 111.473 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -83.95 101.57 11.8 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 122.876 1.322 . . . . 0.0 111.758 -178.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.9 mm -70.05 100.41 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.281 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.2 p -94.2 103.93 15.96 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.325 174.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.6 96.29 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 112.776 -2.011 . . . . 0.0 107.514 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.6 m -88.84 104.52 17.0 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 113.473 -1.694 . . . . 0.0 111.322 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.4 t -108.31 99.24 8.67 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.72 172.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 p30 47.57 75.0 0.14 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.853 1.661 . . . . 0.0 114.011 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.05 -39.77 1.18 Allowed Glycine 0 CA--C 1.542 1.771 0 CA-C-N 113.176 -1.829 . . . . 0.0 114.044 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -77.03 106.9 9.01 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 123.606 1.67 . . . . 0.0 110.807 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -108.86 106.38 16.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 112.355 -2.202 . . . . 0.0 110.621 -170.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -110.47 122.63 48.18 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.93 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.2 t -64.91 119.05 9.96 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 113.468 -1.696 . . . . 0.0 111.676 174.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.66 -11.34 53.48 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.296 -1.774 . . . . 0.0 114.568 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -72.84 -21.12 61.0 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 166.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.5 t -112.55 99.97 8.37 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.38 1.072 . . . . 0.0 112.596 -174.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp -36.77 -54.88 0.9 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 112.99 -1.914 . . . . 0.0 115.131 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -63.48 -46.4 86.33 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.495 -1.684 . . . . 0.0 113.659 -172.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.8 tttm -63.03 -44.42 95.96 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.275 0.63 . . . . 0.0 112.282 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.8 tp -66.61 -44.03 83.2 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -60.56 -26.12 66.69 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.3 t -108.41 60.61 0.61 Allowed 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 124.449 2.071 . . . . 0.0 112.415 172.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.9 tp -124.99 -48.38 1.75 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 111.804 -2.453 . . . . 0.0 110.799 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.09 67.41 0.81 Allowed Glycine 0 CA--C 1.535 1.329 0 O-C-N 124.833 1.333 . . . . 0.0 110.57 176.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.5 mt -88.01 86.68 7.16 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.084 0.945 . . . . 0.0 110.151 -174.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -133.81 -175.24 3.77 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 112.211 -2.268 . . . . 0.0 113.772 -169.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -59.02 112.96 1.87 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.766 2.426 . . . . 0.0 111.915 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.08 -6.9 56.71 Favored Glycine 0 CA--C 1.547 2.076 0 CA-C-N 112.992 -1.913 . . . . 0.0 114.489 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.0 p -75.66 103.34 5.72 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.7 t -65.38 115.21 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 112.858 -1.974 . . . . 0.0 109.05 170.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.5 m -118.94 106.12 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 112.971 -1.922 . . . . 0.0 111.658 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 42.5 m -83.44 95.18 8.18 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 112.233 -2.258 . . . . 0.0 109.358 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -89.48 91.82 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 112.103 -2.317 . . . . 0.0 108.443 -175.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.0 m -104.58 122.48 45.7 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 111.334 -2.666 . . . . 0.0 112.266 -170.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -137.3 147.96 46.02 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 124.86 1.35 . . . . 0.0 112.627 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -134.37 128.29 33.34 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.692 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.08 -159.78 24.76 Favored Glycine 0 N--CA 1.489 2.181 0 O-C-N 124.491 1.119 . . . . 0.0 114.82 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -49.66 -34.98 19.95 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.461 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 11.6 p30 -119.94 12.76 12.1 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 118.947 2.943 . . . . 0.0 118.947 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -33.02 -54.28 0.38 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -60.22 2.61 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 176.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -53.62 -34.46 58.61 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.683 1.593 . . . . 0.0 114.055 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.19 -59.55 3.35 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.825 1.25 . . . . 0.0 112.775 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.87 -51.77 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.928 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -49.27 -51.82 31.31 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.428 1.091 . . . . 0.0 112.71 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -58.83 -55.55 33.69 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.05 0.94 . . . . 0.0 112.416 176.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.4 tp -61.91 -36.88 82.64 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.238 1.415 . . . . 0.0 113.252 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.5 t -73.58 -36.28 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.793 0.837 . . . . 0.0 111.583 175.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -60.12 -37.19 79.27 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 118.2 -0.905 . . . . 0.0 113.17 168.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.3 tp -57.34 -40.68 78.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 123.886 0.741 . . . . 0.0 112.211 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -69.28 -27.08 65.1 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.76 1.224 . . . . 0.0 113.377 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.57 -26.63 26.02 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.538 1.135 . . . . 0.0 113.372 176.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -89.71 28.79 1.25 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.15 1.38 . . . . 0.0 113.227 170.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.3 mt -126.53 153.04 45.72 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.664 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 C--O 1.248 1.021 0 O-C-N 125.662 1.852 . . . . 0.0 107.292 171.115 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 ttt . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -95.1 130.19 41.9 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 124.595 1.184 . . . . 0.0 109.157 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -125.4 122.08 35.71 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.303 -1.771 . . . . 0.0 110.004 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -122.58 119.1 29.84 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.488 1.137 . . . . 0.0 112.343 170.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -96.99 89.2 4.74 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.927 -1.942 . . . . 0.0 108.915 -174.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 m -111.68 141.4 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 114.089 -1.414 . . . . 0.0 114.419 -169.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.1 p -89.72 116.35 27.77 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 114.665 -1.152 . . . . 0.0 113.931 -173.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.16 101.98 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 166.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.0 p -94.09 -11.88 29.66 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 112.391 -2.186 . . . . 0.0 114.23 174.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.74 131.53 94.92 Favored Pre-proline 0 N--CA 1.481 1.112 0 C-N-CA 125.344 1.458 . . . . 0.0 111.092 175.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -50.44 -50.25 14.12 Favored 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 124.205 3.27 . . . . 0.0 114.132 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -98.68 -48.38 4.98 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.08 0.863 . . . . 0.0 112.769 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.09 -126.94 7.68 Favored Glycine 0 N--CA 1.48 1.616 0 O-C-N 124.269 0.981 . . . . 0.0 113.086 170.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.5 mt -85.15 -38.09 19.44 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.0 p -105.69 -50.35 3.22 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 117.778 -3.076 . . . . 0.0 115.575 174.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.265 5.5 mmt180 -80.75 -46.45 1.24 Allowed Pre-proline 0 N--CA 1.482 1.162 0 CA-C-O 116.774 -1.584 . . . . 0.0 115.173 -172.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -61.19 -37.09 76.99 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 121.983 1.789 . . . . 0.0 112.585 166.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.21 -42.86 66.73 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 170.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.63 -38.17 90.08 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 174.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -64.85 -41.55 95.61 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.317 1.047 . . . . 0.0 112.62 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -59.73 -44.3 93.81 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.972 1.309 . . . . 0.0 111.425 172.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.1 t -59.59 -44.65 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 124.073 0.949 . . . . 0.0 111.982 173.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -48.75 -51.23 30.07 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.9 0.88 . . . . 0.0 111.254 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -65.85 -55.78 15.27 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 124.961 1.413 . . . . 0.0 111.766 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.53 -34.7 62.21 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -56.84 -28.32 61.47 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 172.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.81 3.1 65.66 Favored Glycine 0 N--CA 1.49 2.287 0 O-C-N 125.199 1.562 . . . . 0.0 114.874 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -102.6 153.83 19.72 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.546 0.738 . . . . 0.0 111.469 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.487 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 52.4 p -63.08 -44.35 96.01 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.396 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 p -64.04 151.71 42.22 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -97.88 110.63 23.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 113.942 -1.481 . . . . 0.0 107.94 166.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.5 mm -81.19 119.11 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 CA-C-N 111.878 -2.419 . . . . 0.0 109.189 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.08 113.5 27.07 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.091 0.948 . . . . 0.0 112.417 173.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.6 t -94.73 97.69 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 112.634 -2.075 . . . . 0.0 106.345 175.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.8 m -95.91 122.29 38.56 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 113.414 -1.721 . . . . 0.0 110.997 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -128.55 96.6 4.45 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.74 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.8 p30 33.77 90.25 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 126.481 1.912 . . . . 0.0 115.707 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.92 -66.7 3.29 Favored Glycine 0 N--CA 1.479 1.529 0 CA-C-N 112.729 -2.032 . . . . 0.0 112.109 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.54 135.55 47.1 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 115.134 -0.533 . . . . 0.0 111.33 -172.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.4 t -123.25 118.1 26.81 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 124.717 1.261 . . . . 0.0 111.878 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.67 111.36 22.29 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 114.05 -1.432 . . . . 0.0 114.172 -174.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.8 t -61.88 124.37 20.59 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 113.445 -1.707 . . . . 0.0 112.66 169.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.31 7.06 17.64 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.032 -1.44 . . . . 0.0 113.843 171.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -94.92 -10.84 29.92 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 160.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 t -109.72 114.97 29.0 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.177 0.991 . . . . 0.0 110.234 171.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 tp -49.88 -53.57 25.03 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.287 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -64.45 -38.32 90.63 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -60.68 -49.63 76.73 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.11 -39.16 91.58 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 173.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -67.67 -32.91 73.91 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 t -116.31 67.85 0.72 Allowed 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 124.039 1.876 . . . . 0.0 113.089 170.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.6 tp -116.17 -50.91 2.65 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 111.717 -2.492 . . . . 0.0 113.79 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.96 78.6 1.19 Allowed Glycine 0 N--CA 1.477 1.369 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -170.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.3 mt -107.33 80.87 1.46 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.286 -0.957 . . . . 0.0 110.737 -173.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.6 t -142.58 175.5 9.75 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.844 -1.526 . . . . 0.0 114.208 -165.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -50.6 127.2 17.34 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.615 1.966 . . . . 0.0 111.442 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.07 -29.45 10.67 Favored Glycine 0 N--CA 1.482 1.737 0 CA-C-N 112.853 -1.976 . . . . 0.0 113.058 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.8 p -66.98 113.15 4.76 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.4 t -86.04 105.42 14.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 112.739 -2.028 . . . . 0.0 105.797 171.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.4 m -99.55 105.76 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 113.761 -1.563 . . . . 0.0 112.342 -174.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.92 95.71 1.6 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.233 -1.803 . . . . 0.0 109.952 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 79.6 mt -82.18 97.14 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.649 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.7 m -110.03 121.54 45.5 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 112.679 -2.055 . . . . 0.0 109.926 -175.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.96 138.41 45.45 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -133.76 141.73 47.63 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.166 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.78 -150.49 19.04 Favored Glycine 0 CA--C 1.538 1.527 0 O-C-N 124.9 1.375 . . . . 0.0 110.62 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.09 -60.62 3.49 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.487 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 5.9 p30 -91.64 39.26 1.0 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -175.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -52.31 -55.76 19.31 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -45.45 77.53 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.43 1.092 . . . . 0.0 113.06 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -59.59 -50.26 74.56 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.819 1.248 . . . . 0.0 112.049 -176.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.19 -54.06 51.08 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.294 1.038 . . . . 0.0 112.728 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.6 t -62.41 -48.49 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-O 118.06 -0.971 . . . . 0.0 111.045 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -54.23 -53.5 52.72 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.299 1.04 . . . . 0.0 111.718 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -56.33 -52.29 65.09 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.341 1.057 . . . . 0.0 112.449 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.9 mt -66.44 -34.5 78.09 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.95 -51.42 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-O 118.849 -0.596 . . . . 0.0 109.971 170.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -58.34 -42.91 87.89 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.2 tt -55.04 -56.87 14.98 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.245 1.018 . . . . 0.0 111.639 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -57.75 -39.28 76.99 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.842 0.857 . . . . 0.0 112.774 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.83 -29.55 69.51 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -86.51 -25.05 25.3 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.3 tp -74.55 141.33 44.8 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.087 0.955 . . . . 0.0 110.691 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -176.958 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 ttt . . . . . 0 C--O 1.233 0.203 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -121.74 111.58 17.34 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.941 0.776 . . . . 0.0 111.056 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -108.8 116.36 31.83 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 112.603 -2.09 . . . . 0.0 110.45 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -119.62 118.13 30.17 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.251 172.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -89.7 111.66 22.7 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 112.745 -2.025 . . . . 0.0 107.427 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.2 m -127.75 162.09 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.713 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.1 p -113.4 137.65 51.22 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.083 171.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 mt -95.92 111.47 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -103.74 -18.73 14.57 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.98 141.93 74.95 Favored Pre-proline 0 C--O 1.256 1.438 0 CA-C-O 116.989 -1.482 . . . . 0.0 114.173 177.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.93 -56.83 2.7 Favored 'Trans proline' 0 N--CA 1.493 1.475 1 C-N-CA 125.973 4.449 . . . . 0.0 116.256 -169.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -102.67 -20.27 14.47 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.4 -118.26 11.55 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.236 1.874 . . . . 0.0 113.19 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.7 mt -97.91 -22.77 16.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 112.096 -2.052 . . . . 0.0 114.415 -176.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.0 p -104.95 -59.66 1.72 Allowed 'General case' 0 N--CA 1.474 0.764 0 O-C-N 117.258 -3.401 . . . . 0.0 113.554 171.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -75.26 -43.35 4.4 Favored Pre-proline 0 N--CA 1.486 1.348 0 CA-C-O 115.932 -1.985 . . . . 0.0 114.68 -172.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -61.81 -26.48 79.49 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 121.974 1.782 . . . . 0.0 112.091 166.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.05 -35.38 61.9 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.148 0.579 . . . . 0.0 112.476 175.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.96 -38.03 75.27 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.746 1.219 . . . . 0.0 112.482 168.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -65.14 -43.46 91.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.621 0.768 . . . . 0.0 111.971 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -64.05 -39.25 93.67 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.465 1.106 . . . . 0.0 111.558 175.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.4 t -58.53 -49.26 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 125.005 1.322 . . . . 0.0 111.877 173.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -56.21 -42.95 78.04 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.04 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -68.71 -42.26 77.94 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.188 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.12 -27.49 68.08 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -68.93 -11.48 60.69 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 172.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.51 -33.18 7.27 Favored Glycine 0 N--CA 1.481 1.674 0 C-N-CA 124.774 1.178 . . . . 0.0 112.957 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -72.6 128.45 35.6 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.081 1.352 . . . . 0.0 111.765 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.504 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 64.5 p -54.3 -36.92 64.23 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.457 -1.247 . . . . 0.0 113.659 172.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.3 p -61.69 146.24 49.79 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.371 1.044 . . . . 0.0 111.598 167.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -102.15 98.09 8.3 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 113.663 -1.608 . . . . 0.0 108.991 169.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.3 mm -62.22 113.11 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 112.501 -2.136 . . . . 0.0 110.232 177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.1 p -97.62 134.94 40.14 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.048 165.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.2 t -111.37 94.84 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 111.49 -2.595 . . . . 0.0 108.61 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.9 m -88.52 101.67 14.17 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 111.413 -2.63 . . . . 0.0 112.029 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 t -117.85 112.77 20.82 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.841 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.25 20.4 p30 44.73 61.36 2.49 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 126.046 1.738 . . . . 0.0 115.662 -173.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.68 19.87 63.29 Favored Glycine 0 CA--C 1.546 1.974 0 N-CA-C 116.896 1.519 . . . . 0.0 116.896 -176.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.9 mttt -118.75 107.85 14.15 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.743 0.771 . . . . 0.0 109.773 171.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.2 m -90.23 105.71 17.99 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 122.809 1.29 . . . . 0.0 111.606 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.88 105.3 14.43 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.675 -2.057 . . . . 0.0 111.525 -176.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.5 t -50.54 111.35 0.52 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 114.221 -1.354 . . . . 0.0 114.213 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.33 -18.42 65.3 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.283 -1.78 . . . . 0.0 113.666 169.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -77.94 -10.64 59.68 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.2 t -111.81 118.11 34.66 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.48 1.133 . . . . 0.0 112.057 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -46.2 -53.52 10.39 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 111.016 -2.811 . . . . 0.0 113.672 -172.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -69.29 -39.95 78.01 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -64.13 -52.06 60.95 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -167.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.68 -46.43 82.47 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.435 1.094 . . . . 0.0 113.105 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -63.92 -33.87 76.67 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.261 11.1 t -74.23 -48.41 29.01 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.3 tp -37.38 -53.19 1.12 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -167.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.13 67.19 0.52 Allowed Glycine 0 N--CA 1.484 1.839 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.9 mt -81.26 94.77 6.78 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 122.297 1.046 . . . . 0.0 111.4 174.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -150.41 -172.13 4.1 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.301 -2.227 . . . . 0.0 111.213 -168.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -52.21 125.91 17.24 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.812 2.045 . . . . 0.0 114.617 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.28 22.34 63.07 Favored Glycine 0 N--CA 1.484 1.888 0 CA-C-N 111.704 -2.498 . . . . 0.0 114.595 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.3 p -103.39 104.48 14.59 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 122.536 1.16 . . . . 0.0 112.5 -172.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 t -69.69 113.57 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 111.156 -2.747 . . . . 0.0 108.725 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.71 117.24 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 112.892 -1.958 . . . . 0.0 110.812 -175.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.3 m -87.06 100.31 12.55 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.613 174.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.2 mt -89.1 101.4 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 113.655 -1.611 . . . . 0.0 108.674 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.4 m -116.46 127.17 54.35 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 109.76 -3.382 . . . . 0.0 111.086 -167.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.23 123.99 40.74 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.475 -176.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -119.13 108.05 14.22 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.931 1.394 . . . . 0.0 108.379 174.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.44 178.21 30.35 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.58 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -51.77 -41.84 61.93 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -176.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.504 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 13.4 p30 -102.47 39.8 1.46 Allowed 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -176.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -55.04 -40.06 69.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.01 -46.06 10.17 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.723 -176.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -52.39 -46.41 66.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.043 1.737 . . . . 0.0 114.82 171.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.19 -53.46 44.4 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -176.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 68.8 t -60.78 -44.47 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.31 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -56.33 -51.44 68.25 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.421 1.089 . . . . 0.0 111.893 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -54.0 -51.58 63.49 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.778 0.831 . . . . 0.0 112.515 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 98.0 mt -65.62 -47.94 73.92 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.0 t -58.56 -38.28 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 118.945 0.793 . . . . 0.0 110.756 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -60.67 -62.98 1.47 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.68 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.8 tp -47.09 -44.17 20.95 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.942 2.097 . . . . 0.0 114.287 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.6 tmm? -53.59 -61.76 2.1 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.684 1.593 . . . . 0.0 112.427 172.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.43 -26.31 66.35 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -68.05 -29.74 68.78 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 172.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 mp -81.2 160.35 24.35 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 122.917 0.487 . . . . 0.0 111.891 171.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 . . . . . 0 C--O 1.261 1.666 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -167.35 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ttt . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -81.85 133.59 35.34 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.479 167.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -137.17 133.87 35.7 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 112.581 -2.1 . . . . 0.0 110.003 -173.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -126.19 111.29 14.43 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.147 172.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -79.3 80.81 5.63 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.913 1.34 . . . . 0.0 109.72 167.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 m -107.61 135.49 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 114.158 -1.383 . . . . 0.0 113.899 -175.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 p -76.34 140.56 41.49 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 112.444 -2.162 . . . . 0.0 113.471 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.9 mt -105.54 118.12 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.684 167.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.9 p -112.84 -12.39 13.32 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.32 132.66 95.19 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-O 118.024 -0.988 . . . . 0.0 111.712 173.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -42.88 -54.67 3.19 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 124.725 3.617 . . . . 0.0 116.602 -170.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -97.78 -41.9 7.85 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 174.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.06 -120.66 7.32 Favored Glycine 0 CA--C 1.541 1.681 0 C-N-CA 124.059 0.838 . . . . 0.0 112.36 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 31.4 mt -97.91 -42.59 7.47 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -171.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p -104.21 -50.21 3.41 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 118.036 -2.915 . . . . 0.0 114.879 173.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.283 21.0 mmt180 -76.37 -49.42 3.01 Favored Pre-proline 0 N--CA 1.487 1.41 0 CA-C-O 116.442 -1.742 . . . . 0.0 115.242 -174.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -64.5 -31.45 60.9 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 121.698 1.642 . . . . 0.0 113.627 167.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.22 -38.93 77.75 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 169.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.82 -39.97 86.86 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -61.92 -44.7 96.25 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.628 0.771 . . . . 0.0 112.262 173.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -55.27 -43.69 74.93 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.929 1.292 . . . . 0.0 111.588 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.97 -51.03 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 123.661 0.784 . . . . 0.0 111.895 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -48.56 -47.62 39.29 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.673 0.789 . . . . 0.0 110.995 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.62 -50.89 47.93 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.743 1.277 . . . . 0.0 113.276 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.1 -36.63 63.41 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -60.63 -27.38 67.73 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 173.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.79 -23.17 76.99 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.292 1.425 . . . . 0.0 114.159 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -89.98 149.26 22.64 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.952 0.901 . . . . 0.0 110.69 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.42 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 72.1 p -71.5 -39.42 70.83 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.39 0.676 . . . . 0.0 112.073 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.5 p -65.71 137.97 57.65 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.681 1.192 . . . . 0.0 114.163 175.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -85.28 104.21 14.92 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.605 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.7 mm -72.93 94.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 111.94 -2.391 . . . . 0.0 110.289 173.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.4 p -89.48 113.86 25.29 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.275 -1.329 . . . . 0.0 108.993 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -100.57 96.52 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 113.183 -1.826 . . . . 0.0 107.563 -177.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.8 m -87.92 116.65 26.23 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 112.962 -1.927 . . . . 0.0 111.473 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -111.12 105.85 14.7 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.733 173.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 p30 40.21 69.29 0.32 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.591 1.556 . . . . 0.0 114.204 -173.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.33 -39.71 3.0 Favored Glycine 0 N--CA 1.485 1.918 0 CA-C-N 113.197 -1.819 . . . . 0.0 114.15 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -72.74 99.05 2.51 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.353 1.061 . . . . 0.0 112.438 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.3 m -83.94 108.42 16.91 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.541 -1.663 . . . . 0.0 113.398 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.57 115.13 28.66 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.182 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.9 t -67.08 125.77 27.06 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 113.916 -1.493 . . . . 0.0 113.219 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.84 -5.24 47.51 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 112.402 -2.181 . . . . 0.0 113.422 171.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -83.65 8.2 15.11 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 167.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 t -144.41 131.04 20.02 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.933 0.493 . . . . 0.0 112.129 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.07 -68.31 0.22 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 113.733 -1.576 . . . . 0.0 113.552 -171.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -54.64 -39.38 67.93 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -57.1 -55.0 40.38 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 124.165 0.916 . . . . 0.0 112.935 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 tp -68.0 -48.57 65.37 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.895 1.372 . . . . 0.0 113.616 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -61.41 -34.44 75.37 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 -172.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.2 t -72.17 -20.03 61.66 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.1 tp -70.11 -37.53 75.38 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.51 73.83 1.28 Allowed Glycine 0 N--CA 1.484 1.847 0 O-C-N 124.439 1.087 . . . . 0.0 113.074 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.1 mt -84.81 92.93 8.37 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.387 0.613 . . . . 0.0 110.273 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.9 t -141.5 -175.0 4.2 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -169.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -56.5 112.93 1.4 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.106 0.963 . . . . 0.0 111.146 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.54 -30.8 6.25 Favored Glycine 0 CA--C 1.542 1.72 0 CA-C-N 113.611 -1.631 . . . . 0.0 114.496 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.6 p -70.11 103.58 2.35 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.4 t -68.11 117.78 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 163.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.8 m -118.17 109.59 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 113.654 -1.612 . . . . 0.0 113.004 -175.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.71 86.87 2.75 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.052 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.2 mt -78.8 95.28 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.7 m -105.42 128.14 53.37 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 112.948 -1.933 . . . . 0.0 110.693 -174.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.49 116.13 28.34 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -105.97 97.42 7.24 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.74 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.09 -175.05 28.5 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-N 114.536 -1.211 . . . . 0.0 113.361 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -55.88 -54.46 44.34 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 -169.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.42 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 6.2 p30 -83.52 28.88 0.53 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -38.78 -60.64 0.81 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -50.58 72.07 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -67.09 -40.09 86.89 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -175.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.34 -52.43 65.65 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 123.767 0.667 . . . . 0.0 112.678 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.0 t -63.5 -49.58 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.647 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -49.93 -57.44 7.49 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.573 1.549 . . . . 0.0 112.011 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -59.46 -50.79 72.56 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.898 0.879 . . . . 0.0 113.102 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.4 mt -63.22 -36.05 82.36 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -62.02 -48.64 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 123.808 0.693 . . . . 0.0 110.566 171.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -54.25 -55.5 27.51 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 118.234 -0.888 . . . . 0.0 113.062 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.8 tp -52.66 -48.97 66.13 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.047 0.939 . . . . 0.0 112.832 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -57.36 -45.53 84.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.402 1.081 . . . . 0.0 112.642 175.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.54 -25.22 60.3 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -74.55 -41.09 61.17 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.15 1.166 . . . . 0.0 114.15 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.7 mt -66.95 150.51 49.13 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.343 1.057 . . . . 0.0 113.342 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 125.564 1.546 . . . . 0.0 109.139 173.878 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.435 ' H3 ' ' CD ' ' A' ' 70' ' ' GLU . 24.3 ttt . . . . . 0 N--CA 1.465 0.28 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -119.83 139.94 51.58 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 125.066 1.479 . . . . 0.0 110.01 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -134.03 129.75 36.55 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 124.59 1.181 . . . . 0.0 111.729 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -128.47 136.64 51.1 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.374 1.046 . . . . 0.0 112.454 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -98.89 110.24 22.87 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.187 -1.37 . . . . 0.0 110.449 173.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 m -119.79 152.8 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 114.468 -1.242 . . . . 0.0 114.242 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.6 p -111.98 121.94 46.39 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 113.531 -1.668 . . . . 0.0 111.447 -173.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.1 mt -79.69 96.47 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.17 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -74.67 -34.7 62.74 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.15 134.42 68.52 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 125.486 1.514 . . . . 0.0 113.67 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -45.71 -43.91 18.28 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.539 3.493 . . . . 0.0 117.493 -173.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -114.5 -40.8 3.54 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 172.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.17 -114.47 3.91 Favored Glycine 0 N--CA 1.475 1.279 0 C-N-CA 123.986 0.803 . . . . 0.0 111.769 168.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.1 mt -101.29 -43.89 5.83 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.185 1.179 . . . . 0.0 114.185 -167.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.8 p -107.55 -52.02 2.82 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 118.167 -2.833 . . . . 0.0 114.708 171.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.266 20.2 mmt180 -71.8 -54.08 6.56 Favored Pre-proline 0 N--CA 1.487 1.418 0 CA-C-O 116.579 -1.677 . . . . 0.0 115.168 -174.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -62.93 -34.26 71.98 Favored 'Trans proline' 0 N--CA 1.479 0.632 0 CA-C-N 121.899 1.714 . . . . 0.0 113.653 171.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.73 -36.91 62.8 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 172.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.71 -40.38 83.51 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 174.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.32 -45.42 91.4 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -55.48 -45.73 76.94 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.795 1.238 . . . . 0.0 110.934 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.47 -50.22 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 123.403 0.681 . . . . 0.0 111.228 175.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -50.03 -47.08 53.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.289 1.036 . . . . 0.0 112.275 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.09 -49.15 65.96 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 124.269 0.98 . . . . 0.0 113.387 174.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.5 -39.61 76.85 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -47.7 -44.26 27.39 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.71 1.604 . . . . 0.0 113.898 167.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.17 -34.22 69.72 Favored Glycine 0 N--CA 1.475 1.261 0 O-C-N 125.435 1.709 . . . . 0.0 114.355 -176.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -65.69 145.87 55.5 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.306 0.643 . . . . 0.0 111.702 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.488 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 57.9 p -64.12 -35.19 79.94 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.216 176.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.0 p -68.71 144.97 54.24 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.294 -1.321 . . . . 0.0 114.497 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.404 ' CD ' ' HG ' ' A' ' 43' ' ' SER . 16.9 tt0 -92.56 118.21 30.77 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.938 169.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.1 mm -86.17 103.25 12.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 111.706 -2.497 . . . . 0.0 110.195 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.4 p -103.47 118.91 37.84 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.378 175.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.6 t -99.24 95.95 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 112.961 -1.927 . . . . 0.0 107.504 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.5 m -91.34 110.29 21.58 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 113.657 -1.61 . . . . 0.0 110.79 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.8 t -108.16 95.27 5.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 113.544 -1.662 . . . . 0.0 109.634 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.3 p30 43.63 72.43 0.19 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.365 1.466 . . . . 0.0 114.349 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.62 -38.93 2.92 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-N 113.028 -1.896 . . . . 0.0 114.496 -175.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -75.45 88.91 2.65 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -175.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.5 m -74.13 113.62 11.54 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.381 -1.282 . . . . 0.0 112.982 170.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.12 122.77 47.99 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.088 170.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.404 ' HG ' ' CD ' ' A' ' 32' ' ' GLU . 36.9 t -86.84 128.26 35.04 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.331 -177.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.46 16.28 6.7 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 113.117 -1.856 . . . . 0.0 114.092 176.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -92.58 2.84 56.48 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.663 0.744 . . . . 0.0 112.663 158.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.1 t -127.84 125.93 40.67 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.847 1.659 . . . . 0.0 110.799 172.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.65 -54.04 50.66 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.813 171.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -57.69 -48.93 78.16 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.152 -1.385 . . . . 0.0 113.862 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -60.98 -46.57 90.2 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 tp -68.17 -47.88 66.81 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 123.821 0.7 . . . . 0.0 112.002 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -57.1 -42.26 80.47 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -71.78 -14.51 62.01 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.4 tp -75.37 -42.35 54.2 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.56 82.51 0.7 Allowed Glycine 0 N--CA 1.478 1.481 0 O-C-N 124.394 1.059 . . . . 0.0 112.527 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.8 mt -82.85 78.32 9.46 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 122.877 1.322 . . . . 0.0 112.298 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.0 t -85.36 -174.27 5.12 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 111.914 -2.403 . . . . 0.0 112.569 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -60.23 144.23 50.72 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.979 1.712 . . . . 0.0 111.114 175.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.57 -38.07 3.27 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 114.251 -1.34 . . . . 0.0 114.642 171.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.4 p -54.96 104.62 0.12 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.184 1.549 . . . . 0.0 115.184 -174.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.7 t -66.74 112.46 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 112.152 -2.295 . . . . 0.0 107.177 169.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.5 m -119.32 118.08 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 113.35 -1.75 . . . . 0.0 114.641 -172.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.3 m -80.23 100.45 8.33 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 125.447 1.717 . . . . 0.0 109.084 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 80.2 mt -91.76 102.44 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.586 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 m -100.12 131.66 45.94 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.141 -178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.12 105.86 13.97 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 124.035 0.835 . . . . 0.0 112.353 172.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -104.06 92.46 4.39 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.233 -1.348 . . . . 0.0 111.266 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.3 -167.55 39.94 Favored Glycine 0 N--CA 1.48 1.623 0 CA-C-N 112.252 -2.249 . . . . 0.0 111.148 174.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.01 -51.5 66.57 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.488 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 6.7 p30 -82.38 36.49 0.48 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.435 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 5.9 pt-20 -45.83 -72.53 0.05 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 -173.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.05 -47.99 53.1 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -63.05 -47.25 83.75 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.577 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.32 -46.08 80.03 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.23 0.957 . . . . 0.0 113.538 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.0 t -67.35 -56.06 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.225 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -51.02 -47.16 61.7 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.477 1.111 . . . . 0.0 112.687 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -53.15 -61.41 2.31 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.032 1.333 . . . . 0.0 112.067 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.9 mt -64.27 -33.23 75.35 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.7 t -62.05 -56.31 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.103 0.961 . . . . 0.0 110.527 171.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -57.55 -48.26 79.82 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.449 1.099 . . . . 0.0 111.25 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.2 tp -54.57 -52.01 63.47 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.448 1.499 . . . . 0.0 111.954 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -57.86 -44.91 86.88 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.226 1.011 . . . . 0.0 112.033 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.54 -33.62 75.43 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -75.85 -30.39 58.9 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.1 mt -67.89 133.21 48.74 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.927 0.891 . . . . 0.0 112.629 175.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 . . . . . 0 C--O 1.255 1.349 0 O-C-N 125.405 1.691 . . . . 0.0 109.836 179.761 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -108.39 129.18 55.26 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 125.72 1.888 . . . . 0.0 108.001 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -126.98 131.23 51.09 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.621 -170.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -129.32 122.87 30.44 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.432 1.082 . . . . 0.0 113.025 168.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -87.03 100.6 12.74 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 112.442 -2.163 . . . . 0.0 107.945 176.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.5 m -116.97 143.52 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 114.22 -1.355 . . . . 0.0 114.173 -173.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 p -94.03 122.14 36.23 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.408 1.099 . . . . 0.0 111.495 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.2 mt -78.9 97.92 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.6 167.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.7 p -82.81 -26.66 31.52 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 109.962 -3.29 . . . . 0.0 113.526 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.12 120.63 14.44 Favored Pre-proline 0 N--CA 1.476 0.847 0 O-C-N 124.715 1.259 . . . . 0.0 112.277 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -57.38 -48.71 16.33 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 123.785 2.99 . . . . 0.0 113.77 -175.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -68.94 -43.46 75.02 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.545 0.338 . . . . 0.0 111.688 170.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.88 -148.01 17.62 Favored Glycine 0 N--CA 1.475 1.279 0 O-C-N 124.75 1.281 . . . . 0.0 110.984 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.7 mt -98.35 -17.83 18.65 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 113.639 -1.28 . . . . 0.0 112.407 173.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.6 p -99.28 -61.42 1.37 Allowed 'General case' 0 N--CA 1.48 1.039 0 O-C-N 117.955 -2.966 . . . . 0.0 113.437 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.7 -44.23 53.03 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-O 116.874 -1.536 . . . . 0.0 114.903 -175.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -69.17 -33.74 18.12 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.734 1.623 . . . . 0.0 113.391 172.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.49 97.45 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.47 0.708 . . . . 0.0 112.487 171.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.89 -46.2 90.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.235 0.614 . . . . 0.0 112.577 169.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -58.81 -43.7 90.64 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 171.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.16 -43.12 87.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.136 0.974 . . . . 0.0 112.895 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.5 t -61.51 -48.91 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 122.478 0.311 . . . . 0.0 110.95 172.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -52.98 -45.44 67.81 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.498 0.719 . . . . 0.0 112.839 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -64.49 -49.4 71.5 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.568 1.147 . . . . 0.0 112.881 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.88 -29.2 67.45 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -51.91 -26.44 10.26 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 168.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.95 -22.83 77.21 Favored Glycine 0 CA--C 1.543 1.826 0 O-C-N 125.109 1.505 . . . . 0.0 115.704 175.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -96.98 143.4 27.88 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.88 0.847 . . . . 0.0 112.406 -178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.515 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 74.8 p -66.35 -37.15 84.67 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.075 -178.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.9 p -63.84 138.6 58.55 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.748 170.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -95.22 96.67 9.34 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 123.412 1.577 . . . . 0.0 108.95 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mt -77.07 128.81 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 111.612 -2.54 . . . . 0.0 110.542 -172.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.4 p -102.32 134.92 44.83 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.349 173.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.8 t -102.29 90.25 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 170.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.1 m -89.41 112.85 24.08 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.14 -1.391 . . . . 0.0 113.723 -170.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.4 t -116.27 97.36 6.0 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 124.377 1.048 . . . . 0.0 111.156 173.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 p30 39.59 83.02 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.816 1.646 . . . . 0.0 115.183 -175.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.03 -41.3 1.97 Allowed Glycine 0 CA--C 1.55 2.258 0 CA-C-N 114.266 -1.333 . . . . 0.0 113.71 -173.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.2 mtmt -71.85 79.75 0.88 Allowed 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.4 m -72.02 111.78 7.55 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.029 -1.441 . . . . 0.0 112.937 168.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.09 99.02 9.98 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 113.835 -1.529 . . . . 0.0 112.638 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 t -55.45 119.2 5.26 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.57 1.176 . . . . 0.0 113.186 174.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.17 9.57 1.96 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 112.847 -1.979 . . . . 0.0 114.006 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -104.65 19.99 19.43 Favored 'General case' 0 C--O 1.25 1.082 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 164.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.8 t -140.78 125.42 17.93 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.161 1.384 . . . . 0.0 112.749 174.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -55.73 -44.27 77.38 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 113.58 -1.645 . . . . 0.0 114.209 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -64.39 -39.16 93.32 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.16 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -55.4 -56.41 20.44 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.9 mp -67.91 -31.22 70.85 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -176.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -78.64 -34.28 46.62 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.023 -0.99 . . . . 0.0 113.371 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.7 t -79.09 -32.51 44.68 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.3 tp -51.97 -49.79 62.54 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.366 1.246 . . . . 0.0 114.366 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.76 89.04 1.78 Allowed Glycine 0 N--CA 1.476 1.352 0 O-C-N 125.352 1.657 . . . . 0.0 110.817 -175.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 92.0 mt -109.05 99.41 8.73 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.813 -0.694 . . . . 0.0 112.315 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.3 t -150.98 170.57 19.02 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.627 1.571 . . . . 0.0 110.589 -174.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -50.13 118.39 2.92 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.598 1.159 . . . . 0.0 112.987 -172.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.81 -29.4 7.5 Favored Glycine 0 CA--C 1.543 1.781 0 CA-C-N 112.585 -2.098 . . . . 0.0 113.696 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.4 p -62.33 100.91 0.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.2 t -78.76 115.9 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 113.356 -1.747 . . . . 0.0 106.811 171.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 m -127.95 129.5 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 113.58 -1.646 . . . . 0.0 112.982 -174.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.4 m -89.05 96.95 10.94 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.421 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.2 mt -67.25 96.83 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 113.476 -1.693 . . . . 0.0 107.404 167.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.6 m -111.27 103.42 11.82 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 112.968 -1.924 . . . . 0.0 111.669 -175.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.28 100.19 12.1 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.624 0.726 . . . . 0.0 112.034 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -99.5 96.36 7.63 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 112.916 -1.947 . . . . 0.0 111.588 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.88 -162.07 28.83 Favored Glycine 0 N--CA 1.48 1.63 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.606 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -60.63 -28.47 68.57 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 120.452 3.501 . . . . 0.0 120.452 -168.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.515 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 20.2 p30 -116.72 50.56 1.06 Allowed 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 175.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -49.16 -55.43 12.41 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -53.29 59.96 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.918 1.287 . . . . 0.0 114.312 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -55.45 -47.45 76.02 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.021 1.328 . . . . 0.0 113.958 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.96 -53.43 57.35 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.571 -1.195 . . . . 0.0 113.372 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 51.1 t -60.83 -50.63 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 118.936 -0.554 . . . . 0.0 112.128 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -52.78 -57.24 10.81 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.458 1.103 . . . . 0.0 112.841 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -54.55 -50.11 68.72 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.46 1.104 . . . . 0.0 113.075 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 72.1 mt -67.57 -38.03 83.51 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.33 -45.35 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.059 0.543 . . . . 0.0 110.559 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -58.14 -49.05 78.32 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 118.313 -0.851 . . . . 0.0 113.153 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.8 tp -54.19 -51.76 63.38 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.891 0.876 . . . . 0.0 112.586 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -59.64 -44.92 93.32 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.98 0.912 . . . . 0.0 112.884 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.06 91.07 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -79.47 -19.76 49.01 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.9 mt -77.6 124.6 28.13 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 172.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--O 1.249 1.056 0 C-N-CA 127.352 2.261 . . . . 0.0 107.018 173.633 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ttt . . . . . 0 C--O 1.236 0.385 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -117.57 115.33 24.89 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 125.1 1.5 . . . . 0.0 109.123 175.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -102.65 129.92 49.4 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.361 -178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -123.37 103.58 8.58 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 171.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -73.78 95.34 2.38 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.294 -1.776 . . . . 0.0 110.675 172.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 m -117.16 146.22 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 113.388 -1.733 . . . . 0.0 113.862 -174.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.0 p -108.56 128.52 54.89 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.714 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 mp -75.81 130.32 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.765 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 p -88.18 -37.32 16.24 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.323 171.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.61 133.38 88.88 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 125.399 1.48 . . . . 0.0 113.704 -175.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.52 -68.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 124.166 3.244 . . . . 0.0 112.431 -172.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -62.06 -34.59 76.55 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.906 0.882 . . . . 0.0 112.222 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.37 -126.27 7.78 Favored Glycine 0 N--CA 1.481 1.647 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 168.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.6 mp -88.87 -28.64 20.23 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 113.527 -1.337 . . . . 0.0 113.682 176.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.6 p -106.51 -47.87 3.68 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 117.863 -3.023 . . . . 0.0 115.18 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.315 12.9 mmt180 -88.04 -39.69 0.48 Allowed Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 -173.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -61.74 -38.76 58.03 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 121.983 1.789 . . . . 0.0 111.384 163.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.23 73.58 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 168.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.26 86.88 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -60.2 -46.32 90.13 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 124.181 0.926 . . . . 0.0 112.513 174.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -55.57 -53.64 53.87 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.499 1.12 . . . . 0.0 110.766 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.2 t -57.91 -49.75 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.645 0.778 . . . . 0.0 111.313 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -49.74 -52.51 31.07 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.335 1.054 . . . . 0.0 112.992 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -68.97 -43.24 75.36 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.689 1.243 . . . . 0.0 112.772 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.68 -37.8 76.82 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 173.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -53.46 -39.64 64.63 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.0 0.92 . . . . 0.0 112.816 169.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.3 15.0 4.64 Favored Glycine 0 CA--C 1.543 1.792 0 O-C-N 124.747 1.28 . . . . 0.0 115.413 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -113.36 152.03 30.49 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.977 0.894 . . . . 0.0 111.992 172.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.48 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 63.4 p -69.94 -40.3 75.56 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.15 175.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -73.66 145.32 45.39 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.796 0.839 . . . . 0.0 112.882 173.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -96.4 109.78 22.25 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.645 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 mp -83.22 106.89 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 112.182 -2.281 . . . . 0.0 109.45 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.0 p -102.39 128.5 48.95 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 112.959 -1.928 . . . . 0.0 110.214 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.06 105.0 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 113.288 -1.778 . . . . 0.0 107.569 -176.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.0 m -106.83 126.2 52.0 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.3 t -116.25 97.32 5.98 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 112.99 -1.914 . . . . 0.0 110.02 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.257 4.0 p30 40.63 73.47 0.12 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 113.518 -1.674 . . . . 0.0 114.706 -175.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.09 -53.22 4.19 Favored Glycine 0 N--CA 1.488 2.111 0 CA-C-N 113.705 -1.589 . . . . 0.0 113.513 -178.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -60.72 104.56 0.36 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.38 1.472 . . . . 0.0 113.525 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 t -90.93 136.03 33.34 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.644 1.349 . . . . 0.0 114.644 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.28 97.43 5.06 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 113.879 -1.51 . . . . 0.0 113.081 173.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -54.6 130.21 39.28 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.985 168.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.81 13.81 21.29 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.109 -1.405 . . . . 0.0 114.337 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.63 -8.88 27.92 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.074 153.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -113.09 111.61 22.43 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 123.464 1.602 . . . . 0.0 112.54 169.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -54.43 -59.51 4.59 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 111.556 -2.565 . . . . 0.0 114.278 -169.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -65.47 -28.56 69.3 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -54.7 -48.12 72.86 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.4 tp -61.32 -43.26 99.17 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 176.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -58.17 -46.89 84.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 124.051 0.844 . . . . 0.0 112.64 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.2 t -66.72 -37.15 84.1 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.5 tp -66.6 -41.77 87.92 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.41 83.97 0.34 Allowed Glycine 0 N--CA 1.476 1.358 0 C-N-CA 124.348 0.975 . . . . 0.0 115.053 170.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 mp -75.03 109.47 8.53 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.336 -0.932 . . . . 0.0 109.598 174.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -135.59 -174.7 3.72 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.928 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -52.2 109.15 0.35 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.549 1.94 . . . . 0.0 112.729 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.82 35.2 51.29 Favored Glycine 0 CA--C 1.543 1.837 0 CA-C-N 114.627 -1.17 . . . . 0.0 115.545 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.2 p -83.35 118.28 23.58 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 117.313 0.556 . . . . 0.0 110.18 168.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.0 t -90.96 80.5 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 125.758 1.911 . . . . 0.0 106.413 -177.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.1 m -100.15 133.15 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 112.154 -2.294 . . . . 0.0 112.501 -172.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.8 p -92.99 95.95 9.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.314 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 88.4 mt -74.32 94.18 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.428 173.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.6 m -113.94 110.48 20.14 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 112.828 -1.987 . . . . 0.0 111.889 -172.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.14 125.19 50.71 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.827 175.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -115.87 131.2 57.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 112.9 -1.955 . . . . 0.0 109.623 172.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.22 -160.29 24.97 Favored Glycine 0 N--CA 1.482 1.766 0 CA-C-N 113.359 -1.746 . . . . 0.0 110.783 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -58.88 -61.34 2.7 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.48 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 3.8 p30 -88.71 39.03 0.9 Allowed 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -46.27 -55.0 7.84 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 117.976 2.584 . . . . 0.0 117.976 -175.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.423 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -71.88 -45.42 61.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.641 1.176 . . . . 0.0 113.914 -177.338 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -66.07 -45.77 80.12 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.745 1.218 . . . . 0.0 112.466 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.86 -44.18 94.28 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.146 0.903 . . . . 0.0 113.406 176.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.0 t -63.87 -50.81 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 118.612 -0.708 . . . . 0.0 112.343 173.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -50.16 -48.36 53.89 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -57.23 -58.12 9.62 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.037 0.935 . . . . 0.0 111.298 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.53 -29.21 69.25 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.2 t -66.86 -51.67 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 123.497 0.498 . . . . 0.0 111.474 170.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -59.73 -41.22 90.39 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.049 0.54 . . . . 0.0 111.877 175.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.33 -45.69 92.56 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.199 1.399 . . . . 0.0 112.404 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.9 tmm? -57.92 -41.75 83.36 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.19 0.596 . . . . 0.0 111.521 174.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.22 96.7 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -78.06 -22.54 48.93 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.0 mt -70.54 122.83 20.44 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.666 -0.646 . . . . 0.0 111.246 165.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--O 1.25 1.114 0 O-C-N 125.195 1.559 . . . . 0.0 111.447 -177.266 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.403 ' H3 ' ' CD ' ' A' ' 70' ' ' GLU . 21.7 ttt . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -127.64 137.94 52.68 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 125.79 1.931 . . . . 0.0 108.701 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.08 139.9 53.02 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.262 -176.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -148.0 121.82 9.32 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 124.24 0.963 . . . . 0.0 111.314 169.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -92.12 115.27 27.93 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.778 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.1 m -117.32 146.3 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 114.765 -1.107 . . . . 0.0 113.816 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 p -95.93 119.2 33.99 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.56 -1.654 . . . . 0.0 113.628 -174.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.8 mt -82.12 105.71 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.849 170.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.0 p -99.82 -1.74 36.8 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.216 -1.811 . . . . 0.0 114.31 171.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.69 127.43 93.38 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 124.562 1.145 . . . . 0.0 111.95 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -48.91 -44.23 32.81 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 124.381 3.387 . . . . 0.0 117.59 -170.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -105.75 -23.53 12.7 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 173.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.86 -138.16 13.75 Favored Glycine 0 N--CA 1.474 1.225 0 C-N-CA 124.536 1.065 . . . . 0.0 111.147 170.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.6 mp -107.29 -11.49 15.56 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.8 p -103.27 -56.22 2.26 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 118.213 -2.804 . . . . 0.0 115.605 175.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -75.95 -47.6 3.73 Favored Pre-proline 0 N--CA 1.487 1.376 0 CA-C-O 115.752 -2.071 . . . . 0.0 115.732 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -59.03 -39.73 77.62 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.171 1.914 . . . . 0.0 112.004 168.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.22 -51.7 65.75 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 171.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.67 -36.27 78.31 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 175.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -68.11 -44.87 75.2 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 173.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -53.96 -40.86 67.2 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.768 1.227 . . . . 0.0 111.404 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.2 t -55.16 -60.31 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 124.087 0.867 . . . . 0.0 111.687 172.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -62.24 -31.92 72.53 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -174.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -66.23 -55.26 17.05 Favored 'General case' 0 CA--C 1.55 0.942 0 O-C-N 124.26 0.975 . . . . 0.0 111.151 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.89 -37.87 64.2 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 171.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -58.59 -29.56 66.52 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 176.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.46 -12.38 58.57 Favored Glycine 0 CA--C 1.54 1.621 0 O-C-N 125.108 1.505 . . . . 0.0 115.377 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -92.0 158.45 16.24 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.169 0.988 . . . . 0.0 111.863 174.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.437 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 62.2 p -68.78 -46.01 69.83 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.266 177.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.6 p -59.28 137.76 57.86 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.625 1.17 . . . . 0.0 113.919 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -92.23 111.58 23.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.607 -1.179 . . . . 0.0 107.83 170.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mt -95.6 133.01 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-N 111.428 -2.624 . . . . 0.0 110.683 -172.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.5 p -109.05 135.35 50.36 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.228 -1.805 . . . . 0.0 112.133 174.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.97 87.51 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 111.855 -2.429 . . . . 0.0 106.396 177.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.2 m -90.69 109.4 20.58 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.552 -1.658 . . . . 0.0 111.39 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.4 t -116.48 87.65 2.73 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 p30 9.74 108.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 128.208 2.603 . . . . 0.0 118.001 -173.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.12 -49.3 2.45 Favored Glycine 0 N--CA 1.481 1.671 0 CA-C-N 112.985 -1.916 . . . . 0.0 111.881 -171.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -93.95 99.03 11.44 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.793 0.806 . . . . 0.0 111.384 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.1 t -107.25 95.8 5.97 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.93 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.68 142.8 30.49 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 113.604 -1.635 . . . . 0.0 112.297 -176.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.7 t -83.34 123.54 29.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.589 173.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.29 12.83 3.26 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 124.353 1.033 . . . . 0.0 112.793 172.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -112.59 -6.81 13.91 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 168.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.9 t -119.42 131.6 55.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.638 1.175 . . . . 0.0 111.269 172.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -62.09 -62.58 1.68 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 113.286 -1.779 . . . . 0.0 112.307 -172.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -60.15 -29.73 68.85 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 113.912 -1.494 . . . . 0.0 114.593 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -56.67 -57.37 12.71 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.914 0.886 . . . . 0.0 112.022 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.87 -44.9 84.02 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 173.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -54.21 -37.14 64.25 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 t -81.2 -26.04 36.25 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 116.924 2.194 . . . . 0.0 116.924 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.4 tp -41.91 -54.22 3.52 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -167.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.07 88.16 2.04 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -172.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mp -116.21 98.36 6.56 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 125.168 1.158 . . . . 0.0 108.327 -177.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.2 t -138.23 176.9 8.29 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 125.503 1.752 . . . . 0.0 111.781 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -59.83 109.56 0.96 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.839 1.256 . . . . 0.0 110.354 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.39 -30.51 6.43 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 113.948 -1.478 . . . . 0.0 115.069 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.4 p -73.02 96.83 2.21 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 117.942 0.871 . . . . 0.0 112.697 -172.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.0 t -69.4 130.96 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.808 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.2 m -124.35 120.33 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 114.691 -1.141 . . . . 0.0 113.924 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.6 113.34 20.76 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.738 173.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.2 mt -95.54 103.48 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 m -116.48 119.88 37.01 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 112.546 -2.116 . . . . 0.0 110.892 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.48 124.53 51.95 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.355 0.598 . . . . 0.0 112.544 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -117.21 105.96 12.79 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.195 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.79 -160.32 28.56 Favored Glycine 0 N--CA 1.482 1.702 0 CA-C-N 113.037 -1.892 . . . . 0.0 112.972 178.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.54 -49.34 78.16 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.063 1.745 . . . . 0.0 115.243 -174.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.437 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 7.8 p30 -96.21 41.53 1.1 Allowed 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.403 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 7.4 pt-20 -43.27 -67.72 0.25 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -38.47 91.24 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -66.36 -47.97 71.71 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.169 1.388 . . . . 0.0 112.246 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.01 -48.47 81.48 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.903 0.881 . . . . 0.0 112.444 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.8 t -61.25 -52.73 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.571 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -49.41 -51.56 34.46 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.073 0.949 . . . . 0.0 113.073 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -58.5 -51.64 69.0 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.89 0.876 . . . . 0.0 112.44 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.7 mt -70.71 -27.97 64.39 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.0 t -61.64 -55.69 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 123.348 0.659 . . . . 0.0 109.77 168.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -52.68 -51.31 60.81 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 124.417 1.073 . . . . 0.0 112.691 175.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.4 tt -53.45 -50.73 64.66 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.344 1.058 . . . . 0.0 112.737 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -59.55 -44.89 93.11 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.88 0.872 . . . . 0.0 112.428 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.74 -37.28 79.31 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -79.65 10.54 3.89 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.2 mt -98.13 134.48 41.14 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.235 0.614 . . . . 0.0 111.552 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 . . . . . 0 C--O 1.255 1.37 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 160.81 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -96.05 105.06 17.05 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.575 1.172 . . . . 0.0 110.187 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -103.06 94.72 5.69 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 111.424 -2.626 . . . . 0.0 108.939 -176.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -112.61 114.43 27.05 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.541 1.163 . . . . 0.0 111.701 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -86.64 107.34 18.14 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 111.836 -2.438 . . . . 0.0 109.842 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 m -116.05 142.56 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 113.919 -1.492 . . . . 0.0 112.699 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 p -96.47 114.97 26.68 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.284 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.8 mt -66.89 118.3 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.359 172.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -96.04 -30.42 13.58 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.47 -1.241 . . . . 0.0 114.297 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -43.75 121.88 3.64 Favored Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 173.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.67 -55.08 4.1 Favored 'Trans proline' 0 N--CA 1.485 0.999 1 C-N-CA 125.53 4.153 . . . . 0.0 115.147 -166.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -90.76 -37.39 13.7 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.341 0.657 . . . . 0.0 112.193 172.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.18 -142.41 16.06 Favored Glycine 0 N--CA 1.481 1.683 0 O-C-N 124.692 1.245 . . . . 0.0 112.824 168.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.93 -18.76 20.05 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 112.648 -1.776 . . . . 0.0 114.967 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.5 p -106.37 -62.04 1.44 Allowed 'General case' 0 N--CA 1.479 1.012 0 O-C-N 118.283 -2.761 . . . . 0.0 114.138 172.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.282 86.4 mtt-85 -71.88 -40.31 7.91 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 116.866 2.173 . . . . 0.0 116.866 -170.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -65.8 -36.06 33.51 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.268 1.312 . . . . 0.0 112.696 167.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.87 -38.4 64.68 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 172.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.54 -45.46 77.2 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -56.51 -45.13 81.22 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 172.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -61.15 -47.21 87.27 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.432 0.693 . . . . 0.0 112.415 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.5 t -56.2 -53.79 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 123.837 0.711 . . . . 0.0 111.536 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -62.48 -37.57 86.47 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -61.84 -52.76 62.85 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.003 1.321 . . . . 0.0 111.112 175.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.99 -44.68 82.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.64 1.176 . . . . 0.0 113.7 174.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -64.45 -25.15 67.88 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 176.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.83 -5.93 48.73 Favored Glycine 0 CA--C 1.543 1.795 0 C-N-CA 125.197 1.38 . . . . 0.0 114.017 172.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -99.88 147.98 24.95 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.19 0.996 . . . . 0.0 110.337 169.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.78 -41.03 98.03 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.91 176.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.476 ' HG ' ' CG ' ' A' ' 69' ' ' ASP . 54.7 m -53.34 132.36 39.13 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 124.57 1.169 . . . . 0.0 113.78 173.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -82.75 103.56 12.33 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.697 1.237 . . . . 0.0 110.078 173.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.1 mt -89.78 115.16 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 111.346 -2.661 . . . . 0.0 111.055 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.3 p -111.86 139.02 47.69 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.275 171.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.8 t -114.65 116.32 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.952 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.9 m -110.69 127.63 55.38 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.892 -1.504 . . . . 0.0 111.533 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.0 m -136.23 107.72 6.92 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.661 171.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 p30 25.66 64.08 0.06 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.65 -53.16 0.6 Allowed Glycine 0 CA--C 1.539 1.582 0 CA-C-N 113.634 -1.621 . . . . 0.0 112.85 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -76.93 89.41 3.51 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.895 0.855 . . . . 0.0 112.421 -176.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 t -96.21 102.28 14.04 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.953 172.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -118.63 123.39 44.85 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.057 -1.429 . . . . 0.0 113.365 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.2 t -54.79 123.98 15.06 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.179 -1.828 . . . . 0.0 113.688 173.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.37 11.17 8.92 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.067 171.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -96.9 -17.52 20.08 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.915 162.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.5 t -102.34 117.34 34.53 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 122.037 0.922 . . . . 0.0 111.245 172.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -50.25 -62.73 1.41 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.043 -1.89 . . . . 0.0 113.294 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -64.56 -39.87 94.54 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 113.825 -1.534 . . . . 0.0 114.264 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -57.76 -50.32 73.64 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 175.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 tp -68.05 -42.79 80.01 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -59.26 -21.19 59.22 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.6 t -109.29 22.54 15.69 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.2 tt -74.54 -52.15 12.68 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.816 -1.177 . . . . 0.0 110.142 171.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.97 88.9 2.08 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 mt -108.29 81.15 1.44 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.216 -0.992 . . . . 0.0 110.569 -171.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -132.14 172.54 12.26 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.021 -174.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -46.29 116.5 1.28 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.949 1.7 . . . . 0.0 112.133 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.72 -27.87 17.82 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 113.751 -1.568 . . . . 0.0 115.09 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.3 p -61.85 115.4 3.99 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.721 0.772 . . . . 0.0 112.582 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.1 t -84.2 102.93 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 111.9 -2.409 . . . . 0.0 106.884 -176.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.3 m -109.76 117.3 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 113.975 -1.466 . . . . 0.0 113.78 -170.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.56 99.78 12.44 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.437 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.9 mp -78.51 98.19 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 172.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.1 m -103.35 101.85 11.77 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 112.356 -2.202 . . . . 0.0 110.412 -177.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.35 104.42 15.41 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.657 -1.61 . . . . 0.0 113.639 -173.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.31 96.22 10.43 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.297 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.09 -173.19 44.69 Favored Glycine 0 N--CA 1.475 1.295 0 CA-C-N 114.122 -1.399 . . . . 0.0 112.676 173.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -67.87 -46.09 72.69 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.63 1.172 . . . . 0.0 112.749 175.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.476 ' CG ' ' HG ' ' A' ' 31' ' ' SER . 6.3 p-10 -79.09 33.64 0.23 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.715 1.606 . . . . 0.0 113.715 176.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -54.14 -69.29 0.13 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.536 1.935 . . . . 0.0 114.616 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -35.28 65.23 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -66.04 -47.68 73.6 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.152 0.981 . . . . 0.0 112.1 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.81 -49.65 67.88 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.394 1.059 . . . . 0.0 112.155 173.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.86 -50.18 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.191 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.19 -58.31 3.76 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.992 1.317 . . . . 0.0 112.662 178.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -58.31 -51.15 71.01 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.346 1.029 . . . . 0.0 112.283 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.85 -38.69 89.17 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.4 -53.08 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.21 0.604 . . . . 0.0 109.81 174.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -53.89 -52.24 61.14 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.638 1.211 . . . . 0.0 112.614 178.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.9 tp -49.31 -58.12 5.64 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.103 1.761 . . . . 0.0 113.073 174.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.9 tmm? -61.39 -35.44 77.51 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.222 1.409 . . . . 0.0 113.633 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.87 -37.83 18.73 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -77.16 38.74 0.22 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.7 mt -124.0 161.36 25.65 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.095 1.758 . . . . 0.0 110.185 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 C--O 1.25 1.1 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.44 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' H3 ' ' CD ' ' A' ' 70' ' ' GLU . 27.2 ttt . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -126.44 130.42 50.65 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 126.019 2.075 . . . . 0.0 109.238 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -123.97 135.43 53.64 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.714 -1.584 . . . . 0.0 112.149 177.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -123.91 116.85 23.58 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.417 164.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -89.74 97.97 11.5 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.24 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.8 m -113.18 157.9 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 112.244 -2.253 . . . . 0.0 112.517 -174.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.6 p -105.15 139.37 39.91 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.896 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.5 mt -107.95 105.75 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 169.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.3 p -126.03 46.98 2.32 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 114.416 -1.265 . . . . 0.0 114.294 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -116.97 139.49 25.84 Favored Pre-proline 0 N--CA 1.475 0.787 0 CA-C-O 116.962 -1.494 . . . . 0.0 108.854 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -32.04 -56.89 0.27 Allowed 'Trans proline' 0 N--CA 1.483 0.909 1 C-N-CA 125.747 4.298 . . . . 0.0 116.86 -168.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -113.43 -38.87 4.24 Favored 'General case' 0 CA--C 1.551 0.992 0 O-C-N 124.131 0.894 . . . . 0.0 112.407 168.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.05 -89.35 1.44 Allowed Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.908 0.766 . . . . 0.0 113.561 163.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 mp -115.39 -46.07 2.89 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -171.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.2 p -106.08 -44.54 4.56 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 117.932 -2.98 . . . . 0.0 113.815 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.342 60.4 mtt-85 -92.05 -39.15 0.37 Allowed Pre-proline 0 N--CA 1.479 1.024 0 N-CA-C 119.044 2.979 . . . . 0.0 119.044 -170.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -61.98 -39.2 52.27 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 CA-C-N 121.283 1.494 . . . . 0.0 111.353 161.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.88 -34.79 42.72 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 171.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.1 -42.83 63.57 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -52.15 -52.96 48.59 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.689 1.195 . . . . 0.0 113.203 173.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -55.31 -52.57 63.03 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.579 1.552 . . . . 0.0 111.183 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.9 t -70.29 -38.96 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -174.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.65 -32.14 73.54 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 176.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -71.36 -49.45 42.08 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.047 0.939 . . . . 0.0 110.137 173.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.44 -46.01 76.76 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 176.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -60.77 -23.93 65.37 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 173.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.52 -25.45 67.84 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.317 0.96 . . . . 0.0 113.664 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -73.56 139.36 45.55 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.217 1.008 . . . . 0.0 112.56 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.49 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER -58.91 -37.6 77.02 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 113.19 -1.823 . . . . 0.0 113.025 174.353 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.498 ' HG ' ' CG ' ' A' ' 69' ' ' ASP . 50.3 m -63.08 141.93 58.58 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 171.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.89 113.8 22.99 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.842 0.83 . . . . 0.0 108.94 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 mt -106.99 101.57 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.615 -1.63 . . . . 0.0 109.989 -172.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.0 p -86.32 135.2 33.62 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.878 171.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 97.3 t -118.97 100.73 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.9 m -100.43 124.1 45.5 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.729 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.1 t -144.41 137.54 27.11 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.58 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.277 0.2 OUTLIER 43.57 51.77 6.25 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.859 1.664 . . . . 0.0 113.968 -173.027 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.15 -29.39 1.14 Allowed Glycine 0 CA--C 1.547 2.088 0 CA-C-N 114.103 -1.408 . . . . 0.0 114.885 -175.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -70.49 106.49 3.46 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.031 0.932 . . . . 0.0 112.448 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.7 t -89.65 128.82 36.13 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.696 -1.593 . . . . 0.0 111.942 169.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.81 119.81 14.45 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 113.389 -1.732 . . . . 0.0 110.24 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -64.91 124.93 23.3 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 113.117 -1.856 . . . . 0.0 112.376 171.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.54 -3.28 11.09 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 112.949 -1.932 . . . . 0.0 114.627 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -65.33 -11.64 43.86 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 122.086 0.946 . . . . 0.0 113.502 160.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.4 t -124.84 105.45 9.27 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.161 -0.962 . . . . 0.0 112.972 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -40.53 -51.43 2.92 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.175 -1.83 . . . . 0.0 112.524 164.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -55.57 -50.74 69.24 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 113.254 -1.794 . . . . 0.0 113.452 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -66.05 -47.87 72.92 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tp -72.97 -30.18 63.64 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -176.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -65.66 -18.69 65.51 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 t -112.21 61.12 0.63 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 124.029 1.871 . . . . 0.0 112.748 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.4 tp -122.12 -65.95 1.07 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 112.895 -1.957 . . . . 0.0 112.296 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.62 90.96 0.83 Allowed Glycine 0 N--CA 1.478 1.438 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -172.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 mt -121.68 87.06 2.68 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.513 -0.843 . . . . 0.0 109.4 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -153.19 -175.62 5.42 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.714 -168.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -60.2 108.89 0.86 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.119 0.968 . . . . 0.0 112.128 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.08 -12.56 24.28 Favored Glycine 0 N--CA 1.477 1.388 0 CA-C-N 112.477 -2.147 . . . . 0.0 114.591 177.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.0 p -77.83 116.5 18.39 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 117.772 0.786 . . . . 0.0 112.814 -175.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.1 t -92.26 119.97 40.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 113.1 -1.864 . . . . 0.0 107.192 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.42 115.05 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 113.878 -1.51 . . . . 0.0 113.385 -172.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.4 90.57 6.19 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.823 174.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.8 mt -72.97 101.2 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -120.05 101.33 7.77 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.816 -164.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.21 121.01 42.38 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -104.71 112.22 25.23 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 112.947 -1.933 . . . . 0.0 109.412 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.79 -161.22 32.61 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.084 175.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -78.85 -44.76 22.22 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.98 0.895 . . . . 0.0 112.532 176.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.498 ' CG ' ' HG ' ' A' ' 31' ' ' SER . 11.9 p-10 -76.89 22.41 0.19 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.865 1.666 . . . . 0.0 114.369 175.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.409 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 6.9 pt-20 -44.98 -54.67 6.29 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.581 1.952 . . . . 0.0 114.976 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -47.74 67.6 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -62.52 -49.01 77.02 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.704 -1.134 . . . . 0.0 113.191 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.06 -49.17 74.54 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.207 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.02 -51.4 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 117.946 -1.026 . . . . 0.0 111.973 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -52.67 -48.66 66.34 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 124.219 0.949 . . . . 0.0 112.047 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -60.72 -48.53 81.37 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.363 1.065 . . . . 0.0 112.957 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.08 -37.03 84.78 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.7 t -59.04 -50.09 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 123.938 0.774 . . . . 0.0 109.851 172.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -53.66 -55.72 23.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 124.036 0.835 . . . . 0.0 113.096 175.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.2 tt -51.31 -52.12 48.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.524 1.13 . . . . 0.0 112.462 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.9 tmm? -59.86 -49.09 79.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.102 0.961 . . . . 0.0 112.859 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.05 -26.49 67.53 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -83.35 -2.04 54.79 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 87.1 mt -84.05 116.33 22.8 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 C--O 1.252 1.196 0 C-N-CA 126.012 1.725 . . . . 0.0 110.369 -176.084 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.43 ' HG2' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -81.2 126.78 31.93 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.339 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -123.76 123.52 40.68 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 113.702 -1.59 . . . . 0.0 111.461 -175.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -129.91 110.46 11.71 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 125.134 1.521 . . . . 0.0 112.997 168.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -83.53 106.25 15.11 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.354 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.4 m -115.51 144.5 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 114.141 -1.391 . . . . 0.0 113.655 -173.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.561 HG22 HG22 ' A' ' 60' ' ' VAL . 27.6 p -103.63 118.4 36.64 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 113.868 -1.515 . . . . 0.0 111.308 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.0 mt -74.22 113.53 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.653 172.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 p -96.07 -23.15 16.92 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -62.22 133.56 94.33 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 124.383 1.073 . . . . 0.0 112.082 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 77.8 Cg_exo -53.17 -55.93 3.22 Favored 'Trans proline' 0 N--CA 1.481 0.752 0 C-N-CA 124.365 3.377 . . . . 0.0 113.755 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -67.58 -37.31 82.42 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.12 0.968 . . . . 0.0 112.874 176.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.37 -128.01 9.14 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.8 mt . . . . . 0 N--CA 1.478 0.931 0 CA-C-N 113.827 -1.186 . . . . 0.0 113.039 171.094 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.2 p . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.41 ' HD3' ' HA ' ' A' ' 17' ' ' ARG 0.346 15.7 mmt180 -87.17 -45.47 0.52 Allowed Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 118.017 2.599 . . . . 0.0 118.017 -175.742 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -59.01 -33.14 98.65 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 CA-C-N 122.655 1.984 . . . . 0.0 111.751 165.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.523 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -56.67 -48.29 77.93 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.149 0.98 . . . . 0.0 113.46 165.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.01 -38.81 90.03 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.23 -43.0 99.81 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 169.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -58.89 -42.22 89.02 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 124.375 1.047 . . . . 0.0 111.348 172.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 19' ' ' ALA . 66.8 t -57.28 -52.0 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 123.971 0.909 . . . . 0.0 111.032 171.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -53.45 -46.51 69.92 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 124.029 0.831 . . . . 0.0 112.08 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -66.9 -44.96 79.43 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.199 0.999 . . . . 0.0 113.221 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.17 -37.23 76.85 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 124.312 1.045 . . . . 0.0 113.681 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -59.42 -22.15 61.01 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 171.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.21 -20.16 74.74 Favored Glycine 0 N--CA 1.487 2.054 0 O-C-N 124.973 1.421 . . . . 0.0 114.663 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -98.18 148.85 23.16 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.18 0.592 . . . . 0.0 112.387 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.1 p -68.5 -43.37 76.99 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.962 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.0 p -61.1 161.57 8.43 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.816 1.246 . . . . 0.0 113.086 170.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -116.48 102.4 9.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 122.304 1.049 . . . . 0.0 111.979 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.698 HD11 ' HB1' ' A' ' 73' ' ' ALA . 17.1 mm -65.25 106.75 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 112.392 -2.185 . . . . 0.0 111.894 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.0 p -94.25 122.19 36.53 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.573 1.178 . . . . 0.0 109.984 167.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.6 t -104.41 107.09 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 111.95 -2.386 . . . . 0.0 107.848 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.3 m -96.25 113.39 24.99 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.098 -1.864 . . . . 0.0 111.627 -174.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.561 ' HB2' HG12 ' A' ' 61' ' ' VAL . 5.7 t -129.01 121.68 28.45 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.594 172.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 p30 37.94 64.44 0.68 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 125.18 1.55 . . . . 0.0 114.419 -170.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.45 -33.92 1.57 Allowed Glycine 0 N--CA 1.486 1.991 0 CA-C-N 113.636 -1.62 . . . . 0.0 114.509 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -68.51 88.69 0.34 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.315 1.046 . . . . 0.0 112.107 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.9 m -77.28 99.9 5.67 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 113.223 -1.808 . . . . 0.0 111.882 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.95 123.53 46.02 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.46 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.5 t -58.98 103.85 0.2 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.785 168.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.563 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . . . -59.57 -32.33 70.26 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.331 175.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -65.96 -24.69 66.85 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.827 0.851 . . . . 0.0 112.254 174.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.8 t -94.26 111.1 22.82 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 123.104 1.43 . . . . 0.0 112.608 170.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.441 ' HA ' HG21 ' A' ' 23' ' ' VAL . 22.6 tp -32.54 -73.35 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.934 2.494 . . . . 0.0 116.13 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.402 ' O ' HG22 ' A' ' 52' ' ' THR . 67.3 m-85 -64.87 -30.21 71.2 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -175.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -62.8 -48.29 79.77 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.603 0.761 . . . . 0.0 111.638 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 26.3 tp -69.48 -46.58 66.3 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 124.251 0.97 . . . . 0.0 113.066 172.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -52.61 -32.0 39.38 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 48' ' ' PHE . 5.1 t -114.35 24.01 12.31 Favored 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.8 tp -70.35 -48.06 58.13 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.374 -0.829 . . . . 0.0 112.259 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.08 87.35 1.36 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.51 87.24 2.72 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.708 -0.746 . . . . 0.0 111.925 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -135.09 176.14 8.94 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.238 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -58.33 116.34 3.54 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.457 1.103 . . . . 0.0 110.245 172.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.07 -33.78 6.16 Favored Glycine 0 N--CA 1.485 1.932 0 CA-C-N 114.397 -1.274 . . . . 0.0 114.251 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.1 p -59.88 112.84 2.0 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 117.612 0.706 . . . . 0.0 112.421 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.561 HG22 HG22 ' A' ' 7' ' ' THR . 22.0 t -84.51 129.92 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.335 -1.757 . . . . 0.0 108.026 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.561 HG12 ' HB2' ' A' ' 37' ' ' SER . 7.4 m -129.73 118.4 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.443 -174.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 m -85.21 104.81 15.41 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.826 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.9 mt -82.9 109.92 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.9 m -118.01 141.46 48.44 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 113.157 -1.838 . . . . 0.0 111.38 -173.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.91 139.43 27.6 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.43 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 28.2 tt0 -133.33 132.27 41.1 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.658 -1.61 . . . . 0.0 108.826 169.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.31 -161.9 28.18 Favored Glycine 0 N--CA 1.481 1.683 0 C-N-CA 125.023 1.297 . . . . 0.0 111.542 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -59.93 -64.54 0.91 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.917 0.865 . . . . 0.0 113.167 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -83.56 31.59 0.47 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -53.0 -58.21 7.74 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -172.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -43.11 99.61 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -65.62 -45.03 84.66 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.036 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.698 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -56.39 -52.19 65.55 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.125 0.97 . . . . 0.0 113.173 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.8 t -59.5 -53.06 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.949 0.899 . . . . 0.0 110.078 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -51.0 -54.04 27.96 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.215 1.406 . . . . 0.0 112.73 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -62.88 -45.7 91.33 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.7 mt -64.88 -36.22 83.64 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.35 -50.79 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.435 0.694 . . . . 0.0 110.527 169.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -56.21 -47.11 79.03 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.7 tp -49.03 -59.23 3.79 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.607 1.163 . . . . 0.0 111.927 173.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.0 tmm? -58.06 -42.6 85.81 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.32 1.048 . . . . 0.0 112.949 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.03 -29.89 67.05 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -87.66 -31.69 19.63 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 69.1 mt . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 179.023 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttp . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -120.79 112.31 18.67 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.827 1.329 . . . . 0.0 110.087 172.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -107.57 126.81 53.01 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.019 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -122.93 120.17 32.62 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -99.89 92.72 5.42 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 125.294 1.621 . . . . 0.0 108.794 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.401 HG21 HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -119.31 143.39 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 111.469 -2.605 . . . . 0.0 112.641 -173.216 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 p -78.54 131.45 36.8 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -176.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.9 mt -92.59 116.97 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-N 113.485 -1.689 . . . . 0.0 107.159 159.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 p -116.36 -17.81 10.63 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 111.85 -2.432 . . . . 0.0 114.38 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.06 129.96 58.54 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 124.929 1.292 . . . . 0.0 111.694 172.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -56.97 -54.11 4.11 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 124.394 3.396 . . . . 0.0 114.862 -165.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -88.23 -36.97 16.45 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 123.782 0.676 . . . . 0.0 111.762 171.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.89 -128.34 9.53 Favored Glycine 0 N--CA 1.475 1.291 0 O-C-N 123.799 0.687 . . . . 0.0 112.46 167.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.629 HD21 HD13 ' A' ' 84' ' ' LEU . 72.5 mt . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.6 p . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.326 24.1 mtt180 -83.79 -37.36 0.67 Allowed Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 118.396 2.739 . . . . 0.0 118.396 -168.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -62.52 -39.81 42.62 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 121.763 1.642 . . . . 0.0 112.617 163.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.21 -38.18 73.33 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 168.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.18 -38.56 86.94 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 172.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -64.27 -43.91 93.34 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.414 0.686 . . . . 0.0 112.147 172.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -59.02 -44.17 91.69 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.175 1.39 . . . . 0.0 112.221 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.479 HG21 ' HA ' ' A' ' 47' ' ' LEU . 44.6 t -53.97 -60.06 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.042 1.337 . . . . 0.0 112.034 169.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -49.55 -39.06 33.38 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.936 -1.029 . . . . 0.0 113.156 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.455 ' HG2' HD22 ' A' ' 80' ' ' LEU . 8.5 tp10 -61.86 -66.0 0.6 Allowed 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.522 1.139 . . . . 0.0 110.891 169.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.93 -35.16 6.17 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -42.36 -38.21 1.78 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.24 -30.19 70.33 Favored Glycine 0 CA--C 1.546 1.972 0 C-N-CA 124.97 1.272 . . . . 0.0 115.805 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -75.28 144.8 42.3 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -175.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 66.3 p -66.46 -50.27 63.9 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.303 0.641 . . . . 0.0 111.891 -175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.3 p -66.09 173.61 2.99 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 124.877 1.361 . . . . 0.0 113.35 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.418 ' HG3' ' HB3' ' A' ' 45' ' ' LYS . 30.6 tt0 -114.65 94.32 4.72 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.704 0.764 . . . . 0.0 109.331 174.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.75 113.57 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 113.118 -1.855 . . . . 0.0 109.382 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 p -105.78 137.61 43.36 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.677 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.0 t -118.87 126.57 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 113.206 -1.815 . . . . 0.0 109.944 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.3 m -110.98 123.37 50.04 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.214 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.8 t -126.5 120.37 29.5 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.717 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 p30 40.3 64.03 0.99 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.742 1.617 . . . . 0.0 114.634 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.35 -34.96 1.54 Allowed Glycine 0 CA--C 1.542 1.773 0 CA-C-N 113.187 -1.824 . . . . 0.0 115.658 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -81.94 133.04 35.28 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.598 0.759 . . . . 0.0 110.254 -169.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 t -108.4 129.29 55.26 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.123 0.89 . . . . 0.0 113.269 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.519 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -124.71 160.85 27.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 112.541 -2.118 . . . . 0.0 109.626 176.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.534 ' H ' ' HB3' ' A' ' 49' ' ' LYS . 40.3 t -106.08 128.26 53.74 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.131 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.04 -29.47 69.83 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.878 1.361 . . . . 0.0 111.338 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HB3' ' HG3' ' A' ' 32' ' ' GLU . 77.4 tttt -90.81 21.69 3.98 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.245 -0.888 . . . . 0.0 112.609 177.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.498 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 2.0 m -148.01 116.46 6.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.028 1.331 . . . . 0.0 112.274 173.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.479 ' HA ' HG21 ' A' ' 23' ' ' VAL . 31.1 tp -51.21 -59.63 3.99 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 112.429 -2.169 . . . . 0.0 113.324 -176.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -63.85 -32.34 73.82 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.221 -1.354 . . . . 0.0 113.317 -174.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.534 ' HB3' ' H ' ' A' ' 43' ' ' SER . 15.4 mmmt -69.24 -58.48 3.98 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 118.318 -0.848 . . . . 0.0 113.033 173.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.9 tp -60.36 -40.3 90.25 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.201 0.938 . . . . 0.0 112.441 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -62.34 -40.1 95.28 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 t -89.86 8.14 33.59 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.519 HD22 ' HB3' ' A' ' 42' ' ' ALA . 45.3 tp -72.67 -60.95 1.98 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.91 92.88 1.6 Allowed Glycine 0 CA--C 1.535 1.334 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.0 mt -128.47 82.75 2.1 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.269 1.427 . . . . 0.0 109.956 -174.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 t -146.49 164.67 31.78 Favored 'General case' 0 C--O 1.25 1.1 0 C-N-CA 125.826 1.65 . . . . 0.0 110.835 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -41.61 126.63 2.99 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.444 1.898 . . . . 0.0 115.137 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.69 -31.56 5.51 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-N 113.891 -1.504 . . . . 0.0 115.379 173.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.35 121.32 21.19 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.828 2.159 . . . . 0.0 116.828 -173.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.9 t -87.01 94.03 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 m -89.82 125.72 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -169.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.07 93.45 5.78 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.967 1.707 . . . . 0.0 110.429 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.6 mt -98.73 113.33 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 125.496 1.518 . . . . 0.0 107.134 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 m -129.68 124.29 33.24 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.216 -167.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.66 140.84 51.56 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -140.74 110.1 6.27 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.258 1.423 . . . . 0.0 110.301 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.82 -157.05 19.57 Favored Glycine 0 N--CA 1.478 1.497 0 N-CA-C 107.621 -2.191 . . . . 0.0 107.621 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -65.51 -43.5 89.9 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 117.243 0.521 . . . . 0.0 110.156 170.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -86.25 26.94 0.97 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -54.06 -52.64 60.25 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.493 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -78.42 -44.13 25.58 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.649 1.58 . . . . 0.0 113.007 -179.386 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -67.65 -35.83 79.6 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.77 -47.4 53.84 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.707 0.803 . . . . 0.0 112.862 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.9 t -61.6 -48.1 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 118.0 -1.0 . . . . 0.0 111.156 176.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -46.12 -49.01 17.17 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.7 1.2 . . . . 0.0 111.845 171.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -68.19 -62.48 1.38 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.0 mt -59.77 -38.63 82.35 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.401 HG13 HG21 ' A' ' 6' ' ' VAL . 56.4 t -61.42 -48.24 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.315 174.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -59.07 -48.88 80.0 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.297 0.998 . . . . 0.0 112.953 173.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.455 HD22 ' HG2' ' A' ' 25' ' ' GLU . 10.3 tp -52.55 -47.99 66.43 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.642 0.777 . . . . 0.0 112.03 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.518 ' HG3' HD11 ' A' ' 14' ' ' LEU . 48.5 ttp -62.2 -52.26 64.5 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.923 0.889 . . . . 0.0 112.367 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.64 -35.9 63.95 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -88.46 -13.67 39.77 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.629 HD13 HD21 ' A' ' 14' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.775 0 C-N-CA 124.093 0.957 . . . . 0.0 112.411 167.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ttt . . . . . 0 N--CA 1.463 0.204 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -113.79 127.97 56.22 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 124.657 1.223 . . . . 0.0 109.708 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -131.11 94.66 3.63 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.309 -167.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -112.44 108.49 17.64 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 122.518 1.151 . . . . 0.0 113.343 -171.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -80.96 103.99 11.16 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 112.45 -2.159 . . . . 0.0 111.159 175.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.3 148.46 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 114.933 -1.03 . . . . 0.0 113.138 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 p -102.72 128.33 49.48 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.905 -175.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.3 mt -79.54 108.9 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.359 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 p -96.83 -13.51 22.5 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 175.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.442 ' HB3' ' HA2' ' A' ' 13' ' ' GLY . . . -59.9 135.83 90.22 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 124.31 1.044 . . . . 0.0 111.766 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -48.88 -52.45 8.64 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.182 3.255 . . . . 0.0 114.718 -174.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -106.88 -28.43 10.1 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 124.591 1.182 . . . . 0.0 113.741 175.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . 93.25 -153.91 21.6 Favored Glycine 0 N--CA 1.479 1.563 0 CA-C-O 122.045 0.803 . . . . 0.0 113.897 165.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.645 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 87.0 mt . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.5 p . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.303 40.6 mtt85 -89.77 -41.44 0.42 Allowed Pre-proline 0 N--CA 1.486 1.336 0 N-CA-C 118.616 2.821 . . . . 0.0 118.616 -166.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.645 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 90.5 Cg_exo -61.72 -30.8 85.55 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 CA-C-N 120.867 1.345 . . . . 0.0 112.412 163.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -60.19 -44.2 95.3 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 165.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.51 90.61 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 172.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -59.84 -45.5 92.22 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.386 1.074 . . . . 0.0 112.452 172.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -57.86 -46.07 85.37 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.074 1.35 . . . . 0.0 111.782 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.5 HG21 ' HA ' ' A' ' 47' ' ' LEU . 59.2 t -56.0 -42.47 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.025 0.53 . . . . 0.0 112.278 175.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -60.96 -46.43 90.74 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 124.07 0.856 . . . . 0.0 111.916 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.47 ' HB3' HD21 ' A' ' 77' ' ' LEU . 13.7 tp10 -69.58 -44.44 70.79 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.077 0.861 . . . . 0.0 112.616 176.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.37 -33.59 65.85 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -53.81 -34.77 60.21 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 170.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.27 13.74 56.52 Favored Glycine 0 N--CA 1.483 1.81 0 O-C-N 124.557 1.161 . . . . 0.0 115.159 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -119.49 151.19 38.99 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.046 0.497 . . . . 0.0 111.297 172.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.4 p -82.69 -44.2 15.97 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.862 -175.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.3 p -66.08 133.26 50.37 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 124.999 1.437 . . . . 0.0 110.615 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -85.7 103.62 14.67 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.609 1.195 . . . . 0.0 111.831 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.654 HD11 ' HB1' ' A' ' 73' ' ' ALA . 44.4 mm -63.69 113.53 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 111.757 -2.474 . . . . 0.0 111.125 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.1 p -111.66 131.04 55.56 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.601 173.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.469 HG22 HG12 ' A' ' 63' ' ' ILE . 59.3 t -111.0 108.27 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 113.483 -1.689 . . . . 0.0 107.723 -177.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.0 m -103.91 124.05 48.26 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.777 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.526 ' HB2' HG12 ' A' ' 61' ' ' VAL . 48.2 t -128.16 131.99 48.91 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.286 176.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.6 p30 49.83 34.62 7.92 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.39 5.33 87.7 Favored Glycine 0 CA--C 1.545 1.926 0 N-CA-C 115.806 1.082 . . . . 0.0 115.806 -175.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -112.56 140.66 47.13 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.977 0.911 . . . . 0.0 109.915 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.0 t -119.22 135.04 54.88 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -167.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.503 ' HB3' HD12 ' A' ' 53' ' ' LEU . . . -130.61 121.27 25.32 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.036 -1.893 . . . . 0.0 111.398 173.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.9 t -72.98 129.09 37.32 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.633 173.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.75 -14.7 62.08 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 113.175 -1.829 . . . . 0.0 113.297 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.0 mttt -77.29 -2.47 34.98 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 171.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.3 m -123.14 118.62 28.09 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.394 0.677 . . . . 0.0 112.217 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.5 ' HA ' HG21 ' A' ' 23' ' ' VAL . 19.1 tp -45.93 -65.87 0.48 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.588 -1.642 . . . . 0.0 113.732 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.48 ' O ' HG22 ' A' ' 52' ' ' THR . 56.6 m-85 -54.09 -50.93 65.7 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 178.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.5 mmtt -42.04 -58.59 2.04 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.4 tp -66.96 -43.0 84.25 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.638 1.211 . . . . 0.0 113.202 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -59.36 -41.38 89.14 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.989 175.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 48' ' ' PHE 0.263 15.2 t -100.54 54.01 0.88 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 123.497 1.617 . . . . 0.0 113.897 175.549 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.503 HD12 ' HB3' ' A' ' 42' ' ' ALA . 2.6 tt -111.24 -56.5 2.36 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 112.874 -1.966 . . . . 0.0 109.246 161.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.27 66.9 0.61 Allowed Glycine 0 N--CA 1.477 1.416 0 O-C-N 124.348 1.03 . . . . 0.0 111.851 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.2 mt -88.74 98.11 11.51 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.682 0.793 . . . . 0.0 111.537 -174.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.9 t -137.47 175.99 9.11 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.876 -176.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -47.95 128.68 13.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.899 2.08 . . . . 0.0 112.813 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.68 -54.72 0.55 Allowed Glycine 0 N--CA 1.48 1.61 0 CA-C-N 113.408 -1.724 . . . . 0.0 114.175 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.1 p -64.56 131.98 48.55 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -165.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.4 t -79.89 108.48 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 111.124 -2.762 . . . . 0.0 107.193 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.526 HG12 ' HB2' ' A' ' 37' ' ' SER . 13.6 m -105.0 109.49 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 113.523 -1.671 . . . . 0.0 113.214 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.5 95.99 2.85 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.626 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.469 HG12 HG22 ' A' ' 35' ' ' VAL . 77.2 mt -86.61 101.19 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.117 175.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.3 m -106.15 134.56 49.09 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 112.642 -2.072 . . . . 0.0 112.905 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.609 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -139.07 138.22 36.92 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 124.638 1.211 . . . . 0.0 113.223 172.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -132.62 118.7 19.5 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 124.8 1.312 . . . . 0.0 109.484 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.44 -155.5 26.18 Favored Glycine 0 CA--C 1.544 1.879 0 C-N-CA 124.685 1.136 . . . . 0.0 111.232 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -68.09 -61.14 2.0 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -80.56 28.15 0.34 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -53.26 -48.32 68.36 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.78 -50.61 33.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.835 0.854 . . . . 0.0 111.809 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -58.89 -50.92 72.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.587 1.555 . . . . 0.0 112.829 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.654 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -60.25 -44.58 95.14 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.471 1.107 . . . . 0.0 113.587 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.63 -55.52 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.078 175.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -52.05 -50.57 61.22 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.051 0.941 . . . . 0.0 112.975 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -60.01 -50.5 73.49 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.468 1.107 . . . . 0.0 112.64 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.47 HD21 ' HB3' ' A' ' 25' ' ' GLU . 45.8 mt -64.72 -28.32 69.51 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.5 t -69.65 -47.57 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 122.896 0.479 . . . . 0.0 110.896 171.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -51.76 -50.92 59.73 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.937 0.895 . . . . 0.0 111.527 174.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.67 -54.62 21.52 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.213 1.805 . . . . 0.0 112.236 176.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 40.3 ttp -57.12 -47.87 80.03 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.467 1.107 . . . . 0.0 112.363 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.9 -27.84 68.49 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.275 1.43 . . . . 0.0 114.84 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -78.71 -35.74 44.45 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.459 HD13 ' HB3' ' A' ' 18' ' ' PRO . 36.4 mt . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 ttt . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -103.22 136.96 42.02 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 125.095 1.497 . . . . 0.0 108.329 170.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -146.16 134.41 21.74 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.565 -1.652 . . . . 0.0 111.016 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -123.48 118.94 28.56 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.847 170.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -83.98 106.87 15.98 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.079 165.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.6 m -120.73 140.21 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 114.726 -1.124 . . . . 0.0 113.649 -178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.481 HG22 HG22 ' A' ' 60' ' ' VAL . 22.8 p -83.31 136.21 34.45 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.302 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 52.7 mt -81.81 90.31 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 168.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.7 p -74.07 -22.41 59.53 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.513 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.32 131.74 94.89 Favored Pre-proline 0 N--CA 1.484 1.229 0 C-N-CA 125.296 1.438 . . . . 0.0 111.935 -175.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.04 -44.17 9.54 Favored 'Trans proline' 0 N--CA 1.489 1.207 1 C-N-CA 125.355 4.036 . . . . 0.0 117.56 -166.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -110.45 -45.03 3.6 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.85 -147.63 17.6 Favored Glycine 0 N--CA 1.478 1.492 0 CA-C-O 121.725 0.625 . . . . 0.0 112.817 167.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.473 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 95.6 mt . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.3 p . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.286 48.4 mtt85 -86.08 -39.27 0.57 Allowed Pre-proline 0 N--CA 1.487 1.411 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -174.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.473 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 97.9 Cg_exo -62.13 -35.71 73.88 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 121.712 1.608 . . . . 0.0 111.686 164.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.44 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -56.06 -44.38 78.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.601 0.76 . . . . 0.0 112.897 167.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.49 98.81 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 171.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -56.64 -45.25 81.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.716 0.806 . . . . 0.0 113.146 171.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -57.93 -44.18 86.75 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.864 1.266 . . . . 0.0 111.689 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 19' ' ' ALA . 95.7 t -57.12 -42.81 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.322 1.049 . . . . 0.0 113.154 176.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -53.03 -45.27 67.93 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 123.462 0.476 . . . . 0.0 112.17 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -74.61 -50.94 15.95 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.831 1.332 . . . . 0.0 112.215 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.35 -35.95 65.78 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -60.14 -19.38 53.41 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 173.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.45 27.03 14.89 Favored Glycine 0 CA--C 1.544 1.869 0 O-C-N 124.432 1.082 . . . . 0.0 113.646 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -127.93 142.97 51.11 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.143 0.977 . . . . 0.0 111.575 172.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.6 p -71.85 -40.0 69.34 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.438 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.437 ' HB2' ' HB1' ' A' ' 65' ' ' ALA . 63.0 p -65.23 145.86 55.69 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 124.483 1.115 . . . . 0.0 111.624 168.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -95.73 109.51 21.79 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.321 -0.862 . . . . 0.0 110.968 174.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.698 HD13 ' HB2' ' A' ' 65' ' ' ALA . 46.3 mm -70.54 102.06 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 112.64 -2.073 . . . . 0.0 108.852 171.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.3 p -101.89 126.44 48.79 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.497 173.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.469 HG22 HG12 ' A' ' 63' ' ' ILE . 86.7 t -103.54 113.85 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 125.445 1.716 . . . . 0.0 107.767 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.466 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 97.9 m -114.2 127.54 55.95 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.652 -174.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.4 t -122.66 115.04 21.43 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.316 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.5 p30 39.94 51.31 2.52 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -174.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.47 -35.8 4.05 Favored Glycine 0 N--CA 1.484 1.898 0 CA-C-N 113.17 -1.832 . . . . 0.0 114.501 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -72.55 121.63 19.99 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 116.897 0.348 . . . . 0.0 111.11 -174.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.0 t -102.25 136.29 42.35 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.78 1.3 . . . . 0.0 113.789 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.609 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -129.72 106.77 8.93 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 112.748 -2.024 . . . . 0.0 112.005 175.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.7 t -59.5 121.73 12.26 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.526 171.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.61 -30.55 68.31 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.598 170.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -61.8 -32.64 72.95 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.2 m -96.37 104.24 16.19 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 122.028 0.918 . . . . 0.0 111.89 169.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.423 ' HA ' HG21 ' A' ' 23' ' ' VAL . 9.5 tp -44.94 -60.62 1.97 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.54 1.536 . . . . 0.0 113.05 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.437 ' O ' HG22 ' A' ' 52' ' ' THR . 90.2 m-85 -57.21 -37.6 72.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.507 ' HD2' ' HA ' ' A' ' 42' ' ' ALA . 6.2 tmtt? -61.5 -49.82 75.2 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.609 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 19.8 tp -62.48 -41.33 98.72 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 174.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -61.07 -24.88 66.55 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 48' ' ' PHE 0.261 9.6 t -118.12 75.31 1.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 123.449 1.595 . . . . 0.0 114.228 172.472 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.422 HD13 ' HB2' ' A' ' 42' ' ' ALA . 19.7 tp -124.0 -45.39 2.01 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 112.128 -2.305 . . . . 0.0 113.141 168.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.45 69.1 0.84 Allowed Glycine 0 CA--C 1.534 1.266 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -167.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 43.7 mt -95.28 80.64 3.56 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.06 0.933 . . . . 0.0 110.936 -173.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -123.83 151.49 43.34 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 112.748 -2.024 . . . . 0.0 112.889 -165.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -49.13 132.9 19.28 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.46 1.124 . . . . 0.0 112.427 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.58 -69.06 0.22 Allowed Glycine 0 CA--C 1.534 1.267 0 CA-C-N 113.467 -1.697 . . . . 0.0 110.257 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.5 p -30.79 113.19 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.481 HG22 HG22 ' A' ' 7' ' ' THR . 9.2 t -72.96 108.1 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 112.601 -2.09 . . . . 0.0 106.688 168.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.7 m -105.09 111.48 34.75 Favored 'Isoleucine or valine' 0 C--O 1.253 1.261 0 CA-C-N 113.991 -1.458 . . . . 0.0 112.743 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.466 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 2.8 m -65.99 99.11 0.47 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 126.558 1.943 . . . . 0.0 108.87 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.469 HG12 HG22 ' A' ' 35' ' ' VAL . 80.8 mt -96.64 106.73 18.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.7 m -118.53 133.79 55.59 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 112.703 -2.044 . . . . 0.0 112.588 -169.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.698 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -146.78 138.12 24.25 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 125.334 1.646 . . . . 0.0 112.681 170.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -120.05 129.72 54.37 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.97 170.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.1 -157.11 27.26 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.766 1.203 . . . . 0.0 114.909 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -71.77 -44.09 64.63 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.518 ' HA ' ' HD2' ' A' ' 72' ' ' LYS . 5.2 p30 -100.63 24.84 8.49 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.69 -51.22 68.03 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -36.79 83.98 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.254 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.518 ' HD2' ' HA ' ' A' ' 69' ' ' ASP . 22.2 mttt -71.73 -52.8 15.91 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.563 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.17 -51.7 68.46 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.513 1.525 . . . . 0.0 114.266 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.7 t -60.77 -50.64 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.003 0.521 . . . . 0.0 110.863 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -54.58 -55.33 30.5 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.557 1.143 . . . . 0.0 111.514 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -53.76 -54.1 42.96 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.733 1.613 . . . . 0.0 112.923 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.3 mt -69.41 -28.64 66.33 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.54 -43.46 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 119.038 -0.506 . . . . 0.0 110.816 171.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -55.77 -43.81 77.08 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.248 0.619 . . . . 0.0 111.716 172.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.26 -51.08 70.79 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.522 1.129 . . . . 0.0 112.757 174.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 44.4 ttm -55.08 -45.6 75.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 123.531 0.519 . . . . 0.0 112.286 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.09 -19.95 66.24 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -114.85 36.19 3.96 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 mt . . . . . 0 N--CA 1.48 1.068 0 C-N-CA 125.303 1.441 . . . . 0.0 112.73 173.549 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 ttp . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -100.45 131.93 46.1 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 125.597 1.81 . . . . 0.0 107.962 169.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -124.78 115.44 20.7 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.584 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -127.05 110.21 12.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.223 1.011 . . . . 0.0 112.386 173.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -91.59 112.45 24.38 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.624 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 m -128.37 165.35 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 113.134 -1.848 . . . . 0.0 112.301 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.459 HG22 HG22 ' A' ' 60' ' ' VAL . 78.5 p -120.73 147.27 45.53 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.196 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.8 mt -87.93 97.13 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.887 175.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.8 p -85.3 -17.79 35.83 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.47 142.2 41.2 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.985 1.314 . . . . 0.0 112.608 174.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -47.6 -46.96 19.34 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 124.586 3.524 . . . . 0.0 116.246 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -114.86 -39.17 3.76 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.83 -142.51 17.1 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 122.198 0.888 . . . . 0.0 112.824 167.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 -174.078 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 76.8 p . . . . . 0 N--CA 1.476 0.833 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.492 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 65.2 mtt85 -60.57 -53.95 59.49 Favored Pre-proline 0 N--CA 1.488 1.445 0 CA-C-O 116.238 -1.839 . . . . 0.0 115.181 -171.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 51.4 Cg_exo -67.2 -31.12 36.69 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 CA-C-N 122.072 1.776 . . . . 0.0 114.198 174.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.96 85.1 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 171.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.41 -39.29 86.88 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 171.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -62.09 -44.68 96.13 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.006 0.923 . . . . 0.0 113.15 172.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -59.76 -43.5 94.27 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.105 0.878 . . . . 0.0 111.662 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.57 HG11 ' HA ' ' A' ' 47' ' ' LEU . 66.8 t -55.66 -51.67 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.569 0.748 . . . . 0.0 111.654 172.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -46.84 -51.74 15.9 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.617 0.767 . . . . 0.0 111.755 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -65.14 -51.81 59.01 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.466 1.104 . . . . 0.0 111.559 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.28 -34.02 66.06 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -60.51 -32.84 71.83 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 172.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.22 26.24 3.98 Favored Glycine 0 N--CA 1.479 1.526 0 O-C-N 124.382 1.051 . . . . 0.0 114.375 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -129.17 146.24 51.14 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.725 1.21 . . . . 0.0 110.261 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.6 p -69.39 -42.15 75.5 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.442 0.697 . . . . 0.0 112.872 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 p -66.55 157.07 33.24 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.867 1.267 . . . . 0.0 112.836 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -103.4 113.74 27.48 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 122.32 1.057 . . . . 0.0 110.239 172.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' A' ' 44' ' ' ALA . 8.7 mm -81.81 105.74 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 111.818 -2.446 . . . . 0.0 108.495 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.3 p -101.79 121.27 41.77 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.141 0.496 . . . . 0.0 110.805 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.6 t -101.51 97.85 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 125.905 2.003 . . . . 0.0 107.612 -172.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 29.1 m -88.39 101.14 13.6 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.778 -1.555 . . . . 0.0 111.047 -177.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 t -100.35 99.88 10.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.198 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 p30 45.54 62.61 2.11 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 113.186 -1.824 . . . . 0.0 114.009 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.47 -30.36 3.78 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 114.015 -1.448 . . . . 0.0 114.636 -176.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -86.31 92.76 8.9 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.644 0.735 . . . . 0.0 109.67 -174.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 25.3 t -82.73 123.33 29.2 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.771 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -126.2 132.86 51.69 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.597 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.6 t -71.22 129.7 39.57 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.715 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.57 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . . . -72.2 -19.0 61.81 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 112.972 -1.922 . . . . 0.0 112.508 170.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -77.11 -6.11 51.56 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 m -112.49 115.93 29.46 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.57 ' HA ' HG11 ' A' ' 23' ' ' VAL . 32.4 tp -52.84 -64.79 0.7 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 111.325 -2.67 . . . . 0.0 114.302 -170.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.459 ' O ' HG22 ' A' ' 52' ' ' THR . 49.5 m-85 -77.39 -28.77 52.9 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -60.65 -44.85 95.93 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.444 ' HG ' HD11 ' A' ' 55' ' ' LEU . 6.0 tp -69.62 -35.52 75.33 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.591 1.182 . . . . 0.0 113.283 175.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -65.48 -35.9 82.28 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 172.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 48' ' ' PHE 0.251 14.0 t -100.06 50.66 0.91 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 123.716 1.722 . . . . 0.0 112.547 173.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.457 HD22 ' HB3' ' A' ' 42' ' ' ALA . 59.5 tp -115.6 -37.86 3.88 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 112.883 -1.962 . . . . 0.0 112.742 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.09 55.92 1.66 Allowed Glycine 0 CA--C 1.53 1.031 0 C-N-CA 123.962 0.791 . . . . 0.0 111.824 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.444 HD11 ' HG ' ' A' ' 50' ' ' LEU . 78.3 mt -77.51 85.5 3.88 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -133.41 175.97 8.94 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 113.873 -1.512 . . . . 0.0 112.928 -172.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -46.47 112.78 0.54 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.471 1.909 . . . . 0.0 111.613 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.15 -38.71 3.09 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-N 113.259 -1.791 . . . . 0.0 114.157 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.5 p -48.84 110.22 0.33 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -172.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.459 HG22 HG22 ' A' ' 7' ' ' THR . 17.9 t -70.38 123.59 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-N 111.083 -2.78 . . . . 0.0 108.067 175.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 m -127.98 101.19 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 113.708 -1.587 . . . . 0.0 112.638 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.6 m -77.81 90.04 4.05 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.118 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 73.0 mt -78.84 96.88 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 113.006 -1.907 . . . . 0.0 107.725 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.0 m -119.88 136.83 54.35 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 113.136 -1.847 . . . . 0.0 111.991 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.78 142.59 25.66 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.636 1.21 . . . . 0.0 113.305 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -123.37 126.84 47.57 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.656 1.222 . . . . 0.0 110.431 170.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.44 -165.68 36.83 Favored Glycine 0 N--CA 1.484 1.869 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.094 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -63.94 -55.44 22.55 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -92.42 17.91 9.24 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 8.0 pt-20 -45.0 -58.96 2.83 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -173.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.497 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -60.98 -48.9 79.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.923 1.289 . . . . 0.0 114.285 179.693 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -64.4 -46.28 83.99 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.786 0.834 . . . . 0.0 112.256 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.65 -52.38 65.67 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.247 1.019 . . . . 0.0 112.688 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.8 t -63.58 -47.1 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 117.586 -1.197 . . . . 0.0 111.306 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -50.33 -59.32 4.09 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.226 1.01 . . . . 0.0 111.656 175.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -53.94 -49.55 68.45 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.323 1.049 . . . . 0.0 113.438 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.5 mt -62.9 -39.66 95.2 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.7 t -58.17 -44.06 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.75 0.82 . . . . 0.0 111.084 174.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -60.26 -53.73 54.25 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.852 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.7 tp -51.6 -49.72 61.6 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.162 0.985 . . . . 0.0 113.277 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.8 ttt -62.66 -36.6 83.41 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.984 0.914 . . . . 0.0 113.188 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.17 -35.32 56.03 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -86.27 1.99 48.85 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.8 mt . . . . . 0 N--CA 1.488 1.433 0 C-N-CA 124.653 1.181 . . . . 0.0 114.055 170.539 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ttp . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -121.41 132.06 54.53 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 125.259 1.6 . . . . 0.0 112.026 173.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.464 ' HG3' ' OG ' ' A' ' 64' ' ' SER . 0.5 OUTLIER -132.93 146.93 52.23 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.6 174.075 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -119.22 150.9 39.31 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 124.384 1.053 . . . . 0.0 110.871 169.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -117.28 98.69 6.56 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 123.309 1.528 . . . . 0.0 110.823 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.24 149.55 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 113.902 -1.499 . . . . 0.0 112.219 -169.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.502 HG22 HG22 ' A' ' 60' ' ' VAL . 2.6 p -100.87 143.44 31.02 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.269 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.5 mp -81.16 115.97 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 165.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.2 p -99.85 -36.09 9.54 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 112.594 -2.094 . . . . 0.0 112.497 -174.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.482 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -53.99 142.15 46.73 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.978 0.911 . . . . 0.0 112.462 170.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 50.2 Cg_exo -58.48 -44.27 38.89 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.996 3.131 . . . . 0.0 115.332 -172.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . 0.257 11.1 p30 -105.21 -29.92 10.02 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 176.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.71 -127.24 7.86 Favored Glycine 0 CA--C 1.538 1.5 0 O-C-N 124.287 0.992 . . . . 0.0 114.263 169.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -174.956 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.669 HG22 ' HB3' ' A' ' 51' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.341 97.0 mtt180 -83.36 -43.46 0.84 Allowed Pre-proline 0 N--CA 1.479 1.014 0 N-CA-C 118.049 2.611 . . . . 0.0 118.049 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -62.0 -37.21 66.52 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 CA-C-N 123.233 2.19 . . . . 0.0 110.884 170.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.65 -30.52 21.93 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 164.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.38 -40.62 97.07 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 119.474 1.034 . . . . 0.0 112.327 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.83 -35.54 80.28 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 118.436 -0.792 . . . . 0.0 112.973 171.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -62.17 -48.03 81.87 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.94 0.336 . . . . 0.0 111.032 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.1 t -50.61 -50.72 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.933 0.873 . . . . 0.0 111.411 173.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.42 -44.21 95.98 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.54 -1.209 . . . . 0.0 113.121 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.463 ' HG2' HD22 ' A' ' 80' ' ' LEU . 12.9 tp10 -63.36 -40.29 96.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.355 1.462 . . . . 0.0 113.67 175.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.42 99.13 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.101 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.585 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . 79.6 mttt -56.99 -30.15 63.9 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.6 -25.73 36.39 Favored Glycine 0 CA--C 1.543 1.818 0 O-C-N 125.343 1.652 . . . . 0.0 114.849 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -97.63 146.68 25.07 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.093 0.957 . . . . 0.0 112.928 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -58.61 -50.35 74.16 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.758 1.623 . . . . 0.0 112.387 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.1 p -53.15 147.61 9.54 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 125.043 1.465 . . . . 0.0 113.975 170.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -103.06 87.67 2.97 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 122.706 1.241 . . . . 0.0 109.422 170.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.499 ' CD1' ' HB2' ' A' ' 65' ' ' ALA . 6.3 mm -48.57 112.34 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 112.131 -2.304 . . . . 0.0 111.556 172.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.5 p -101.18 143.5 31.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.458 171.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.5 t -127.75 111.77 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.2 m -109.98 126.97 54.49 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.538 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -123.89 136.77 54.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.643 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.6 p30 51.08 22.83 1.35 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 128.739 2.816 . . . . 0.0 117.067 -178.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.54 -28.4 14.39 Favored Glycine 0 CA--C 1.544 1.894 0 CA-C-N 115.238 -0.892 . . . . 0.0 114.367 -171.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -81.09 135.47 35.81 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.447 0.624 . . . . 0.0 111.345 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.0 t -113.55 120.26 40.35 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.847 -170.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -126.19 129.2 48.53 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.702 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.5 t -76.15 131.77 39.59 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.898 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.15 -40.95 82.24 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 125.149 1.531 . . . . 0.0 112.559 174.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.585 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 72.8 mttt -57.76 -18.42 21.42 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 171.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 t -107.39 114.43 28.44 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.618 1.199 . . . . 0.0 110.045 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.3 tp -62.03 -59.21 5.42 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.94 -1.936 . . . . 0.0 115.555 -165.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -69.68 -31.1 68.95 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -57.03 -61.4 2.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.016 0.926 . . . . 0.0 109.919 171.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.0 tp -57.39 -44.66 84.67 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.669 ' HB3' HG22 ' A' ' 16' ' ' THR . 75.3 mt-30 -61.9 -42.84 99.56 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 t -67.45 -12.67 60.83 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.402 HD22 ' HB3' ' A' ' 42' ' ' ALA . 11.4 tp -69.87 -52.51 24.21 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -173.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.03 72.88 0.88 Allowed Glycine 0 N--CA 1.471 0.985 0 O-C-N 124.256 0.973 . . . . 0.0 112.383 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.1 mt -86.55 73.66 10.04 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 123.62 1.676 . . . . 0.0 111.007 175.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.4 t -127.8 172.25 11.01 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 111.802 -2.454 . . . . 0.0 111.517 -172.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -40.26 143.4 0.3 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.521 1.929 . . . . 0.0 112.236 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.37 -33.76 2.02 Favored Glycine 0 N--CA 1.481 1.644 0 CA-C-O 118.362 -1.243 . . . . 0.0 114.875 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.0 p -61.97 115.68 4.27 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.064 1.432 . . . . 0.0 114.492 -174.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 7' ' ' THR . 25.7 t -88.81 100.94 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 110.721 -2.945 . . . . 0.0 106.184 173.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.0 m -102.78 123.8 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 112.902 -1.954 . . . . 0.0 111.611 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 p -84.5 109.76 18.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 112.306 -2.224 . . . . 0.0 111.391 171.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.8 mt -104.55 110.38 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.079 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.464 ' OG ' ' HG3' ' A' ' 3' ' ' GLN . 4.4 m -117.57 126.44 52.55 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 113.741 -1.572 . . . . 0.0 115.098 -168.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.499 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . . . -126.18 137.84 53.6 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.293 -1.321 . . . . 0.0 112.921 176.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -139.1 113.98 9.31 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.446 -1.706 . . . . 0.0 108.996 166.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.75 -155.59 16.74 Favored Glycine 0 N--CA 1.479 1.545 0 C-N-CA 126.07 1.795 . . . . 0.0 109.439 -175.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -77.78 -35.33 51.68 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 122.218 1.009 . . . . 0.0 111.569 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -105.02 26.94 8.66 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.848 1.659 . . . . 0.0 115.154 -177.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -44.61 -43.15 7.97 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.464 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -73.36 -46.43 49.2 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 174.241 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.426 ' HE2' ' OE1' ' A' ' 71' ' ' GLN . 39.0 mtmt -72.76 -32.04 65.34 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.119 1.368 . . . . 0.0 113.271 -173.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.96 -53.37 58.75 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.027 1.331 . . . . 0.0 111.269 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 t -65.66 -52.44 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.135 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -47.03 -57.2 5.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.021 1.328 . . . . 0.0 112.478 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -60.29 -60.32 4.0 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mt -58.23 -36.0 72.53 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.83 -42.77 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.568 0.747 . . . . 0.0 111.572 171.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -63.82 -34.52 78.1 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.463 HD22 ' HG2' ' A' ' 25' ' ' GLU . 4.5 tp -58.37 -52.54 65.16 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.447 1.099 . . . . 0.0 112.157 164.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 48.2 ttm -48.86 -51.43 29.74 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.867 0.867 . . . . 0.0 112.581 173.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.5 -50.5 73.67 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -84.77 15.08 4.11 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -174.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.552 1.05 0 C-N-CA 124.299 1.039 . . . . 0.0 111.594 169.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -127.98 141.15 51.61 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.398 1.479 . . . . 0.0 109.879 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.48 128.36 11.75 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.053 0.541 . . . . 0.0 111.863 -172.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -125.13 119.46 28.64 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -83.08 115.68 21.98 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 113.18 -1.827 . . . . 0.0 111.086 164.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.1 164.31 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 113.249 -1.796 . . . . 0.0 113.076 176.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.9 p -121.31 126.04 48.53 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -172.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.42 HD12 ' OG1' ' A' ' 59' ' ' THR . 47.5 mt -80.26 111.9 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.411 170.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 p -107.07 -8.77 16.4 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 113.218 -1.81 . . . . 0.0 115.555 173.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.27 137.03 68.45 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.965 0.906 . . . . 0.0 112.535 177.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -45.78 -46.17 15.76 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 124.843 3.695 . . . . 0.0 115.943 -170.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.22 -34.32 5.96 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 175.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.32 -135.56 12.54 Favored Glycine 0 N--CA 1.482 1.74 0 O-C-N 123.761 0.663 . . . . 0.0 111.627 169.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 7.7 mp . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.5 p . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 63.4 mtt-85 -75.27 -45.18 4.59 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-O 115.706 -2.093 . . . . 0.0 115.599 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -63.34 -28.46 71.97 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 CA-C-N 122.565 1.952 . . . . 0.0 112.569 168.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.501 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -61.2 -22.24 64.57 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 169.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.4 -36.36 63.48 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -55.9 -47.27 77.75 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 170.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -55.62 -43.61 76.27 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.899 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.604 HG12 ' HE2' ' A' ' 27' ' ' LYS . 19.5 t -59.23 -52.55 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.752 0.821 . . . . 0.0 111.214 176.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.22 -56.44 11.09 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.584 1.154 . . . . 0.0 113.028 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.505 ' HG2' HD11 ' A' ' 80' ' ' LEU . 10.0 tp10 -58.8 -45.2 90.43 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 124.779 1.3 . . . . 0.0 112.395 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.59 80.18 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.604 ' HE2' HG12 ' A' ' 23' ' ' VAL . 63.1 mttm -50.25 -38.42 40.69 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 175.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.94 3.78 55.87 Favored Glycine 0 CA--C 1.54 1.605 0 O-C-N 124.769 1.293 . . . . 0.0 116.298 -173.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -100.75 158.3 16.06 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.305 1.042 . . . . 0.0 112.869 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.3 p -68.57 -52.32 33.1 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 118.639 -0.696 . . . . 0.0 109.482 168.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.0 p -59.05 136.52 57.97 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.875 1.27 . . . . 0.0 112.947 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -95.27 92.15 6.61 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.362 173.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.606 HD13 ' HB2' ' A' ' 65' ' ' ALA . 29.7 mm -57.55 115.68 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 112.132 -2.304 . . . . 0.0 110.211 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.5 p -105.54 117.29 33.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.702 173.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.6 t -103.89 117.71 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.717 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.448 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 35.0 m -107.8 129.7 55.03 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 112.553 -2.112 . . . . 0.0 112.042 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.1 t -136.25 137.68 41.03 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 111.979 -2.373 . . . . 0.0 107.727 171.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.8 p30 40.02 44.54 1.47 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.36 -40.65 3.08 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 124.185 0.898 . . . . 0.0 114.388 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -57.84 123.93 17.46 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.872 1.269 . . . . 0.0 112.645 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -109.74 101.44 10.33 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.489 -176.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.71 134.65 47.52 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.622 1.201 . . . . 0.0 112.846 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.0 t -73.21 112.19 9.03 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 112.485 -2.143 . . . . 0.0 112.143 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.55 -14.58 63.11 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 112.717 -2.038 . . . . 0.0 114.232 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -72.27 -22.28 61.24 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.2 t -109.91 122.43 47.53 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.843 0.83 . . . . 0.0 111.744 -176.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.445 ' HA ' HG21 ' A' ' 23' ' ' VAL . 6.3 tp -55.54 -59.4 4.89 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.588 -2.096 . . . . 0.0 114.615 -169.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -64.79 -33.38 75.86 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -61.97 -51.72 66.91 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 123.805 0.69 . . . . 0.0 112.382 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.5 tp -61.96 -38.74 89.67 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -64.9 -39.28 93.29 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -72.96 -28.68 62.55 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 172.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.3 tp -45.19 -60.95 1.85 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.61 93.46 2.02 Favored Glycine 0 CA--C 1.539 1.57 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 71.5 mt -120.06 87.04 2.67 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 113.337 -1.432 . . . . 0.0 107.906 178.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 t -135.38 -174.87 3.75 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.337 -1.302 . . . . 0.0 111.351 -173.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -61.05 118.48 6.82 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.288 0.566 . . . . 0.0 109.993 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.78 -7.81 65.44 Favored Glycine 0 N--CA 1.478 1.435 0 CA-C-N 114.368 -1.287 . . . . 0.0 115.665 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.42 ' OG1' HD12 ' A' ' 8' ' ' ILE . 42.3 p -71.44 99.59 2.03 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.351 1.075 . . . . 0.0 111.652 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.2 t -60.44 104.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 111.497 -2.592 . . . . 0.0 107.986 173.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.4 m -106.78 113.4 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.418 -168.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.448 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 6.7 m -100.25 104.97 16.49 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 112.271 -2.24 . . . . 0.0 108.973 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 24.3 mt -98.64 102.25 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.118 -1.855 . . . . 0.0 107.9 -174.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -102.56 140.86 36.28 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 113.642 -1.617 . . . . 0.0 112.31 -176.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.606 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -146.71 142.05 27.43 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.419 1.074 . . . . 0.0 112.904 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -140.12 114.25 9.05 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.12 169.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.99 -152.56 15.13 Favored Glycine 0 N--CA 1.483 1.791 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.581 -175.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -86.32 -57.7 2.91 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 120.742 0.306 . . . . 0.0 110.503 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.55 5.49 3.81 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.783 2.142 . . . . 0.0 116.783 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -41.93 -53.71 3.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.425 ' HG2' ' HG3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -58.91 -49.24 78.56 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.949 1.3 . . . . 0.0 113.477 179.208 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 72.4 mttt -76.62 -34.94 58.32 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.278 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.42 68.5 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.015 0.926 . . . . 0.0 111.959 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.54 -45.51 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-O 118.459 -0.782 . . . . 0.0 111.731 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -52.94 -51.06 62.67 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 123.876 0.735 . . . . 0.0 111.994 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -59.23 -51.82 68.33 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.438 1.495 . . . . 0.0 111.697 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.417 HD13 HG21 ' A' ' 33' ' ' ILE . 30.2 mt -65.93 -29.91 70.41 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.94 -46.19 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 121.329 0.585 . . . . 0.0 109.725 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -71.42 -30.31 65.93 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.432 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.505 HD11 ' HG2' ' A' ' 25' ' ' GLU . 0.6 OUTLIER -59.54 -52.84 63.85 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 124.142 0.901 . . . . 0.0 112.459 166.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.7 tmm? -53.12 -47.47 68.63 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 124.49 1.119 . . . . 0.0 111.892 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.04 -40.35 97.46 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -90.0 -9.98 46.64 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.479 1.004 0 C-N-CA 122.888 0.475 . . . . 0.0 110.696 161.485 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.413 ' HD2' ' HB ' ' A' ' 74' ' ' VAL . 12.6 t80 -118.4 118.91 33.05 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 125.425 1.703 . . . . 0.0 110.567 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.75 122.34 37.18 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.438 -172.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -134.02 140.28 46.58 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.751 0.821 . . . . 0.0 113.073 171.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.6 ' HG2' HG12 ' A' ' 60' ' ' VAL . 39.9 tt0 -112.32 122.87 48.96 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.958 -172.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.409 HG11 HG13 ' A' ' 78' ' ' VAL . 3.2 m -128.63 130.33 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.582 HG23 HG22 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -91.21 128.01 36.86 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 113.684 -1.598 . . . . 0.0 111.518 -177.698 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.1 mt -87.5 118.14 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.709 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 p -95.51 -26.72 15.7 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 113.516 -1.675 . . . . 0.0 113.748 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.477 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -64.28 127.95 92.66 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 123.486 0.714 . . . . 0.0 111.943 173.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HA ' ' HB2' ' A' ' 57' ' ' GLN . 65.4 Cg_exo -54.62 -51.98 9.19 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.171 3.247 . . . . 0.0 113.725 -170.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -95.81 -46.39 6.59 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.866 1.354 . . . . 0.0 111.031 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.09 -107.86 2.26 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.655 1.121 . . . . 0.0 112.764 166.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 24.0 mt . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.4 p . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -74.43 -44.56 5.77 Favored Pre-proline 0 N--CA 1.483 1.188 0 CA-C-O 116.248 -1.834 . . . . 0.0 115.908 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.425 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 82.8 Cg_exo -64.3 -40.61 24.55 Favored 'Trans proline' 0 N--CA 1.486 1.063 0 CA-C-N 121.826 1.688 . . . . 0.0 112.866 170.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -51.16 -37.56 47.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.587 1.155 . . . . 0.0 113.959 172.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.73 75.71 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 175.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -80.73 -28.18 36.66 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 174.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -62.04 -38.91 90.53 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.296 0.639 . . . . 0.0 110.551 168.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 19' ' ' ALA . 46.4 t -60.65 -48.12 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 124.472 1.109 . . . . 0.0 110.978 169.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -51.47 -46.97 63.29 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 118.895 -0.574 . . . . 0.0 111.622 175.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.403 ' HG2' HD22 ' A' ' 80' ' ' LEU . 11.4 tp10 -61.58 -56.28 21.64 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 125.13 1.519 . . . . 0.0 111.567 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.82 -40.71 63.55 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.435 ' HE2' HG12 ' A' ' 23' ' ' VAL . 65.1 mttm -57.93 -27.85 63.75 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 176.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.68 -46.38 94.56 Favored Glycine 0 CA--C 1.542 1.772 0 C-N-CA 124.948 1.261 . . . . 0.0 112.892 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -69.12 144.15 53.96 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.991 0.916 . . . . 0.0 112.459 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.3 p -67.72 -45.77 74.11 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.285 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.7 p -63.12 167.0 5.34 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.683 1.593 . . . . 0.0 113.206 171.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -114.03 111.57 21.86 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 122.365 1.078 . . . . 0.0 110.903 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.739 HD13 ' HB2' ' A' ' 65' ' ' ALA . 39.5 mm -69.47 103.77 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 112.567 -2.106 . . . . 0.0 110.773 175.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.9 p -88.3 118.2 27.75 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.315 167.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -105.39 92.45 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 113.545 -1.661 . . . . 0.0 106.876 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 12.0 m -81.59 124.94 29.95 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 112.12 -2.309 . . . . 0.0 110.961 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -128.65 106.64 9.09 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.662 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 p30 35.43 83.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 112.557 -2.111 . . . . 0.0 116.533 -176.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.52 -52.68 4.59 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-N 113.037 -1.892 . . . . 0.0 112.903 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -69.21 117.68 11.15 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.305 1.042 . . . . 0.0 111.509 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 1.7 t -111.29 108.94 18.73 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.81 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.49 118.6 37.05 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.478 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.4 t -57.11 111.88 1.19 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.185 -1.371 . . . . 0.0 111.153 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.22 -24.34 67.18 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.876 172.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -70.46 -26.87 63.84 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.236 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -95.29 102.6 14.42 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 123.063 1.411 . . . . 0.0 112.006 172.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.406 ' HA ' HG21 ' A' ' 23' ' ' VAL . 16.9 tp -39.43 -59.86 1.02 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.093 2.157 . . . . 0.0 115.704 -175.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -66.32 -33.15 75.08 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -67.07 -44.52 79.88 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.43 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 tp -66.93 -45.47 77.78 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 124.444 1.09 . . . . 0.0 112.02 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -57.49 -30.55 65.19 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 t -94.07 -0.0 55.65 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.5 -41.8 96.22 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.23 86.65 1.86 Allowed Glycine 0 CA--C 1.537 1.417 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -172.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.549 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 10.6 mt -115.29 77.22 1.06 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.192 0.996 . . . . 0.0 109.73 -172.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.9 t -132.05 168.29 18.2 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.468 -163.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.595 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 40.7 tt0 -57.54 106.71 0.36 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.031 0.932 . . . . 0.0 111.468 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.62 -38.21 2.61 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 113.311 -1.768 . . . . 0.0 114.526 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.8 p -64.55 122.85 17.78 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 118.165 0.982 . . . . 0.0 112.88 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.6 HG12 ' HG2' ' A' ' 5' ' ' GLU . 1.1 t -97.86 111.22 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 113.073 -1.876 . . . . 0.0 106.792 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.7 m -105.52 117.07 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 112.701 -2.045 . . . . 0.0 113.778 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.3 93.66 9.14 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 112.466 -2.152 . . . . 0.0 111.88 -175.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.457 HG22 HG22 ' A' ' 74' ' ' VAL . 81.2 mt -80.15 102.81 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 113.845 -1.525 . . . . 0.0 107.724 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.2 m -121.31 134.08 55.14 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 112.62 -2.082 . . . . 0.0 112.978 -175.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.739 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -145.84 152.31 39.29 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 124.822 1.326 . . . . 0.0 112.767 177.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -137.28 133.27 34.82 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.971 172.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.44 -159.73 24.9 Favored Glycine 0 N--CA 1.484 1.894 0 O-C-N 124.169 0.918 . . . . 0.0 113.519 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -50.26 -47.47 55.17 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -108.79 31.23 5.81 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -51.26 -52.29 46.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -71.8 -42.21 67.33 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 112.765 -2.016 . . . . 0.0 113.151 178.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -66.62 -47.36 72.88 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.593 1.157 . . . . 0.0 111.987 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.576 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -60.33 -47.36 86.37 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.366 1.066 . . . . 0.0 113.429 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.457 HG22 HG22 ' A' ' 63' ' ' ILE . 95.4 t -68.94 -45.81 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 117.537 -1.221 . . . . 0.0 111.261 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -52.08 -49.76 62.91 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.981 0.913 . . . . 0.0 111.019 175.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -62.69 -58.1 8.65 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.107 1.363 . . . . 0.0 113.442 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.3 mt -64.74 -29.78 70.77 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.409 HG13 HG11 ' A' ' 6' ' ' VAL . 28.5 t -63.24 -54.79 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 124.036 0.835 . . . . 0.0 110.686 168.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt -56.34 -47.05 79.6 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.736 0.814 . . . . 0.0 112.969 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.403 HD22 ' HG2' ' A' ' 25' ' ' GLU . 37.7 tp -52.51 -56.08 17.65 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.435 1.094 . . . . 0.0 111.607 175.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.415 ' HG2' HD11 ' A' ' 14' ' ' LEU . 6.5 tmm? -53.99 -43.72 70.23 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.085 0.954 . . . . 0.0 112.021 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.6 -35.56 80.5 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -177.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.99 -21.04 34.05 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.7 mt . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -177.928 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.465 ' HG2' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -132.87 139.55 47.48 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 125.337 1.648 . . . . 0.0 108.907 165.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -137.58 128.46 27.23 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.227 -177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -125.05 108.04 11.42 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.976 168.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -87.3 97.25 10.68 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 112.587 -2.097 . . . . 0.0 109.123 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 m -120.34 117.49 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 112.243 -2.253 . . . . 0.0 112.91 -173.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 p -71.77 126.77 30.57 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.728 -1.123 . . . . 0.0 111.665 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.9 mt -71.2 126.54 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 114.876 -1.057 . . . . 0.0 108.756 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -98.94 -37.53 9.36 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 113.957 -1.474 . . . . 0.0 114.336 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.68 123.86 24.94 Favored Pre-proline 0 N--CA 1.482 1.147 0 O-C-N 123.863 0.727 . . . . 0.0 111.485 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.609 ' HA ' ' HB2' ' A' ' 57' ' ' GLN . 96.8 Cg_exo -51.3 -42.43 54.39 Favored 'Trans proline' 0 N--CA 1.482 0.851 0 C-N-CA 123.973 3.116 . . . . 0.0 112.03 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -71.91 -56.07 6.36 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.922 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.7 -127.28 9.09 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.932 1.253 . . . . 0.0 110.522 171.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 21.2 mt . . . . . 0 N--CA 1.482 1.157 0 CA-C-N 113.931 -1.135 . . . . 0.0 113.241 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.3 p . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.4 mmt-85 -64.22 -48.39 76.65 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-O 116.03 -1.938 . . . . 0.0 114.593 -174.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -65.41 -41.7 14.96 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.415 2.077 . . . . 0.0 112.912 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.73 -38.22 60.47 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.41 -41.68 94.4 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.919 0.887 . . . . 0.0 113.013 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -67.5 -44.44 78.48 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.344 1.058 . . . . 0.0 111.631 175.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -58.36 -45.76 87.61 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.256 1.423 . . . . 0.0 111.447 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.754 HG11 ' HA ' ' A' ' 47' ' ' LEU . 51.9 t -53.88 -46.7 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 124.296 1.038 . . . . 0.0 111.672 173.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -57.05 -44.99 83.55 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 118.98 -0.534 . . . . 0.0 111.876 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -62.36 -47.79 82.65 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.501 1.126 . . . . 0.0 112.627 174.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.24 -39.52 83.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.68 1.192 . . . . 0.0 114.174 175.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -60.03 -26.24 65.95 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 172.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.86 -20.93 64.9 Favored Glycine 0 CA--C 1.546 1.977 0 O-C-N 124.535 1.147 . . . . 0.0 114.187 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -99.95 145.84 27.37 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.592 1.187 . . . . 0.0 113.307 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.1 p -73.14 -37.04 66.75 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.334 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.6 p -63.38 160.55 15.86 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 124.599 1.187 . . . . 0.0 112.121 168.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -107.05 110.57 22.73 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.655 HD13 ' HB2' ' A' ' 65' ' ' ALA . 46.2 mm -72.43 92.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.024 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.2 107.44 14.0 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 110.845 -2.889 . . . . 0.0 107.886 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.96 101.85 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.269 -176.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.579 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 9.5 m -96.74 118.69 33.75 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 113.523 -1.671 . . . . 0.0 112.043 -177.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.9 t -130.53 114.37 15.4 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.325 171.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 p30 43.26 70.13 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 125.372 1.469 . . . . 0.0 114.17 -172.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.91 -35.5 1.24 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-N 113.389 -1.732 . . . . 0.0 115.241 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -74.34 108.58 7.21 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.163 0.985 . . . . 0.0 111.415 -174.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.5 m -98.96 100.62 11.82 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.871 176.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -105.91 115.31 30.01 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.837 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.3 t -64.56 119.06 9.75 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.889 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -23.13 65.96 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.433 -1.712 . . . . 0.0 113.525 171.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -70.78 -24.07 62.52 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.137 177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.9 t -103.07 123.43 46.63 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.217 0.532 . . . . 0.0 111.393 167.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.754 ' HA ' HG11 ' A' ' 23' ' ' VAL . 32.4 tp -42.91 -61.32 1.31 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 111.041 -2.8 . . . . 0.0 114.919 -171.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -82.75 -6.96 59.66 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -74.01 -58.31 3.39 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.8 tp -54.11 -39.51 66.48 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -67.24 -2.88 6.52 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.2 t -133.1 59.37 1.74 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 124.578 2.132 . . . . 0.0 112.538 166.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.518 HD23 HD21 ' A' ' 55' ' ' LEU . 40.2 tp -110.3 -50.71 2.94 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 113.08 -1.873 . . . . 0.0 113.095 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.72 90.12 1.93 Allowed Glycine 0 CA--C 1.531 1.087 0 N-CA-C 107.804 -2.119 . . . . 0.0 107.804 -169.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.518 HD21 HD23 ' A' ' 53' ' ' LEU . 59.4 mt -122.88 90.25 3.26 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.054 -1.073 . . . . 0.0 109.44 -171.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.4 t -162.94 157.81 21.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 126.385 2.303 . . . . 0.0 109.346 -164.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.609 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 32.6 tt0 -40.05 132.04 1.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -175.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.19 -20.58 32.65 Favored Glycine 0 N--CA 1.479 1.553 0 CA-C-N 113.003 -1.908 . . . . 0.0 114.518 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.3 p -60.98 108.06 0.81 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 122.925 1.345 . . . . 0.0 112.992 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.3 94.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 110.779 -2.919 . . . . 0.0 106.919 -175.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.5 m -92.25 98.0 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 113.648 -1.614 . . . . 0.0 112.691 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.579 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 4.8 m -73.66 88.03 1.69 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 111.834 -2.439 . . . . 0.0 108.778 175.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.445 HG23 HG23 ' A' ' 33' ' ' ILE . 85.9 mt -82.22 108.28 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.158 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.3 m -120.0 136.74 54.44 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 113.404 -1.725 . . . . 0.0 113.427 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.655 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -144.83 130.81 19.3 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.042 172.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.465 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 25.2 tt0 -123.19 118.65 28.12 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.682 -1.145 . . . . 0.0 107.984 163.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 170.14 -173.44 44.17 Favored Glycine 0 N--CA 1.478 1.486 0 CA-C-N 113.93 -1.486 . . . . 0.0 112.697 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.418 ' HG2' ' H ' ' A' ' 68' ' ' GLU . 4.5 mm-40 -47.41 -45.95 25.91 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 125.015 1.326 . . . . 0.0 113.667 -178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -114.22 34.78 4.49 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.592 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 8.5 pt-20 -46.05 -72.85 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 -175.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.592 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -52.22 -43.33 64.21 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 177.076 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -62.77 -45.82 90.9 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.319 -1.31 . . . . 0.0 112.864 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -57.1 -52.44 65.27 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.481 1.113 . . . . 0.0 112.802 174.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.6 t -64.75 -46.36 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.952 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -55.07 -52.25 63.8 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -60.78 -48.42 81.9 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.888 0.875 . . . . 0.0 113.076 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.4 mt -63.03 -37.79 88.6 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.82 -45.27 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.316 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -55.15 -54.35 44.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 123.617 0.573 . . . . 0.0 111.052 173.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -49.36 -54.86 15.12 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 125.636 1.575 . . . . 0.0 111.846 175.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -58.12 -40.62 81.71 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.466 1.106 . . . . 0.0 113.07 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.79 -44.06 64.6 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 175.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -70.56 -3.27 17.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.518 1.527 . . . . 0.0 114.293 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.9 mt . . . . . 0 N--CA 1.48 1.056 0 C-N-CA 124.856 1.262 . . . . 0.0 110.761 169.628 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ttt . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.498 ' HB3' HG21 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -77.77 141.84 39.02 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.282 -1.326 . . . . 0.0 113.091 173.623 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -148.55 127.82 12.98 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.427 -1.715 . . . . 0.0 110.031 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -126.77 117.7 23.2 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.012 0.82 . . . . 0.0 112.597 164.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -84.06 97.81 9.52 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 125.643 1.84 . . . . 0.0 108.623 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.795 HG23 HG23 ' A' ' 61' ' ' VAL . 2.7 m -125.93 141.48 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 113.592 -1.64 . . . . 0.0 112.491 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.4 p -107.77 137.87 45.02 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.3 mt -76.75 122.85 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.487 175.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.2 p -91.49 -43.47 9.67 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.107 -1.406 . . . . 0.0 114.114 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -28.77 133.44 0.19 Allowed Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 126.978 2.111 . . . . 0.0 115.121 175.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 54.5 Cg_exo -54.53 -54.19 4.98 Favored 'Trans proline' 0 N--CA 1.482 0.841 0 C-N-CA 124.296 3.331 . . . . 0.0 112.49 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -78.15 -43.59 28.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.166 0.986 . . . . 0.0 112.559 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 56' ' ' THR . . . 101.12 -152.91 19.02 Favored Glycine 0 N--CA 1.475 1.239 0 C-N-CA 125.464 1.507 . . . . 0.0 110.508 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 172.687 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.421 ' HD3' ' HA ' ' A' ' 17' ' ' ARG 0.279 83.0 mmt-85 -85.32 -44.06 0.65 Allowed Pre-proline 0 N--CA 1.483 1.205 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 -176.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -62.74 -37.35 56.89 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 121.528 1.486 . . . . 0.0 111.703 164.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.27 -40.95 71.6 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.96 -36.97 75.72 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 173.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -66.66 -49.77 65.08 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.822 0.701 . . . . 0.0 111.418 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -54.99 -43.48 73.6 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 124.045 0.841 . . . . 0.0 111.45 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 44' ' ' ALA . 40.1 t -53.18 -61.83 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.657 1.183 . . . . 0.0 111.324 171.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -49.23 -46.37 45.8 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 124.176 0.922 . . . . 0.0 111.822 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.32 -55.62 17.22 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.678 1.236 . . . . 0.0 112.906 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.56 -30.17 70.49 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -55.51 -30.82 61.36 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 170.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.99 -5.9 66.47 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.12 1.343 . . . . 0.0 114.896 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -95.89 142.48 28.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.153 0.581 . . . . 0.0 111.737 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.7 p -63.87 -39.01 93.2 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.174 0.99 . . . . 0.0 111.51 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 p -62.04 141.43 58.09 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.372 -1.285 . . . . 0.0 112.71 168.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -94.26 108.56 20.43 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 123.311 1.529 . . . . 0.0 110.117 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.486 HD11 ' HB1' ' A' ' 73' ' ' ALA . 37.4 mm -73.79 106.91 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 111.228 -2.715 . . . . 0.0 109.87 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.4 p -108.8 110.41 21.78 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 122.806 1.288 . . . . 0.0 112.063 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.523 HG13 ' HA ' ' A' ' 61' ' ' VAL . 30.0 t -81.87 106.27 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 112.379 -2.192 . . . . 0.0 109.057 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.455 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 19.5 m -85.72 105.67 16.42 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 122.354 1.073 . . . . 0.0 110.016 172.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.8 t -118.75 109.42 16.06 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 113.338 -1.756 . . . . 0.0 110.458 171.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 p30 43.94 71.25 0.26 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.72 9.25 37.85 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-N 112.99 -1.914 . . . . 0.0 116.349 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.415 ' HE3' HD12 ' A' ' 53' ' ' LEU . 40.5 mtmt -118.82 99.25 6.64 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 122.328 -0.513 . . . . 0.0 110.841 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.4 m -79.97 98.76 7.31 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.651 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.88 124.53 49.11 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 113.366 -1.743 . . . . 0.0 112.709 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.6 t -70.37 132.17 45.22 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 113.164 -1.835 . . . . 0.0 113.297 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.479 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -74.77 -25.37 59.03 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 113.924 -1.489 . . . . 0.0 114.054 167.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -73.69 -27.27 61.13 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.8 t -96.16 92.65 6.51 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.347 1.07 . . . . 0.0 109.177 171.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.2 tp -37.78 -55.01 1.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 126.98 2.112 . . . . 0.0 114.529 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.482 ' O ' HG22 ' A' ' 52' ' ' THR . 80.3 m-85 -65.69 -33.48 75.99 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -59.98 -49.48 77.52 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tp -63.84 -39.63 94.68 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -65.69 -37.49 86.62 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 48' ' ' PHE . 12.4 t -99.84 78.69 2.14 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 125.046 2.355 . . . . 0.0 111.91 175.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.415 HD12 ' HE3' ' A' ' 40' ' ' LYS . 37.2 tp -149.58 -51.0 0.15 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 111.361 -2.654 . . . . 0.0 112.473 -173.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.427 ' O ' HG21 ' A' ' 59' ' ' THR . . . 96.5 65.26 0.93 Allowed Glycine 0 N--CA 1.472 1.06 0 O-C-N 125.467 1.73 . . . . 0.0 110.387 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 78.7 mt -85.14 91.63 8.17 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.441 0.638 . . . . 0.0 110.258 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.528 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 6.4 t -135.91 -163.43 1.4 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.373 -171.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -63.8 118.83 8.9 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.825 0.85 . . . . 0.0 111.145 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.11 -10.05 76.04 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-N 113.6 -1.636 . . . . 0.0 115.371 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.427 HG21 ' O ' ' A' ' 54' ' ' GLY . 67.2 p -75.81 142.5 42.25 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 117.656 0.728 . . . . 0.0 112.383 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.28 137.21 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 113.022 -1.899 . . . . 0.0 109.307 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.795 HG23 HG23 ' A' ' 6' ' ' VAL . 3.2 m -110.54 78.85 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-N 112.473 -2.149 . . . . 0.0 107.398 165.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.455 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 3.0 m -74.95 86.29 2.28 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 173.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.478 HG23 HG23 ' A' ' 33' ' ' ILE . 57.1 mt -74.72 87.65 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.246 -173.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 75.0 m -88.67 125.55 34.89 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 112.806 -1.997 . . . . 0.0 110.272 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.55 136.15 20.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.281 -1.327 . . . . 0.0 113.489 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -130.91 128.66 40.97 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.334 1.022 . . . . 0.0 110.067 172.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.39 -176.93 30.44 Favored Glycine 0 N--CA 1.492 2.428 0 O-C-N 124.193 0.933 . . . . 0.0 115.142 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -53.85 -33.79 57.38 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -111.61 19.18 18.35 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -46.8 -51.93 15.31 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.474 ' NE2' ' H ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -62.54 -42.58 99.62 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 177.133 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -69.09 -46.13 68.55 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.477 -177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.486 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -53.67 -53.98 44.36 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.313 1.445 . . . . 0.0 113.133 174.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.498 HG21 ' HB3' ' A' ' 2' ' ' PHE . 79.8 t -59.09 -52.75 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.36 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.34 -47.54 81.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.737 0.815 . . . . 0.0 113.14 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -57.48 -55.46 34.58 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.84 1.256 . . . . 0.0 111.423 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.9 mt -66.44 -30.17 70.47 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.7 t -65.58 -48.56 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 123.373 0.42 . . . . 0.0 110.059 170.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -63.62 -44.8 92.88 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 117.94 -1.029 . . . . 0.0 113.294 175.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.7 tp -51.51 -51.52 54.52 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.359 1.063 . . . . 0.0 111.313 172.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -57.75 -42.57 84.24 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.051 0.94 . . . . 0.0 112.994 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.28 -43.87 66.33 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -82.98 35.68 0.48 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.845 1.658 . . . . 0.0 112.932 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 mt . . . . . 0 N--CA 1.481 1.121 0 C-N-CA 125.572 1.549 . . . . 0.0 112.704 179.298 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttt . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -110.48 136.89 48.92 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 125.958 2.036 . . . . 0.0 109.883 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -120.02 143.72 47.92 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 113.336 -1.756 . . . . 0.0 109.171 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -141.95 102.07 4.07 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.525 1.141 . . . . 0.0 109.674 171.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -81.87 102.13 10.66 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 111.938 -2.392 . . . . 0.0 108.682 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.48 HG23 HG23 ' A' ' 61' ' ' VAL . 5.2 m -125.02 158.2 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 112.507 -2.133 . . . . 0.0 111.76 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.484 HG22 HG22 ' A' ' 60' ' ' VAL . 81.5 p -109.68 137.46 47.46 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.805 0.812 . . . . 0.0 111.696 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.2 mt -91.53 93.18 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 166.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 p -86.43 -17.05 35.3 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 111.424 -2.625 . . . . 0.0 115.43 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.49 133.97 85.53 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.611 1.165 . . . . 0.0 112.155 175.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -44.55 -51.49 7.04 Favored 'Trans proline' 0 CA--C 1.541 0.836 1 C-N-CA 125.318 4.012 . . . . 0.0 116.563 -170.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -106.13 -27.64 10.97 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 172.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.21 -108.67 2.6 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 124.467 1.032 . . . . 0.0 112.691 170.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . 33.1 mt . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -175.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.8 p . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.415 ' HB2' ' HD3' ' A' ' 18' ' ' PRO 0.256 88.5 mmt-85 -74.74 -56.45 2.21 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-O 115.721 -2.085 . . . . 0.0 115.011 -175.576 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 87.0 Cg_exo -59.47 -34.57 97.18 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.778 2.319 . . . . 0.0 113.952 174.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.7 -25.99 2.08 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 172.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.26 98.57 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -65.99 -38.83 89.51 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.977 0.911 . . . . 0.0 112.674 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.41 -42.01 86.23 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.06 0.85 . . . . 0.0 112.134 172.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.686 HG21 ' HA ' ' A' ' 47' ' ' LEU . 73.3 t -64.92 -51.5 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.274 0.63 . . . . 0.0 112.06 170.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -49.87 -43.13 48.98 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.606 1.162 . . . . 0.0 112.608 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -67.58 -51.67 47.64 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.019 0.824 . . . . 0.0 111.915 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.49 -32.18 73.56 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HE2' ' O ' ' A' ' 45' ' ' LYS . 25.8 mmtt -44.65 -39.39 5.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.896 1.278 . . . . 0.0 114.431 167.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.35 -32.22 75.39 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 125.15 1.531 . . . . 0.0 114.898 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -74.82 133.46 41.91 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.0 p -65.89 -46.87 76.78 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.972 -173.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.2 p -66.53 137.75 57.01 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.817 1.647 . . . . 0.0 111.473 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -83.95 101.57 11.8 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 122.876 1.322 . . . . 0.0 111.758 -178.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' A' ' 44' ' ' ALA . 6.9 mm -70.05 100.41 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.281 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.2 p -94.2 103.93 15.96 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.325 174.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.6 96.29 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 112.776 -2.011 . . . . 0.0 107.514 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.6 m -88.84 104.52 17.0 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 113.473 -1.694 . . . . 0.0 111.322 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.4 t -108.31 99.24 8.67 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.72 172.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 p30 47.57 75.0 0.14 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.853 1.661 . . . . 0.0 114.011 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.05 -39.77 1.18 Allowed Glycine 0 CA--C 1.542 1.771 0 CA-C-N 113.176 -1.829 . . . . 0.0 114.044 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -77.03 106.9 9.01 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 123.606 1.67 . . . . 0.0 110.807 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -108.86 106.38 16.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 112.355 -2.202 . . . . 0.0 110.621 -170.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.464 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -110.47 122.63 48.18 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.93 -175.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.2 t -64.91 119.05 9.96 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 113.468 -1.696 . . . . 0.0 111.676 174.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.523 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . . . -66.66 -11.34 53.48 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.296 -1.774 . . . . 0.0 114.568 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.468 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 95.2 mttt -72.84 -21.12 61.0 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 166.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.5 t -112.55 99.97 8.37 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.38 1.072 . . . . 0.0 112.596 -174.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.686 ' HA ' HG21 ' A' ' 23' ' ' VAL . 19.0 tp -36.77 -54.88 0.9 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 112.99 -1.914 . . . . 0.0 115.131 178.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -63.48 -46.4 86.33 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.495 -1.684 . . . . 0.0 113.659 -172.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.8 tttm -63.03 -44.42 95.96 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.275 0.63 . . . . 0.0 112.282 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.8 tp -66.61 -44.03 83.2 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -60.56 -26.12 66.69 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.3 t -108.41 60.61 0.61 Allowed 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 124.449 2.071 . . . . 0.0 112.415 172.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.564 HD23 HD21 ' A' ' 55' ' ' LEU . 8.9 tp -124.99 -48.38 1.75 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 111.804 -2.453 . . . . 0.0 110.799 175.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.09 67.41 0.81 Allowed Glycine 0 CA--C 1.535 1.329 0 O-C-N 124.833 1.333 . . . . 0.0 110.57 176.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.564 HD21 HD23 ' A' ' 53' ' ' LEU . 57.5 mt -88.01 86.68 7.16 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.084 0.945 . . . . 0.0 110.151 -174.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -133.81 -175.24 3.77 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 112.211 -2.268 . . . . 0.0 113.772 -169.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -59.02 112.96 1.87 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.766 2.426 . . . . 0.0 111.915 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.08 -6.9 56.71 Favored Glycine 0 CA--C 1.547 2.076 0 CA-C-N 112.992 -1.913 . . . . 0.0 114.489 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.0 p -75.66 103.34 5.72 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 7' ' ' THR . 47.7 t -65.38 115.21 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 112.858 -1.974 . . . . 0.0 109.05 170.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.48 HG23 HG23 ' A' ' 6' ' ' VAL . 13.5 m -118.94 106.12 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 112.971 -1.922 . . . . 0.0 111.658 -177.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 42.5 m -83.44 95.18 8.18 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 112.233 -2.258 . . . . 0.0 109.358 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -89.48 91.82 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 112.103 -2.317 . . . . 0.0 108.443 -175.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.0 m -104.58 122.48 45.7 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 111.334 -2.666 . . . . 0.0 112.266 -170.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -137.3 147.96 46.02 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 124.86 1.35 . . . . 0.0 112.627 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -134.37 128.29 33.34 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.692 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.08 -159.78 24.76 Favored Glycine 0 N--CA 1.489 2.181 0 O-C-N 124.491 1.119 . . . . 0.0 114.82 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -49.66 -34.98 19.95 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -119.94 12.76 12.1 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 118.947 2.943 . . . . 0.0 118.947 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -33.02 -54.28 0.38 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.432 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -68.38 -60.22 2.61 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 176.2 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -53.62 -34.46 58.61 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.683 1.593 . . . . 0.0 114.055 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.19 -59.55 3.35 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.825 1.25 . . . . 0.0 112.775 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.87 -51.77 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.928 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -49.27 -51.82 31.31 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.428 1.091 . . . . 0.0 112.71 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -58.83 -55.55 33.69 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.05 0.94 . . . . 0.0 112.416 176.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.4 tp -61.91 -36.88 82.64 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.238 1.415 . . . . 0.0 113.252 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.48 HG11 HG11 ' A' ' 6' ' ' VAL . 86.5 t -73.58 -36.28 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.793 0.837 . . . . 0.0 111.583 175.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -60.12 -37.19 79.27 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 118.2 -0.905 . . . . 0.0 113.17 168.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.3 tp -57.34 -40.68 78.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 123.886 0.741 . . . . 0.0 112.211 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -69.28 -27.08 65.1 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.76 1.224 . . . . 0.0 113.377 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.57 -26.63 26.02 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.538 1.135 . . . . 0.0 113.372 176.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -89.71 28.79 1.25 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.15 1.38 . . . . 0.0 113.227 170.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.3 mt . . . . . 0 CA--C 1.548 0.886 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.664 178.425 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 ttt . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -95.1 130.19 41.9 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 124.595 1.184 . . . . 0.0 109.157 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -125.4 122.08 35.71 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.303 -1.771 . . . . 0.0 110.004 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -122.58 119.1 29.84 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.488 1.137 . . . . 0.0 112.343 170.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -96.99 89.2 4.74 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.927 -1.942 . . . . 0.0 108.915 -174.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 m -111.68 141.4 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 114.089 -1.414 . . . . 0.0 114.419 -169.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.583 HG22 HG22 ' A' ' 60' ' ' VAL . 17.1 p -89.72 116.35 27.77 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 114.665 -1.152 . . . . 0.0 113.931 -173.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.16 101.98 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 166.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.0 p -94.09 -11.88 29.66 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 112.391 -2.186 . . . . 0.0 114.23 174.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -63.74 131.53 94.92 Favored Pre-proline 0 N--CA 1.481 1.112 0 C-N-CA 125.344 1.458 . . . . 0.0 111.092 175.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 98.7 Cg_exo -50.44 -50.25 14.12 Favored 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 124.205 3.27 . . . . 0.0 114.132 -174.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -98.68 -48.38 4.98 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.08 0.863 . . . . 0.0 112.769 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.09 -126.94 7.68 Favored Glycine 0 N--CA 1.48 1.616 0 O-C-N 124.269 0.981 . . . . 0.0 113.086 170.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 60.5 mt . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.265 5.5 mmt180 -80.75 -46.45 1.24 Allowed Pre-proline 0 N--CA 1.482 1.162 0 CA-C-O 116.774 -1.584 . . . . 0.0 115.173 -172.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -61.19 -37.09 76.99 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 121.983 1.789 . . . . 0.0 112.585 166.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.21 -42.86 66.73 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 170.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.427 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . . . -64.63 -38.17 90.08 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 174.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -64.85 -41.55 95.61 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.317 1.047 . . . . 0.0 112.62 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.472 ' HD1' HD22 ' A' ' 80' ' ' LEU . 18.4 t80 -59.73 -44.3 93.81 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.972 1.309 . . . . 0.0 111.425 172.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.1 t -59.59 -44.65 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 124.073 0.949 . . . . 0.0 111.982 173.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -48.75 -51.23 30.07 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.9 0.88 . . . . 0.0 111.254 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -65.85 -55.78 15.27 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 124.961 1.413 . . . . 0.0 111.766 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.53 -34.7 62.21 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -56.84 -28.32 61.47 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 172.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.81 3.1 65.66 Favored Glycine 0 N--CA 1.49 2.287 0 O-C-N 125.199 1.562 . . . . 0.0 114.874 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -102.6 153.83 19.72 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.546 0.738 . . . . 0.0 111.469 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.4 p -63.08 -44.35 96.01 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.396 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 p -64.04 151.71 42.22 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -97.88 110.63 23.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 113.942 -1.481 . . . . 0.0 107.94 166.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' A' ' 44' ' ' ALA . 3.5 mm -81.19 119.11 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 CA-C-N 111.878 -2.419 . . . . 0.0 109.189 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.08 113.5 27.07 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.091 0.948 . . . . 0.0 112.417 173.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.45 HG22 HG12 ' A' ' 63' ' ' ILE . 92.6 t -94.73 97.69 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 112.634 -2.075 . . . . 0.0 106.345 175.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.8 m -95.91 122.29 38.56 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 113.414 -1.721 . . . . 0.0 110.997 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.431 ' HB2' HG12 ' A' ' 61' ' ' VAL . 22.6 t -128.55 96.6 4.45 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.74 -177.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.8 p30 33.77 90.25 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 126.481 1.912 . . . . 0.0 115.707 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.92 -66.7 3.29 Favored Glycine 0 N--CA 1.479 1.529 0 CA-C-N 112.729 -2.032 . . . . 0.0 112.109 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.54 135.55 47.1 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 115.134 -0.533 . . . . 0.0 111.33 -172.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.4 t -123.25 118.1 26.81 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 124.717 1.261 . . . . 0.0 111.878 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.481 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -111.67 111.36 22.29 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 114.05 -1.432 . . . . 0.0 114.172 -174.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.8 t -61.88 124.37 20.59 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 113.445 -1.707 . . . . 0.0 112.66 169.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . . . -83.31 7.06 17.64 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.032 -1.44 . . . . 0.0 113.843 171.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -94.92 -10.84 29.92 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 160.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 39.0 t -109.72 114.97 29.0 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.177 0.991 . . . . 0.0 110.234 171.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 tp -49.88 -53.57 25.03 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.287 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -64.45 -38.32 90.63 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 15.1 mttm -60.68 -49.63 76.73 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.11 -39.16 91.58 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 173.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.427 ' NE2' ' HB2' ' A' ' 20' ' ' ALA . 90.0 mt-30 -67.67 -32.91 73.91 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 -177.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 t -116.31 67.85 0.72 Allowed 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 124.039 1.876 . . . . 0.0 113.089 170.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.481 HD13 ' HB2' ' A' ' 42' ' ' ALA . 41.6 tp -116.17 -50.91 2.65 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 111.717 -2.492 . . . . 0.0 113.79 174.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.96 78.6 1.19 Allowed Glycine 0 N--CA 1.477 1.369 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -170.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 36.3 mt -107.33 80.87 1.46 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.286 -0.957 . . . . 0.0 110.737 -173.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.6 t -142.58 175.5 9.75 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.844 -1.526 . . . . 0.0 114.208 -165.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -50.6 127.2 17.34 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.615 1.966 . . . . 0.0 111.442 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.07 -29.45 10.67 Favored Glycine 0 N--CA 1.482 1.737 0 CA-C-N 112.853 -1.976 . . . . 0.0 113.058 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.8 p -66.98 113.15 4.76 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.583 HG22 HG22 ' A' ' 7' ' ' THR . 4.4 t -86.04 105.42 14.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 112.739 -2.028 . . . . 0.0 105.797 171.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.431 HG12 ' HB2' ' A' ' 37' ' ' SER . 18.4 m -99.55 105.76 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 113.761 -1.563 . . . . 0.0 112.342 -174.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.92 95.71 1.6 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.233 -1.803 . . . . 0.0 109.952 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.45 HG12 HG22 ' A' ' 35' ' ' VAL . 79.6 mt -82.18 97.14 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.649 174.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.7 m -110.03 121.54 45.5 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 112.679 -2.055 . . . . 0.0 109.926 -175.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.96 138.41 45.45 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -133.76 141.73 47.63 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.166 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.78 -150.49 19.04 Favored Glycine 0 CA--C 1.538 1.527 0 O-C-N 124.9 1.375 . . . . 0.0 110.62 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.09 -60.62 3.49 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -91.64 39.26 1.0 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -52.31 -55.76 19.31 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -45.45 77.53 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.43 1.092 . . . . 0.0 113.06 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -59.59 -50.26 74.56 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.819 1.248 . . . . 0.0 112.049 -176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.19 -54.06 51.08 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.294 1.038 . . . . 0.0 112.728 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.6 t -62.41 -48.49 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-O 118.06 -0.971 . . . . 0.0 111.045 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -54.23 -53.5 52.72 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.299 1.04 . . . . 0.0 111.718 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -56.33 -52.29 65.09 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.341 1.057 . . . . 0.0 112.449 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.9 mt -66.44 -34.5 78.09 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.95 -51.42 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-O 118.849 -0.596 . . . . 0.0 109.971 170.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -58.34 -42.91 87.89 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.472 HD22 ' HD1' ' A' ' 22' ' ' PHE . 5.2 tt -55.04 -56.87 14.98 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.245 1.018 . . . . 0.0 111.639 174.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -57.75 -39.28 76.99 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.842 0.857 . . . . 0.0 112.774 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.83 -29.55 69.51 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -86.51 -25.05 25.3 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.3 tp . . . . . 0 CA--C 1.549 0.905 0 C-N-CA 124.087 0.955 . . . . 0.0 110.691 173.746 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 ttt . . . . . 0 C--O 1.233 0.203 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -121.74 111.58 17.34 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.941 0.776 . . . . 0.0 111.056 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -108.8 116.36 31.83 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 112.603 -2.09 . . . . 0.0 110.45 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.406 ' HB2' HG11 ' A' ' 74' ' ' VAL . 9.4 tt0 -119.62 118.13 30.17 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.251 172.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -89.7 111.66 22.7 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 112.745 -2.025 . . . . 0.0 107.427 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.435 HG11 HG13 ' A' ' 78' ' ' VAL . 20.2 m -127.75 162.09 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.713 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.544 HG22 HG22 ' A' ' 60' ' ' VAL . 44.1 p -113.4 137.65 51.22 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.083 171.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 mt -95.92 111.47 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.426 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 1.7 p -103.74 -18.73 14.57 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.98 141.93 74.95 Favored Pre-proline 0 C--O 1.256 1.438 0 CA-C-O 116.989 -1.482 . . . . 0.0 114.173 177.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.93 -56.83 2.7 Favored 'Trans proline' 0 N--CA 1.493 1.475 1 C-N-CA 125.973 4.449 . . . . 0.0 116.256 -169.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -102.67 -20.27 14.47 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.4 -118.26 11.55 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.236 1.874 . . . . 0.0 113.19 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.7 mt . . . . . 0 N--CA 1.474 0.743 0 CA-C-N 112.096 -2.052 . . . . 0.0 114.415 -176.129 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.0 p . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -75.26 -43.35 4.4 Favored Pre-proline 0 N--CA 1.486 1.348 0 CA-C-O 115.932 -1.985 . . . . 0.0 114.68 -172.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -61.81 -26.48 79.49 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 121.974 1.782 . . . . 0.0 112.091 166.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -75.05 -35.38 61.9 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.148 0.579 . . . . 0.0 112.476 175.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . . . -57.96 -38.03 75.27 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.746 1.219 . . . . 0.0 112.482 168.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -65.14 -43.46 91.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.621 0.768 . . . . 0.0 111.971 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -64.05 -39.25 93.67 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.465 1.106 . . . . 0.0 111.558 175.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 19' ' ' ALA . 91.4 t -58.53 -49.26 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 125.005 1.322 . . . . 0.0 111.877 173.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -56.21 -42.95 78.04 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.04 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -68.71 -42.26 77.94 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.188 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.12 -27.49 68.08 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -68.93 -11.48 60.69 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 172.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.51 -33.18 7.27 Favored Glycine 0 N--CA 1.481 1.674 0 C-N-CA 124.774 1.178 . . . . 0.0 112.957 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -72.6 128.45 35.6 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.081 1.352 . . . . 0.0 111.765 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.5 p -54.3 -36.92 64.23 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.457 -1.247 . . . . 0.0 113.659 172.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.3 p -61.69 146.24 49.79 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.371 1.044 . . . . 0.0 111.598 167.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -102.15 98.09 8.3 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 113.663 -1.608 . . . . 0.0 108.991 169.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.489 HD11 ' HB1' ' A' ' 73' ' ' ALA . 36.3 mm -62.22 113.11 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 112.501 -2.136 . . . . 0.0 110.232 177.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.1 p -97.62 134.94 40.14 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.048 165.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.2 t -111.37 94.84 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 111.49 -2.595 . . . . 0.0 108.61 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.541 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 25.9 m -88.52 101.67 14.17 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 111.413 -2.63 . . . . 0.0 112.029 -178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 t -117.85 112.77 20.82 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.841 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.25 20.4 p30 44.73 61.36 2.49 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 126.046 1.738 . . . . 0.0 115.662 -173.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.68 19.87 63.29 Favored Glycine 0 CA--C 1.546 1.974 0 N-CA-C 116.896 1.519 . . . . 0.0 116.896 -176.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.9 mttt -118.75 107.85 14.15 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.743 0.771 . . . . 0.0 109.773 171.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.2 m -90.23 105.71 17.99 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 122.809 1.29 . . . . 0.0 111.606 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.88 105.3 14.43 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.675 -2.057 . . . . 0.0 111.525 -176.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.5 t -50.54 111.35 0.52 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 114.221 -1.354 . . . . 0.0 114.213 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.33 -18.42 65.3 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.283 -1.78 . . . . 0.0 113.666 169.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -77.94 -10.64 59.68 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.2 t -111.81 118.11 34.66 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.48 1.133 . . . . 0.0 112.057 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -46.2 -53.52 10.39 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 111.016 -2.811 . . . . 0.0 113.672 -172.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -69.29 -39.95 78.01 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -64.13 -52.06 60.95 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -167.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.68 -46.43 82.47 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.435 1.094 . . . . 0.0 113.105 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.453 ' NE2' ' HB2' ' A' ' 20' ' ' ALA . 67.0 mt-30 -63.92 -33.87 76.67 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.261 11.1 t -74.23 -48.41 29.01 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.474 HD23 HD21 ' A' ' 55' ' ' LEU . 27.3 tp -37.38 -53.19 1.12 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -167.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.13 67.19 0.52 Allowed Glycine 0 N--CA 1.484 1.839 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.474 HD21 HD23 ' A' ' 53' ' ' LEU . 24.9 mt -81.26 94.77 6.78 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 122.297 1.046 . . . . 0.0 111.4 174.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -150.41 -172.13 4.1 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.301 -2.227 . . . . 0.0 111.213 -168.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 9' ' ' THR . 52.6 tt0 -52.21 125.91 17.24 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.812 2.045 . . . . 0.0 114.617 -176.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.28 22.34 63.07 Favored Glycine 0 N--CA 1.484 1.888 0 CA-C-N 111.704 -2.498 . . . . 0.0 114.595 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.3 p -103.39 104.48 14.59 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 122.536 1.16 . . . . 0.0 112.5 -172.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.544 HG22 HG22 ' A' ' 7' ' ' THR . 4.6 t -69.69 113.57 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 111.156 -2.747 . . . . 0.0 108.725 176.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.71 117.24 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 112.892 -1.958 . . . . 0.0 110.812 -175.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.541 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 4.3 m -87.06 100.31 12.55 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.613 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.488 HG22 HG22 ' A' ' 74' ' ' VAL . 95.2 mt -89.1 101.4 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 113.655 -1.611 . . . . 0.0 108.674 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.4 m -116.46 127.17 54.35 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 109.76 -3.382 . . . . 0.0 111.086 -167.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.23 123.99 40.74 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.475 -176.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -119.13 108.05 14.22 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.931 1.394 . . . . 0.0 108.379 174.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.44 178.21 30.35 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.58 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -51.77 -41.84 61.93 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -176.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 p30 -102.47 39.8 1.46 Allowed 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -176.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -55.04 -40.06 69.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.01 -46.06 10.17 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.723 -176.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -52.39 -46.41 66.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.043 1.737 . . . . 0.0 114.82 171.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.489 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -65.19 -53.46 44.4 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -176.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 63' ' ' ILE . 68.8 t -60.78 -44.47 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.31 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -56.33 -51.44 68.25 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.421 1.089 . . . . 0.0 111.893 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -54.0 -51.58 63.49 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.778 0.831 . . . . 0.0 112.515 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 98.0 mt -65.62 -47.94 73.92 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.435 HG13 HG11 ' A' ' 6' ' ' VAL . 90.0 t -58.56 -38.28 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 118.945 0.793 . . . . 0.0 110.756 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -60.67 -62.98 1.47 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.68 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.8 tp -47.09 -44.17 20.95 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.942 2.097 . . . . 0.0 114.287 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.6 tmm? -53.59 -61.76 2.1 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.684 1.593 . . . . 0.0 112.427 172.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.43 -26.31 66.35 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -68.05 -29.74 68.78 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 172.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 CA--C 1.545 0.788 0 C-N-CA 122.917 0.487 . . . . 0.0 111.891 171.193 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ttt . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -81.85 133.59 35.34 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.479 167.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -137.17 133.87 35.7 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 112.581 -2.1 . . . . 0.0 110.003 -173.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -126.19 111.29 14.43 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.147 172.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.611 ' HG2' HG23 ' A' ' 62' ' ' THR . 34.3 mt-10 -79.3 80.81 5.63 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.913 1.34 . . . . 0.0 109.72 167.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.452 HG21 HG22 ' A' ' 78' ' ' VAL . 3.3 m -107.61 135.49 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 114.158 -1.383 . . . . 0.0 113.899 -175.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 p -76.34 140.56 41.49 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 112.444 -2.162 . . . . 0.0 113.471 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.9 mt -105.54 118.12 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.684 167.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.9 p -112.84 -12.39 13.32 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.32 132.66 95.19 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-O 118.024 -0.988 . . . . 0.0 111.712 173.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -42.88 -54.67 3.19 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 124.725 3.617 . . . . 0.0 116.602 -170.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -97.78 -41.9 7.85 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 174.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.06 -120.66 7.32 Favored Glycine 0 CA--C 1.541 1.681 0 C-N-CA 124.059 0.838 . . . . 0.0 112.36 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 31.4 mt . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -171.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.425 ' HB2' ' HD3' ' A' ' 18' ' ' PRO 0.283 21.0 mmt180 -76.37 -49.42 3.01 Favored Pre-proline 0 N--CA 1.487 1.41 0 CA-C-O 116.442 -1.742 . . . . 0.0 115.242 -174.241 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.536 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 77.3 Cg_exo -64.5 -31.45 60.9 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 121.698 1.642 . . . . 0.0 113.627 167.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.22 -38.93 77.75 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 169.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.469 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . . . -59.82 -39.97 86.86 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 171.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -61.92 -44.7 96.25 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.628 0.771 . . . . 0.0 112.262 173.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -55.27 -43.69 74.93 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.929 1.292 . . . . 0.0 111.588 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.97 -51.03 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 123.661 0.784 . . . . 0.0 111.895 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -48.56 -47.62 39.29 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.673 0.789 . . . . 0.0 110.995 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.62 -50.89 47.93 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.743 1.277 . . . . 0.0 113.276 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.428 ' HA ' ' HD2' ' A' ' 29' ' ' PHE . . . -54.1 -36.63 63.41 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -60.63 -27.38 67.73 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 173.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.79 -23.17 76.99 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.292 1.425 . . . . 0.0 114.159 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.428 ' HD2' ' HA ' ' A' ' 26' ' ' ALA . 73.6 m-85 -89.98 149.26 22.64 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.952 0.901 . . . . 0.0 110.69 177.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.1 p -71.5 -39.42 70.83 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.39 0.676 . . . . 0.0 112.073 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.5 p -65.71 137.97 57.65 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.681 1.192 . . . . 0.0 114.163 175.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -85.28 104.21 14.92 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.605 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.524 HG23 HG23 ' A' ' 63' ' ' ILE . 47.7 mm -72.93 94.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 111.94 -2.391 . . . . 0.0 110.289 173.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.4 p -89.48 113.86 25.29 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.275 -1.329 . . . . 0.0 108.993 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -100.57 96.52 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 113.183 -1.826 . . . . 0.0 107.563 -177.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 40.8 m -87.92 116.65 26.23 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 112.962 -1.927 . . . . 0.0 111.473 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -111.12 105.85 14.7 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.733 173.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 p30 40.21 69.29 0.32 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.591 1.556 . . . . 0.0 114.204 -173.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.33 -39.71 3.0 Favored Glycine 0 N--CA 1.485 1.918 0 CA-C-N 113.197 -1.819 . . . . 0.0 114.15 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -72.74 99.05 2.51 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.353 1.061 . . . . 0.0 112.438 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.3 m -83.94 108.42 16.91 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.541 -1.663 . . . . 0.0 113.398 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.57 115.13 28.66 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.182 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.9 t -67.08 125.77 27.06 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 113.916 -1.493 . . . . 0.0 113.219 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.84 -5.24 47.51 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 112.402 -2.181 . . . . 0.0 113.422 171.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -83.65 8.2 15.11 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 167.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 t -144.41 131.04 20.02 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.933 0.493 . . . . 0.0 112.129 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.07 -68.31 0.22 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 113.733 -1.576 . . . . 0.0 113.552 -171.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -54.64 -39.38 67.93 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -57.1 -55.0 40.38 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 124.165 0.916 . . . . 0.0 112.935 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 tp -68.0 -48.57 65.37 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.895 1.372 . . . . 0.0 113.616 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.469 ' NE2' ' HB2' ' A' ' 20' ' ' ALA . 57.2 mt-30 -61.41 -34.44 75.37 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 -172.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.2 t -72.17 -20.03 61.66 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.1 tp -70.11 -37.53 75.38 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.51 73.83 1.28 Allowed Glycine 0 N--CA 1.484 1.847 0 O-C-N 124.439 1.087 . . . . 0.0 113.074 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.1 mt -84.81 92.93 8.37 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.387 0.613 . . . . 0.0 110.273 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.9 t -141.5 -175.0 4.2 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -169.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -56.5 112.93 1.4 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.106 0.963 . . . . 0.0 111.146 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.54 -30.8 6.25 Favored Glycine 0 CA--C 1.542 1.72 0 CA-C-N 113.611 -1.631 . . . . 0.0 114.496 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.6 p -70.11 103.58 2.35 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.4 t -68.11 117.78 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 163.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.8 m -118.17 109.59 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 113.654 -1.612 . . . . 0.0 113.004 -175.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.611 HG23 ' HG2' ' A' ' 5' ' ' GLU . 0.6 OUTLIER -75.71 86.87 2.75 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.052 176.355 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.524 HG23 HG23 ' A' ' 33' ' ' ILE . 34.2 mt -78.8 95.28 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.7 m -105.42 128.14 53.37 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 112.948 -1.933 . . . . 0.0 110.693 -174.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.49 116.13 28.34 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -105.97 97.42 7.24 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.74 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.09 -175.05 28.5 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-N 114.536 -1.211 . . . . 0.0 113.361 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -55.88 -54.46 44.34 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 -169.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -83.52 28.88 0.53 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 6.4 pt-20 -38.78 -60.64 0.81 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.464 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -56.89 -50.58 72.07 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 178.732 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -67.09 -40.09 86.89 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -175.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.406 ' CB ' HD11 ' A' ' 33' ' ' ILE . . . -59.34 -52.43 65.65 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 123.767 0.667 . . . . 0.0 112.678 176.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.414 HG22 HG22 ' A' ' 63' ' ' ILE . 47.0 t -63.5 -49.58 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.647 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -49.93 -57.44 7.49 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.573 1.549 . . . . 0.0 112.011 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -59.46 -50.79 72.56 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.898 0.879 . . . . 0.0 113.102 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.4 mt -63.22 -36.05 82.36 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.452 HG22 HG21 ' A' ' 6' ' ' VAL . 90.3 t -62.02 -48.64 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 123.808 0.693 . . . . 0.0 110.566 171.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -54.25 -55.5 27.51 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 118.234 -0.888 . . . . 0.0 113.062 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.8 tp -52.66 -48.97 66.13 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.047 0.939 . . . . 0.0 112.832 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -57.36 -45.53 84.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.402 1.081 . . . . 0.0 112.642 175.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.54 -25.22 60.3 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -74.55 -41.09 61.17 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.15 1.166 . . . . 0.0 114.15 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.7 mt . . . . . 0 N--CA 1.483 1.192 0 C-N-CA 124.343 1.057 . . . . 0.0 113.342 177.247 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.465 0.28 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -119.83 139.94 51.58 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 125.066 1.479 . . . . 0.0 110.01 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -134.03 129.75 36.55 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 124.59 1.181 . . . . 0.0 111.729 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -128.47 136.64 51.1 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.374 1.046 . . . . 0.0 112.454 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -98.89 110.24 22.87 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.187 -1.37 . . . . 0.0 110.449 173.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.679 HG11 HG13 ' A' ' 78' ' ' VAL . 8.5 m -119.79 152.8 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 114.468 -1.242 . . . . 0.0 114.242 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.565 HG22 HG22 ' A' ' 60' ' ' VAL . 20.6 p -111.98 121.94 46.39 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 113.531 -1.668 . . . . 0.0 111.447 -173.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.1 mt -79.69 96.47 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.17 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -74.67 -34.7 62.74 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -55.15 134.42 68.52 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 125.486 1.514 . . . . 0.0 113.67 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 48.8 Cg_exo -45.71 -43.91 18.28 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.539 3.493 . . . . 0.0 117.493 -173.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -114.5 -40.8 3.54 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 172.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.17 -114.47 3.91 Favored Glycine 0 N--CA 1.475 1.279 0 C-N-CA 123.986 0.803 . . . . 0.0 111.769 168.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.559 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 34.1 mt . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 114.185 1.179 . . . . 0.0 114.185 -167.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.8 p . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.508 ' HB2' ' HD3' ' A' ' 18' ' ' PRO 0.266 20.2 mmt180 -71.8 -54.08 6.56 Favored Pre-proline 0 N--CA 1.487 1.418 0 CA-C-O 116.579 -1.677 . . . . 0.0 115.168 -174.798 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.559 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 71.5 Cg_exo -62.93 -34.26 71.98 Favored 'Trans proline' 0 N--CA 1.479 0.632 0 CA-C-N 121.899 1.714 . . . . 0.0 113.653 171.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -53.73 -36.91 62.8 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 172.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.71 -40.38 83.51 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 174.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.32 -45.42 91.4 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -55.48 -45.73 76.94 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.795 1.238 . . . . 0.0 110.934 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 19' ' ' ALA . 22.0 t -62.47 -50.22 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 123.403 0.681 . . . . 0.0 111.228 175.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -50.03 -47.08 53.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.289 1.036 . . . . 0.0 112.275 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.09 -49.15 65.96 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 124.269 0.98 . . . . 0.0 113.387 174.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.5 -39.61 76.85 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -47.7 -44.26 27.39 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.71 1.604 . . . . 0.0 113.898 167.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.17 -34.22 69.72 Favored Glycine 0 N--CA 1.475 1.261 0 O-C-N 125.435 1.709 . . . . 0.0 114.355 -176.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -65.69 145.87 55.5 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.306 0.643 . . . . 0.0 111.702 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 57.9 p -64.12 -35.19 79.94 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.216 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.0 p -68.71 144.97 54.24 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.294 -1.321 . . . . 0.0 114.497 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -92.56 118.21 30.77 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.938 169.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.701 HD11 ' HB1' ' A' ' 73' ' ' ALA . 43.1 mm -86.17 103.25 12.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 111.706 -2.497 . . . . 0.0 110.195 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.4 p -103.47 118.91 37.84 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.378 175.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 63' ' ' ILE . 92.6 t -99.24 95.95 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 112.961 -1.927 . . . . 0.0 107.504 -178.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.5 m -91.34 110.29 21.58 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 113.657 -1.61 . . . . 0.0 110.79 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.8 t -108.16 95.27 5.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 113.544 -1.662 . . . . 0.0 109.634 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.3 p30 43.63 72.43 0.19 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.365 1.466 . . . . 0.0 114.349 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.62 -38.93 2.92 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-N 113.028 -1.896 . . . . 0.0 114.496 -175.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -75.45 88.91 2.65 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -175.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.5 m -74.13 113.62 11.54 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.381 -1.282 . . . . 0.0 112.982 170.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.12 122.77 47.99 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.088 170.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.9 t -86.84 128.26 35.04 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.331 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.46 16.28 6.7 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 113.117 -1.856 . . . . 0.0 114.092 176.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -92.58 2.84 56.48 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.663 0.744 . . . . 0.0 112.663 158.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.1 t -127.84 125.93 40.67 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.847 1.659 . . . . 0.0 110.799 172.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.65 -54.04 50.66 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.813 171.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -57.69 -48.93 78.16 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.152 -1.385 . . . . 0.0 113.862 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -60.98 -46.57 90.2 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 tp -68.17 -47.88 66.81 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 123.821 0.7 . . . . 0.0 112.002 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -57.1 -42.26 80.47 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -71.78 -14.51 62.01 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.4 tp -75.37 -42.35 54.2 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.56 82.51 0.7 Allowed Glycine 0 N--CA 1.478 1.481 0 O-C-N 124.394 1.059 . . . . 0.0 112.527 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 85.8 mt -82.85 78.32 9.46 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 122.877 1.322 . . . . 0.0 112.298 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.0 t -85.36 -174.27 5.12 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 111.914 -2.403 . . . . 0.0 112.569 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -60.23 144.23 50.72 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.979 1.712 . . . . 0.0 111.114 175.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.57 -38.07 3.27 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 114.251 -1.34 . . . . 0.0 114.642 171.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.4 p -54.96 104.62 0.12 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.184 1.549 . . . . 0.0 115.184 -174.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 7' ' ' THR . 16.7 t -66.74 112.46 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 112.152 -2.295 . . . . 0.0 107.177 169.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.5 m -119.32 118.08 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 113.35 -1.75 . . . . 0.0 114.641 -172.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.3 m -80.23 100.45 8.33 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 125.447 1.717 . . . . 0.0 109.084 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.448 HG12 HG22 ' A' ' 35' ' ' VAL . 80.2 mt -91.76 102.44 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.586 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 m -100.12 131.66 45.94 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.141 -178.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.12 105.86 13.97 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 124.035 0.835 . . . . 0.0 112.353 172.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -104.06 92.46 4.39 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.233 -1.348 . . . . 0.0 111.266 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.3 -167.55 39.94 Favored Glycine 0 N--CA 1.48 1.623 0 CA-C-N 112.252 -2.249 . . . . 0.0 111.148 174.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.01 -51.5 66.57 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -82.38 36.49 0.48 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.612 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 5.9 pt-20 -45.83 -72.53 0.05 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 -173.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.612 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -50.05 -47.99 53.1 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -179.888 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -63.05 -47.25 83.75 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.577 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.701 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -56.32 -46.08 80.03 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.23 0.957 . . . . 0.0 113.538 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.0 t -67.35 -56.06 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.225 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -51.02 -47.16 61.7 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.477 1.111 . . . . 0.0 112.687 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -53.15 -61.41 2.31 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.032 1.333 . . . . 0.0 112.067 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.9 mt -64.27 -33.23 75.35 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.679 HG13 HG11 ' A' ' 6' ' ' VAL . 11.7 t -62.05 -56.31 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.103 0.961 . . . . 0.0 110.527 171.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -57.55 -48.26 79.82 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.449 1.099 . . . . 0.0 111.25 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.2 tp -54.57 -52.01 63.47 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.448 1.499 . . . . 0.0 111.954 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -57.86 -44.91 86.88 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.226 1.011 . . . . 0.0 112.033 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.54 -33.62 75.43 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -75.85 -30.39 58.9 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.484 1.245 0 C-N-CA 123.927 0.891 . . . . 0.0 112.629 175.676 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.402 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 4.7 t80 -108.39 129.18 55.26 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 125.72 1.888 . . . . 0.0 108.001 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -126.98 131.23 51.09 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.621 -170.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -129.32 122.87 30.44 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.432 1.082 . . . . 0.0 113.025 168.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -87.03 100.6 12.74 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 112.442 -2.163 . . . . 0.0 107.945 176.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.5 m -116.97 143.52 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 114.22 -1.355 . . . . 0.0 114.173 -173.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.544 HG22 HG22 ' A' ' 60' ' ' VAL . 14.0 p -94.03 122.14 36.23 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.408 1.099 . . . . 0.0 111.495 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.2 mt -78.9 97.92 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.6 167.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.7 p -82.81 -26.66 31.52 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 109.962 -3.29 . . . . 0.0 113.526 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.463 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -51.12 120.63 14.44 Favored Pre-proline 0 N--CA 1.476 0.847 0 O-C-N 124.715 1.259 . . . . 0.0 112.277 177.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 80.8 Cg_exo -57.38 -48.71 16.33 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 123.785 2.99 . . . . 0.0 113.77 -175.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -68.94 -43.46 75.02 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.545 0.338 . . . . 0.0 111.688 170.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 56' ' ' THR . . . 101.88 -148.01 17.62 Favored Glycine 0 N--CA 1.475 1.279 0 O-C-N 124.75 1.281 . . . . 0.0 110.984 174.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.433 HD12 HD13 ' A' ' 55' ' ' LEU . 83.7 mt . . . . . 0 CA--C 1.545 0.777 0 CA-C-N 113.639 -1.28 . . . . 0.0 112.407 173.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.512 ' HA ' ' HG2' ' A' ' 51' ' ' GLN . 59.6 p . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.7 -44.23 53.03 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-O 116.874 -1.536 . . . . 0.0 114.903 -175.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -69.17 -33.74 18.12 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.734 1.623 . . . . 0.0 113.391 172.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.49 97.45 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.47 0.708 . . . . 0.0 112.487 171.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.89 -46.2 90.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.235 0.614 . . . . 0.0 112.577 169.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -58.81 -43.7 90.64 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 171.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.16 -43.12 87.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.136 0.974 . . . . 0.0 112.895 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.462 HG11 HD22 ' A' ' 47' ' ' LEU . 59.5 t -61.51 -48.91 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 122.478 0.311 . . . . 0.0 110.95 172.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -52.98 -45.44 67.81 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.498 0.719 . . . . 0.0 112.839 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -64.49 -49.4 71.5 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.568 1.147 . . . . 0.0 112.881 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.88 -29.2 67.45 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -51.91 -26.44 10.26 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 168.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.95 -22.83 77.21 Favored Glycine 0 CA--C 1.543 1.826 0 O-C-N 125.109 1.505 . . . . 0.0 115.704 175.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -96.98 143.4 27.88 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.88 0.847 . . . . 0.0 112.406 -178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.8 p -66.35 -37.15 84.67 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.075 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.9 p -63.84 138.6 58.55 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.748 170.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -95.22 96.67 9.34 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 123.412 1.577 . . . . 0.0 108.95 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mt -77.07 128.81 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 111.612 -2.54 . . . . 0.0 110.542 -172.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.4 p -102.32 134.92 44.83 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.349 173.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.8 t -102.29 90.25 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 170.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.1 m -89.41 112.85 24.08 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.14 -1.391 . . . . 0.0 113.723 -170.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 40' ' ' LYS . 32.4 t -116.27 97.36 6.0 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 124.377 1.048 . . . . 0.0 111.156 173.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 p30 39.59 83.02 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.816 1.646 . . . . 0.0 115.183 -175.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.03 -41.3 1.97 Allowed Glycine 0 CA--C 1.55 2.258 0 CA-C-N 114.266 -1.333 . . . . 0.0 113.71 -173.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 37' ' ' SER . 33.2 mtmt -71.85 79.75 0.88 Allowed 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.4 m -72.02 111.78 7.55 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.029 -1.441 . . . . 0.0 112.937 168.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.09 99.02 9.98 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 113.835 -1.529 . . . . 0.0 112.638 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 t -55.45 119.2 5.26 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.57 1.176 . . . . 0.0 113.186 174.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.17 9.57 1.96 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 112.847 -1.979 . . . . 0.0 114.006 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -104.65 19.99 19.43 Favored 'General case' 0 C--O 1.25 1.082 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 164.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.8 t -140.78 125.42 17.93 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.161 1.384 . . . . 0.0 112.749 174.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.462 HD22 HG11 ' A' ' 23' ' ' VAL . 3.6 mm? -55.73 -44.27 77.38 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 113.58 -1.645 . . . . 0.0 114.209 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -64.39 -39.16 93.32 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.16 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -55.4 -56.41 20.44 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.9 mp -67.91 -31.22 70.85 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -176.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.512 ' HG2' ' HA ' ' A' ' 16' ' ' THR . 36.3 mt-30 -78.64 -34.28 46.62 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.023 -0.99 . . . . 0.0 113.371 176.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.7 t -79.09 -32.51 44.68 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.591 HD23 HD21 ' A' ' 55' ' ' LEU . 17.3 tp -51.97 -49.79 62.54 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.366 1.246 . . . . 0.0 114.366 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.76 89.04 1.78 Allowed Glycine 0 N--CA 1.476 1.352 0 O-C-N 125.352 1.657 . . . . 0.0 110.817 -175.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.591 HD21 HD23 ' A' ' 53' ' ' LEU . 92.0 mt -109.05 99.41 8.73 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.813 -0.694 . . . . 0.0 112.315 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.412 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 12.3 t -150.98 170.57 19.02 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.627 1.571 . . . . 0.0 110.589 -174.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 59.8 tt0 -50.13 118.39 2.92 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.598 1.159 . . . . 0.0 112.987 -172.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.81 -29.4 7.5 Favored Glycine 0 CA--C 1.543 1.781 0 CA-C-N 112.585 -2.098 . . . . 0.0 113.696 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.4 p -62.33 100.91 0.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.544 HG22 HG22 ' A' ' 7' ' ' THR . 3.2 t -78.76 115.9 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 113.356 -1.747 . . . . 0.0 106.811 171.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 m -127.95 129.5 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 113.58 -1.646 . . . . 0.0 112.982 -174.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.4 m -89.05 96.95 10.94 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.421 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.456 HG22 HG22 ' A' ' 74' ' ' VAL . 89.2 mt -67.25 96.83 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 113.476 -1.693 . . . . 0.0 107.404 167.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.6 m -111.27 103.42 11.82 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 112.968 -1.924 . . . . 0.0 111.669 -175.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.28 100.19 12.1 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.624 0.726 . . . . 0.0 112.034 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -99.5 96.36 7.63 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 112.916 -1.947 . . . . 0.0 111.588 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.88 -162.07 28.83 Favored Glycine 0 N--CA 1.48 1.63 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.606 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -60.63 -28.47 68.57 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 120.452 3.501 . . . . 0.0 120.452 -168.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.2 p30 -116.72 50.56 1.06 Allowed 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 2' ' ' PHE . 11.4 pt-20 -49.16 -55.43 12.41 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -174.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -53.29 59.96 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.918 1.287 . . . . 0.0 114.312 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -55.45 -47.45 76.02 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.021 1.328 . . . . 0.0 113.958 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.96 -53.43 57.35 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.571 -1.195 . . . . 0.0 113.372 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.456 HG22 HG22 ' A' ' 63' ' ' ILE . 51.1 t -60.83 -50.63 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 118.936 -0.554 . . . . 0.0 112.128 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -52.78 -57.24 10.81 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.458 1.103 . . . . 0.0 112.841 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -54.55 -50.11 68.72 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.46 1.104 . . . . 0.0 113.075 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 72.1 mt -67.57 -38.03 83.51 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.33 -45.35 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.059 0.543 . . . . 0.0 110.559 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -58.14 -49.05 78.32 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 118.313 -0.851 . . . . 0.0 113.153 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.8 tp -54.19 -51.76 63.38 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.891 0.876 . . . . 0.0 112.586 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -59.64 -44.92 93.32 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.98 0.912 . . . . 0.0 112.884 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.06 91.07 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -79.47 -19.76 49.01 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 172.089 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ttt . . . . . 0 C--O 1.236 0.385 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -117.57 115.33 24.89 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 125.1 1.5 . . . . 0.0 109.123 175.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -102.65 129.92 49.4 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.361 -178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -123.37 103.58 8.58 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 171.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -73.78 95.34 2.38 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.294 -1.776 . . . . 0.0 110.675 172.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.424 HG11 HG13 ' A' ' 78' ' ' VAL . 17.2 m -117.16 146.22 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 113.388 -1.733 . . . . 0.0 113.862 -174.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.448 HG22 HG22 ' A' ' 60' ' ' VAL . 48.0 p -108.56 128.52 54.89 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.714 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.493 HG13 ' SD ' ' A' ' 81' ' ' MET . 1.9 mp -75.81 130.32 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.765 173.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 p -88.18 -37.32 16.24 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.323 171.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -59.61 133.38 88.88 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 125.399 1.48 . . . . 0.0 113.704 -175.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 32.3 Cg_exo -61.52 -68.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 124.166 3.244 . . . . 0.0 112.431 -172.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -62.06 -34.59 76.55 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.906 0.882 . . . . 0.0 112.222 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.37 -126.27 7.78 Favored Glycine 0 N--CA 1.481 1.647 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 168.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . 7.6 mp . . . . . 0 N--CA 1.475 0.82 0 CA-C-N 113.527 -1.337 . . . . 0.0 113.682 176.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.315 12.9 mmt180 -88.04 -39.69 0.48 Allowed Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 -173.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -61.74 -38.76 58.03 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 121.983 1.789 . . . . 0.0 111.384 163.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.23 73.58 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 168.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.26 86.88 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -60.2 -46.32 90.13 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 124.181 0.926 . . . . 0.0 112.513 174.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -55.57 -53.64 53.87 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.499 1.12 . . . . 0.0 110.766 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.695 HG11 ' HA ' ' A' ' 47' ' ' LEU . 30.2 t -57.91 -49.75 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.645 0.778 . . . . 0.0 111.313 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -49.74 -52.51 31.07 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.335 1.054 . . . . 0.0 112.992 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -68.97 -43.24 75.36 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.689 1.243 . . . . 0.0 112.772 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.557 ' HA ' ' HD2' ' A' ' 29' ' ' PHE . . . -58.68 -37.8 76.82 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 173.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -53.46 -39.64 64.63 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.0 0.92 . . . . 0.0 112.816 169.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.3 15.0 4.64 Favored Glycine 0 CA--C 1.543 1.792 0 O-C-N 124.747 1.28 . . . . 0.0 115.413 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.557 ' HD2' ' HA ' ' A' ' 26' ' ' ALA . 65.9 m-85 -113.36 152.03 30.49 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.977 0.894 . . . . 0.0 111.992 172.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.4 p -69.94 -40.3 75.56 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.15 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -73.66 145.32 45.39 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.796 0.839 . . . . 0.0 112.882 173.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -96.4 109.78 22.25 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.645 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.687 HG13 ' HB2' ' A' ' 65' ' ' ALA . 5.0 mp -83.22 106.89 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 112.182 -2.281 . . . . 0.0 109.45 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.0 p -102.39 128.5 48.95 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 112.959 -1.928 . . . . 0.0 110.214 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.418 HG11 HD21 ' A' ' 55' ' ' LEU . 59.8 t -107.06 105.0 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 113.288 -1.778 . . . . 0.0 107.569 -176.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.0 m -106.83 126.2 52.0 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.3 t -116.25 97.32 5.98 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 112.99 -1.914 . . . . 0.0 110.02 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.257 4.0 p30 40.63 73.47 0.12 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 113.518 -1.674 . . . . 0.0 114.706 -175.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.09 -53.22 4.19 Favored Glycine 0 N--CA 1.488 2.111 0 CA-C-N 113.705 -1.589 . . . . 0.0 113.513 -178.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -60.72 104.56 0.36 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.38 1.472 . . . . 0.0 113.525 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 t -90.93 136.03 33.34 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.644 1.349 . . . . 0.0 114.644 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.28 97.43 5.06 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 113.879 -1.51 . . . . 0.0 113.081 173.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -54.6 130.21 39.28 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.985 168.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.81 13.81 21.29 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.109 -1.405 . . . . 0.0 114.337 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.63 -8.88 27.92 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.074 153.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -113.09 111.61 22.43 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 123.464 1.602 . . . . 0.0 112.54 169.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.695 ' HA ' HG11 ' A' ' 23' ' ' VAL . 1.4 tm? -54.43 -59.51 4.59 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 111.556 -2.565 . . . . 0.0 114.278 -169.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -65.47 -28.56 69.3 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -54.7 -48.12 72.86 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.4 tp -61.32 -43.26 99.17 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 176.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -58.17 -46.89 84.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 124.051 0.844 . . . . 0.0 112.64 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.2 t -66.72 -37.15 84.1 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.5 tp -66.6 -41.77 87.92 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.41 83.97 0.34 Allowed Glycine 0 N--CA 1.476 1.358 0 C-N-CA 124.348 0.975 . . . . 0.0 115.053 170.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 7.1 mp -75.03 109.47 8.53 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.336 -0.932 . . . . 0.0 109.598 174.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -135.59 -174.7 3.72 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.928 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -52.2 109.15 0.35 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.549 1.94 . . . . 0.0 112.729 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.82 35.2 51.29 Favored Glycine 0 CA--C 1.543 1.837 0 CA-C-N 114.627 -1.17 . . . . 0.0 115.545 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.2 p -83.35 118.28 23.58 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 117.313 0.556 . . . . 0.0 110.18 168.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.448 HG22 HG22 ' A' ' 7' ' ' THR . 5.0 t -90.96 80.5 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 125.758 1.911 . . . . 0.0 106.413 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.1 m -100.15 133.15 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 112.154 -2.294 . . . . 0.0 112.501 -172.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.8 p -92.99 95.95 9.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.314 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.412 HG22 HG22 ' A' ' 74' ' ' VAL . 88.4 mt -74.32 94.18 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.428 173.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.6 m -113.94 110.48 20.14 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 112.828 -1.987 . . . . 0.0 111.889 -172.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.687 ' HB2' HG13 ' A' ' 33' ' ' ILE . . . -105.14 125.19 50.71 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.827 175.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -115.87 131.2 57.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 112.9 -1.955 . . . . 0.0 109.623 172.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.22 -160.29 24.97 Favored Glycine 0 N--CA 1.482 1.766 0 CA-C-N 113.359 -1.746 . . . . 0.0 110.783 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -58.88 -61.34 2.7 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -88.71 39.03 0.9 Allowed 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -46.27 -55.0 7.84 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 117.976 2.584 . . . . 0.0 117.976 -175.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.521 ' OE1' ' HE2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -71.88 -45.42 61.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.641 1.176 . . . . 0.0 113.914 -177.338 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.521 ' HE2' ' OE1' ' A' ' 71' ' ' GLN . 41.6 mtmt -66.07 -45.77 80.12 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.745 1.218 . . . . 0.0 112.466 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.465 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -59.86 -44.18 94.28 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.146 0.903 . . . . 0.0 113.406 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.412 HG22 HG22 ' A' ' 63' ' ' ILE . 34.0 t -63.87 -50.81 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 118.612 -0.708 . . . . 0.0 112.343 173.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -50.16 -48.36 53.89 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -57.23 -58.12 9.62 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.037 0.935 . . . . 0.0 111.298 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.432 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 80.1 mt -66.53 -29.21 69.25 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -176.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.424 HG13 HG11 ' A' ' 6' ' ' VAL . 44.2 t -66.86 -51.67 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 123.497 0.498 . . . . 0.0 111.474 170.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -59.73 -41.22 90.39 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.049 0.54 . . . . 0.0 111.877 175.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.432 ' HB3' ' HA ' ' A' ' 77' ' ' LEU . 6.0 tt -60.33 -45.69 92.56 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.199 1.399 . . . . 0.0 112.404 174.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.493 ' SD ' HG13 ' A' ' 8' ' ' ILE . 13.9 tmm? -57.92 -41.75 83.36 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.19 0.596 . . . . 0.0 111.521 174.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.22 96.7 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -78.06 -22.54 48.93 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.0 mt . . . . . 0 N--CA 1.479 0.996 0 O-C-N 121.666 -0.646 . . . . 0.0 111.246 165.15 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ttt . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -127.64 137.94 52.68 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 125.79 1.931 . . . . 0.0 108.701 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.08 139.9 53.02 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.262 -176.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -148.0 121.82 9.32 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 124.24 0.963 . . . . 0.0 111.314 169.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 24.0 tt0 -92.12 115.27 27.93 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.778 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.526 HG11 HG13 ' A' ' 78' ' ' VAL . 24.1 m -117.32 146.3 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 114.765 -1.107 . . . . 0.0 113.816 -175.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 p -95.93 119.2 33.99 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.56 -1.654 . . . . 0.0 113.628 -174.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.8 mt -82.12 105.71 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.849 170.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.0 p -99.82 -1.74 36.8 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.216 -1.811 . . . . 0.0 114.31 171.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.69 127.43 93.38 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 124.562 1.145 . . . . 0.0 111.95 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -48.91 -44.23 32.81 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 124.381 3.387 . . . . 0.0 117.59 -170.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -105.75 -23.53 12.7 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 173.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.86 -138.16 13.75 Favored Glycine 0 N--CA 1.474 1.225 0 C-N-CA 124.536 1.065 . . . . 0.0 111.147 170.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.451 ' HB2' HD22 ' A' ' 55' ' ' LEU . 6.6 mp . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.8 p . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -75.95 -47.6 3.73 Favored Pre-proline 0 N--CA 1.487 1.376 0 CA-C-O 115.752 -2.071 . . . . 0.0 115.732 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -59.03 -39.73 77.62 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.171 1.914 . . . . 0.0 112.004 168.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.22 -51.7 65.75 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 171.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.67 -36.27 78.31 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 175.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -68.11 -44.87 75.2 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 173.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -53.96 -40.86 67.2 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.768 1.227 . . . . 0.0 111.404 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.43 HG21 ' HA ' ' A' ' 47' ' ' LEU . 91.2 t -55.16 -60.31 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 124.087 0.867 . . . . 0.0 111.687 172.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -62.24 -31.92 72.53 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -174.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -66.23 -55.26 17.05 Favored 'General case' 0 CA--C 1.55 0.942 0 O-C-N 124.26 0.975 . . . . 0.0 111.151 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.89 -37.87 64.2 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 171.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.517 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . 32.7 tttt -58.59 -29.56 66.52 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 176.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.46 -12.38 58.57 Favored Glycine 0 CA--C 1.54 1.621 0 O-C-N 125.108 1.505 . . . . 0.0 115.377 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -92.0 158.45 16.24 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.169 0.988 . . . . 0.0 111.863 174.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.2 p -68.78 -46.01 69.83 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.266 177.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.6 p -59.28 137.76 57.86 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.625 1.17 . . . . 0.0 113.919 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -92.23 111.58 23.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.607 -1.179 . . . . 0.0 107.83 170.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mt -95.6 133.01 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-N 111.428 -2.624 . . . . 0.0 110.683 -172.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.5 p -109.05 135.35 50.36 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.228 -1.805 . . . . 0.0 112.133 174.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.97 87.51 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 111.855 -2.429 . . . . 0.0 106.396 177.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.2 m -90.69 109.4 20.58 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.552 -1.658 . . . . 0.0 111.39 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.4 t -116.48 87.65 2.73 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 p30 9.74 108.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 128.208 2.603 . . . . 0.0 118.001 -173.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.12 -49.3 2.45 Favored Glycine 0 N--CA 1.481 1.671 0 CA-C-N 112.985 -1.916 . . . . 0.0 111.881 -171.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.484 ' HB3' HD12 ' A' ' 53' ' ' LEU . 92.7 mttt -93.95 99.03 11.44 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.793 0.806 . . . . 0.0 111.384 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.1 t -107.25 95.8 5.97 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.93 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.563 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -83.68 142.8 30.49 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 113.604 -1.635 . . . . 0.0 112.297 -176.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.7 t -83.34 123.54 29.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.589 173.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.29 12.83 3.26 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 124.353 1.033 . . . . 0.0 112.793 172.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.517 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 86.8 mttt -112.59 -6.81 13.91 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 168.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.9 t -119.42 131.6 55.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.638 1.175 . . . . 0.0 111.269 172.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.43 ' HA ' HG21 ' A' ' 23' ' ' VAL . 2.7 mm? -62.09 -62.58 1.68 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 113.286 -1.779 . . . . 0.0 112.307 -172.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -60.15 -29.73 68.85 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 113.912 -1.494 . . . . 0.0 114.593 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -56.67 -57.37 12.71 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.914 0.886 . . . . 0.0 112.022 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.87 -44.9 84.02 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 173.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -54.21 -37.14 64.25 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 t -81.2 -26.04 36.25 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 116.924 2.194 . . . . 0.0 116.924 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.563 HD13 ' HB2' ' A' ' 42' ' ' ALA . 14.4 tp -41.91 -54.22 3.52 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -167.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.07 88.16 2.04 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -172.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.451 HD22 ' HB2' ' A' ' 14' ' ' LEU . 4.2 mp -116.21 98.36 6.56 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 125.168 1.158 . . . . 0.0 108.327 -177.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.2 t -138.23 176.9 8.29 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 125.503 1.752 . . . . 0.0 111.781 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -59.83 109.56 0.96 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.839 1.256 . . . . 0.0 110.354 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.39 -30.51 6.43 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 113.948 -1.478 . . . . 0.0 115.069 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.4 p -73.02 96.83 2.21 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 117.942 0.871 . . . . 0.0 112.697 -172.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.0 t -69.4 130.96 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.808 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.2 m -124.35 120.33 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 114.691 -1.141 . . . . 0.0 113.924 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 0.7 OUTLIER -83.6 113.34 20.76 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.738 173.617 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.2 mt -95.54 103.48 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 m -116.48 119.88 37.01 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 112.546 -2.116 . . . . 0.0 110.892 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.48 124.53 51.95 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.355 0.598 . . . . 0.0 112.544 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -117.21 105.96 12.79 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.195 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.79 -160.32 28.56 Favored Glycine 0 N--CA 1.482 1.702 0 CA-C-N 113.037 -1.892 . . . . 0.0 112.972 178.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.54 -49.34 78.16 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.063 1.745 . . . . 0.0 115.243 -174.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -96.21 41.53 1.1 Allowed 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 176.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.521 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 7.4 pt-20 -43.27 -67.72 0.25 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.521 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -63.54 -38.47 91.24 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -179.229 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -66.36 -47.97 71.71 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.169 1.388 . . . . 0.0 112.246 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.01 -48.47 81.48 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.903 0.881 . . . . 0.0 112.444 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.8 t -61.25 -52.73 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.571 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -49.41 -51.56 34.46 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.073 0.949 . . . . 0.0 113.073 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -58.5 -51.64 69.0 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.89 0.876 . . . . 0.0 112.44 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.7 mt -70.71 -27.97 64.39 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.526 HG13 HG11 ' A' ' 6' ' ' VAL . 53.0 t -61.64 -55.69 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 123.348 0.659 . . . . 0.0 109.77 168.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -52.68 -51.31 60.81 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 124.417 1.073 . . . . 0.0 112.691 175.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.4 tt -53.45 -50.73 64.66 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.344 1.058 . . . . 0.0 112.737 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -59.55 -44.89 93.11 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.88 0.872 . . . . 0.0 112.428 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.74 -37.28 79.31 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -79.65 10.54 3.89 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 N--CA 1.474 0.745 0 C-N-CA 123.235 0.614 . . . . 0.0 111.552 177.348 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -96.05 105.06 17.05 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.575 1.172 . . . . 0.0 110.187 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -103.06 94.72 5.69 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 111.424 -2.626 . . . . 0.0 108.939 -176.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -112.61 114.43 27.05 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.541 1.163 . . . . 0.0 111.701 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -86.64 107.34 18.14 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 111.836 -2.438 . . . . 0.0 109.842 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 m -116.05 142.56 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 113.919 -1.492 . . . . 0.0 112.699 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.489 HG22 HG22 ' A' ' 60' ' ' VAL . 31.1 p -96.47 114.97 26.68 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.284 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.8 mt -66.89 118.3 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.359 172.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -96.04 -30.42 13.58 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.47 -1.241 . . . . 0.0 114.297 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.44 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -43.75 121.88 3.64 Favored Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 173.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 53.8 Cg_exo -52.67 -55.08 4.1 Favored 'Trans proline' 0 N--CA 1.485 0.999 1 C-N-CA 125.53 4.153 . . . . 0.0 115.147 -166.014 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -90.76 -37.39 13.7 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.341 0.657 . . . . 0.0 112.193 172.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.18 -142.41 16.06 Favored Glycine 0 N--CA 1.481 1.683 0 O-C-N 124.692 1.245 . . . . 0.0 112.824 168.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 N--CA 1.479 1.003 0 CA-C-N 112.648 -1.776 . . . . 0.0 114.967 -177.661 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.5 p . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.282 86.4 mtt-85 -71.88 -40.31 7.91 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 116.866 2.173 . . . . 0.0 116.866 -170.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -65.8 -36.06 33.51 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.268 1.312 . . . . 0.0 112.696 167.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -53.87 -38.4 64.68 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 172.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.54 -45.46 77.2 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.47 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 2.7 mp0 -56.51 -45.13 81.22 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 172.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -61.15 -47.21 87.27 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.432 0.693 . . . . 0.0 112.415 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 19' ' ' ALA . 19.5 t -56.2 -53.79 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 123.837 0.711 . . . . 0.0 111.536 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.47 ' HE3' ' HA ' ' A' ' 21' ' ' GLN . 22.4 pttp -62.48 -37.57 86.47 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -61.84 -52.76 62.85 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.003 1.321 . . . . 0.0 111.112 175.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.99 -44.68 82.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.64 1.176 . . . . 0.0 113.7 174.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -64.45 -25.15 67.88 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 176.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.83 -5.93 48.73 Favored Glycine 0 CA--C 1.543 1.795 0 C-N-CA 125.197 1.38 . . . . 0.0 114.017 172.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -99.88 147.98 24.95 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.19 0.996 . . . . 0.0 110.337 169.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.78 -41.03 98.03 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.91 176.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.7 m -53.34 132.36 39.13 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 124.57 1.169 . . . . 0.0 113.78 173.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.57 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 3.8 tt0 -82.75 103.56 12.33 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.697 1.237 . . . . 0.0 110.078 173.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.528 HD11 ' HB1' ' A' ' 73' ' ' ALA . 12.1 mt -89.78 115.16 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 111.346 -2.661 . . . . 0.0 111.055 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.3 p -111.86 139.02 47.69 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.275 171.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.434 HG22 HG13 ' A' ' 63' ' ' ILE . 93.8 t -114.65 116.32 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.952 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.9 m -110.69 127.63 55.38 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.892 -1.504 . . . . 0.0 111.533 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.0 m -136.23 107.72 6.92 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.661 171.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 p30 25.66 64.08 0.06 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.65 -53.16 0.6 Allowed Glycine 0 CA--C 1.539 1.582 0 CA-C-N 113.634 -1.621 . . . . 0.0 112.85 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -76.93 89.41 3.51 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.895 0.855 . . . . 0.0 112.421 -176.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 t -96.21 102.28 14.04 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.953 172.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.519 ' HB3' HD12 ' A' ' 53' ' ' LEU . . . -118.63 123.39 44.85 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.057 -1.429 . . . . 0.0 113.365 -174.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.2 t -54.79 123.98 15.06 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.179 -1.828 . . . . 0.0 113.688 173.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.37 11.17 8.92 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.067 171.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.57 ' HE3' ' HA ' ' A' ' 32' ' ' GLU . 82.5 mttt -96.9 -17.52 20.08 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.915 162.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.5 t -102.34 117.34 34.53 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 122.037 0.922 . . . . 0.0 111.245 172.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -50.25 -62.73 1.41 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.043 -1.89 . . . . 0.0 113.294 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -64.56 -39.87 94.54 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 113.825 -1.534 . . . . 0.0 114.264 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -57.76 -50.32 73.64 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 175.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 tp -68.05 -42.79 80.01 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -59.26 -21.19 59.22 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.6 t -109.29 22.54 15.69 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.519 HD12 ' HB3' ' A' ' 42' ' ' ALA . 7.2 tt -74.54 -52.15 12.68 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.816 -1.177 . . . . 0.0 110.142 171.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.97 88.9 2.08 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 mt -108.29 81.15 1.44 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.216 -0.992 . . . . 0.0 110.569 -171.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -132.14 172.54 12.26 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.021 -174.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -46.29 116.5 1.28 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.949 1.7 . . . . 0.0 112.133 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.72 -27.87 17.82 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 113.751 -1.568 . . . . 0.0 115.09 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.3 p -61.85 115.4 3.99 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.721 0.772 . . . . 0.0 112.582 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.489 HG22 HG22 ' A' ' 7' ' ' THR . 15.1 t -84.2 102.93 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 111.9 -2.409 . . . . 0.0 106.884 -176.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.3 m -109.76 117.3 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 113.975 -1.466 . . . . 0.0 113.78 -170.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.56 99.78 12.44 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.437 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.516 HG22 HG22 ' A' ' 74' ' ' VAL . 2.9 mp -78.51 98.19 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 172.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.1 m -103.35 101.85 11.77 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 112.356 -2.202 . . . . 0.0 110.412 -177.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.35 104.42 15.41 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.657 -1.61 . . . . 0.0 113.639 -173.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.31 96.22 10.43 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.297 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.09 -173.19 44.69 Favored Glycine 0 N--CA 1.475 1.295 0 CA-C-N 114.122 -1.399 . . . . 0.0 112.676 173.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -67.87 -46.09 72.69 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.63 1.172 . . . . 0.0 112.749 175.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -79.09 33.64 0.23 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.715 1.606 . . . . 0.0 113.715 176.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.635 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 3.6 pt-20 -54.14 -69.29 0.13 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.536 1.935 . . . . 0.0 114.616 -176.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.635 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -55.42 -35.28 65.23 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 174.498 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -66.04 -47.68 73.6 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.152 0.981 . . . . 0.0 112.1 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.528 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -53.81 -49.65 67.88 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.394 1.059 . . . . 0.0 112.155 173.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.516 HG22 HG22 ' A' ' 63' ' ' ILE . 94.6 t -61.86 -50.18 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.191 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.19 -58.31 3.76 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.992 1.317 . . . . 0.0 112.662 178.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -58.31 -51.15 71.01 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.346 1.029 . . . . 0.0 112.283 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.85 -38.69 89.17 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.4 -53.08 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.21 0.604 . . . . 0.0 109.81 174.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -53.89 -52.24 61.14 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.638 1.211 . . . . 0.0 112.614 178.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.9 tp -49.31 -58.12 5.64 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.103 1.761 . . . . 0.0 113.073 174.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.9 tmm? -61.39 -35.44 77.51 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.222 1.409 . . . . 0.0 113.633 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.87 -37.83 18.73 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -77.16 38.74 0.22 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.7 mt . . . . . 0 CA--C 1.545 0.777 0 C-N-CA 126.095 1.758 . . . . 0.0 110.185 179.182 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -126.44 130.42 50.65 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 126.019 2.075 . . . . 0.0 109.238 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -123.97 135.43 53.64 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.714 -1.584 . . . . 0.0 112.149 177.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -123.91 116.85 23.58 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.417 164.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -89.74 97.97 11.5 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.24 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.8 m -113.18 157.9 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 112.244 -2.253 . . . . 0.0 112.517 -174.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.417 HG22 HG22 ' A' ' 60' ' ' VAL . 22.6 p -105.15 139.37 39.91 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.896 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.407 HG12 ' SD ' ' A' ' 81' ' ' MET . 36.5 mt -107.95 105.75 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 169.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.3 p -126.03 46.98 2.32 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 114.416 -1.265 . . . . 0.0 114.294 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -116.97 139.49 25.84 Favored Pre-proline 0 N--CA 1.475 0.787 0 CA-C-O 116.962 -1.494 . . . . 0.0 108.854 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -32.04 -56.89 0.27 Allowed 'Trans proline' 0 N--CA 1.483 0.909 1 C-N-CA 125.747 4.298 . . . . 0.0 116.86 -168.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -113.43 -38.87 4.24 Favored 'General case' 0 CA--C 1.551 0.992 0 O-C-N 124.131 0.894 . . . . 0.0 112.407 168.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.05 -89.35 1.44 Allowed Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.908 0.766 . . . . 0.0 113.561 163.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -171.047 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.2 p . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.342 60.4 mtt-85 -92.05 -39.15 0.37 Allowed Pre-proline 0 N--CA 1.479 1.024 0 N-CA-C 119.044 2.979 . . . . 0.0 119.044 -170.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -61.98 -39.2 52.27 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 CA-C-N 121.283 1.494 . . . . 0.0 111.353 161.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -51.88 -34.79 42.72 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 171.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.1 -42.83 63.57 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -52.15 -52.96 48.59 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.689 1.195 . . . . 0.0 113.203 173.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -55.31 -52.57 63.03 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.579 1.552 . . . . 0.0 111.183 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.701 HG22 HD23 ' A' ' 50' ' ' LEU . 1.9 t -70.29 -38.96 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -174.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.65 -32.14 73.54 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 176.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -71.36 -49.45 42.08 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.047 0.939 . . . . 0.0 110.137 173.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.424 ' HA ' ' HD2' ' A' ' 29' ' ' PHE . . . -55.44 -46.01 76.76 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 176.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -60.77 -23.93 65.37 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 173.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.52 -25.45 67.84 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.317 0.96 . . . . 0.0 113.664 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.424 ' HD2' ' HA ' ' A' ' 26' ' ' ALA . 63.9 m-85 -73.56 139.36 45.55 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.217 1.008 . . . . 0.0 112.56 177.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -58.91 -37.6 77.02 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 113.19 -1.823 . . . . 0.0 113.025 174.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.3 m -63.08 141.93 58.58 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 171.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.89 113.8 22.99 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.842 0.83 . . . . 0.0 108.94 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 mt -106.99 101.57 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.615 -1.63 . . . . 0.0 109.989 -172.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.0 p -86.32 135.2 33.62 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.878 171.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.586 ' HB ' HD11 ' A' ' 50' ' ' LEU . 97.3 t -118.97 100.73 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 178.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.9 m -100.43 124.1 45.5 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.729 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.437 ' HB2' HG12 ' A' ' 61' ' ' VAL . 4.1 t -144.41 137.54 27.11 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.58 176.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.277 0.2 OUTLIER 43.57 51.77 6.25 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.859 1.664 . . . . 0.0 113.968 -173.027 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.15 -29.39 1.14 Allowed Glycine 0 CA--C 1.547 2.088 0 CA-C-N 114.103 -1.408 . . . . 0.0 114.885 -175.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -70.49 106.49 3.46 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.031 0.932 . . . . 0.0 112.448 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.7 t -89.65 128.82 36.13 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.696 -1.593 . . . . 0.0 111.942 169.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.81 119.81 14.45 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 113.389 -1.732 . . . . 0.0 110.24 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -64.91 124.93 23.3 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 113.117 -1.856 . . . . 0.0 112.376 171.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.54 -3.28 11.09 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 112.949 -1.932 . . . . 0.0 114.627 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -65.33 -11.64 43.86 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 122.086 0.946 . . . . 0.0 113.502 160.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.4 t -124.84 105.45 9.27 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.161 -0.962 . . . . 0.0 112.972 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.435 HD13 ' HB ' ' A' ' 23' ' ' VAL . 3.5 mm? -40.53 -51.43 2.92 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.175 -1.83 . . . . 0.0 112.524 164.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -55.57 -50.74 69.24 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 113.254 -1.794 . . . . 0.0 113.452 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -66.05 -47.87 72.92 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.701 HD23 HG22 ' A' ' 23' ' ' VAL . 7.6 tp -72.97 -30.18 63.64 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -176.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -65.66 -18.69 65.51 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 t -112.21 61.12 0.63 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 124.029 1.871 . . . . 0.0 112.748 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.4 tp -122.12 -65.95 1.07 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 112.895 -1.957 . . . . 0.0 112.296 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.62 90.96 0.83 Allowed Glycine 0 N--CA 1.478 1.438 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -172.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 mt -121.68 87.06 2.68 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.513 -0.843 . . . . 0.0 109.4 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -153.19 -175.62 5.42 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.714 -168.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -60.2 108.89 0.86 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.119 0.968 . . . . 0.0 112.128 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.08 -12.56 24.28 Favored Glycine 0 N--CA 1.477 1.388 0 CA-C-N 112.477 -2.147 . . . . 0.0 114.591 177.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.0 p -77.83 116.5 18.39 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 117.772 0.786 . . . . 0.0 112.814 -175.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.417 HG22 HG22 ' A' ' 7' ' ' THR . 22.1 t -92.26 119.97 40.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 113.1 -1.864 . . . . 0.0 107.192 177.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' A' ' 37' ' ' SER . 14.8 m -123.42 115.05 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 113.878 -1.51 . . . . 0.0 113.385 -172.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.4 90.57 6.19 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.823 174.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.8 mt -72.97 101.2 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -120.05 101.33 7.77 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.816 -164.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.21 121.01 42.38 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -104.71 112.22 25.23 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 112.947 -1.933 . . . . 0.0 109.412 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.79 -161.22 32.61 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.084 175.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -78.85 -44.76 22.22 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.98 0.895 . . . . 0.0 112.532 176.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -76.89 22.41 0.19 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.865 1.666 . . . . 0.0 114.369 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.446 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 6.9 pt-20 -44.98 -54.67 6.29 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.581 1.952 . . . . 0.0 114.976 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.446 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -68.03 -47.74 67.6 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -62.52 -49.01 77.02 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.704 -1.134 . . . . 0.0 113.191 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.06 -49.17 74.54 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.207 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.02 -51.4 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 117.946 -1.026 . . . . 0.0 111.973 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -52.67 -48.66 66.34 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 124.219 0.949 . . . . 0.0 112.047 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -60.72 -48.53 81.37 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.363 1.065 . . . . 0.0 112.957 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.08 -37.03 84.78 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.7 t -59.04 -50.09 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 123.938 0.774 . . . . 0.0 109.851 172.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -53.66 -55.72 23.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 124.036 0.835 . . . . 0.0 113.096 175.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.2 tt -51.31 -52.12 48.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.524 1.13 . . . . 0.0 112.462 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.407 ' SD ' HG12 ' A' ' 8' ' ' ILE . 16.9 tmm? -59.86 -49.09 79.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.102 0.961 . . . . 0.0 112.859 178.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.05 -26.49 67.53 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -83.35 -2.04 54.79 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 87.1 mt . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 177.374 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.43 ' HG2' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -81.2 126.78 31.93 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.339 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -123.76 123.52 40.68 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 113.702 -1.59 . . . . 0.0 111.461 -175.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -129.91 110.46 11.71 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 125.134 1.521 . . . . 0.0 112.997 168.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -83.53 106.25 15.11 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.354 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.4 m -115.51 144.5 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 114.141 -1.391 . . . . 0.0 113.655 -173.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.561 HG22 HG22 ' A' ' 60' ' ' VAL . 27.6 p -103.63 118.4 36.64 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 113.868 -1.515 . . . . 0.0 111.308 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.0 mt -74.22 113.53 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.653 172.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 p -96.07 -23.15 16.92 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -62.22 133.56 94.33 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 124.383 1.073 . . . . 0.0 112.082 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 77.8 Cg_exo -53.17 -55.93 3.22 Favored 'Trans proline' 0 N--CA 1.481 0.752 0 C-N-CA 124.365 3.377 . . . . 0.0 113.755 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -67.58 -37.31 82.42 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.12 0.968 . . . . 0.0 112.874 176.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.37 -128.01 9.14 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.8 mt -114.13 -17.56 11.88 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 113.827 -1.186 . . . . 0.0 113.039 171.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.2 p -107.6 -44.21 4.33 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 118.038 -2.914 . . . . 0.0 113.737 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.41 ' HD3' ' HA ' ' A' ' 17' ' ' ARG 0.346 15.7 mmt180 -87.17 -45.47 0.52 Allowed Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 118.017 2.599 . . . . 0.0 118.017 -175.742 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -59.01 -33.14 98.65 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 CA-C-N 122.655 1.984 . . . . 0.0 111.751 165.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.523 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -56.67 -48.29 77.93 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.149 0.98 . . . . 0.0 113.46 165.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.01 -38.81 90.03 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.23 -43.0 99.81 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 169.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -58.89 -42.22 89.02 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 124.375 1.047 . . . . 0.0 111.348 172.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 19' ' ' ALA . 66.8 t -57.28 -52.0 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 123.971 0.909 . . . . 0.0 111.032 171.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -53.45 -46.51 69.92 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 124.029 0.831 . . . . 0.0 112.08 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -66.9 -44.96 79.43 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.199 0.999 . . . . 0.0 113.221 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.17 -37.23 76.85 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 124.312 1.045 . . . . 0.0 113.681 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -59.42 -22.15 61.01 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 171.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.21 -20.16 74.74 Favored Glycine 0 N--CA 1.487 2.054 0 O-C-N 124.973 1.421 . . . . 0.0 114.663 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -98.18 148.85 23.16 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.18 0.592 . . . . 0.0 112.387 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.1 p -68.5 -43.37 76.99 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.962 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.0 p -61.1 161.57 8.43 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.816 1.246 . . . . 0.0 113.086 170.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -116.48 102.4 9.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 122.304 1.049 . . . . 0.0 111.979 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.698 HD11 ' HB1' ' A' ' 73' ' ' ALA . 17.1 mm -65.25 106.75 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 112.392 -2.185 . . . . 0.0 111.894 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.0 p -94.25 122.19 36.53 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.573 1.178 . . . . 0.0 109.984 167.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.6 t -104.41 107.09 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 111.95 -2.386 . . . . 0.0 107.848 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.3 m -96.25 113.39 24.99 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.098 -1.864 . . . . 0.0 111.627 -174.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.561 ' HB2' HG12 ' A' ' 61' ' ' VAL . 5.7 t -129.01 121.68 28.45 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.594 172.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 p30 37.94 64.44 0.68 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 125.18 1.55 . . . . 0.0 114.419 -170.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.45 -33.92 1.57 Allowed Glycine 0 N--CA 1.486 1.991 0 CA-C-N 113.636 -1.62 . . . . 0.0 114.509 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -68.51 88.69 0.34 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.315 1.046 . . . . 0.0 112.107 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.9 m -77.28 99.9 5.67 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 113.223 -1.808 . . . . 0.0 111.882 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.95 123.53 46.02 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.46 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.5 t -58.98 103.85 0.2 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.785 168.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.563 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . . . -59.57 -32.33 70.26 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.331 175.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -65.96 -24.69 66.85 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.827 0.851 . . . . 0.0 112.254 174.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.8 t -94.26 111.1 22.82 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 123.104 1.43 . . . . 0.0 112.608 170.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.441 ' HA ' HG21 ' A' ' 23' ' ' VAL . 22.6 tp -32.54 -73.35 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.934 2.494 . . . . 0.0 116.13 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.402 ' O ' HG22 ' A' ' 52' ' ' THR . 67.3 m-85 -64.87 -30.21 71.2 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -175.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -62.8 -48.29 79.77 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.603 0.761 . . . . 0.0 111.638 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 26.3 tp -69.48 -46.58 66.3 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 124.251 0.97 . . . . 0.0 113.066 172.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -52.61 -32.0 39.38 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 48' ' ' PHE . 5.1 t -114.35 24.01 12.31 Favored 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.8 tp -70.35 -48.06 58.13 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.374 -0.829 . . . . 0.0 112.259 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.08 87.35 1.36 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.51 87.24 2.72 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.708 -0.746 . . . . 0.0 111.925 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -135.09 176.14 8.94 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.238 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -58.33 116.34 3.54 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.457 1.103 . . . . 0.0 110.245 172.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.07 -33.78 6.16 Favored Glycine 0 N--CA 1.485 1.932 0 CA-C-N 114.397 -1.274 . . . . 0.0 114.251 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.1 p -59.88 112.84 2.0 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 117.612 0.706 . . . . 0.0 112.421 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.561 HG22 HG22 ' A' ' 7' ' ' THR . 22.0 t -84.51 129.92 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.335 -1.757 . . . . 0.0 108.026 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.561 HG12 ' HB2' ' A' ' 37' ' ' SER . 7.4 m -129.73 118.4 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.443 -174.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 m -85.21 104.81 15.41 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.826 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.9 mt -82.9 109.92 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.9 m -118.01 141.46 48.44 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 113.157 -1.838 . . . . 0.0 111.38 -173.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.91 139.43 27.6 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.43 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 28.2 tt0 -133.33 132.27 41.1 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.658 -1.61 . . . . 0.0 108.826 169.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.31 -161.9 28.18 Favored Glycine 0 N--CA 1.481 1.683 0 C-N-CA 125.023 1.297 . . . . 0.0 111.542 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -59.93 -64.54 0.91 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.917 0.865 . . . . 0.0 113.167 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -83.56 31.59 0.47 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -53.0 -58.21 7.74 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -172.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -43.11 99.61 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -65.62 -45.03 84.66 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.036 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.698 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -56.39 -52.19 65.55 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.125 0.97 . . . . 0.0 113.173 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.8 t -59.5 -53.06 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.949 0.899 . . . . 0.0 110.078 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -51.0 -54.04 27.96 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.215 1.406 . . . . 0.0 112.73 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -62.88 -45.7 91.33 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.7 mt -64.88 -36.22 83.64 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.35 -50.79 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.435 0.694 . . . . 0.0 110.527 169.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -56.21 -47.11 79.03 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.7 tp -49.03 -59.23 3.79 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.607 1.163 . . . . 0.0 111.927 173.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.0 tmm? -58.06 -42.6 85.81 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.32 1.048 . . . . 0.0 112.949 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.03 -29.89 67.05 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -87.66 -31.69 19.63 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 69.1 mt -48.79 144.73 4.27 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 . . . . . 0 N--CA 1.483 1.2 0 O-C-N 125.618 1.824 . . . . 0.0 114.429 -178.2 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttp . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -120.79 112.31 18.67 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.827 1.329 . . . . 0.0 110.087 172.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -107.57 126.81 53.01 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.019 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -122.93 120.17 32.62 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -99.89 92.72 5.42 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 125.294 1.621 . . . . 0.0 108.794 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.401 HG21 HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -119.31 143.39 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 111.469 -2.605 . . . . 0.0 112.641 -173.216 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 p -78.54 131.45 36.8 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -176.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.9 mt -92.59 116.97 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-N 113.485 -1.689 . . . . 0.0 107.159 159.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 p -116.36 -17.81 10.63 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 111.85 -2.432 . . . . 0.0 114.38 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.06 129.96 58.54 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 124.929 1.292 . . . . 0.0 111.694 172.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -56.97 -54.11 4.11 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 124.394 3.396 . . . . 0.0 114.862 -165.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.426 ' O ' ' HD2' ' A' ' 15' ' ' HIP . 11.7 p30 -88.23 -36.97 16.45 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 123.782 0.676 . . . . 0.0 111.762 171.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.89 -128.34 9.53 Favored Glycine 0 N--CA 1.475 1.291 0 O-C-N 123.799 0.687 . . . . 0.0 112.46 167.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.629 HD21 HD13 ' A' ' 84' ' ' LEU . 72.5 mt -104.45 -32.82 8.82 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.426 ' HD2' ' O ' ' A' ' 12' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.6 p -100.2 -62.67 1.21 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 118.112 -2.867 . . . . 0.0 113.489 174.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.326 24.1 mtt180 -83.79 -37.36 0.67 Allowed Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 118.396 2.739 . . . . 0.0 118.396 -168.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -62.52 -39.81 42.62 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 121.763 1.642 . . . . 0.0 112.617 163.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.21 -38.18 73.33 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 168.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.18 -38.56 86.94 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 172.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -64.27 -43.91 93.34 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.414 0.686 . . . . 0.0 112.147 172.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -59.02 -44.17 91.69 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.175 1.39 . . . . 0.0 112.221 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.479 HG21 ' HA ' ' A' ' 47' ' ' LEU . 44.6 t -53.97 -60.06 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.042 1.337 . . . . 0.0 112.034 169.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -49.55 -39.06 33.38 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.936 -1.029 . . . . 0.0 113.156 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.455 ' HG2' HD22 ' A' ' 80' ' ' LEU . 8.5 tp10 -61.86 -66.0 0.6 Allowed 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.522 1.139 . . . . 0.0 110.891 169.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.93 -35.16 6.17 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -42.36 -38.21 1.78 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.24 -30.19 70.33 Favored Glycine 0 CA--C 1.546 1.972 0 C-N-CA 124.97 1.272 . . . . 0.0 115.805 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -75.28 144.8 42.3 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -175.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 66.3 p -66.46 -50.27 63.9 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.303 0.641 . . . . 0.0 111.891 -175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.3 p -66.09 173.61 2.99 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 124.877 1.361 . . . . 0.0 113.35 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.418 ' HG3' ' HB3' ' A' ' 45' ' ' LYS . 30.6 tt0 -114.65 94.32 4.72 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.704 0.764 . . . . 0.0 109.331 174.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.75 113.57 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 113.118 -1.855 . . . . 0.0 109.382 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 p -105.78 137.61 43.36 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.677 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.0 t -118.87 126.57 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 113.206 -1.815 . . . . 0.0 109.944 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.3 m -110.98 123.37 50.04 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.214 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.8 t -126.5 120.37 29.5 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.717 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 p30 40.3 64.03 0.99 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.742 1.617 . . . . 0.0 114.634 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.35 -34.96 1.54 Allowed Glycine 0 CA--C 1.542 1.773 0 CA-C-N 113.187 -1.824 . . . . 0.0 115.658 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -81.94 133.04 35.28 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.598 0.759 . . . . 0.0 110.254 -169.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 t -108.4 129.29 55.26 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.123 0.89 . . . . 0.0 113.269 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.519 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -124.71 160.85 27.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 112.541 -2.118 . . . . 0.0 109.626 176.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.534 ' H ' ' HB3' ' A' ' 49' ' ' LYS . 40.3 t -106.08 128.26 53.74 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.131 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.04 -29.47 69.83 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.878 1.361 . . . . 0.0 111.338 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HB3' ' HG3' ' A' ' 32' ' ' GLU . 77.4 tttt -90.81 21.69 3.98 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.245 -0.888 . . . . 0.0 112.609 177.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.498 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 2.0 m -148.01 116.46 6.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.028 1.331 . . . . 0.0 112.274 173.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.479 ' HA ' HG21 ' A' ' 23' ' ' VAL . 31.1 tp -51.21 -59.63 3.99 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 112.429 -2.169 . . . . 0.0 113.324 -176.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -63.85 -32.34 73.82 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.221 -1.354 . . . . 0.0 113.317 -174.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.534 ' HB3' ' H ' ' A' ' 43' ' ' SER . 15.4 mmmt -69.24 -58.48 3.98 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 118.318 -0.848 . . . . 0.0 113.033 173.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.9 tp -60.36 -40.3 90.25 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.201 0.938 . . . . 0.0 112.441 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -62.34 -40.1 95.28 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 t -89.86 8.14 33.59 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.519 HD22 ' HB3' ' A' ' 42' ' ' ALA . 45.3 tp -72.67 -60.95 1.98 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.91 92.88 1.6 Allowed Glycine 0 CA--C 1.535 1.334 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.0 mt -128.47 82.75 2.1 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.269 1.427 . . . . 0.0 109.956 -174.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 t -146.49 164.67 31.78 Favored 'General case' 0 C--O 1.25 1.1 0 C-N-CA 125.826 1.65 . . . . 0.0 110.835 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -41.61 126.63 2.99 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.444 1.898 . . . . 0.0 115.137 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.69 -31.56 5.51 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-N 113.891 -1.504 . . . . 0.0 115.379 173.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.35 121.32 21.19 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.828 2.159 . . . . 0.0 116.828 -173.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.9 t -87.01 94.03 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 m -89.82 125.72 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -169.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.07 93.45 5.78 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.967 1.707 . . . . 0.0 110.429 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.6 mt -98.73 113.33 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 125.496 1.518 . . . . 0.0 107.134 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 m -129.68 124.29 33.24 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.216 -167.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.66 140.84 51.56 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -140.74 110.1 6.27 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.258 1.423 . . . . 0.0 110.301 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.82 -157.05 19.57 Favored Glycine 0 N--CA 1.478 1.497 0 N-CA-C 107.621 -2.191 . . . . 0.0 107.621 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -65.51 -43.5 89.9 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 117.243 0.521 . . . . 0.0 110.156 170.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -86.25 26.94 0.97 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -54.06 -52.64 60.25 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.493 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -78.42 -44.13 25.58 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.649 1.58 . . . . 0.0 113.007 -179.386 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -67.65 -35.83 79.6 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.77 -47.4 53.84 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.707 0.803 . . . . 0.0 112.862 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.9 t -61.6 -48.1 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 118.0 -1.0 . . . . 0.0 111.156 176.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -46.12 -49.01 17.17 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.7 1.2 . . . . 0.0 111.845 171.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -68.19 -62.48 1.38 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.0 mt -59.77 -38.63 82.35 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.401 HG13 HG21 ' A' ' 6' ' ' VAL . 56.4 t -61.42 -48.24 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.315 174.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -59.07 -48.88 80.0 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.297 0.998 . . . . 0.0 112.953 173.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.455 HD22 ' HG2' ' A' ' 25' ' ' GLU . 10.3 tp -52.55 -47.99 66.43 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.642 0.777 . . . . 0.0 112.03 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.518 ' HG3' HD11 ' A' ' 14' ' ' LEU . 48.5 ttp -62.2 -52.26 64.5 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.923 0.889 . . . . 0.0 112.367 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.64 -35.9 63.95 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -88.46 -13.67 39.77 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.629 HD13 HD21 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -63.37 153.07 36.26 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 124.093 0.957 . . . . 0.0 112.411 167.813 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 . . . . . 0 N--CA 1.486 1.366 0 C-N-CA 125.318 1.447 . . . . 0.0 110.632 -175.782 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ttt . . . . . 0 N--CA 1.463 0.204 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -113.79 127.97 56.22 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 124.657 1.223 . . . . 0.0 109.708 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -131.11 94.66 3.63 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.309 -167.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -112.44 108.49 17.64 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 122.518 1.151 . . . . 0.0 113.343 -171.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -80.96 103.99 11.16 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 112.45 -2.159 . . . . 0.0 111.159 175.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.3 148.46 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 114.933 -1.03 . . . . 0.0 113.138 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 p -102.72 128.33 49.48 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.905 -175.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.3 mt -79.54 108.9 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.359 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 p -96.83 -13.51 22.5 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 175.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.442 ' HB3' ' HA2' ' A' ' 13' ' ' GLY . . . -59.9 135.83 90.22 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 124.31 1.044 . . . . 0.0 111.766 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -48.88 -52.45 8.64 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.182 3.255 . . . . 0.0 114.718 -174.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -106.88 -28.43 10.1 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 124.591 1.182 . . . . 0.0 113.741 175.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . 93.25 -153.91 21.6 Favored Glycine 0 N--CA 1.479 1.563 0 CA-C-O 122.045 0.803 . . . . 0.0 113.897 165.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.645 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 87.0 mt -72.08 -34.05 68.39 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 177.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.5 p -88.0 -51.54 5.76 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 117.133 -3.48 . . . . 0.0 115.563 170.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.303 40.6 mtt85 -89.77 -41.44 0.42 Allowed Pre-proline 0 N--CA 1.486 1.336 0 N-CA-C 118.616 2.821 . . . . 0.0 118.616 -166.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.645 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 90.5 Cg_exo -61.72 -30.8 85.55 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 CA-C-N 120.867 1.345 . . . . 0.0 112.412 163.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -60.19 -44.2 95.3 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 165.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.51 90.61 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 172.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -59.84 -45.5 92.22 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.386 1.074 . . . . 0.0 112.452 172.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -57.86 -46.07 85.37 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.074 1.35 . . . . 0.0 111.782 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.5 HG21 ' HA ' ' A' ' 47' ' ' LEU . 59.2 t -56.0 -42.47 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.025 0.53 . . . . 0.0 112.278 175.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -60.96 -46.43 90.74 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 124.07 0.856 . . . . 0.0 111.916 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.47 ' HB3' HD21 ' A' ' 77' ' ' LEU . 13.7 tp10 -69.58 -44.44 70.79 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.077 0.861 . . . . 0.0 112.616 176.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.37 -33.59 65.85 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -53.81 -34.77 60.21 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 170.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.27 13.74 56.52 Favored Glycine 0 N--CA 1.483 1.81 0 O-C-N 124.557 1.161 . . . . 0.0 115.159 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -119.49 151.19 38.99 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.046 0.497 . . . . 0.0 111.297 172.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.4 p -82.69 -44.2 15.97 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.862 -175.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.3 p -66.08 133.26 50.37 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 124.999 1.437 . . . . 0.0 110.615 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -85.7 103.62 14.67 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.609 1.195 . . . . 0.0 111.831 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.654 HD11 ' HB1' ' A' ' 73' ' ' ALA . 44.4 mm -63.69 113.53 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 111.757 -2.474 . . . . 0.0 111.125 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.1 p -111.66 131.04 55.56 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.601 173.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.469 HG22 HG12 ' A' ' 63' ' ' ILE . 59.3 t -111.0 108.27 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 113.483 -1.689 . . . . 0.0 107.723 -177.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.0 m -103.91 124.05 48.26 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.777 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.526 ' HB2' HG12 ' A' ' 61' ' ' VAL . 48.2 t -128.16 131.99 48.91 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.286 176.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.6 p30 49.83 34.62 7.92 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.39 5.33 87.7 Favored Glycine 0 CA--C 1.545 1.926 0 N-CA-C 115.806 1.082 . . . . 0.0 115.806 -175.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -112.56 140.66 47.13 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.977 0.911 . . . . 0.0 109.915 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.0 t -119.22 135.04 54.88 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -167.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.503 ' HB3' HD12 ' A' ' 53' ' ' LEU . . . -130.61 121.27 25.32 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.036 -1.893 . . . . 0.0 111.398 173.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.9 t -72.98 129.09 37.32 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.633 173.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.75 -14.7 62.08 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 113.175 -1.829 . . . . 0.0 113.297 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.0 mttt -77.29 -2.47 34.98 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 171.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.3 m -123.14 118.62 28.09 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.394 0.677 . . . . 0.0 112.217 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.5 ' HA ' HG21 ' A' ' 23' ' ' VAL . 19.1 tp -45.93 -65.87 0.48 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.588 -1.642 . . . . 0.0 113.732 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.48 ' O ' HG22 ' A' ' 52' ' ' THR . 56.6 m-85 -54.09 -50.93 65.7 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 178.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.5 mmtt -42.04 -58.59 2.04 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.4 tp -66.96 -43.0 84.25 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.638 1.211 . . . . 0.0 113.202 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -59.36 -41.38 89.14 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.989 175.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 48' ' ' PHE 0.263 15.2 t -100.54 54.01 0.88 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 123.497 1.617 . . . . 0.0 113.897 175.549 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.503 HD12 ' HB3' ' A' ' 42' ' ' ALA . 2.6 tt -111.24 -56.5 2.36 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 112.874 -1.966 . . . . 0.0 109.246 161.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.27 66.9 0.61 Allowed Glycine 0 N--CA 1.477 1.416 0 O-C-N 124.348 1.03 . . . . 0.0 111.851 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.2 mt -88.74 98.11 11.51 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.682 0.793 . . . . 0.0 111.537 -174.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.9 t -137.47 175.99 9.11 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.876 -176.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -47.95 128.68 13.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.899 2.08 . . . . 0.0 112.813 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.68 -54.72 0.55 Allowed Glycine 0 N--CA 1.48 1.61 0 CA-C-N 113.408 -1.724 . . . . 0.0 114.175 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.1 p -64.56 131.98 48.55 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -165.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.4 t -79.89 108.48 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 111.124 -2.762 . . . . 0.0 107.193 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.526 HG12 ' HB2' ' A' ' 37' ' ' SER . 13.6 m -105.0 109.49 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 113.523 -1.671 . . . . 0.0 113.214 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.5 95.99 2.85 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.626 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.469 HG12 HG22 ' A' ' 35' ' ' VAL . 77.2 mt -86.61 101.19 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.117 175.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.3 m -106.15 134.56 49.09 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 112.642 -2.072 . . . . 0.0 112.905 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.609 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -139.07 138.22 36.92 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 124.638 1.211 . . . . 0.0 113.223 172.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -132.62 118.7 19.5 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 124.8 1.312 . . . . 0.0 109.484 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.44 -155.5 26.18 Favored Glycine 0 CA--C 1.544 1.879 0 C-N-CA 124.685 1.136 . . . . 0.0 111.232 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -68.09 -61.14 2.0 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -80.56 28.15 0.34 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -53.26 -48.32 68.36 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.78 -50.61 33.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.835 0.854 . . . . 0.0 111.809 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -58.89 -50.92 72.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.587 1.555 . . . . 0.0 112.829 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.654 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -60.25 -44.58 95.14 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.471 1.107 . . . . 0.0 113.587 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.63 -55.52 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.078 175.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -52.05 -50.57 61.22 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.051 0.941 . . . . 0.0 112.975 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -60.01 -50.5 73.49 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.468 1.107 . . . . 0.0 112.64 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.47 HD21 ' HB3' ' A' ' 25' ' ' GLU . 45.8 mt -64.72 -28.32 69.51 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.5 t -69.65 -47.57 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 122.896 0.479 . . . . 0.0 110.896 171.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -51.76 -50.92 59.73 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.937 0.895 . . . . 0.0 111.527 174.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.67 -54.62 21.52 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.213 1.805 . . . . 0.0 112.236 176.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 40.3 ttp -57.12 -47.87 80.03 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.467 1.107 . . . . 0.0 112.363 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.9 -27.84 68.49 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.275 1.43 . . . . 0.0 114.84 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -78.71 -35.74 44.45 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.459 HD13 ' HB3' ' A' ' 18' ' ' PRO . 36.4 mt -57.64 156.93 7.7 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 175.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 C--O 1.259 1.562 0 C-N-CA 126.558 1.943 . . . . 0.0 114.771 -173.858 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 ttt . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -103.22 136.96 42.02 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 125.095 1.497 . . . . 0.0 108.329 170.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -146.16 134.41 21.74 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.565 -1.652 . . . . 0.0 111.016 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -123.48 118.94 28.56 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.847 170.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -83.98 106.87 15.98 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.079 165.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.6 m -120.73 140.21 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 114.726 -1.124 . . . . 0.0 113.649 -178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.481 HG22 HG22 ' A' ' 60' ' ' VAL . 22.8 p -83.31 136.21 34.45 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.302 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 52.7 mt -81.81 90.31 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 168.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.7 p -74.07 -22.41 59.53 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.513 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.32 131.74 94.89 Favored Pre-proline 0 N--CA 1.484 1.229 0 C-N-CA 125.296 1.438 . . . . 0.0 111.935 -175.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.04 -44.17 9.54 Favored 'Trans proline' 0 N--CA 1.489 1.207 1 C-N-CA 125.355 4.036 . . . . 0.0 117.56 -166.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -110.45 -45.03 3.6 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.85 -147.63 17.6 Favored Glycine 0 N--CA 1.478 1.492 0 CA-C-O 121.725 0.625 . . . . 0.0 112.817 167.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.473 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 95.6 mt -88.31 -30.34 19.68 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.3 p -111.37 -46.13 3.32 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 118.201 -2.812 . . . . 0.0 115.213 170.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.286 48.4 mtt85 -86.08 -39.27 0.57 Allowed Pre-proline 0 N--CA 1.487 1.411 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -174.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.473 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 97.9 Cg_exo -62.13 -35.71 73.88 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 121.712 1.608 . . . . 0.0 111.686 164.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.44 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -56.06 -44.38 78.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.601 0.76 . . . . 0.0 112.897 167.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.49 98.81 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 171.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -56.64 -45.25 81.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.716 0.806 . . . . 0.0 113.146 171.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -57.93 -44.18 86.75 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.864 1.266 . . . . 0.0 111.689 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 19' ' ' ALA . 95.7 t -57.12 -42.81 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.322 1.049 . . . . 0.0 113.154 176.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -53.03 -45.27 67.93 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 123.462 0.476 . . . . 0.0 112.17 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -74.61 -50.94 15.95 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.831 1.332 . . . . 0.0 112.215 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.35 -35.95 65.78 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -60.14 -19.38 53.41 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 173.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.45 27.03 14.89 Favored Glycine 0 CA--C 1.544 1.869 0 O-C-N 124.432 1.082 . . . . 0.0 113.646 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -127.93 142.97 51.11 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.143 0.977 . . . . 0.0 111.575 172.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.6 p -71.85 -40.0 69.34 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.438 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.437 ' HB2' ' HB1' ' A' ' 65' ' ' ALA . 63.0 p -65.23 145.86 55.69 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 124.483 1.115 . . . . 0.0 111.624 168.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -95.73 109.51 21.79 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.321 -0.862 . . . . 0.0 110.968 174.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.698 HD13 ' HB2' ' A' ' 65' ' ' ALA . 46.3 mm -70.54 102.06 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 112.64 -2.073 . . . . 0.0 108.852 171.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.3 p -101.89 126.44 48.79 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.497 173.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.469 HG22 HG12 ' A' ' 63' ' ' ILE . 86.7 t -103.54 113.85 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 125.445 1.716 . . . . 0.0 107.767 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.466 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 97.9 m -114.2 127.54 55.95 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.652 -174.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.4 t -122.66 115.04 21.43 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.316 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.5 p30 39.94 51.31 2.52 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -174.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.47 -35.8 4.05 Favored Glycine 0 N--CA 1.484 1.898 0 CA-C-N 113.17 -1.832 . . . . 0.0 114.501 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -72.55 121.63 19.99 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 116.897 0.348 . . . . 0.0 111.11 -174.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.0 t -102.25 136.29 42.35 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.78 1.3 . . . . 0.0 113.789 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.609 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -129.72 106.77 8.93 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 112.748 -2.024 . . . . 0.0 112.005 175.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.7 t -59.5 121.73 12.26 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.526 171.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.61 -30.55 68.31 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.598 170.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -61.8 -32.64 72.95 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.2 m -96.37 104.24 16.19 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 122.028 0.918 . . . . 0.0 111.89 169.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.423 ' HA ' HG21 ' A' ' 23' ' ' VAL . 9.5 tp -44.94 -60.62 1.97 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.54 1.536 . . . . 0.0 113.05 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.437 ' O ' HG22 ' A' ' 52' ' ' THR . 90.2 m-85 -57.21 -37.6 72.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.507 ' HD2' ' HA ' ' A' ' 42' ' ' ALA . 6.2 tmtt? -61.5 -49.82 75.2 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.609 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 19.8 tp -62.48 -41.33 98.72 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 174.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -61.07 -24.88 66.55 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 48' ' ' PHE 0.261 9.6 t -118.12 75.31 1.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 123.449 1.595 . . . . 0.0 114.228 172.472 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.422 HD13 ' HB2' ' A' ' 42' ' ' ALA . 19.7 tp -124.0 -45.39 2.01 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 112.128 -2.305 . . . . 0.0 113.141 168.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.45 69.1 0.84 Allowed Glycine 0 CA--C 1.534 1.266 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -167.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 43.7 mt -95.28 80.64 3.56 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.06 0.933 . . . . 0.0 110.936 -173.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -123.83 151.49 43.34 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 112.748 -2.024 . . . . 0.0 112.889 -165.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -49.13 132.9 19.28 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.46 1.124 . . . . 0.0 112.427 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.58 -69.06 0.22 Allowed Glycine 0 CA--C 1.534 1.267 0 CA-C-N 113.467 -1.697 . . . . 0.0 110.257 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.5 p -30.79 113.19 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.481 HG22 HG22 ' A' ' 7' ' ' THR . 9.2 t -72.96 108.1 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 112.601 -2.09 . . . . 0.0 106.688 168.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.7 m -105.09 111.48 34.75 Favored 'Isoleucine or valine' 0 C--O 1.253 1.261 0 CA-C-N 113.991 -1.458 . . . . 0.0 112.743 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.466 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 2.8 m -65.99 99.11 0.47 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 126.558 1.943 . . . . 0.0 108.87 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.469 HG12 HG22 ' A' ' 35' ' ' VAL . 80.8 mt -96.64 106.73 18.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.7 m -118.53 133.79 55.59 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 112.703 -2.044 . . . . 0.0 112.588 -169.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.698 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -146.78 138.12 24.25 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 125.334 1.646 . . . . 0.0 112.681 170.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -120.05 129.72 54.37 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.97 170.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.1 -157.11 27.26 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.766 1.203 . . . . 0.0 114.909 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -71.77 -44.09 64.63 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.518 ' HA ' ' HD2' ' A' ' 72' ' ' LYS . 5.2 p30 -100.63 24.84 8.49 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.69 -51.22 68.03 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -36.79 83.98 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.254 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.518 ' HD2' ' HA ' ' A' ' 69' ' ' ASP . 22.2 mttt -71.73 -52.8 15.91 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.563 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.17 -51.7 68.46 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.513 1.525 . . . . 0.0 114.266 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.7 t -60.77 -50.64 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.003 0.521 . . . . 0.0 110.863 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -54.58 -55.33 30.5 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.557 1.143 . . . . 0.0 111.514 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -53.76 -54.1 42.96 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.733 1.613 . . . . 0.0 112.923 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.3 mt -69.41 -28.64 66.33 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.54 -43.46 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 119.038 -0.506 . . . . 0.0 110.816 171.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -55.77 -43.81 77.08 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.248 0.619 . . . . 0.0 111.716 172.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.26 -51.08 70.79 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.522 1.129 . . . . 0.0 112.757 174.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 44.4 ttm -55.08 -45.6 75.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 123.531 0.519 . . . . 0.0 112.286 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.09 -19.95 66.24 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -114.85 36.19 3.96 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 mt -107.06 175.24 5.57 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.303 1.441 . . . . 0.0 112.73 173.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 . . . . . 0 N--CA 1.488 1.442 0 C-N-CA 125.59 1.556 . . . . 0.0 112.273 178.273 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 ttp . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -100.45 131.93 46.1 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 125.597 1.81 . . . . 0.0 107.962 169.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -124.78 115.44 20.7 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.584 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -127.05 110.21 12.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.223 1.011 . . . . 0.0 112.386 173.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -91.59 112.45 24.38 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.624 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 m -128.37 165.35 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 113.134 -1.848 . . . . 0.0 112.301 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.459 HG22 HG22 ' A' ' 60' ' ' VAL . 78.5 p -120.73 147.27 45.53 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.196 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.8 mt -87.93 97.13 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.887 175.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.8 p -85.3 -17.79 35.83 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.47 142.2 41.2 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.985 1.314 . . . . 0.0 112.608 174.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -47.6 -46.96 19.34 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 124.586 3.524 . . . . 0.0 116.246 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -114.86 -39.17 3.76 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.83 -142.51 17.1 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 122.198 0.888 . . . . 0.0 112.824 167.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 mp -104.21 -27.87 11.78 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 -174.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 76.8 p -101.22 -68.05 0.83 Allowed 'General case' 0 N--CA 1.476 0.833 0 O-C-N 117.449 -3.282 . . . . 0.0 114.358 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.492 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 65.2 mtt85 -60.57 -53.95 59.49 Favored Pre-proline 0 N--CA 1.488 1.445 0 CA-C-O 116.238 -1.839 . . . . 0.0 115.181 -171.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 51.4 Cg_exo -67.2 -31.12 36.69 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 CA-C-N 122.072 1.776 . . . . 0.0 114.198 174.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.96 85.1 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 171.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.41 -39.29 86.88 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 171.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -62.09 -44.68 96.13 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.006 0.923 . . . . 0.0 113.15 172.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -59.76 -43.5 94.27 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.105 0.878 . . . . 0.0 111.662 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.57 HG11 ' HA ' ' A' ' 47' ' ' LEU . 66.8 t -55.66 -51.67 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.569 0.748 . . . . 0.0 111.654 172.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -46.84 -51.74 15.9 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.617 0.767 . . . . 0.0 111.755 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -65.14 -51.81 59.01 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.466 1.104 . . . . 0.0 111.559 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.28 -34.02 66.06 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -60.51 -32.84 71.83 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 172.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.22 26.24 3.98 Favored Glycine 0 N--CA 1.479 1.526 0 O-C-N 124.382 1.051 . . . . 0.0 114.375 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -129.17 146.24 51.14 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.725 1.21 . . . . 0.0 110.261 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.6 p -69.39 -42.15 75.5 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.442 0.697 . . . . 0.0 112.872 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 p -66.55 157.07 33.24 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.867 1.267 . . . . 0.0 112.836 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -103.4 113.74 27.48 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 122.32 1.057 . . . . 0.0 110.239 172.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' A' ' 44' ' ' ALA . 8.7 mm -81.81 105.74 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 111.818 -2.446 . . . . 0.0 108.495 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.3 p -101.79 121.27 41.77 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.141 0.496 . . . . 0.0 110.805 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.6 t -101.51 97.85 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 125.905 2.003 . . . . 0.0 107.612 -172.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 29.1 m -88.39 101.14 13.6 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.778 -1.555 . . . . 0.0 111.047 -177.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 t -100.35 99.88 10.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.198 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 p30 45.54 62.61 2.11 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 113.186 -1.824 . . . . 0.0 114.009 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.47 -30.36 3.78 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 114.015 -1.448 . . . . 0.0 114.636 -176.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -86.31 92.76 8.9 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.644 0.735 . . . . 0.0 109.67 -174.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 25.3 t -82.73 123.33 29.2 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.771 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -126.2 132.86 51.69 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.597 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.6 t -71.22 129.7 39.57 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.715 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.57 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . . . -72.2 -19.0 61.81 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 112.972 -1.922 . . . . 0.0 112.508 170.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -77.11 -6.11 51.56 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 m -112.49 115.93 29.46 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.57 ' HA ' HG11 ' A' ' 23' ' ' VAL . 32.4 tp -52.84 -64.79 0.7 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 111.325 -2.67 . . . . 0.0 114.302 -170.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.459 ' O ' HG22 ' A' ' 52' ' ' THR . 49.5 m-85 -77.39 -28.77 52.9 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -60.65 -44.85 95.93 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.444 ' HG ' HD11 ' A' ' 55' ' ' LEU . 6.0 tp -69.62 -35.52 75.33 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.591 1.182 . . . . 0.0 113.283 175.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -65.48 -35.9 82.28 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 172.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 48' ' ' PHE 0.251 14.0 t -100.06 50.66 0.91 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 123.716 1.722 . . . . 0.0 112.547 173.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.457 HD22 ' HB3' ' A' ' 42' ' ' ALA . 59.5 tp -115.6 -37.86 3.88 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 112.883 -1.962 . . . . 0.0 112.742 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.09 55.92 1.66 Allowed Glycine 0 CA--C 1.53 1.031 0 C-N-CA 123.962 0.791 . . . . 0.0 111.824 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.444 HD11 ' HG ' ' A' ' 50' ' ' LEU . 78.3 mt -77.51 85.5 3.88 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -133.41 175.97 8.94 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 113.873 -1.512 . . . . 0.0 112.928 -172.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -46.47 112.78 0.54 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.471 1.909 . . . . 0.0 111.613 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.15 -38.71 3.09 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-N 113.259 -1.791 . . . . 0.0 114.157 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.5 p -48.84 110.22 0.33 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -172.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.459 HG22 HG22 ' A' ' 7' ' ' THR . 17.9 t -70.38 123.59 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-N 111.083 -2.78 . . . . 0.0 108.067 175.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 m -127.98 101.19 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 113.708 -1.587 . . . . 0.0 112.638 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.6 m -77.81 90.04 4.05 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.118 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 73.0 mt -78.84 96.88 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 113.006 -1.907 . . . . 0.0 107.725 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.0 m -119.88 136.83 54.35 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 113.136 -1.847 . . . . 0.0 111.991 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.78 142.59 25.66 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.636 1.21 . . . . 0.0 113.305 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -123.37 126.84 47.57 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.656 1.222 . . . . 0.0 110.431 170.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.44 -165.68 36.83 Favored Glycine 0 N--CA 1.484 1.869 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.094 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -63.94 -55.44 22.55 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -92.42 17.91 9.24 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 8.0 pt-20 -45.0 -58.96 2.83 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -173.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.497 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -60.98 -48.9 79.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.923 1.289 . . . . 0.0 114.285 179.693 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -64.4 -46.28 83.99 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.786 0.834 . . . . 0.0 112.256 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.65 -52.38 65.67 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.247 1.019 . . . . 0.0 112.688 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.8 t -63.58 -47.1 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 117.586 -1.197 . . . . 0.0 111.306 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -50.33 -59.32 4.09 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.226 1.01 . . . . 0.0 111.656 175.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -53.94 -49.55 68.45 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.323 1.049 . . . . 0.0 113.438 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.5 mt -62.9 -39.66 95.2 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.7 t -58.17 -44.06 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.75 0.82 . . . . 0.0 111.084 174.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -60.26 -53.73 54.25 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.852 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.7 tp -51.6 -49.72 61.6 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.162 0.985 . . . . 0.0 113.277 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.8 ttt -62.66 -36.6 83.41 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.984 0.914 . . . . 0.0 113.188 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.17 -35.32 56.03 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -86.27 1.99 48.85 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.8 mt -77.45 151.05 34.89 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.653 1.181 . . . . 0.0 114.055 170.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.557 1.239 0 C-N-CA 127.995 2.518 . . . . 0.0 113.157 -173.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ttp . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -121.41 132.06 54.53 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 125.259 1.6 . . . . 0.0 112.026 173.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.464 ' HG3' ' OG ' ' A' ' 64' ' ' SER . 0.5 OUTLIER -132.93 146.93 52.23 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.6 174.075 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -119.22 150.9 39.31 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 124.384 1.053 . . . . 0.0 110.871 169.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -117.28 98.69 6.56 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 123.309 1.528 . . . . 0.0 110.823 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.24 149.55 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 113.902 -1.499 . . . . 0.0 112.219 -169.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.502 HG22 HG22 ' A' ' 60' ' ' VAL . 2.6 p -100.87 143.44 31.02 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.269 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.5 mp -81.16 115.97 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 165.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.2 p -99.85 -36.09 9.54 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 112.594 -2.094 . . . . 0.0 112.497 -174.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.482 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -53.99 142.15 46.73 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.978 0.911 . . . . 0.0 112.462 170.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 50.2 Cg_exo -58.48 -44.27 38.89 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.996 3.131 . . . . 0.0 115.332 -172.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . 0.257 11.1 p30 -105.21 -29.92 10.02 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 176.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.71 -127.24 7.86 Favored Glycine 0 CA--C 1.538 1.5 0 O-C-N 124.287 0.992 . . . . 0.0 114.263 169.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.87 -30.45 12.03 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.669 HG22 ' HB3' ' A' ' 51' ' ' GLN . 0.2 OUTLIER -113.57 -48.3 2.94 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 118.592 -2.568 . . . . 0.0 113.626 174.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.341 97.0 mtt180 -83.36 -43.46 0.84 Allowed Pre-proline 0 N--CA 1.479 1.014 0 N-CA-C 118.049 2.611 . . . . 0.0 118.049 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -62.0 -37.21 66.52 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 CA-C-N 123.233 2.19 . . . . 0.0 110.884 170.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.65 -30.52 21.93 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 164.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.38 -40.62 97.07 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 119.474 1.034 . . . . 0.0 112.327 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.83 -35.54 80.28 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 118.436 -0.792 . . . . 0.0 112.973 171.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -62.17 -48.03 81.87 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.94 0.336 . . . . 0.0 111.032 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.1 t -50.61 -50.72 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.933 0.873 . . . . 0.0 111.411 173.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.42 -44.21 95.98 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.54 -1.209 . . . . 0.0 113.121 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.463 ' HG2' HD22 ' A' ' 80' ' ' LEU . 12.9 tp10 -63.36 -40.29 96.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.355 1.462 . . . . 0.0 113.67 175.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.42 99.13 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.101 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.585 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . 79.6 mttt -56.99 -30.15 63.9 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.6 -25.73 36.39 Favored Glycine 0 CA--C 1.543 1.818 0 O-C-N 125.343 1.652 . . . . 0.0 114.849 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -97.63 146.68 25.07 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.093 0.957 . . . . 0.0 112.928 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -58.61 -50.35 74.16 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.758 1.623 . . . . 0.0 112.387 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.1 p -53.15 147.61 9.54 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 125.043 1.465 . . . . 0.0 113.975 170.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -103.06 87.67 2.97 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 122.706 1.241 . . . . 0.0 109.422 170.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.499 ' CD1' ' HB2' ' A' ' 65' ' ' ALA . 6.3 mm -48.57 112.34 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 112.131 -2.304 . . . . 0.0 111.556 172.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.5 p -101.18 143.5 31.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.458 171.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.5 t -127.75 111.77 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.2 m -109.98 126.97 54.49 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.538 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -123.89 136.77 54.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.643 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.6 p30 51.08 22.83 1.35 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 128.739 2.816 . . . . 0.0 117.067 -178.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.54 -28.4 14.39 Favored Glycine 0 CA--C 1.544 1.894 0 CA-C-N 115.238 -0.892 . . . . 0.0 114.367 -171.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -81.09 135.47 35.81 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.447 0.624 . . . . 0.0 111.345 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.0 t -113.55 120.26 40.35 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.847 -170.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -126.19 129.2 48.53 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.702 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.5 t -76.15 131.77 39.59 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.898 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.15 -40.95 82.24 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 125.149 1.531 . . . . 0.0 112.559 174.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.585 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 72.8 mttt -57.76 -18.42 21.42 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 171.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 t -107.39 114.43 28.44 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.618 1.199 . . . . 0.0 110.045 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.3 tp -62.03 -59.21 5.42 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.94 -1.936 . . . . 0.0 115.555 -165.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -69.68 -31.1 68.95 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -57.03 -61.4 2.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.016 0.926 . . . . 0.0 109.919 171.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.0 tp -57.39 -44.66 84.67 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.669 ' HB3' HG22 ' A' ' 16' ' ' THR . 75.3 mt-30 -61.9 -42.84 99.56 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 t -67.45 -12.67 60.83 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.402 HD22 ' HB3' ' A' ' 42' ' ' ALA . 11.4 tp -69.87 -52.51 24.21 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -173.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.03 72.88 0.88 Allowed Glycine 0 N--CA 1.471 0.985 0 O-C-N 124.256 0.973 . . . . 0.0 112.383 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.1 mt -86.55 73.66 10.04 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 123.62 1.676 . . . . 0.0 111.007 175.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.4 t -127.8 172.25 11.01 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 111.802 -2.454 . . . . 0.0 111.517 -172.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -40.26 143.4 0.3 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.521 1.929 . . . . 0.0 112.236 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.37 -33.76 2.02 Favored Glycine 0 N--CA 1.481 1.644 0 CA-C-O 118.362 -1.243 . . . . 0.0 114.875 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.0 p -61.97 115.68 4.27 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.064 1.432 . . . . 0.0 114.492 -174.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 7' ' ' THR . 25.7 t -88.81 100.94 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 110.721 -2.945 . . . . 0.0 106.184 173.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.0 m -102.78 123.8 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 112.902 -1.954 . . . . 0.0 111.611 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 p -84.5 109.76 18.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 112.306 -2.224 . . . . 0.0 111.391 171.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.8 mt -104.55 110.38 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.079 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.464 ' OG ' ' HG3' ' A' ' 3' ' ' GLN . 4.4 m -117.57 126.44 52.55 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 113.741 -1.572 . . . . 0.0 115.098 -168.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.499 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . . . -126.18 137.84 53.6 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.293 -1.321 . . . . 0.0 112.921 176.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -139.1 113.98 9.31 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.446 -1.706 . . . . 0.0 108.996 166.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.75 -155.59 16.74 Favored Glycine 0 N--CA 1.479 1.545 0 C-N-CA 126.07 1.795 . . . . 0.0 109.439 -175.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -77.78 -35.33 51.68 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 122.218 1.009 . . . . 0.0 111.569 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -105.02 26.94 8.66 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.848 1.659 . . . . 0.0 115.154 -177.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -44.61 -43.15 7.97 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.464 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -73.36 -46.43 49.2 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 174.241 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.426 ' HE2' ' OE1' ' A' ' 71' ' ' GLN . 39.0 mtmt -72.76 -32.04 65.34 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.119 1.368 . . . . 0.0 113.271 -173.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.96 -53.37 58.75 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.027 1.331 . . . . 0.0 111.269 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 t -65.66 -52.44 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.135 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -47.03 -57.2 5.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.021 1.328 . . . . 0.0 112.478 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -60.29 -60.32 4.0 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mt -58.23 -36.0 72.53 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.83 -42.77 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.568 0.747 . . . . 0.0 111.572 171.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -63.82 -34.52 78.1 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.463 HD22 ' HG2' ' A' ' 25' ' ' GLU . 4.5 tp -58.37 -52.54 65.16 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.447 1.099 . . . . 0.0 112.157 164.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 48.2 ttm -48.86 -51.43 29.74 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.867 0.867 . . . . 0.0 112.581 173.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.5 -50.5 73.67 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -84.77 15.08 4.11 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -174.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.85 -150.03 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.299 1.039 . . . . 0.0 111.594 169.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.589 -0.719 . . . . 0.0 110.9 -170.543 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -127.98 141.15 51.61 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.398 1.479 . . . . 0.0 109.879 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.48 128.36 11.75 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.053 0.541 . . . . 0.0 111.863 -172.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -125.13 119.46 28.64 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -83.08 115.68 21.98 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 113.18 -1.827 . . . . 0.0 111.086 164.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.1 164.31 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 113.249 -1.796 . . . . 0.0 113.076 176.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.9 p -121.31 126.04 48.53 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -172.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.42 HD12 ' OG1' ' A' ' 59' ' ' THR . 47.5 mt -80.26 111.9 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.411 170.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 p -107.07 -8.77 16.4 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 113.218 -1.81 . . . . 0.0 115.555 173.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.27 137.03 68.45 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.965 0.906 . . . . 0.0 112.535 177.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -45.78 -46.17 15.76 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 124.843 3.695 . . . . 0.0 115.943 -170.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.22 -34.32 5.96 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 175.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.32 -135.56 12.54 Favored Glycine 0 N--CA 1.482 1.74 0 O-C-N 123.761 0.663 . . . . 0.0 111.627 169.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 7.7 mp -103.64 -26.59 12.73 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -176.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.5 p -110.34 -51.9 2.83 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 117.762 -3.086 . . . . 0.0 114.156 173.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 63.4 mtt-85 -75.27 -45.18 4.59 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-O 115.706 -2.093 . . . . 0.0 115.599 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -63.34 -28.46 71.97 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 CA-C-N 122.565 1.952 . . . . 0.0 112.569 168.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.501 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -61.2 -22.24 64.57 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 169.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.4 -36.36 63.48 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -55.9 -47.27 77.75 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 170.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -55.62 -43.61 76.27 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.899 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.604 HG12 ' HE2' ' A' ' 27' ' ' LYS . 19.5 t -59.23 -52.55 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.752 0.821 . . . . 0.0 111.214 176.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.22 -56.44 11.09 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.584 1.154 . . . . 0.0 113.028 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.505 ' HG2' HD11 ' A' ' 80' ' ' LEU . 10.0 tp10 -58.8 -45.2 90.43 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 124.779 1.3 . . . . 0.0 112.395 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.59 80.18 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.604 ' HE2' HG12 ' A' ' 23' ' ' VAL . 63.1 mttm -50.25 -38.42 40.69 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 175.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.94 3.78 55.87 Favored Glycine 0 CA--C 1.54 1.605 0 O-C-N 124.769 1.293 . . . . 0.0 116.298 -173.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -100.75 158.3 16.06 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.305 1.042 . . . . 0.0 112.869 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.3 p -68.57 -52.32 33.1 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 118.639 -0.696 . . . . 0.0 109.482 168.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.0 p -59.05 136.52 57.97 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.875 1.27 . . . . 0.0 112.947 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -95.27 92.15 6.61 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.362 173.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.606 HD13 ' HB2' ' A' ' 65' ' ' ALA . 29.7 mm -57.55 115.68 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 112.132 -2.304 . . . . 0.0 110.211 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.5 p -105.54 117.29 33.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.702 173.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.6 t -103.89 117.71 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.717 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.448 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 35.0 m -107.8 129.7 55.03 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 112.553 -2.112 . . . . 0.0 112.042 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.1 t -136.25 137.68 41.03 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 111.979 -2.373 . . . . 0.0 107.727 171.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.8 p30 40.02 44.54 1.47 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.36 -40.65 3.08 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 124.185 0.898 . . . . 0.0 114.388 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -57.84 123.93 17.46 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.872 1.269 . . . . 0.0 112.645 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -109.74 101.44 10.33 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.489 -176.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.71 134.65 47.52 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.622 1.201 . . . . 0.0 112.846 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.0 t -73.21 112.19 9.03 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 112.485 -2.143 . . . . 0.0 112.143 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.55 -14.58 63.11 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 112.717 -2.038 . . . . 0.0 114.232 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -72.27 -22.28 61.24 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.2 t -109.91 122.43 47.53 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.843 0.83 . . . . 0.0 111.744 -176.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.445 ' HA ' HG21 ' A' ' 23' ' ' VAL . 6.3 tp -55.54 -59.4 4.89 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.588 -2.096 . . . . 0.0 114.615 -169.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -64.79 -33.38 75.86 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -61.97 -51.72 66.91 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 123.805 0.69 . . . . 0.0 112.382 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.5 tp -61.96 -38.74 89.67 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -64.9 -39.28 93.29 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -72.96 -28.68 62.55 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 172.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.3 tp -45.19 -60.95 1.85 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.61 93.46 2.02 Favored Glycine 0 CA--C 1.539 1.57 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 71.5 mt -120.06 87.04 2.67 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 113.337 -1.432 . . . . 0.0 107.906 178.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 t -135.38 -174.87 3.75 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.337 -1.302 . . . . 0.0 111.351 -173.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -61.05 118.48 6.82 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.288 0.566 . . . . 0.0 109.993 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.78 -7.81 65.44 Favored Glycine 0 N--CA 1.478 1.435 0 CA-C-N 114.368 -1.287 . . . . 0.0 115.665 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.42 ' OG1' HD12 ' A' ' 8' ' ' ILE . 42.3 p -71.44 99.59 2.03 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.351 1.075 . . . . 0.0 111.652 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.2 t -60.44 104.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 111.497 -2.592 . . . . 0.0 107.986 173.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.4 m -106.78 113.4 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.418 -168.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.448 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 6.7 m -100.25 104.97 16.49 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 112.271 -2.24 . . . . 0.0 108.973 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 24.3 mt -98.64 102.25 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.118 -1.855 . . . . 0.0 107.9 -174.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -102.56 140.86 36.28 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 113.642 -1.617 . . . . 0.0 112.31 -176.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.606 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -146.71 142.05 27.43 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.419 1.074 . . . . 0.0 112.904 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -140.12 114.25 9.05 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.12 169.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.99 -152.56 15.13 Favored Glycine 0 N--CA 1.483 1.791 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.581 -175.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -86.32 -57.7 2.91 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 120.742 0.306 . . . . 0.0 110.503 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.55 5.49 3.81 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.783 2.142 . . . . 0.0 116.783 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -41.93 -53.71 3.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.425 ' HG2' ' HG3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -58.91 -49.24 78.56 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.949 1.3 . . . . 0.0 113.477 179.208 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 72.4 mttt -76.62 -34.94 58.32 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.278 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.42 68.5 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.015 0.926 . . . . 0.0 111.959 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.54 -45.51 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-O 118.459 -0.782 . . . . 0.0 111.731 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -52.94 -51.06 62.67 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 123.876 0.735 . . . . 0.0 111.994 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -59.23 -51.82 68.33 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.438 1.495 . . . . 0.0 111.697 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.417 HD13 HG21 ' A' ' 33' ' ' ILE . 30.2 mt -65.93 -29.91 70.41 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.94 -46.19 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 121.329 0.585 . . . . 0.0 109.725 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -71.42 -30.31 65.93 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.432 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.505 HD11 ' HG2' ' A' ' 25' ' ' GLU . 0.6 OUTLIER -59.54 -52.84 63.85 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 124.142 0.901 . . . . 0.0 112.459 166.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.7 tmm? -53.12 -47.47 68.63 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 124.49 1.119 . . . . 0.0 111.892 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.04 -40.35 97.46 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -90.0 -9.98 46.64 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.4 mt -63.9 145.55 55.63 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.888 0.475 . . . . 0.0 110.696 161.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 C--O 1.255 1.358 0 O-C-N 125.671 1.857 . . . . 0.0 111.147 -166.525 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.413 ' HD2' ' HB ' ' A' ' 74' ' ' VAL . 12.6 t80 -118.4 118.91 33.05 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 125.425 1.703 . . . . 0.0 110.567 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.75 122.34 37.18 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.438 -172.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -134.02 140.28 46.58 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.751 0.821 . . . . 0.0 113.073 171.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.6 ' HG2' HG12 ' A' ' 60' ' ' VAL . 39.9 tt0 -112.32 122.87 48.96 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.958 -172.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.409 HG11 HG13 ' A' ' 78' ' ' VAL . 3.2 m -128.63 130.33 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.582 HG23 HG22 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -91.21 128.01 36.86 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 113.684 -1.598 . . . . 0.0 111.518 -177.698 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.1 mt -87.5 118.14 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.709 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 p -95.51 -26.72 15.7 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 113.516 -1.675 . . . . 0.0 113.748 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.477 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -64.28 127.95 92.66 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 123.486 0.714 . . . . 0.0 111.943 173.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HA ' ' HB2' ' A' ' 57' ' ' GLN . 65.4 Cg_exo -54.62 -51.98 9.19 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.171 3.247 . . . . 0.0 113.725 -170.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -95.81 -46.39 6.59 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.866 1.354 . . . . 0.0 111.031 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.09 -107.86 2.26 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.655 1.121 . . . . 0.0 112.764 166.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 24.0 mt -84.44 -29.78 25.83 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.4 p -118.5 -47.75 2.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 118.181 -2.824 . . . . 0.0 112.963 169.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -74.43 -44.56 5.77 Favored Pre-proline 0 N--CA 1.483 1.188 0 CA-C-O 116.248 -1.834 . . . . 0.0 115.908 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.425 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 82.8 Cg_exo -64.3 -40.61 24.55 Favored 'Trans proline' 0 N--CA 1.486 1.063 0 CA-C-N 121.826 1.688 . . . . 0.0 112.866 170.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -51.16 -37.56 47.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.587 1.155 . . . . 0.0 113.959 172.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.73 75.71 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 175.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -80.73 -28.18 36.66 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 174.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -62.04 -38.91 90.53 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.296 0.639 . . . . 0.0 110.551 168.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 19' ' ' ALA . 46.4 t -60.65 -48.12 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 124.472 1.109 . . . . 0.0 110.978 169.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -51.47 -46.97 63.29 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 118.895 -0.574 . . . . 0.0 111.622 175.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.403 ' HG2' HD22 ' A' ' 80' ' ' LEU . 11.4 tp10 -61.58 -56.28 21.64 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 125.13 1.519 . . . . 0.0 111.567 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.82 -40.71 63.55 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.435 ' HE2' HG12 ' A' ' 23' ' ' VAL . 65.1 mttm -57.93 -27.85 63.75 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 176.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.68 -46.38 94.56 Favored Glycine 0 CA--C 1.542 1.772 0 C-N-CA 124.948 1.261 . . . . 0.0 112.892 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -69.12 144.15 53.96 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.991 0.916 . . . . 0.0 112.459 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.3 p -67.72 -45.77 74.11 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.285 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.7 p -63.12 167.0 5.34 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.683 1.593 . . . . 0.0 113.206 171.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -114.03 111.57 21.86 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 122.365 1.078 . . . . 0.0 110.903 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.739 HD13 ' HB2' ' A' ' 65' ' ' ALA . 39.5 mm -69.47 103.77 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 112.567 -2.106 . . . . 0.0 110.773 175.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.9 p -88.3 118.2 27.75 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.315 167.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -105.39 92.45 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 113.545 -1.661 . . . . 0.0 106.876 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 12.0 m -81.59 124.94 29.95 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 112.12 -2.309 . . . . 0.0 110.961 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -128.65 106.64 9.09 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.662 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 p30 35.43 83.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 112.557 -2.111 . . . . 0.0 116.533 -176.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.52 -52.68 4.59 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-N 113.037 -1.892 . . . . 0.0 112.903 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -69.21 117.68 11.15 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.305 1.042 . . . . 0.0 111.509 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 1.7 t -111.29 108.94 18.73 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.81 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.49 118.6 37.05 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.478 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.4 t -57.11 111.88 1.19 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.185 -1.371 . . . . 0.0 111.153 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.22 -24.34 67.18 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.876 172.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -70.46 -26.87 63.84 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.236 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -95.29 102.6 14.42 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 123.063 1.411 . . . . 0.0 112.006 172.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.406 ' HA ' HG21 ' A' ' 23' ' ' VAL . 16.9 tp -39.43 -59.86 1.02 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.093 2.157 . . . . 0.0 115.704 -175.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -66.32 -33.15 75.08 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -67.07 -44.52 79.88 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.43 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 tp -66.93 -45.47 77.78 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 124.444 1.09 . . . . 0.0 112.02 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -57.49 -30.55 65.19 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 t -94.07 -0.0 55.65 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.5 -41.8 96.22 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.23 86.65 1.86 Allowed Glycine 0 CA--C 1.537 1.417 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -172.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.549 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 10.6 mt -115.29 77.22 1.06 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.192 0.996 . . . . 0.0 109.73 -172.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.9 t -132.05 168.29 18.2 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.468 -163.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.595 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 40.7 tt0 -57.54 106.71 0.36 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.031 0.932 . . . . 0.0 111.468 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.62 -38.21 2.61 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 113.311 -1.768 . . . . 0.0 114.526 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.8 p -64.55 122.85 17.78 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 118.165 0.982 . . . . 0.0 112.88 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.6 HG12 ' HG2' ' A' ' 5' ' ' GLU . 1.1 t -97.86 111.22 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 113.073 -1.876 . . . . 0.0 106.792 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.7 m -105.52 117.07 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 112.701 -2.045 . . . . 0.0 113.778 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.3 93.66 9.14 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 112.466 -2.152 . . . . 0.0 111.88 -175.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.457 HG22 HG22 ' A' ' 74' ' ' VAL . 81.2 mt -80.15 102.81 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 113.845 -1.525 . . . . 0.0 107.724 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.2 m -121.31 134.08 55.14 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 112.62 -2.082 . . . . 0.0 112.978 -175.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.739 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -145.84 152.31 39.29 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 124.822 1.326 . . . . 0.0 112.767 177.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -137.28 133.27 34.82 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.971 172.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.44 -159.73 24.9 Favored Glycine 0 N--CA 1.484 1.894 0 O-C-N 124.169 0.918 . . . . 0.0 113.519 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -50.26 -47.47 55.17 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -108.79 31.23 5.81 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -51.26 -52.29 46.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -71.8 -42.21 67.33 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 112.765 -2.016 . . . . 0.0 113.151 178.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -66.62 -47.36 72.88 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.593 1.157 . . . . 0.0 111.987 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.576 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -60.33 -47.36 86.37 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.366 1.066 . . . . 0.0 113.429 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.457 HG22 HG22 ' A' ' 63' ' ' ILE . 95.4 t -68.94 -45.81 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 117.537 -1.221 . . . . 0.0 111.261 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -52.08 -49.76 62.91 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.981 0.913 . . . . 0.0 111.019 175.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -62.69 -58.1 8.65 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.107 1.363 . . . . 0.0 113.442 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.3 mt -64.74 -29.78 70.77 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.409 HG13 HG11 ' A' ' 6' ' ' VAL . 28.5 t -63.24 -54.79 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 124.036 0.835 . . . . 0.0 110.686 168.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt -56.34 -47.05 79.6 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.736 0.814 . . . . 0.0 112.969 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.403 HD22 ' HG2' ' A' ' 25' ' ' GLU . 37.7 tp -52.51 -56.08 17.65 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.435 1.094 . . . . 0.0 111.607 175.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.415 ' HG2' HD11 ' A' ' 14' ' ' LEU . 6.5 tmm? -53.99 -43.72 70.23 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.085 0.954 . . . . 0.0 112.021 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.6 -35.56 80.5 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -177.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.99 -21.04 34.05 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.7 mt -62.59 158.81 17.25 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 . . . . . 0 N--CA 1.487 1.391 0 C-N-CA 125.768 1.627 . . . . 0.0 112.696 167.325 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.465 ' HG2' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -132.87 139.55 47.48 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 125.337 1.648 . . . . 0.0 108.907 165.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -137.58 128.46 27.23 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.227 -177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -125.05 108.04 11.42 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.976 168.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -87.3 97.25 10.68 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 112.587 -2.097 . . . . 0.0 109.123 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 m -120.34 117.49 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 112.243 -2.253 . . . . 0.0 112.91 -173.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 p -71.77 126.77 30.57 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.728 -1.123 . . . . 0.0 111.665 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.9 mt -71.2 126.54 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 114.876 -1.057 . . . . 0.0 108.756 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -98.94 -37.53 9.36 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 113.957 -1.474 . . . . 0.0 114.336 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.68 123.86 24.94 Favored Pre-proline 0 N--CA 1.482 1.147 0 O-C-N 123.863 0.727 . . . . 0.0 111.485 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.609 ' HA ' ' HB2' ' A' ' 57' ' ' GLN . 96.8 Cg_exo -51.3 -42.43 54.39 Favored 'Trans proline' 0 N--CA 1.482 0.851 0 C-N-CA 123.973 3.116 . . . . 0.0 112.03 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -71.91 -56.07 6.36 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.922 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.7 -127.28 9.09 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.932 1.253 . . . . 0.0 110.522 171.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 21.2 mt -112.17 -13.13 13.56 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 113.931 -1.135 . . . . 0.0 113.241 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.3 p -103.69 -55.73 2.33 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 117.519 -3.238 . . . . 0.0 114.05 171.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.4 mmt-85 -64.22 -48.39 76.65 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-O 116.03 -1.938 . . . . 0.0 114.593 -174.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -65.41 -41.7 14.96 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.415 2.077 . . . . 0.0 112.912 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.73 -38.22 60.47 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.41 -41.68 94.4 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.919 0.887 . . . . 0.0 113.013 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -67.5 -44.44 78.48 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.344 1.058 . . . . 0.0 111.631 175.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -58.36 -45.76 87.61 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.256 1.423 . . . . 0.0 111.447 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.754 HG11 ' HA ' ' A' ' 47' ' ' LEU . 51.9 t -53.88 -46.7 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 124.296 1.038 . . . . 0.0 111.672 173.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -57.05 -44.99 83.55 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 118.98 -0.534 . . . . 0.0 111.876 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -62.36 -47.79 82.65 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.501 1.126 . . . . 0.0 112.627 174.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.24 -39.52 83.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.68 1.192 . . . . 0.0 114.174 175.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -60.03 -26.24 65.95 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 172.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.86 -20.93 64.9 Favored Glycine 0 CA--C 1.546 1.977 0 O-C-N 124.535 1.147 . . . . 0.0 114.187 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -99.95 145.84 27.37 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.592 1.187 . . . . 0.0 113.307 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.1 p -73.14 -37.04 66.75 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.334 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.6 p -63.38 160.55 15.86 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 124.599 1.187 . . . . 0.0 112.121 168.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -107.05 110.57 22.73 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.655 HD13 ' HB2' ' A' ' 65' ' ' ALA . 46.2 mm -72.43 92.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.024 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.2 107.44 14.0 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 110.845 -2.889 . . . . 0.0 107.886 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.96 101.85 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.269 -176.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.579 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 9.5 m -96.74 118.69 33.75 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 113.523 -1.671 . . . . 0.0 112.043 -177.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.9 t -130.53 114.37 15.4 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.325 171.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 p30 43.26 70.13 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 125.372 1.469 . . . . 0.0 114.17 -172.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.91 -35.5 1.24 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-N 113.389 -1.732 . . . . 0.0 115.241 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -74.34 108.58 7.21 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.163 0.985 . . . . 0.0 111.415 -174.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.5 m -98.96 100.62 11.82 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.871 176.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -105.91 115.31 30.01 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.837 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.3 t -64.56 119.06 9.75 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.889 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -23.13 65.96 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.433 -1.712 . . . . 0.0 113.525 171.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -70.78 -24.07 62.52 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.137 177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.9 t -103.07 123.43 46.63 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.217 0.532 . . . . 0.0 111.393 167.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.754 ' HA ' HG11 ' A' ' 23' ' ' VAL . 32.4 tp -42.91 -61.32 1.31 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 111.041 -2.8 . . . . 0.0 114.919 -171.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -82.75 -6.96 59.66 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -74.01 -58.31 3.39 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.8 tp -54.11 -39.51 66.48 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -67.24 -2.88 6.52 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.2 t -133.1 59.37 1.74 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 124.578 2.132 . . . . 0.0 112.538 166.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.518 HD23 HD21 ' A' ' 55' ' ' LEU . 40.2 tp -110.3 -50.71 2.94 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 113.08 -1.873 . . . . 0.0 113.095 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.72 90.12 1.93 Allowed Glycine 0 CA--C 1.531 1.087 0 N-CA-C 107.804 -2.119 . . . . 0.0 107.804 -169.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.518 HD21 HD23 ' A' ' 53' ' ' LEU . 59.4 mt -122.88 90.25 3.26 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.054 -1.073 . . . . 0.0 109.44 -171.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.4 t -162.94 157.81 21.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 126.385 2.303 . . . . 0.0 109.346 -164.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.609 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 32.6 tt0 -40.05 132.04 1.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -175.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.19 -20.58 32.65 Favored Glycine 0 N--CA 1.479 1.553 0 CA-C-N 113.003 -1.908 . . . . 0.0 114.518 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.3 p -60.98 108.06 0.81 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 122.925 1.345 . . . . 0.0 112.992 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.3 94.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 110.779 -2.919 . . . . 0.0 106.919 -175.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.5 m -92.25 98.0 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 113.648 -1.614 . . . . 0.0 112.691 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.579 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 4.8 m -73.66 88.03 1.69 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 111.834 -2.439 . . . . 0.0 108.778 175.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.445 HG23 HG23 ' A' ' 33' ' ' ILE . 85.9 mt -82.22 108.28 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.158 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.3 m -120.0 136.74 54.44 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 113.404 -1.725 . . . . 0.0 113.427 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.655 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -144.83 130.81 19.3 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.042 172.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.465 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 25.2 tt0 -123.19 118.65 28.12 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.682 -1.145 . . . . 0.0 107.984 163.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 170.14 -173.44 44.17 Favored Glycine 0 N--CA 1.478 1.486 0 CA-C-N 113.93 -1.486 . . . . 0.0 112.697 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.418 ' HG2' ' H ' ' A' ' 68' ' ' GLU . 4.5 mm-40 -47.41 -45.95 25.91 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 125.015 1.326 . . . . 0.0 113.667 -178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -114.22 34.78 4.49 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.592 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 8.5 pt-20 -46.05 -72.85 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 -175.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.592 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -52.22 -43.33 64.21 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 177.076 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -62.77 -45.82 90.9 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.319 -1.31 . . . . 0.0 112.864 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -57.1 -52.44 65.27 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.481 1.113 . . . . 0.0 112.802 174.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.6 t -64.75 -46.36 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.952 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -55.07 -52.25 63.8 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -60.78 -48.42 81.9 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.888 0.875 . . . . 0.0 113.076 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.4 mt -63.03 -37.79 88.6 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.82 -45.27 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.316 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -55.15 -54.35 44.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 123.617 0.573 . . . . 0.0 111.052 173.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -49.36 -54.86 15.12 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 125.636 1.575 . . . . 0.0 111.846 175.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -58.12 -40.62 81.71 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.466 1.106 . . . . 0.0 113.07 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.79 -44.06 64.6 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 175.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -70.56 -3.27 17.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.518 1.527 . . . . 0.0 114.293 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.9 mt -90.15 101.8 14.51 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.856 1.262 . . . . 0.0 110.761 169.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 C--O 1.254 1.291 0 O-C-N 124.985 1.428 . . . . 0.0 112.388 -178.087 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ttt . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.498 ' HB3' HG21 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -77.77 141.84 39.02 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.282 -1.326 . . . . 0.0 113.091 173.623 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -148.55 127.82 12.98 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.427 -1.715 . . . . 0.0 110.031 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -126.77 117.7 23.2 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.012 0.82 . . . . 0.0 112.597 164.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -84.06 97.81 9.52 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 125.643 1.84 . . . . 0.0 108.623 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.795 HG23 HG23 ' A' ' 61' ' ' VAL . 2.7 m -125.93 141.48 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 113.592 -1.64 . . . . 0.0 112.491 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.4 p -107.77 137.87 45.02 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.3 mt -76.75 122.85 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.487 175.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.2 p -91.49 -43.47 9.67 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.107 -1.406 . . . . 0.0 114.114 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -28.77 133.44 0.19 Allowed Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 126.978 2.111 . . . . 0.0 115.121 175.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 54.5 Cg_exo -54.53 -54.19 4.98 Favored 'Trans proline' 0 N--CA 1.482 0.841 0 C-N-CA 124.296 3.331 . . . . 0.0 112.49 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.415 ' H ' ' ND2' ' A' ' 12' ' ' ASN . 3.8 p30 -78.15 -43.59 28.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.166 0.986 . . . . 0.0 112.559 176.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 56' ' ' THR . . . 101.12 -152.91 19.02 Favored Glycine 0 N--CA 1.475 1.239 0 C-N-CA 125.464 1.507 . . . . 0.0 110.508 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.8 mt -87.57 -26.98 22.85 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 172.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.2 p -109.69 -43.05 4.13 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 117.679 -3.138 . . . . 0.0 115.631 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.421 ' HD3' ' HA ' ' A' ' 17' ' ' ARG 0.279 83.0 mmt-85 -85.32 -44.06 0.65 Allowed Pre-proline 0 N--CA 1.483 1.205 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 -176.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -62.74 -37.35 56.89 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 121.528 1.486 . . . . 0.0 111.703 164.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.27 -40.95 71.6 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.96 -36.97 75.72 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 173.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -66.66 -49.77 65.08 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.822 0.701 . . . . 0.0 111.418 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -54.99 -43.48 73.6 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 124.045 0.841 . . . . 0.0 111.45 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 44' ' ' ALA . 40.1 t -53.18 -61.83 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.657 1.183 . . . . 0.0 111.324 171.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -49.23 -46.37 45.8 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 124.176 0.922 . . . . 0.0 111.822 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.32 -55.62 17.22 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.678 1.236 . . . . 0.0 112.906 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.56 -30.17 70.49 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -55.51 -30.82 61.36 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 170.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.99 -5.9 66.47 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.12 1.343 . . . . 0.0 114.896 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -95.89 142.48 28.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.153 0.581 . . . . 0.0 111.737 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.7 p -63.87 -39.01 93.2 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.174 0.99 . . . . 0.0 111.51 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 p -62.04 141.43 58.09 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.372 -1.285 . . . . 0.0 112.71 168.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -94.26 108.56 20.43 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 123.311 1.529 . . . . 0.0 110.117 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.486 HD11 ' HB1' ' A' ' 73' ' ' ALA . 37.4 mm -73.79 106.91 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 111.228 -2.715 . . . . 0.0 109.87 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.4 p -108.8 110.41 21.78 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 122.806 1.288 . . . . 0.0 112.063 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.523 HG13 ' HA ' ' A' ' 61' ' ' VAL . 30.0 t -81.87 106.27 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 112.379 -2.192 . . . . 0.0 109.057 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.455 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 19.5 m -85.72 105.67 16.42 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 122.354 1.073 . . . . 0.0 110.016 172.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.8 t -118.75 109.42 16.06 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 113.338 -1.756 . . . . 0.0 110.458 171.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 p30 43.94 71.25 0.26 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.72 9.25 37.85 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-N 112.99 -1.914 . . . . 0.0 116.349 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.415 ' HE3' HD12 ' A' ' 53' ' ' LEU . 40.5 mtmt -118.82 99.25 6.64 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 122.328 -0.513 . . . . 0.0 110.841 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.4 m -79.97 98.76 7.31 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.651 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.88 124.53 49.11 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 113.366 -1.743 . . . . 0.0 112.709 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.6 t -70.37 132.17 45.22 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 113.164 -1.835 . . . . 0.0 113.297 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.479 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -74.77 -25.37 59.03 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 113.924 -1.489 . . . . 0.0 114.054 167.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -73.69 -27.27 61.13 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.8 t -96.16 92.65 6.51 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.347 1.07 . . . . 0.0 109.177 171.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.2 tp -37.78 -55.01 1.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 126.98 2.112 . . . . 0.0 114.529 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.482 ' O ' HG22 ' A' ' 52' ' ' THR . 80.3 m-85 -65.69 -33.48 75.99 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -59.98 -49.48 77.52 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tp -63.84 -39.63 94.68 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -65.69 -37.49 86.62 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 48' ' ' PHE . 12.4 t -99.84 78.69 2.14 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 125.046 2.355 . . . . 0.0 111.91 175.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.415 HD12 ' HE3' ' A' ' 40' ' ' LYS . 37.2 tp -149.58 -51.0 0.15 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 111.361 -2.654 . . . . 0.0 112.473 -173.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.427 ' O ' HG21 ' A' ' 59' ' ' THR . . . 96.5 65.26 0.93 Allowed Glycine 0 N--CA 1.472 1.06 0 O-C-N 125.467 1.73 . . . . 0.0 110.387 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 78.7 mt -85.14 91.63 8.17 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.441 0.638 . . . . 0.0 110.258 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.528 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 6.4 t -135.91 -163.43 1.4 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.373 -171.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -63.8 118.83 8.9 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.825 0.85 . . . . 0.0 111.145 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.11 -10.05 76.04 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-N 113.6 -1.636 . . . . 0.0 115.371 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.427 HG21 ' O ' ' A' ' 54' ' ' GLY . 67.2 p -75.81 142.5 42.25 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 117.656 0.728 . . . . 0.0 112.383 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.28 137.21 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 113.022 -1.899 . . . . 0.0 109.307 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.795 HG23 HG23 ' A' ' 6' ' ' VAL . 3.2 m -110.54 78.85 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-N 112.473 -2.149 . . . . 0.0 107.398 165.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.455 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 3.0 m -74.95 86.29 2.28 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 173.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.478 HG23 HG23 ' A' ' 33' ' ' ILE . 57.1 mt -74.72 87.65 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.246 -173.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 75.0 m -88.67 125.55 34.89 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 112.806 -1.997 . . . . 0.0 110.272 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.55 136.15 20.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.281 -1.327 . . . . 0.0 113.489 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -130.91 128.66 40.97 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.334 1.022 . . . . 0.0 110.067 172.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.39 -176.93 30.44 Favored Glycine 0 N--CA 1.492 2.428 0 O-C-N 124.193 0.933 . . . . 0.0 115.142 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -53.85 -33.79 57.38 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -111.61 19.18 18.35 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -46.8 -51.93 15.31 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.474 ' NE2' ' H ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -62.54 -42.58 99.62 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 177.133 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -69.09 -46.13 68.55 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.477 -177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.486 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -53.67 -53.98 44.36 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.313 1.445 . . . . 0.0 113.133 174.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.498 HG21 ' HB3' ' A' ' 2' ' ' PHE . 79.8 t -59.09 -52.75 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.36 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.34 -47.54 81.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.737 0.815 . . . . 0.0 113.14 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -57.48 -55.46 34.58 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.84 1.256 . . . . 0.0 111.423 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.9 mt -66.44 -30.17 70.47 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.7 t -65.58 -48.56 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 123.373 0.42 . . . . 0.0 110.059 170.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -63.62 -44.8 92.88 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 117.94 -1.029 . . . . 0.0 113.294 175.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.7 tp -51.51 -51.52 54.52 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.359 1.063 . . . . 0.0 111.313 172.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -57.75 -42.57 84.24 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.051 0.94 . . . . 0.0 112.994 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.28 -43.87 66.33 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -82.98 35.68 0.48 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.845 1.658 . . . . 0.0 112.932 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 mt -127.03 117.06 21.72 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.572 1.549 . . . . 0.0 112.704 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 . . . . . 0 C--O 1.259 1.572 0 C-N-CA 126.073 1.749 . . . . 0.0 108.473 -177.354 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttt . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -110.48 136.89 48.92 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 125.958 2.036 . . . . 0.0 109.883 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -120.02 143.72 47.92 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 113.336 -1.756 . . . . 0.0 109.171 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -141.95 102.07 4.07 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.525 1.141 . . . . 0.0 109.674 171.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -81.87 102.13 10.66 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 111.938 -2.392 . . . . 0.0 108.682 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.48 HG23 HG23 ' A' ' 61' ' ' VAL . 5.2 m -125.02 158.2 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 112.507 -2.133 . . . . 0.0 111.76 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.484 HG22 HG22 ' A' ' 60' ' ' VAL . 81.5 p -109.68 137.46 47.46 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.805 0.812 . . . . 0.0 111.696 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.2 mt -91.53 93.18 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 166.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 p -86.43 -17.05 35.3 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 111.424 -2.625 . . . . 0.0 115.43 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.49 133.97 85.53 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.611 1.165 . . . . 0.0 112.155 175.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -44.55 -51.49 7.04 Favored 'Trans proline' 0 CA--C 1.541 0.836 1 C-N-CA 125.318 4.012 . . . . 0.0 116.563 -170.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -106.13 -27.64 10.97 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 172.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.21 -108.67 2.6 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 124.467 1.032 . . . . 0.0 112.691 170.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . 33.1 mt -112.92 -24.6 9.44 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -175.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.8 p -112.12 -43.19 3.59 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 117.813 -3.054 . . . . 0.0 111.817 167.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.415 ' HB2' ' HD3' ' A' ' 18' ' ' PRO 0.256 88.5 mmt-85 -74.74 -56.45 2.21 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-O 115.721 -2.085 . . . . 0.0 115.011 -175.576 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 87.0 Cg_exo -59.47 -34.57 97.18 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.778 2.319 . . . . 0.0 113.952 174.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.7 -25.99 2.08 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 172.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.26 98.57 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -65.99 -38.83 89.51 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.977 0.911 . . . . 0.0 112.674 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.41 -42.01 86.23 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.06 0.85 . . . . 0.0 112.134 172.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.686 HG21 ' HA ' ' A' ' 47' ' ' LEU . 73.3 t -64.92 -51.5 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.274 0.63 . . . . 0.0 112.06 170.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -49.87 -43.13 48.98 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.606 1.162 . . . . 0.0 112.608 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -67.58 -51.67 47.64 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.019 0.824 . . . . 0.0 111.915 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.49 -32.18 73.56 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HE2' ' O ' ' A' ' 45' ' ' LYS . 25.8 mmtt -44.65 -39.39 5.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.896 1.278 . . . . 0.0 114.431 167.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.35 -32.22 75.39 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 125.15 1.531 . . . . 0.0 114.898 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -74.82 133.46 41.91 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.0 p -65.89 -46.87 76.78 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.972 -173.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.2 p -66.53 137.75 57.01 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.817 1.647 . . . . 0.0 111.473 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -83.95 101.57 11.8 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 122.876 1.322 . . . . 0.0 111.758 -178.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' A' ' 44' ' ' ALA . 6.9 mm -70.05 100.41 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.281 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.2 p -94.2 103.93 15.96 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.325 174.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.6 96.29 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 112.776 -2.011 . . . . 0.0 107.514 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.6 m -88.84 104.52 17.0 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 113.473 -1.694 . . . . 0.0 111.322 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.4 t -108.31 99.24 8.67 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.72 172.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 p30 47.57 75.0 0.14 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.853 1.661 . . . . 0.0 114.011 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.05 -39.77 1.18 Allowed Glycine 0 CA--C 1.542 1.771 0 CA-C-N 113.176 -1.829 . . . . 0.0 114.044 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -77.03 106.9 9.01 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 123.606 1.67 . . . . 0.0 110.807 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -108.86 106.38 16.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 112.355 -2.202 . . . . 0.0 110.621 -170.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.464 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -110.47 122.63 48.18 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.93 -175.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.2 t -64.91 119.05 9.96 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 113.468 -1.696 . . . . 0.0 111.676 174.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.523 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . . . -66.66 -11.34 53.48 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.296 -1.774 . . . . 0.0 114.568 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.468 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 95.2 mttt -72.84 -21.12 61.0 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 166.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.5 t -112.55 99.97 8.37 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.38 1.072 . . . . 0.0 112.596 -174.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.686 ' HA ' HG21 ' A' ' 23' ' ' VAL . 19.0 tp -36.77 -54.88 0.9 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 112.99 -1.914 . . . . 0.0 115.131 178.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -63.48 -46.4 86.33 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.495 -1.684 . . . . 0.0 113.659 -172.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.8 tttm -63.03 -44.42 95.96 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.275 0.63 . . . . 0.0 112.282 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.8 tp -66.61 -44.03 83.2 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -60.56 -26.12 66.69 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.3 t -108.41 60.61 0.61 Allowed 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 124.449 2.071 . . . . 0.0 112.415 172.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.564 HD23 HD21 ' A' ' 55' ' ' LEU . 8.9 tp -124.99 -48.38 1.75 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 111.804 -2.453 . . . . 0.0 110.799 175.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.09 67.41 0.81 Allowed Glycine 0 CA--C 1.535 1.329 0 O-C-N 124.833 1.333 . . . . 0.0 110.57 176.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.564 HD21 HD23 ' A' ' 53' ' ' LEU . 57.5 mt -88.01 86.68 7.16 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.084 0.945 . . . . 0.0 110.151 -174.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -133.81 -175.24 3.77 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 112.211 -2.268 . . . . 0.0 113.772 -169.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -59.02 112.96 1.87 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.766 2.426 . . . . 0.0 111.915 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.08 -6.9 56.71 Favored Glycine 0 CA--C 1.547 2.076 0 CA-C-N 112.992 -1.913 . . . . 0.0 114.489 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.0 p -75.66 103.34 5.72 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 7' ' ' THR . 47.7 t -65.38 115.21 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 112.858 -1.974 . . . . 0.0 109.05 170.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.48 HG23 HG23 ' A' ' 6' ' ' VAL . 13.5 m -118.94 106.12 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 112.971 -1.922 . . . . 0.0 111.658 -177.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 42.5 m -83.44 95.18 8.18 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 112.233 -2.258 . . . . 0.0 109.358 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -89.48 91.82 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 112.103 -2.317 . . . . 0.0 108.443 -175.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.0 m -104.58 122.48 45.7 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 111.334 -2.666 . . . . 0.0 112.266 -170.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -137.3 147.96 46.02 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 124.86 1.35 . . . . 0.0 112.627 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -134.37 128.29 33.34 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.692 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.08 -159.78 24.76 Favored Glycine 0 N--CA 1.489 2.181 0 O-C-N 124.491 1.119 . . . . 0.0 114.82 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -49.66 -34.98 19.95 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -119.94 12.76 12.1 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 118.947 2.943 . . . . 0.0 118.947 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -33.02 -54.28 0.38 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.432 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -68.38 -60.22 2.61 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 176.2 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -53.62 -34.46 58.61 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.683 1.593 . . . . 0.0 114.055 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.19 -59.55 3.35 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.825 1.25 . . . . 0.0 112.775 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.87 -51.77 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.928 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -49.27 -51.82 31.31 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.428 1.091 . . . . 0.0 112.71 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -58.83 -55.55 33.69 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.05 0.94 . . . . 0.0 112.416 176.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.4 tp -61.91 -36.88 82.64 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.238 1.415 . . . . 0.0 113.252 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.48 HG11 HG11 ' A' ' 6' ' ' VAL . 86.5 t -73.58 -36.28 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.793 0.837 . . . . 0.0 111.583 175.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -60.12 -37.19 79.27 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 118.2 -0.905 . . . . 0.0 113.17 168.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.3 tp -57.34 -40.68 78.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 123.886 0.741 . . . . 0.0 112.211 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -69.28 -27.08 65.1 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.76 1.224 . . . . 0.0 113.377 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.57 -26.63 26.02 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.538 1.135 . . . . 0.0 113.372 176.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -89.71 28.79 1.25 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.15 1.38 . . . . 0.0 113.227 170.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.3 mt -126.53 153.04 45.72 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.664 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 C--O 1.248 1.021 0 O-C-N 125.662 1.852 . . . . 0.0 107.292 171.115 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 ttt . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -95.1 130.19 41.9 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 124.595 1.184 . . . . 0.0 109.157 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -125.4 122.08 35.71 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.303 -1.771 . . . . 0.0 110.004 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -122.58 119.1 29.84 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.488 1.137 . . . . 0.0 112.343 170.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -96.99 89.2 4.74 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.927 -1.942 . . . . 0.0 108.915 -174.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 m -111.68 141.4 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 114.089 -1.414 . . . . 0.0 114.419 -169.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.583 HG22 HG22 ' A' ' 60' ' ' VAL . 17.1 p -89.72 116.35 27.77 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 114.665 -1.152 . . . . 0.0 113.931 -173.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.16 101.98 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 166.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.0 p -94.09 -11.88 29.66 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 112.391 -2.186 . . . . 0.0 114.23 174.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -63.74 131.53 94.92 Favored Pre-proline 0 N--CA 1.481 1.112 0 C-N-CA 125.344 1.458 . . . . 0.0 111.092 175.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 98.7 Cg_exo -50.44 -50.25 14.12 Favored 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 124.205 3.27 . . . . 0.0 114.132 -174.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -98.68 -48.38 4.98 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.08 0.863 . . . . 0.0 112.769 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.09 -126.94 7.68 Favored Glycine 0 N--CA 1.48 1.616 0 O-C-N 124.269 0.981 . . . . 0.0 113.086 170.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 60.5 mt -85.15 -38.09 19.44 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -176.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.0 p -105.69 -50.35 3.22 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 117.778 -3.076 . . . . 0.0 115.575 174.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.265 5.5 mmt180 -80.75 -46.45 1.24 Allowed Pre-proline 0 N--CA 1.482 1.162 0 CA-C-O 116.774 -1.584 . . . . 0.0 115.173 -172.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -61.19 -37.09 76.99 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 121.983 1.789 . . . . 0.0 112.585 166.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.21 -42.86 66.73 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 170.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.427 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . . . -64.63 -38.17 90.08 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 174.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -64.85 -41.55 95.61 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.317 1.047 . . . . 0.0 112.62 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.472 ' HD1' HD22 ' A' ' 80' ' ' LEU . 18.4 t80 -59.73 -44.3 93.81 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.972 1.309 . . . . 0.0 111.425 172.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.1 t -59.59 -44.65 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 124.073 0.949 . . . . 0.0 111.982 173.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -48.75 -51.23 30.07 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.9 0.88 . . . . 0.0 111.254 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -65.85 -55.78 15.27 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 124.961 1.413 . . . . 0.0 111.766 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.53 -34.7 62.21 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -56.84 -28.32 61.47 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 172.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.81 3.1 65.66 Favored Glycine 0 N--CA 1.49 2.287 0 O-C-N 125.199 1.562 . . . . 0.0 114.874 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -102.6 153.83 19.72 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.546 0.738 . . . . 0.0 111.469 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.4 p -63.08 -44.35 96.01 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.396 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 p -64.04 151.71 42.22 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -97.88 110.63 23.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 113.942 -1.481 . . . . 0.0 107.94 166.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' A' ' 44' ' ' ALA . 3.5 mm -81.19 119.11 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 CA-C-N 111.878 -2.419 . . . . 0.0 109.189 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.08 113.5 27.07 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.091 0.948 . . . . 0.0 112.417 173.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.45 HG22 HG12 ' A' ' 63' ' ' ILE . 92.6 t -94.73 97.69 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 112.634 -2.075 . . . . 0.0 106.345 175.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.8 m -95.91 122.29 38.56 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 113.414 -1.721 . . . . 0.0 110.997 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.431 ' HB2' HG12 ' A' ' 61' ' ' VAL . 22.6 t -128.55 96.6 4.45 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.74 -177.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.8 p30 33.77 90.25 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 126.481 1.912 . . . . 0.0 115.707 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.92 -66.7 3.29 Favored Glycine 0 N--CA 1.479 1.529 0 CA-C-N 112.729 -2.032 . . . . 0.0 112.109 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.54 135.55 47.1 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 115.134 -0.533 . . . . 0.0 111.33 -172.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.4 t -123.25 118.1 26.81 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 124.717 1.261 . . . . 0.0 111.878 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.481 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -111.67 111.36 22.29 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 114.05 -1.432 . . . . 0.0 114.172 -174.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.8 t -61.88 124.37 20.59 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 113.445 -1.707 . . . . 0.0 112.66 169.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . . . -83.31 7.06 17.64 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.032 -1.44 . . . . 0.0 113.843 171.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -94.92 -10.84 29.92 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 160.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 39.0 t -109.72 114.97 29.0 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.177 0.991 . . . . 0.0 110.234 171.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 tp -49.88 -53.57 25.03 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.287 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -64.45 -38.32 90.63 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 15.1 mttm -60.68 -49.63 76.73 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.11 -39.16 91.58 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 173.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.427 ' NE2' ' HB2' ' A' ' 20' ' ' ALA . 90.0 mt-30 -67.67 -32.91 73.91 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 -177.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 t -116.31 67.85 0.72 Allowed 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 124.039 1.876 . . . . 0.0 113.089 170.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.481 HD13 ' HB2' ' A' ' 42' ' ' ALA . 41.6 tp -116.17 -50.91 2.65 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 111.717 -2.492 . . . . 0.0 113.79 174.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.96 78.6 1.19 Allowed Glycine 0 N--CA 1.477 1.369 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -170.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 36.3 mt -107.33 80.87 1.46 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.286 -0.957 . . . . 0.0 110.737 -173.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.6 t -142.58 175.5 9.75 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.844 -1.526 . . . . 0.0 114.208 -165.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -50.6 127.2 17.34 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.615 1.966 . . . . 0.0 111.442 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.07 -29.45 10.67 Favored Glycine 0 N--CA 1.482 1.737 0 CA-C-N 112.853 -1.976 . . . . 0.0 113.058 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.8 p -66.98 113.15 4.76 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.583 HG22 HG22 ' A' ' 7' ' ' THR . 4.4 t -86.04 105.42 14.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 112.739 -2.028 . . . . 0.0 105.797 171.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.431 HG12 ' HB2' ' A' ' 37' ' ' SER . 18.4 m -99.55 105.76 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 113.761 -1.563 . . . . 0.0 112.342 -174.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.92 95.71 1.6 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.233 -1.803 . . . . 0.0 109.952 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.45 HG12 HG22 ' A' ' 35' ' ' VAL . 79.6 mt -82.18 97.14 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.649 174.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.7 m -110.03 121.54 45.5 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 112.679 -2.055 . . . . 0.0 109.926 -175.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.96 138.41 45.45 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -133.76 141.73 47.63 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.166 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.78 -150.49 19.04 Favored Glycine 0 CA--C 1.538 1.527 0 O-C-N 124.9 1.375 . . . . 0.0 110.62 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.09 -60.62 3.49 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -91.64 39.26 1.0 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -52.31 -55.76 19.31 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -45.45 77.53 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.43 1.092 . . . . 0.0 113.06 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -59.59 -50.26 74.56 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.819 1.248 . . . . 0.0 112.049 -176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.19 -54.06 51.08 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.294 1.038 . . . . 0.0 112.728 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.6 t -62.41 -48.49 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-O 118.06 -0.971 . . . . 0.0 111.045 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -54.23 -53.5 52.72 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.299 1.04 . . . . 0.0 111.718 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -56.33 -52.29 65.09 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.341 1.057 . . . . 0.0 112.449 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.9 mt -66.44 -34.5 78.09 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.95 -51.42 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-O 118.849 -0.596 . . . . 0.0 109.971 170.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -58.34 -42.91 87.89 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.472 HD22 ' HD1' ' A' ' 22' ' ' PHE . 5.2 tt -55.04 -56.87 14.98 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.245 1.018 . . . . 0.0 111.639 174.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -57.75 -39.28 76.99 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.842 0.857 . . . . 0.0 112.774 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.83 -29.55 69.51 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -86.51 -25.05 25.3 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.3 tp -74.55 141.33 44.8 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.087 0.955 . . . . 0.0 110.691 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -176.958 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 ttt . . . . . 0 C--O 1.233 0.203 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -121.74 111.58 17.34 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.941 0.776 . . . . 0.0 111.056 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -108.8 116.36 31.83 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 112.603 -2.09 . . . . 0.0 110.45 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.406 ' HB2' HG11 ' A' ' 74' ' ' VAL . 9.4 tt0 -119.62 118.13 30.17 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.251 172.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -89.7 111.66 22.7 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 112.745 -2.025 . . . . 0.0 107.427 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.435 HG11 HG13 ' A' ' 78' ' ' VAL . 20.2 m -127.75 162.09 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.713 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.544 HG22 HG22 ' A' ' 60' ' ' VAL . 44.1 p -113.4 137.65 51.22 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.083 171.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 mt -95.92 111.47 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.426 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 1.7 p -103.74 -18.73 14.57 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.98 141.93 74.95 Favored Pre-proline 0 C--O 1.256 1.438 0 CA-C-O 116.989 -1.482 . . . . 0.0 114.173 177.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.93 -56.83 2.7 Favored 'Trans proline' 0 N--CA 1.493 1.475 1 C-N-CA 125.973 4.449 . . . . 0.0 116.256 -169.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -102.67 -20.27 14.47 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.4 -118.26 11.55 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.236 1.874 . . . . 0.0 113.19 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.7 mt -97.91 -22.77 16.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 112.096 -2.052 . . . . 0.0 114.415 -176.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.0 p -104.95 -59.66 1.72 Allowed 'General case' 0 N--CA 1.474 0.764 0 O-C-N 117.258 -3.401 . . . . 0.0 113.554 171.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -75.26 -43.35 4.4 Favored Pre-proline 0 N--CA 1.486 1.348 0 CA-C-O 115.932 -1.985 . . . . 0.0 114.68 -172.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -61.81 -26.48 79.49 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 121.974 1.782 . . . . 0.0 112.091 166.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -75.05 -35.38 61.9 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.148 0.579 . . . . 0.0 112.476 175.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . . . -57.96 -38.03 75.27 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.746 1.219 . . . . 0.0 112.482 168.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -65.14 -43.46 91.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.621 0.768 . . . . 0.0 111.971 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -64.05 -39.25 93.67 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.465 1.106 . . . . 0.0 111.558 175.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 19' ' ' ALA . 91.4 t -58.53 -49.26 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 125.005 1.322 . . . . 0.0 111.877 173.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -56.21 -42.95 78.04 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.04 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -68.71 -42.26 77.94 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.188 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.12 -27.49 68.08 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -68.93 -11.48 60.69 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 172.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.51 -33.18 7.27 Favored Glycine 0 N--CA 1.481 1.674 0 C-N-CA 124.774 1.178 . . . . 0.0 112.957 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -72.6 128.45 35.6 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.081 1.352 . . . . 0.0 111.765 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.5 p -54.3 -36.92 64.23 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.457 -1.247 . . . . 0.0 113.659 172.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.3 p -61.69 146.24 49.79 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.371 1.044 . . . . 0.0 111.598 167.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -102.15 98.09 8.3 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 113.663 -1.608 . . . . 0.0 108.991 169.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.489 HD11 ' HB1' ' A' ' 73' ' ' ALA . 36.3 mm -62.22 113.11 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 112.501 -2.136 . . . . 0.0 110.232 177.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.1 p -97.62 134.94 40.14 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.048 165.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.2 t -111.37 94.84 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 111.49 -2.595 . . . . 0.0 108.61 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.541 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 25.9 m -88.52 101.67 14.17 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 111.413 -2.63 . . . . 0.0 112.029 -178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 t -117.85 112.77 20.82 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.841 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.25 20.4 p30 44.73 61.36 2.49 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 126.046 1.738 . . . . 0.0 115.662 -173.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.68 19.87 63.29 Favored Glycine 0 CA--C 1.546 1.974 0 N-CA-C 116.896 1.519 . . . . 0.0 116.896 -176.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.9 mttt -118.75 107.85 14.15 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.743 0.771 . . . . 0.0 109.773 171.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.2 m -90.23 105.71 17.99 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 122.809 1.29 . . . . 0.0 111.606 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.88 105.3 14.43 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.675 -2.057 . . . . 0.0 111.525 -176.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.5 t -50.54 111.35 0.52 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 114.221 -1.354 . . . . 0.0 114.213 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.33 -18.42 65.3 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.283 -1.78 . . . . 0.0 113.666 169.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -77.94 -10.64 59.68 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.2 t -111.81 118.11 34.66 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.48 1.133 . . . . 0.0 112.057 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -46.2 -53.52 10.39 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 111.016 -2.811 . . . . 0.0 113.672 -172.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -69.29 -39.95 78.01 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -64.13 -52.06 60.95 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -167.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.68 -46.43 82.47 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.435 1.094 . . . . 0.0 113.105 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.453 ' NE2' ' HB2' ' A' ' 20' ' ' ALA . 67.0 mt-30 -63.92 -33.87 76.67 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.261 11.1 t -74.23 -48.41 29.01 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.474 HD23 HD21 ' A' ' 55' ' ' LEU . 27.3 tp -37.38 -53.19 1.12 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -167.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.13 67.19 0.52 Allowed Glycine 0 N--CA 1.484 1.839 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.474 HD21 HD23 ' A' ' 53' ' ' LEU . 24.9 mt -81.26 94.77 6.78 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 122.297 1.046 . . . . 0.0 111.4 174.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -150.41 -172.13 4.1 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.301 -2.227 . . . . 0.0 111.213 -168.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 9' ' ' THR . 52.6 tt0 -52.21 125.91 17.24 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.812 2.045 . . . . 0.0 114.617 -176.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.28 22.34 63.07 Favored Glycine 0 N--CA 1.484 1.888 0 CA-C-N 111.704 -2.498 . . . . 0.0 114.595 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.3 p -103.39 104.48 14.59 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 122.536 1.16 . . . . 0.0 112.5 -172.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.544 HG22 HG22 ' A' ' 7' ' ' THR . 4.6 t -69.69 113.57 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 111.156 -2.747 . . . . 0.0 108.725 176.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.71 117.24 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 112.892 -1.958 . . . . 0.0 110.812 -175.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.541 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 4.3 m -87.06 100.31 12.55 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.613 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.488 HG22 HG22 ' A' ' 74' ' ' VAL . 95.2 mt -89.1 101.4 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 113.655 -1.611 . . . . 0.0 108.674 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.4 m -116.46 127.17 54.35 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 109.76 -3.382 . . . . 0.0 111.086 -167.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.23 123.99 40.74 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.475 -176.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -119.13 108.05 14.22 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.931 1.394 . . . . 0.0 108.379 174.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.44 178.21 30.35 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.58 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -51.77 -41.84 61.93 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -176.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 p30 -102.47 39.8 1.46 Allowed 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -176.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -55.04 -40.06 69.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.01 -46.06 10.17 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.723 -176.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -52.39 -46.41 66.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.043 1.737 . . . . 0.0 114.82 171.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.489 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -65.19 -53.46 44.4 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -176.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 63' ' ' ILE . 68.8 t -60.78 -44.47 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.31 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -56.33 -51.44 68.25 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.421 1.089 . . . . 0.0 111.893 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -54.0 -51.58 63.49 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.778 0.831 . . . . 0.0 112.515 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 98.0 mt -65.62 -47.94 73.92 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.435 HG13 HG11 ' A' ' 6' ' ' VAL . 90.0 t -58.56 -38.28 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 118.945 0.793 . . . . 0.0 110.756 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -60.67 -62.98 1.47 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.68 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.8 tp -47.09 -44.17 20.95 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.942 2.097 . . . . 0.0 114.287 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.6 tmm? -53.59 -61.76 2.1 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.684 1.593 . . . . 0.0 112.427 172.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.43 -26.31 66.35 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -68.05 -29.74 68.78 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 172.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 mp -81.2 160.35 24.35 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 122.917 0.487 . . . . 0.0 111.891 171.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 . . . . . 0 C--O 1.261 1.666 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -167.35 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ttt . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -81.85 133.59 35.34 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.479 167.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -137.17 133.87 35.7 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 112.581 -2.1 . . . . 0.0 110.003 -173.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -126.19 111.29 14.43 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.147 172.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.611 ' HG2' HG23 ' A' ' 62' ' ' THR . 34.3 mt-10 -79.3 80.81 5.63 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.913 1.34 . . . . 0.0 109.72 167.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.452 HG21 HG22 ' A' ' 78' ' ' VAL . 3.3 m -107.61 135.49 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 114.158 -1.383 . . . . 0.0 113.899 -175.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 p -76.34 140.56 41.49 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 112.444 -2.162 . . . . 0.0 113.471 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.9 mt -105.54 118.12 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.684 167.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.9 p -112.84 -12.39 13.32 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.32 132.66 95.19 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-O 118.024 -0.988 . . . . 0.0 111.712 173.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -42.88 -54.67 3.19 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 124.725 3.617 . . . . 0.0 116.602 -170.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.428 ' O ' ' HD2' ' A' ' 15' ' ' HIP . 10.1 p30 -97.78 -41.9 7.85 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 174.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.06 -120.66 7.32 Favored Glycine 0 CA--C 1.541 1.681 0 C-N-CA 124.059 0.838 . . . . 0.0 112.36 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 31.4 mt -97.91 -42.59 7.47 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -171.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIP . . . . . 0.428 ' HD2' ' O ' ' A' ' 12' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p -104.21 -50.21 3.41 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 118.036 -2.915 . . . . 0.0 114.879 173.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.425 ' HB2' ' HD3' ' A' ' 18' ' ' PRO 0.283 21.0 mmt180 -76.37 -49.42 3.01 Favored Pre-proline 0 N--CA 1.487 1.41 0 CA-C-O 116.442 -1.742 . . . . 0.0 115.242 -174.241 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.536 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 77.3 Cg_exo -64.5 -31.45 60.9 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 121.698 1.642 . . . . 0.0 113.627 167.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.22 -38.93 77.75 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 169.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.469 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . . . -59.82 -39.97 86.86 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 171.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -61.92 -44.7 96.25 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.628 0.771 . . . . 0.0 112.262 173.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -55.27 -43.69 74.93 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.929 1.292 . . . . 0.0 111.588 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.97 -51.03 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 123.661 0.784 . . . . 0.0 111.895 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -48.56 -47.62 39.29 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.673 0.789 . . . . 0.0 110.995 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.62 -50.89 47.93 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.743 1.277 . . . . 0.0 113.276 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.428 ' HA ' ' HD2' ' A' ' 29' ' ' PHE . . . -54.1 -36.63 63.41 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -60.63 -27.38 67.73 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 173.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.79 -23.17 76.99 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.292 1.425 . . . . 0.0 114.159 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.428 ' HD2' ' HA ' ' A' ' 26' ' ' ALA . 73.6 m-85 -89.98 149.26 22.64 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.952 0.901 . . . . 0.0 110.69 177.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.1 p -71.5 -39.42 70.83 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.39 0.676 . . . . 0.0 112.073 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.5 p -65.71 137.97 57.65 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.681 1.192 . . . . 0.0 114.163 175.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -85.28 104.21 14.92 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.605 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.524 HG23 HG23 ' A' ' 63' ' ' ILE . 47.7 mm -72.93 94.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 111.94 -2.391 . . . . 0.0 110.289 173.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.4 p -89.48 113.86 25.29 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.275 -1.329 . . . . 0.0 108.993 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -100.57 96.52 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 113.183 -1.826 . . . . 0.0 107.563 -177.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 40.8 m -87.92 116.65 26.23 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 112.962 -1.927 . . . . 0.0 111.473 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -111.12 105.85 14.7 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.733 173.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 p30 40.21 69.29 0.32 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.591 1.556 . . . . 0.0 114.204 -173.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.33 -39.71 3.0 Favored Glycine 0 N--CA 1.485 1.918 0 CA-C-N 113.197 -1.819 . . . . 0.0 114.15 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -72.74 99.05 2.51 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.353 1.061 . . . . 0.0 112.438 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.3 m -83.94 108.42 16.91 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.541 -1.663 . . . . 0.0 113.398 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.57 115.13 28.66 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.182 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.9 t -67.08 125.77 27.06 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 113.916 -1.493 . . . . 0.0 113.219 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.84 -5.24 47.51 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 112.402 -2.181 . . . . 0.0 113.422 171.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -83.65 8.2 15.11 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 167.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 t -144.41 131.04 20.02 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.933 0.493 . . . . 0.0 112.129 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.07 -68.31 0.22 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 113.733 -1.576 . . . . 0.0 113.552 -171.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -54.64 -39.38 67.93 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -57.1 -55.0 40.38 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 124.165 0.916 . . . . 0.0 112.935 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 tp -68.0 -48.57 65.37 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.895 1.372 . . . . 0.0 113.616 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.469 ' NE2' ' HB2' ' A' ' 20' ' ' ALA . 57.2 mt-30 -61.41 -34.44 75.37 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 -172.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.2 t -72.17 -20.03 61.66 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.1 tp -70.11 -37.53 75.38 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.51 73.83 1.28 Allowed Glycine 0 N--CA 1.484 1.847 0 O-C-N 124.439 1.087 . . . . 0.0 113.074 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.1 mt -84.81 92.93 8.37 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.387 0.613 . . . . 0.0 110.273 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.9 t -141.5 -175.0 4.2 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -169.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -56.5 112.93 1.4 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.106 0.963 . . . . 0.0 111.146 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.54 -30.8 6.25 Favored Glycine 0 CA--C 1.542 1.72 0 CA-C-N 113.611 -1.631 . . . . 0.0 114.496 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.6 p -70.11 103.58 2.35 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.4 t -68.11 117.78 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 163.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.8 m -118.17 109.59 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 113.654 -1.612 . . . . 0.0 113.004 -175.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.611 HG23 ' HG2' ' A' ' 5' ' ' GLU . 0.6 OUTLIER -75.71 86.87 2.75 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.052 176.355 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.524 HG23 HG23 ' A' ' 33' ' ' ILE . 34.2 mt -78.8 95.28 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.7 m -105.42 128.14 53.37 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 112.948 -1.933 . . . . 0.0 110.693 -174.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.49 116.13 28.34 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -105.97 97.42 7.24 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.74 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.09 -175.05 28.5 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-N 114.536 -1.211 . . . . 0.0 113.361 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -55.88 -54.46 44.34 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 -169.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -83.52 28.88 0.53 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 6.4 pt-20 -38.78 -60.64 0.81 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.464 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -56.89 -50.58 72.07 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 178.732 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -67.09 -40.09 86.89 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -175.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.406 ' CB ' HD11 ' A' ' 33' ' ' ILE . . . -59.34 -52.43 65.65 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 123.767 0.667 . . . . 0.0 112.678 176.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.414 HG22 HG22 ' A' ' 63' ' ' ILE . 47.0 t -63.5 -49.58 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.647 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -49.93 -57.44 7.49 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.573 1.549 . . . . 0.0 112.011 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -59.46 -50.79 72.56 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.898 0.879 . . . . 0.0 113.102 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.4 mt -63.22 -36.05 82.36 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.452 HG22 HG21 ' A' ' 6' ' ' VAL . 90.3 t -62.02 -48.64 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 123.808 0.693 . . . . 0.0 110.566 171.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -54.25 -55.5 27.51 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 118.234 -0.888 . . . . 0.0 113.062 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.8 tp -52.66 -48.97 66.13 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.047 0.939 . . . . 0.0 112.832 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -57.36 -45.53 84.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.402 1.081 . . . . 0.0 112.642 175.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.54 -25.22 60.3 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -74.55 -41.09 61.17 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.15 1.166 . . . . 0.0 114.15 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.7 mt -66.95 150.51 49.13 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.343 1.057 . . . . 0.0 113.342 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 125.564 1.546 . . . . 0.0 109.139 173.878 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.465 0.28 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -119.83 139.94 51.58 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 125.066 1.479 . . . . 0.0 110.01 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -134.03 129.75 36.55 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 124.59 1.181 . . . . 0.0 111.729 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -128.47 136.64 51.1 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.374 1.046 . . . . 0.0 112.454 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -98.89 110.24 22.87 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.187 -1.37 . . . . 0.0 110.449 173.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.679 HG11 HG13 ' A' ' 78' ' ' VAL . 8.5 m -119.79 152.8 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 114.468 -1.242 . . . . 0.0 114.242 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.565 HG22 HG22 ' A' ' 60' ' ' VAL . 20.6 p -111.98 121.94 46.39 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 113.531 -1.668 . . . . 0.0 111.447 -173.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.1 mt -79.69 96.47 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.17 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -74.67 -34.7 62.74 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -55.15 134.42 68.52 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 125.486 1.514 . . . . 0.0 113.67 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 48.8 Cg_exo -45.71 -43.91 18.28 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.539 3.493 . . . . 0.0 117.493 -173.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -114.5 -40.8 3.54 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 172.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.17 -114.47 3.91 Favored Glycine 0 N--CA 1.475 1.279 0 C-N-CA 123.986 0.803 . . . . 0.0 111.769 168.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.559 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 34.1 mt -101.29 -43.89 5.83 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.185 1.179 . . . . 0.0 114.185 -167.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.8 p -107.55 -52.02 2.82 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 118.167 -2.833 . . . . 0.0 114.708 171.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.508 ' HB2' ' HD3' ' A' ' 18' ' ' PRO 0.266 20.2 mmt180 -71.8 -54.08 6.56 Favored Pre-proline 0 N--CA 1.487 1.418 0 CA-C-O 116.579 -1.677 . . . . 0.0 115.168 -174.798 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.559 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 71.5 Cg_exo -62.93 -34.26 71.98 Favored 'Trans proline' 0 N--CA 1.479 0.632 0 CA-C-N 121.899 1.714 . . . . 0.0 113.653 171.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -53.73 -36.91 62.8 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 172.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.71 -40.38 83.51 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 174.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.32 -45.42 91.4 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -55.48 -45.73 76.94 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.795 1.238 . . . . 0.0 110.934 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 19' ' ' ALA . 22.0 t -62.47 -50.22 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 123.403 0.681 . . . . 0.0 111.228 175.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -50.03 -47.08 53.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.289 1.036 . . . . 0.0 112.275 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.09 -49.15 65.96 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 124.269 0.98 . . . . 0.0 113.387 174.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.5 -39.61 76.85 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -47.7 -44.26 27.39 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.71 1.604 . . . . 0.0 113.898 167.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.17 -34.22 69.72 Favored Glycine 0 N--CA 1.475 1.261 0 O-C-N 125.435 1.709 . . . . 0.0 114.355 -176.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -65.69 145.87 55.5 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.306 0.643 . . . . 0.0 111.702 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 57.9 p -64.12 -35.19 79.94 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.216 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.0 p -68.71 144.97 54.24 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.294 -1.321 . . . . 0.0 114.497 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -92.56 118.21 30.77 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.938 169.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.701 HD11 ' HB1' ' A' ' 73' ' ' ALA . 43.1 mm -86.17 103.25 12.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 111.706 -2.497 . . . . 0.0 110.195 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.4 p -103.47 118.91 37.84 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.378 175.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 63' ' ' ILE . 92.6 t -99.24 95.95 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 112.961 -1.927 . . . . 0.0 107.504 -178.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.5 m -91.34 110.29 21.58 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 113.657 -1.61 . . . . 0.0 110.79 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.8 t -108.16 95.27 5.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 113.544 -1.662 . . . . 0.0 109.634 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.3 p30 43.63 72.43 0.19 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.365 1.466 . . . . 0.0 114.349 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.62 -38.93 2.92 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-N 113.028 -1.896 . . . . 0.0 114.496 -175.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -75.45 88.91 2.65 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -175.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.5 m -74.13 113.62 11.54 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.381 -1.282 . . . . 0.0 112.982 170.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.12 122.77 47.99 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.088 170.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.9 t -86.84 128.26 35.04 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.331 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.46 16.28 6.7 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 113.117 -1.856 . . . . 0.0 114.092 176.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -92.58 2.84 56.48 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.663 0.744 . . . . 0.0 112.663 158.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.1 t -127.84 125.93 40.67 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.847 1.659 . . . . 0.0 110.799 172.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.65 -54.04 50.66 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.813 171.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -57.69 -48.93 78.16 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.152 -1.385 . . . . 0.0 113.862 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -60.98 -46.57 90.2 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 tp -68.17 -47.88 66.81 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 123.821 0.7 . . . . 0.0 112.002 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -57.1 -42.26 80.47 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -71.78 -14.51 62.01 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.4 tp -75.37 -42.35 54.2 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.56 82.51 0.7 Allowed Glycine 0 N--CA 1.478 1.481 0 O-C-N 124.394 1.059 . . . . 0.0 112.527 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 85.8 mt -82.85 78.32 9.46 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 122.877 1.322 . . . . 0.0 112.298 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.0 t -85.36 -174.27 5.12 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 111.914 -2.403 . . . . 0.0 112.569 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -60.23 144.23 50.72 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.979 1.712 . . . . 0.0 111.114 175.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.57 -38.07 3.27 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 114.251 -1.34 . . . . 0.0 114.642 171.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.4 p -54.96 104.62 0.12 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.184 1.549 . . . . 0.0 115.184 -174.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 7' ' ' THR . 16.7 t -66.74 112.46 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 112.152 -2.295 . . . . 0.0 107.177 169.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.5 m -119.32 118.08 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 113.35 -1.75 . . . . 0.0 114.641 -172.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.3 m -80.23 100.45 8.33 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 125.447 1.717 . . . . 0.0 109.084 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.448 HG12 HG22 ' A' ' 35' ' ' VAL . 80.2 mt -91.76 102.44 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.586 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 m -100.12 131.66 45.94 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.141 -178.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.12 105.86 13.97 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 124.035 0.835 . . . . 0.0 112.353 172.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -104.06 92.46 4.39 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.233 -1.348 . . . . 0.0 111.266 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.3 -167.55 39.94 Favored Glycine 0 N--CA 1.48 1.623 0 CA-C-N 112.252 -2.249 . . . . 0.0 111.148 174.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.01 -51.5 66.57 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -82.38 36.49 0.48 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.612 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 5.9 pt-20 -45.83 -72.53 0.05 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 -173.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.612 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -50.05 -47.99 53.1 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -179.888 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -63.05 -47.25 83.75 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.577 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.701 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -56.32 -46.08 80.03 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.23 0.957 . . . . 0.0 113.538 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.0 t -67.35 -56.06 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.225 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -51.02 -47.16 61.7 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.477 1.111 . . . . 0.0 112.687 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -53.15 -61.41 2.31 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.032 1.333 . . . . 0.0 112.067 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.9 mt -64.27 -33.23 75.35 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.679 HG13 HG11 ' A' ' 6' ' ' VAL . 11.7 t -62.05 -56.31 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.103 0.961 . . . . 0.0 110.527 171.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -57.55 -48.26 79.82 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.449 1.099 . . . . 0.0 111.25 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.2 tp -54.57 -52.01 63.47 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.448 1.499 . . . . 0.0 111.954 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -57.86 -44.91 86.88 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.226 1.011 . . . . 0.0 112.033 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.54 -33.62 75.43 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -75.85 -30.39 58.9 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.1 mt -67.89 133.21 48.74 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.927 0.891 . . . . 0.0 112.629 175.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 . . . . . 0 C--O 1.255 1.349 0 O-C-N 125.405 1.691 . . . . 0.0 109.836 179.761 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.402 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 4.7 t80 -108.39 129.18 55.26 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 125.72 1.888 . . . . 0.0 108.001 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -126.98 131.23 51.09 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.621 -170.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -129.32 122.87 30.44 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.432 1.082 . . . . 0.0 113.025 168.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -87.03 100.6 12.74 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 112.442 -2.163 . . . . 0.0 107.945 176.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.5 m -116.97 143.52 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 114.22 -1.355 . . . . 0.0 114.173 -173.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.544 HG22 HG22 ' A' ' 60' ' ' VAL . 14.0 p -94.03 122.14 36.23 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.408 1.099 . . . . 0.0 111.495 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.2 mt -78.9 97.92 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.6 167.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.7 p -82.81 -26.66 31.52 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 109.962 -3.29 . . . . 0.0 113.526 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.463 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -51.12 120.63 14.44 Favored Pre-proline 0 N--CA 1.476 0.847 0 O-C-N 124.715 1.259 . . . . 0.0 112.277 177.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 80.8 Cg_exo -57.38 -48.71 16.33 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 123.785 2.99 . . . . 0.0 113.77 -175.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -68.94 -43.46 75.02 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.545 0.338 . . . . 0.0 111.688 170.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 56' ' ' THR . . . 101.88 -148.01 17.62 Favored Glycine 0 N--CA 1.475 1.279 0 O-C-N 124.75 1.281 . . . . 0.0 110.984 174.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.433 HD12 HD13 ' A' ' 55' ' ' LEU . 83.7 mt -98.35 -17.83 18.65 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 113.639 -1.28 . . . . 0.0 112.407 173.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.512 ' HA ' ' HG2' ' A' ' 51' ' ' GLN . 59.6 p -99.28 -61.42 1.37 Allowed 'General case' 0 N--CA 1.48 1.039 0 O-C-N 117.955 -2.966 . . . . 0.0 113.437 176.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.7 -44.23 53.03 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-O 116.874 -1.536 . . . . 0.0 114.903 -175.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -69.17 -33.74 18.12 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.734 1.623 . . . . 0.0 113.391 172.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.49 97.45 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.47 0.708 . . . . 0.0 112.487 171.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.89 -46.2 90.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.235 0.614 . . . . 0.0 112.577 169.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -58.81 -43.7 90.64 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 171.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.16 -43.12 87.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.136 0.974 . . . . 0.0 112.895 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.462 HG11 HD22 ' A' ' 47' ' ' LEU . 59.5 t -61.51 -48.91 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 122.478 0.311 . . . . 0.0 110.95 172.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -52.98 -45.44 67.81 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.498 0.719 . . . . 0.0 112.839 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -64.49 -49.4 71.5 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.568 1.147 . . . . 0.0 112.881 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.88 -29.2 67.45 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -51.91 -26.44 10.26 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 168.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.95 -22.83 77.21 Favored Glycine 0 CA--C 1.543 1.826 0 O-C-N 125.109 1.505 . . . . 0.0 115.704 175.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -96.98 143.4 27.88 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.88 0.847 . . . . 0.0 112.406 -178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.8 p -66.35 -37.15 84.67 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.075 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.9 p -63.84 138.6 58.55 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.748 170.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -95.22 96.67 9.34 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 123.412 1.577 . . . . 0.0 108.95 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mt -77.07 128.81 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 111.612 -2.54 . . . . 0.0 110.542 -172.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.4 p -102.32 134.92 44.83 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.349 173.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.8 t -102.29 90.25 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 170.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.1 m -89.41 112.85 24.08 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.14 -1.391 . . . . 0.0 113.723 -170.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 40' ' ' LYS . 32.4 t -116.27 97.36 6.0 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 124.377 1.048 . . . . 0.0 111.156 173.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 p30 39.59 83.02 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.816 1.646 . . . . 0.0 115.183 -175.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.03 -41.3 1.97 Allowed Glycine 0 CA--C 1.55 2.258 0 CA-C-N 114.266 -1.333 . . . . 0.0 113.71 -173.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 37' ' ' SER . 33.2 mtmt -71.85 79.75 0.88 Allowed 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.4 m -72.02 111.78 7.55 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.029 -1.441 . . . . 0.0 112.937 168.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.09 99.02 9.98 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 113.835 -1.529 . . . . 0.0 112.638 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 t -55.45 119.2 5.26 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.57 1.176 . . . . 0.0 113.186 174.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.17 9.57 1.96 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 112.847 -1.979 . . . . 0.0 114.006 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -104.65 19.99 19.43 Favored 'General case' 0 C--O 1.25 1.082 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 164.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.8 t -140.78 125.42 17.93 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.161 1.384 . . . . 0.0 112.749 174.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.462 HD22 HG11 ' A' ' 23' ' ' VAL . 3.6 mm? -55.73 -44.27 77.38 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 113.58 -1.645 . . . . 0.0 114.209 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -64.39 -39.16 93.32 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.16 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -55.4 -56.41 20.44 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.9 mp -67.91 -31.22 70.85 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -176.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.512 ' HG2' ' HA ' ' A' ' 16' ' ' THR . 36.3 mt-30 -78.64 -34.28 46.62 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.023 -0.99 . . . . 0.0 113.371 176.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.7 t -79.09 -32.51 44.68 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.591 HD23 HD21 ' A' ' 55' ' ' LEU . 17.3 tp -51.97 -49.79 62.54 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.366 1.246 . . . . 0.0 114.366 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.76 89.04 1.78 Allowed Glycine 0 N--CA 1.476 1.352 0 O-C-N 125.352 1.657 . . . . 0.0 110.817 -175.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.591 HD21 HD23 ' A' ' 53' ' ' LEU . 92.0 mt -109.05 99.41 8.73 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.813 -0.694 . . . . 0.0 112.315 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.412 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 12.3 t -150.98 170.57 19.02 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.627 1.571 . . . . 0.0 110.589 -174.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 59.8 tt0 -50.13 118.39 2.92 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.598 1.159 . . . . 0.0 112.987 -172.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.81 -29.4 7.5 Favored Glycine 0 CA--C 1.543 1.781 0 CA-C-N 112.585 -2.098 . . . . 0.0 113.696 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.4 p -62.33 100.91 0.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.544 HG22 HG22 ' A' ' 7' ' ' THR . 3.2 t -78.76 115.9 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 113.356 -1.747 . . . . 0.0 106.811 171.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 m -127.95 129.5 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 113.58 -1.646 . . . . 0.0 112.982 -174.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.4 m -89.05 96.95 10.94 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.421 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.456 HG22 HG22 ' A' ' 74' ' ' VAL . 89.2 mt -67.25 96.83 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 113.476 -1.693 . . . . 0.0 107.404 167.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.6 m -111.27 103.42 11.82 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 112.968 -1.924 . . . . 0.0 111.669 -175.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.28 100.19 12.1 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.624 0.726 . . . . 0.0 112.034 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -99.5 96.36 7.63 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 112.916 -1.947 . . . . 0.0 111.588 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.88 -162.07 28.83 Favored Glycine 0 N--CA 1.48 1.63 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.606 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -60.63 -28.47 68.57 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 120.452 3.501 . . . . 0.0 120.452 -168.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.2 p30 -116.72 50.56 1.06 Allowed 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 2' ' ' PHE . 11.4 pt-20 -49.16 -55.43 12.41 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -174.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -53.29 59.96 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.918 1.287 . . . . 0.0 114.312 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -55.45 -47.45 76.02 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.021 1.328 . . . . 0.0 113.958 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.96 -53.43 57.35 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.571 -1.195 . . . . 0.0 113.372 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.456 HG22 HG22 ' A' ' 63' ' ' ILE . 51.1 t -60.83 -50.63 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 118.936 -0.554 . . . . 0.0 112.128 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -52.78 -57.24 10.81 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.458 1.103 . . . . 0.0 112.841 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -54.55 -50.11 68.72 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.46 1.104 . . . . 0.0 113.075 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 72.1 mt -67.57 -38.03 83.51 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.33 -45.35 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.059 0.543 . . . . 0.0 110.559 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -58.14 -49.05 78.32 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 118.313 -0.851 . . . . 0.0 113.153 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.8 tp -54.19 -51.76 63.38 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.891 0.876 . . . . 0.0 112.586 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -59.64 -44.92 93.32 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.98 0.912 . . . . 0.0 112.884 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.06 91.07 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -79.47 -19.76 49.01 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.9 mt -77.6 124.6 28.13 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 172.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--O 1.249 1.056 0 C-N-CA 127.352 2.261 . . . . 0.0 107.018 173.633 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ttt . . . . . 0 C--O 1.236 0.385 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -117.57 115.33 24.89 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 125.1 1.5 . . . . 0.0 109.123 175.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -102.65 129.92 49.4 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.361 -178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -123.37 103.58 8.58 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 171.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -73.78 95.34 2.38 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.294 -1.776 . . . . 0.0 110.675 172.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.424 HG11 HG13 ' A' ' 78' ' ' VAL . 17.2 m -117.16 146.22 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 113.388 -1.733 . . . . 0.0 113.862 -174.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.448 HG22 HG22 ' A' ' 60' ' ' VAL . 48.0 p -108.56 128.52 54.89 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.714 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.493 HG13 ' SD ' ' A' ' 81' ' ' MET . 1.9 mp -75.81 130.32 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.765 173.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 p -88.18 -37.32 16.24 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.323 171.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -59.61 133.38 88.88 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 125.399 1.48 . . . . 0.0 113.704 -175.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 32.3 Cg_exo -61.52 -68.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 124.166 3.244 . . . . 0.0 112.431 -172.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -62.06 -34.59 76.55 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.906 0.882 . . . . 0.0 112.222 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.37 -126.27 7.78 Favored Glycine 0 N--CA 1.481 1.647 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 168.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . 7.6 mp -88.87 -28.64 20.23 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 113.527 -1.337 . . . . 0.0 113.682 176.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.6 p -106.51 -47.87 3.68 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 117.863 -3.023 . . . . 0.0 115.18 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.315 12.9 mmt180 -88.04 -39.69 0.48 Allowed Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 -173.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -61.74 -38.76 58.03 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 121.983 1.789 . . . . 0.0 111.384 163.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.23 73.58 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 168.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.26 86.88 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -60.2 -46.32 90.13 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 124.181 0.926 . . . . 0.0 112.513 174.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -55.57 -53.64 53.87 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.499 1.12 . . . . 0.0 110.766 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.695 HG11 ' HA ' ' A' ' 47' ' ' LEU . 30.2 t -57.91 -49.75 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.645 0.778 . . . . 0.0 111.313 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -49.74 -52.51 31.07 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.335 1.054 . . . . 0.0 112.992 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -68.97 -43.24 75.36 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.689 1.243 . . . . 0.0 112.772 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.557 ' HA ' ' HD2' ' A' ' 29' ' ' PHE . . . -58.68 -37.8 76.82 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 173.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -53.46 -39.64 64.63 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.0 0.92 . . . . 0.0 112.816 169.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.3 15.0 4.64 Favored Glycine 0 CA--C 1.543 1.792 0 O-C-N 124.747 1.28 . . . . 0.0 115.413 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.557 ' HD2' ' HA ' ' A' ' 26' ' ' ALA . 65.9 m-85 -113.36 152.03 30.49 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.977 0.894 . . . . 0.0 111.992 172.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.4 p -69.94 -40.3 75.56 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.15 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -73.66 145.32 45.39 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.796 0.839 . . . . 0.0 112.882 173.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -96.4 109.78 22.25 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.645 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.687 HG13 ' HB2' ' A' ' 65' ' ' ALA . 5.0 mp -83.22 106.89 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 112.182 -2.281 . . . . 0.0 109.45 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.0 p -102.39 128.5 48.95 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 112.959 -1.928 . . . . 0.0 110.214 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.418 HG11 HD21 ' A' ' 55' ' ' LEU . 59.8 t -107.06 105.0 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 113.288 -1.778 . . . . 0.0 107.569 -176.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.0 m -106.83 126.2 52.0 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.3 t -116.25 97.32 5.98 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 112.99 -1.914 . . . . 0.0 110.02 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.257 4.0 p30 40.63 73.47 0.12 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 113.518 -1.674 . . . . 0.0 114.706 -175.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.09 -53.22 4.19 Favored Glycine 0 N--CA 1.488 2.111 0 CA-C-N 113.705 -1.589 . . . . 0.0 113.513 -178.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -60.72 104.56 0.36 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.38 1.472 . . . . 0.0 113.525 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 t -90.93 136.03 33.34 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.644 1.349 . . . . 0.0 114.644 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.28 97.43 5.06 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 113.879 -1.51 . . . . 0.0 113.081 173.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -54.6 130.21 39.28 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.985 168.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.81 13.81 21.29 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.109 -1.405 . . . . 0.0 114.337 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.63 -8.88 27.92 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.074 153.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -113.09 111.61 22.43 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 123.464 1.602 . . . . 0.0 112.54 169.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.695 ' HA ' HG11 ' A' ' 23' ' ' VAL . 1.4 tm? -54.43 -59.51 4.59 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 111.556 -2.565 . . . . 0.0 114.278 -169.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -65.47 -28.56 69.3 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -54.7 -48.12 72.86 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.4 tp -61.32 -43.26 99.17 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 176.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -58.17 -46.89 84.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 124.051 0.844 . . . . 0.0 112.64 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.2 t -66.72 -37.15 84.1 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.5 tp -66.6 -41.77 87.92 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.41 83.97 0.34 Allowed Glycine 0 N--CA 1.476 1.358 0 C-N-CA 124.348 0.975 . . . . 0.0 115.053 170.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 7.1 mp -75.03 109.47 8.53 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.336 -0.932 . . . . 0.0 109.598 174.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -135.59 -174.7 3.72 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.928 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -52.2 109.15 0.35 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.549 1.94 . . . . 0.0 112.729 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.82 35.2 51.29 Favored Glycine 0 CA--C 1.543 1.837 0 CA-C-N 114.627 -1.17 . . . . 0.0 115.545 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.2 p -83.35 118.28 23.58 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 117.313 0.556 . . . . 0.0 110.18 168.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.448 HG22 HG22 ' A' ' 7' ' ' THR . 5.0 t -90.96 80.5 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 125.758 1.911 . . . . 0.0 106.413 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.1 m -100.15 133.15 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 112.154 -2.294 . . . . 0.0 112.501 -172.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.8 p -92.99 95.95 9.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.314 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.412 HG22 HG22 ' A' ' 74' ' ' VAL . 88.4 mt -74.32 94.18 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.428 173.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.6 m -113.94 110.48 20.14 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 112.828 -1.987 . . . . 0.0 111.889 -172.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.687 ' HB2' HG13 ' A' ' 33' ' ' ILE . . . -105.14 125.19 50.71 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.827 175.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -115.87 131.2 57.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 112.9 -1.955 . . . . 0.0 109.623 172.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.22 -160.29 24.97 Favored Glycine 0 N--CA 1.482 1.766 0 CA-C-N 113.359 -1.746 . . . . 0.0 110.783 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -58.88 -61.34 2.7 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -88.71 39.03 0.9 Allowed 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -46.27 -55.0 7.84 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 117.976 2.584 . . . . 0.0 117.976 -175.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.521 ' OE1' ' HE2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -71.88 -45.42 61.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.641 1.176 . . . . 0.0 113.914 -177.338 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.521 ' HE2' ' OE1' ' A' ' 71' ' ' GLN . 41.6 mtmt -66.07 -45.77 80.12 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.745 1.218 . . . . 0.0 112.466 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.465 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -59.86 -44.18 94.28 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.146 0.903 . . . . 0.0 113.406 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.412 HG22 HG22 ' A' ' 63' ' ' ILE . 34.0 t -63.87 -50.81 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 118.612 -0.708 . . . . 0.0 112.343 173.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -50.16 -48.36 53.89 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -57.23 -58.12 9.62 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.037 0.935 . . . . 0.0 111.298 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.432 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 80.1 mt -66.53 -29.21 69.25 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -176.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.424 HG13 HG11 ' A' ' 6' ' ' VAL . 44.2 t -66.86 -51.67 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 123.497 0.498 . . . . 0.0 111.474 170.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -59.73 -41.22 90.39 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.049 0.54 . . . . 0.0 111.877 175.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.432 ' HB3' ' HA ' ' A' ' 77' ' ' LEU . 6.0 tt -60.33 -45.69 92.56 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.199 1.399 . . . . 0.0 112.404 174.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.493 ' SD ' HG13 ' A' ' 8' ' ' ILE . 13.9 tmm? -57.92 -41.75 83.36 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.19 0.596 . . . . 0.0 111.521 174.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.22 96.7 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -78.06 -22.54 48.93 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.0 mt -70.54 122.83 20.44 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.666 -0.646 . . . . 0.0 111.246 165.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--O 1.25 1.114 0 O-C-N 125.195 1.559 . . . . 0.0 111.447 -177.266 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ttt . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -127.64 137.94 52.68 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 125.79 1.931 . . . . 0.0 108.701 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.08 139.9 53.02 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.262 -176.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -148.0 121.82 9.32 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 124.24 0.963 . . . . 0.0 111.314 169.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 24.0 tt0 -92.12 115.27 27.93 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.778 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.526 HG11 HG13 ' A' ' 78' ' ' VAL . 24.1 m -117.32 146.3 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 114.765 -1.107 . . . . 0.0 113.816 -175.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 p -95.93 119.2 33.99 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.56 -1.654 . . . . 0.0 113.628 -174.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.8 mt -82.12 105.71 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.849 170.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.0 p -99.82 -1.74 36.8 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.216 -1.811 . . . . 0.0 114.31 171.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.69 127.43 93.38 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 124.562 1.145 . . . . 0.0 111.95 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -48.91 -44.23 32.81 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 124.381 3.387 . . . . 0.0 117.59 -170.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -105.75 -23.53 12.7 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 173.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.86 -138.16 13.75 Favored Glycine 0 N--CA 1.474 1.225 0 C-N-CA 124.536 1.065 . . . . 0.0 111.147 170.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.451 ' HB2' HD22 ' A' ' 55' ' ' LEU . 6.6 mp -107.29 -11.49 15.56 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.8 p -103.27 -56.22 2.26 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 118.213 -2.804 . . . . 0.0 115.605 175.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -75.95 -47.6 3.73 Favored Pre-proline 0 N--CA 1.487 1.376 0 CA-C-O 115.752 -2.071 . . . . 0.0 115.732 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -59.03 -39.73 77.62 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.171 1.914 . . . . 0.0 112.004 168.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.22 -51.7 65.75 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 171.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.67 -36.27 78.31 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 175.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -68.11 -44.87 75.2 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 173.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -53.96 -40.86 67.2 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.768 1.227 . . . . 0.0 111.404 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.43 HG21 ' HA ' ' A' ' 47' ' ' LEU . 91.2 t -55.16 -60.31 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 124.087 0.867 . . . . 0.0 111.687 172.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -62.24 -31.92 72.53 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -174.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -66.23 -55.26 17.05 Favored 'General case' 0 CA--C 1.55 0.942 0 O-C-N 124.26 0.975 . . . . 0.0 111.151 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.89 -37.87 64.2 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 171.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.517 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . 32.7 tttt -58.59 -29.56 66.52 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 176.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.46 -12.38 58.57 Favored Glycine 0 CA--C 1.54 1.621 0 O-C-N 125.108 1.505 . . . . 0.0 115.377 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -92.0 158.45 16.24 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.169 0.988 . . . . 0.0 111.863 174.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.2 p -68.78 -46.01 69.83 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.266 177.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.6 p -59.28 137.76 57.86 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.625 1.17 . . . . 0.0 113.919 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -92.23 111.58 23.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.607 -1.179 . . . . 0.0 107.83 170.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mt -95.6 133.01 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-N 111.428 -2.624 . . . . 0.0 110.683 -172.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.5 p -109.05 135.35 50.36 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.228 -1.805 . . . . 0.0 112.133 174.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.97 87.51 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 111.855 -2.429 . . . . 0.0 106.396 177.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.2 m -90.69 109.4 20.58 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.552 -1.658 . . . . 0.0 111.39 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.4 t -116.48 87.65 2.73 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 p30 9.74 108.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 128.208 2.603 . . . . 0.0 118.001 -173.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.12 -49.3 2.45 Favored Glycine 0 N--CA 1.481 1.671 0 CA-C-N 112.985 -1.916 . . . . 0.0 111.881 -171.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.484 ' HB3' HD12 ' A' ' 53' ' ' LEU . 92.7 mttt -93.95 99.03 11.44 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.793 0.806 . . . . 0.0 111.384 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.1 t -107.25 95.8 5.97 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.93 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.563 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -83.68 142.8 30.49 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 113.604 -1.635 . . . . 0.0 112.297 -176.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.7 t -83.34 123.54 29.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.589 173.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.29 12.83 3.26 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 124.353 1.033 . . . . 0.0 112.793 172.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.517 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 86.8 mttt -112.59 -6.81 13.91 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 168.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.9 t -119.42 131.6 55.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.638 1.175 . . . . 0.0 111.269 172.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.43 ' HA ' HG21 ' A' ' 23' ' ' VAL . 2.7 mm? -62.09 -62.58 1.68 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 113.286 -1.779 . . . . 0.0 112.307 -172.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -60.15 -29.73 68.85 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 113.912 -1.494 . . . . 0.0 114.593 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -56.67 -57.37 12.71 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.914 0.886 . . . . 0.0 112.022 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.87 -44.9 84.02 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 173.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -54.21 -37.14 64.25 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 t -81.2 -26.04 36.25 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 116.924 2.194 . . . . 0.0 116.924 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.563 HD13 ' HB2' ' A' ' 42' ' ' ALA . 14.4 tp -41.91 -54.22 3.52 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -167.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.07 88.16 2.04 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -172.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.451 HD22 ' HB2' ' A' ' 14' ' ' LEU . 4.2 mp -116.21 98.36 6.56 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 125.168 1.158 . . . . 0.0 108.327 -177.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.2 t -138.23 176.9 8.29 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 125.503 1.752 . . . . 0.0 111.781 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -59.83 109.56 0.96 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.839 1.256 . . . . 0.0 110.354 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.39 -30.51 6.43 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 113.948 -1.478 . . . . 0.0 115.069 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.4 p -73.02 96.83 2.21 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 117.942 0.871 . . . . 0.0 112.697 -172.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.0 t -69.4 130.96 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.808 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.2 m -124.35 120.33 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 114.691 -1.141 . . . . 0.0 113.924 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 0.7 OUTLIER -83.6 113.34 20.76 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.738 173.617 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.2 mt -95.54 103.48 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 m -116.48 119.88 37.01 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 112.546 -2.116 . . . . 0.0 110.892 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.48 124.53 51.95 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.355 0.598 . . . . 0.0 112.544 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -117.21 105.96 12.79 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.195 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.79 -160.32 28.56 Favored Glycine 0 N--CA 1.482 1.702 0 CA-C-N 113.037 -1.892 . . . . 0.0 112.972 178.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.54 -49.34 78.16 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.063 1.745 . . . . 0.0 115.243 -174.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -96.21 41.53 1.1 Allowed 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 176.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.521 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 7.4 pt-20 -43.27 -67.72 0.25 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.521 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -63.54 -38.47 91.24 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -179.229 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -66.36 -47.97 71.71 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.169 1.388 . . . . 0.0 112.246 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.01 -48.47 81.48 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.903 0.881 . . . . 0.0 112.444 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.8 t -61.25 -52.73 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.571 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -49.41 -51.56 34.46 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.073 0.949 . . . . 0.0 113.073 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -58.5 -51.64 69.0 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.89 0.876 . . . . 0.0 112.44 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.7 mt -70.71 -27.97 64.39 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.526 HG13 HG11 ' A' ' 6' ' ' VAL . 53.0 t -61.64 -55.69 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 123.348 0.659 . . . . 0.0 109.77 168.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -52.68 -51.31 60.81 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 124.417 1.073 . . . . 0.0 112.691 175.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.4 tt -53.45 -50.73 64.66 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.344 1.058 . . . . 0.0 112.737 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -59.55 -44.89 93.11 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.88 0.872 . . . . 0.0 112.428 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.74 -37.28 79.31 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -79.65 10.54 3.89 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.2 mt -98.13 134.48 41.14 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.235 0.614 . . . . 0.0 111.552 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 . . . . . 0 C--O 1.255 1.37 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 160.81 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -96.05 105.06 17.05 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.575 1.172 . . . . 0.0 110.187 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -103.06 94.72 5.69 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 111.424 -2.626 . . . . 0.0 108.939 -176.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -112.61 114.43 27.05 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.541 1.163 . . . . 0.0 111.701 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -86.64 107.34 18.14 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 111.836 -2.438 . . . . 0.0 109.842 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 m -116.05 142.56 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 113.919 -1.492 . . . . 0.0 112.699 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.489 HG22 HG22 ' A' ' 60' ' ' VAL . 31.1 p -96.47 114.97 26.68 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.284 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.8 mt -66.89 118.3 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.359 172.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -96.04 -30.42 13.58 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.47 -1.241 . . . . 0.0 114.297 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.44 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -43.75 121.88 3.64 Favored Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 173.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 53.8 Cg_exo -52.67 -55.08 4.1 Favored 'Trans proline' 0 N--CA 1.485 0.999 1 C-N-CA 125.53 4.153 . . . . 0.0 115.147 -166.014 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -90.76 -37.39 13.7 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.341 0.657 . . . . 0.0 112.193 172.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.18 -142.41 16.06 Favored Glycine 0 N--CA 1.481 1.683 0 O-C-N 124.692 1.245 . . . . 0.0 112.824 168.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.93 -18.76 20.05 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 112.648 -1.776 . . . . 0.0 114.967 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.5 p -106.37 -62.04 1.44 Allowed 'General case' 0 N--CA 1.479 1.012 0 O-C-N 118.283 -2.761 . . . . 0.0 114.138 172.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.282 86.4 mtt-85 -71.88 -40.31 7.91 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 116.866 2.173 . . . . 0.0 116.866 -170.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -65.8 -36.06 33.51 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.268 1.312 . . . . 0.0 112.696 167.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -53.87 -38.4 64.68 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 172.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.54 -45.46 77.2 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.47 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 2.7 mp0 -56.51 -45.13 81.22 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 172.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -61.15 -47.21 87.27 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.432 0.693 . . . . 0.0 112.415 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 19' ' ' ALA . 19.5 t -56.2 -53.79 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 123.837 0.711 . . . . 0.0 111.536 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.47 ' HE3' ' HA ' ' A' ' 21' ' ' GLN . 22.4 pttp -62.48 -37.57 86.47 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -61.84 -52.76 62.85 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.003 1.321 . . . . 0.0 111.112 175.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.99 -44.68 82.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.64 1.176 . . . . 0.0 113.7 174.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -64.45 -25.15 67.88 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 176.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.83 -5.93 48.73 Favored Glycine 0 CA--C 1.543 1.795 0 C-N-CA 125.197 1.38 . . . . 0.0 114.017 172.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -99.88 147.98 24.95 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.19 0.996 . . . . 0.0 110.337 169.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.78 -41.03 98.03 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.91 176.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.7 m -53.34 132.36 39.13 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 124.57 1.169 . . . . 0.0 113.78 173.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.57 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 3.8 tt0 -82.75 103.56 12.33 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.697 1.237 . . . . 0.0 110.078 173.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.528 HD11 ' HB1' ' A' ' 73' ' ' ALA . 12.1 mt -89.78 115.16 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 111.346 -2.661 . . . . 0.0 111.055 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.3 p -111.86 139.02 47.69 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.275 171.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.434 HG22 HG13 ' A' ' 63' ' ' ILE . 93.8 t -114.65 116.32 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.952 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.9 m -110.69 127.63 55.38 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.892 -1.504 . . . . 0.0 111.533 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.0 m -136.23 107.72 6.92 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.661 171.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 p30 25.66 64.08 0.06 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.65 -53.16 0.6 Allowed Glycine 0 CA--C 1.539 1.582 0 CA-C-N 113.634 -1.621 . . . . 0.0 112.85 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -76.93 89.41 3.51 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.895 0.855 . . . . 0.0 112.421 -176.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 t -96.21 102.28 14.04 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.953 172.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.519 ' HB3' HD12 ' A' ' 53' ' ' LEU . . . -118.63 123.39 44.85 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.057 -1.429 . . . . 0.0 113.365 -174.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.2 t -54.79 123.98 15.06 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.179 -1.828 . . . . 0.0 113.688 173.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.37 11.17 8.92 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.067 171.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.57 ' HE3' ' HA ' ' A' ' 32' ' ' GLU . 82.5 mttt -96.9 -17.52 20.08 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.915 162.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.5 t -102.34 117.34 34.53 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 122.037 0.922 . . . . 0.0 111.245 172.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -50.25 -62.73 1.41 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.043 -1.89 . . . . 0.0 113.294 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -64.56 -39.87 94.54 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 113.825 -1.534 . . . . 0.0 114.264 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -57.76 -50.32 73.64 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 175.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 tp -68.05 -42.79 80.01 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -59.26 -21.19 59.22 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.6 t -109.29 22.54 15.69 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.519 HD12 ' HB3' ' A' ' 42' ' ' ALA . 7.2 tt -74.54 -52.15 12.68 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.816 -1.177 . . . . 0.0 110.142 171.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.97 88.9 2.08 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 mt -108.29 81.15 1.44 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.216 -0.992 . . . . 0.0 110.569 -171.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -132.14 172.54 12.26 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.021 -174.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -46.29 116.5 1.28 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.949 1.7 . . . . 0.0 112.133 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.72 -27.87 17.82 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 113.751 -1.568 . . . . 0.0 115.09 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.3 p -61.85 115.4 3.99 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.721 0.772 . . . . 0.0 112.582 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.489 HG22 HG22 ' A' ' 7' ' ' THR . 15.1 t -84.2 102.93 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 111.9 -2.409 . . . . 0.0 106.884 -176.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.3 m -109.76 117.3 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 113.975 -1.466 . . . . 0.0 113.78 -170.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.56 99.78 12.44 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.437 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.516 HG22 HG22 ' A' ' 74' ' ' VAL . 2.9 mp -78.51 98.19 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 172.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.1 m -103.35 101.85 11.77 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 112.356 -2.202 . . . . 0.0 110.412 -177.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.35 104.42 15.41 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.657 -1.61 . . . . 0.0 113.639 -173.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.31 96.22 10.43 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.297 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.09 -173.19 44.69 Favored Glycine 0 N--CA 1.475 1.295 0 CA-C-N 114.122 -1.399 . . . . 0.0 112.676 173.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -67.87 -46.09 72.69 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.63 1.172 . . . . 0.0 112.749 175.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -79.09 33.64 0.23 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.715 1.606 . . . . 0.0 113.715 176.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.635 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 3.6 pt-20 -54.14 -69.29 0.13 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.536 1.935 . . . . 0.0 114.616 -176.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.635 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -55.42 -35.28 65.23 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 174.498 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -66.04 -47.68 73.6 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.152 0.981 . . . . 0.0 112.1 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.528 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -53.81 -49.65 67.88 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.394 1.059 . . . . 0.0 112.155 173.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.516 HG22 HG22 ' A' ' 63' ' ' ILE . 94.6 t -61.86 -50.18 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.191 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.19 -58.31 3.76 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.992 1.317 . . . . 0.0 112.662 178.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -58.31 -51.15 71.01 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.346 1.029 . . . . 0.0 112.283 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.85 -38.69 89.17 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.4 -53.08 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.21 0.604 . . . . 0.0 109.81 174.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -53.89 -52.24 61.14 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.638 1.211 . . . . 0.0 112.614 178.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.9 tp -49.31 -58.12 5.64 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.103 1.761 . . . . 0.0 113.073 174.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.9 tmm? -61.39 -35.44 77.51 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.222 1.409 . . . . 0.0 113.633 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.87 -37.83 18.73 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -77.16 38.74 0.22 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.7 mt -124.0 161.36 25.65 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.095 1.758 . . . . 0.0 110.185 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 C--O 1.25 1.1 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.44 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -126.44 130.42 50.65 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 126.019 2.075 . . . . 0.0 109.238 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -123.97 135.43 53.64 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.714 -1.584 . . . . 0.0 112.149 177.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -123.91 116.85 23.58 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.417 164.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -89.74 97.97 11.5 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.24 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.8 m -113.18 157.9 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 112.244 -2.253 . . . . 0.0 112.517 -174.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.417 HG22 HG22 ' A' ' 60' ' ' VAL . 22.6 p -105.15 139.37 39.91 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.896 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.407 HG12 ' SD ' ' A' ' 81' ' ' MET . 36.5 mt -107.95 105.75 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 169.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.3 p -126.03 46.98 2.32 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 114.416 -1.265 . . . . 0.0 114.294 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -116.97 139.49 25.84 Favored Pre-proline 0 N--CA 1.475 0.787 0 CA-C-O 116.962 -1.494 . . . . 0.0 108.854 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -32.04 -56.89 0.27 Allowed 'Trans proline' 0 N--CA 1.483 0.909 1 C-N-CA 125.747 4.298 . . . . 0.0 116.86 -168.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -113.43 -38.87 4.24 Favored 'General case' 0 CA--C 1.551 0.992 0 O-C-N 124.131 0.894 . . . . 0.0 112.407 168.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.05 -89.35 1.44 Allowed Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.908 0.766 . . . . 0.0 113.561 163.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 mp -115.39 -46.07 2.89 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -171.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.2 p -106.08 -44.54 4.56 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 117.932 -2.98 . . . . 0.0 113.815 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.342 60.4 mtt-85 -92.05 -39.15 0.37 Allowed Pre-proline 0 N--CA 1.479 1.024 0 N-CA-C 119.044 2.979 . . . . 0.0 119.044 -170.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -61.98 -39.2 52.27 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 CA-C-N 121.283 1.494 . . . . 0.0 111.353 161.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -51.88 -34.79 42.72 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 171.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.1 -42.83 63.57 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -52.15 -52.96 48.59 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.689 1.195 . . . . 0.0 113.203 173.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -55.31 -52.57 63.03 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.579 1.552 . . . . 0.0 111.183 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.701 HG22 HD23 ' A' ' 50' ' ' LEU . 1.9 t -70.29 -38.96 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -174.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.65 -32.14 73.54 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 176.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -71.36 -49.45 42.08 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.047 0.939 . . . . 0.0 110.137 173.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.424 ' HA ' ' HD2' ' A' ' 29' ' ' PHE . . . -55.44 -46.01 76.76 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 176.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -60.77 -23.93 65.37 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 173.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.52 -25.45 67.84 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.317 0.96 . . . . 0.0 113.664 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.424 ' HD2' ' HA ' ' A' ' 26' ' ' ALA . 63.9 m-85 -73.56 139.36 45.55 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.217 1.008 . . . . 0.0 112.56 177.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -58.91 -37.6 77.02 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 113.19 -1.823 . . . . 0.0 113.025 174.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.3 m -63.08 141.93 58.58 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 171.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.89 113.8 22.99 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.842 0.83 . . . . 0.0 108.94 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 mt -106.99 101.57 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.615 -1.63 . . . . 0.0 109.989 -172.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.0 p -86.32 135.2 33.62 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.878 171.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.586 ' HB ' HD11 ' A' ' 50' ' ' LEU . 97.3 t -118.97 100.73 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 178.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.9 m -100.43 124.1 45.5 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.729 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.437 ' HB2' HG12 ' A' ' 61' ' ' VAL . 4.1 t -144.41 137.54 27.11 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.58 176.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.277 0.2 OUTLIER 43.57 51.77 6.25 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.859 1.664 . . . . 0.0 113.968 -173.027 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.15 -29.39 1.14 Allowed Glycine 0 CA--C 1.547 2.088 0 CA-C-N 114.103 -1.408 . . . . 0.0 114.885 -175.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -70.49 106.49 3.46 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.031 0.932 . . . . 0.0 112.448 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.7 t -89.65 128.82 36.13 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.696 -1.593 . . . . 0.0 111.942 169.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.81 119.81 14.45 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 113.389 -1.732 . . . . 0.0 110.24 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -64.91 124.93 23.3 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 113.117 -1.856 . . . . 0.0 112.376 171.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.54 -3.28 11.09 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 112.949 -1.932 . . . . 0.0 114.627 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -65.33 -11.64 43.86 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 122.086 0.946 . . . . 0.0 113.502 160.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.4 t -124.84 105.45 9.27 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.161 -0.962 . . . . 0.0 112.972 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.435 HD13 ' HB ' ' A' ' 23' ' ' VAL . 3.5 mm? -40.53 -51.43 2.92 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.175 -1.83 . . . . 0.0 112.524 164.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -55.57 -50.74 69.24 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 113.254 -1.794 . . . . 0.0 113.452 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -66.05 -47.87 72.92 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.701 HD23 HG22 ' A' ' 23' ' ' VAL . 7.6 tp -72.97 -30.18 63.64 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -176.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -65.66 -18.69 65.51 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 t -112.21 61.12 0.63 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 124.029 1.871 . . . . 0.0 112.748 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.4 tp -122.12 -65.95 1.07 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 112.895 -1.957 . . . . 0.0 112.296 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.62 90.96 0.83 Allowed Glycine 0 N--CA 1.478 1.438 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -172.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 mt -121.68 87.06 2.68 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.513 -0.843 . . . . 0.0 109.4 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -153.19 -175.62 5.42 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.714 -168.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -60.2 108.89 0.86 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.119 0.968 . . . . 0.0 112.128 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.08 -12.56 24.28 Favored Glycine 0 N--CA 1.477 1.388 0 CA-C-N 112.477 -2.147 . . . . 0.0 114.591 177.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.0 p -77.83 116.5 18.39 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 117.772 0.786 . . . . 0.0 112.814 -175.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.417 HG22 HG22 ' A' ' 7' ' ' THR . 22.1 t -92.26 119.97 40.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 113.1 -1.864 . . . . 0.0 107.192 177.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' A' ' 37' ' ' SER . 14.8 m -123.42 115.05 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 113.878 -1.51 . . . . 0.0 113.385 -172.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.4 90.57 6.19 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.823 174.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.8 mt -72.97 101.2 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -120.05 101.33 7.77 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.816 -164.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.21 121.01 42.38 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -104.71 112.22 25.23 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 112.947 -1.933 . . . . 0.0 109.412 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.79 -161.22 32.61 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.084 175.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -78.85 -44.76 22.22 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.98 0.895 . . . . 0.0 112.532 176.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -76.89 22.41 0.19 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.865 1.666 . . . . 0.0 114.369 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.446 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 6.9 pt-20 -44.98 -54.67 6.29 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.581 1.952 . . . . 0.0 114.976 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.446 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -68.03 -47.74 67.6 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -62.52 -49.01 77.02 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.704 -1.134 . . . . 0.0 113.191 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.06 -49.17 74.54 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.207 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.02 -51.4 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 117.946 -1.026 . . . . 0.0 111.973 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -52.67 -48.66 66.34 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 124.219 0.949 . . . . 0.0 112.047 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -60.72 -48.53 81.37 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.363 1.065 . . . . 0.0 112.957 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.08 -37.03 84.78 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.7 t -59.04 -50.09 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 123.938 0.774 . . . . 0.0 109.851 172.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -53.66 -55.72 23.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 124.036 0.835 . . . . 0.0 113.096 175.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.2 tt -51.31 -52.12 48.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.524 1.13 . . . . 0.0 112.462 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.407 ' SD ' HG12 ' A' ' 8' ' ' ILE . 16.9 tmm? -59.86 -49.09 79.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.102 0.961 . . . . 0.0 112.859 178.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.05 -26.49 67.53 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -83.35 -2.04 54.79 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 87.1 mt -84.05 116.33 22.8 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 C--O 1.252 1.196 0 C-N-CA 126.012 1.725 . . . . 0.0 110.369 -176.084 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.43 ' HG2' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -81.2 126.78 31.93 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.339 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -123.76 123.52 40.68 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 113.702 -1.59 . . . . 0.0 111.461 -175.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -129.91 110.46 11.71 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 125.134 1.521 . . . . 0.0 112.997 168.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -83.53 106.25 15.11 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.354 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.4 m -115.51 144.5 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 114.141 -1.391 . . . . 0.0 113.655 -173.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.561 HG22 HG22 ' A' ' 60' ' ' VAL . 27.6 p -103.63 118.4 36.64 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 113.868 -1.515 . . . . 0.0 111.308 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.0 mt -74.22 113.53 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.653 172.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 p -96.07 -23.15 16.92 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -62.22 133.56 94.33 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 124.383 1.073 . . . . 0.0 112.082 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 77.8 Cg_exo -53.17 -55.93 3.22 Favored 'Trans proline' 0 N--CA 1.481 0.752 0 C-N-CA 124.365 3.377 . . . . 0.0 113.755 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -67.58 -37.31 82.42 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.12 0.968 . . . . 0.0 112.874 176.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.37 -128.01 9.14 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.8 mt . . . . . 0 N--CA 1.478 0.931 0 CA-C-N 113.827 -1.186 . . . . 0.0 113.039 171.094 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.2 p . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.41 ' HD3' ' HA ' ' A' ' 17' ' ' ARG 0.346 15.7 mmt180 -87.17 -45.47 0.52 Allowed Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 118.017 2.599 . . . . 0.0 118.017 -175.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -59.01 -33.14 98.65 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 CA-C-N 122.655 1.984 . . . . 0.0 111.751 165.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.523 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -56.67 -48.29 77.93 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.149 0.98 . . . . 0.0 113.46 165.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.01 -38.81 90.03 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.23 -43.0 99.81 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 169.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -58.89 -42.22 89.02 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 124.375 1.047 . . . . 0.0 111.348 172.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 19' ' ' ALA . 66.8 t -57.28 -52.0 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 123.971 0.909 . . . . 0.0 111.032 171.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -53.45 -46.51 69.92 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 124.029 0.831 . . . . 0.0 112.08 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -66.9 -44.96 79.43 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.199 0.999 . . . . 0.0 113.221 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.17 -37.23 76.85 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 124.312 1.045 . . . . 0.0 113.681 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -59.42 -22.15 61.01 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 171.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.21 -20.16 74.74 Favored Glycine 0 N--CA 1.487 2.054 0 O-C-N 124.973 1.421 . . . . 0.0 114.663 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -98.18 148.85 23.16 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.18 0.592 . . . . 0.0 112.387 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.1 p -68.5 -43.37 76.99 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.962 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.0 p -61.1 161.57 8.43 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.816 1.246 . . . . 0.0 113.086 170.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -116.48 102.4 9.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 122.304 1.049 . . . . 0.0 111.979 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.698 HD11 ' HB1' ' A' ' 73' ' ' ALA . 17.1 mm -65.25 106.75 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 112.392 -2.185 . . . . 0.0 111.894 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.0 p -94.25 122.19 36.53 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.573 1.178 . . . . 0.0 109.984 167.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.6 t -104.41 107.09 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 111.95 -2.386 . . . . 0.0 107.848 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.3 m -96.25 113.39 24.99 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.098 -1.864 . . . . 0.0 111.627 -174.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.561 ' HB2' HG12 ' A' ' 61' ' ' VAL . 5.7 t -129.01 121.68 28.45 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.594 172.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 p30 37.94 64.44 0.68 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 125.18 1.55 . . . . 0.0 114.419 -170.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.45 -33.92 1.57 Allowed Glycine 0 N--CA 1.486 1.991 0 CA-C-N 113.636 -1.62 . . . . 0.0 114.509 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -68.51 88.69 0.34 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.315 1.046 . . . . 0.0 112.107 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.9 m -77.28 99.9 5.67 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 113.223 -1.808 . . . . 0.0 111.882 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.95 123.53 46.02 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.46 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.5 t -58.98 103.85 0.2 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.785 168.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.563 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . . . -59.57 -32.33 70.26 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.331 175.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -65.96 -24.69 66.85 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.827 0.851 . . . . 0.0 112.254 174.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.8 t -94.26 111.1 22.82 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 123.104 1.43 . . . . 0.0 112.608 170.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.441 ' HA ' HG21 ' A' ' 23' ' ' VAL . 22.6 tp -32.54 -73.35 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.934 2.494 . . . . 0.0 116.13 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.402 ' O ' HG22 ' A' ' 52' ' ' THR . 67.3 m-85 -64.87 -30.21 71.2 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -175.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -62.8 -48.29 79.77 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.603 0.761 . . . . 0.0 111.638 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 26.3 tp -69.48 -46.58 66.3 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 124.251 0.97 . . . . 0.0 113.066 172.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -52.61 -32.0 39.38 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 48' ' ' PHE . 5.1 t -114.35 24.01 12.31 Favored 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.8 tp -70.35 -48.06 58.13 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.374 -0.829 . . . . 0.0 112.259 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.08 87.35 1.36 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.51 87.24 2.72 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.708 -0.746 . . . . 0.0 111.925 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -135.09 176.14 8.94 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.238 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -58.33 116.34 3.54 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.457 1.103 . . . . 0.0 110.245 172.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.07 -33.78 6.16 Favored Glycine 0 N--CA 1.485 1.932 0 CA-C-N 114.397 -1.274 . . . . 0.0 114.251 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.1 p -59.88 112.84 2.0 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 117.612 0.706 . . . . 0.0 112.421 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.561 HG22 HG22 ' A' ' 7' ' ' THR . 22.0 t -84.51 129.92 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.335 -1.757 . . . . 0.0 108.026 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.561 HG12 ' HB2' ' A' ' 37' ' ' SER . 7.4 m -129.73 118.4 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.443 -174.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 m -85.21 104.81 15.41 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.826 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.9 mt -82.9 109.92 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.9 m -118.01 141.46 48.44 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 113.157 -1.838 . . . . 0.0 111.38 -173.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.91 139.43 27.6 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.43 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 28.2 tt0 -133.33 132.27 41.1 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.658 -1.61 . . . . 0.0 108.826 169.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.31 -161.9 28.18 Favored Glycine 0 N--CA 1.481 1.683 0 C-N-CA 125.023 1.297 . . . . 0.0 111.542 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -59.93 -64.54 0.91 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.917 0.865 . . . . 0.0 113.167 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -83.56 31.59 0.47 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -53.0 -58.21 7.74 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -172.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -43.11 99.61 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -65.62 -45.03 84.66 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.036 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.698 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -56.39 -52.19 65.55 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.125 0.97 . . . . 0.0 113.173 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.8 t -59.5 -53.06 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.949 0.899 . . . . 0.0 110.078 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -51.0 -54.04 27.96 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.215 1.406 . . . . 0.0 112.73 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -62.88 -45.7 91.33 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.7 mt -64.88 -36.22 83.64 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.35 -50.79 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.435 0.694 . . . . 0.0 110.527 169.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -56.21 -47.11 79.03 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.7 tp -49.03 -59.23 3.79 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.607 1.163 . . . . 0.0 111.927 173.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.0 tmm? -58.06 -42.6 85.81 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.32 1.048 . . . . 0.0 112.949 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.03 -29.89 67.05 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -87.66 -31.69 19.63 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 69.1 mt . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 179.023 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttp . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -120.79 112.31 18.67 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.827 1.329 . . . . 0.0 110.087 172.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -107.57 126.81 53.01 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.019 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -122.93 120.17 32.62 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -99.89 92.72 5.42 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 125.294 1.621 . . . . 0.0 108.794 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.401 HG21 HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -119.31 143.39 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 111.469 -2.605 . . . . 0.0 112.641 -173.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 p -78.54 131.45 36.8 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -176.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.9 mt -92.59 116.97 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-N 113.485 -1.689 . . . . 0.0 107.159 159.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 p -116.36 -17.81 10.63 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 111.85 -2.432 . . . . 0.0 114.38 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.06 129.96 58.54 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 124.929 1.292 . . . . 0.0 111.694 172.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -56.97 -54.11 4.11 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 124.394 3.396 . . . . 0.0 114.862 -165.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -88.23 -36.97 16.45 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 123.782 0.676 . . . . 0.0 111.762 171.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.89 -128.34 9.53 Favored Glycine 0 N--CA 1.475 1.291 0 O-C-N 123.799 0.687 . . . . 0.0 112.46 167.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.629 HD21 HD13 ' A' ' 84' ' ' LEU . 72.5 mt . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.6 p . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.326 24.1 mtt180 -83.79 -37.36 0.67 Allowed Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 118.396 2.739 . . . . 0.0 118.396 -168.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -62.52 -39.81 42.62 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 121.763 1.642 . . . . 0.0 112.617 163.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.21 -38.18 73.33 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 168.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.18 -38.56 86.94 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 172.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -64.27 -43.91 93.34 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.414 0.686 . . . . 0.0 112.147 172.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -59.02 -44.17 91.69 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.175 1.39 . . . . 0.0 112.221 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.479 HG21 ' HA ' ' A' ' 47' ' ' LEU . 44.6 t -53.97 -60.06 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.042 1.337 . . . . 0.0 112.034 169.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -49.55 -39.06 33.38 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.936 -1.029 . . . . 0.0 113.156 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.455 ' HG2' HD22 ' A' ' 80' ' ' LEU . 8.5 tp10 -61.86 -66.0 0.6 Allowed 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.522 1.139 . . . . 0.0 110.891 169.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.93 -35.16 6.17 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -42.36 -38.21 1.78 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.24 -30.19 70.33 Favored Glycine 0 CA--C 1.546 1.972 0 C-N-CA 124.97 1.272 . . . . 0.0 115.805 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -75.28 144.8 42.3 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -175.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 66.3 p -66.46 -50.27 63.9 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.303 0.641 . . . . 0.0 111.891 -175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.3 p -66.09 173.61 2.99 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 124.877 1.361 . . . . 0.0 113.35 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.418 ' HG3' ' HB3' ' A' ' 45' ' ' LYS . 30.6 tt0 -114.65 94.32 4.72 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.704 0.764 . . . . 0.0 109.331 174.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.75 113.57 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 113.118 -1.855 . . . . 0.0 109.382 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 p -105.78 137.61 43.36 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.677 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.0 t -118.87 126.57 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 113.206 -1.815 . . . . 0.0 109.944 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.3 m -110.98 123.37 50.04 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.214 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.8 t -126.5 120.37 29.5 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.717 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 p30 40.3 64.03 0.99 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.742 1.617 . . . . 0.0 114.634 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.35 -34.96 1.54 Allowed Glycine 0 CA--C 1.542 1.773 0 CA-C-N 113.187 -1.824 . . . . 0.0 115.658 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -81.94 133.04 35.28 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.598 0.759 . . . . 0.0 110.254 -169.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 t -108.4 129.29 55.26 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.123 0.89 . . . . 0.0 113.269 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.519 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -124.71 160.85 27.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 112.541 -2.118 . . . . 0.0 109.626 176.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.534 ' H ' ' HB3' ' A' ' 49' ' ' LYS . 40.3 t -106.08 128.26 53.74 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.131 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.04 -29.47 69.83 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.878 1.361 . . . . 0.0 111.338 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HB3' ' HG3' ' A' ' 32' ' ' GLU . 77.4 tttt -90.81 21.69 3.98 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.245 -0.888 . . . . 0.0 112.609 177.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.498 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 2.0 m -148.01 116.46 6.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.028 1.331 . . . . 0.0 112.274 173.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.479 ' HA ' HG21 ' A' ' 23' ' ' VAL . 31.1 tp -51.21 -59.63 3.99 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 112.429 -2.169 . . . . 0.0 113.324 -176.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -63.85 -32.34 73.82 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.221 -1.354 . . . . 0.0 113.317 -174.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.534 ' HB3' ' H ' ' A' ' 43' ' ' SER . 15.4 mmmt -69.24 -58.48 3.98 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 118.318 -0.848 . . . . 0.0 113.033 173.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.9 tp -60.36 -40.3 90.25 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.201 0.938 . . . . 0.0 112.441 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -62.34 -40.1 95.28 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 t -89.86 8.14 33.59 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.519 HD22 ' HB3' ' A' ' 42' ' ' ALA . 45.3 tp -72.67 -60.95 1.98 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.91 92.88 1.6 Allowed Glycine 0 CA--C 1.535 1.334 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.0 mt -128.47 82.75 2.1 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.269 1.427 . . . . 0.0 109.956 -174.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 t -146.49 164.67 31.78 Favored 'General case' 0 C--O 1.25 1.1 0 C-N-CA 125.826 1.65 . . . . 0.0 110.835 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -41.61 126.63 2.99 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.444 1.898 . . . . 0.0 115.137 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.69 -31.56 5.51 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-N 113.891 -1.504 . . . . 0.0 115.379 173.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.35 121.32 21.19 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.828 2.159 . . . . 0.0 116.828 -173.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.9 t -87.01 94.03 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 m -89.82 125.72 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -169.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.07 93.45 5.78 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.967 1.707 . . . . 0.0 110.429 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.6 mt -98.73 113.33 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 125.496 1.518 . . . . 0.0 107.134 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 m -129.68 124.29 33.24 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.216 -167.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.66 140.84 51.56 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -140.74 110.1 6.27 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.258 1.423 . . . . 0.0 110.301 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.82 -157.05 19.57 Favored Glycine 0 N--CA 1.478 1.497 0 N-CA-C 107.621 -2.191 . . . . 0.0 107.621 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -65.51 -43.5 89.9 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 117.243 0.521 . . . . 0.0 110.156 170.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -86.25 26.94 0.97 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -54.06 -52.64 60.25 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.493 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -78.42 -44.13 25.58 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.649 1.58 . . . . 0.0 113.007 -179.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -67.65 -35.83 79.6 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.77 -47.4 53.84 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.707 0.803 . . . . 0.0 112.862 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.9 t -61.6 -48.1 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 118.0 -1.0 . . . . 0.0 111.156 176.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -46.12 -49.01 17.17 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.7 1.2 . . . . 0.0 111.845 171.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -68.19 -62.48 1.38 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.0 mt -59.77 -38.63 82.35 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.401 HG13 HG21 ' A' ' 6' ' ' VAL . 56.4 t -61.42 -48.24 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.315 174.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -59.07 -48.88 80.0 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.297 0.998 . . . . 0.0 112.953 173.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.455 HD22 ' HG2' ' A' ' 25' ' ' GLU . 10.3 tp -52.55 -47.99 66.43 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.642 0.777 . . . . 0.0 112.03 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.518 ' HG3' HD11 ' A' ' 14' ' ' LEU . 48.5 ttp -62.2 -52.26 64.5 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.923 0.889 . . . . 0.0 112.367 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.64 -35.9 63.95 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -88.46 -13.67 39.77 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.629 HD13 HD21 ' A' ' 14' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.775 0 C-N-CA 124.093 0.957 . . . . 0.0 112.411 167.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ttt . . . . . 0 N--CA 1.463 0.204 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -113.79 127.97 56.22 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 124.657 1.223 . . . . 0.0 109.708 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -131.11 94.66 3.63 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.309 -167.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -112.44 108.49 17.64 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 122.518 1.151 . . . . 0.0 113.343 -171.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -80.96 103.99 11.16 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 112.45 -2.159 . . . . 0.0 111.159 175.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.3 148.46 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 114.933 -1.03 . . . . 0.0 113.138 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 p -102.72 128.33 49.48 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.905 -175.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.3 mt -79.54 108.9 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.359 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 p -96.83 -13.51 22.5 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 175.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.442 ' HB3' ' HA2' ' A' ' 13' ' ' GLY . . . -59.9 135.83 90.22 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 124.31 1.044 . . . . 0.0 111.766 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.451 ' HA ' HE21 ' A' ' 57' ' ' GLN . 92.1 Cg_exo -48.88 -52.45 8.64 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.182 3.255 . . . . 0.0 114.718 -174.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -106.88 -28.43 10.1 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 124.591 1.182 . . . . 0.0 113.741 175.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . 93.25 -153.91 21.6 Favored Glycine 0 N--CA 1.479 1.563 0 CA-C-O 122.045 0.803 . . . . 0.0 113.897 165.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.645 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 87.0 mt . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.5 p . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.303 40.6 mtt85 -89.77 -41.44 0.42 Allowed Pre-proline 0 N--CA 1.486 1.336 0 N-CA-C 118.616 2.821 . . . . 0.0 118.616 -166.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.645 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 90.5 Cg_exo -61.72 -30.8 85.55 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 CA-C-N 120.867 1.345 . . . . 0.0 112.412 163.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -60.19 -44.2 95.3 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 165.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.41 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . . . -60.26 -40.51 90.61 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 172.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -59.84 -45.5 92.22 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.386 1.074 . . . . 0.0 112.452 172.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -57.86 -46.07 85.37 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.074 1.35 . . . . 0.0 111.782 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.5 HG21 ' HA ' ' A' ' 47' ' ' LEU . 59.2 t -56.0 -42.47 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.025 0.53 . . . . 0.0 112.278 175.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -60.96 -46.43 90.74 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 124.07 0.856 . . . . 0.0 111.916 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.47 ' HB3' HD21 ' A' ' 77' ' ' LEU . 13.7 tp10 -69.58 -44.44 70.79 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.077 0.861 . . . . 0.0 112.616 176.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.37 -33.59 65.85 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -53.81 -34.77 60.21 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 170.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.27 13.74 56.52 Favored Glycine 0 N--CA 1.483 1.81 0 O-C-N 124.557 1.161 . . . . 0.0 115.159 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -119.49 151.19 38.99 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.046 0.497 . . . . 0.0 111.297 172.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.4 p -82.69 -44.2 15.97 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.862 -175.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.3 p -66.08 133.26 50.37 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 124.999 1.437 . . . . 0.0 110.615 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -85.7 103.62 14.67 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.609 1.195 . . . . 0.0 111.831 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.654 HD11 ' HB1' ' A' ' 73' ' ' ALA . 44.4 mm -63.69 113.53 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 111.757 -2.474 . . . . 0.0 111.125 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.1 p -111.66 131.04 55.56 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.601 173.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.469 HG22 HG12 ' A' ' 63' ' ' ILE . 59.3 t -111.0 108.27 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 113.483 -1.689 . . . . 0.0 107.723 -177.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.0 m -103.91 124.05 48.26 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.777 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.526 ' HB2' HG12 ' A' ' 61' ' ' VAL . 48.2 t -128.16 131.99 48.91 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.286 176.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.6 p30 49.83 34.62 7.92 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.39 5.33 87.7 Favored Glycine 0 CA--C 1.545 1.926 0 N-CA-C 115.806 1.082 . . . . 0.0 115.806 -175.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -112.56 140.66 47.13 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.977 0.911 . . . . 0.0 109.915 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.0 t -119.22 135.04 54.88 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -167.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.503 ' HB3' HD12 ' A' ' 53' ' ' LEU . . . -130.61 121.27 25.32 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.036 -1.893 . . . . 0.0 111.398 173.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.9 t -72.98 129.09 37.32 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.633 173.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.75 -14.7 62.08 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 113.175 -1.829 . . . . 0.0 113.297 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.0 mttt -77.29 -2.47 34.98 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 171.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.3 m -123.14 118.62 28.09 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.394 0.677 . . . . 0.0 112.217 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.5 ' HA ' HG21 ' A' ' 23' ' ' VAL . 19.1 tp -45.93 -65.87 0.48 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.588 -1.642 . . . . 0.0 113.732 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.48 ' O ' HG22 ' A' ' 52' ' ' THR . 56.6 m-85 -54.09 -50.93 65.7 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 178.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.5 mmtt -42.04 -58.59 2.04 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.4 tp -66.96 -43.0 84.25 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.638 1.211 . . . . 0.0 113.202 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.41 ' NE2' ' HB2' ' A' ' 20' ' ' ALA . 90.3 mt-30 -59.36 -41.38 89.14 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.989 175.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 48' ' ' PHE 0.263 15.2 t -100.54 54.01 0.88 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 123.497 1.617 . . . . 0.0 113.897 175.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.503 HD12 ' HB3' ' A' ' 42' ' ' ALA . 2.6 tt -111.24 -56.5 2.36 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 112.874 -1.966 . . . . 0.0 109.246 161.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.27 66.9 0.61 Allowed Glycine 0 N--CA 1.477 1.416 0 O-C-N 124.348 1.03 . . . . 0.0 111.851 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.2 mt -88.74 98.11 11.51 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.682 0.793 . . . . 0.0 111.537 -174.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.9 t -137.47 175.99 9.11 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.876 -176.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' A' ' 11' ' ' PRO . 19.8 tt0 -47.95 128.68 13.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.899 2.08 . . . . 0.0 112.813 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.68 -54.72 0.55 Allowed Glycine 0 N--CA 1.48 1.61 0 CA-C-N 113.408 -1.724 . . . . 0.0 114.175 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.1 p -64.56 131.98 48.55 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -165.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.4 t -79.89 108.48 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 111.124 -2.762 . . . . 0.0 107.193 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.526 HG12 ' HB2' ' A' ' 37' ' ' SER . 13.6 m -105.0 109.49 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 113.523 -1.671 . . . . 0.0 113.214 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.5 95.99 2.85 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.626 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.469 HG12 HG22 ' A' ' 35' ' ' VAL . 77.2 mt -86.61 101.19 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.117 175.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.3 m -106.15 134.56 49.09 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 112.642 -2.072 . . . . 0.0 112.905 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.609 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -139.07 138.22 36.92 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 124.638 1.211 . . . . 0.0 113.223 172.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -132.62 118.7 19.5 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 124.8 1.312 . . . . 0.0 109.484 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.44 -155.5 26.18 Favored Glycine 0 CA--C 1.544 1.879 0 C-N-CA 124.685 1.136 . . . . 0.0 111.232 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -68.09 -61.14 2.0 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -80.56 28.15 0.34 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -53.26 -48.32 68.36 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.78 -50.61 33.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.835 0.854 . . . . 0.0 111.809 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -58.89 -50.92 72.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.587 1.555 . . . . 0.0 112.829 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.654 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -60.25 -44.58 95.14 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.471 1.107 . . . . 0.0 113.587 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.63 -55.52 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.078 175.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -52.05 -50.57 61.22 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.051 0.941 . . . . 0.0 112.975 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -60.01 -50.5 73.49 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.468 1.107 . . . . 0.0 112.64 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.47 HD21 ' HB3' ' A' ' 25' ' ' GLU . 45.8 mt -64.72 -28.32 69.51 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.5 t -69.65 -47.57 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 122.896 0.479 . . . . 0.0 110.896 171.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -51.76 -50.92 59.73 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.937 0.895 . . . . 0.0 111.527 174.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.67 -54.62 21.52 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.213 1.805 . . . . 0.0 112.236 176.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 40.3 ttp -57.12 -47.87 80.03 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.467 1.107 . . . . 0.0 112.363 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.9 -27.84 68.49 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.275 1.43 . . . . 0.0 114.84 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -78.71 -35.74 44.45 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.459 HD13 ' HB3' ' A' ' 18' ' ' PRO . 36.4 mt . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 ttt . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -103.22 136.96 42.02 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 125.095 1.497 . . . . 0.0 108.329 170.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -146.16 134.41 21.74 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.565 -1.652 . . . . 0.0 111.016 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -123.48 118.94 28.56 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.847 170.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -83.98 106.87 15.98 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.079 165.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.6 m -120.73 140.21 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 114.726 -1.124 . . . . 0.0 113.649 -178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.481 HG22 HG22 ' A' ' 60' ' ' VAL . 22.8 p -83.31 136.21 34.45 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.302 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 52.7 mt -81.81 90.31 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 168.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.7 p -74.07 -22.41 59.53 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.513 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.32 131.74 94.89 Favored Pre-proline 0 N--CA 1.484 1.229 0 C-N-CA 125.296 1.438 . . . . 0.0 111.935 -175.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.04 -44.17 9.54 Favored 'Trans proline' 0 N--CA 1.489 1.207 1 C-N-CA 125.355 4.036 . . . . 0.0 117.56 -166.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -110.45 -45.03 3.6 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.85 -147.63 17.6 Favored Glycine 0 N--CA 1.478 1.492 0 CA-C-O 121.725 0.625 . . . . 0.0 112.817 167.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.473 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 95.6 mt . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.3 p . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.286 48.4 mtt85 -86.08 -39.27 0.57 Allowed Pre-proline 0 N--CA 1.487 1.411 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -174.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.473 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 97.9 Cg_exo -62.13 -35.71 73.88 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 121.712 1.608 . . . . 0.0 111.686 164.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.44 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -56.06 -44.38 78.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.601 0.76 . . . . 0.0 112.897 167.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.49 98.81 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 171.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -56.64 -45.25 81.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.716 0.806 . . . . 0.0 113.146 171.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -57.93 -44.18 86.75 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.864 1.266 . . . . 0.0 111.689 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 19' ' ' ALA . 95.7 t -57.12 -42.81 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.322 1.049 . . . . 0.0 113.154 176.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -53.03 -45.27 67.93 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 123.462 0.476 . . . . 0.0 112.17 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -74.61 -50.94 15.95 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.831 1.332 . . . . 0.0 112.215 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.35 -35.95 65.78 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -60.14 -19.38 53.41 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 173.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.45 27.03 14.89 Favored Glycine 0 CA--C 1.544 1.869 0 O-C-N 124.432 1.082 . . . . 0.0 113.646 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -127.93 142.97 51.11 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.143 0.977 . . . . 0.0 111.575 172.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.6 p -71.85 -40.0 69.34 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.438 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.437 ' HB2' ' HB1' ' A' ' 65' ' ' ALA . 63.0 p -65.23 145.86 55.69 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 124.483 1.115 . . . . 0.0 111.624 168.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -95.73 109.51 21.79 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.321 -0.862 . . . . 0.0 110.968 174.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.698 HD13 ' HB2' ' A' ' 65' ' ' ALA . 46.3 mm -70.54 102.06 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 112.64 -2.073 . . . . 0.0 108.852 171.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.3 p -101.89 126.44 48.79 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.497 173.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.469 HG22 HG12 ' A' ' 63' ' ' ILE . 86.7 t -103.54 113.85 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 125.445 1.716 . . . . 0.0 107.767 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.466 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 97.9 m -114.2 127.54 55.95 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.652 -174.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.4 t -122.66 115.04 21.43 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.316 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.5 p30 39.94 51.31 2.52 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -174.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.47 -35.8 4.05 Favored Glycine 0 N--CA 1.484 1.898 0 CA-C-N 113.17 -1.832 . . . . 0.0 114.501 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -72.55 121.63 19.99 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 116.897 0.348 . . . . 0.0 111.11 -174.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.0 t -102.25 136.29 42.35 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.78 1.3 . . . . 0.0 113.789 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.609 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -129.72 106.77 8.93 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 112.748 -2.024 . . . . 0.0 112.005 175.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.7 t -59.5 121.73 12.26 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.526 171.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.61 -30.55 68.31 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.598 170.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -61.8 -32.64 72.95 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.2 m -96.37 104.24 16.19 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 122.028 0.918 . . . . 0.0 111.89 169.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.423 ' HA ' HG21 ' A' ' 23' ' ' VAL . 9.5 tp -44.94 -60.62 1.97 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.54 1.536 . . . . 0.0 113.05 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.437 ' O ' HG22 ' A' ' 52' ' ' THR . 90.2 m-85 -57.21 -37.6 72.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.507 ' HD2' ' HA ' ' A' ' 42' ' ' ALA . 6.2 tmtt? -61.5 -49.82 75.2 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.609 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 19.8 tp -62.48 -41.33 98.72 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 174.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -61.07 -24.88 66.55 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 48' ' ' PHE 0.261 9.6 t -118.12 75.31 1.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 123.449 1.595 . . . . 0.0 114.228 172.472 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.422 HD13 ' HB2' ' A' ' 42' ' ' ALA . 19.7 tp -124.0 -45.39 2.01 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 112.128 -2.305 . . . . 0.0 113.141 168.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.45 69.1 0.84 Allowed Glycine 0 CA--C 1.534 1.266 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -167.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 43.7 mt -95.28 80.64 3.56 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.06 0.933 . . . . 0.0 110.936 -173.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -123.83 151.49 43.34 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 112.748 -2.024 . . . . 0.0 112.889 -165.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -49.13 132.9 19.28 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.46 1.124 . . . . 0.0 112.427 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.58 -69.06 0.22 Allowed Glycine 0 CA--C 1.534 1.267 0 CA-C-N 113.467 -1.697 . . . . 0.0 110.257 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.5 p -30.79 113.19 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.481 HG22 HG22 ' A' ' 7' ' ' THR . 9.2 t -72.96 108.1 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 112.601 -2.09 . . . . 0.0 106.688 168.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.7 m -105.09 111.48 34.75 Favored 'Isoleucine or valine' 0 C--O 1.253 1.261 0 CA-C-N 113.991 -1.458 . . . . 0.0 112.743 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.466 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 2.8 m -65.99 99.11 0.47 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 126.558 1.943 . . . . 0.0 108.87 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.469 HG12 HG22 ' A' ' 35' ' ' VAL . 80.8 mt -96.64 106.73 18.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.7 m -118.53 133.79 55.59 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 112.703 -2.044 . . . . 0.0 112.588 -169.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.698 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -146.78 138.12 24.25 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 125.334 1.646 . . . . 0.0 112.681 170.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -120.05 129.72 54.37 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.97 170.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.1 -157.11 27.26 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.766 1.203 . . . . 0.0 114.909 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -71.77 -44.09 64.63 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.518 ' HA ' ' HD2' ' A' ' 72' ' ' LYS . 5.2 p30 -100.63 24.84 8.49 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.69 -51.22 68.03 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -36.79 83.98 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.254 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.518 ' HD2' ' HA ' ' A' ' 69' ' ' ASP . 22.2 mttt -71.73 -52.8 15.91 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.563 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.17 -51.7 68.46 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.513 1.525 . . . . 0.0 114.266 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.7 t -60.77 -50.64 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.003 0.521 . . . . 0.0 110.863 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -54.58 -55.33 30.5 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.557 1.143 . . . . 0.0 111.514 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -53.76 -54.1 42.96 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.733 1.613 . . . . 0.0 112.923 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.3 mt -69.41 -28.64 66.33 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.54 -43.46 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 119.038 -0.506 . . . . 0.0 110.816 171.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -55.77 -43.81 77.08 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.248 0.619 . . . . 0.0 111.716 172.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.26 -51.08 70.79 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.522 1.129 . . . . 0.0 112.757 174.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 44.4 ttm -55.08 -45.6 75.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 123.531 0.519 . . . . 0.0 112.286 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.09 -19.95 66.24 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -114.85 36.19 3.96 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 mt . . . . . 0 N--CA 1.48 1.068 0 C-N-CA 125.303 1.441 . . . . 0.0 112.73 173.549 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 ttp . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -100.45 131.93 46.1 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 125.597 1.81 . . . . 0.0 107.962 169.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -124.78 115.44 20.7 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.584 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -127.05 110.21 12.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.223 1.011 . . . . 0.0 112.386 173.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -91.59 112.45 24.38 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.624 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 m -128.37 165.35 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 113.134 -1.848 . . . . 0.0 112.301 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.459 HG22 HG22 ' A' ' 60' ' ' VAL . 78.5 p -120.73 147.27 45.53 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.196 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.8 mt -87.93 97.13 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.887 175.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.8 p -85.3 -17.79 35.83 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.47 142.2 41.2 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.985 1.314 . . . . 0.0 112.608 174.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -47.6 -46.96 19.34 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 124.586 3.524 . . . . 0.0 116.246 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -114.86 -39.17 3.76 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.83 -142.51 17.1 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 122.198 0.888 . . . . 0.0 112.824 167.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 -174.078 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 76.8 p . . . . . 0 N--CA 1.476 0.833 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.492 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 65.2 mtt85 -60.57 -53.95 59.49 Favored Pre-proline 0 N--CA 1.488 1.445 0 CA-C-O 116.238 -1.839 . . . . 0.0 115.181 -171.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 51.4 Cg_exo -67.2 -31.12 36.69 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 CA-C-N 122.072 1.776 . . . . 0.0 114.198 174.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.96 85.1 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 171.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.41 -39.29 86.88 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 171.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -62.09 -44.68 96.13 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.006 0.923 . . . . 0.0 113.15 172.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -59.76 -43.5 94.27 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.105 0.878 . . . . 0.0 111.662 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.57 HG11 ' HA ' ' A' ' 47' ' ' LEU . 66.8 t -55.66 -51.67 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.569 0.748 . . . . 0.0 111.654 172.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -46.84 -51.74 15.9 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.617 0.767 . . . . 0.0 111.755 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -65.14 -51.81 59.01 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.466 1.104 . . . . 0.0 111.559 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.28 -34.02 66.06 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -60.51 -32.84 71.83 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 172.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.22 26.24 3.98 Favored Glycine 0 N--CA 1.479 1.526 0 O-C-N 124.382 1.051 . . . . 0.0 114.375 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -129.17 146.24 51.14 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.725 1.21 . . . . 0.0 110.261 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.6 p -69.39 -42.15 75.5 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.442 0.697 . . . . 0.0 112.872 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 p -66.55 157.07 33.24 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.867 1.267 . . . . 0.0 112.836 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -103.4 113.74 27.48 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 122.32 1.057 . . . . 0.0 110.239 172.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' A' ' 44' ' ' ALA . 8.7 mm -81.81 105.74 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 111.818 -2.446 . . . . 0.0 108.495 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.3 p -101.79 121.27 41.77 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.141 0.496 . . . . 0.0 110.805 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.6 t -101.51 97.85 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 125.905 2.003 . . . . 0.0 107.612 -172.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 29.1 m -88.39 101.14 13.6 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.778 -1.555 . . . . 0.0 111.047 -177.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 t -100.35 99.88 10.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.198 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 p30 45.54 62.61 2.11 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 113.186 -1.824 . . . . 0.0 114.009 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.47 -30.36 3.78 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 114.015 -1.448 . . . . 0.0 114.636 -176.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -86.31 92.76 8.9 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.644 0.735 . . . . 0.0 109.67 -174.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 25.3 t -82.73 123.33 29.2 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.771 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -126.2 132.86 51.69 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.597 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.6 t -71.22 129.7 39.57 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.715 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.57 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . . . -72.2 -19.0 61.81 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 112.972 -1.922 . . . . 0.0 112.508 170.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -77.11 -6.11 51.56 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 m -112.49 115.93 29.46 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.57 ' HA ' HG11 ' A' ' 23' ' ' VAL . 32.4 tp -52.84 -64.79 0.7 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 111.325 -2.67 . . . . 0.0 114.302 -170.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.459 ' O ' HG22 ' A' ' 52' ' ' THR . 49.5 m-85 -77.39 -28.77 52.9 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -60.65 -44.85 95.93 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.444 ' HG ' HD11 ' A' ' 55' ' ' LEU . 6.0 tp -69.62 -35.52 75.33 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.591 1.182 . . . . 0.0 113.283 175.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -65.48 -35.9 82.28 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 172.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 48' ' ' PHE 0.251 14.0 t -100.06 50.66 0.91 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 123.716 1.722 . . . . 0.0 112.547 173.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.457 HD22 ' HB3' ' A' ' 42' ' ' ALA . 59.5 tp -115.6 -37.86 3.88 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 112.883 -1.962 . . . . 0.0 112.742 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.09 55.92 1.66 Allowed Glycine 0 CA--C 1.53 1.031 0 C-N-CA 123.962 0.791 . . . . 0.0 111.824 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.444 HD11 ' HG ' ' A' ' 50' ' ' LEU . 78.3 mt -77.51 85.5 3.88 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -133.41 175.97 8.94 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 113.873 -1.512 . . . . 0.0 112.928 -172.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -46.47 112.78 0.54 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.471 1.909 . . . . 0.0 111.613 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.15 -38.71 3.09 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-N 113.259 -1.791 . . . . 0.0 114.157 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.5 p -48.84 110.22 0.33 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -172.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.459 HG22 HG22 ' A' ' 7' ' ' THR . 17.9 t -70.38 123.59 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-N 111.083 -2.78 . . . . 0.0 108.067 175.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 m -127.98 101.19 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 113.708 -1.587 . . . . 0.0 112.638 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.6 m -77.81 90.04 4.05 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.118 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 73.0 mt -78.84 96.88 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 113.006 -1.907 . . . . 0.0 107.725 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.0 m -119.88 136.83 54.35 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 113.136 -1.847 . . . . 0.0 111.991 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.78 142.59 25.66 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.636 1.21 . . . . 0.0 113.305 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -123.37 126.84 47.57 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.656 1.222 . . . . 0.0 110.431 170.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.44 -165.68 36.83 Favored Glycine 0 N--CA 1.484 1.869 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.094 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -63.94 -55.44 22.55 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -92.42 17.91 9.24 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 8.0 pt-20 -45.0 -58.96 2.83 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -173.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.497 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -60.98 -48.9 79.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.923 1.289 . . . . 0.0 114.285 179.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -64.4 -46.28 83.99 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.786 0.834 . . . . 0.0 112.256 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.65 -52.38 65.67 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.247 1.019 . . . . 0.0 112.688 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.8 t -63.58 -47.1 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 117.586 -1.197 . . . . 0.0 111.306 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -50.33 -59.32 4.09 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.226 1.01 . . . . 0.0 111.656 175.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -53.94 -49.55 68.45 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.323 1.049 . . . . 0.0 113.438 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.5 mt -62.9 -39.66 95.2 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.7 t -58.17 -44.06 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.75 0.82 . . . . 0.0 111.084 174.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -60.26 -53.73 54.25 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.852 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.7 tp -51.6 -49.72 61.6 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.162 0.985 . . . . 0.0 113.277 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.8 ttt -62.66 -36.6 83.41 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.984 0.914 . . . . 0.0 113.188 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.17 -35.32 56.03 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -86.27 1.99 48.85 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.8 mt . . . . . 0 N--CA 1.488 1.433 0 C-N-CA 124.653 1.181 . . . . 0.0 114.055 170.539 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ttp . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -121.41 132.06 54.53 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 125.259 1.6 . . . . 0.0 112.026 173.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.464 ' HG3' ' OG ' ' A' ' 64' ' ' SER . 0.5 OUTLIER -132.93 146.93 52.23 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.6 174.075 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -119.22 150.9 39.31 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 124.384 1.053 . . . . 0.0 110.871 169.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -117.28 98.69 6.56 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 123.309 1.528 . . . . 0.0 110.823 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.24 149.55 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 113.902 -1.499 . . . . 0.0 112.219 -169.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.502 HG22 HG22 ' A' ' 60' ' ' VAL . 2.6 p -100.87 143.44 31.02 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.269 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.5 mp -81.16 115.97 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 165.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.2 p -99.85 -36.09 9.54 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 112.594 -2.094 . . . . 0.0 112.497 -174.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.482 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -53.99 142.15 46.73 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.978 0.911 . . . . 0.0 112.462 170.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 50.2 Cg_exo -58.48 -44.27 38.89 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.996 3.131 . . . . 0.0 115.332 -172.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . 0.257 11.1 p30 -105.21 -29.92 10.02 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 176.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.71 -127.24 7.86 Favored Glycine 0 CA--C 1.538 1.5 0 O-C-N 124.287 0.992 . . . . 0.0 114.263 169.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -174.956 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.669 HG22 ' HB3' ' A' ' 51' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.341 97.0 mtt180 -83.36 -43.46 0.84 Allowed Pre-proline 0 N--CA 1.479 1.014 0 N-CA-C 118.049 2.611 . . . . 0.0 118.049 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -62.0 -37.21 66.52 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 CA-C-N 123.233 2.19 . . . . 0.0 110.884 170.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.65 -30.52 21.93 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 164.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.38 -40.62 97.07 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 119.474 1.034 . . . . 0.0 112.327 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.83 -35.54 80.28 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 118.436 -0.792 . . . . 0.0 112.973 171.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -62.17 -48.03 81.87 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.94 0.336 . . . . 0.0 111.032 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.1 t -50.61 -50.72 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.933 0.873 . . . . 0.0 111.411 173.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.42 -44.21 95.98 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.54 -1.209 . . . . 0.0 113.121 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.463 ' HG2' HD22 ' A' ' 80' ' ' LEU . 12.9 tp10 -63.36 -40.29 96.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.355 1.462 . . . . 0.0 113.67 175.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.42 99.13 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.101 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.585 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . 79.6 mttt -56.99 -30.15 63.9 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.6 -25.73 36.39 Favored Glycine 0 CA--C 1.543 1.818 0 O-C-N 125.343 1.652 . . . . 0.0 114.849 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -97.63 146.68 25.07 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.093 0.957 . . . . 0.0 112.928 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -58.61 -50.35 74.16 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.758 1.623 . . . . 0.0 112.387 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.1 p -53.15 147.61 9.54 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 125.043 1.465 . . . . 0.0 113.975 170.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -103.06 87.67 2.97 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 122.706 1.241 . . . . 0.0 109.422 170.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.499 ' CD1' ' HB2' ' A' ' 65' ' ' ALA . 6.3 mm -48.57 112.34 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 112.131 -2.304 . . . . 0.0 111.556 172.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.5 p -101.18 143.5 31.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.458 171.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.5 t -127.75 111.77 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.2 m -109.98 126.97 54.49 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.538 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -123.89 136.77 54.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.643 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.6 p30 51.08 22.83 1.35 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 128.739 2.816 . . . . 0.0 117.067 -178.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.54 -28.4 14.39 Favored Glycine 0 CA--C 1.544 1.894 0 CA-C-N 115.238 -0.892 . . . . 0.0 114.367 -171.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -81.09 135.47 35.81 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.447 0.624 . . . . 0.0 111.345 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.0 t -113.55 120.26 40.35 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.847 -170.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -126.19 129.2 48.53 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.702 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.5 t -76.15 131.77 39.59 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.898 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.15 -40.95 82.24 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 125.149 1.531 . . . . 0.0 112.559 174.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.585 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 72.8 mttt -57.76 -18.42 21.42 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 171.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 t -107.39 114.43 28.44 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.618 1.199 . . . . 0.0 110.045 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.3 tp -62.03 -59.21 5.42 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.94 -1.936 . . . . 0.0 115.555 -165.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -69.68 -31.1 68.95 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -57.03 -61.4 2.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.016 0.926 . . . . 0.0 109.919 171.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.0 tp -57.39 -44.66 84.67 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.669 ' HB3' HG22 ' A' ' 16' ' ' THR . 75.3 mt-30 -61.9 -42.84 99.56 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 t -67.45 -12.67 60.83 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.402 HD22 ' HB3' ' A' ' 42' ' ' ALA . 11.4 tp -69.87 -52.51 24.21 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -173.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.03 72.88 0.88 Allowed Glycine 0 N--CA 1.471 0.985 0 O-C-N 124.256 0.973 . . . . 0.0 112.383 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.1 mt -86.55 73.66 10.04 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 123.62 1.676 . . . . 0.0 111.007 175.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.4 t -127.8 172.25 11.01 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 111.802 -2.454 . . . . 0.0 111.517 -172.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -40.26 143.4 0.3 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.521 1.929 . . . . 0.0 112.236 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.37 -33.76 2.02 Favored Glycine 0 N--CA 1.481 1.644 0 CA-C-O 118.362 -1.243 . . . . 0.0 114.875 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.0 p -61.97 115.68 4.27 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.064 1.432 . . . . 0.0 114.492 -174.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 7' ' ' THR . 25.7 t -88.81 100.94 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 110.721 -2.945 . . . . 0.0 106.184 173.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.0 m -102.78 123.8 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 112.902 -1.954 . . . . 0.0 111.611 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 p -84.5 109.76 18.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 112.306 -2.224 . . . . 0.0 111.391 171.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.8 mt -104.55 110.38 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.079 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.464 ' OG ' ' HG3' ' A' ' 3' ' ' GLN . 4.4 m -117.57 126.44 52.55 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 113.741 -1.572 . . . . 0.0 115.098 -168.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.499 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . . . -126.18 137.84 53.6 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.293 -1.321 . . . . 0.0 112.921 176.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -139.1 113.98 9.31 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.446 -1.706 . . . . 0.0 108.996 166.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.75 -155.59 16.74 Favored Glycine 0 N--CA 1.479 1.545 0 C-N-CA 126.07 1.795 . . . . 0.0 109.439 -175.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -77.78 -35.33 51.68 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 122.218 1.009 . . . . 0.0 111.569 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -105.02 26.94 8.66 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.848 1.659 . . . . 0.0 115.154 -177.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -44.61 -43.15 7.97 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.464 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -73.36 -46.43 49.2 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 174.241 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.426 ' HE2' ' OE1' ' A' ' 71' ' ' GLN . 39.0 mtmt -72.76 -32.04 65.34 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.119 1.368 . . . . 0.0 113.271 -173.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.96 -53.37 58.75 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.027 1.331 . . . . 0.0 111.269 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 t -65.66 -52.44 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.135 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -47.03 -57.2 5.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.021 1.328 . . . . 0.0 112.478 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -60.29 -60.32 4.0 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mt -58.23 -36.0 72.53 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.83 -42.77 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.568 0.747 . . . . 0.0 111.572 171.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -63.82 -34.52 78.1 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.463 HD22 ' HG2' ' A' ' 25' ' ' GLU . 4.5 tp -58.37 -52.54 65.16 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.447 1.099 . . . . 0.0 112.157 164.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 48.2 ttm -48.86 -51.43 29.74 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.867 0.867 . . . . 0.0 112.581 173.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.5 -50.5 73.67 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -84.77 15.08 4.11 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -174.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.552 1.05 0 C-N-CA 124.299 1.039 . . . . 0.0 111.594 169.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -127.98 141.15 51.61 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.398 1.479 . . . . 0.0 109.879 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.48 128.36 11.75 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.053 0.541 . . . . 0.0 111.863 -172.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -125.13 119.46 28.64 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -83.08 115.68 21.98 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 113.18 -1.827 . . . . 0.0 111.086 164.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.1 164.31 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 113.249 -1.796 . . . . 0.0 113.076 176.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.9 p -121.31 126.04 48.53 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -172.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.42 HD12 ' OG1' ' A' ' 59' ' ' THR . 47.5 mt -80.26 111.9 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.411 170.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 p -107.07 -8.77 16.4 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 113.218 -1.81 . . . . 0.0 115.555 173.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.27 137.03 68.45 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.965 0.906 . . . . 0.0 112.535 177.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -45.78 -46.17 15.76 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 124.843 3.695 . . . . 0.0 115.943 -170.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.22 -34.32 5.96 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 175.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.32 -135.56 12.54 Favored Glycine 0 N--CA 1.482 1.74 0 O-C-N 123.761 0.663 . . . . 0.0 111.627 169.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 7.7 mp . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.5 p . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 63.4 mtt-85 -75.27 -45.18 4.59 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-O 115.706 -2.093 . . . . 0.0 115.599 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -63.34 -28.46 71.97 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 CA-C-N 122.565 1.952 . . . . 0.0 112.569 168.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.501 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -61.2 -22.24 64.57 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 169.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.4 -36.36 63.48 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -55.9 -47.27 77.75 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 170.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -55.62 -43.61 76.27 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.899 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.604 HG12 ' HE2' ' A' ' 27' ' ' LYS . 19.5 t -59.23 -52.55 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.752 0.821 . . . . 0.0 111.214 176.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.22 -56.44 11.09 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.584 1.154 . . . . 0.0 113.028 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.505 ' HG2' HD11 ' A' ' 80' ' ' LEU . 10.0 tp10 -58.8 -45.2 90.43 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 124.779 1.3 . . . . 0.0 112.395 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.59 80.18 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.604 ' HE2' HG12 ' A' ' 23' ' ' VAL . 63.1 mttm -50.25 -38.42 40.69 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 175.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.94 3.78 55.87 Favored Glycine 0 CA--C 1.54 1.605 0 O-C-N 124.769 1.293 . . . . 0.0 116.298 -173.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -100.75 158.3 16.06 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.305 1.042 . . . . 0.0 112.869 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.3 p -68.57 -52.32 33.1 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 118.639 -0.696 . . . . 0.0 109.482 168.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.0 p -59.05 136.52 57.97 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.875 1.27 . . . . 0.0 112.947 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -95.27 92.15 6.61 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.362 173.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.606 HD13 ' HB2' ' A' ' 65' ' ' ALA . 29.7 mm -57.55 115.68 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 112.132 -2.304 . . . . 0.0 110.211 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.5 p -105.54 117.29 33.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.702 173.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.6 t -103.89 117.71 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.717 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.448 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 35.0 m -107.8 129.7 55.03 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 112.553 -2.112 . . . . 0.0 112.042 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.1 t -136.25 137.68 41.03 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 111.979 -2.373 . . . . 0.0 107.727 171.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.8 p30 40.02 44.54 1.47 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.36 -40.65 3.08 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 124.185 0.898 . . . . 0.0 114.388 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -57.84 123.93 17.46 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.872 1.269 . . . . 0.0 112.645 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -109.74 101.44 10.33 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.489 -176.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.71 134.65 47.52 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.622 1.201 . . . . 0.0 112.846 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.0 t -73.21 112.19 9.03 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 112.485 -2.143 . . . . 0.0 112.143 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.55 -14.58 63.11 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 112.717 -2.038 . . . . 0.0 114.232 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -72.27 -22.28 61.24 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.2 t -109.91 122.43 47.53 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.843 0.83 . . . . 0.0 111.744 -176.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.445 ' HA ' HG21 ' A' ' 23' ' ' VAL . 6.3 tp -55.54 -59.4 4.89 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.588 -2.096 . . . . 0.0 114.615 -169.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -64.79 -33.38 75.86 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -61.97 -51.72 66.91 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 123.805 0.69 . . . . 0.0 112.382 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.5 tp -61.96 -38.74 89.67 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -64.9 -39.28 93.29 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -72.96 -28.68 62.55 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 172.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.3 tp -45.19 -60.95 1.85 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.61 93.46 2.02 Favored Glycine 0 CA--C 1.539 1.57 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 71.5 mt -120.06 87.04 2.67 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 113.337 -1.432 . . . . 0.0 107.906 178.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 t -135.38 -174.87 3.75 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.337 -1.302 . . . . 0.0 111.351 -173.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -61.05 118.48 6.82 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.288 0.566 . . . . 0.0 109.993 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.78 -7.81 65.44 Favored Glycine 0 N--CA 1.478 1.435 0 CA-C-N 114.368 -1.287 . . . . 0.0 115.665 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.42 ' OG1' HD12 ' A' ' 8' ' ' ILE . 42.3 p -71.44 99.59 2.03 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.351 1.075 . . . . 0.0 111.652 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.2 t -60.44 104.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 111.497 -2.592 . . . . 0.0 107.986 173.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.4 m -106.78 113.4 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.418 -168.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.448 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 6.7 m -100.25 104.97 16.49 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 112.271 -2.24 . . . . 0.0 108.973 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 24.3 mt -98.64 102.25 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.118 -1.855 . . . . 0.0 107.9 -174.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -102.56 140.86 36.28 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 113.642 -1.617 . . . . 0.0 112.31 -176.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.606 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -146.71 142.05 27.43 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.419 1.074 . . . . 0.0 112.904 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -140.12 114.25 9.05 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.12 169.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.99 -152.56 15.13 Favored Glycine 0 N--CA 1.483 1.791 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.581 -175.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -86.32 -57.7 2.91 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 120.742 0.306 . . . . 0.0 110.503 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.55 5.49 3.81 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.783 2.142 . . . . 0.0 116.783 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -41.93 -53.71 3.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.425 ' HG2' ' HG3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -58.91 -49.24 78.56 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.949 1.3 . . . . 0.0 113.477 179.208 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 72.4 mttt -76.62 -34.94 58.32 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.278 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.42 68.5 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.015 0.926 . . . . 0.0 111.959 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.54 -45.51 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-O 118.459 -0.782 . . . . 0.0 111.731 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -52.94 -51.06 62.67 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 123.876 0.735 . . . . 0.0 111.994 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -59.23 -51.82 68.33 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.438 1.495 . . . . 0.0 111.697 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.417 HD13 HG21 ' A' ' 33' ' ' ILE . 30.2 mt -65.93 -29.91 70.41 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.94 -46.19 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 121.329 0.585 . . . . 0.0 109.725 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -71.42 -30.31 65.93 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.432 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.505 HD11 ' HG2' ' A' ' 25' ' ' GLU . 0.6 OUTLIER -59.54 -52.84 63.85 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 124.142 0.901 . . . . 0.0 112.459 166.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.7 tmm? -53.12 -47.47 68.63 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 124.49 1.119 . . . . 0.0 111.892 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.04 -40.35 97.46 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -90.0 -9.98 46.64 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.479 1.004 0 C-N-CA 122.888 0.475 . . . . 0.0 110.696 161.485 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.413 ' HD2' ' HB ' ' A' ' 74' ' ' VAL . 12.6 t80 -118.4 118.91 33.05 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 125.425 1.703 . . . . 0.0 110.567 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.75 122.34 37.18 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.438 -172.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -134.02 140.28 46.58 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.751 0.821 . . . . 0.0 113.073 171.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.6 ' HG2' HG12 ' A' ' 60' ' ' VAL . 39.9 tt0 -112.32 122.87 48.96 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.958 -172.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.409 HG11 HG13 ' A' ' 78' ' ' VAL . 3.2 m -128.63 130.33 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.582 HG23 HG22 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -91.21 128.01 36.86 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 113.684 -1.598 . . . . 0.0 111.518 -177.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.1 mt -87.5 118.14 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.709 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 p -95.51 -26.72 15.7 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 113.516 -1.675 . . . . 0.0 113.748 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.477 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -64.28 127.95 92.66 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 123.486 0.714 . . . . 0.0 111.943 173.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HA ' ' HB2' ' A' ' 57' ' ' GLN . 65.4 Cg_exo -54.62 -51.98 9.19 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.171 3.247 . . . . 0.0 113.725 -170.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -95.81 -46.39 6.59 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.866 1.354 . . . . 0.0 111.031 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.09 -107.86 2.26 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.655 1.121 . . . . 0.0 112.764 166.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 24.0 mt . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.4 p . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -74.43 -44.56 5.77 Favored Pre-proline 0 N--CA 1.483 1.188 0 CA-C-O 116.248 -1.834 . . . . 0.0 115.908 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.425 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 82.8 Cg_exo -64.3 -40.61 24.55 Favored 'Trans proline' 0 N--CA 1.486 1.063 0 CA-C-N 121.826 1.688 . . . . 0.0 112.866 170.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -51.16 -37.56 47.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.587 1.155 . . . . 0.0 113.959 172.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.73 75.71 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 175.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -80.73 -28.18 36.66 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 174.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -62.04 -38.91 90.53 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.296 0.639 . . . . 0.0 110.551 168.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 19' ' ' ALA . 46.4 t -60.65 -48.12 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 124.472 1.109 . . . . 0.0 110.978 169.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -51.47 -46.97 63.29 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 118.895 -0.574 . . . . 0.0 111.622 175.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.403 ' HG2' HD22 ' A' ' 80' ' ' LEU . 11.4 tp10 -61.58 -56.28 21.64 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 125.13 1.519 . . . . 0.0 111.567 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.82 -40.71 63.55 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.435 ' HE2' HG12 ' A' ' 23' ' ' VAL . 65.1 mttm -57.93 -27.85 63.75 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 176.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.68 -46.38 94.56 Favored Glycine 0 CA--C 1.542 1.772 0 C-N-CA 124.948 1.261 . . . . 0.0 112.892 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -69.12 144.15 53.96 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.991 0.916 . . . . 0.0 112.459 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.3 p -67.72 -45.77 74.11 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.285 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.7 p -63.12 167.0 5.34 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.683 1.593 . . . . 0.0 113.206 171.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -114.03 111.57 21.86 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 122.365 1.078 . . . . 0.0 110.903 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.739 HD13 ' HB2' ' A' ' 65' ' ' ALA . 39.5 mm -69.47 103.77 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 112.567 -2.106 . . . . 0.0 110.773 175.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.9 p -88.3 118.2 27.75 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.315 167.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -105.39 92.45 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 113.545 -1.661 . . . . 0.0 106.876 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 12.0 m -81.59 124.94 29.95 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 112.12 -2.309 . . . . 0.0 110.961 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -128.65 106.64 9.09 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.662 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 p30 35.43 83.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 112.557 -2.111 . . . . 0.0 116.533 -176.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.52 -52.68 4.59 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-N 113.037 -1.892 . . . . 0.0 112.903 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -69.21 117.68 11.15 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.305 1.042 . . . . 0.0 111.509 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 1.7 t -111.29 108.94 18.73 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.81 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.49 118.6 37.05 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.478 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.4 t -57.11 111.88 1.19 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.185 -1.371 . . . . 0.0 111.153 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.22 -24.34 67.18 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.876 172.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -70.46 -26.87 63.84 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.236 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -95.29 102.6 14.42 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 123.063 1.411 . . . . 0.0 112.006 172.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.406 ' HA ' HG21 ' A' ' 23' ' ' VAL . 16.9 tp -39.43 -59.86 1.02 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.093 2.157 . . . . 0.0 115.704 -175.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -66.32 -33.15 75.08 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -67.07 -44.52 79.88 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.43 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 tp -66.93 -45.47 77.78 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 124.444 1.09 . . . . 0.0 112.02 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -57.49 -30.55 65.19 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 t -94.07 -0.0 55.65 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.5 -41.8 96.22 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.23 86.65 1.86 Allowed Glycine 0 CA--C 1.537 1.417 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -172.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.549 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 10.6 mt -115.29 77.22 1.06 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.192 0.996 . . . . 0.0 109.73 -172.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.9 t -132.05 168.29 18.2 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.468 -163.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.595 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 40.7 tt0 -57.54 106.71 0.36 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.031 0.932 . . . . 0.0 111.468 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.62 -38.21 2.61 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 113.311 -1.768 . . . . 0.0 114.526 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.8 p -64.55 122.85 17.78 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 118.165 0.982 . . . . 0.0 112.88 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.6 HG12 ' HG2' ' A' ' 5' ' ' GLU . 1.1 t -97.86 111.22 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 113.073 -1.876 . . . . 0.0 106.792 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.7 m -105.52 117.07 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 112.701 -2.045 . . . . 0.0 113.778 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.3 93.66 9.14 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 112.466 -2.152 . . . . 0.0 111.88 -175.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.457 HG22 HG22 ' A' ' 74' ' ' VAL . 81.2 mt -80.15 102.81 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 113.845 -1.525 . . . . 0.0 107.724 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.2 m -121.31 134.08 55.14 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 112.62 -2.082 . . . . 0.0 112.978 -175.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.739 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -145.84 152.31 39.29 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 124.822 1.326 . . . . 0.0 112.767 177.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -137.28 133.27 34.82 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.971 172.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.44 -159.73 24.9 Favored Glycine 0 N--CA 1.484 1.894 0 O-C-N 124.169 0.918 . . . . 0.0 113.519 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -50.26 -47.47 55.17 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -108.79 31.23 5.81 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -51.26 -52.29 46.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -71.8 -42.21 67.33 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 112.765 -2.016 . . . . 0.0 113.151 178.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -66.62 -47.36 72.88 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.593 1.157 . . . . 0.0 111.987 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.576 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -60.33 -47.36 86.37 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.366 1.066 . . . . 0.0 113.429 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.457 HG22 HG22 ' A' ' 63' ' ' ILE . 95.4 t -68.94 -45.81 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 117.537 -1.221 . . . . 0.0 111.261 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -52.08 -49.76 62.91 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.981 0.913 . . . . 0.0 111.019 175.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -62.69 -58.1 8.65 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.107 1.363 . . . . 0.0 113.442 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.3 mt -64.74 -29.78 70.77 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.409 HG13 HG11 ' A' ' 6' ' ' VAL . 28.5 t -63.24 -54.79 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 124.036 0.835 . . . . 0.0 110.686 168.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt -56.34 -47.05 79.6 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.736 0.814 . . . . 0.0 112.969 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.403 HD22 ' HG2' ' A' ' 25' ' ' GLU . 37.7 tp -52.51 -56.08 17.65 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.435 1.094 . . . . 0.0 111.607 175.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.415 ' HG2' HD11 ' A' ' 14' ' ' LEU . 6.5 tmm? -53.99 -43.72 70.23 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.085 0.954 . . . . 0.0 112.021 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.6 -35.56 80.5 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -177.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.99 -21.04 34.05 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.7 mt . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -177.928 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.465 ' HG2' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -132.87 139.55 47.48 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 125.337 1.648 . . . . 0.0 108.907 165.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -137.58 128.46 27.23 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.227 -177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -125.05 108.04 11.42 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.976 168.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -87.3 97.25 10.68 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 112.587 -2.097 . . . . 0.0 109.123 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 m -120.34 117.49 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 112.243 -2.253 . . . . 0.0 112.91 -173.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 p -71.77 126.77 30.57 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.728 -1.123 . . . . 0.0 111.665 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.9 mt -71.2 126.54 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 114.876 -1.057 . . . . 0.0 108.756 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -98.94 -37.53 9.36 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 113.957 -1.474 . . . . 0.0 114.336 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.68 123.86 24.94 Favored Pre-proline 0 N--CA 1.482 1.147 0 O-C-N 123.863 0.727 . . . . 0.0 111.485 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.609 ' HA ' ' HB2' ' A' ' 57' ' ' GLN . 96.8 Cg_exo -51.3 -42.43 54.39 Favored 'Trans proline' 0 N--CA 1.482 0.851 0 C-N-CA 123.973 3.116 . . . . 0.0 112.03 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -71.91 -56.07 6.36 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.922 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.7 -127.28 9.09 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.932 1.253 . . . . 0.0 110.522 171.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 21.2 mt . . . . . 0 N--CA 1.482 1.157 0 CA-C-N 113.931 -1.135 . . . . 0.0 113.241 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.3 p . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.4 mmt-85 -64.22 -48.39 76.65 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-O 116.03 -1.938 . . . . 0.0 114.593 -174.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -65.41 -41.7 14.96 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.415 2.077 . . . . 0.0 112.912 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.73 -38.22 60.47 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.41 -41.68 94.4 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.919 0.887 . . . . 0.0 113.013 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -67.5 -44.44 78.48 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.344 1.058 . . . . 0.0 111.631 175.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -58.36 -45.76 87.61 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.256 1.423 . . . . 0.0 111.447 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.754 HG11 ' HA ' ' A' ' 47' ' ' LEU . 51.9 t -53.88 -46.7 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 124.296 1.038 . . . . 0.0 111.672 173.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -57.05 -44.99 83.55 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 118.98 -0.534 . . . . 0.0 111.876 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -62.36 -47.79 82.65 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.501 1.126 . . . . 0.0 112.627 174.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.24 -39.52 83.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.68 1.192 . . . . 0.0 114.174 175.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -60.03 -26.24 65.95 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 172.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.86 -20.93 64.9 Favored Glycine 0 CA--C 1.546 1.977 0 O-C-N 124.535 1.147 . . . . 0.0 114.187 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -99.95 145.84 27.37 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.592 1.187 . . . . 0.0 113.307 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.1 p -73.14 -37.04 66.75 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.334 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.6 p -63.38 160.55 15.86 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 124.599 1.187 . . . . 0.0 112.121 168.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -107.05 110.57 22.73 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.655 HD13 ' HB2' ' A' ' 65' ' ' ALA . 46.2 mm -72.43 92.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.024 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.2 107.44 14.0 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 110.845 -2.889 . . . . 0.0 107.886 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.96 101.85 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.269 -176.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.579 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 9.5 m -96.74 118.69 33.75 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 113.523 -1.671 . . . . 0.0 112.043 -177.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.9 t -130.53 114.37 15.4 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.325 171.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 p30 43.26 70.13 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 125.372 1.469 . . . . 0.0 114.17 -172.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.91 -35.5 1.24 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-N 113.389 -1.732 . . . . 0.0 115.241 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -74.34 108.58 7.21 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.163 0.985 . . . . 0.0 111.415 -174.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.5 m -98.96 100.62 11.82 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.871 176.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -105.91 115.31 30.01 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.837 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.3 t -64.56 119.06 9.75 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.889 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -23.13 65.96 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.433 -1.712 . . . . 0.0 113.525 171.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -70.78 -24.07 62.52 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.137 177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.9 t -103.07 123.43 46.63 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.217 0.532 . . . . 0.0 111.393 167.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.754 ' HA ' HG11 ' A' ' 23' ' ' VAL . 32.4 tp -42.91 -61.32 1.31 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 111.041 -2.8 . . . . 0.0 114.919 -171.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -82.75 -6.96 59.66 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -74.01 -58.31 3.39 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.8 tp -54.11 -39.51 66.48 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -67.24 -2.88 6.52 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.2 t -133.1 59.37 1.74 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 124.578 2.132 . . . . 0.0 112.538 166.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.518 HD23 HD21 ' A' ' 55' ' ' LEU . 40.2 tp -110.3 -50.71 2.94 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 113.08 -1.873 . . . . 0.0 113.095 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.72 90.12 1.93 Allowed Glycine 0 CA--C 1.531 1.087 0 N-CA-C 107.804 -2.119 . . . . 0.0 107.804 -169.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.518 HD21 HD23 ' A' ' 53' ' ' LEU . 59.4 mt -122.88 90.25 3.26 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.054 -1.073 . . . . 0.0 109.44 -171.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.4 t -162.94 157.81 21.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 126.385 2.303 . . . . 0.0 109.346 -164.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.609 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 32.6 tt0 -40.05 132.04 1.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -175.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.19 -20.58 32.65 Favored Glycine 0 N--CA 1.479 1.553 0 CA-C-N 113.003 -1.908 . . . . 0.0 114.518 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.3 p -60.98 108.06 0.81 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 122.925 1.345 . . . . 0.0 112.992 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.3 94.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 110.779 -2.919 . . . . 0.0 106.919 -175.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.5 m -92.25 98.0 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 113.648 -1.614 . . . . 0.0 112.691 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.579 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 4.8 m -73.66 88.03 1.69 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 111.834 -2.439 . . . . 0.0 108.778 175.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.445 HG23 HG23 ' A' ' 33' ' ' ILE . 85.9 mt -82.22 108.28 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.158 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.3 m -120.0 136.74 54.44 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 113.404 -1.725 . . . . 0.0 113.427 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.655 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -144.83 130.81 19.3 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.042 172.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.465 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 25.2 tt0 -123.19 118.65 28.12 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.682 -1.145 . . . . 0.0 107.984 163.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 170.14 -173.44 44.17 Favored Glycine 0 N--CA 1.478 1.486 0 CA-C-N 113.93 -1.486 . . . . 0.0 112.697 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.418 ' HG2' ' H ' ' A' ' 68' ' ' GLU . 4.5 mm-40 -47.41 -45.95 25.91 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 125.015 1.326 . . . . 0.0 113.667 -178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -114.22 34.78 4.49 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.592 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 8.5 pt-20 -46.05 -72.85 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 -175.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.592 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -52.22 -43.33 64.21 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 177.076 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -62.77 -45.82 90.9 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.319 -1.31 . . . . 0.0 112.864 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -57.1 -52.44 65.27 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.481 1.113 . . . . 0.0 112.802 174.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.6 t -64.75 -46.36 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.952 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -55.07 -52.25 63.8 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -60.78 -48.42 81.9 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.888 0.875 . . . . 0.0 113.076 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.4 mt -63.03 -37.79 88.6 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.82 -45.27 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.316 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -55.15 -54.35 44.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 123.617 0.573 . . . . 0.0 111.052 173.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -49.36 -54.86 15.12 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 125.636 1.575 . . . . 0.0 111.846 175.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -58.12 -40.62 81.71 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.466 1.106 . . . . 0.0 113.07 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.79 -44.06 64.6 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 175.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -70.56 -3.27 17.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.518 1.527 . . . . 0.0 114.293 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.9 mt . . . . . 0 N--CA 1.48 1.056 0 C-N-CA 124.856 1.262 . . . . 0.0 110.761 169.628 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ttt . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.498 ' HB3' HG21 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -77.77 141.84 39.02 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.282 -1.326 . . . . 0.0 113.091 173.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -148.55 127.82 12.98 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.427 -1.715 . . . . 0.0 110.031 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -126.77 117.7 23.2 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.012 0.82 . . . . 0.0 112.597 164.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -84.06 97.81 9.52 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 125.643 1.84 . . . . 0.0 108.623 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.795 HG23 HG23 ' A' ' 61' ' ' VAL . 2.7 m -125.93 141.48 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 113.592 -1.64 . . . . 0.0 112.491 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.4 p -107.77 137.87 45.02 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.3 mt -76.75 122.85 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.487 175.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.2 p -91.49 -43.47 9.67 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.107 -1.406 . . . . 0.0 114.114 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -28.77 133.44 0.19 Allowed Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 126.978 2.111 . . . . 0.0 115.121 175.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 54.5 Cg_exo -54.53 -54.19 4.98 Favored 'Trans proline' 0 N--CA 1.482 0.841 0 C-N-CA 124.296 3.331 . . . . 0.0 112.49 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.415 ' H ' ' ND2' ' A' ' 12' ' ' ASN . 3.8 p30 -78.15 -43.59 28.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.166 0.986 . . . . 0.0 112.559 176.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 56' ' ' THR . . . 101.12 -152.91 19.02 Favored Glycine 0 N--CA 1.475 1.239 0 C-N-CA 125.464 1.507 . . . . 0.0 110.508 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 172.687 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.421 ' HD3' ' HA ' ' A' ' 17' ' ' ARG 0.279 83.0 mmt-85 -85.32 -44.06 0.65 Allowed Pre-proline 0 N--CA 1.483 1.205 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 -176.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -62.74 -37.35 56.89 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 121.528 1.486 . . . . 0.0 111.703 164.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.27 -40.95 71.6 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.96 -36.97 75.72 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 173.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -66.66 -49.77 65.08 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.822 0.701 . . . . 0.0 111.418 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -54.99 -43.48 73.6 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 124.045 0.841 . . . . 0.0 111.45 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 44' ' ' ALA . 40.1 t -53.18 -61.83 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.657 1.183 . . . . 0.0 111.324 171.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -49.23 -46.37 45.8 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 124.176 0.922 . . . . 0.0 111.822 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.32 -55.62 17.22 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.678 1.236 . . . . 0.0 112.906 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.56 -30.17 70.49 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -55.51 -30.82 61.36 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 170.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.99 -5.9 66.47 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.12 1.343 . . . . 0.0 114.896 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -95.89 142.48 28.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.153 0.581 . . . . 0.0 111.737 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.7 p -63.87 -39.01 93.2 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.174 0.99 . . . . 0.0 111.51 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 p -62.04 141.43 58.09 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.372 -1.285 . . . . 0.0 112.71 168.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -94.26 108.56 20.43 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 123.311 1.529 . . . . 0.0 110.117 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.486 HD11 ' HB1' ' A' ' 73' ' ' ALA . 37.4 mm -73.79 106.91 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 111.228 -2.715 . . . . 0.0 109.87 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.4 p -108.8 110.41 21.78 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 122.806 1.288 . . . . 0.0 112.063 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.523 HG13 ' HA ' ' A' ' 61' ' ' VAL . 30.0 t -81.87 106.27 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 112.379 -2.192 . . . . 0.0 109.057 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.455 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 19.5 m -85.72 105.67 16.42 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 122.354 1.073 . . . . 0.0 110.016 172.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.8 t -118.75 109.42 16.06 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 113.338 -1.756 . . . . 0.0 110.458 171.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 p30 43.94 71.25 0.26 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.72 9.25 37.85 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-N 112.99 -1.914 . . . . 0.0 116.349 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.415 ' HE3' HD12 ' A' ' 53' ' ' LEU . 40.5 mtmt -118.82 99.25 6.64 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 122.328 -0.513 . . . . 0.0 110.841 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.4 m -79.97 98.76 7.31 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.651 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.88 124.53 49.11 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 113.366 -1.743 . . . . 0.0 112.709 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.6 t -70.37 132.17 45.22 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 113.164 -1.835 . . . . 0.0 113.297 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.479 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -74.77 -25.37 59.03 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 113.924 -1.489 . . . . 0.0 114.054 167.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -73.69 -27.27 61.13 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.8 t -96.16 92.65 6.51 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.347 1.07 . . . . 0.0 109.177 171.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.2 tp -37.78 -55.01 1.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 126.98 2.112 . . . . 0.0 114.529 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.482 ' O ' HG22 ' A' ' 52' ' ' THR . 80.3 m-85 -65.69 -33.48 75.99 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -59.98 -49.48 77.52 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tp -63.84 -39.63 94.68 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -65.69 -37.49 86.62 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 48' ' ' PHE . 12.4 t -99.84 78.69 2.14 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 125.046 2.355 . . . . 0.0 111.91 175.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.415 HD12 ' HE3' ' A' ' 40' ' ' LYS . 37.2 tp -149.58 -51.0 0.15 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 111.361 -2.654 . . . . 0.0 112.473 -173.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.427 ' O ' HG21 ' A' ' 59' ' ' THR . . . 96.5 65.26 0.93 Allowed Glycine 0 N--CA 1.472 1.06 0 O-C-N 125.467 1.73 . . . . 0.0 110.387 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 78.7 mt -85.14 91.63 8.17 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.441 0.638 . . . . 0.0 110.258 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.528 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 6.4 t -135.91 -163.43 1.4 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.373 -171.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -63.8 118.83 8.9 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.825 0.85 . . . . 0.0 111.145 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.11 -10.05 76.04 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-N 113.6 -1.636 . . . . 0.0 115.371 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.427 HG21 ' O ' ' A' ' 54' ' ' GLY . 67.2 p -75.81 142.5 42.25 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 117.656 0.728 . . . . 0.0 112.383 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.28 137.21 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 113.022 -1.899 . . . . 0.0 109.307 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.795 HG23 HG23 ' A' ' 6' ' ' VAL . 3.2 m -110.54 78.85 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-N 112.473 -2.149 . . . . 0.0 107.398 165.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.455 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 3.0 m -74.95 86.29 2.28 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 173.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.478 HG23 HG23 ' A' ' 33' ' ' ILE . 57.1 mt -74.72 87.65 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.246 -173.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 75.0 m -88.67 125.55 34.89 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 112.806 -1.997 . . . . 0.0 110.272 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.55 136.15 20.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.281 -1.327 . . . . 0.0 113.489 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -130.91 128.66 40.97 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.334 1.022 . . . . 0.0 110.067 172.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.39 -176.93 30.44 Favored Glycine 0 N--CA 1.492 2.428 0 O-C-N 124.193 0.933 . . . . 0.0 115.142 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -53.85 -33.79 57.38 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -111.61 19.18 18.35 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -46.8 -51.93 15.31 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.474 ' NE2' ' H ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -62.54 -42.58 99.62 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 177.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -69.09 -46.13 68.55 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.477 -177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.486 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -53.67 -53.98 44.36 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.313 1.445 . . . . 0.0 113.133 174.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.498 HG21 ' HB3' ' A' ' 2' ' ' PHE . 79.8 t -59.09 -52.75 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.36 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.34 -47.54 81.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.737 0.815 . . . . 0.0 113.14 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -57.48 -55.46 34.58 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.84 1.256 . . . . 0.0 111.423 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.9 mt -66.44 -30.17 70.47 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.7 t -65.58 -48.56 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 123.373 0.42 . . . . 0.0 110.059 170.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -63.62 -44.8 92.88 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 117.94 -1.029 . . . . 0.0 113.294 175.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.7 tp -51.51 -51.52 54.52 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.359 1.063 . . . . 0.0 111.313 172.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -57.75 -42.57 84.24 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.051 0.94 . . . . 0.0 112.994 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.28 -43.87 66.33 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -82.98 35.68 0.48 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.845 1.658 . . . . 0.0 112.932 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 mt . . . . . 0 N--CA 1.481 1.121 0 C-N-CA 125.572 1.549 . . . . 0.0 112.704 179.298 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttt . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -110.48 136.89 48.92 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 125.958 2.036 . . . . 0.0 109.883 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -120.02 143.72 47.92 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 113.336 -1.756 . . . . 0.0 109.171 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -141.95 102.07 4.07 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.525 1.141 . . . . 0.0 109.674 171.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -81.87 102.13 10.66 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 111.938 -2.392 . . . . 0.0 108.682 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.48 HG23 HG23 ' A' ' 61' ' ' VAL . 5.2 m -125.02 158.2 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 112.507 -2.133 . . . . 0.0 111.76 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.484 HG22 HG22 ' A' ' 60' ' ' VAL . 81.5 p -109.68 137.46 47.46 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.805 0.812 . . . . 0.0 111.696 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.2 mt -91.53 93.18 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 166.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 p -86.43 -17.05 35.3 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 111.424 -2.625 . . . . 0.0 115.43 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.49 133.97 85.53 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.611 1.165 . . . . 0.0 112.155 175.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -44.55 -51.49 7.04 Favored 'Trans proline' 0 CA--C 1.541 0.836 1 C-N-CA 125.318 4.012 . . . . 0.0 116.563 -170.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -106.13 -27.64 10.97 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 172.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.21 -108.67 2.6 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 124.467 1.032 . . . . 0.0 112.691 170.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . 33.1 mt . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -175.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.8 p . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.415 ' HB2' ' HD3' ' A' ' 18' ' ' PRO 0.256 88.5 mmt-85 -74.74 -56.45 2.21 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-O 115.721 -2.085 . . . . 0.0 115.011 -175.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 87.0 Cg_exo -59.47 -34.57 97.18 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.778 2.319 . . . . 0.0 113.952 174.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.7 -25.99 2.08 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 172.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.26 98.57 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -65.99 -38.83 89.51 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.977 0.911 . . . . 0.0 112.674 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.41 -42.01 86.23 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.06 0.85 . . . . 0.0 112.134 172.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.686 HG21 ' HA ' ' A' ' 47' ' ' LEU . 73.3 t -64.92 -51.5 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.274 0.63 . . . . 0.0 112.06 170.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -49.87 -43.13 48.98 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.606 1.162 . . . . 0.0 112.608 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -67.58 -51.67 47.64 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.019 0.824 . . . . 0.0 111.915 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.49 -32.18 73.56 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HE2' ' O ' ' A' ' 45' ' ' LYS . 25.8 mmtt -44.65 -39.39 5.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.896 1.278 . . . . 0.0 114.431 167.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.35 -32.22 75.39 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 125.15 1.531 . . . . 0.0 114.898 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -74.82 133.46 41.91 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.0 p -65.89 -46.87 76.78 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.972 -173.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.2 p -66.53 137.75 57.01 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.817 1.647 . . . . 0.0 111.473 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -83.95 101.57 11.8 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 122.876 1.322 . . . . 0.0 111.758 -178.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' A' ' 44' ' ' ALA . 6.9 mm -70.05 100.41 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.281 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.2 p -94.2 103.93 15.96 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.325 174.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.6 96.29 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 112.776 -2.011 . . . . 0.0 107.514 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.6 m -88.84 104.52 17.0 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 113.473 -1.694 . . . . 0.0 111.322 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.4 t -108.31 99.24 8.67 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.72 172.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 p30 47.57 75.0 0.14 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.853 1.661 . . . . 0.0 114.011 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.05 -39.77 1.18 Allowed Glycine 0 CA--C 1.542 1.771 0 CA-C-N 113.176 -1.829 . . . . 0.0 114.044 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -77.03 106.9 9.01 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 123.606 1.67 . . . . 0.0 110.807 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -108.86 106.38 16.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 112.355 -2.202 . . . . 0.0 110.621 -170.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.464 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -110.47 122.63 48.18 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.93 -175.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.2 t -64.91 119.05 9.96 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 113.468 -1.696 . . . . 0.0 111.676 174.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.523 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . . . -66.66 -11.34 53.48 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.296 -1.774 . . . . 0.0 114.568 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.468 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 95.2 mttt -72.84 -21.12 61.0 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 166.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.5 t -112.55 99.97 8.37 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.38 1.072 . . . . 0.0 112.596 -174.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.686 ' HA ' HG21 ' A' ' 23' ' ' VAL . 19.0 tp -36.77 -54.88 0.9 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 112.99 -1.914 . . . . 0.0 115.131 178.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -63.48 -46.4 86.33 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.495 -1.684 . . . . 0.0 113.659 -172.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.8 tttm -63.03 -44.42 95.96 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.275 0.63 . . . . 0.0 112.282 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.8 tp -66.61 -44.03 83.2 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -60.56 -26.12 66.69 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.3 t -108.41 60.61 0.61 Allowed 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 124.449 2.071 . . . . 0.0 112.415 172.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.564 HD23 HD21 ' A' ' 55' ' ' LEU . 8.9 tp -124.99 -48.38 1.75 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 111.804 -2.453 . . . . 0.0 110.799 175.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.09 67.41 0.81 Allowed Glycine 0 CA--C 1.535 1.329 0 O-C-N 124.833 1.333 . . . . 0.0 110.57 176.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.564 HD21 HD23 ' A' ' 53' ' ' LEU . 57.5 mt -88.01 86.68 7.16 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.084 0.945 . . . . 0.0 110.151 -174.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -133.81 -175.24 3.77 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 112.211 -2.268 . . . . 0.0 113.772 -169.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -59.02 112.96 1.87 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.766 2.426 . . . . 0.0 111.915 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.08 -6.9 56.71 Favored Glycine 0 CA--C 1.547 2.076 0 CA-C-N 112.992 -1.913 . . . . 0.0 114.489 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.0 p -75.66 103.34 5.72 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 7' ' ' THR . 47.7 t -65.38 115.21 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 112.858 -1.974 . . . . 0.0 109.05 170.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.48 HG23 HG23 ' A' ' 6' ' ' VAL . 13.5 m -118.94 106.12 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 112.971 -1.922 . . . . 0.0 111.658 -177.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 42.5 m -83.44 95.18 8.18 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 112.233 -2.258 . . . . 0.0 109.358 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -89.48 91.82 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 112.103 -2.317 . . . . 0.0 108.443 -175.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.0 m -104.58 122.48 45.7 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 111.334 -2.666 . . . . 0.0 112.266 -170.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -137.3 147.96 46.02 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 124.86 1.35 . . . . 0.0 112.627 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -134.37 128.29 33.34 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.692 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.08 -159.78 24.76 Favored Glycine 0 N--CA 1.489 2.181 0 O-C-N 124.491 1.119 . . . . 0.0 114.82 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -49.66 -34.98 19.95 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -119.94 12.76 12.1 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 118.947 2.943 . . . . 0.0 118.947 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -33.02 -54.28 0.38 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.432 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -68.38 -60.22 2.61 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 176.2 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -53.62 -34.46 58.61 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.683 1.593 . . . . 0.0 114.055 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.19 -59.55 3.35 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.825 1.25 . . . . 0.0 112.775 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.87 -51.77 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.928 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -49.27 -51.82 31.31 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.428 1.091 . . . . 0.0 112.71 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -58.83 -55.55 33.69 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.05 0.94 . . . . 0.0 112.416 176.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.4 tp -61.91 -36.88 82.64 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.238 1.415 . . . . 0.0 113.252 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.48 HG11 HG11 ' A' ' 6' ' ' VAL . 86.5 t -73.58 -36.28 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.793 0.837 . . . . 0.0 111.583 175.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -60.12 -37.19 79.27 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 118.2 -0.905 . . . . 0.0 113.17 168.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.3 tp -57.34 -40.68 78.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 123.886 0.741 . . . . 0.0 112.211 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -69.28 -27.08 65.1 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.76 1.224 . . . . 0.0 113.377 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.57 -26.63 26.02 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.538 1.135 . . . . 0.0 113.372 176.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -89.71 28.79 1.25 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.15 1.38 . . . . 0.0 113.227 170.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.3 mt . . . . . 0 CA--C 1.548 0.886 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.664 178.425 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 ttt . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -95.1 130.19 41.9 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 124.595 1.184 . . . . 0.0 109.157 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -125.4 122.08 35.71 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.303 -1.771 . . . . 0.0 110.004 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -122.58 119.1 29.84 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.488 1.137 . . . . 0.0 112.343 170.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -96.99 89.2 4.74 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.927 -1.942 . . . . 0.0 108.915 -174.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 m -111.68 141.4 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 114.089 -1.414 . . . . 0.0 114.419 -169.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.583 HG22 HG22 ' A' ' 60' ' ' VAL . 17.1 p -89.72 116.35 27.77 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 114.665 -1.152 . . . . 0.0 113.931 -173.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.16 101.98 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 166.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.0 p -94.09 -11.88 29.66 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 112.391 -2.186 . . . . 0.0 114.23 174.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -63.74 131.53 94.92 Favored Pre-proline 0 N--CA 1.481 1.112 0 C-N-CA 125.344 1.458 . . . . 0.0 111.092 175.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 98.7 Cg_exo -50.44 -50.25 14.12 Favored 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 124.205 3.27 . . . . 0.0 114.132 -174.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -98.68 -48.38 4.98 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.08 0.863 . . . . 0.0 112.769 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.09 -126.94 7.68 Favored Glycine 0 N--CA 1.48 1.616 0 O-C-N 124.269 0.981 . . . . 0.0 113.086 170.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 60.5 mt . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.265 5.5 mmt180 -80.75 -46.45 1.24 Allowed Pre-proline 0 N--CA 1.482 1.162 0 CA-C-O 116.774 -1.584 . . . . 0.0 115.173 -172.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -61.19 -37.09 76.99 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 121.983 1.789 . . . . 0.0 112.585 166.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.21 -42.86 66.73 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 170.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.427 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . . . -64.63 -38.17 90.08 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 174.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -64.85 -41.55 95.61 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.317 1.047 . . . . 0.0 112.62 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.472 ' HD1' HD22 ' A' ' 80' ' ' LEU . 18.4 t80 -59.73 -44.3 93.81 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.972 1.309 . . . . 0.0 111.425 172.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.1 t -59.59 -44.65 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 124.073 0.949 . . . . 0.0 111.982 173.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -48.75 -51.23 30.07 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.9 0.88 . . . . 0.0 111.254 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -65.85 -55.78 15.27 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 124.961 1.413 . . . . 0.0 111.766 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.53 -34.7 62.21 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -56.84 -28.32 61.47 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 172.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.81 3.1 65.66 Favored Glycine 0 N--CA 1.49 2.287 0 O-C-N 125.199 1.562 . . . . 0.0 114.874 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -102.6 153.83 19.72 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.546 0.738 . . . . 0.0 111.469 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.4 p -63.08 -44.35 96.01 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.396 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 p -64.04 151.71 42.22 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -97.88 110.63 23.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 113.942 -1.481 . . . . 0.0 107.94 166.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' A' ' 44' ' ' ALA . 3.5 mm -81.19 119.11 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 CA-C-N 111.878 -2.419 . . . . 0.0 109.189 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.08 113.5 27.07 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.091 0.948 . . . . 0.0 112.417 173.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.45 HG22 HG12 ' A' ' 63' ' ' ILE . 92.6 t -94.73 97.69 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 112.634 -2.075 . . . . 0.0 106.345 175.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.8 m -95.91 122.29 38.56 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 113.414 -1.721 . . . . 0.0 110.997 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.431 ' HB2' HG12 ' A' ' 61' ' ' VAL . 22.6 t -128.55 96.6 4.45 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.74 -177.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.8 p30 33.77 90.25 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 126.481 1.912 . . . . 0.0 115.707 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.92 -66.7 3.29 Favored Glycine 0 N--CA 1.479 1.529 0 CA-C-N 112.729 -2.032 . . . . 0.0 112.109 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.54 135.55 47.1 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 115.134 -0.533 . . . . 0.0 111.33 -172.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.4 t -123.25 118.1 26.81 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 124.717 1.261 . . . . 0.0 111.878 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.481 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -111.67 111.36 22.29 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 114.05 -1.432 . . . . 0.0 114.172 -174.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.8 t -61.88 124.37 20.59 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 113.445 -1.707 . . . . 0.0 112.66 169.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . . . -83.31 7.06 17.64 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.032 -1.44 . . . . 0.0 113.843 171.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -94.92 -10.84 29.92 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 160.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 39.0 t -109.72 114.97 29.0 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.177 0.991 . . . . 0.0 110.234 171.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 tp -49.88 -53.57 25.03 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.287 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -64.45 -38.32 90.63 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 15.1 mttm -60.68 -49.63 76.73 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.11 -39.16 91.58 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 173.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.427 ' NE2' ' HB2' ' A' ' 20' ' ' ALA . 90.0 mt-30 -67.67 -32.91 73.91 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 -177.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 t -116.31 67.85 0.72 Allowed 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 124.039 1.876 . . . . 0.0 113.089 170.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.481 HD13 ' HB2' ' A' ' 42' ' ' ALA . 41.6 tp -116.17 -50.91 2.65 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 111.717 -2.492 . . . . 0.0 113.79 174.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.96 78.6 1.19 Allowed Glycine 0 N--CA 1.477 1.369 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -170.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 36.3 mt -107.33 80.87 1.46 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.286 -0.957 . . . . 0.0 110.737 -173.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.6 t -142.58 175.5 9.75 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.844 -1.526 . . . . 0.0 114.208 -165.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -50.6 127.2 17.34 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.615 1.966 . . . . 0.0 111.442 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.07 -29.45 10.67 Favored Glycine 0 N--CA 1.482 1.737 0 CA-C-N 112.853 -1.976 . . . . 0.0 113.058 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.8 p -66.98 113.15 4.76 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.583 HG22 HG22 ' A' ' 7' ' ' THR . 4.4 t -86.04 105.42 14.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 112.739 -2.028 . . . . 0.0 105.797 171.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.431 HG12 ' HB2' ' A' ' 37' ' ' SER . 18.4 m -99.55 105.76 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 113.761 -1.563 . . . . 0.0 112.342 -174.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.92 95.71 1.6 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.233 -1.803 . . . . 0.0 109.952 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.45 HG12 HG22 ' A' ' 35' ' ' VAL . 79.6 mt -82.18 97.14 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.649 174.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.7 m -110.03 121.54 45.5 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 112.679 -2.055 . . . . 0.0 109.926 -175.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.96 138.41 45.45 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -133.76 141.73 47.63 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.166 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.78 -150.49 19.04 Favored Glycine 0 CA--C 1.538 1.527 0 O-C-N 124.9 1.375 . . . . 0.0 110.62 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.09 -60.62 3.49 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -91.64 39.26 1.0 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -52.31 -55.76 19.31 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -45.45 77.53 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.43 1.092 . . . . 0.0 113.06 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -59.59 -50.26 74.56 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.819 1.248 . . . . 0.0 112.049 -176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.19 -54.06 51.08 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.294 1.038 . . . . 0.0 112.728 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.6 t -62.41 -48.49 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-O 118.06 -0.971 . . . . 0.0 111.045 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -54.23 -53.5 52.72 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.299 1.04 . . . . 0.0 111.718 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -56.33 -52.29 65.09 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.341 1.057 . . . . 0.0 112.449 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.9 mt -66.44 -34.5 78.09 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.95 -51.42 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-O 118.849 -0.596 . . . . 0.0 109.971 170.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -58.34 -42.91 87.89 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.472 HD22 ' HD1' ' A' ' 22' ' ' PHE . 5.2 tt -55.04 -56.87 14.98 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.245 1.018 . . . . 0.0 111.639 174.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -57.75 -39.28 76.99 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.842 0.857 . . . . 0.0 112.774 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.83 -29.55 69.51 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -86.51 -25.05 25.3 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.3 tp . . . . . 0 CA--C 1.549 0.905 0 C-N-CA 124.087 0.955 . . . . 0.0 110.691 173.746 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 ttt . . . . . 0 C--O 1.233 0.203 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -121.74 111.58 17.34 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.941 0.776 . . . . 0.0 111.056 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -108.8 116.36 31.83 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 112.603 -2.09 . . . . 0.0 110.45 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.406 ' HB2' HG11 ' A' ' 74' ' ' VAL . 9.4 tt0 -119.62 118.13 30.17 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.251 172.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -89.7 111.66 22.7 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 112.745 -2.025 . . . . 0.0 107.427 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.435 HG11 HG13 ' A' ' 78' ' ' VAL . 20.2 m -127.75 162.09 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.713 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.544 HG22 HG22 ' A' ' 60' ' ' VAL . 44.1 p -113.4 137.65 51.22 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.083 171.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 mt -95.92 111.47 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.426 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 1.7 p -103.74 -18.73 14.57 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.98 141.93 74.95 Favored Pre-proline 0 C--O 1.256 1.438 0 CA-C-O 116.989 -1.482 . . . . 0.0 114.173 177.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.93 -56.83 2.7 Favored 'Trans proline' 0 N--CA 1.493 1.475 1 C-N-CA 125.973 4.449 . . . . 0.0 116.256 -169.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -102.67 -20.27 14.47 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.4 -118.26 11.55 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.236 1.874 . . . . 0.0 113.19 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.7 mt . . . . . 0 N--CA 1.474 0.743 0 CA-C-N 112.096 -2.052 . . . . 0.0 114.415 -176.129 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.0 p . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -75.26 -43.35 4.4 Favored Pre-proline 0 N--CA 1.486 1.348 0 CA-C-O 115.932 -1.985 . . . . 0.0 114.68 -172.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -61.81 -26.48 79.49 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 121.974 1.782 . . . . 0.0 112.091 166.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -75.05 -35.38 61.9 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.148 0.579 . . . . 0.0 112.476 175.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . . . -57.96 -38.03 75.27 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.746 1.219 . . . . 0.0 112.482 168.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -65.14 -43.46 91.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.621 0.768 . . . . 0.0 111.971 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -64.05 -39.25 93.67 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.465 1.106 . . . . 0.0 111.558 175.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 19' ' ' ALA . 91.4 t -58.53 -49.26 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 125.005 1.322 . . . . 0.0 111.877 173.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -56.21 -42.95 78.04 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.04 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -68.71 -42.26 77.94 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.188 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.12 -27.49 68.08 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -68.93 -11.48 60.69 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 172.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.51 -33.18 7.27 Favored Glycine 0 N--CA 1.481 1.674 0 C-N-CA 124.774 1.178 . . . . 0.0 112.957 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -72.6 128.45 35.6 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.081 1.352 . . . . 0.0 111.765 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.5 p -54.3 -36.92 64.23 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.457 -1.247 . . . . 0.0 113.659 172.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.3 p -61.69 146.24 49.79 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.371 1.044 . . . . 0.0 111.598 167.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -102.15 98.09 8.3 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 113.663 -1.608 . . . . 0.0 108.991 169.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.489 HD11 ' HB1' ' A' ' 73' ' ' ALA . 36.3 mm -62.22 113.11 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 112.501 -2.136 . . . . 0.0 110.232 177.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.1 p -97.62 134.94 40.14 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.048 165.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.2 t -111.37 94.84 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 111.49 -2.595 . . . . 0.0 108.61 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.541 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 25.9 m -88.52 101.67 14.17 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 111.413 -2.63 . . . . 0.0 112.029 -178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 t -117.85 112.77 20.82 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.841 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.25 20.4 p30 44.73 61.36 2.49 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 126.046 1.738 . . . . 0.0 115.662 -173.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.68 19.87 63.29 Favored Glycine 0 CA--C 1.546 1.974 0 N-CA-C 116.896 1.519 . . . . 0.0 116.896 -176.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.9 mttt -118.75 107.85 14.15 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.743 0.771 . . . . 0.0 109.773 171.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.2 m -90.23 105.71 17.99 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 122.809 1.29 . . . . 0.0 111.606 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.88 105.3 14.43 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.675 -2.057 . . . . 0.0 111.525 -176.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.5 t -50.54 111.35 0.52 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 114.221 -1.354 . . . . 0.0 114.213 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.33 -18.42 65.3 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.283 -1.78 . . . . 0.0 113.666 169.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -77.94 -10.64 59.68 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.2 t -111.81 118.11 34.66 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.48 1.133 . . . . 0.0 112.057 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -46.2 -53.52 10.39 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 111.016 -2.811 . . . . 0.0 113.672 -172.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -69.29 -39.95 78.01 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -64.13 -52.06 60.95 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -167.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.68 -46.43 82.47 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.435 1.094 . . . . 0.0 113.105 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.453 ' NE2' ' HB2' ' A' ' 20' ' ' ALA . 67.0 mt-30 -63.92 -33.87 76.67 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.261 11.1 t -74.23 -48.41 29.01 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.474 HD23 HD21 ' A' ' 55' ' ' LEU . 27.3 tp -37.38 -53.19 1.12 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -167.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.13 67.19 0.52 Allowed Glycine 0 N--CA 1.484 1.839 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.474 HD21 HD23 ' A' ' 53' ' ' LEU . 24.9 mt -81.26 94.77 6.78 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 122.297 1.046 . . . . 0.0 111.4 174.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -150.41 -172.13 4.1 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.301 -2.227 . . . . 0.0 111.213 -168.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 9' ' ' THR . 52.6 tt0 -52.21 125.91 17.24 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.812 2.045 . . . . 0.0 114.617 -176.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.28 22.34 63.07 Favored Glycine 0 N--CA 1.484 1.888 0 CA-C-N 111.704 -2.498 . . . . 0.0 114.595 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.3 p -103.39 104.48 14.59 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 122.536 1.16 . . . . 0.0 112.5 -172.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.544 HG22 HG22 ' A' ' 7' ' ' THR . 4.6 t -69.69 113.57 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 111.156 -2.747 . . . . 0.0 108.725 176.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.71 117.24 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 112.892 -1.958 . . . . 0.0 110.812 -175.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.541 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 4.3 m -87.06 100.31 12.55 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.613 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.488 HG22 HG22 ' A' ' 74' ' ' VAL . 95.2 mt -89.1 101.4 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 113.655 -1.611 . . . . 0.0 108.674 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.4 m -116.46 127.17 54.35 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 109.76 -3.382 . . . . 0.0 111.086 -167.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.23 123.99 40.74 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.475 -176.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -119.13 108.05 14.22 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.931 1.394 . . . . 0.0 108.379 174.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.44 178.21 30.35 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.58 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -51.77 -41.84 61.93 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -176.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 p30 -102.47 39.8 1.46 Allowed 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -176.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -55.04 -40.06 69.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.01 -46.06 10.17 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.723 -176.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -52.39 -46.41 66.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.043 1.737 . . . . 0.0 114.82 171.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.489 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -65.19 -53.46 44.4 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -176.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 63' ' ' ILE . 68.8 t -60.78 -44.47 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.31 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -56.33 -51.44 68.25 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.421 1.089 . . . . 0.0 111.893 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -54.0 -51.58 63.49 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.778 0.831 . . . . 0.0 112.515 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 98.0 mt -65.62 -47.94 73.92 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.435 HG13 HG11 ' A' ' 6' ' ' VAL . 90.0 t -58.56 -38.28 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 118.945 0.793 . . . . 0.0 110.756 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -60.67 -62.98 1.47 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.68 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.8 tp -47.09 -44.17 20.95 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.942 2.097 . . . . 0.0 114.287 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.6 tmm? -53.59 -61.76 2.1 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.684 1.593 . . . . 0.0 112.427 172.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.43 -26.31 66.35 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -68.05 -29.74 68.78 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 172.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 CA--C 1.545 0.788 0 C-N-CA 122.917 0.487 . . . . 0.0 111.891 171.193 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ttt . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -81.85 133.59 35.34 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.479 167.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -137.17 133.87 35.7 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 112.581 -2.1 . . . . 0.0 110.003 -173.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -126.19 111.29 14.43 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.147 172.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.611 ' HG2' HG23 ' A' ' 62' ' ' THR . 34.3 mt-10 -79.3 80.81 5.63 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.913 1.34 . . . . 0.0 109.72 167.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.452 HG21 HG22 ' A' ' 78' ' ' VAL . 3.3 m -107.61 135.49 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 114.158 -1.383 . . . . 0.0 113.899 -175.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 p -76.34 140.56 41.49 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 112.444 -2.162 . . . . 0.0 113.471 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.9 mt -105.54 118.12 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.684 167.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.9 p -112.84 -12.39 13.32 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.32 132.66 95.19 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-O 118.024 -0.988 . . . . 0.0 111.712 173.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -42.88 -54.67 3.19 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 124.725 3.617 . . . . 0.0 116.602 -170.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -97.78 -41.9 7.85 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 174.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.06 -120.66 7.32 Favored Glycine 0 CA--C 1.541 1.681 0 C-N-CA 124.059 0.838 . . . . 0.0 112.36 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 31.4 mt . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -171.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.425 ' HB2' ' HD3' ' A' ' 18' ' ' PRO 0.283 21.0 mmt180 -76.37 -49.42 3.01 Favored Pre-proline 0 N--CA 1.487 1.41 0 CA-C-O 116.442 -1.742 . . . . 0.0 115.242 -174.241 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.536 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 77.3 Cg_exo -64.5 -31.45 60.9 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 121.698 1.642 . . . . 0.0 113.627 167.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.22 -38.93 77.75 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 169.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.469 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . . . -59.82 -39.97 86.86 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 171.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -61.92 -44.7 96.25 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.628 0.771 . . . . 0.0 112.262 173.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -55.27 -43.69 74.93 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.929 1.292 . . . . 0.0 111.588 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.97 -51.03 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 123.661 0.784 . . . . 0.0 111.895 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -48.56 -47.62 39.29 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.673 0.789 . . . . 0.0 110.995 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.62 -50.89 47.93 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.743 1.277 . . . . 0.0 113.276 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.428 ' HA ' ' HD2' ' A' ' 29' ' ' PHE . . . -54.1 -36.63 63.41 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -60.63 -27.38 67.73 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 173.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.79 -23.17 76.99 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.292 1.425 . . . . 0.0 114.159 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.428 ' HD2' ' HA ' ' A' ' 26' ' ' ALA . 73.6 m-85 -89.98 149.26 22.64 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.952 0.901 . . . . 0.0 110.69 177.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.1 p -71.5 -39.42 70.83 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.39 0.676 . . . . 0.0 112.073 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.5 p -65.71 137.97 57.65 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.681 1.192 . . . . 0.0 114.163 175.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -85.28 104.21 14.92 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.605 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.524 HG23 HG23 ' A' ' 63' ' ' ILE . 47.7 mm -72.93 94.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 111.94 -2.391 . . . . 0.0 110.289 173.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.4 p -89.48 113.86 25.29 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.275 -1.329 . . . . 0.0 108.993 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -100.57 96.52 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 113.183 -1.826 . . . . 0.0 107.563 -177.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 40.8 m -87.92 116.65 26.23 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 112.962 -1.927 . . . . 0.0 111.473 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -111.12 105.85 14.7 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.733 173.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 p30 40.21 69.29 0.32 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.591 1.556 . . . . 0.0 114.204 -173.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.33 -39.71 3.0 Favored Glycine 0 N--CA 1.485 1.918 0 CA-C-N 113.197 -1.819 . . . . 0.0 114.15 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -72.74 99.05 2.51 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.353 1.061 . . . . 0.0 112.438 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.3 m -83.94 108.42 16.91 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.541 -1.663 . . . . 0.0 113.398 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.57 115.13 28.66 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.182 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.9 t -67.08 125.77 27.06 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 113.916 -1.493 . . . . 0.0 113.219 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.84 -5.24 47.51 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 112.402 -2.181 . . . . 0.0 113.422 171.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -83.65 8.2 15.11 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 167.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 t -144.41 131.04 20.02 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.933 0.493 . . . . 0.0 112.129 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.07 -68.31 0.22 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 113.733 -1.576 . . . . 0.0 113.552 -171.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -54.64 -39.38 67.93 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -57.1 -55.0 40.38 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 124.165 0.916 . . . . 0.0 112.935 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 tp -68.0 -48.57 65.37 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.895 1.372 . . . . 0.0 113.616 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.469 ' NE2' ' HB2' ' A' ' 20' ' ' ALA . 57.2 mt-30 -61.41 -34.44 75.37 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 -172.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.2 t -72.17 -20.03 61.66 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.1 tp -70.11 -37.53 75.38 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.51 73.83 1.28 Allowed Glycine 0 N--CA 1.484 1.847 0 O-C-N 124.439 1.087 . . . . 0.0 113.074 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.1 mt -84.81 92.93 8.37 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.387 0.613 . . . . 0.0 110.273 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.9 t -141.5 -175.0 4.2 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -169.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -56.5 112.93 1.4 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.106 0.963 . . . . 0.0 111.146 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.54 -30.8 6.25 Favored Glycine 0 CA--C 1.542 1.72 0 CA-C-N 113.611 -1.631 . . . . 0.0 114.496 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.6 p -70.11 103.58 2.35 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.4 t -68.11 117.78 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 163.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.8 m -118.17 109.59 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 113.654 -1.612 . . . . 0.0 113.004 -175.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.611 HG23 ' HG2' ' A' ' 5' ' ' GLU . 0.6 OUTLIER -75.71 86.87 2.75 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.052 176.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.524 HG23 HG23 ' A' ' 33' ' ' ILE . 34.2 mt -78.8 95.28 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.7 m -105.42 128.14 53.37 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 112.948 -1.933 . . . . 0.0 110.693 -174.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.49 116.13 28.34 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -105.97 97.42 7.24 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.74 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.09 -175.05 28.5 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-N 114.536 -1.211 . . . . 0.0 113.361 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -55.88 -54.46 44.34 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 -169.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -83.52 28.88 0.53 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 6.4 pt-20 -38.78 -60.64 0.81 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.464 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -56.89 -50.58 72.07 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 178.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -67.09 -40.09 86.89 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -175.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.406 ' CB ' HD11 ' A' ' 33' ' ' ILE . . . -59.34 -52.43 65.65 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 123.767 0.667 . . . . 0.0 112.678 176.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.414 HG22 HG22 ' A' ' 63' ' ' ILE . 47.0 t -63.5 -49.58 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.647 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -49.93 -57.44 7.49 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.573 1.549 . . . . 0.0 112.011 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -59.46 -50.79 72.56 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.898 0.879 . . . . 0.0 113.102 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.4 mt -63.22 -36.05 82.36 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.452 HG22 HG21 ' A' ' 6' ' ' VAL . 90.3 t -62.02 -48.64 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 123.808 0.693 . . . . 0.0 110.566 171.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -54.25 -55.5 27.51 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 118.234 -0.888 . . . . 0.0 113.062 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.8 tp -52.66 -48.97 66.13 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.047 0.939 . . . . 0.0 112.832 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -57.36 -45.53 84.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.402 1.081 . . . . 0.0 112.642 175.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.54 -25.22 60.3 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -74.55 -41.09 61.17 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.15 1.166 . . . . 0.0 114.15 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.7 mt . . . . . 0 N--CA 1.483 1.192 0 C-N-CA 124.343 1.057 . . . . 0.0 113.342 177.247 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.465 0.28 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -119.83 139.94 51.58 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 125.066 1.479 . . . . 0.0 110.01 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -134.03 129.75 36.55 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 124.59 1.181 . . . . 0.0 111.729 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -128.47 136.64 51.1 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.374 1.046 . . . . 0.0 112.454 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -98.89 110.24 22.87 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.187 -1.37 . . . . 0.0 110.449 173.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.679 HG11 HG13 ' A' ' 78' ' ' VAL . 8.5 m -119.79 152.8 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 114.468 -1.242 . . . . 0.0 114.242 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.565 HG22 HG22 ' A' ' 60' ' ' VAL . 20.6 p -111.98 121.94 46.39 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 113.531 -1.668 . . . . 0.0 111.447 -173.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.1 mt -79.69 96.47 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.17 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -74.67 -34.7 62.74 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -55.15 134.42 68.52 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 125.486 1.514 . . . . 0.0 113.67 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 48.8 Cg_exo -45.71 -43.91 18.28 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.539 3.493 . . . . 0.0 117.493 -173.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -114.5 -40.8 3.54 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 172.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.17 -114.47 3.91 Favored Glycine 0 N--CA 1.475 1.279 0 C-N-CA 123.986 0.803 . . . . 0.0 111.769 168.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.559 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 34.1 mt . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 114.185 1.179 . . . . 0.0 114.185 -167.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.8 p . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.508 ' HB2' ' HD3' ' A' ' 18' ' ' PRO 0.266 20.2 mmt180 -71.8 -54.08 6.56 Favored Pre-proline 0 N--CA 1.487 1.418 0 CA-C-O 116.579 -1.677 . . . . 0.0 115.168 -174.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.559 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 71.5 Cg_exo -62.93 -34.26 71.98 Favored 'Trans proline' 0 N--CA 1.479 0.632 0 CA-C-N 121.899 1.714 . . . . 0.0 113.653 171.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -53.73 -36.91 62.8 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 172.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.71 -40.38 83.51 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 174.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.32 -45.42 91.4 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -55.48 -45.73 76.94 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.795 1.238 . . . . 0.0 110.934 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 19' ' ' ALA . 22.0 t -62.47 -50.22 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 123.403 0.681 . . . . 0.0 111.228 175.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -50.03 -47.08 53.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.289 1.036 . . . . 0.0 112.275 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.09 -49.15 65.96 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 124.269 0.98 . . . . 0.0 113.387 174.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.5 -39.61 76.85 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -47.7 -44.26 27.39 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.71 1.604 . . . . 0.0 113.898 167.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.17 -34.22 69.72 Favored Glycine 0 N--CA 1.475 1.261 0 O-C-N 125.435 1.709 . . . . 0.0 114.355 -176.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -65.69 145.87 55.5 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.306 0.643 . . . . 0.0 111.702 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 57.9 p -64.12 -35.19 79.94 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.216 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.0 p -68.71 144.97 54.24 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.294 -1.321 . . . . 0.0 114.497 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -92.56 118.21 30.77 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.938 169.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.701 HD11 ' HB1' ' A' ' 73' ' ' ALA . 43.1 mm -86.17 103.25 12.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 111.706 -2.497 . . . . 0.0 110.195 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.4 p -103.47 118.91 37.84 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.378 175.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 63' ' ' ILE . 92.6 t -99.24 95.95 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 112.961 -1.927 . . . . 0.0 107.504 -178.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.5 m -91.34 110.29 21.58 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 113.657 -1.61 . . . . 0.0 110.79 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.8 t -108.16 95.27 5.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 113.544 -1.662 . . . . 0.0 109.634 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.3 p30 43.63 72.43 0.19 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.365 1.466 . . . . 0.0 114.349 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.62 -38.93 2.92 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-N 113.028 -1.896 . . . . 0.0 114.496 -175.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -75.45 88.91 2.65 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -175.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.5 m -74.13 113.62 11.54 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.381 -1.282 . . . . 0.0 112.982 170.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.12 122.77 47.99 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.088 170.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.9 t -86.84 128.26 35.04 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.331 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.46 16.28 6.7 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 113.117 -1.856 . . . . 0.0 114.092 176.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -92.58 2.84 56.48 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.663 0.744 . . . . 0.0 112.663 158.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.1 t -127.84 125.93 40.67 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.847 1.659 . . . . 0.0 110.799 172.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.65 -54.04 50.66 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.813 171.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -57.69 -48.93 78.16 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.152 -1.385 . . . . 0.0 113.862 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -60.98 -46.57 90.2 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 tp -68.17 -47.88 66.81 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 123.821 0.7 . . . . 0.0 112.002 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -57.1 -42.26 80.47 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -71.78 -14.51 62.01 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.4 tp -75.37 -42.35 54.2 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.56 82.51 0.7 Allowed Glycine 0 N--CA 1.478 1.481 0 O-C-N 124.394 1.059 . . . . 0.0 112.527 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 85.8 mt -82.85 78.32 9.46 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 122.877 1.322 . . . . 0.0 112.298 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.0 t -85.36 -174.27 5.12 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 111.914 -2.403 . . . . 0.0 112.569 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -60.23 144.23 50.72 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.979 1.712 . . . . 0.0 111.114 175.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.57 -38.07 3.27 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 114.251 -1.34 . . . . 0.0 114.642 171.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.4 p -54.96 104.62 0.12 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.184 1.549 . . . . 0.0 115.184 -174.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 7' ' ' THR . 16.7 t -66.74 112.46 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 112.152 -2.295 . . . . 0.0 107.177 169.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.5 m -119.32 118.08 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 113.35 -1.75 . . . . 0.0 114.641 -172.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.3 m -80.23 100.45 8.33 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 125.447 1.717 . . . . 0.0 109.084 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.448 HG12 HG22 ' A' ' 35' ' ' VAL . 80.2 mt -91.76 102.44 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.586 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 m -100.12 131.66 45.94 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.141 -178.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.12 105.86 13.97 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 124.035 0.835 . . . . 0.0 112.353 172.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -104.06 92.46 4.39 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.233 -1.348 . . . . 0.0 111.266 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.3 -167.55 39.94 Favored Glycine 0 N--CA 1.48 1.623 0 CA-C-N 112.252 -2.249 . . . . 0.0 111.148 174.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.01 -51.5 66.57 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -82.38 36.49 0.48 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.612 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 5.9 pt-20 -45.83 -72.53 0.05 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 -173.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.612 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -50.05 -47.99 53.1 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -179.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -63.05 -47.25 83.75 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.577 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.701 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -56.32 -46.08 80.03 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.23 0.957 . . . . 0.0 113.538 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.0 t -67.35 -56.06 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.225 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -51.02 -47.16 61.7 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.477 1.111 . . . . 0.0 112.687 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -53.15 -61.41 2.31 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.032 1.333 . . . . 0.0 112.067 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.9 mt -64.27 -33.23 75.35 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.679 HG13 HG11 ' A' ' 6' ' ' VAL . 11.7 t -62.05 -56.31 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.103 0.961 . . . . 0.0 110.527 171.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -57.55 -48.26 79.82 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.449 1.099 . . . . 0.0 111.25 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.2 tp -54.57 -52.01 63.47 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.448 1.499 . . . . 0.0 111.954 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -57.86 -44.91 86.88 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.226 1.011 . . . . 0.0 112.033 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.54 -33.62 75.43 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -75.85 -30.39 58.9 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.484 1.245 0 C-N-CA 123.927 0.891 . . . . 0.0 112.629 175.676 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.402 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 4.7 t80 -108.39 129.18 55.26 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 125.72 1.888 . . . . 0.0 108.001 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -126.98 131.23 51.09 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.621 -170.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -129.32 122.87 30.44 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.432 1.082 . . . . 0.0 113.025 168.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -87.03 100.6 12.74 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 112.442 -2.163 . . . . 0.0 107.945 176.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.5 m -116.97 143.52 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 114.22 -1.355 . . . . 0.0 114.173 -173.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.544 HG22 HG22 ' A' ' 60' ' ' VAL . 14.0 p -94.03 122.14 36.23 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.408 1.099 . . . . 0.0 111.495 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.2 mt -78.9 97.92 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.6 167.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.7 p -82.81 -26.66 31.52 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 109.962 -3.29 . . . . 0.0 113.526 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.463 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -51.12 120.63 14.44 Favored Pre-proline 0 N--CA 1.476 0.847 0 O-C-N 124.715 1.259 . . . . 0.0 112.277 177.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 80.8 Cg_exo -57.38 -48.71 16.33 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 123.785 2.99 . . . . 0.0 113.77 -175.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -68.94 -43.46 75.02 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.545 0.338 . . . . 0.0 111.688 170.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 56' ' ' THR . . . 101.88 -148.01 17.62 Favored Glycine 0 N--CA 1.475 1.279 0 O-C-N 124.75 1.281 . . . . 0.0 110.984 174.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.433 HD12 HD13 ' A' ' 55' ' ' LEU . 83.7 mt . . . . . 0 CA--C 1.545 0.777 0 CA-C-N 113.639 -1.28 . . . . 0.0 112.407 173.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.512 ' HA ' ' HG2' ' A' ' 51' ' ' GLN . 59.6 p . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.7 -44.23 53.03 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-O 116.874 -1.536 . . . . 0.0 114.903 -175.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -69.17 -33.74 18.12 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.734 1.623 . . . . 0.0 113.391 172.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.49 97.45 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.47 0.708 . . . . 0.0 112.487 171.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.89 -46.2 90.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.235 0.614 . . . . 0.0 112.577 169.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -58.81 -43.7 90.64 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 171.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.16 -43.12 87.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.136 0.974 . . . . 0.0 112.895 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.462 HG11 HD22 ' A' ' 47' ' ' LEU . 59.5 t -61.51 -48.91 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 122.478 0.311 . . . . 0.0 110.95 172.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -52.98 -45.44 67.81 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.498 0.719 . . . . 0.0 112.839 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -64.49 -49.4 71.5 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.568 1.147 . . . . 0.0 112.881 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.88 -29.2 67.45 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -51.91 -26.44 10.26 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 168.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.95 -22.83 77.21 Favored Glycine 0 CA--C 1.543 1.826 0 O-C-N 125.109 1.505 . . . . 0.0 115.704 175.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -96.98 143.4 27.88 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.88 0.847 . . . . 0.0 112.406 -178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.8 p -66.35 -37.15 84.67 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.075 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.9 p -63.84 138.6 58.55 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.748 170.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -95.22 96.67 9.34 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 123.412 1.577 . . . . 0.0 108.95 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mt -77.07 128.81 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 111.612 -2.54 . . . . 0.0 110.542 -172.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.4 p -102.32 134.92 44.83 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.349 173.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.8 t -102.29 90.25 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 170.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.1 m -89.41 112.85 24.08 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.14 -1.391 . . . . 0.0 113.723 -170.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 40' ' ' LYS . 32.4 t -116.27 97.36 6.0 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 124.377 1.048 . . . . 0.0 111.156 173.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 p30 39.59 83.02 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.816 1.646 . . . . 0.0 115.183 -175.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.03 -41.3 1.97 Allowed Glycine 0 CA--C 1.55 2.258 0 CA-C-N 114.266 -1.333 . . . . 0.0 113.71 -173.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 37' ' ' SER . 33.2 mtmt -71.85 79.75 0.88 Allowed 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.4 m -72.02 111.78 7.55 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.029 -1.441 . . . . 0.0 112.937 168.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.09 99.02 9.98 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 113.835 -1.529 . . . . 0.0 112.638 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 t -55.45 119.2 5.26 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.57 1.176 . . . . 0.0 113.186 174.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.17 9.57 1.96 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 112.847 -1.979 . . . . 0.0 114.006 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -104.65 19.99 19.43 Favored 'General case' 0 C--O 1.25 1.082 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 164.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.8 t -140.78 125.42 17.93 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.161 1.384 . . . . 0.0 112.749 174.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.462 HD22 HG11 ' A' ' 23' ' ' VAL . 3.6 mm? -55.73 -44.27 77.38 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 113.58 -1.645 . . . . 0.0 114.209 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -64.39 -39.16 93.32 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.16 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -55.4 -56.41 20.44 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.9 mp -67.91 -31.22 70.85 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -176.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.512 ' HG2' ' HA ' ' A' ' 16' ' ' THR . 36.3 mt-30 -78.64 -34.28 46.62 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.023 -0.99 . . . . 0.0 113.371 176.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.7 t -79.09 -32.51 44.68 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.591 HD23 HD21 ' A' ' 55' ' ' LEU . 17.3 tp -51.97 -49.79 62.54 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.366 1.246 . . . . 0.0 114.366 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.76 89.04 1.78 Allowed Glycine 0 N--CA 1.476 1.352 0 O-C-N 125.352 1.657 . . . . 0.0 110.817 -175.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.591 HD21 HD23 ' A' ' 53' ' ' LEU . 92.0 mt -109.05 99.41 8.73 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.813 -0.694 . . . . 0.0 112.315 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.412 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 12.3 t -150.98 170.57 19.02 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.627 1.571 . . . . 0.0 110.589 -174.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 59.8 tt0 -50.13 118.39 2.92 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.598 1.159 . . . . 0.0 112.987 -172.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.81 -29.4 7.5 Favored Glycine 0 CA--C 1.543 1.781 0 CA-C-N 112.585 -2.098 . . . . 0.0 113.696 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.4 p -62.33 100.91 0.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.544 HG22 HG22 ' A' ' 7' ' ' THR . 3.2 t -78.76 115.9 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 113.356 -1.747 . . . . 0.0 106.811 171.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 m -127.95 129.5 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 113.58 -1.646 . . . . 0.0 112.982 -174.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.4 m -89.05 96.95 10.94 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.421 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.456 HG22 HG22 ' A' ' 74' ' ' VAL . 89.2 mt -67.25 96.83 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 113.476 -1.693 . . . . 0.0 107.404 167.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.6 m -111.27 103.42 11.82 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 112.968 -1.924 . . . . 0.0 111.669 -175.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.28 100.19 12.1 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.624 0.726 . . . . 0.0 112.034 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -99.5 96.36 7.63 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 112.916 -1.947 . . . . 0.0 111.588 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.88 -162.07 28.83 Favored Glycine 0 N--CA 1.48 1.63 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.606 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -60.63 -28.47 68.57 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 120.452 3.501 . . . . 0.0 120.452 -168.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.2 p30 -116.72 50.56 1.06 Allowed 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 2' ' ' PHE . 11.4 pt-20 -49.16 -55.43 12.41 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -174.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -53.29 59.96 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.918 1.287 . . . . 0.0 114.312 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -55.45 -47.45 76.02 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.021 1.328 . . . . 0.0 113.958 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.96 -53.43 57.35 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.571 -1.195 . . . . 0.0 113.372 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.456 HG22 HG22 ' A' ' 63' ' ' ILE . 51.1 t -60.83 -50.63 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 118.936 -0.554 . . . . 0.0 112.128 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -52.78 -57.24 10.81 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.458 1.103 . . . . 0.0 112.841 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -54.55 -50.11 68.72 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.46 1.104 . . . . 0.0 113.075 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 72.1 mt -67.57 -38.03 83.51 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.33 -45.35 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.059 0.543 . . . . 0.0 110.559 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -58.14 -49.05 78.32 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 118.313 -0.851 . . . . 0.0 113.153 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.8 tp -54.19 -51.76 63.38 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.891 0.876 . . . . 0.0 112.586 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -59.64 -44.92 93.32 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.98 0.912 . . . . 0.0 112.884 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.06 91.07 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -79.47 -19.76 49.01 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 172.089 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ttt . . . . . 0 C--O 1.236 0.385 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -117.57 115.33 24.89 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 125.1 1.5 . . . . 0.0 109.123 175.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -102.65 129.92 49.4 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.361 -178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -123.37 103.58 8.58 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 171.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -73.78 95.34 2.38 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.294 -1.776 . . . . 0.0 110.675 172.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.424 HG11 HG13 ' A' ' 78' ' ' VAL . 17.2 m -117.16 146.22 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 113.388 -1.733 . . . . 0.0 113.862 -174.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.448 HG22 HG22 ' A' ' 60' ' ' VAL . 48.0 p -108.56 128.52 54.89 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.714 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.493 HG13 ' SD ' ' A' ' 81' ' ' MET . 1.9 mp -75.81 130.32 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.765 173.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 p -88.18 -37.32 16.24 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.323 171.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -59.61 133.38 88.88 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 125.399 1.48 . . . . 0.0 113.704 -175.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 32.3 Cg_exo -61.52 -68.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 124.166 3.244 . . . . 0.0 112.431 -172.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -62.06 -34.59 76.55 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.906 0.882 . . . . 0.0 112.222 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.37 -126.27 7.78 Favored Glycine 0 N--CA 1.481 1.647 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 168.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . 7.6 mp . . . . . 0 N--CA 1.475 0.82 0 CA-C-N 113.527 -1.337 . . . . 0.0 113.682 176.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.315 12.9 mmt180 -88.04 -39.69 0.48 Allowed Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 -173.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -61.74 -38.76 58.03 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 121.983 1.789 . . . . 0.0 111.384 163.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.23 73.58 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 168.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.26 86.88 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -60.2 -46.32 90.13 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 124.181 0.926 . . . . 0.0 112.513 174.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -55.57 -53.64 53.87 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.499 1.12 . . . . 0.0 110.766 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.695 HG11 ' HA ' ' A' ' 47' ' ' LEU . 30.2 t -57.91 -49.75 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.645 0.778 . . . . 0.0 111.313 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -49.74 -52.51 31.07 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.335 1.054 . . . . 0.0 112.992 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -68.97 -43.24 75.36 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.689 1.243 . . . . 0.0 112.772 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.557 ' HA ' ' HD2' ' A' ' 29' ' ' PHE . . . -58.68 -37.8 76.82 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 173.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -53.46 -39.64 64.63 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.0 0.92 . . . . 0.0 112.816 169.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.3 15.0 4.64 Favored Glycine 0 CA--C 1.543 1.792 0 O-C-N 124.747 1.28 . . . . 0.0 115.413 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.557 ' HD2' ' HA ' ' A' ' 26' ' ' ALA . 65.9 m-85 -113.36 152.03 30.49 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.977 0.894 . . . . 0.0 111.992 172.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.4 p -69.94 -40.3 75.56 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.15 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -73.66 145.32 45.39 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.796 0.839 . . . . 0.0 112.882 173.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -96.4 109.78 22.25 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.645 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.687 HG13 ' HB2' ' A' ' 65' ' ' ALA . 5.0 mp -83.22 106.89 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 112.182 -2.281 . . . . 0.0 109.45 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.0 p -102.39 128.5 48.95 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 112.959 -1.928 . . . . 0.0 110.214 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.418 HG11 HD21 ' A' ' 55' ' ' LEU . 59.8 t -107.06 105.0 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 113.288 -1.778 . . . . 0.0 107.569 -176.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.0 m -106.83 126.2 52.0 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.3 t -116.25 97.32 5.98 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 112.99 -1.914 . . . . 0.0 110.02 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.257 4.0 p30 40.63 73.47 0.12 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 113.518 -1.674 . . . . 0.0 114.706 -175.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.09 -53.22 4.19 Favored Glycine 0 N--CA 1.488 2.111 0 CA-C-N 113.705 -1.589 . . . . 0.0 113.513 -178.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -60.72 104.56 0.36 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.38 1.472 . . . . 0.0 113.525 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 t -90.93 136.03 33.34 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.644 1.349 . . . . 0.0 114.644 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.28 97.43 5.06 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 113.879 -1.51 . . . . 0.0 113.081 173.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -54.6 130.21 39.28 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.985 168.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.81 13.81 21.29 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.109 -1.405 . . . . 0.0 114.337 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.63 -8.88 27.92 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.074 153.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -113.09 111.61 22.43 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 123.464 1.602 . . . . 0.0 112.54 169.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.695 ' HA ' HG11 ' A' ' 23' ' ' VAL . 1.4 tm? -54.43 -59.51 4.59 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 111.556 -2.565 . . . . 0.0 114.278 -169.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -65.47 -28.56 69.3 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -54.7 -48.12 72.86 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.4 tp -61.32 -43.26 99.17 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 176.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -58.17 -46.89 84.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 124.051 0.844 . . . . 0.0 112.64 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.2 t -66.72 -37.15 84.1 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.5 tp -66.6 -41.77 87.92 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.41 83.97 0.34 Allowed Glycine 0 N--CA 1.476 1.358 0 C-N-CA 124.348 0.975 . . . . 0.0 115.053 170.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 7.1 mp -75.03 109.47 8.53 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.336 -0.932 . . . . 0.0 109.598 174.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -135.59 -174.7 3.72 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.928 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -52.2 109.15 0.35 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.549 1.94 . . . . 0.0 112.729 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.82 35.2 51.29 Favored Glycine 0 CA--C 1.543 1.837 0 CA-C-N 114.627 -1.17 . . . . 0.0 115.545 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.2 p -83.35 118.28 23.58 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 117.313 0.556 . . . . 0.0 110.18 168.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.448 HG22 HG22 ' A' ' 7' ' ' THR . 5.0 t -90.96 80.5 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 125.758 1.911 . . . . 0.0 106.413 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.1 m -100.15 133.15 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 112.154 -2.294 . . . . 0.0 112.501 -172.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.8 p -92.99 95.95 9.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.314 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.412 HG22 HG22 ' A' ' 74' ' ' VAL . 88.4 mt -74.32 94.18 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.428 173.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.6 m -113.94 110.48 20.14 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 112.828 -1.987 . . . . 0.0 111.889 -172.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.687 ' HB2' HG13 ' A' ' 33' ' ' ILE . . . -105.14 125.19 50.71 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.827 175.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -115.87 131.2 57.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 112.9 -1.955 . . . . 0.0 109.623 172.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.22 -160.29 24.97 Favored Glycine 0 N--CA 1.482 1.766 0 CA-C-N 113.359 -1.746 . . . . 0.0 110.783 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -58.88 -61.34 2.7 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -88.71 39.03 0.9 Allowed 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -46.27 -55.0 7.84 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 117.976 2.584 . . . . 0.0 117.976 -175.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.521 ' OE1' ' HE2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -71.88 -45.42 61.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.641 1.176 . . . . 0.0 113.914 -177.338 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.521 ' HE2' ' OE1' ' A' ' 71' ' ' GLN . 41.6 mtmt -66.07 -45.77 80.12 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.745 1.218 . . . . 0.0 112.466 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.465 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -59.86 -44.18 94.28 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.146 0.903 . . . . 0.0 113.406 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.412 HG22 HG22 ' A' ' 63' ' ' ILE . 34.0 t -63.87 -50.81 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 118.612 -0.708 . . . . 0.0 112.343 173.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -50.16 -48.36 53.89 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -57.23 -58.12 9.62 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.037 0.935 . . . . 0.0 111.298 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.432 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 80.1 mt -66.53 -29.21 69.25 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -176.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.424 HG13 HG11 ' A' ' 6' ' ' VAL . 44.2 t -66.86 -51.67 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 123.497 0.498 . . . . 0.0 111.474 170.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -59.73 -41.22 90.39 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.049 0.54 . . . . 0.0 111.877 175.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.432 ' HB3' ' HA ' ' A' ' 77' ' ' LEU . 6.0 tt -60.33 -45.69 92.56 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.199 1.399 . . . . 0.0 112.404 174.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.493 ' SD ' HG13 ' A' ' 8' ' ' ILE . 13.9 tmm? -57.92 -41.75 83.36 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.19 0.596 . . . . 0.0 111.521 174.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.22 96.7 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -78.06 -22.54 48.93 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.0 mt . . . . . 0 N--CA 1.479 0.996 0 O-C-N 121.666 -0.646 . . . . 0.0 111.246 165.15 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ttt . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -127.64 137.94 52.68 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 125.79 1.931 . . . . 0.0 108.701 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.08 139.9 53.02 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.262 -176.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -148.0 121.82 9.32 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 124.24 0.963 . . . . 0.0 111.314 169.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 24.0 tt0 -92.12 115.27 27.93 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.778 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.526 HG11 HG13 ' A' ' 78' ' ' VAL . 24.1 m -117.32 146.3 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 114.765 -1.107 . . . . 0.0 113.816 -175.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 p -95.93 119.2 33.99 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.56 -1.654 . . . . 0.0 113.628 -174.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.8 mt -82.12 105.71 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.849 170.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.0 p -99.82 -1.74 36.8 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.216 -1.811 . . . . 0.0 114.31 171.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.69 127.43 93.38 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 124.562 1.145 . . . . 0.0 111.95 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -48.91 -44.23 32.81 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 124.381 3.387 . . . . 0.0 117.59 -170.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -105.75 -23.53 12.7 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 173.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.86 -138.16 13.75 Favored Glycine 0 N--CA 1.474 1.225 0 C-N-CA 124.536 1.065 . . . . 0.0 111.147 170.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.451 ' HB2' HD22 ' A' ' 55' ' ' LEU . 6.6 mp . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.8 p . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -75.95 -47.6 3.73 Favored Pre-proline 0 N--CA 1.487 1.376 0 CA-C-O 115.752 -2.071 . . . . 0.0 115.732 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -59.03 -39.73 77.62 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.171 1.914 . . . . 0.0 112.004 168.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.22 -51.7 65.75 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 171.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.67 -36.27 78.31 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 175.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -68.11 -44.87 75.2 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 173.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -53.96 -40.86 67.2 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.768 1.227 . . . . 0.0 111.404 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.43 HG21 ' HA ' ' A' ' 47' ' ' LEU . 91.2 t -55.16 -60.31 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 124.087 0.867 . . . . 0.0 111.687 172.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -62.24 -31.92 72.53 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -174.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -66.23 -55.26 17.05 Favored 'General case' 0 CA--C 1.55 0.942 0 O-C-N 124.26 0.975 . . . . 0.0 111.151 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.89 -37.87 64.2 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 171.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.517 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . 32.7 tttt -58.59 -29.56 66.52 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 176.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.46 -12.38 58.57 Favored Glycine 0 CA--C 1.54 1.621 0 O-C-N 125.108 1.505 . . . . 0.0 115.377 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -92.0 158.45 16.24 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.169 0.988 . . . . 0.0 111.863 174.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.2 p -68.78 -46.01 69.83 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.266 177.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.6 p -59.28 137.76 57.86 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.625 1.17 . . . . 0.0 113.919 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -92.23 111.58 23.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.607 -1.179 . . . . 0.0 107.83 170.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mt -95.6 133.01 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-N 111.428 -2.624 . . . . 0.0 110.683 -172.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.5 p -109.05 135.35 50.36 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.228 -1.805 . . . . 0.0 112.133 174.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.97 87.51 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 111.855 -2.429 . . . . 0.0 106.396 177.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.2 m -90.69 109.4 20.58 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.552 -1.658 . . . . 0.0 111.39 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.4 t -116.48 87.65 2.73 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 p30 9.74 108.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 128.208 2.603 . . . . 0.0 118.001 -173.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.12 -49.3 2.45 Favored Glycine 0 N--CA 1.481 1.671 0 CA-C-N 112.985 -1.916 . . . . 0.0 111.881 -171.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.484 ' HB3' HD12 ' A' ' 53' ' ' LEU . 92.7 mttt -93.95 99.03 11.44 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.793 0.806 . . . . 0.0 111.384 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.1 t -107.25 95.8 5.97 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.93 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.563 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -83.68 142.8 30.49 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 113.604 -1.635 . . . . 0.0 112.297 -176.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.7 t -83.34 123.54 29.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.589 173.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.29 12.83 3.26 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 124.353 1.033 . . . . 0.0 112.793 172.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.517 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 86.8 mttt -112.59 -6.81 13.91 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 168.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.9 t -119.42 131.6 55.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.638 1.175 . . . . 0.0 111.269 172.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.43 ' HA ' HG21 ' A' ' 23' ' ' VAL . 2.7 mm? -62.09 -62.58 1.68 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 113.286 -1.779 . . . . 0.0 112.307 -172.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -60.15 -29.73 68.85 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 113.912 -1.494 . . . . 0.0 114.593 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -56.67 -57.37 12.71 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.914 0.886 . . . . 0.0 112.022 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.87 -44.9 84.02 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 173.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -54.21 -37.14 64.25 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 t -81.2 -26.04 36.25 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 116.924 2.194 . . . . 0.0 116.924 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.563 HD13 ' HB2' ' A' ' 42' ' ' ALA . 14.4 tp -41.91 -54.22 3.52 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -167.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.07 88.16 2.04 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -172.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.451 HD22 ' HB2' ' A' ' 14' ' ' LEU . 4.2 mp -116.21 98.36 6.56 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 125.168 1.158 . . . . 0.0 108.327 -177.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.2 t -138.23 176.9 8.29 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 125.503 1.752 . . . . 0.0 111.781 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -59.83 109.56 0.96 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.839 1.256 . . . . 0.0 110.354 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.39 -30.51 6.43 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 113.948 -1.478 . . . . 0.0 115.069 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.4 p -73.02 96.83 2.21 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 117.942 0.871 . . . . 0.0 112.697 -172.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.0 t -69.4 130.96 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.808 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.2 m -124.35 120.33 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 114.691 -1.141 . . . . 0.0 113.924 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 0.7 OUTLIER -83.6 113.34 20.76 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.738 173.617 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.2 mt -95.54 103.48 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 m -116.48 119.88 37.01 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 112.546 -2.116 . . . . 0.0 110.892 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.48 124.53 51.95 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.355 0.598 . . . . 0.0 112.544 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -117.21 105.96 12.79 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.195 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.79 -160.32 28.56 Favored Glycine 0 N--CA 1.482 1.702 0 CA-C-N 113.037 -1.892 . . . . 0.0 112.972 178.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.54 -49.34 78.16 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.063 1.745 . . . . 0.0 115.243 -174.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -96.21 41.53 1.1 Allowed 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 176.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.521 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 7.4 pt-20 -43.27 -67.72 0.25 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.521 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -63.54 -38.47 91.24 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -179.229 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -66.36 -47.97 71.71 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.169 1.388 . . . . 0.0 112.246 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.01 -48.47 81.48 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.903 0.881 . . . . 0.0 112.444 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.8 t -61.25 -52.73 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.571 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -49.41 -51.56 34.46 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.073 0.949 . . . . 0.0 113.073 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -58.5 -51.64 69.0 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.89 0.876 . . . . 0.0 112.44 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.7 mt -70.71 -27.97 64.39 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.526 HG13 HG11 ' A' ' 6' ' ' VAL . 53.0 t -61.64 -55.69 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 123.348 0.659 . . . . 0.0 109.77 168.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -52.68 -51.31 60.81 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 124.417 1.073 . . . . 0.0 112.691 175.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.4 tt -53.45 -50.73 64.66 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.344 1.058 . . . . 0.0 112.737 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -59.55 -44.89 93.11 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.88 0.872 . . . . 0.0 112.428 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.74 -37.28 79.31 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -79.65 10.54 3.89 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 N--CA 1.474 0.745 0 C-N-CA 123.235 0.614 . . . . 0.0 111.552 177.348 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -96.05 105.06 17.05 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.575 1.172 . . . . 0.0 110.187 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -103.06 94.72 5.69 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 111.424 -2.626 . . . . 0.0 108.939 -176.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -112.61 114.43 27.05 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.541 1.163 . . . . 0.0 111.701 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -86.64 107.34 18.14 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 111.836 -2.438 . . . . 0.0 109.842 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 m -116.05 142.56 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 113.919 -1.492 . . . . 0.0 112.699 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.489 HG22 HG22 ' A' ' 60' ' ' VAL . 31.1 p -96.47 114.97 26.68 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.284 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.8 mt -66.89 118.3 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.359 172.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -96.04 -30.42 13.58 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.47 -1.241 . . . . 0.0 114.297 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.44 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -43.75 121.88 3.64 Favored Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 173.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 53.8 Cg_exo -52.67 -55.08 4.1 Favored 'Trans proline' 0 N--CA 1.485 0.999 1 C-N-CA 125.53 4.153 . . . . 0.0 115.147 -166.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -90.76 -37.39 13.7 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.341 0.657 . . . . 0.0 112.193 172.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.18 -142.41 16.06 Favored Glycine 0 N--CA 1.481 1.683 0 O-C-N 124.692 1.245 . . . . 0.0 112.824 168.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 N--CA 1.479 1.003 0 CA-C-N 112.648 -1.776 . . . . 0.0 114.967 -177.661 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.5 p . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.282 86.4 mtt-85 -71.88 -40.31 7.91 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 116.866 2.173 . . . . 0.0 116.866 -170.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -65.8 -36.06 33.51 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.268 1.312 . . . . 0.0 112.696 167.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -53.87 -38.4 64.68 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 172.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.54 -45.46 77.2 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.47 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 2.7 mp0 -56.51 -45.13 81.22 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 172.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -61.15 -47.21 87.27 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.432 0.693 . . . . 0.0 112.415 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 19' ' ' ALA . 19.5 t -56.2 -53.79 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 123.837 0.711 . . . . 0.0 111.536 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.47 ' HE3' ' HA ' ' A' ' 21' ' ' GLN . 22.4 pttp -62.48 -37.57 86.47 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -61.84 -52.76 62.85 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.003 1.321 . . . . 0.0 111.112 175.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.99 -44.68 82.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.64 1.176 . . . . 0.0 113.7 174.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -64.45 -25.15 67.88 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 176.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.83 -5.93 48.73 Favored Glycine 0 CA--C 1.543 1.795 0 C-N-CA 125.197 1.38 . . . . 0.0 114.017 172.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -99.88 147.98 24.95 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.19 0.996 . . . . 0.0 110.337 169.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.78 -41.03 98.03 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.91 176.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.7 m -53.34 132.36 39.13 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 124.57 1.169 . . . . 0.0 113.78 173.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.57 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 3.8 tt0 -82.75 103.56 12.33 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.697 1.237 . . . . 0.0 110.078 173.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.528 HD11 ' HB1' ' A' ' 73' ' ' ALA . 12.1 mt -89.78 115.16 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 111.346 -2.661 . . . . 0.0 111.055 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.3 p -111.86 139.02 47.69 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.275 171.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.434 HG22 HG13 ' A' ' 63' ' ' ILE . 93.8 t -114.65 116.32 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.952 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.9 m -110.69 127.63 55.38 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.892 -1.504 . . . . 0.0 111.533 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.0 m -136.23 107.72 6.92 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.661 171.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 p30 25.66 64.08 0.06 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.65 -53.16 0.6 Allowed Glycine 0 CA--C 1.539 1.582 0 CA-C-N 113.634 -1.621 . . . . 0.0 112.85 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -76.93 89.41 3.51 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.895 0.855 . . . . 0.0 112.421 -176.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 t -96.21 102.28 14.04 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.953 172.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.519 ' HB3' HD12 ' A' ' 53' ' ' LEU . . . -118.63 123.39 44.85 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.057 -1.429 . . . . 0.0 113.365 -174.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.2 t -54.79 123.98 15.06 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.179 -1.828 . . . . 0.0 113.688 173.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.37 11.17 8.92 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.067 171.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.57 ' HE3' ' HA ' ' A' ' 32' ' ' GLU . 82.5 mttt -96.9 -17.52 20.08 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.915 162.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.5 t -102.34 117.34 34.53 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 122.037 0.922 . . . . 0.0 111.245 172.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -50.25 -62.73 1.41 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.043 -1.89 . . . . 0.0 113.294 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -64.56 -39.87 94.54 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 113.825 -1.534 . . . . 0.0 114.264 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -57.76 -50.32 73.64 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 175.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 tp -68.05 -42.79 80.01 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -59.26 -21.19 59.22 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.6 t -109.29 22.54 15.69 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.519 HD12 ' HB3' ' A' ' 42' ' ' ALA . 7.2 tt -74.54 -52.15 12.68 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.816 -1.177 . . . . 0.0 110.142 171.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.97 88.9 2.08 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 mt -108.29 81.15 1.44 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.216 -0.992 . . . . 0.0 110.569 -171.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -132.14 172.54 12.26 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.021 -174.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -46.29 116.5 1.28 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.949 1.7 . . . . 0.0 112.133 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.72 -27.87 17.82 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 113.751 -1.568 . . . . 0.0 115.09 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.3 p -61.85 115.4 3.99 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.721 0.772 . . . . 0.0 112.582 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.489 HG22 HG22 ' A' ' 7' ' ' THR . 15.1 t -84.2 102.93 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 111.9 -2.409 . . . . 0.0 106.884 -176.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.3 m -109.76 117.3 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 113.975 -1.466 . . . . 0.0 113.78 -170.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.56 99.78 12.44 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.437 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.516 HG22 HG22 ' A' ' 74' ' ' VAL . 2.9 mp -78.51 98.19 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 172.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.1 m -103.35 101.85 11.77 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 112.356 -2.202 . . . . 0.0 110.412 -177.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.35 104.42 15.41 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.657 -1.61 . . . . 0.0 113.639 -173.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.31 96.22 10.43 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.297 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.09 -173.19 44.69 Favored Glycine 0 N--CA 1.475 1.295 0 CA-C-N 114.122 -1.399 . . . . 0.0 112.676 173.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -67.87 -46.09 72.69 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.63 1.172 . . . . 0.0 112.749 175.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -79.09 33.64 0.23 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.715 1.606 . . . . 0.0 113.715 176.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.635 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 3.6 pt-20 -54.14 -69.29 0.13 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.536 1.935 . . . . 0.0 114.616 -176.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.635 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -55.42 -35.28 65.23 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 174.498 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -66.04 -47.68 73.6 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.152 0.981 . . . . 0.0 112.1 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.528 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -53.81 -49.65 67.88 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.394 1.059 . . . . 0.0 112.155 173.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.516 HG22 HG22 ' A' ' 63' ' ' ILE . 94.6 t -61.86 -50.18 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.191 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.19 -58.31 3.76 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.992 1.317 . . . . 0.0 112.662 178.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -58.31 -51.15 71.01 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.346 1.029 . . . . 0.0 112.283 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.85 -38.69 89.17 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.4 -53.08 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.21 0.604 . . . . 0.0 109.81 174.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -53.89 -52.24 61.14 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.638 1.211 . . . . 0.0 112.614 178.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.9 tp -49.31 -58.12 5.64 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.103 1.761 . . . . 0.0 113.073 174.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.9 tmm? -61.39 -35.44 77.51 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.222 1.409 . . . . 0.0 113.633 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.87 -37.83 18.73 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -77.16 38.74 0.22 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.7 mt . . . . . 0 CA--C 1.545 0.777 0 C-N-CA 126.095 1.758 . . . . 0.0 110.185 179.182 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -126.44 130.42 50.65 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 126.019 2.075 . . . . 0.0 109.238 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -123.97 135.43 53.64 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.714 -1.584 . . . . 0.0 112.149 177.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -123.91 116.85 23.58 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.417 164.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -89.74 97.97 11.5 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.24 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.8 m -113.18 157.9 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 112.244 -2.253 . . . . 0.0 112.517 -174.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.417 HG22 HG22 ' A' ' 60' ' ' VAL . 22.6 p -105.15 139.37 39.91 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.896 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.407 HG12 ' SD ' ' A' ' 81' ' ' MET . 36.5 mt -107.95 105.75 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 169.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.3 p -126.03 46.98 2.32 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 114.416 -1.265 . . . . 0.0 114.294 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -116.97 139.49 25.84 Favored Pre-proline 0 N--CA 1.475 0.787 0 CA-C-O 116.962 -1.494 . . . . 0.0 108.854 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -32.04 -56.89 0.27 Allowed 'Trans proline' 0 N--CA 1.483 0.909 1 C-N-CA 125.747 4.298 . . . . 0.0 116.86 -168.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -113.43 -38.87 4.24 Favored 'General case' 0 CA--C 1.551 0.992 0 O-C-N 124.131 0.894 . . . . 0.0 112.407 168.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.05 -89.35 1.44 Allowed Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.908 0.766 . . . . 0.0 113.561 163.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -171.047 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.2 p . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.342 60.4 mtt-85 -92.05 -39.15 0.37 Allowed Pre-proline 0 N--CA 1.479 1.024 0 N-CA-C 119.044 2.979 . . . . 0.0 119.044 -170.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -61.98 -39.2 52.27 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 CA-C-N 121.283 1.494 . . . . 0.0 111.353 161.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -51.88 -34.79 42.72 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 171.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.1 -42.83 63.57 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -52.15 -52.96 48.59 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.689 1.195 . . . . 0.0 113.203 173.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -55.31 -52.57 63.03 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.579 1.552 . . . . 0.0 111.183 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.701 HG22 HD23 ' A' ' 50' ' ' LEU . 1.9 t -70.29 -38.96 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -174.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.65 -32.14 73.54 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 176.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -71.36 -49.45 42.08 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.047 0.939 . . . . 0.0 110.137 173.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.424 ' HA ' ' HD2' ' A' ' 29' ' ' PHE . . . -55.44 -46.01 76.76 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 176.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -60.77 -23.93 65.37 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 173.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.52 -25.45 67.84 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.317 0.96 . . . . 0.0 113.664 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.424 ' HD2' ' HA ' ' A' ' 26' ' ' ALA . 63.9 m-85 -73.56 139.36 45.55 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.217 1.008 . . . . 0.0 112.56 177.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -58.91 -37.6 77.02 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 113.19 -1.823 . . . . 0.0 113.025 174.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.3 m -63.08 141.93 58.58 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 171.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.89 113.8 22.99 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.842 0.83 . . . . 0.0 108.94 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 mt -106.99 101.57 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.615 -1.63 . . . . 0.0 109.989 -172.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.0 p -86.32 135.2 33.62 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.878 171.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.586 ' HB ' HD11 ' A' ' 50' ' ' LEU . 97.3 t -118.97 100.73 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 178.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.9 m -100.43 124.1 45.5 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.729 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.437 ' HB2' HG12 ' A' ' 61' ' ' VAL . 4.1 t -144.41 137.54 27.11 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.58 176.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.277 0.2 OUTLIER 43.57 51.77 6.25 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.859 1.664 . . . . 0.0 113.968 -173.027 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.15 -29.39 1.14 Allowed Glycine 0 CA--C 1.547 2.088 0 CA-C-N 114.103 -1.408 . . . . 0.0 114.885 -175.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -70.49 106.49 3.46 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.031 0.932 . . . . 0.0 112.448 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.7 t -89.65 128.82 36.13 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.696 -1.593 . . . . 0.0 111.942 169.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.81 119.81 14.45 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 113.389 -1.732 . . . . 0.0 110.24 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -64.91 124.93 23.3 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 113.117 -1.856 . . . . 0.0 112.376 171.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.54 -3.28 11.09 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 112.949 -1.932 . . . . 0.0 114.627 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -65.33 -11.64 43.86 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 122.086 0.946 . . . . 0.0 113.502 160.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.4 t -124.84 105.45 9.27 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.161 -0.962 . . . . 0.0 112.972 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.435 HD13 ' HB ' ' A' ' 23' ' ' VAL . 3.5 mm? -40.53 -51.43 2.92 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.175 -1.83 . . . . 0.0 112.524 164.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -55.57 -50.74 69.24 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 113.254 -1.794 . . . . 0.0 113.452 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -66.05 -47.87 72.92 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.701 HD23 HG22 ' A' ' 23' ' ' VAL . 7.6 tp -72.97 -30.18 63.64 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -176.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -65.66 -18.69 65.51 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 t -112.21 61.12 0.63 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 124.029 1.871 . . . . 0.0 112.748 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.4 tp -122.12 -65.95 1.07 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 112.895 -1.957 . . . . 0.0 112.296 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.62 90.96 0.83 Allowed Glycine 0 N--CA 1.478 1.438 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -172.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 mt -121.68 87.06 2.68 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.513 -0.843 . . . . 0.0 109.4 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -153.19 -175.62 5.42 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.714 -168.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -60.2 108.89 0.86 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.119 0.968 . . . . 0.0 112.128 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.08 -12.56 24.28 Favored Glycine 0 N--CA 1.477 1.388 0 CA-C-N 112.477 -2.147 . . . . 0.0 114.591 177.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.0 p -77.83 116.5 18.39 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 117.772 0.786 . . . . 0.0 112.814 -175.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.417 HG22 HG22 ' A' ' 7' ' ' THR . 22.1 t -92.26 119.97 40.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 113.1 -1.864 . . . . 0.0 107.192 177.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' A' ' 37' ' ' SER . 14.8 m -123.42 115.05 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 113.878 -1.51 . . . . 0.0 113.385 -172.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.4 90.57 6.19 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.823 174.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.8 mt -72.97 101.2 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -120.05 101.33 7.77 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.816 -164.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.21 121.01 42.38 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -104.71 112.22 25.23 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 112.947 -1.933 . . . . 0.0 109.412 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.79 -161.22 32.61 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.084 175.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -78.85 -44.76 22.22 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.98 0.895 . . . . 0.0 112.532 176.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -76.89 22.41 0.19 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.865 1.666 . . . . 0.0 114.369 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.446 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 6.9 pt-20 -44.98 -54.67 6.29 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.581 1.952 . . . . 0.0 114.976 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.446 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -68.03 -47.74 67.6 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -62.52 -49.01 77.02 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.704 -1.134 . . . . 0.0 113.191 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.06 -49.17 74.54 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.207 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.02 -51.4 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 117.946 -1.026 . . . . 0.0 111.973 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -52.67 -48.66 66.34 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 124.219 0.949 . . . . 0.0 112.047 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -60.72 -48.53 81.37 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.363 1.065 . . . . 0.0 112.957 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.08 -37.03 84.78 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.7 t -59.04 -50.09 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 123.938 0.774 . . . . 0.0 109.851 172.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -53.66 -55.72 23.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 124.036 0.835 . . . . 0.0 113.096 175.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.2 tt -51.31 -52.12 48.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.524 1.13 . . . . 0.0 112.462 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.407 ' SD ' HG12 ' A' ' 8' ' ' ILE . 16.9 tmm? -59.86 -49.09 79.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.102 0.961 . . . . 0.0 112.859 178.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.05 -26.49 67.53 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -83.35 -2.04 54.79 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 87.1 mt . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 177.374 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.43 ' HG2' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -81.2 126.78 31.93 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.339 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -123.76 123.52 40.68 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 113.702 -1.59 . . . . 0.0 111.461 -175.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -129.91 110.46 11.71 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 125.134 1.521 . . . . 0.0 112.997 168.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -83.53 106.25 15.11 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.354 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.4 m -115.51 144.5 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 114.141 -1.391 . . . . 0.0 113.655 -173.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.561 HG22 HG22 ' A' ' 60' ' ' VAL . 27.6 p -103.63 118.4 36.64 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 113.868 -1.515 . . . . 0.0 111.308 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.0 mt -74.22 113.53 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.653 172.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 p -96.07 -23.15 16.92 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -62.22 133.56 94.33 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 124.383 1.073 . . . . 0.0 112.082 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 77.8 Cg_exo -53.17 -55.93 3.22 Favored 'Trans proline' 0 N--CA 1.481 0.752 0 C-N-CA 124.365 3.377 . . . . 0.0 113.755 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -67.58 -37.31 82.42 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.12 0.968 . . . . 0.0 112.874 176.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.37 -128.01 9.14 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.8 mt -114.13 -17.56 11.88 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 113.827 -1.186 . . . . 0.0 113.039 171.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.2 p -107.6 -44.21 4.33 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 118.038 -2.914 . . . . 0.0 113.737 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.41 ' HD3' ' HA ' ' A' ' 17' ' ' ARG 0.346 15.7 mmt180 -87.17 -45.47 0.52 Allowed Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 118.017 2.599 . . . . 0.0 118.017 -175.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -59.01 -33.14 98.65 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 CA-C-N 122.655 1.984 . . . . 0.0 111.751 165.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.523 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -56.67 -48.29 77.93 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.149 0.98 . . . . 0.0 113.46 165.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.01 -38.81 90.03 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.23 -43.0 99.81 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 169.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -58.89 -42.22 89.02 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 124.375 1.047 . . . . 0.0 111.348 172.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 19' ' ' ALA . 66.8 t -57.28 -52.0 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 123.971 0.909 . . . . 0.0 111.032 171.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -53.45 -46.51 69.92 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 124.029 0.831 . . . . 0.0 112.08 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -66.9 -44.96 79.43 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.199 0.999 . . . . 0.0 113.221 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.17 -37.23 76.85 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 124.312 1.045 . . . . 0.0 113.681 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -59.42 -22.15 61.01 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 171.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.21 -20.16 74.74 Favored Glycine 0 N--CA 1.487 2.054 0 O-C-N 124.973 1.421 . . . . 0.0 114.663 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -98.18 148.85 23.16 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.18 0.592 . . . . 0.0 112.387 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.1 p -68.5 -43.37 76.99 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.962 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.0 p -61.1 161.57 8.43 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.816 1.246 . . . . 0.0 113.086 170.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -116.48 102.4 9.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 122.304 1.049 . . . . 0.0 111.979 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.698 HD11 ' HB1' ' A' ' 73' ' ' ALA . 17.1 mm -65.25 106.75 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 112.392 -2.185 . . . . 0.0 111.894 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.0 p -94.25 122.19 36.53 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.573 1.178 . . . . 0.0 109.984 167.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.6 t -104.41 107.09 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 111.95 -2.386 . . . . 0.0 107.848 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.3 m -96.25 113.39 24.99 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.098 -1.864 . . . . 0.0 111.627 -174.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.561 ' HB2' HG12 ' A' ' 61' ' ' VAL . 5.7 t -129.01 121.68 28.45 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.594 172.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 p30 37.94 64.44 0.68 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 125.18 1.55 . . . . 0.0 114.419 -170.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.45 -33.92 1.57 Allowed Glycine 0 N--CA 1.486 1.991 0 CA-C-N 113.636 -1.62 . . . . 0.0 114.509 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -68.51 88.69 0.34 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.315 1.046 . . . . 0.0 112.107 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.9 m -77.28 99.9 5.67 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 113.223 -1.808 . . . . 0.0 111.882 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.95 123.53 46.02 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.46 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.5 t -58.98 103.85 0.2 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.785 168.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.563 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . . . -59.57 -32.33 70.26 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.331 175.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -65.96 -24.69 66.85 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.827 0.851 . . . . 0.0 112.254 174.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.8 t -94.26 111.1 22.82 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 123.104 1.43 . . . . 0.0 112.608 170.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.441 ' HA ' HG21 ' A' ' 23' ' ' VAL . 22.6 tp -32.54 -73.35 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.934 2.494 . . . . 0.0 116.13 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.402 ' O ' HG22 ' A' ' 52' ' ' THR . 67.3 m-85 -64.87 -30.21 71.2 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -175.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -62.8 -48.29 79.77 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.603 0.761 . . . . 0.0 111.638 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 44' ' ' ALA . 26.3 tp -69.48 -46.58 66.3 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 124.251 0.97 . . . . 0.0 113.066 172.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -52.61 -32.0 39.38 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 48' ' ' PHE . 5.1 t -114.35 24.01 12.31 Favored 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.8 tp -70.35 -48.06 58.13 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.374 -0.829 . . . . 0.0 112.259 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.08 87.35 1.36 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.51 87.24 2.72 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.708 -0.746 . . . . 0.0 111.925 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -135.09 176.14 8.94 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 114.286 -1.325 . . . . 0.0 112.238 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -58.33 116.34 3.54 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.457 1.103 . . . . 0.0 110.245 172.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.07 -33.78 6.16 Favored Glycine 0 N--CA 1.485 1.932 0 CA-C-N 114.397 -1.274 . . . . 0.0 114.251 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.1 p -59.88 112.84 2.0 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 117.612 0.706 . . . . 0.0 112.421 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.561 HG22 HG22 ' A' ' 7' ' ' THR . 22.0 t -84.51 129.92 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.335 -1.757 . . . . 0.0 108.026 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.561 HG12 ' HB2' ' A' ' 37' ' ' SER . 7.4 m -129.73 118.4 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.443 -174.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.5 m -85.21 104.81 15.41 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.826 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.9 mt -82.9 109.92 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.9 m -118.01 141.46 48.44 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 113.157 -1.838 . . . . 0.0 111.38 -173.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.91 139.43 27.6 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.43 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 28.2 tt0 -133.33 132.27 41.1 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.658 -1.61 . . . . 0.0 108.826 169.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.31 -161.9 28.18 Favored Glycine 0 N--CA 1.481 1.683 0 C-N-CA 125.023 1.297 . . . . 0.0 111.542 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -59.93 -64.54 0.91 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.917 0.865 . . . . 0.0 113.167 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -83.56 31.59 0.47 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -53.0 -58.21 7.74 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -172.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -43.11 99.61 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -65.62 -45.03 84.66 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.036 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.698 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -56.39 -52.19 65.55 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.125 0.97 . . . . 0.0 113.173 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.8 t -59.5 -53.06 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.949 0.899 . . . . 0.0 110.078 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -51.0 -54.04 27.96 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.215 1.406 . . . . 0.0 112.73 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -62.88 -45.7 91.33 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.7 mt -64.88 -36.22 83.64 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.35 -50.79 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.435 0.694 . . . . 0.0 110.527 169.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -56.21 -47.11 79.03 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.7 tp -49.03 -59.23 3.79 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.607 1.163 . . . . 0.0 111.927 173.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.0 tmm? -58.06 -42.6 85.81 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.32 1.048 . . . . 0.0 112.949 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.03 -29.89 67.05 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -87.66 -31.69 19.63 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 69.1 mt -48.79 144.73 4.27 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 . . . . . 0 N--CA 1.483 1.2 0 O-C-N 125.618 1.824 . . . . 0.0 114.429 -178.2 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttp . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -120.79 112.31 18.67 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.827 1.329 . . . . 0.0 110.087 172.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -107.57 126.81 53.01 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.019 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -122.93 120.17 32.62 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -99.89 92.72 5.42 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 125.294 1.621 . . . . 0.0 108.794 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.401 HG21 HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -119.31 143.39 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 111.469 -2.605 . . . . 0.0 112.641 -173.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 p -78.54 131.45 36.8 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -176.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.9 mt -92.59 116.97 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-N 113.485 -1.689 . . . . 0.0 107.159 159.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 p -116.36 -17.81 10.63 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 111.85 -2.432 . . . . 0.0 114.38 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.06 129.96 58.54 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 124.929 1.292 . . . . 0.0 111.694 172.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -56.97 -54.11 4.11 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 124.394 3.396 . . . . 0.0 114.862 -165.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.426 ' O ' ' HD2' ' A' ' 15' ' ' HIP . 11.7 p30 -88.23 -36.97 16.45 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 123.782 0.676 . . . . 0.0 111.762 171.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.89 -128.34 9.53 Favored Glycine 0 N--CA 1.475 1.291 0 O-C-N 123.799 0.687 . . . . 0.0 112.46 167.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.629 HD21 HD13 ' A' ' 84' ' ' LEU . 72.5 mt -104.45 -32.82 8.82 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.426 ' HD2' ' O ' ' A' ' 12' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.6 p -100.2 -62.67 1.21 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 118.112 -2.867 . . . . 0.0 113.489 174.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.326 24.1 mtt180 -83.79 -37.36 0.67 Allowed Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 118.396 2.739 . . . . 0.0 118.396 -168.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -62.52 -39.81 42.62 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 121.763 1.642 . . . . 0.0 112.617 163.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.21 -38.18 73.33 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 168.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.18 -38.56 86.94 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 172.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -64.27 -43.91 93.34 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.414 0.686 . . . . 0.0 112.147 172.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -59.02 -44.17 91.69 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.175 1.39 . . . . 0.0 112.221 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.479 HG21 ' HA ' ' A' ' 47' ' ' LEU . 44.6 t -53.97 -60.06 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.042 1.337 . . . . 0.0 112.034 169.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -49.55 -39.06 33.38 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.936 -1.029 . . . . 0.0 113.156 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.455 ' HG2' HD22 ' A' ' 80' ' ' LEU . 8.5 tp10 -61.86 -66.0 0.6 Allowed 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.522 1.139 . . . . 0.0 110.891 169.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.93 -35.16 6.17 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -42.36 -38.21 1.78 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.24 -30.19 70.33 Favored Glycine 0 CA--C 1.546 1.972 0 C-N-CA 124.97 1.272 . . . . 0.0 115.805 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -75.28 144.8 42.3 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -175.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 66.3 p -66.46 -50.27 63.9 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.303 0.641 . . . . 0.0 111.891 -175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.3 p -66.09 173.61 2.99 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 124.877 1.361 . . . . 0.0 113.35 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.418 ' HG3' ' HB3' ' A' ' 45' ' ' LYS . 30.6 tt0 -114.65 94.32 4.72 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.704 0.764 . . . . 0.0 109.331 174.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.75 113.57 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 113.118 -1.855 . . . . 0.0 109.382 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 p -105.78 137.61 43.36 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.677 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.0 t -118.87 126.57 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 113.206 -1.815 . . . . 0.0 109.944 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.3 m -110.98 123.37 50.04 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.214 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.8 t -126.5 120.37 29.5 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.717 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 p30 40.3 64.03 0.99 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.742 1.617 . . . . 0.0 114.634 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.35 -34.96 1.54 Allowed Glycine 0 CA--C 1.542 1.773 0 CA-C-N 113.187 -1.824 . . . . 0.0 115.658 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -81.94 133.04 35.28 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.598 0.759 . . . . 0.0 110.254 -169.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.5 t -108.4 129.29 55.26 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.123 0.89 . . . . 0.0 113.269 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.519 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -124.71 160.85 27.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 112.541 -2.118 . . . . 0.0 109.626 176.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.534 ' H ' ' HB3' ' A' ' 49' ' ' LYS . 40.3 t -106.08 128.26 53.74 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.131 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.04 -29.47 69.83 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.878 1.361 . . . . 0.0 111.338 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HB3' ' HG3' ' A' ' 32' ' ' GLU . 77.4 tttt -90.81 21.69 3.98 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.245 -0.888 . . . . 0.0 112.609 177.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.498 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 2.0 m -148.01 116.46 6.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.028 1.331 . . . . 0.0 112.274 173.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.479 ' HA ' HG21 ' A' ' 23' ' ' VAL . 31.1 tp -51.21 -59.63 3.99 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 112.429 -2.169 . . . . 0.0 113.324 -176.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -63.85 -32.34 73.82 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.221 -1.354 . . . . 0.0 113.317 -174.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.534 ' HB3' ' H ' ' A' ' 43' ' ' SER . 15.4 mmmt -69.24 -58.48 3.98 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 118.318 -0.848 . . . . 0.0 113.033 173.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.9 tp -60.36 -40.3 90.25 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 124.201 0.938 . . . . 0.0 112.441 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -62.34 -40.1 95.28 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 t -89.86 8.14 33.59 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.519 HD22 ' HB3' ' A' ' 42' ' ' ALA . 45.3 tp -72.67 -60.95 1.98 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.91 92.88 1.6 Allowed Glycine 0 CA--C 1.535 1.334 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.0 mt -128.47 82.75 2.1 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.269 1.427 . . . . 0.0 109.956 -174.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 t -146.49 164.67 31.78 Favored 'General case' 0 C--O 1.25 1.1 0 C-N-CA 125.826 1.65 . . . . 0.0 110.835 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -41.61 126.63 2.99 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.444 1.898 . . . . 0.0 115.137 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.69 -31.56 5.51 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-N 113.891 -1.504 . . . . 0.0 115.379 173.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.35 121.32 21.19 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.828 2.159 . . . . 0.0 116.828 -173.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.9 t -87.01 94.03 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 m -89.82 125.72 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -169.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.07 93.45 5.78 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.967 1.707 . . . . 0.0 110.429 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.6 mt -98.73 113.33 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 125.496 1.518 . . . . 0.0 107.134 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 m -129.68 124.29 33.24 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.247 -1.342 . . . . 0.0 112.216 -167.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.66 140.84 51.56 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -140.74 110.1 6.27 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.258 1.423 . . . . 0.0 110.301 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.82 -157.05 19.57 Favored Glycine 0 N--CA 1.478 1.497 0 N-CA-C 107.621 -2.191 . . . . 0.0 107.621 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -65.51 -43.5 89.9 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 117.243 0.521 . . . . 0.0 110.156 170.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -86.25 26.94 0.97 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -54.06 -52.64 60.25 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.493 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -78.42 -44.13 25.58 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.649 1.58 . . . . 0.0 113.007 -179.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -67.65 -35.83 79.6 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.77 -47.4 53.84 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.707 0.803 . . . . 0.0 112.862 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.9 t -61.6 -48.1 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 118.0 -1.0 . . . . 0.0 111.156 176.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -46.12 -49.01 17.17 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.7 1.2 . . . . 0.0 111.845 171.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -68.19 -62.48 1.38 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.0 mt -59.77 -38.63 82.35 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.401 HG13 HG21 ' A' ' 6' ' ' VAL . 56.4 t -61.42 -48.24 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.315 174.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -59.07 -48.88 80.0 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.297 0.998 . . . . 0.0 112.953 173.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.455 HD22 ' HG2' ' A' ' 25' ' ' GLU . 10.3 tp -52.55 -47.99 66.43 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.642 0.777 . . . . 0.0 112.03 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.518 ' HG3' HD11 ' A' ' 14' ' ' LEU . 48.5 ttp -62.2 -52.26 64.5 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.923 0.889 . . . . 0.0 112.367 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.64 -35.9 63.95 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -88.46 -13.67 39.77 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.629 HD13 HD21 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -63.37 153.07 36.26 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 124.093 0.957 . . . . 0.0 112.411 167.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 . . . . . 0 N--CA 1.486 1.366 0 C-N-CA 125.318 1.447 . . . . 0.0 110.632 -175.782 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ttt . . . . . 0 N--CA 1.463 0.204 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -113.79 127.97 56.22 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 124.657 1.223 . . . . 0.0 109.708 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -131.11 94.66 3.63 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.309 -167.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -112.44 108.49 17.64 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 122.518 1.151 . . . . 0.0 113.343 -171.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -80.96 103.99 11.16 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 112.45 -2.159 . . . . 0.0 111.159 175.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.3 148.46 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 114.933 -1.03 . . . . 0.0 113.138 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 p -102.72 128.33 49.48 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.905 -175.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.3 mt -79.54 108.9 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.359 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 p -96.83 -13.51 22.5 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 175.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.442 ' HB3' ' HA2' ' A' ' 13' ' ' GLY . . . -59.9 135.83 90.22 Favored Pre-proline 0 N--CA 1.486 1.331 0 C-N-CA 124.31 1.044 . . . . 0.0 111.766 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.451 ' HA ' HE21 ' A' ' 57' ' ' GLN . 92.1 Cg_exo -48.88 -52.45 8.64 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.182 3.255 . . . . 0.0 114.718 -174.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -106.88 -28.43 10.1 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 124.591 1.182 . . . . 0.0 113.741 175.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . 93.25 -153.91 21.6 Favored Glycine 0 N--CA 1.479 1.563 0 CA-C-O 122.045 0.803 . . . . 0.0 113.897 165.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.645 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 87.0 mt -72.08 -34.05 68.39 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 177.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.5 p -88.0 -51.54 5.76 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 117.133 -3.48 . . . . 0.0 115.563 170.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.303 40.6 mtt85 -89.77 -41.44 0.42 Allowed Pre-proline 0 N--CA 1.486 1.336 0 N-CA-C 118.616 2.821 . . . . 0.0 118.616 -166.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.645 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 90.5 Cg_exo -61.72 -30.8 85.55 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 CA-C-N 120.867 1.345 . . . . 0.0 112.412 163.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -60.19 -44.2 95.3 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 165.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.41 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . . . -60.26 -40.51 90.61 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 172.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -59.84 -45.5 92.22 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.386 1.074 . . . . 0.0 112.452 172.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -57.86 -46.07 85.37 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.074 1.35 . . . . 0.0 111.782 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.5 HG21 ' HA ' ' A' ' 47' ' ' LEU . 59.2 t -56.0 -42.47 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.025 0.53 . . . . 0.0 112.278 175.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -60.96 -46.43 90.74 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 124.07 0.856 . . . . 0.0 111.916 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.47 ' HB3' HD21 ' A' ' 77' ' ' LEU . 13.7 tp10 -69.58 -44.44 70.79 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.077 0.861 . . . . 0.0 112.616 176.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.37 -33.59 65.85 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -53.81 -34.77 60.21 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 170.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.27 13.74 56.52 Favored Glycine 0 N--CA 1.483 1.81 0 O-C-N 124.557 1.161 . . . . 0.0 115.159 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -119.49 151.19 38.99 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.046 0.497 . . . . 0.0 111.297 172.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.4 p -82.69 -44.2 15.97 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.862 -175.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.3 p -66.08 133.26 50.37 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 124.999 1.437 . . . . 0.0 110.615 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -85.7 103.62 14.67 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.609 1.195 . . . . 0.0 111.831 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.654 HD11 ' HB1' ' A' ' 73' ' ' ALA . 44.4 mm -63.69 113.53 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 111.757 -2.474 . . . . 0.0 111.125 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.1 p -111.66 131.04 55.56 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.601 173.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.469 HG22 HG12 ' A' ' 63' ' ' ILE . 59.3 t -111.0 108.27 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 113.483 -1.689 . . . . 0.0 107.723 -177.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.0 m -103.91 124.05 48.26 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.777 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.526 ' HB2' HG12 ' A' ' 61' ' ' VAL . 48.2 t -128.16 131.99 48.91 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.286 176.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.6 p30 49.83 34.62 7.92 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.39 5.33 87.7 Favored Glycine 0 CA--C 1.545 1.926 0 N-CA-C 115.806 1.082 . . . . 0.0 115.806 -175.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -112.56 140.66 47.13 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.977 0.911 . . . . 0.0 109.915 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.0 t -119.22 135.04 54.88 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -167.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.503 ' HB3' HD12 ' A' ' 53' ' ' LEU . . . -130.61 121.27 25.32 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.036 -1.893 . . . . 0.0 111.398 173.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.9 t -72.98 129.09 37.32 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.633 173.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.75 -14.7 62.08 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 113.175 -1.829 . . . . 0.0 113.297 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.0 mttt -77.29 -2.47 34.98 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 171.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.3 m -123.14 118.62 28.09 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.394 0.677 . . . . 0.0 112.217 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.5 ' HA ' HG21 ' A' ' 23' ' ' VAL . 19.1 tp -45.93 -65.87 0.48 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.588 -1.642 . . . . 0.0 113.732 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.48 ' O ' HG22 ' A' ' 52' ' ' THR . 56.6 m-85 -54.09 -50.93 65.7 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 178.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.5 mmtt -42.04 -58.59 2.04 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.4 tp -66.96 -43.0 84.25 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.638 1.211 . . . . 0.0 113.202 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.41 ' NE2' ' HB2' ' A' ' 20' ' ' ALA . 90.3 mt-30 -59.36 -41.38 89.14 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.989 175.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 48' ' ' PHE 0.263 15.2 t -100.54 54.01 0.88 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 123.497 1.617 . . . . 0.0 113.897 175.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.503 HD12 ' HB3' ' A' ' 42' ' ' ALA . 2.6 tt -111.24 -56.5 2.36 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 112.874 -1.966 . . . . 0.0 109.246 161.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.27 66.9 0.61 Allowed Glycine 0 N--CA 1.477 1.416 0 O-C-N 124.348 1.03 . . . . 0.0 111.851 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.2 mt -88.74 98.11 11.51 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.682 0.793 . . . . 0.0 111.537 -174.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.9 t -137.47 175.99 9.11 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.876 -176.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' A' ' 11' ' ' PRO . 19.8 tt0 -47.95 128.68 13.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.899 2.08 . . . . 0.0 112.813 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.68 -54.72 0.55 Allowed Glycine 0 N--CA 1.48 1.61 0 CA-C-N 113.408 -1.724 . . . . 0.0 114.175 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.1 p -64.56 131.98 48.55 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -165.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.4 t -79.89 108.48 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 111.124 -2.762 . . . . 0.0 107.193 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.526 HG12 ' HB2' ' A' ' 37' ' ' SER . 13.6 m -105.0 109.49 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 113.523 -1.671 . . . . 0.0 113.214 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.5 95.99 2.85 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.626 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.469 HG12 HG22 ' A' ' 35' ' ' VAL . 77.2 mt -86.61 101.19 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.117 175.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.3 m -106.15 134.56 49.09 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 112.642 -2.072 . . . . 0.0 112.905 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.609 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -139.07 138.22 36.92 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 124.638 1.211 . . . . 0.0 113.223 172.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -132.62 118.7 19.5 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 124.8 1.312 . . . . 0.0 109.484 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.44 -155.5 26.18 Favored Glycine 0 CA--C 1.544 1.879 0 C-N-CA 124.685 1.136 . . . . 0.0 111.232 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -68.09 -61.14 2.0 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -80.56 28.15 0.34 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -53.26 -48.32 68.36 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.78 -50.61 33.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.835 0.854 . . . . 0.0 111.809 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -58.89 -50.92 72.19 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.587 1.555 . . . . 0.0 112.829 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.654 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -60.25 -44.58 95.14 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.471 1.107 . . . . 0.0 113.587 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.63 -55.52 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.078 175.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -52.05 -50.57 61.22 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.051 0.941 . . . . 0.0 112.975 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -60.01 -50.5 73.49 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.468 1.107 . . . . 0.0 112.64 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.47 HD21 ' HB3' ' A' ' 25' ' ' GLU . 45.8 mt -64.72 -28.32 69.51 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.5 t -69.65 -47.57 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 122.896 0.479 . . . . 0.0 110.896 171.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -51.76 -50.92 59.73 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.937 0.895 . . . . 0.0 111.527 174.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.67 -54.62 21.52 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.213 1.805 . . . . 0.0 112.236 176.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 40.3 ttp -57.12 -47.87 80.03 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.467 1.107 . . . . 0.0 112.363 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.9 -27.84 68.49 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.275 1.43 . . . . 0.0 114.84 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -78.71 -35.74 44.45 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.459 HD13 ' HB3' ' A' ' 18' ' ' PRO . 36.4 mt -57.64 156.93 7.7 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 175.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 C--O 1.259 1.562 0 C-N-CA 126.558 1.943 . . . . 0.0 114.771 -173.858 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 ttt . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -103.22 136.96 42.02 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 125.095 1.497 . . . . 0.0 108.329 170.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -146.16 134.41 21.74 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.565 -1.652 . . . . 0.0 111.016 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -123.48 118.94 28.56 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.847 170.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -83.98 106.87 15.98 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.079 165.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.6 m -120.73 140.21 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 114.726 -1.124 . . . . 0.0 113.649 -178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.481 HG22 HG22 ' A' ' 60' ' ' VAL . 22.8 p -83.31 136.21 34.45 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.302 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 52.7 mt -81.81 90.31 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 168.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.7 p -74.07 -22.41 59.53 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.513 174.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.32 131.74 94.89 Favored Pre-proline 0 N--CA 1.484 1.229 0 C-N-CA 125.296 1.438 . . . . 0.0 111.935 -175.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.04 -44.17 9.54 Favored 'Trans proline' 0 N--CA 1.489 1.207 1 C-N-CA 125.355 4.036 . . . . 0.0 117.56 -166.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -110.45 -45.03 3.6 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.85 -147.63 17.6 Favored Glycine 0 N--CA 1.478 1.492 0 CA-C-O 121.725 0.625 . . . . 0.0 112.817 167.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.473 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 95.6 mt -88.31 -30.34 19.68 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.3 p -111.37 -46.13 3.32 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 118.201 -2.812 . . . . 0.0 115.213 170.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.286 48.4 mtt85 -86.08 -39.27 0.57 Allowed Pre-proline 0 N--CA 1.487 1.411 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -174.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.473 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 97.9 Cg_exo -62.13 -35.71 73.88 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 121.712 1.608 . . . . 0.0 111.686 164.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.44 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -56.06 -44.38 78.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.601 0.76 . . . . 0.0 112.897 167.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.49 98.81 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 171.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -56.64 -45.25 81.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.716 0.806 . . . . 0.0 113.146 171.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -57.93 -44.18 86.75 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.864 1.266 . . . . 0.0 111.689 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 19' ' ' ALA . 95.7 t -57.12 -42.81 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.322 1.049 . . . . 0.0 113.154 176.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -53.03 -45.27 67.93 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 123.462 0.476 . . . . 0.0 112.17 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -74.61 -50.94 15.95 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.831 1.332 . . . . 0.0 112.215 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.35 -35.95 65.78 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -60.14 -19.38 53.41 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 173.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.45 27.03 14.89 Favored Glycine 0 CA--C 1.544 1.869 0 O-C-N 124.432 1.082 . . . . 0.0 113.646 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -127.93 142.97 51.11 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.143 0.977 . . . . 0.0 111.575 172.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.6 p -71.85 -40.0 69.34 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.438 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.437 ' HB2' ' HB1' ' A' ' 65' ' ' ALA . 63.0 p -65.23 145.86 55.69 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 124.483 1.115 . . . . 0.0 111.624 168.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -95.73 109.51 21.79 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 121.321 -0.862 . . . . 0.0 110.968 174.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.698 HD13 ' HB2' ' A' ' 65' ' ' ALA . 46.3 mm -70.54 102.06 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 112.64 -2.073 . . . . 0.0 108.852 171.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.3 p -101.89 126.44 48.79 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.497 173.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.469 HG22 HG12 ' A' ' 63' ' ' ILE . 86.7 t -103.54 113.85 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 125.445 1.716 . . . . 0.0 107.767 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.466 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 97.9 m -114.2 127.54 55.95 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.652 -174.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.4 t -122.66 115.04 21.43 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.316 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.5 p30 39.94 51.31 2.52 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -174.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.47 -35.8 4.05 Favored Glycine 0 N--CA 1.484 1.898 0 CA-C-N 113.17 -1.832 . . . . 0.0 114.501 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -72.55 121.63 19.99 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 116.897 0.348 . . . . 0.0 111.11 -174.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.0 t -102.25 136.29 42.35 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.78 1.3 . . . . 0.0 113.789 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.609 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -129.72 106.77 8.93 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 112.748 -2.024 . . . . 0.0 112.005 175.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.7 t -59.5 121.73 12.26 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.526 171.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.61 -30.55 68.31 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.598 170.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -61.8 -32.64 72.95 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.2 m -96.37 104.24 16.19 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 122.028 0.918 . . . . 0.0 111.89 169.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.423 ' HA ' HG21 ' A' ' 23' ' ' VAL . 9.5 tp -44.94 -60.62 1.97 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.54 1.536 . . . . 0.0 113.05 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.437 ' O ' HG22 ' A' ' 52' ' ' THR . 90.2 m-85 -57.21 -37.6 72.45 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.507 ' HD2' ' HA ' ' A' ' 42' ' ' ALA . 6.2 tmtt? -61.5 -49.82 75.2 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.609 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 19.8 tp -62.48 -41.33 98.72 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 174.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -61.07 -24.88 66.55 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 174.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 48' ' ' PHE 0.261 9.6 t -118.12 75.31 1.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 123.449 1.595 . . . . 0.0 114.228 172.472 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.422 HD13 ' HB2' ' A' ' 42' ' ' ALA . 19.7 tp -124.0 -45.39 2.01 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 112.128 -2.305 . . . . 0.0 113.141 168.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.45 69.1 0.84 Allowed Glycine 0 CA--C 1.534 1.266 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -167.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 43.7 mt -95.28 80.64 3.56 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.06 0.933 . . . . 0.0 110.936 -173.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -123.83 151.49 43.34 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 112.748 -2.024 . . . . 0.0 112.889 -165.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -49.13 132.9 19.28 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.46 1.124 . . . . 0.0 112.427 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.58 -69.06 0.22 Allowed Glycine 0 CA--C 1.534 1.267 0 CA-C-N 113.467 -1.697 . . . . 0.0 110.257 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.5 p -30.79 113.19 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.481 HG22 HG22 ' A' ' 7' ' ' THR . 9.2 t -72.96 108.1 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 112.601 -2.09 . . . . 0.0 106.688 168.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.7 m -105.09 111.48 34.75 Favored 'Isoleucine or valine' 0 C--O 1.253 1.261 0 CA-C-N 113.991 -1.458 . . . . 0.0 112.743 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.466 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 2.8 m -65.99 99.11 0.47 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 126.558 1.943 . . . . 0.0 108.87 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.469 HG12 HG22 ' A' ' 35' ' ' VAL . 80.8 mt -96.64 106.73 18.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.7 m -118.53 133.79 55.59 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 112.703 -2.044 . . . . 0.0 112.588 -169.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.698 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -146.78 138.12 24.25 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 125.334 1.646 . . . . 0.0 112.681 170.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -120.05 129.72 54.37 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.97 170.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.1 -157.11 27.26 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.766 1.203 . . . . 0.0 114.909 174.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -71.77 -44.09 64.63 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.518 ' HA ' ' HD2' ' A' ' 72' ' ' LYS . 5.2 p30 -100.63 24.84 8.49 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.69 -51.22 68.03 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -36.79 83.98 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.254 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.518 ' HD2' ' HA ' ' A' ' 69' ' ' ASP . 22.2 mttt -71.73 -52.8 15.91 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.563 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.17 -51.7 68.46 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.513 1.525 . . . . 0.0 114.266 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.7 t -60.77 -50.64 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.003 0.521 . . . . 0.0 110.863 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -54.58 -55.33 30.5 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.557 1.143 . . . . 0.0 111.514 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -53.76 -54.1 42.96 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.733 1.613 . . . . 0.0 112.923 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.3 mt -69.41 -28.64 66.33 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.54 -43.46 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 119.038 -0.506 . . . . 0.0 110.816 171.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -55.77 -43.81 77.08 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.248 0.619 . . . . 0.0 111.716 172.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.26 -51.08 70.79 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.522 1.129 . . . . 0.0 112.757 174.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 44.4 ttm -55.08 -45.6 75.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 123.531 0.519 . . . . 0.0 112.286 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.09 -19.95 66.24 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -114.85 36.19 3.96 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 mt -107.06 175.24 5.57 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.303 1.441 . . . . 0.0 112.73 173.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 . . . . . 0 N--CA 1.488 1.442 0 C-N-CA 125.59 1.556 . . . . 0.0 112.273 178.273 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 ttp . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -100.45 131.93 46.1 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 125.597 1.81 . . . . 0.0 107.962 169.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -124.78 115.44 20.7 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.584 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -127.05 110.21 12.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.223 1.011 . . . . 0.0 112.386 173.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -91.59 112.45 24.38 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.624 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 m -128.37 165.35 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 113.134 -1.848 . . . . 0.0 112.301 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.459 HG22 HG22 ' A' ' 60' ' ' VAL . 78.5 p -120.73 147.27 45.53 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.196 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.8 mt -87.93 97.13 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.887 175.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.8 p -85.3 -17.79 35.83 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.47 142.2 41.2 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.985 1.314 . . . . 0.0 112.608 174.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -47.6 -46.96 19.34 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 124.586 3.524 . . . . 0.0 116.246 -173.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -114.86 -39.17 3.76 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.83 -142.51 17.1 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 122.198 0.888 . . . . 0.0 112.824 167.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 mp -104.21 -27.87 11.78 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 -174.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 76.8 p -101.22 -68.05 0.83 Allowed 'General case' 0 N--CA 1.476 0.833 0 O-C-N 117.449 -3.282 . . . . 0.0 114.358 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.492 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 65.2 mtt85 -60.57 -53.95 59.49 Favored Pre-proline 0 N--CA 1.488 1.445 0 CA-C-O 116.238 -1.839 . . . . 0.0 115.181 -171.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 51.4 Cg_exo -67.2 -31.12 36.69 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 CA-C-N 122.072 1.776 . . . . 0.0 114.198 174.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.69 -40.96 85.1 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 171.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.41 -39.29 86.88 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 171.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -62.09 -44.68 96.13 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.006 0.923 . . . . 0.0 113.15 172.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -59.76 -43.5 94.27 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.105 0.878 . . . . 0.0 111.662 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.57 HG11 ' HA ' ' A' ' 47' ' ' LEU . 66.8 t -55.66 -51.67 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.569 0.748 . . . . 0.0 111.654 172.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -46.84 -51.74 15.9 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.617 0.767 . . . . 0.0 111.755 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -65.14 -51.81 59.01 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.466 1.104 . . . . 0.0 111.559 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.28 -34.02 66.06 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -60.51 -32.84 71.83 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 172.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.22 26.24 3.98 Favored Glycine 0 N--CA 1.479 1.526 0 O-C-N 124.382 1.051 . . . . 0.0 114.375 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -129.17 146.24 51.14 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.725 1.21 . . . . 0.0 110.261 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.6 p -69.39 -42.15 75.5 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.442 0.697 . . . . 0.0 112.872 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 p -66.55 157.07 33.24 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.867 1.267 . . . . 0.0 112.836 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -103.4 113.74 27.48 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 122.32 1.057 . . . . 0.0 110.239 172.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' A' ' 44' ' ' ALA . 8.7 mm -81.81 105.74 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 111.818 -2.446 . . . . 0.0 108.495 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.3 p -101.79 121.27 41.77 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.141 0.496 . . . . 0.0 110.805 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.6 t -101.51 97.85 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 125.905 2.003 . . . . 0.0 107.612 -172.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 29.1 m -88.39 101.14 13.6 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.778 -1.555 . . . . 0.0 111.047 -177.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 t -100.35 99.88 10.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.198 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 p30 45.54 62.61 2.11 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 113.186 -1.824 . . . . 0.0 114.009 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.47 -30.36 3.78 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 114.015 -1.448 . . . . 0.0 114.636 -176.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -86.31 92.76 8.9 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.644 0.735 . . . . 0.0 109.67 -174.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 25.3 t -82.73 123.33 29.2 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.771 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -126.2 132.86 51.69 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.597 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.6 t -71.22 129.7 39.57 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.715 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.57 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . . . -72.2 -19.0 61.81 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 112.972 -1.922 . . . . 0.0 112.508 170.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -77.11 -6.11 51.56 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 m -112.49 115.93 29.46 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.57 ' HA ' HG11 ' A' ' 23' ' ' VAL . 32.4 tp -52.84 -64.79 0.7 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 111.325 -2.67 . . . . 0.0 114.302 -170.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.459 ' O ' HG22 ' A' ' 52' ' ' THR . 49.5 m-85 -77.39 -28.77 52.9 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -60.65 -44.85 95.93 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.444 ' HG ' HD11 ' A' ' 55' ' ' LEU . 6.0 tp -69.62 -35.52 75.33 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.591 1.182 . . . . 0.0 113.283 175.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -65.48 -35.9 82.28 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 172.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 48' ' ' PHE 0.251 14.0 t -100.06 50.66 0.91 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 123.716 1.722 . . . . 0.0 112.547 173.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.457 HD22 ' HB3' ' A' ' 42' ' ' ALA . 59.5 tp -115.6 -37.86 3.88 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 112.883 -1.962 . . . . 0.0 112.742 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.09 55.92 1.66 Allowed Glycine 0 CA--C 1.53 1.031 0 C-N-CA 123.962 0.791 . . . . 0.0 111.824 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.444 HD11 ' HG ' ' A' ' 50' ' ' LEU . 78.3 mt -77.51 85.5 3.88 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -133.41 175.97 8.94 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 113.873 -1.512 . . . . 0.0 112.928 -172.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -46.47 112.78 0.54 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.471 1.909 . . . . 0.0 111.613 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.15 -38.71 3.09 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-N 113.259 -1.791 . . . . 0.0 114.157 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.5 p -48.84 110.22 0.33 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -172.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.459 HG22 HG22 ' A' ' 7' ' ' THR . 17.9 t -70.38 123.59 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-N 111.083 -2.78 . . . . 0.0 108.067 175.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 m -127.98 101.19 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 113.708 -1.587 . . . . 0.0 112.638 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.6 m -77.81 90.04 4.05 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.118 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 73.0 mt -78.84 96.88 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 113.006 -1.907 . . . . 0.0 107.725 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.0 m -119.88 136.83 54.35 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 113.136 -1.847 . . . . 0.0 111.991 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.78 142.59 25.66 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.636 1.21 . . . . 0.0 113.305 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -123.37 126.84 47.57 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.656 1.222 . . . . 0.0 110.431 170.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.44 -165.68 36.83 Favored Glycine 0 N--CA 1.484 1.869 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.094 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -63.94 -55.44 22.55 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -92.42 17.91 9.24 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 8.0 pt-20 -45.0 -58.96 2.83 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -173.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.497 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -60.98 -48.9 79.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.923 1.289 . . . . 0.0 114.285 179.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -64.4 -46.28 83.99 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.786 0.834 . . . . 0.0 112.256 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.65 -52.38 65.67 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.247 1.019 . . . . 0.0 112.688 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.8 t -63.58 -47.1 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 117.586 -1.197 . . . . 0.0 111.306 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -50.33 -59.32 4.09 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.226 1.01 . . . . 0.0 111.656 175.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -53.94 -49.55 68.45 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.323 1.049 . . . . 0.0 113.438 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.5 mt -62.9 -39.66 95.2 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.7 t -58.17 -44.06 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.75 0.82 . . . . 0.0 111.084 174.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -60.26 -53.73 54.25 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.852 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.7 tp -51.6 -49.72 61.6 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.162 0.985 . . . . 0.0 113.277 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.8 ttt -62.66 -36.6 83.41 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.984 0.914 . . . . 0.0 113.188 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.17 -35.32 56.03 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -86.27 1.99 48.85 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.8 mt -77.45 151.05 34.89 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.653 1.181 . . . . 0.0 114.055 170.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.557 1.239 0 C-N-CA 127.995 2.518 . . . . 0.0 113.157 -173.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ttp . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -121.41 132.06 54.53 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 125.259 1.6 . . . . 0.0 112.026 173.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.464 ' HG3' ' OG ' ' A' ' 64' ' ' SER . 0.5 OUTLIER -132.93 146.93 52.23 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.6 174.075 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -119.22 150.9 39.31 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 124.384 1.053 . . . . 0.0 110.871 169.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -117.28 98.69 6.56 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 123.309 1.528 . . . . 0.0 110.823 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.24 149.55 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 113.902 -1.499 . . . . 0.0 112.219 -169.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.502 HG22 HG22 ' A' ' 60' ' ' VAL . 2.6 p -100.87 143.44 31.02 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.269 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.5 mp -81.16 115.97 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 165.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.2 p -99.85 -36.09 9.54 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 112.594 -2.094 . . . . 0.0 112.497 -174.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.482 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -53.99 142.15 46.73 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.978 0.911 . . . . 0.0 112.462 170.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 50.2 Cg_exo -58.48 -44.27 38.89 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.996 3.131 . . . . 0.0 115.332 -172.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . 0.257 11.1 p30 -105.21 -29.92 10.02 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 176.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.71 -127.24 7.86 Favored Glycine 0 CA--C 1.538 1.5 0 O-C-N 124.287 0.992 . . . . 0.0 114.263 169.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.87 -30.45 12.03 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.669 HG22 ' HB3' ' A' ' 51' ' ' GLN . 0.2 OUTLIER -113.57 -48.3 2.94 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 118.592 -2.568 . . . . 0.0 113.626 174.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.341 97.0 mtt180 -83.36 -43.46 0.84 Allowed Pre-proline 0 N--CA 1.479 1.014 0 N-CA-C 118.049 2.611 . . . . 0.0 118.049 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -62.0 -37.21 66.52 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 CA-C-N 123.233 2.19 . . . . 0.0 110.884 170.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.65 -30.52 21.93 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 164.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.38 -40.62 97.07 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 119.474 1.034 . . . . 0.0 112.327 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.83 -35.54 80.28 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 118.436 -0.792 . . . . 0.0 112.973 171.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -62.17 -48.03 81.87 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 117.94 0.336 . . . . 0.0 111.032 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.1 t -50.61 -50.72 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.933 0.873 . . . . 0.0 111.411 173.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.42 -44.21 95.98 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.54 -1.209 . . . . 0.0 113.121 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.463 ' HG2' HD22 ' A' ' 80' ' ' LEU . 12.9 tp10 -63.36 -40.29 96.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.355 1.462 . . . . 0.0 113.67 175.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.42 99.13 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.101 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.585 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . 79.6 mttt -56.99 -30.15 63.9 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.6 -25.73 36.39 Favored Glycine 0 CA--C 1.543 1.818 0 O-C-N 125.343 1.652 . . . . 0.0 114.849 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -97.63 146.68 25.07 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.093 0.957 . . . . 0.0 112.928 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -58.61 -50.35 74.16 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.758 1.623 . . . . 0.0 112.387 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.1 p -53.15 147.61 9.54 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 125.043 1.465 . . . . 0.0 113.975 170.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -103.06 87.67 2.97 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 122.706 1.241 . . . . 0.0 109.422 170.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.499 ' CD1' ' HB2' ' A' ' 65' ' ' ALA . 6.3 mm -48.57 112.34 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 112.131 -2.304 . . . . 0.0 111.556 172.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.5 p -101.18 143.5 31.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.458 171.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.5 t -127.75 111.77 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.2 m -109.98 126.97 54.49 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.538 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -123.89 136.77 54.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.643 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.6 p30 51.08 22.83 1.35 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 128.739 2.816 . . . . 0.0 117.067 -178.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.54 -28.4 14.39 Favored Glycine 0 CA--C 1.544 1.894 0 CA-C-N 115.238 -0.892 . . . . 0.0 114.367 -171.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -81.09 135.47 35.81 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.447 0.624 . . . . 0.0 111.345 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.0 t -113.55 120.26 40.35 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.847 -170.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -126.19 129.2 48.53 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.702 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.5 t -76.15 131.77 39.59 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.898 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.15 -40.95 82.24 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 125.149 1.531 . . . . 0.0 112.559 174.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.585 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 72.8 mttt -57.76 -18.42 21.42 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 171.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 t -107.39 114.43 28.44 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.618 1.199 . . . . 0.0 110.045 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.3 tp -62.03 -59.21 5.42 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.94 -1.936 . . . . 0.0 115.555 -165.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -69.68 -31.1 68.95 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -57.03 -61.4 2.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.016 0.926 . . . . 0.0 109.919 171.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.0 tp -57.39 -44.66 84.67 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.669 ' HB3' HG22 ' A' ' 16' ' ' THR . 75.3 mt-30 -61.9 -42.84 99.56 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 t -67.45 -12.67 60.83 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.402 HD22 ' HB3' ' A' ' 42' ' ' ALA . 11.4 tp -69.87 -52.51 24.21 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -173.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.03 72.88 0.88 Allowed Glycine 0 N--CA 1.471 0.985 0 O-C-N 124.256 0.973 . . . . 0.0 112.383 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.1 mt -86.55 73.66 10.04 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 123.62 1.676 . . . . 0.0 111.007 175.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.4 t -127.8 172.25 11.01 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 111.802 -2.454 . . . . 0.0 111.517 -172.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -40.26 143.4 0.3 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.521 1.929 . . . . 0.0 112.236 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.37 -33.76 2.02 Favored Glycine 0 N--CA 1.481 1.644 0 CA-C-O 118.362 -1.243 . . . . 0.0 114.875 -175.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.0 p -61.97 115.68 4.27 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.064 1.432 . . . . 0.0 114.492 -174.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 7' ' ' THR . 25.7 t -88.81 100.94 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 110.721 -2.945 . . . . 0.0 106.184 173.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.0 m -102.78 123.8 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 112.902 -1.954 . . . . 0.0 111.611 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 p -84.5 109.76 18.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 112.306 -2.224 . . . . 0.0 111.391 171.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.8 mt -104.55 110.38 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.079 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.464 ' OG ' ' HG3' ' A' ' 3' ' ' GLN . 4.4 m -117.57 126.44 52.55 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 113.741 -1.572 . . . . 0.0 115.098 -168.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.499 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . . . -126.18 137.84 53.6 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.293 -1.321 . . . . 0.0 112.921 176.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -139.1 113.98 9.31 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.446 -1.706 . . . . 0.0 108.996 166.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.75 -155.59 16.74 Favored Glycine 0 N--CA 1.479 1.545 0 C-N-CA 126.07 1.795 . . . . 0.0 109.439 -175.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -77.78 -35.33 51.68 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 122.218 1.009 . . . . 0.0 111.569 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -105.02 26.94 8.66 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.848 1.659 . . . . 0.0 115.154 -177.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -44.61 -43.15 7.97 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.464 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -73.36 -46.43 49.2 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 174.241 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.426 ' HE2' ' OE1' ' A' ' 71' ' ' GLN . 39.0 mtmt -72.76 -32.04 65.34 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.119 1.368 . . . . 0.0 113.271 -173.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.96 -53.37 58.75 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.027 1.331 . . . . 0.0 111.269 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 t -65.66 -52.44 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.135 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -47.03 -57.2 5.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.021 1.328 . . . . 0.0 112.478 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -60.29 -60.32 4.0 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mt -58.23 -36.0 72.53 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.83 -42.77 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.568 0.747 . . . . 0.0 111.572 171.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -63.82 -34.52 78.1 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.463 HD22 ' HG2' ' A' ' 25' ' ' GLU . 4.5 tp -58.37 -52.54 65.16 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.447 1.099 . . . . 0.0 112.157 164.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 48.2 ttm -48.86 -51.43 29.74 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.867 0.867 . . . . 0.0 112.581 173.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.5 -50.5 73.67 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -84.77 15.08 4.11 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -174.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.85 -150.03 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.299 1.039 . . . . 0.0 111.594 169.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.589 -0.719 . . . . 0.0 110.9 -170.543 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -127.98 141.15 51.61 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.398 1.479 . . . . 0.0 109.879 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.48 128.36 11.75 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.053 0.541 . . . . 0.0 111.863 -172.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -125.13 119.46 28.64 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -83.08 115.68 21.98 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 113.18 -1.827 . . . . 0.0 111.086 164.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.1 164.31 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 113.249 -1.796 . . . . 0.0 113.076 176.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.9 p -121.31 126.04 48.53 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -172.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.42 HD12 ' OG1' ' A' ' 59' ' ' THR . 47.5 mt -80.26 111.9 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.411 170.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 p -107.07 -8.77 16.4 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 113.218 -1.81 . . . . 0.0 115.555 173.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.27 137.03 68.45 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.965 0.906 . . . . 0.0 112.535 177.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -45.78 -46.17 15.76 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 124.843 3.695 . . . . 0.0 115.943 -170.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.22 -34.32 5.96 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 175.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.32 -135.56 12.54 Favored Glycine 0 N--CA 1.482 1.74 0 O-C-N 123.761 0.663 . . . . 0.0 111.627 169.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 7.7 mp -103.64 -26.59 12.73 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -176.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.5 p -110.34 -51.9 2.83 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 117.762 -3.086 . . . . 0.0 114.156 173.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 63.4 mtt-85 -75.27 -45.18 4.59 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-O 115.706 -2.093 . . . . 0.0 115.599 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -63.34 -28.46 71.97 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 CA-C-N 122.565 1.952 . . . . 0.0 112.569 168.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.501 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -61.2 -22.24 64.57 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 169.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.4 -36.36 63.48 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -55.9 -47.27 77.75 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 170.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -55.62 -43.61 76.27 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.347 -1.297 . . . . 0.0 112.899 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.604 HG12 ' HE2' ' A' ' 27' ' ' LYS . 19.5 t -59.23 -52.55 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.752 0.821 . . . . 0.0 111.214 176.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.22 -56.44 11.09 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.584 1.154 . . . . 0.0 113.028 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.505 ' HG2' HD11 ' A' ' 80' ' ' LEU . 10.0 tp10 -58.8 -45.2 90.43 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 124.779 1.3 . . . . 0.0 112.395 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.59 80.18 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.604 ' HE2' HG12 ' A' ' 23' ' ' VAL . 63.1 mttm -50.25 -38.42 40.69 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 175.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.94 3.78 55.87 Favored Glycine 0 CA--C 1.54 1.605 0 O-C-N 124.769 1.293 . . . . 0.0 116.298 -173.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -100.75 158.3 16.06 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.305 1.042 . . . . 0.0 112.869 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.3 p -68.57 -52.32 33.1 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 118.639 -0.696 . . . . 0.0 109.482 168.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.0 p -59.05 136.52 57.97 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.875 1.27 . . . . 0.0 112.947 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -95.27 92.15 6.61 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.362 173.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.606 HD13 ' HB2' ' A' ' 65' ' ' ALA . 29.7 mm -57.55 115.68 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 112.132 -2.304 . . . . 0.0 110.211 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.5 p -105.54 117.29 33.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.702 173.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.6 t -103.89 117.71 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.717 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.448 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 35.0 m -107.8 129.7 55.03 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 112.553 -2.112 . . . . 0.0 112.042 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.1 t -136.25 137.68 41.03 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 111.979 -2.373 . . . . 0.0 107.727 171.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.8 p30 40.02 44.54 1.47 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.36 -40.65 3.08 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 124.185 0.898 . . . . 0.0 114.388 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -57.84 123.93 17.46 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.872 1.269 . . . . 0.0 112.645 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -109.74 101.44 10.33 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.489 -176.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.71 134.65 47.52 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.622 1.201 . . . . 0.0 112.846 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.0 t -73.21 112.19 9.03 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 112.485 -2.143 . . . . 0.0 112.143 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.55 -14.58 63.11 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 112.717 -2.038 . . . . 0.0 114.232 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -72.27 -22.28 61.24 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.2 t -109.91 122.43 47.53 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.843 0.83 . . . . 0.0 111.744 -176.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.445 ' HA ' HG21 ' A' ' 23' ' ' VAL . 6.3 tp -55.54 -59.4 4.89 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.588 -2.096 . . . . 0.0 114.615 -169.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -64.79 -33.38 75.86 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -61.97 -51.72 66.91 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 123.805 0.69 . . . . 0.0 112.382 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.5 tp -61.96 -38.74 89.67 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -64.9 -39.28 93.29 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -72.96 -28.68 62.55 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 172.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.3 tp -45.19 -60.95 1.85 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.61 93.46 2.02 Favored Glycine 0 CA--C 1.539 1.57 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 71.5 mt -120.06 87.04 2.67 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 113.337 -1.432 . . . . 0.0 107.906 178.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 t -135.38 -174.87 3.75 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.337 -1.302 . . . . 0.0 111.351 -173.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -61.05 118.48 6.82 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.288 0.566 . . . . 0.0 109.993 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.78 -7.81 65.44 Favored Glycine 0 N--CA 1.478 1.435 0 CA-C-N 114.368 -1.287 . . . . 0.0 115.665 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.42 ' OG1' HD12 ' A' ' 8' ' ' ILE . 42.3 p -71.44 99.59 2.03 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.351 1.075 . . . . 0.0 111.652 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.2 t -60.44 104.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 111.497 -2.592 . . . . 0.0 107.986 173.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.4 m -106.78 113.4 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.418 -168.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.448 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 6.7 m -100.25 104.97 16.49 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 112.271 -2.24 . . . . 0.0 108.973 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 24.3 mt -98.64 102.25 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.118 -1.855 . . . . 0.0 107.9 -174.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -102.56 140.86 36.28 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 113.642 -1.617 . . . . 0.0 112.31 -176.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.606 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -146.71 142.05 27.43 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.419 1.074 . . . . 0.0 112.904 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -140.12 114.25 9.05 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.12 169.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.99 -152.56 15.13 Favored Glycine 0 N--CA 1.483 1.791 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.581 -175.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -86.32 -57.7 2.91 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 120.742 0.306 . . . . 0.0 110.503 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.55 5.49 3.81 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.783 2.142 . . . . 0.0 116.783 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -41.93 -53.71 3.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.425 ' HG2' ' HG3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -58.91 -49.24 78.56 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.949 1.3 . . . . 0.0 113.477 179.208 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 72.4 mttt -76.62 -34.94 58.32 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.278 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.42 68.5 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.015 0.926 . . . . 0.0 111.959 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.54 -45.51 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-O 118.459 -0.782 . . . . 0.0 111.731 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -52.94 -51.06 62.67 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 123.876 0.735 . . . . 0.0 111.994 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -59.23 -51.82 68.33 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.438 1.495 . . . . 0.0 111.697 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.417 HD13 HG21 ' A' ' 33' ' ' ILE . 30.2 mt -65.93 -29.91 70.41 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.94 -46.19 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 121.329 0.585 . . . . 0.0 109.725 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -71.42 -30.31 65.93 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.432 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.505 HD11 ' HG2' ' A' ' 25' ' ' GLU . 0.6 OUTLIER -59.54 -52.84 63.85 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 124.142 0.901 . . . . 0.0 112.459 166.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.7 tmm? -53.12 -47.47 68.63 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 124.49 1.119 . . . . 0.0 111.892 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.04 -40.35 97.46 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -90.0 -9.98 46.64 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.4 mt -63.9 145.55 55.63 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.888 0.475 . . . . 0.0 110.696 161.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 C--O 1.255 1.358 0 O-C-N 125.671 1.857 . . . . 0.0 111.147 -166.525 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.413 ' HD2' ' HB ' ' A' ' 74' ' ' VAL . 12.6 t80 -118.4 118.91 33.05 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 125.425 1.703 . . . . 0.0 110.567 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.75 122.34 37.18 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.438 -172.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -134.02 140.28 46.58 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.751 0.821 . . . . 0.0 113.073 171.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.6 ' HG2' HG12 ' A' ' 60' ' ' VAL . 39.9 tt0 -112.32 122.87 48.96 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.683 -1.599 . . . . 0.0 110.958 -172.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.409 HG11 HG13 ' A' ' 78' ' ' VAL . 3.2 m -128.63 130.33 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.582 HG23 HG22 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -91.21 128.01 36.86 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 113.684 -1.598 . . . . 0.0 111.518 -177.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.1 mt -87.5 118.14 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.709 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 p -95.51 -26.72 15.7 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 113.516 -1.675 . . . . 0.0 113.748 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.477 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -64.28 127.95 92.66 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 123.486 0.714 . . . . 0.0 111.943 173.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HA ' ' HB2' ' A' ' 57' ' ' GLN . 65.4 Cg_exo -54.62 -51.98 9.19 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.171 3.247 . . . . 0.0 113.725 -170.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -95.81 -46.39 6.59 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.866 1.354 . . . . 0.0 111.031 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.09 -107.86 2.26 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.655 1.121 . . . . 0.0 112.764 166.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 24.0 mt -84.44 -29.78 25.83 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.4 p -118.5 -47.75 2.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 118.181 -2.824 . . . . 0.0 112.963 169.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -74.43 -44.56 5.77 Favored Pre-proline 0 N--CA 1.483 1.188 0 CA-C-O 116.248 -1.834 . . . . 0.0 115.908 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.425 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 82.8 Cg_exo -64.3 -40.61 24.55 Favored 'Trans proline' 0 N--CA 1.486 1.063 0 CA-C-N 121.826 1.688 . . . . 0.0 112.866 170.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -51.16 -37.56 47.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.587 1.155 . . . . 0.0 113.959 172.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.73 75.71 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 175.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -80.73 -28.18 36.66 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 174.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -62.04 -38.91 90.53 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.296 0.639 . . . . 0.0 110.551 168.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 19' ' ' ALA . 46.4 t -60.65 -48.12 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 124.472 1.109 . . . . 0.0 110.978 169.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -51.47 -46.97 63.29 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 118.895 -0.574 . . . . 0.0 111.622 175.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.403 ' HG2' HD22 ' A' ' 80' ' ' LEU . 11.4 tp10 -61.58 -56.28 21.64 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 125.13 1.519 . . . . 0.0 111.567 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.82 -40.71 63.55 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.435 ' HE2' HG12 ' A' ' 23' ' ' VAL . 65.1 mttm -57.93 -27.85 63.75 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 176.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.68 -46.38 94.56 Favored Glycine 0 CA--C 1.542 1.772 0 C-N-CA 124.948 1.261 . . . . 0.0 112.892 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -69.12 144.15 53.96 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.991 0.916 . . . . 0.0 112.459 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.3 p -67.72 -45.77 74.11 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.285 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.7 p -63.12 167.0 5.34 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.683 1.593 . . . . 0.0 113.206 171.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -114.03 111.57 21.86 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 122.365 1.078 . . . . 0.0 110.903 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.739 HD13 ' HB2' ' A' ' 65' ' ' ALA . 39.5 mm -69.47 103.77 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 112.567 -2.106 . . . . 0.0 110.773 175.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.9 p -88.3 118.2 27.75 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.315 167.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -105.39 92.45 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 113.545 -1.661 . . . . 0.0 106.876 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 12.0 m -81.59 124.94 29.95 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 112.12 -2.309 . . . . 0.0 110.961 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -128.65 106.64 9.09 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.662 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 p30 35.43 83.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 112.557 -2.111 . . . . 0.0 116.533 -176.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.52 -52.68 4.59 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-N 113.037 -1.892 . . . . 0.0 112.903 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -69.21 117.68 11.15 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.305 1.042 . . . . 0.0 111.509 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 1.7 t -111.29 108.94 18.73 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.81 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.49 118.6 37.05 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.478 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.4 t -57.11 111.88 1.19 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.185 -1.371 . . . . 0.0 111.153 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.22 -24.34 67.18 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.876 172.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -70.46 -26.87 63.84 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.236 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -95.29 102.6 14.42 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 123.063 1.411 . . . . 0.0 112.006 172.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.406 ' HA ' HG21 ' A' ' 23' ' ' VAL . 16.9 tp -39.43 -59.86 1.02 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.093 2.157 . . . . 0.0 115.704 -175.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -66.32 -33.15 75.08 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -67.07 -44.52 79.88 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.43 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.1 tp -66.93 -45.47 77.78 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 124.444 1.09 . . . . 0.0 112.02 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -57.49 -30.55 65.19 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 t -94.07 -0.0 55.65 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.5 -41.8 96.22 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.23 86.65 1.86 Allowed Glycine 0 CA--C 1.537 1.417 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -172.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.549 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 10.6 mt -115.29 77.22 1.06 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.192 0.996 . . . . 0.0 109.73 -172.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.9 t -132.05 168.29 18.2 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 113.328 -1.76 . . . . 0.0 112.468 -163.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.595 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 40.7 tt0 -57.54 106.71 0.36 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.031 0.932 . . . . 0.0 111.468 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.62 -38.21 2.61 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 113.311 -1.768 . . . . 0.0 114.526 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.8 p -64.55 122.85 17.78 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 118.165 0.982 . . . . 0.0 112.88 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.6 HG12 ' HG2' ' A' ' 5' ' ' GLU . 1.1 t -97.86 111.22 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 113.073 -1.876 . . . . 0.0 106.792 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.7 m -105.52 117.07 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 112.701 -2.045 . . . . 0.0 113.778 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.3 93.66 9.14 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 112.466 -2.152 . . . . 0.0 111.88 -175.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.457 HG22 HG22 ' A' ' 74' ' ' VAL . 81.2 mt -80.15 102.81 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 113.845 -1.525 . . . . 0.0 107.724 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.2 m -121.31 134.08 55.14 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 112.62 -2.082 . . . . 0.0 112.978 -175.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.739 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -145.84 152.31 39.29 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 124.822 1.326 . . . . 0.0 112.767 177.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -137.28 133.27 34.82 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.971 172.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.44 -159.73 24.9 Favored Glycine 0 N--CA 1.484 1.894 0 O-C-N 124.169 0.918 . . . . 0.0 113.519 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -50.26 -47.47 55.17 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -108.79 31.23 5.81 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 177.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -51.26 -52.29 46.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -71.8 -42.21 67.33 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 112.765 -2.016 . . . . 0.0 113.151 178.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -66.62 -47.36 72.88 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.593 1.157 . . . . 0.0 111.987 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.576 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -60.33 -47.36 86.37 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.366 1.066 . . . . 0.0 113.429 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.457 HG22 HG22 ' A' ' 63' ' ' ILE . 95.4 t -68.94 -45.81 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 117.537 -1.221 . . . . 0.0 111.261 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -52.08 -49.76 62.91 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.981 0.913 . . . . 0.0 111.019 175.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -62.69 -58.1 8.65 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.107 1.363 . . . . 0.0 113.442 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.3 mt -64.74 -29.78 70.77 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.409 HG13 HG11 ' A' ' 6' ' ' VAL . 28.5 t -63.24 -54.79 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 124.036 0.835 . . . . 0.0 110.686 168.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt -56.34 -47.05 79.6 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.736 0.814 . . . . 0.0 112.969 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.403 HD22 ' HG2' ' A' ' 25' ' ' GLU . 37.7 tp -52.51 -56.08 17.65 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.435 1.094 . . . . 0.0 111.607 175.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.415 ' HG2' HD11 ' A' ' 14' ' ' LEU . 6.5 tmm? -53.99 -43.72 70.23 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.085 0.954 . . . . 0.0 112.021 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.6 -35.56 80.5 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -177.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.99 -21.04 34.05 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 57.7 mt -62.59 158.81 17.25 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 . . . . . 0 N--CA 1.487 1.391 0 C-N-CA 125.768 1.627 . . . . 0.0 112.696 167.325 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.465 ' HG2' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -132.87 139.55 47.48 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 125.337 1.648 . . . . 0.0 108.907 165.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -137.58 128.46 27.23 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.227 -177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -125.05 108.04 11.42 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.976 168.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -87.3 97.25 10.68 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 112.587 -2.097 . . . . 0.0 109.123 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 m -120.34 117.49 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 112.243 -2.253 . . . . 0.0 112.91 -173.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 p -71.77 126.77 30.57 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.728 -1.123 . . . . 0.0 111.665 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.9 mt -71.2 126.54 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 114.876 -1.057 . . . . 0.0 108.756 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -98.94 -37.53 9.36 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 113.957 -1.474 . . . . 0.0 114.336 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.68 123.86 24.94 Favored Pre-proline 0 N--CA 1.482 1.147 0 O-C-N 123.863 0.727 . . . . 0.0 111.485 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.609 ' HA ' ' HB2' ' A' ' 57' ' ' GLN . 96.8 Cg_exo -51.3 -42.43 54.39 Favored 'Trans proline' 0 N--CA 1.482 0.851 0 C-N-CA 123.973 3.116 . . . . 0.0 112.03 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -71.91 -56.07 6.36 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.922 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.7 -127.28 9.09 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.932 1.253 . . . . 0.0 110.522 171.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 21.2 mt -112.17 -13.13 13.56 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 113.931 -1.135 . . . . 0.0 113.241 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.3 p -103.69 -55.73 2.33 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 117.519 -3.238 . . . . 0.0 114.05 171.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.4 mmt-85 -64.22 -48.39 76.65 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-O 116.03 -1.938 . . . . 0.0 114.593 -174.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -65.41 -41.7 14.96 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.415 2.077 . . . . 0.0 112.912 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.73 -38.22 60.47 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.41 -41.68 94.4 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.919 0.887 . . . . 0.0 113.013 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -67.5 -44.44 78.48 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.344 1.058 . . . . 0.0 111.631 175.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -58.36 -45.76 87.61 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.256 1.423 . . . . 0.0 111.447 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.754 HG11 ' HA ' ' A' ' 47' ' ' LEU . 51.9 t -53.88 -46.7 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 124.296 1.038 . . . . 0.0 111.672 173.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -57.05 -44.99 83.55 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 118.98 -0.534 . . . . 0.0 111.876 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -62.36 -47.79 82.65 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.501 1.126 . . . . 0.0 112.627 174.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.24 -39.52 83.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.68 1.192 . . . . 0.0 114.174 175.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -60.03 -26.24 65.95 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 172.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.86 -20.93 64.9 Favored Glycine 0 CA--C 1.546 1.977 0 O-C-N 124.535 1.147 . . . . 0.0 114.187 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -99.95 145.84 27.37 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.592 1.187 . . . . 0.0 113.307 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.1 p -73.14 -37.04 66.75 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.334 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.6 p -63.38 160.55 15.86 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 124.599 1.187 . . . . 0.0 112.121 168.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -107.05 110.57 22.73 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.655 HD13 ' HB2' ' A' ' 65' ' ' ALA . 46.2 mm -72.43 92.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.024 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.2 107.44 14.0 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 110.845 -2.889 . . . . 0.0 107.886 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.96 101.85 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.269 -176.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.579 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 9.5 m -96.74 118.69 33.75 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 113.523 -1.671 . . . . 0.0 112.043 -177.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.9 t -130.53 114.37 15.4 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.325 171.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 p30 43.26 70.13 0.33 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 125.372 1.469 . . . . 0.0 114.17 -172.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.91 -35.5 1.24 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-N 113.389 -1.732 . . . . 0.0 115.241 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -74.34 108.58 7.21 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.163 0.985 . . . . 0.0 111.415 -174.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.5 m -98.96 100.62 11.82 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.871 176.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -105.91 115.31 30.01 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.837 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.3 t -64.56 119.06 9.75 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.889 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -23.13 65.96 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.433 -1.712 . . . . 0.0 113.525 171.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -70.78 -24.07 62.52 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.137 177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.9 t -103.07 123.43 46.63 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.217 0.532 . . . . 0.0 111.393 167.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.754 ' HA ' HG11 ' A' ' 23' ' ' VAL . 32.4 tp -42.91 -61.32 1.31 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 111.041 -2.8 . . . . 0.0 114.919 -171.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -82.75 -6.96 59.66 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -74.01 -58.31 3.39 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.8 tp -54.11 -39.51 66.48 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -67.24 -2.88 6.52 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.2 t -133.1 59.37 1.74 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 124.578 2.132 . . . . 0.0 112.538 166.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.518 HD23 HD21 ' A' ' 55' ' ' LEU . 40.2 tp -110.3 -50.71 2.94 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 113.08 -1.873 . . . . 0.0 113.095 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.72 90.12 1.93 Allowed Glycine 0 CA--C 1.531 1.087 0 N-CA-C 107.804 -2.119 . . . . 0.0 107.804 -169.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.518 HD21 HD23 ' A' ' 53' ' ' LEU . 59.4 mt -122.88 90.25 3.26 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.054 -1.073 . . . . 0.0 109.44 -171.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.4 t -162.94 157.81 21.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 126.385 2.303 . . . . 0.0 109.346 -164.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.609 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 32.6 tt0 -40.05 132.04 1.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -175.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.19 -20.58 32.65 Favored Glycine 0 N--CA 1.479 1.553 0 CA-C-N 113.003 -1.908 . . . . 0.0 114.518 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.3 p -60.98 108.06 0.81 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 122.925 1.345 . . . . 0.0 112.992 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.3 94.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 110.779 -2.919 . . . . 0.0 106.919 -175.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.5 m -92.25 98.0 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 113.648 -1.614 . . . . 0.0 112.691 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.579 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 4.8 m -73.66 88.03 1.69 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 111.834 -2.439 . . . . 0.0 108.778 175.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.445 HG23 HG23 ' A' ' 33' ' ' ILE . 85.9 mt -82.22 108.28 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.158 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.3 m -120.0 136.74 54.44 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 113.404 -1.725 . . . . 0.0 113.427 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.655 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -144.83 130.81 19.3 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.042 172.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.465 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 25.2 tt0 -123.19 118.65 28.12 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.682 -1.145 . . . . 0.0 107.984 163.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 170.14 -173.44 44.17 Favored Glycine 0 N--CA 1.478 1.486 0 CA-C-N 113.93 -1.486 . . . . 0.0 112.697 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.418 ' HG2' ' H ' ' A' ' 68' ' ' GLU . 4.5 mm-40 -47.41 -45.95 25.91 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 125.015 1.326 . . . . 0.0 113.667 -178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -114.22 34.78 4.49 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.592 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 8.5 pt-20 -46.05 -72.85 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 116.957 2.206 . . . . 0.0 116.957 -175.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.592 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -52.22 -43.33 64.21 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 177.076 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -62.77 -45.82 90.9 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.319 -1.31 . . . . 0.0 112.864 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -57.1 -52.44 65.27 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.481 1.113 . . . . 0.0 112.802 174.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.6 t -64.75 -46.36 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.952 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -55.07 -52.25 63.8 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -60.78 -48.42 81.9 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.888 0.875 . . . . 0.0 113.076 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.4 mt -63.03 -37.79 88.6 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.82 -45.27 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.316 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -55.15 -54.35 44.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 123.617 0.573 . . . . 0.0 111.052 173.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -49.36 -54.86 15.12 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 125.636 1.575 . . . . 0.0 111.846 175.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -58.12 -40.62 81.71 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.466 1.106 . . . . 0.0 113.07 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.79 -44.06 64.6 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 175.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -70.56 -3.27 17.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.518 1.527 . . . . 0.0 114.293 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.9 mt -90.15 101.8 14.51 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.856 1.262 . . . . 0.0 110.761 169.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 C--O 1.254 1.291 0 O-C-N 124.985 1.428 . . . . 0.0 112.388 -178.087 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ttt . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.498 ' HB3' HG21 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -77.77 141.84 39.02 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.282 -1.326 . . . . 0.0 113.091 173.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -148.55 127.82 12.98 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.427 -1.715 . . . . 0.0 110.031 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -126.77 117.7 23.2 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.012 0.82 . . . . 0.0 112.597 164.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -84.06 97.81 9.52 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 125.643 1.84 . . . . 0.0 108.623 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.795 HG23 HG23 ' A' ' 61' ' ' VAL . 2.7 m -125.93 141.48 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 113.592 -1.64 . . . . 0.0 112.491 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.4 p -107.77 137.87 45.02 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.3 mt -76.75 122.85 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.487 175.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.2 p -91.49 -43.47 9.67 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.107 -1.406 . . . . 0.0 114.114 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -28.77 133.44 0.19 Allowed Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 126.978 2.111 . . . . 0.0 115.121 175.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 54.5 Cg_exo -54.53 -54.19 4.98 Favored 'Trans proline' 0 N--CA 1.482 0.841 0 C-N-CA 124.296 3.331 . . . . 0.0 112.49 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.415 ' H ' ' ND2' ' A' ' 12' ' ' ASN . 3.8 p30 -78.15 -43.59 28.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.166 0.986 . . . . 0.0 112.559 176.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 56' ' ' THR . . . 101.12 -152.91 19.02 Favored Glycine 0 N--CA 1.475 1.239 0 C-N-CA 125.464 1.507 . . . . 0.0 110.508 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.8 mt -87.57 -26.98 22.85 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 172.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.2 p -109.69 -43.05 4.13 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 117.679 -3.138 . . . . 0.0 115.631 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.421 ' HD3' ' HA ' ' A' ' 17' ' ' ARG 0.279 83.0 mmt-85 -85.32 -44.06 0.65 Allowed Pre-proline 0 N--CA 1.483 1.205 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 -176.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -62.74 -37.35 56.89 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 121.528 1.486 . . . . 0.0 111.703 164.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.27 -40.95 71.6 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.96 -36.97 75.72 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 173.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -66.66 -49.77 65.08 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.822 0.701 . . . . 0.0 111.418 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -54.99 -43.48 73.6 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 124.045 0.841 . . . . 0.0 111.45 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 44' ' ' ALA . 40.1 t -53.18 -61.83 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.657 1.183 . . . . 0.0 111.324 171.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -49.23 -46.37 45.8 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 124.176 0.922 . . . . 0.0 111.822 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.32 -55.62 17.22 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.678 1.236 . . . . 0.0 112.906 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.56 -30.17 70.49 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -55.51 -30.82 61.36 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 170.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.99 -5.9 66.47 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.12 1.343 . . . . 0.0 114.896 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -95.89 142.48 28.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.153 0.581 . . . . 0.0 111.737 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.7 p -63.87 -39.01 93.2 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.174 0.99 . . . . 0.0 111.51 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 p -62.04 141.43 58.09 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.372 -1.285 . . . . 0.0 112.71 168.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -94.26 108.56 20.43 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 123.311 1.529 . . . . 0.0 110.117 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.486 HD11 ' HB1' ' A' ' 73' ' ' ALA . 37.4 mm -73.79 106.91 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 111.228 -2.715 . . . . 0.0 109.87 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.4 p -108.8 110.41 21.78 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 122.806 1.288 . . . . 0.0 112.063 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.523 HG13 ' HA ' ' A' ' 61' ' ' VAL . 30.0 t -81.87 106.27 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 112.379 -2.192 . . . . 0.0 109.057 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.455 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 19.5 m -85.72 105.67 16.42 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 122.354 1.073 . . . . 0.0 110.016 172.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.8 t -118.75 109.42 16.06 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 113.338 -1.756 . . . . 0.0 110.458 171.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 p30 43.94 71.25 0.26 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.72 9.25 37.85 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-N 112.99 -1.914 . . . . 0.0 116.349 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.415 ' HE3' HD12 ' A' ' 53' ' ' LEU . 40.5 mtmt -118.82 99.25 6.64 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 122.328 -0.513 . . . . 0.0 110.841 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.4 m -79.97 98.76 7.31 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.651 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.88 124.53 49.11 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 113.366 -1.743 . . . . 0.0 112.709 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.6 t -70.37 132.17 45.22 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 113.164 -1.835 . . . . 0.0 113.297 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.479 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -74.77 -25.37 59.03 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 113.924 -1.489 . . . . 0.0 114.054 167.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -73.69 -27.27 61.13 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.8 t -96.16 92.65 6.51 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.347 1.07 . . . . 0.0 109.177 171.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.2 tp -37.78 -55.01 1.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 126.98 2.112 . . . . 0.0 114.529 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.482 ' O ' HG22 ' A' ' 52' ' ' THR . 80.3 m-85 -65.69 -33.48 75.99 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -59.98 -49.48 77.52 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tp -63.84 -39.63 94.68 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -65.69 -37.49 86.62 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 48' ' ' PHE . 12.4 t -99.84 78.69 2.14 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 125.046 2.355 . . . . 0.0 111.91 175.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.415 HD12 ' HE3' ' A' ' 40' ' ' LYS . 37.2 tp -149.58 -51.0 0.15 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 111.361 -2.654 . . . . 0.0 112.473 -173.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.427 ' O ' HG21 ' A' ' 59' ' ' THR . . . 96.5 65.26 0.93 Allowed Glycine 0 N--CA 1.472 1.06 0 O-C-N 125.467 1.73 . . . . 0.0 110.387 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 78.7 mt -85.14 91.63 8.17 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.441 0.638 . . . . 0.0 110.258 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.528 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 6.4 t -135.91 -163.43 1.4 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.373 -171.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -63.8 118.83 8.9 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.825 0.85 . . . . 0.0 111.145 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.11 -10.05 76.04 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-N 113.6 -1.636 . . . . 0.0 115.371 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.427 HG21 ' O ' ' A' ' 54' ' ' GLY . 67.2 p -75.81 142.5 42.25 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 117.656 0.728 . . . . 0.0 112.383 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.28 137.21 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 113.022 -1.899 . . . . 0.0 109.307 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.795 HG23 HG23 ' A' ' 6' ' ' VAL . 3.2 m -110.54 78.85 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-N 112.473 -2.149 . . . . 0.0 107.398 165.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.455 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 3.0 m -74.95 86.29 2.28 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 173.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.478 HG23 HG23 ' A' ' 33' ' ' ILE . 57.1 mt -74.72 87.65 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.246 -173.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 75.0 m -88.67 125.55 34.89 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 112.806 -1.997 . . . . 0.0 110.272 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.55 136.15 20.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.281 -1.327 . . . . 0.0 113.489 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -130.91 128.66 40.97 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.334 1.022 . . . . 0.0 110.067 172.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.39 -176.93 30.44 Favored Glycine 0 N--CA 1.492 2.428 0 O-C-N 124.193 0.933 . . . . 0.0 115.142 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -53.85 -33.79 57.38 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -111.61 19.18 18.35 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -46.8 -51.93 15.31 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.474 ' NE2' ' H ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -62.54 -42.58 99.62 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 177.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -69.09 -46.13 68.55 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.477 -177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.486 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -53.67 -53.98 44.36 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.313 1.445 . . . . 0.0 113.133 174.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.498 HG21 ' HB3' ' A' ' 2' ' ' PHE . 79.8 t -59.09 -52.75 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.36 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.34 -47.54 81.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.737 0.815 . . . . 0.0 113.14 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -57.48 -55.46 34.58 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.84 1.256 . . . . 0.0 111.423 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.9 mt -66.44 -30.17 70.47 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.7 t -65.58 -48.56 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 123.373 0.42 . . . . 0.0 110.059 170.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -63.62 -44.8 92.88 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 117.94 -1.029 . . . . 0.0 113.294 175.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.7 tp -51.51 -51.52 54.52 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.359 1.063 . . . . 0.0 111.313 172.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -57.75 -42.57 84.24 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.051 0.94 . . . . 0.0 112.994 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.28 -43.87 66.33 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -82.98 35.68 0.48 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.845 1.658 . . . . 0.0 112.932 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 mt -127.03 117.06 21.72 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.572 1.549 . . . . 0.0 112.704 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 . . . . . 0 C--O 1.259 1.572 0 C-N-CA 126.073 1.749 . . . . 0.0 108.473 -177.354 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttt . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -110.48 136.89 48.92 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 125.958 2.036 . . . . 0.0 109.883 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -120.02 143.72 47.92 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 113.336 -1.756 . . . . 0.0 109.171 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -141.95 102.07 4.07 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.525 1.141 . . . . 0.0 109.674 171.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -81.87 102.13 10.66 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 111.938 -2.392 . . . . 0.0 108.682 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.48 HG23 HG23 ' A' ' 61' ' ' VAL . 5.2 m -125.02 158.2 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 112.507 -2.133 . . . . 0.0 111.76 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.484 HG22 HG22 ' A' ' 60' ' ' VAL . 81.5 p -109.68 137.46 47.46 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.805 0.812 . . . . 0.0 111.696 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.2 mt -91.53 93.18 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 166.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 p -86.43 -17.05 35.3 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 111.424 -2.625 . . . . 0.0 115.43 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.49 133.97 85.53 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.611 1.165 . . . . 0.0 112.155 175.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -44.55 -51.49 7.04 Favored 'Trans proline' 0 CA--C 1.541 0.836 1 C-N-CA 125.318 4.012 . . . . 0.0 116.563 -170.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -106.13 -27.64 10.97 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 172.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.21 -108.67 2.6 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 124.467 1.032 . . . . 0.0 112.691 170.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . 33.1 mt -112.92 -24.6 9.44 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -175.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.8 p -112.12 -43.19 3.59 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 117.813 -3.054 . . . . 0.0 111.817 167.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.415 ' HB2' ' HD3' ' A' ' 18' ' ' PRO 0.256 88.5 mmt-85 -74.74 -56.45 2.21 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-O 115.721 -2.085 . . . . 0.0 115.011 -175.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 87.0 Cg_exo -59.47 -34.57 97.18 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.778 2.319 . . . . 0.0 113.952 174.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.7 -25.99 2.08 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 172.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.26 98.57 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -65.99 -38.83 89.51 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.977 0.911 . . . . 0.0 112.674 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.41 -42.01 86.23 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.06 0.85 . . . . 0.0 112.134 172.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.686 HG21 ' HA ' ' A' ' 47' ' ' LEU . 73.3 t -64.92 -51.5 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.274 0.63 . . . . 0.0 112.06 170.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -49.87 -43.13 48.98 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.606 1.162 . . . . 0.0 112.608 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -67.58 -51.67 47.64 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 124.019 0.824 . . . . 0.0 111.915 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.49 -32.18 73.56 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HE2' ' O ' ' A' ' 45' ' ' LYS . 25.8 mmtt -44.65 -39.39 5.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.896 1.278 . . . . 0.0 114.431 167.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.35 -32.22 75.39 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 125.15 1.531 . . . . 0.0 114.898 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -74.82 133.46 41.91 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.0 p -65.89 -46.87 76.78 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.972 -173.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.2 p -66.53 137.75 57.01 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.817 1.647 . . . . 0.0 111.473 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -83.95 101.57 11.8 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 122.876 1.322 . . . . 0.0 111.758 -178.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' A' ' 44' ' ' ALA . 6.9 mm -70.05 100.41 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.281 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.2 p -94.2 103.93 15.96 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.325 174.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.6 96.29 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 112.776 -2.011 . . . . 0.0 107.514 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.6 m -88.84 104.52 17.0 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 113.473 -1.694 . . . . 0.0 111.322 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.4 t -108.31 99.24 8.67 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.72 172.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 p30 47.57 75.0 0.14 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.853 1.661 . . . . 0.0 114.011 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.05 -39.77 1.18 Allowed Glycine 0 CA--C 1.542 1.771 0 CA-C-N 113.176 -1.829 . . . . 0.0 114.044 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -77.03 106.9 9.01 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 123.606 1.67 . . . . 0.0 110.807 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -108.86 106.38 16.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 112.355 -2.202 . . . . 0.0 110.621 -170.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.464 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -110.47 122.63 48.18 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.93 -175.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.2 t -64.91 119.05 9.96 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 113.468 -1.696 . . . . 0.0 111.676 174.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.523 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . . . -66.66 -11.34 53.48 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.296 -1.774 . . . . 0.0 114.568 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.468 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 95.2 mttt -72.84 -21.12 61.0 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 166.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.5 t -112.55 99.97 8.37 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.38 1.072 . . . . 0.0 112.596 -174.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.686 ' HA ' HG21 ' A' ' 23' ' ' VAL . 19.0 tp -36.77 -54.88 0.9 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 112.99 -1.914 . . . . 0.0 115.131 178.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -63.48 -46.4 86.33 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.495 -1.684 . . . . 0.0 113.659 -172.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.8 tttm -63.03 -44.42 95.96 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.275 0.63 . . . . 0.0 112.282 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.8 tp -66.61 -44.03 83.2 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -60.56 -26.12 66.69 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.3 t -108.41 60.61 0.61 Allowed 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 124.449 2.071 . . . . 0.0 112.415 172.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.564 HD23 HD21 ' A' ' 55' ' ' LEU . 8.9 tp -124.99 -48.38 1.75 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 111.804 -2.453 . . . . 0.0 110.799 175.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.09 67.41 0.81 Allowed Glycine 0 CA--C 1.535 1.329 0 O-C-N 124.833 1.333 . . . . 0.0 110.57 176.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.564 HD21 HD23 ' A' ' 53' ' ' LEU . 57.5 mt -88.01 86.68 7.16 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.084 0.945 . . . . 0.0 110.151 -174.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -133.81 -175.24 3.77 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 112.211 -2.268 . . . . 0.0 113.772 -169.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -59.02 112.96 1.87 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.766 2.426 . . . . 0.0 111.915 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.08 -6.9 56.71 Favored Glycine 0 CA--C 1.547 2.076 0 CA-C-N 112.992 -1.913 . . . . 0.0 114.489 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.0 p -75.66 103.34 5.72 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 7' ' ' THR . 47.7 t -65.38 115.21 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 112.858 -1.974 . . . . 0.0 109.05 170.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.48 HG23 HG23 ' A' ' 6' ' ' VAL . 13.5 m -118.94 106.12 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 112.971 -1.922 . . . . 0.0 111.658 -177.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 42.5 m -83.44 95.18 8.18 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 112.233 -2.258 . . . . 0.0 109.358 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -89.48 91.82 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 112.103 -2.317 . . . . 0.0 108.443 -175.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.0 m -104.58 122.48 45.7 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 111.334 -2.666 . . . . 0.0 112.266 -170.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -137.3 147.96 46.02 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 124.86 1.35 . . . . 0.0 112.627 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -134.37 128.29 33.34 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.692 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.08 -159.78 24.76 Favored Glycine 0 N--CA 1.489 2.181 0 O-C-N 124.491 1.119 . . . . 0.0 114.82 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -49.66 -34.98 19.95 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -119.94 12.76 12.1 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 118.947 2.943 . . . . 0.0 118.947 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -33.02 -54.28 0.38 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.432 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -68.38 -60.22 2.61 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 176.2 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -53.62 -34.46 58.61 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.683 1.593 . . . . 0.0 114.055 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.19 -59.55 3.35 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.825 1.25 . . . . 0.0 112.775 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.87 -51.77 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.928 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -49.27 -51.82 31.31 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.428 1.091 . . . . 0.0 112.71 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -58.83 -55.55 33.69 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.05 0.94 . . . . 0.0 112.416 176.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.4 tp -61.91 -36.88 82.64 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.238 1.415 . . . . 0.0 113.252 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.48 HG11 HG11 ' A' ' 6' ' ' VAL . 86.5 t -73.58 -36.28 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.793 0.837 . . . . 0.0 111.583 175.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -60.12 -37.19 79.27 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 118.2 -0.905 . . . . 0.0 113.17 168.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.3 tp -57.34 -40.68 78.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 123.886 0.741 . . . . 0.0 112.211 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -69.28 -27.08 65.1 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.76 1.224 . . . . 0.0 113.377 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.57 -26.63 26.02 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.538 1.135 . . . . 0.0 113.372 176.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -89.71 28.79 1.25 Allowed 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.15 1.38 . . . . 0.0 113.227 170.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.3 mt -126.53 153.04 45.72 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.664 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 C--O 1.248 1.021 0 O-C-N 125.662 1.852 . . . . 0.0 107.292 171.115 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 ttt . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -95.1 130.19 41.9 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 124.595 1.184 . . . . 0.0 109.157 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -125.4 122.08 35.71 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.303 -1.771 . . . . 0.0 110.004 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -122.58 119.1 29.84 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.488 1.137 . . . . 0.0 112.343 170.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -96.99 89.2 4.74 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 112.927 -1.942 . . . . 0.0 108.915 -174.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.2 m -111.68 141.4 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 114.089 -1.414 . . . . 0.0 114.419 -169.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.583 HG22 HG22 ' A' ' 60' ' ' VAL . 17.1 p -89.72 116.35 27.77 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 114.665 -1.152 . . . . 0.0 113.931 -173.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.16 101.98 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 166.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.0 p -94.09 -11.88 29.66 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 112.391 -2.186 . . . . 0.0 114.23 174.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -63.74 131.53 94.92 Favored Pre-proline 0 N--CA 1.481 1.112 0 C-N-CA 125.344 1.458 . . . . 0.0 111.092 175.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 98.7 Cg_exo -50.44 -50.25 14.12 Favored 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 124.205 3.27 . . . . 0.0 114.132 -174.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -98.68 -48.38 4.98 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.08 0.863 . . . . 0.0 112.769 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.09 -126.94 7.68 Favored Glycine 0 N--CA 1.48 1.616 0 O-C-N 124.269 0.981 . . . . 0.0 113.086 170.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 60.5 mt -85.15 -38.09 19.44 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -176.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.0 p -105.69 -50.35 3.22 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 117.778 -3.076 . . . . 0.0 115.575 174.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.265 5.5 mmt180 -80.75 -46.45 1.24 Allowed Pre-proline 0 N--CA 1.482 1.162 0 CA-C-O 116.774 -1.584 . . . . 0.0 115.173 -172.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -61.19 -37.09 76.99 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 121.983 1.789 . . . . 0.0 112.585 166.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.21 -42.86 66.73 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 170.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.427 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . . . -64.63 -38.17 90.08 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 174.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -64.85 -41.55 95.61 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.317 1.047 . . . . 0.0 112.62 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.472 ' HD1' HD22 ' A' ' 80' ' ' LEU . 18.4 t80 -59.73 -44.3 93.81 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.972 1.309 . . . . 0.0 111.425 172.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.1 t -59.59 -44.65 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 124.073 0.949 . . . . 0.0 111.982 173.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -48.75 -51.23 30.07 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.9 0.88 . . . . 0.0 111.254 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -65.85 -55.78 15.27 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 124.961 1.413 . . . . 0.0 111.766 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.53 -34.7 62.21 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -56.84 -28.32 61.47 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 172.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.81 3.1 65.66 Favored Glycine 0 N--CA 1.49 2.287 0 O-C-N 125.199 1.562 . . . . 0.0 114.874 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -102.6 153.83 19.72 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.546 0.738 . . . . 0.0 111.469 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.4 p -63.08 -44.35 96.01 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.396 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 p -64.04 151.71 42.22 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -97.88 110.63 23.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 113.942 -1.481 . . . . 0.0 107.94 166.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' A' ' 44' ' ' ALA . 3.5 mm -81.19 119.11 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 CA-C-N 111.878 -2.419 . . . . 0.0 109.189 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.08 113.5 27.07 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.091 0.948 . . . . 0.0 112.417 173.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.45 HG22 HG12 ' A' ' 63' ' ' ILE . 92.6 t -94.73 97.69 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 112.634 -2.075 . . . . 0.0 106.345 175.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.8 m -95.91 122.29 38.56 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 113.414 -1.721 . . . . 0.0 110.997 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.431 ' HB2' HG12 ' A' ' 61' ' ' VAL . 22.6 t -128.55 96.6 4.45 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.74 -177.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.8 p30 33.77 90.25 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 126.481 1.912 . . . . 0.0 115.707 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.92 -66.7 3.29 Favored Glycine 0 N--CA 1.479 1.529 0 CA-C-N 112.729 -2.032 . . . . 0.0 112.109 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.54 135.55 47.1 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 115.134 -0.533 . . . . 0.0 111.33 -172.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.4 t -123.25 118.1 26.81 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 124.717 1.261 . . . . 0.0 111.878 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.481 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -111.67 111.36 22.29 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 114.05 -1.432 . . . . 0.0 114.172 -174.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.8 t -61.88 124.37 20.59 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 113.445 -1.707 . . . . 0.0 112.66 169.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . . . -83.31 7.06 17.64 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.032 -1.44 . . . . 0.0 113.843 171.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -94.92 -10.84 29.92 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 160.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 39.0 t -109.72 114.97 29.0 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.177 0.991 . . . . 0.0 110.234 171.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 tp -49.88 -53.57 25.03 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.405 -1.725 . . . . 0.0 111.287 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -64.45 -38.32 90.63 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 15.1 mttm -60.68 -49.63 76.73 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.11 -39.16 91.58 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 173.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.427 ' NE2' ' HB2' ' A' ' 20' ' ' ALA . 90.0 mt-30 -67.67 -32.91 73.91 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 -177.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 t -116.31 67.85 0.72 Allowed 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 124.039 1.876 . . . . 0.0 113.089 170.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.481 HD13 ' HB2' ' A' ' 42' ' ' ALA . 41.6 tp -116.17 -50.91 2.65 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 111.717 -2.492 . . . . 0.0 113.79 174.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.96 78.6 1.19 Allowed Glycine 0 N--CA 1.477 1.369 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -170.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 36.3 mt -107.33 80.87 1.46 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.286 -0.957 . . . . 0.0 110.737 -173.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.6 t -142.58 175.5 9.75 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.844 -1.526 . . . . 0.0 114.208 -165.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -50.6 127.2 17.34 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.615 1.966 . . . . 0.0 111.442 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.07 -29.45 10.67 Favored Glycine 0 N--CA 1.482 1.737 0 CA-C-N 112.853 -1.976 . . . . 0.0 113.058 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.8 p -66.98 113.15 4.76 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.583 HG22 HG22 ' A' ' 7' ' ' THR . 4.4 t -86.04 105.42 14.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 112.739 -2.028 . . . . 0.0 105.797 171.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.431 HG12 ' HB2' ' A' ' 37' ' ' SER . 18.4 m -99.55 105.76 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 113.761 -1.563 . . . . 0.0 112.342 -174.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.92 95.71 1.6 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.233 -1.803 . . . . 0.0 109.952 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.45 HG12 HG22 ' A' ' 35' ' ' VAL . 79.6 mt -82.18 97.14 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.649 174.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.7 m -110.03 121.54 45.5 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 112.679 -2.055 . . . . 0.0 109.926 -175.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -133.96 138.41 45.45 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -133.76 141.73 47.63 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.166 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.78 -150.49 19.04 Favored Glycine 0 CA--C 1.538 1.527 0 O-C-N 124.9 1.375 . . . . 0.0 110.62 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.09 -60.62 3.49 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -91.64 39.26 1.0 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -52.31 -55.76 19.31 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -45.45 77.53 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.43 1.092 . . . . 0.0 113.06 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -59.59 -50.26 74.56 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.819 1.248 . . . . 0.0 112.049 -176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.19 -54.06 51.08 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.294 1.038 . . . . 0.0 112.728 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.6 t -62.41 -48.49 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-O 118.06 -0.971 . . . . 0.0 111.045 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -54.23 -53.5 52.72 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.299 1.04 . . . . 0.0 111.718 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -56.33 -52.29 65.09 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.341 1.057 . . . . 0.0 112.449 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.9 mt -66.44 -34.5 78.09 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.95 -51.42 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-O 118.849 -0.596 . . . . 0.0 109.971 170.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -58.34 -42.91 87.89 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.472 HD22 ' HD1' ' A' ' 22' ' ' PHE . 5.2 tt -55.04 -56.87 14.98 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.245 1.018 . . . . 0.0 111.639 174.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -57.75 -39.28 76.99 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.842 0.857 . . . . 0.0 112.774 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.83 -29.55 69.51 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -86.51 -25.05 25.3 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.3 tp -74.55 141.33 44.8 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.087 0.955 . . . . 0.0 110.691 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -176.958 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 ttt . . . . . 0 C--O 1.233 0.203 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -121.74 111.58 17.34 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.941 0.776 . . . . 0.0 111.056 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -108.8 116.36 31.83 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 112.603 -2.09 . . . . 0.0 110.45 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.406 ' HB2' HG11 ' A' ' 74' ' ' VAL . 9.4 tt0 -119.62 118.13 30.17 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.251 172.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -89.7 111.66 22.7 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 112.745 -2.025 . . . . 0.0 107.427 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.435 HG11 HG13 ' A' ' 78' ' ' VAL . 20.2 m -127.75 162.09 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 113.463 -1.699 . . . . 0.0 110.713 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.544 HG22 HG22 ' A' ' 60' ' ' VAL . 44.1 p -113.4 137.65 51.22 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.083 171.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.0 mt -95.92 111.47 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.426 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 1.7 p -103.74 -18.73 14.57 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.98 141.93 74.95 Favored Pre-proline 0 C--O 1.256 1.438 0 CA-C-O 116.989 -1.482 . . . . 0.0 114.173 177.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.93 -56.83 2.7 Favored 'Trans proline' 0 N--CA 1.493 1.475 1 C-N-CA 125.973 4.449 . . . . 0.0 116.256 -169.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -102.67 -20.27 14.47 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.4 -118.26 11.55 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.236 1.874 . . . . 0.0 113.19 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.7 mt -97.91 -22.77 16.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 112.096 -2.052 . . . . 0.0 114.415 -176.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.0 p -104.95 -59.66 1.72 Allowed 'General case' 0 N--CA 1.474 0.764 0 O-C-N 117.258 -3.401 . . . . 0.0 113.554 171.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -75.26 -43.35 4.4 Favored Pre-proline 0 N--CA 1.486 1.348 0 CA-C-O 115.932 -1.985 . . . . 0.0 114.68 -172.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -61.81 -26.48 79.49 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 121.974 1.782 . . . . 0.0 112.091 166.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -75.05 -35.38 61.9 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.148 0.579 . . . . 0.0 112.476 175.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . . . -57.96 -38.03 75.27 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.746 1.219 . . . . 0.0 112.482 168.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -65.14 -43.46 91.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.621 0.768 . . . . 0.0 111.971 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -64.05 -39.25 93.67 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.465 1.106 . . . . 0.0 111.558 175.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 19' ' ' ALA . 91.4 t -58.53 -49.26 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 125.005 1.322 . . . . 0.0 111.877 173.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -56.21 -42.95 78.04 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.04 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -68.71 -42.26 77.94 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.188 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.12 -27.49 68.08 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -68.93 -11.48 60.69 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 172.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.51 -33.18 7.27 Favored Glycine 0 N--CA 1.481 1.674 0 C-N-CA 124.774 1.178 . . . . 0.0 112.957 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -72.6 128.45 35.6 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.081 1.352 . . . . 0.0 111.765 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.5 p -54.3 -36.92 64.23 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.457 -1.247 . . . . 0.0 113.659 172.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.3 p -61.69 146.24 49.79 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.371 1.044 . . . . 0.0 111.598 167.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -102.15 98.09 8.3 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 113.663 -1.608 . . . . 0.0 108.991 169.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.489 HD11 ' HB1' ' A' ' 73' ' ' ALA . 36.3 mm -62.22 113.11 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 112.501 -2.136 . . . . 0.0 110.232 177.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.1 p -97.62 134.94 40.14 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.048 165.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.2 t -111.37 94.84 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 111.49 -2.595 . . . . 0.0 108.61 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.541 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 25.9 m -88.52 101.67 14.17 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 111.413 -2.63 . . . . 0.0 112.029 -178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 t -117.85 112.77 20.82 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.841 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.25 20.4 p30 44.73 61.36 2.49 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 126.046 1.738 . . . . 0.0 115.662 -173.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.68 19.87 63.29 Favored Glycine 0 CA--C 1.546 1.974 0 N-CA-C 116.896 1.519 . . . . 0.0 116.896 -176.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.9 mttt -118.75 107.85 14.15 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.743 0.771 . . . . 0.0 109.773 171.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.2 m -90.23 105.71 17.99 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 122.809 1.29 . . . . 0.0 111.606 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.88 105.3 14.43 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.675 -2.057 . . . . 0.0 111.525 -176.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.5 t -50.54 111.35 0.52 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 114.221 -1.354 . . . . 0.0 114.213 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.33 -18.42 65.3 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.283 -1.78 . . . . 0.0 113.666 169.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -77.94 -10.64 59.68 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.2 t -111.81 118.11 34.66 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.48 1.133 . . . . 0.0 112.057 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -46.2 -53.52 10.39 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 111.016 -2.811 . . . . 0.0 113.672 -172.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -69.29 -39.95 78.01 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -64.13 -52.06 60.95 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -167.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.68 -46.43 82.47 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.435 1.094 . . . . 0.0 113.105 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.453 ' NE2' ' HB2' ' A' ' 20' ' ' ALA . 67.0 mt-30 -63.92 -33.87 76.67 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.261 11.1 t -74.23 -48.41 29.01 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.474 HD23 HD21 ' A' ' 55' ' ' LEU . 27.3 tp -37.38 -53.19 1.12 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -167.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.13 67.19 0.52 Allowed Glycine 0 N--CA 1.484 1.839 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.474 HD21 HD23 ' A' ' 53' ' ' LEU . 24.9 mt -81.26 94.77 6.78 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 122.297 1.046 . . . . 0.0 111.4 174.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -150.41 -172.13 4.1 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 112.301 -2.227 . . . . 0.0 111.213 -168.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 9' ' ' THR . 52.6 tt0 -52.21 125.91 17.24 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.812 2.045 . . . . 0.0 114.617 -176.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.28 22.34 63.07 Favored Glycine 0 N--CA 1.484 1.888 0 CA-C-N 111.704 -2.498 . . . . 0.0 114.595 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.3 p -103.39 104.48 14.59 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 122.536 1.16 . . . . 0.0 112.5 -172.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.544 HG22 HG22 ' A' ' 7' ' ' THR . 4.6 t -69.69 113.57 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 111.156 -2.747 . . . . 0.0 108.725 176.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.71 117.24 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 112.892 -1.958 . . . . 0.0 110.812 -175.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.541 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 4.3 m -87.06 100.31 12.55 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.613 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.488 HG22 HG22 ' A' ' 74' ' ' VAL . 95.2 mt -89.1 101.4 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 113.655 -1.611 . . . . 0.0 108.674 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.4 m -116.46 127.17 54.35 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 109.76 -3.382 . . . . 0.0 111.086 -167.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.23 123.99 40.74 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.475 -176.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -119.13 108.05 14.22 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.931 1.394 . . . . 0.0 108.379 174.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.44 178.21 30.35 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.58 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -51.77 -41.84 61.93 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -176.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 p30 -102.47 39.8 1.46 Allowed 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -176.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -55.04 -40.06 69.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.01 -46.06 10.17 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.723 -176.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -52.39 -46.41 66.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.043 1.737 . . . . 0.0 114.82 171.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.489 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -65.19 -53.46 44.4 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -176.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 63' ' ' ILE . 68.8 t -60.78 -44.47 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.31 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -56.33 -51.44 68.25 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.421 1.089 . . . . 0.0 111.893 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -54.0 -51.58 63.49 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.778 0.831 . . . . 0.0 112.515 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 98.0 mt -65.62 -47.94 73.92 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.435 HG13 HG11 ' A' ' 6' ' ' VAL . 90.0 t -58.56 -38.28 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 118.945 0.793 . . . . 0.0 110.756 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -60.67 -62.98 1.47 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 118.394 -0.812 . . . . 0.0 110.68 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.8 tp -47.09 -44.17 20.95 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.942 2.097 . . . . 0.0 114.287 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.6 tmm? -53.59 -61.76 2.1 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.684 1.593 . . . . 0.0 112.427 172.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.43 -26.31 66.35 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -68.05 -29.74 68.78 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 172.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 mp -81.2 160.35 24.35 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 122.917 0.487 . . . . 0.0 111.891 171.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 . . . . . 0 C--O 1.261 1.666 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 -167.35 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ttt . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -81.85 133.59 35.34 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.479 167.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -137.17 133.87 35.7 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 112.581 -2.1 . . . . 0.0 110.003 -173.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -126.19 111.29 14.43 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.147 172.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.611 ' HG2' HG23 ' A' ' 62' ' ' THR . 34.3 mt-10 -79.3 80.81 5.63 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.913 1.34 . . . . 0.0 109.72 167.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.452 HG21 HG22 ' A' ' 78' ' ' VAL . 3.3 m -107.61 135.49 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 114.158 -1.383 . . . . 0.0 113.899 -175.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 p -76.34 140.56 41.49 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 112.444 -2.162 . . . . 0.0 113.471 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.9 mt -105.54 118.12 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.684 167.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.9 p -112.84 -12.39 13.32 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.32 132.66 95.19 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-O 118.024 -0.988 . . . . 0.0 111.712 173.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -42.88 -54.67 3.19 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 124.725 3.617 . . . . 0.0 116.602 -170.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.428 ' O ' ' HD2' ' A' ' 15' ' ' HIP . 10.1 p30 -97.78 -41.9 7.85 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 174.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.06 -120.66 7.32 Favored Glycine 0 CA--C 1.541 1.681 0 C-N-CA 124.059 0.838 . . . . 0.0 112.36 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 31.4 mt -97.91 -42.59 7.47 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -171.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . 0.428 ' HD2' ' O ' ' A' ' 12' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p -104.21 -50.21 3.41 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 118.036 -2.915 . . . . 0.0 114.879 173.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.425 ' HB2' ' HD3' ' A' ' 18' ' ' PRO 0.283 21.0 mmt180 -76.37 -49.42 3.01 Favored Pre-proline 0 N--CA 1.487 1.41 0 CA-C-O 116.442 -1.742 . . . . 0.0 115.242 -174.241 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.536 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 77.3 Cg_exo -64.5 -31.45 60.9 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 121.698 1.642 . . . . 0.0 113.627 167.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.22 -38.93 77.75 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 169.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.469 ' HB2' ' NE2' ' A' ' 51' ' ' GLN . . . -59.82 -39.97 86.86 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 171.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -61.92 -44.7 96.25 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.628 0.771 . . . . 0.0 112.262 173.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -55.27 -43.69 74.93 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.929 1.292 . . . . 0.0 111.588 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.97 -51.03 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 123.661 0.784 . . . . 0.0 111.895 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -48.56 -47.62 39.29 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.673 0.789 . . . . 0.0 110.995 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.62 -50.89 47.93 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.743 1.277 . . . . 0.0 113.276 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.428 ' HA ' ' HD2' ' A' ' 29' ' ' PHE . . . -54.1 -36.63 63.41 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mttm -60.63 -27.38 67.73 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 173.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.79 -23.17 76.99 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.292 1.425 . . . . 0.0 114.159 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.428 ' HD2' ' HA ' ' A' ' 26' ' ' ALA . 73.6 m-85 -89.98 149.26 22.64 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.952 0.901 . . . . 0.0 110.69 177.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.1 p -71.5 -39.42 70.83 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.39 0.676 . . . . 0.0 112.073 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.5 p -65.71 137.97 57.65 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.681 1.192 . . . . 0.0 114.163 175.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -85.28 104.21 14.92 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.605 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.524 HG23 HG23 ' A' ' 63' ' ' ILE . 47.7 mm -72.93 94.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 111.94 -2.391 . . . . 0.0 110.289 173.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.4 p -89.48 113.86 25.29 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.275 -1.329 . . . . 0.0 108.993 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -100.57 96.52 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 113.183 -1.826 . . . . 0.0 107.563 -177.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 40.8 m -87.92 116.65 26.23 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 112.962 -1.927 . . . . 0.0 111.473 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -111.12 105.85 14.7 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.733 173.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 p30 40.21 69.29 0.32 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.591 1.556 . . . . 0.0 114.204 -173.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.33 -39.71 3.0 Favored Glycine 0 N--CA 1.485 1.918 0 CA-C-N 113.197 -1.819 . . . . 0.0 114.15 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -72.74 99.05 2.51 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.353 1.061 . . . . 0.0 112.438 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.3 m -83.94 108.42 16.91 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.541 -1.663 . . . . 0.0 113.398 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.57 115.13 28.66 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.182 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.9 t -67.08 125.77 27.06 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 113.916 -1.493 . . . . 0.0 113.219 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.84 -5.24 47.51 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 112.402 -2.181 . . . . 0.0 113.422 171.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -83.65 8.2 15.11 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 167.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 t -144.41 131.04 20.02 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.933 0.493 . . . . 0.0 112.129 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.07 -68.31 0.22 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 113.733 -1.576 . . . . 0.0 113.552 -171.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -54.64 -39.38 67.93 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -57.1 -55.0 40.38 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 124.165 0.916 . . . . 0.0 112.935 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 tp -68.0 -48.57 65.37 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.895 1.372 . . . . 0.0 113.616 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.469 ' NE2' ' HB2' ' A' ' 20' ' ' ALA . 57.2 mt-30 -61.41 -34.44 75.37 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 -172.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.2 t -72.17 -20.03 61.66 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.1 tp -70.11 -37.53 75.38 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.51 73.83 1.28 Allowed Glycine 0 N--CA 1.484 1.847 0 O-C-N 124.439 1.087 . . . . 0.0 113.074 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.1 mt -84.81 92.93 8.37 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.387 0.613 . . . . 0.0 110.273 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.9 t -141.5 -175.0 4.2 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -169.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -56.5 112.93 1.4 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.106 0.963 . . . . 0.0 111.146 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.54 -30.8 6.25 Favored Glycine 0 CA--C 1.542 1.72 0 CA-C-N 113.611 -1.631 . . . . 0.0 114.496 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.6 p -70.11 103.58 2.35 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -175.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.4 t -68.11 117.78 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 163.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.8 m -118.17 109.59 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 113.654 -1.612 . . . . 0.0 113.004 -175.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.611 HG23 ' HG2' ' A' ' 5' ' ' GLU . 0.6 OUTLIER -75.71 86.87 2.75 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.052 176.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.524 HG23 HG23 ' A' ' 33' ' ' ILE . 34.2 mt -78.8 95.28 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.7 m -105.42 128.14 53.37 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 112.948 -1.933 . . . . 0.0 110.693 -174.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.49 116.13 28.34 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -105.97 97.42 7.24 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.74 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.09 -175.05 28.5 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-N 114.536 -1.211 . . . . 0.0 113.361 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -55.88 -54.46 44.34 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 -169.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -83.52 28.88 0.53 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 6.4 pt-20 -38.78 -60.64 0.81 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.464 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -56.89 -50.58 72.07 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 178.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -67.09 -40.09 86.89 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -175.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.406 ' CB ' HD11 ' A' ' 33' ' ' ILE . . . -59.34 -52.43 65.65 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 123.767 0.667 . . . . 0.0 112.678 176.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.414 HG22 HG22 ' A' ' 63' ' ' ILE . 47.0 t -63.5 -49.58 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.647 176.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -49.93 -57.44 7.49 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.573 1.549 . . . . 0.0 112.011 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -59.46 -50.79 72.56 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.898 0.879 . . . . 0.0 113.102 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.4 mt -63.22 -36.05 82.36 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.452 HG22 HG21 ' A' ' 6' ' ' VAL . 90.3 t -62.02 -48.64 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 123.808 0.693 . . . . 0.0 110.566 171.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -54.25 -55.5 27.51 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 118.234 -0.888 . . . . 0.0 113.062 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.8 tp -52.66 -48.97 66.13 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.047 0.939 . . . . 0.0 112.832 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -57.36 -45.53 84.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.402 1.081 . . . . 0.0 112.642 175.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.54 -25.22 60.3 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -74.55 -41.09 61.17 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 114.15 1.166 . . . . 0.0 114.15 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.7 mt -66.95 150.51 49.13 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.343 1.057 . . . . 0.0 113.342 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 125.564 1.546 . . . . 0.0 109.139 173.878 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.465 0.28 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -119.83 139.94 51.58 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 125.066 1.479 . . . . 0.0 110.01 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -134.03 129.75 36.55 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 124.59 1.181 . . . . 0.0 111.729 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -128.47 136.64 51.1 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.374 1.046 . . . . 0.0 112.454 169.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -98.89 110.24 22.87 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.187 -1.37 . . . . 0.0 110.449 173.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.679 HG11 HG13 ' A' ' 78' ' ' VAL . 8.5 m -119.79 152.8 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 114.468 -1.242 . . . . 0.0 114.242 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.565 HG22 HG22 ' A' ' 60' ' ' VAL . 20.6 p -111.98 121.94 46.39 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 113.531 -1.668 . . . . 0.0 111.447 -173.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.1 mt -79.69 96.47 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.17 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -74.67 -34.7 62.74 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -55.15 134.42 68.52 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 125.486 1.514 . . . . 0.0 113.67 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 48.8 Cg_exo -45.71 -43.91 18.28 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.539 3.493 . . . . 0.0 117.493 -173.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -114.5 -40.8 3.54 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 172.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.17 -114.47 3.91 Favored Glycine 0 N--CA 1.475 1.279 0 C-N-CA 123.986 0.803 . . . . 0.0 111.769 168.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.559 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 34.1 mt -101.29 -43.89 5.83 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.185 1.179 . . . . 0.0 114.185 -167.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.8 p -107.55 -52.02 2.82 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 118.167 -2.833 . . . . 0.0 114.708 171.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.508 ' HB2' ' HD3' ' A' ' 18' ' ' PRO 0.266 20.2 mmt180 -71.8 -54.08 6.56 Favored Pre-proline 0 N--CA 1.487 1.418 0 CA-C-O 116.579 -1.677 . . . . 0.0 115.168 -174.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.559 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 71.5 Cg_exo -62.93 -34.26 71.98 Favored 'Trans proline' 0 N--CA 1.479 0.632 0 CA-C-N 121.899 1.714 . . . . 0.0 113.653 171.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -53.73 -36.91 62.8 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 172.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.71 -40.38 83.51 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 174.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.32 -45.42 91.4 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -55.48 -45.73 76.94 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.795 1.238 . . . . 0.0 110.934 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 19' ' ' ALA . 22.0 t -62.47 -50.22 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 123.403 0.681 . . . . 0.0 111.228 175.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -50.03 -47.08 53.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.289 1.036 . . . . 0.0 112.275 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.09 -49.15 65.96 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 124.269 0.98 . . . . 0.0 113.387 174.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.5 -39.61 76.85 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -47.7 -44.26 27.39 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.71 1.604 . . . . 0.0 113.898 167.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.17 -34.22 69.72 Favored Glycine 0 N--CA 1.475 1.261 0 O-C-N 125.435 1.709 . . . . 0.0 114.355 -176.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -65.69 145.87 55.5 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.306 0.643 . . . . 0.0 111.702 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 57.9 p -64.12 -35.19 79.94 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.216 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.0 p -68.71 144.97 54.24 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.294 -1.321 . . . . 0.0 114.497 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -92.56 118.21 30.77 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.938 169.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.701 HD11 ' HB1' ' A' ' 73' ' ' ALA . 43.1 mm -86.17 103.25 12.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 111.706 -2.497 . . . . 0.0 110.195 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.4 p -103.47 118.91 37.84 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.378 175.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 63' ' ' ILE . 92.6 t -99.24 95.95 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 112.961 -1.927 . . . . 0.0 107.504 -178.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.5 m -91.34 110.29 21.58 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 113.657 -1.61 . . . . 0.0 110.79 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.8 t -108.16 95.27 5.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 113.544 -1.662 . . . . 0.0 109.634 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.3 p30 43.63 72.43 0.19 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.365 1.466 . . . . 0.0 114.349 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.62 -38.93 2.92 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-N 113.028 -1.896 . . . . 0.0 114.496 -175.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -75.45 88.91 2.65 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -175.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.5 m -74.13 113.62 11.54 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.381 -1.282 . . . . 0.0 112.982 170.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.12 122.77 47.99 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.088 170.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.9 t -86.84 128.26 35.04 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.331 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.46 16.28 6.7 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 113.117 -1.856 . . . . 0.0 114.092 176.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -92.58 2.84 56.48 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 121.663 0.744 . . . . 0.0 112.663 158.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.1 t -127.84 125.93 40.67 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.847 1.659 . . . . 0.0 110.799 172.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.65 -54.04 50.66 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.813 171.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -57.69 -48.93 78.16 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.152 -1.385 . . . . 0.0 113.862 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -60.98 -46.57 90.2 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 tp -68.17 -47.88 66.81 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 123.821 0.7 . . . . 0.0 112.002 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -57.1 -42.26 80.47 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -71.78 -14.51 62.01 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.4 tp -75.37 -42.35 54.2 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.56 82.51 0.7 Allowed Glycine 0 N--CA 1.478 1.481 0 O-C-N 124.394 1.059 . . . . 0.0 112.527 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 85.8 mt -82.85 78.32 9.46 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 122.877 1.322 . . . . 0.0 112.298 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.0 t -85.36 -174.27 5.12 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 111.914 -2.403 . . . . 0.0 112.569 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -60.23 144.23 50.72 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.979 1.712 . . . . 0.0 111.114 175.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.57 -38.07 3.27 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 114.251 -1.34 . . . . 0.0 114.642 171.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.4 p -54.96 104.62 0.12 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.184 1.549 . . . . 0.0 115.184 -174.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 7' ' ' THR . 16.7 t -66.74 112.46 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 112.152 -2.295 . . . . 0.0 107.177 169.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.5 m -119.32 118.08 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 113.35 -1.75 . . . . 0.0 114.641 -172.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.3 m -80.23 100.45 8.33 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 125.447 1.717 . . . . 0.0 109.084 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.448 HG12 HG22 ' A' ' 35' ' ' VAL . 80.2 mt -91.76 102.44 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.586 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 m -100.12 131.66 45.94 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 113.01 -1.904 . . . . 0.0 110.141 -178.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.12 105.86 13.97 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 124.035 0.835 . . . . 0.0 112.353 172.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -104.06 92.46 4.39 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.233 -1.348 . . . . 0.0 111.266 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.3 -167.55 39.94 Favored Glycine 0 N--CA 1.48 1.623 0 CA-C-N 112.252 -2.249 . . . . 0.0 111.148 174.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.01 -51.5 66.57 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -82.38 36.49 0.48 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.612 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 5.9 pt-20 -45.83 -72.53 0.05 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 -173.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.612 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -50.05 -47.99 53.1 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -179.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -63.05 -47.25 83.75 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.577 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.701 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -56.32 -46.08 80.03 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.23 0.957 . . . . 0.0 113.538 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.0 t -67.35 -56.06 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.225 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -51.02 -47.16 61.7 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.477 1.111 . . . . 0.0 112.687 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -53.15 -61.41 2.31 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.032 1.333 . . . . 0.0 112.067 174.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.9 mt -64.27 -33.23 75.35 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.679 HG13 HG11 ' A' ' 6' ' ' VAL . 11.7 t -62.05 -56.31 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.103 0.961 . . . . 0.0 110.527 171.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -57.55 -48.26 79.82 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.449 1.099 . . . . 0.0 111.25 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.2 tp -54.57 -52.01 63.47 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.448 1.499 . . . . 0.0 111.954 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -57.86 -44.91 86.88 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.226 1.011 . . . . 0.0 112.033 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.54 -33.62 75.43 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -75.85 -30.39 58.9 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.1 mt -67.89 133.21 48.74 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.927 0.891 . . . . 0.0 112.629 175.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 . . . . . 0 C--O 1.255 1.349 0 O-C-N 125.405 1.691 . . . . 0.0 109.836 179.761 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.402 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 4.7 t80 -108.39 129.18 55.26 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 125.72 1.888 . . . . 0.0 108.001 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -126.98 131.23 51.09 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.621 -170.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -129.32 122.87 30.44 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.432 1.082 . . . . 0.0 113.025 168.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -87.03 100.6 12.74 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 112.442 -2.163 . . . . 0.0 107.945 176.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.5 m -116.97 143.52 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 114.22 -1.355 . . . . 0.0 114.173 -173.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.544 HG22 HG22 ' A' ' 60' ' ' VAL . 14.0 p -94.03 122.14 36.23 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.408 1.099 . . . . 0.0 111.495 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.2 mt -78.9 97.92 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.6 167.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.7 p -82.81 -26.66 31.52 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 109.962 -3.29 . . . . 0.0 113.526 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.463 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -51.12 120.63 14.44 Favored Pre-proline 0 N--CA 1.476 0.847 0 O-C-N 124.715 1.259 . . . . 0.0 112.277 177.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 80.8 Cg_exo -57.38 -48.71 16.33 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 123.785 2.99 . . . . 0.0 113.77 -175.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -68.94 -43.46 75.02 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.545 0.338 . . . . 0.0 111.688 170.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 56' ' ' THR . . . 101.88 -148.01 17.62 Favored Glycine 0 N--CA 1.475 1.279 0 O-C-N 124.75 1.281 . . . . 0.0 110.984 174.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.433 HD12 HD13 ' A' ' 55' ' ' LEU . 83.7 mt -98.35 -17.83 18.65 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 113.639 -1.28 . . . . 0.0 112.407 173.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.512 ' HA ' ' HG2' ' A' ' 51' ' ' GLN . 59.6 p -99.28 -61.42 1.37 Allowed 'General case' 0 N--CA 1.48 1.039 0 O-C-N 117.955 -2.966 . . . . 0.0 113.437 176.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.7 -44.23 53.03 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-O 116.874 -1.536 . . . . 0.0 114.903 -175.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -69.17 -33.74 18.12 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.734 1.623 . . . . 0.0 113.391 172.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.49 97.45 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.47 0.708 . . . . 0.0 112.487 171.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.89 -46.2 90.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.235 0.614 . . . . 0.0 112.577 169.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -58.81 -43.7 90.64 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 171.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.16 -43.12 87.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.136 0.974 . . . . 0.0 112.895 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.462 HG11 HD22 ' A' ' 47' ' ' LEU . 59.5 t -61.51 -48.91 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 122.478 0.311 . . . . 0.0 110.95 172.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -52.98 -45.44 67.81 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.498 0.719 . . . . 0.0 112.839 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -64.49 -49.4 71.5 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.568 1.147 . . . . 0.0 112.881 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.88 -29.2 67.45 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -51.91 -26.44 10.26 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 168.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.95 -22.83 77.21 Favored Glycine 0 CA--C 1.543 1.826 0 O-C-N 125.109 1.505 . . . . 0.0 115.704 175.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -96.98 143.4 27.88 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.88 0.847 . . . . 0.0 112.406 -178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.8 p -66.35 -37.15 84.67 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.075 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.9 p -63.84 138.6 58.55 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.748 170.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -95.22 96.67 9.34 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 123.412 1.577 . . . . 0.0 108.95 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mt -77.07 128.81 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 111.612 -2.54 . . . . 0.0 110.542 -172.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.4 p -102.32 134.92 44.83 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.349 173.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.8 t -102.29 90.25 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 170.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.1 m -89.41 112.85 24.08 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.14 -1.391 . . . . 0.0 113.723 -170.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 40' ' ' LYS . 32.4 t -116.27 97.36 6.0 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 124.377 1.048 . . . . 0.0 111.156 173.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 p30 39.59 83.02 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.816 1.646 . . . . 0.0 115.183 -175.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.03 -41.3 1.97 Allowed Glycine 0 CA--C 1.55 2.258 0 CA-C-N 114.266 -1.333 . . . . 0.0 113.71 -173.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 37' ' ' SER . 33.2 mtmt -71.85 79.75 0.88 Allowed 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.4 m -72.02 111.78 7.55 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.029 -1.441 . . . . 0.0 112.937 168.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.09 99.02 9.98 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 113.835 -1.529 . . . . 0.0 112.638 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 t -55.45 119.2 5.26 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.57 1.176 . . . . 0.0 113.186 174.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.17 9.57 1.96 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 112.847 -1.979 . . . . 0.0 114.006 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -104.65 19.99 19.43 Favored 'General case' 0 C--O 1.25 1.082 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 164.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.8 t -140.78 125.42 17.93 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.161 1.384 . . . . 0.0 112.749 174.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.462 HD22 HG11 ' A' ' 23' ' ' VAL . 3.6 mm? -55.73 -44.27 77.38 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 113.58 -1.645 . . . . 0.0 114.209 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -64.39 -39.16 93.32 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.16 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -55.4 -56.41 20.44 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.9 mp -67.91 -31.22 70.85 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -176.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.512 ' HG2' ' HA ' ' A' ' 16' ' ' THR . 36.3 mt-30 -78.64 -34.28 46.62 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.023 -0.99 . . . . 0.0 113.371 176.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.7 t -79.09 -32.51 44.68 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.591 HD23 HD21 ' A' ' 55' ' ' LEU . 17.3 tp -51.97 -49.79 62.54 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.366 1.246 . . . . 0.0 114.366 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.76 89.04 1.78 Allowed Glycine 0 N--CA 1.476 1.352 0 O-C-N 125.352 1.657 . . . . 0.0 110.817 -175.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.591 HD21 HD23 ' A' ' 53' ' ' LEU . 92.0 mt -109.05 99.41 8.73 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 114.813 -0.694 . . . . 0.0 112.315 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.412 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 12.3 t -150.98 170.57 19.02 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.627 1.571 . . . . 0.0 110.589 -174.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 59.8 tt0 -50.13 118.39 2.92 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.598 1.159 . . . . 0.0 112.987 -172.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.81 -29.4 7.5 Favored Glycine 0 CA--C 1.543 1.781 0 CA-C-N 112.585 -2.098 . . . . 0.0 113.696 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.4 p -62.33 100.91 0.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.544 HG22 HG22 ' A' ' 7' ' ' THR . 3.2 t -78.76 115.9 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 113.356 -1.747 . . . . 0.0 106.811 171.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 m -127.95 129.5 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 113.58 -1.646 . . . . 0.0 112.982 -174.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.4 m -89.05 96.95 10.94 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.421 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.456 HG22 HG22 ' A' ' 74' ' ' VAL . 89.2 mt -67.25 96.83 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 113.476 -1.693 . . . . 0.0 107.404 167.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.6 m -111.27 103.42 11.82 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 112.968 -1.924 . . . . 0.0 111.669 -175.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.28 100.19 12.1 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.624 0.726 . . . . 0.0 112.034 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -99.5 96.36 7.63 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 112.916 -1.947 . . . . 0.0 111.588 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.88 -162.07 28.83 Favored Glycine 0 N--CA 1.48 1.63 0 CA-C-N 114.177 -1.374 . . . . 0.0 113.606 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -60.63 -28.47 68.57 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 120.452 3.501 . . . . 0.0 120.452 -168.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.2 p30 -116.72 50.56 1.06 Allowed 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 2' ' ' PHE . 11.4 pt-20 -49.16 -55.43 12.41 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -174.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -53.29 59.96 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.918 1.287 . . . . 0.0 114.312 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -55.45 -47.45 76.02 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.021 1.328 . . . . 0.0 113.958 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.96 -53.43 57.35 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.571 -1.195 . . . . 0.0 113.372 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.456 HG22 HG22 ' A' ' 63' ' ' ILE . 51.1 t -60.83 -50.63 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 118.936 -0.554 . . . . 0.0 112.128 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -52.78 -57.24 10.81 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.458 1.103 . . . . 0.0 112.841 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -54.55 -50.11 68.72 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.46 1.104 . . . . 0.0 113.075 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 72.1 mt -67.57 -38.03 83.51 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.33 -45.35 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.059 0.543 . . . . 0.0 110.559 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -58.14 -49.05 78.32 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 118.313 -0.851 . . . . 0.0 113.153 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.8 tp -54.19 -51.76 63.38 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.891 0.876 . . . . 0.0 112.586 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -59.64 -44.92 93.32 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.98 0.912 . . . . 0.0 112.884 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.06 91.07 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -79.47 -19.76 49.01 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.9 mt -77.6 124.6 28.13 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 172.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--O 1.249 1.056 0 C-N-CA 127.352 2.261 . . . . 0.0 107.018 173.633 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ttt . . . . . 0 C--O 1.236 0.385 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -117.57 115.33 24.89 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 125.1 1.5 . . . . 0.0 109.123 175.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -102.65 129.92 49.4 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.361 -178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -123.37 103.58 8.58 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 171.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -73.78 95.34 2.38 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.294 -1.776 . . . . 0.0 110.675 172.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.424 HG11 HG13 ' A' ' 78' ' ' VAL . 17.2 m -117.16 146.22 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 113.388 -1.733 . . . . 0.0 113.862 -174.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.448 HG22 HG22 ' A' ' 60' ' ' VAL . 48.0 p -108.56 128.52 54.89 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.714 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.493 HG13 ' SD ' ' A' ' 81' ' ' MET . 1.9 mp -75.81 130.32 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.765 173.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 p -88.18 -37.32 16.24 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.323 171.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -59.61 133.38 88.88 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 125.399 1.48 . . . . 0.0 113.704 -175.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 32.3 Cg_exo -61.52 -68.81 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 124.166 3.244 . . . . 0.0 112.431 -172.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -62.06 -34.59 76.55 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.906 0.882 . . . . 0.0 112.222 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.37 -126.27 7.78 Favored Glycine 0 N--CA 1.481 1.647 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 168.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . 7.6 mp -88.87 -28.64 20.23 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 113.527 -1.337 . . . . 0.0 113.682 176.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.6 p -106.51 -47.87 3.68 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 117.863 -3.023 . . . . 0.0 115.18 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.315 12.9 mmt180 -88.04 -39.69 0.48 Allowed Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 -173.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -61.74 -38.76 58.03 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 121.983 1.789 . . . . 0.0 111.384 163.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.23 73.58 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 168.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.26 86.88 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -60.2 -46.32 90.13 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 124.181 0.926 . . . . 0.0 112.513 174.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -55.57 -53.64 53.87 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.499 1.12 . . . . 0.0 110.766 174.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.695 HG11 ' HA ' ' A' ' 47' ' ' LEU . 30.2 t -57.91 -49.75 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.645 0.778 . . . . 0.0 111.313 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -49.74 -52.51 31.07 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.335 1.054 . . . . 0.0 112.992 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -68.97 -43.24 75.36 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.689 1.243 . . . . 0.0 112.772 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.557 ' HA ' ' HD2' ' A' ' 29' ' ' PHE . . . -58.68 -37.8 76.82 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 173.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -53.46 -39.64 64.63 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.0 0.92 . . . . 0.0 112.816 169.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.3 15.0 4.64 Favored Glycine 0 CA--C 1.543 1.792 0 O-C-N 124.747 1.28 . . . . 0.0 115.413 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.557 ' HD2' ' HA ' ' A' ' 26' ' ' ALA . 65.9 m-85 -113.36 152.03 30.49 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.977 0.894 . . . . 0.0 111.992 172.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.4 p -69.94 -40.3 75.56 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.15 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.1 p -73.66 145.32 45.39 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.796 0.839 . . . . 0.0 112.882 173.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -96.4 109.78 22.25 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.645 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.687 HG13 ' HB2' ' A' ' 65' ' ' ALA . 5.0 mp -83.22 106.89 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 112.182 -2.281 . . . . 0.0 109.45 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.0 p -102.39 128.5 48.95 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 112.959 -1.928 . . . . 0.0 110.214 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.418 HG11 HD21 ' A' ' 55' ' ' LEU . 59.8 t -107.06 105.0 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 113.288 -1.778 . . . . 0.0 107.569 -176.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.0 m -106.83 126.2 52.0 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.3 t -116.25 97.32 5.98 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 112.99 -1.914 . . . . 0.0 110.02 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.257 4.0 p30 40.63 73.47 0.12 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 113.518 -1.674 . . . . 0.0 114.706 -175.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.09 -53.22 4.19 Favored Glycine 0 N--CA 1.488 2.111 0 CA-C-N 113.705 -1.589 . . . . 0.0 113.513 -178.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -60.72 104.56 0.36 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.38 1.472 . . . . 0.0 113.525 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 t -90.93 136.03 33.34 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.644 1.349 . . . . 0.0 114.644 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.28 97.43 5.06 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 113.879 -1.51 . . . . 0.0 113.081 173.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -54.6 130.21 39.28 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.985 168.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -93.81 13.81 21.29 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.109 -1.405 . . . . 0.0 114.337 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.63 -8.88 27.92 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.074 153.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -113.09 111.61 22.43 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 123.464 1.602 . . . . 0.0 112.54 169.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.695 ' HA ' HG11 ' A' ' 23' ' ' VAL . 1.4 tm? -54.43 -59.51 4.59 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 111.556 -2.565 . . . . 0.0 114.278 -169.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -65.47 -28.56 69.3 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -54.7 -48.12 72.86 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.4 tp -61.32 -43.26 99.17 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 176.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -58.17 -46.89 84.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 124.051 0.844 . . . . 0.0 112.64 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.2 t -66.72 -37.15 84.1 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.5 tp -66.6 -41.77 87.92 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.41 83.97 0.34 Allowed Glycine 0 N--CA 1.476 1.358 0 C-N-CA 124.348 0.975 . . . . 0.0 115.053 170.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 7.1 mp -75.03 109.47 8.53 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.336 -0.932 . . . . 0.0 109.598 174.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -135.59 -174.7 3.72 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.928 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -52.2 109.15 0.35 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.549 1.94 . . . . 0.0 112.729 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.82 35.2 51.29 Favored Glycine 0 CA--C 1.543 1.837 0 CA-C-N 114.627 -1.17 . . . . 0.0 115.545 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.2 p -83.35 118.28 23.58 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 117.313 0.556 . . . . 0.0 110.18 168.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.448 HG22 HG22 ' A' ' 7' ' ' THR . 5.0 t -90.96 80.5 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 125.758 1.911 . . . . 0.0 106.413 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.1 m -100.15 133.15 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 112.154 -2.294 . . . . 0.0 112.501 -172.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.8 p -92.99 95.95 9.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.314 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.412 HG22 HG22 ' A' ' 74' ' ' VAL . 88.4 mt -74.32 94.18 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.428 173.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.6 m -113.94 110.48 20.14 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 112.828 -1.987 . . . . 0.0 111.889 -172.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.687 ' HB2' HG13 ' A' ' 33' ' ' ILE . . . -105.14 125.19 50.71 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.827 175.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -115.87 131.2 57.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 112.9 -1.955 . . . . 0.0 109.623 172.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.22 -160.29 24.97 Favored Glycine 0 N--CA 1.482 1.766 0 CA-C-N 113.359 -1.746 . . . . 0.0 110.783 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -58.88 -61.34 2.7 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -88.71 39.03 0.9 Allowed 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -46.27 -55.0 7.84 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 117.976 2.584 . . . . 0.0 117.976 -175.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.521 ' OE1' ' HE2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -71.88 -45.42 61.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.641 1.176 . . . . 0.0 113.914 -177.338 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.521 ' HE2' ' OE1' ' A' ' 71' ' ' GLN . 41.6 mtmt -66.07 -45.77 80.12 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.745 1.218 . . . . 0.0 112.466 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.465 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -59.86 -44.18 94.28 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.146 0.903 . . . . 0.0 113.406 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.412 HG22 HG22 ' A' ' 63' ' ' ILE . 34.0 t -63.87 -50.81 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 118.612 -0.708 . . . . 0.0 112.343 173.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -50.16 -48.36 53.89 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -57.23 -58.12 9.62 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.037 0.935 . . . . 0.0 111.298 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.432 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 80.1 mt -66.53 -29.21 69.25 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -176.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.424 HG13 HG11 ' A' ' 6' ' ' VAL . 44.2 t -66.86 -51.67 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 123.497 0.498 . . . . 0.0 111.474 170.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -59.73 -41.22 90.39 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.049 0.54 . . . . 0.0 111.877 175.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.432 ' HB3' ' HA ' ' A' ' 77' ' ' LEU . 6.0 tt -60.33 -45.69 92.56 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.199 1.399 . . . . 0.0 112.404 174.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.493 ' SD ' HG13 ' A' ' 8' ' ' ILE . 13.9 tmm? -57.92 -41.75 83.36 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.19 0.596 . . . . 0.0 111.521 174.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.22 96.7 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -78.06 -22.54 48.93 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.0 mt -70.54 122.83 20.44 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.666 -0.646 . . . . 0.0 111.246 165.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--O 1.25 1.114 0 O-C-N 125.195 1.559 . . . . 0.0 111.447 -177.266 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ttt . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -127.64 137.94 52.68 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 125.79 1.931 . . . . 0.0 108.701 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.08 139.9 53.02 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.262 -176.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -148.0 121.82 9.32 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 124.24 0.963 . . . . 0.0 111.314 169.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 24.0 tt0 -92.12 115.27 27.93 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.778 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.526 HG11 HG13 ' A' ' 78' ' ' VAL . 24.1 m -117.32 146.3 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 114.765 -1.107 . . . . 0.0 113.816 -175.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 p -95.93 119.2 33.99 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.56 -1.654 . . . . 0.0 113.628 -174.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.8 mt -82.12 105.71 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.849 170.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.0 p -99.82 -1.74 36.8 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.216 -1.811 . . . . 0.0 114.31 171.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.69 127.43 93.38 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 124.562 1.145 . . . . 0.0 111.95 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -48.91 -44.23 32.81 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 124.381 3.387 . . . . 0.0 117.59 -170.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -105.75 -23.53 12.7 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 173.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.86 -138.16 13.75 Favored Glycine 0 N--CA 1.474 1.225 0 C-N-CA 124.536 1.065 . . . . 0.0 111.147 170.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.451 ' HB2' HD22 ' A' ' 55' ' ' LEU . 6.6 mp -107.29 -11.49 15.56 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.8 p -103.27 -56.22 2.26 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 118.213 -2.804 . . . . 0.0 115.605 175.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -75.95 -47.6 3.73 Favored Pre-proline 0 N--CA 1.487 1.376 0 CA-C-O 115.752 -2.071 . . . . 0.0 115.732 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -59.03 -39.73 77.62 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.171 1.914 . . . . 0.0 112.004 168.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.22 -51.7 65.75 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 171.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.67 -36.27 78.31 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 175.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -68.11 -44.87 75.2 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 173.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -53.96 -40.86 67.2 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.768 1.227 . . . . 0.0 111.404 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.43 HG21 ' HA ' ' A' ' 47' ' ' LEU . 91.2 t -55.16 -60.31 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 124.087 0.867 . . . . 0.0 111.687 172.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -62.24 -31.92 72.53 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -174.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -66.23 -55.26 17.05 Favored 'General case' 0 CA--C 1.55 0.942 0 O-C-N 124.26 0.975 . . . . 0.0 111.151 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.89 -37.87 64.2 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 171.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.517 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . 32.7 tttt -58.59 -29.56 66.52 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 176.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.46 -12.38 58.57 Favored Glycine 0 CA--C 1.54 1.621 0 O-C-N 125.108 1.505 . . . . 0.0 115.377 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -92.0 158.45 16.24 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.169 0.988 . . . . 0.0 111.863 174.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.2 p -68.78 -46.01 69.83 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.266 177.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.6 p -59.28 137.76 57.86 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.625 1.17 . . . . 0.0 113.919 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -92.23 111.58 23.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.607 -1.179 . . . . 0.0 107.83 170.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mt -95.6 133.01 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-N 111.428 -2.624 . . . . 0.0 110.683 -172.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.5 p -109.05 135.35 50.36 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.228 -1.805 . . . . 0.0 112.133 174.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.97 87.51 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 111.855 -2.429 . . . . 0.0 106.396 177.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.2 m -90.69 109.4 20.58 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.552 -1.658 . . . . 0.0 111.39 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.4 t -116.48 87.65 2.73 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 p30 9.74 108.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 128.208 2.603 . . . . 0.0 118.001 -173.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.12 -49.3 2.45 Favored Glycine 0 N--CA 1.481 1.671 0 CA-C-N 112.985 -1.916 . . . . 0.0 111.881 -171.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.484 ' HB3' HD12 ' A' ' 53' ' ' LEU . 92.7 mttt -93.95 99.03 11.44 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.793 0.806 . . . . 0.0 111.384 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.1 t -107.25 95.8 5.97 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.93 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.563 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -83.68 142.8 30.49 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 113.604 -1.635 . . . . 0.0 112.297 -176.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.7 t -83.34 123.54 29.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.589 173.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.29 12.83 3.26 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 124.353 1.033 . . . . 0.0 112.793 172.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.517 ' HE2' ' HA ' ' A' ' 27' ' ' LYS . 86.8 mttt -112.59 -6.81 13.91 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 168.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.9 t -119.42 131.6 55.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.638 1.175 . . . . 0.0 111.269 172.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.43 ' HA ' HG21 ' A' ' 23' ' ' VAL . 2.7 mm? -62.09 -62.58 1.68 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 113.286 -1.779 . . . . 0.0 112.307 -172.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -60.15 -29.73 68.85 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 113.912 -1.494 . . . . 0.0 114.593 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -56.67 -57.37 12.71 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.914 0.886 . . . . 0.0 112.022 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.87 -44.9 84.02 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 173.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -54.21 -37.14 64.25 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 t -81.2 -26.04 36.25 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 116.924 2.194 . . . . 0.0 116.924 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.563 HD13 ' HB2' ' A' ' 42' ' ' ALA . 14.4 tp -41.91 -54.22 3.52 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -167.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.07 88.16 2.04 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -172.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.451 HD22 ' HB2' ' A' ' 14' ' ' LEU . 4.2 mp -116.21 98.36 6.56 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 125.168 1.158 . . . . 0.0 108.327 -177.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.2 t -138.23 176.9 8.29 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 125.503 1.752 . . . . 0.0 111.781 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -59.83 109.56 0.96 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.839 1.256 . . . . 0.0 110.354 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.39 -30.51 6.43 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-N 113.948 -1.478 . . . . 0.0 115.069 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.4 p -73.02 96.83 2.21 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 117.942 0.871 . . . . 0.0 112.697 -172.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.0 t -69.4 130.96 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 114.078 -1.419 . . . . 0.0 109.808 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.2 m -124.35 120.33 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 114.691 -1.141 . . . . 0.0 113.924 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 0.7 OUTLIER -83.6 113.34 20.76 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.738 173.617 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.2 mt -95.54 103.48 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 m -116.48 119.88 37.01 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 112.546 -2.116 . . . . 0.0 110.892 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.48 124.53 51.95 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.355 0.598 . . . . 0.0 112.544 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -117.21 105.96 12.79 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.195 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.79 -160.32 28.56 Favored Glycine 0 N--CA 1.482 1.702 0 CA-C-N 113.037 -1.892 . . . . 0.0 112.972 178.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.54 -49.34 78.16 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.063 1.745 . . . . 0.0 115.243 -174.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -96.21 41.53 1.1 Allowed 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 115.902 1.815 . . . . 0.0 115.902 176.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.521 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 7.4 pt-20 -43.27 -67.72 0.25 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.521 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -63.54 -38.47 91.24 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -179.229 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt -66.36 -47.97 71.71 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.169 1.388 . . . . 0.0 112.246 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.01 -48.47 81.48 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.903 0.881 . . . . 0.0 112.444 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.8 t -61.25 -52.73 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.571 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -49.41 -51.56 34.46 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.073 0.949 . . . . 0.0 113.073 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -58.5 -51.64 69.0 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.89 0.876 . . . . 0.0 112.44 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.7 mt -70.71 -27.97 64.39 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.526 HG13 HG11 ' A' ' 6' ' ' VAL . 53.0 t -61.64 -55.69 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 123.348 0.659 . . . . 0.0 109.77 168.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -52.68 -51.31 60.81 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 124.417 1.073 . . . . 0.0 112.691 175.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.4 tt -53.45 -50.73 64.66 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.344 1.058 . . . . 0.0 112.737 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -59.55 -44.89 93.11 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.88 0.872 . . . . 0.0 112.428 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.74 -37.28 79.31 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -79.65 10.54 3.89 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.2 mt -98.13 134.48 41.14 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.235 0.614 . . . . 0.0 111.552 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 . . . . . 0 C--O 1.255 1.37 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 160.81 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -96.05 105.06 17.05 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.575 1.172 . . . . 0.0 110.187 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -103.06 94.72 5.69 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 111.424 -2.626 . . . . 0.0 108.939 -176.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -112.61 114.43 27.05 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.541 1.163 . . . . 0.0 111.701 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -86.64 107.34 18.14 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 111.836 -2.438 . . . . 0.0 109.842 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 m -116.05 142.56 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 113.919 -1.492 . . . . 0.0 112.699 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.489 HG22 HG22 ' A' ' 60' ' ' VAL . 31.1 p -96.47 114.97 26.68 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.284 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.8 mt -66.89 118.3 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.359 172.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -96.04 -30.42 13.58 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.47 -1.241 . . . . 0.0 114.297 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.44 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -43.75 121.88 3.64 Favored Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 173.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 53.8 Cg_exo -52.67 -55.08 4.1 Favored 'Trans proline' 0 N--CA 1.485 0.999 1 C-N-CA 125.53 4.153 . . . . 0.0 115.147 -166.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -90.76 -37.39 13.7 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.341 0.657 . . . . 0.0 112.193 172.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.18 -142.41 16.06 Favored Glycine 0 N--CA 1.481 1.683 0 O-C-N 124.692 1.245 . . . . 0.0 112.824 168.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.93 -18.76 20.05 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 112.648 -1.776 . . . . 0.0 114.967 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.5 p -106.37 -62.04 1.44 Allowed 'General case' 0 N--CA 1.479 1.012 0 O-C-N 118.283 -2.761 . . . . 0.0 114.138 172.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.282 86.4 mtt-85 -71.88 -40.31 7.91 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 116.866 2.173 . . . . 0.0 116.866 -170.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -65.8 -36.06 33.51 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 121.268 1.312 . . . . 0.0 112.696 167.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -53.87 -38.4 64.68 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 172.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.54 -45.46 77.2 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.47 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 2.7 mp0 -56.51 -45.13 81.22 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 172.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -61.15 -47.21 87.27 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.432 0.693 . . . . 0.0 112.415 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 19' ' ' ALA . 19.5 t -56.2 -53.79 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 123.837 0.711 . . . . 0.0 111.536 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.47 ' HE3' ' HA ' ' A' ' 21' ' ' GLN . 22.4 pttp -62.48 -37.57 86.47 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -61.84 -52.76 62.85 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.003 1.321 . . . . 0.0 111.112 175.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.99 -44.68 82.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.64 1.176 . . . . 0.0 113.7 174.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -64.45 -25.15 67.88 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 176.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.83 -5.93 48.73 Favored Glycine 0 CA--C 1.543 1.795 0 C-N-CA 125.197 1.38 . . . . 0.0 114.017 172.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -99.88 147.98 24.95 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.19 0.996 . . . . 0.0 110.337 169.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.78 -41.03 98.03 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.91 176.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.7 m -53.34 132.36 39.13 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 124.57 1.169 . . . . 0.0 113.78 173.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.57 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 3.8 tt0 -82.75 103.56 12.33 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.697 1.237 . . . . 0.0 110.078 173.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.528 HD11 ' HB1' ' A' ' 73' ' ' ALA . 12.1 mt -89.78 115.16 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 111.346 -2.661 . . . . 0.0 111.055 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.3 p -111.86 139.02 47.69 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 112.785 -2.007 . . . . 0.0 110.275 171.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.434 HG22 HG13 ' A' ' 63' ' ' ILE . 93.8 t -114.65 116.32 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.952 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.9 m -110.69 127.63 55.38 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 113.892 -1.504 . . . . 0.0 111.533 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.0 m -136.23 107.72 6.92 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.661 171.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 p30 25.66 64.08 0.06 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.65 -53.16 0.6 Allowed Glycine 0 CA--C 1.539 1.582 0 CA-C-N 113.634 -1.621 . . . . 0.0 112.85 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -76.93 89.41 3.51 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.895 0.855 . . . . 0.0 112.421 -176.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 t -96.21 102.28 14.04 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.953 172.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.519 ' HB3' HD12 ' A' ' 53' ' ' LEU . . . -118.63 123.39 44.85 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.057 -1.429 . . . . 0.0 113.365 -174.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.2 t -54.79 123.98 15.06 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.179 -1.828 . . . . 0.0 113.688 173.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.37 11.17 8.92 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.067 171.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.57 ' HE3' ' HA ' ' A' ' 32' ' ' GLU . 82.5 mttt -96.9 -17.52 20.08 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.915 162.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.5 t -102.34 117.34 34.53 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 122.037 0.922 . . . . 0.0 111.245 172.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -50.25 -62.73 1.41 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.043 -1.89 . . . . 0.0 113.294 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -64.56 -39.87 94.54 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 113.825 -1.534 . . . . 0.0 114.264 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -57.76 -50.32 73.64 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 175.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 tp -68.05 -42.79 80.01 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -59.26 -21.19 59.22 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.6 t -109.29 22.54 15.69 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 172.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.519 HD12 ' HB3' ' A' ' 42' ' ' ALA . 7.2 tt -74.54 -52.15 12.68 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 120.816 -1.177 . . . . 0.0 110.142 171.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.97 88.9 2.08 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 mt -108.29 81.15 1.44 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.216 -0.992 . . . . 0.0 110.569 -171.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -132.14 172.54 12.26 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.021 -174.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -46.29 116.5 1.28 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.949 1.7 . . . . 0.0 112.133 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.72 -27.87 17.82 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 113.751 -1.568 . . . . 0.0 115.09 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.3 p -61.85 115.4 3.99 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.721 0.772 . . . . 0.0 112.582 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.489 HG22 HG22 ' A' ' 7' ' ' THR . 15.1 t -84.2 102.93 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 111.9 -2.409 . . . . 0.0 106.884 -176.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.3 m -109.76 117.3 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 113.975 -1.466 . . . . 0.0 113.78 -170.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.56 99.78 12.44 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.437 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.516 HG22 HG22 ' A' ' 74' ' ' VAL . 2.9 mp -78.51 98.19 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 172.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.1 m -103.35 101.85 11.77 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 112.356 -2.202 . . . . 0.0 110.412 -177.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.35 104.42 15.41 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.657 -1.61 . . . . 0.0 113.639 -173.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -91.31 96.22 10.43 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.297 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.09 -173.19 44.69 Favored Glycine 0 N--CA 1.475 1.295 0 CA-C-N 114.122 -1.399 . . . . 0.0 112.676 173.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -67.87 -46.09 72.69 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.63 1.172 . . . . 0.0 112.749 175.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -79.09 33.64 0.23 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.715 1.606 . . . . 0.0 113.715 176.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.635 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 3.6 pt-20 -54.14 -69.29 0.13 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.536 1.935 . . . . 0.0 114.616 -176.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.635 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -55.42 -35.28 65.23 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 174.498 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -66.04 -47.68 73.6 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.152 0.981 . . . . 0.0 112.1 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.528 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -53.81 -49.65 67.88 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.394 1.059 . . . . 0.0 112.155 173.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.516 HG22 HG22 ' A' ' 63' ' ' ILE . 94.6 t -61.86 -50.18 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.191 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.19 -58.31 3.76 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.992 1.317 . . . . 0.0 112.662 178.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -58.31 -51.15 71.01 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.346 1.029 . . . . 0.0 112.283 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.85 -38.69 89.17 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.4 -53.08 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.21 0.604 . . . . 0.0 109.81 174.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -53.89 -52.24 61.14 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.638 1.211 . . . . 0.0 112.614 178.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.9 tp -49.31 -58.12 5.64 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.103 1.761 . . . . 0.0 113.073 174.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.9 tmm? -61.39 -35.44 77.51 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.222 1.409 . . . . 0.0 113.633 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.87 -37.83 18.73 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -77.16 38.74 0.22 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.7 mt -124.0 161.36 25.65 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.095 1.758 . . . . 0.0 110.185 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 C--O 1.25 1.1 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.44 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -126.44 130.42 50.65 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 126.019 2.075 . . . . 0.0 109.238 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -123.97 135.43 53.64 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 113.714 -1.584 . . . . 0.0 112.149 177.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -123.91 116.85 23.58 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.417 164.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -89.74 97.97 11.5 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.24 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.8 m -113.18 157.9 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 112.244 -2.253 . . . . 0.0 112.517 -174.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.417 HG22 HG22 ' A' ' 60' ' ' VAL . 22.6 p -105.15 139.37 39.91 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.896 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.407 HG12 ' SD ' ' A' ' 81' ' ' MET . 36.5 mt -107.95 105.75 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 169.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.3 p -126.03 46.98 2.32 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 114.416 -1.265 . . . . 0.0 114.294 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -116.97 139.49 25.84 Favored Pre-proline 0 N--CA 1.475 0.787 0 CA-C-O 116.962 -1.494 . . . . 0.0 108.854 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -32.04 -56.89 0.27 Allowed 'Trans proline' 0 N--CA 1.483 0.909 1 C-N-CA 125.747 4.298 . . . . 0.0 116.86 -168.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -113.43 -38.87 4.24 Favored 'General case' 0 CA--C 1.551 0.992 0 O-C-N 124.131 0.894 . . . . 0.0 112.407 168.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.05 -89.35 1.44 Allowed Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.908 0.766 . . . . 0.0 113.561 163.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 mp -115.39 -46.07 2.89 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -171.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.2 p -106.08 -44.54 4.56 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 117.932 -2.98 . . . . 0.0 113.815 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.342 60.4 mtt-85 -92.05 -39.15 0.37 Allowed Pre-proline 0 N--CA 1.479 1.024 0 N-CA-C 119.044 2.979 . . . . 0.0 119.044 -170.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -61.98 -39.2 52.27 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 CA-C-N 121.283 1.494 . . . . 0.0 111.353 161.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -51.88 -34.79 42.72 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 171.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.1 -42.83 63.57 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 177.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -52.15 -52.96 48.59 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.689 1.195 . . . . 0.0 113.203 173.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -55.31 -52.57 63.03 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.579 1.552 . . . . 0.0 111.183 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.701 HG22 HD23 ' A' ' 50' ' ' LEU . 1.9 t -70.29 -38.96 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -174.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.65 -32.14 73.54 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 176.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -71.36 -49.45 42.08 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.047 0.939 . . . . 0.0 110.137 173.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.424 ' HA ' ' HD2' ' A' ' 29' ' ' PHE . . . -55.44 -46.01 76.76 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 176.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -60.77 -23.93 65.37 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 173.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.52 -25.45 67.84 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.317 0.96 . . . . 0.0 113.664 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.424 ' HD2' ' HA ' ' A' ' 26' ' ' ALA . 63.9 m-85 -73.56 139.36 45.55 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.217 1.008 . . . . 0.0 112.56 177.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -58.91 -37.6 77.02 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 113.19 -1.823 . . . . 0.0 113.025 174.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.3 m -63.08 141.93 58.58 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 171.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.89 113.8 22.99 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.842 0.83 . . . . 0.0 108.94 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.1 mt -106.99 101.57 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.615 -1.63 . . . . 0.0 109.989 -172.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.0 p -86.32 135.2 33.62 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.878 171.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.586 ' HB ' HD11 ' A' ' 50' ' ' LEU . 97.3 t -118.97 100.73 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 178.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.9 m -100.43 124.1 45.5 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 113.894 -1.503 . . . . 0.0 111.729 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.437 ' HB2' HG12 ' A' ' 61' ' ' VAL . 4.1 t -144.41 137.54 27.11 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.58 176.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.277 0.2 OUTLIER 43.57 51.77 6.25 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.859 1.664 . . . . 0.0 113.968 -173.027 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.15 -29.39 1.14 Allowed Glycine 0 CA--C 1.547 2.088 0 CA-C-N 114.103 -1.408 . . . . 0.0 114.885 -175.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -70.49 106.49 3.46 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.031 0.932 . . . . 0.0 112.448 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.7 t -89.65 128.82 36.13 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.696 -1.593 . . . . 0.0 111.942 169.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.81 119.81 14.45 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 113.389 -1.732 . . . . 0.0 110.24 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -64.91 124.93 23.3 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 113.117 -1.856 . . . . 0.0 112.376 171.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.54 -3.28 11.09 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 112.949 -1.932 . . . . 0.0 114.627 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -65.33 -11.64 43.86 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 122.086 0.946 . . . . 0.0 113.502 160.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.4 t -124.84 105.45 9.27 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.161 -0.962 . . . . 0.0 112.972 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.435 HD13 ' HB ' ' A' ' 23' ' ' VAL . 3.5 mm? -40.53 -51.43 2.92 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.175 -1.83 . . . . 0.0 112.524 164.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -55.57 -50.74 69.24 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 113.254 -1.794 . . . . 0.0 113.452 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -66.05 -47.87 72.92 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.701 HD23 HG22 ' A' ' 23' ' ' VAL . 7.6 tp -72.97 -30.18 63.64 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -176.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -65.66 -18.69 65.51 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 t -112.21 61.12 0.63 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 124.029 1.871 . . . . 0.0 112.748 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.4 tp -122.12 -65.95 1.07 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 112.895 -1.957 . . . . 0.0 112.296 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.62 90.96 0.83 Allowed Glycine 0 N--CA 1.478 1.438 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -172.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 mt -121.68 87.06 2.68 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.513 -0.843 . . . . 0.0 109.4 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -153.19 -175.62 5.42 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.714 -168.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -60.2 108.89 0.86 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.119 0.968 . . . . 0.0 112.128 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.08 -12.56 24.28 Favored Glycine 0 N--CA 1.477 1.388 0 CA-C-N 112.477 -2.147 . . . . 0.0 114.591 177.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.0 p -77.83 116.5 18.39 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 117.772 0.786 . . . . 0.0 112.814 -175.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.417 HG22 HG22 ' A' ' 7' ' ' THR . 22.1 t -92.26 119.97 40.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 113.1 -1.864 . . . . 0.0 107.192 177.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' A' ' 37' ' ' SER . 14.8 m -123.42 115.05 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 113.878 -1.51 . . . . 0.0 113.385 -172.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.4 90.57 6.19 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.823 174.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.8 mt -72.97 101.2 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -120.05 101.33 7.77 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.816 -164.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.21 121.01 42.38 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -176.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -104.71 112.22 25.23 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 112.947 -1.933 . . . . 0.0 109.412 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 160.79 -161.22 32.61 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.084 175.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -78.85 -44.76 22.22 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.98 0.895 . . . . 0.0 112.532 176.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -76.89 22.41 0.19 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.865 1.666 . . . . 0.0 114.369 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.446 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 6.9 pt-20 -44.98 -54.67 6.29 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.581 1.952 . . . . 0.0 114.976 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.446 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -68.03 -47.74 67.6 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -62.52 -49.01 77.02 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.704 -1.134 . . . . 0.0 113.191 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.06 -49.17 74.54 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.207 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.02 -51.4 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 117.946 -1.026 . . . . 0.0 111.973 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -52.67 -48.66 66.34 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 124.219 0.949 . . . . 0.0 112.047 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -60.72 -48.53 81.37 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.363 1.065 . . . . 0.0 112.957 177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.08 -37.03 84.78 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.7 t -59.04 -50.09 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 123.938 0.774 . . . . 0.0 109.851 172.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -53.66 -55.72 23.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 124.036 0.835 . . . . 0.0 113.096 175.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.2 tt -51.31 -52.12 48.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.524 1.13 . . . . 0.0 112.462 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.407 ' SD ' HG12 ' A' ' 8' ' ' ILE . 16.9 tmm? -59.86 -49.09 79.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.102 0.961 . . . . 0.0 112.859 178.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.05 -26.49 67.53 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -83.35 -2.04 54.79 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 87.1 mt -84.05 116.33 22.8 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 C--O 1.252 1.196 0 C-N-CA 126.012 1.725 . . . . 0.0 110.369 -176.084 . . . . . . . . 0 0 . 1 stop_ save_